data_2yh1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2yh1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.554 0.216 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -157.11 148.58 22.18 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 122.962 0.505 . . . . 6.3499999999999996 111.293 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.583 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.6 mt -140.8 143.55 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 5.5099999999999998 111.188 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.57 125.15 40.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.859 -0.793 . . . . 6.8200000000000003 108.859 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.78 101.22 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.097 0.475 . . . . 5.0899999999999999 110.24 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.78 -178.22 35.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.002 -0.618 . . . . 6.2000000000000002 112.763 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.87 40.76 21.43 Favored 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 125.065 1.346 . . . . 0.0 110.201 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.77 149.78 88.21 Favored Pre-proline 1 C--N 1.428 4.015 0 C-N-CA 123.448 0.699 . . . . 7.79 111.327 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.98 144.43 89.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.288 1.992 . . . . 8.9900000000000002 110.978 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.65 52.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.022 0.439 . . . . 11.75 111.934 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.56 61.18 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.818 -0.628 . . . . 10.470000000000001 114.313 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.07 136.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.307 0.553 . . . . 8.9100000000000001 110.306 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.534 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 36.1 p -84.84 153.92 22.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.697 0.284 . . . . 9.9100000000000001 110.645 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.13 -43.24 95.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 7.7599999999999998 110.192 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.7 -45.93 91.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.001 -0.545 . . . . 9.8900000000000006 110.562 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.3 -2.125 . . . . 0.0 111.724 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.417 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.11 67.84 Favored 'General case' 1 C--N 1.428 4.006 0 O-C-N 123.877 0.736 . . . . 6.7800000000000002 111.733 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.433 ' HE2' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.56 -54.35 7.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.449 0.699 . . . . 6.9699999999999998 111.074 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -54.48 -33.7 60.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.366 -0.834 . . . . 8.8000000000000007 111.41 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.79 -53.62 17.42 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.472 -0.491 . . . . 7.8700000000000001 111.58 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.417 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.1 m-85 -61.27 -48.29 82.09 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.139 0.422 . . . . 5.9400000000000004 112.139 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.97 80.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.265 -0.574 . . . . 7.1200000000000001 109.586 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.7 -23.58 65.3 Favored 'General case' 0 C--N 1.407 3.097 0 O-C-N 120.254 -1.529 . . . . 0.0 111.298 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.48 -37.62 36.4 Favored 'General case' 0 C--N 1.427 3.972 0 O-C-N 123.611 0.569 . . . . 7.9299999999999997 110.328 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.46 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.79 -36.79 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.595 -0.73 . . . . 7.7300000000000004 111.014 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -75.93 -43.12 46.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.429 0.529 . . . . 9.9600000000000009 112.429 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.03 -37.71 88.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.189 0.519 . . . . 10.42 110.447 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.15 -16.42 74.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.297 -0.954 . . . . 9.2300000000000004 112.814 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.02 72.03 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 110.878 -0.889 . . . . 9.6099999999999994 110.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.89 5.31 51.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.975 0.732 . . . . 8.4600000000000009 112.975 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.63 143.45 30.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.616 0.246 . . . . 9.1600000000000001 110.577 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.148 0.425 . . . . 10.23 112.148 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.4 24.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.646 -0.252 . . . . 10.24 110.714 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.29 143.51 99.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.946 1.764 . . . . 11.43 110.822 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.35 161.6 20.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.663 -0.779 . . . . 9.4499999999999993 112.43 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 112.117 0.414 . . . . 8.3300000000000001 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.519 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.21 -51.04 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.544 2.163 . . . . 6.9699999999999998 111.283 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.433 ' O ' ' HE2' ' A' ' 166' ' ' MET . 22.0 t -69.64 106.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.126 -0.488 . . . . 5.8700000000000001 111.075 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 -37.15 30.41 Favored 'General case' 0 N--CA 1.536 3.837 0 O-C-N 119.885 -1.76 . . . . 0.0 112.963 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.36 164.38 36.83 Favored 'General case' 0 C--N 1.382 1.983 0 C-N-CA 125.78 1.632 . . . . 0.0 110.736 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 130.45 10.53 Favored 'Isoleucine or valine' 0 C--N 1.37 1.499 0 C-N-CA 126.584 1.954 . . . . 5.6699999999999999 109.331 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -114.06 126.61 55.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.789 -0.449 . . . . 6.6799999999999997 109.789 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.2 mt -114.92 125.95 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 116.912 2.189 . . . . 7.0999999999999996 116.912 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.06 91.42 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 103.153 -2.906 . . . . 8.1600000000000001 103.153 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -57.37 7.99 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 115.73 1.752 . . . . 10.279999999999999 115.73 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.21 -48.78 75.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.812 0.671 . . . . 10.51 112.812 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.0 -9.06 50.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.832 0.308 . . . . 9.9399999999999995 111.832 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.21 15.49 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.528 1.307 . . . . 8.4499999999999993 114.528 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.59 168.68 19.29 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 119.074 -1.05 . . . . 7.25 111.601 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.542 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.04 41.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.143 -1.389 . . . . 5.1900000000000004 110.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.3 129.5 51.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.657 -0.868 . . . . 6.0899999999999999 108.657 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.94 137.56 33.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 4.2699999999999996 110.272 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.77 114.65 25.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.744 -0.465 . . . . 6.21 109.744 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -99.6 164.7 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.597 0.561 . . . . 6.1399999999999997 112.073 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.59 -25.98 22.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.473 -0.785 . . . . 8.6899999999999995 111.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 87.9 p -128.89 159.59 35.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.173 0.511 . . . . 8.3300000000000001 111.568 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.33 -41.71 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 8.9600000000000009 112.232 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.72 -41.79 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.325 0.491 . . . . 9.2599999999999998 112.325 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.4 mt-10 -61.84 -43.82 98.09 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.298 -0.26 . . . . 7.6200000000000001 110.298 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.583 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.2 m -54.19 -53.97 46.24 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.149 -1.056 . . . . 6.4199999999999999 108.149 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.5 m -55.18 -27.11 43.43 Favored 'General case' 0 C--N 1.428 3.98 0 C-N-CA 126.956 2.102 . . . . 0.0 109.86 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -34.03 43.12 Favored 'General case' 0 C--N 1.422 3.73 0 N-CA-C 113.606 0.965 . . . . 8.75 113.606 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.659 0.614 . . . . 5.9400000000000004 112.659 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.86 63.38 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.394 1.059 . . . . 7.1500000000000004 111.587 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.38 -9.37 53.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 7.7000000000000002 111.651 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.2 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.516 -0.311 . . . . 7.4699999999999998 111.619 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.84 120.92 13.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 7.3799999999999999 110.78 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.91 65.94 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.918 -0.658 . . . . 7.9199999999999999 113.559 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.07 142.36 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.854 0.327 . . . . 7.71 111.101 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.93 121.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.333 0.587 . . . . 10.0 111.266 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.28 107.73 7.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 8.4499999999999993 110.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.67 13.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 10.44 111.73 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.06 -5.47 54.01 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.169 0.828 . . . . 10.609999999999999 115.169 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.62 130.94 55.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.665 0.733 . . . . 10.279999999999999 112.381 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.79 101.55 11.0 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.449 -0.945 . . . . 8.8300000000000001 108.449 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.981 1.104 . . . . 6.9699999999999998 113.981 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.406 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.9 tttt -108.53 110.21 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.567 -1.272 . . . . 8.5099999999999998 107.567 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.91 126.91 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.349 0.5 . . . . 6.1699999999999999 112.349 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.406 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.57 170.53 15.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.413 -0.812 . . . . 8.3000000000000007 110.051 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.12 154.7 49.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.535 -0.913 . . . . 8.1400000000000006 108.535 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.38 175.04 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.942 1.761 . . . . 7.79 112.079 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.797 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.004 0.43 . . . . 11.33 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.92 139.41 58.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 8.5 110.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 334' ' ' ARG . 65.5 mt -109.88 143.94 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.114 -0.948 . . . . 6.5800000000000001 112.769 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -104.38 132.08 51.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.176 -1.416 . . . . 7.1399999999999997 107.176 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.421 HD12 ' HG ' ' A' ' 305' ' ' CYS . 4.1 mp -127.0 121.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.573 -0.529 . . . . 5.6799999999999997 109.573 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.456 -0.878 . . . . 6.5700000000000003 112.679 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.2 86.6 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 8.0399999999999991 111.506 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.6 mt -70.89 135.21 85.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.492 0.182 . . . . 8.1600000000000001 111.492 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 26.2 Cg_exo -61.82 141.56 90.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.93 1.753 . . . . 9.4399999999999995 108.76 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -65.36 -14.88 61.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.797 1.406 . . . . 11.74 114.797 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.16 -23.1 30.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.807 1.41 . . . . 11.65 114.807 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.35 149.12 50.86 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.169 0.44 . . . . 9.3599999999999994 111.306 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.403 ' O ' HG21 ' A' ' 275' ' ' VAL . 17.6 p-10 -114.53 -176.48 2.91 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.269 -0.271 . . . . 10.609999999999999 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 9.9 m-20 -53.46 -55.41 25.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 114.699 1.37 . . . . 10.07 114.699 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.66 -26.05 67.77 Favored 'General case' 0 C--N 1.406 3.023 0 C-N-CA 125.633 1.573 . . . . 0.0 112.559 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -80.28 -48.3 13.25 Favored 'General case' 1 C--N 1.429 4.064 0 CA-C-N 118.27 0.487 . . . . 10.289999999999999 111.414 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 271' ' ' ASN . 75.1 t -62.63 -49.16 84.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.784 -0.644 . . . . 8.0 110.329 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.6 mtmm -54.37 -36.44 63.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.647 -0.706 . . . . 10.199999999999999 111.312 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.97 -53.37 56.63 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.137 0.494 . . . . 10.199999999999999 110.701 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.406 HD12 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -51.74 -33.19 33.72 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.124 -0.489 . . . . 7.6200000000000001 110.328 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.476 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -82.64 -41.55 19.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.651 0.611 . . . . 7.7400000000000002 112.651 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.8 m -56.85 -29.57 63.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.566 0.95 . . . . 10.390000000000001 113.566 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 m -50.61 -9.99 0.06 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 124.873 1.269 . . . . 0.0 112.511 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.76 -11.96 13.9 Favored 'General case' 1 C--N 1.443 4.637 0 CA-C-N 118.398 0.544 . . . . 10.23 111.483 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 10.98 111.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.66 147.03 93.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.681 2.254 . . . . 12.75 112.744 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.4 mt -102.4 146.29 28.29 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.913 -0.585 . . . . 10.66 111.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.473 ' HD2' ' OE2' ' A' ' 306' ' ' GLU . 18.7 ptpt -101.02 -22.67 14.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.222 -0.658 . . . . 11.630000000000001 109.222 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.59 4.67 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.061 -2.274 . . . . 0.0 109.229 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.4 t80 -142.79 134.78 27.08 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 122.81 0.444 . . . . 9.0099999999999998 111.968 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.82 124.09 12.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.794 0.33 . . . . 8.7300000000000004 111.467 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 56.8 tp -101.03 118.13 36.4 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.634 -1.247 . . . . 8.9399999999999995 107.634 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.2 122.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.445 0.906 . . . . 9.7400000000000002 113.445 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.09 148.1 43.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.263 -0.88 . . . . 11.34 109.359 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.625 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.7 t70 -58.89 141.14 54.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.919 0.39 . . . . 13.83 111.039 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 38.0 m -49.59 -61.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.649 0.611 . . . . 14.779999999999999 112.649 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.16 -63.96 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.497 0.555 . . . . 16.440000000000001 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 14.9 m -42.46 -59.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.302 -0.408 . . . . 15.24 111.221 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.58 -6.04 62.7 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.65 -0.786 . . . . 13.609999999999999 114.531 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.32 167.56 13.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.411 0.606 . . . . 13.529999999999999 110.926 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.5 t -59.13 142.08 52.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 10.51 111.588 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.449 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 5.4 mmmp? -87.99 -9.47 53.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.771 -0.65 . . . . 11.73 109.566 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.55 -3.29 39.6 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.624 -0.716 . . . . 8.6300000000000008 113.908 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -143.02 146.4 33.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.04 0.92 . . . . 9.3900000000000006 112.837 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.63 155.14 46.62 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.131 -0.941 . . . . 6.5499999999999998 112.258 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.34 146.86 36.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.172 -0.922 . . . . 7.4299999999999997 110.405 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.568 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.3 p -157.91 156.18 30.87 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 119.903 -0.719 . . . . 6.7699999999999996 111.84 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 31.3 tt0 -145.26 127.16 15.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.585 -0.734 . . . . 9.5899999999999999 109.629 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 57.8 m-85 -82.5 164.89 20.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.042 0.386 . . . . 9.9100000000000001 112.042 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . 0.463 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 64.0 t -71.59 -46.08 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.357 -0.979 . . . . 13.09 108.357 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.735 ' O ' HG23 ' A' ' 312' ' ' VAL . 15.3 t70 -96.35 102.35 14.13 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.442 -1.318 . . . . 13.18 107.442 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.521 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 115.27 1.582 . . . . 12.48 115.27 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -56.87 -38.69 73.08 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 122.246 1.022 . . . . 13.4 109.026 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.84 -22.57 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.296 -2.229 . . . . 11.43 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.61 -48.26 72.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.933 -0.766 . . . . 9.5 108.933 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.36 -42.82 99.71 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.252 -0.579 . . . . 10.31 110.554 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.82 -32.41 73.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.857 -0.737 . . . . 12.41 111.949 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.54 -34.78 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.671 -1.604 . . . . 8.3900000000000006 113.025 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 73.0 mt -68.57 -51.25 48.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 7.71 110.883 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.78 67.86 Favored 'General case' 0 C--N 1.419 3.611 0 C-N-CA 126.266 1.826 . . . . 0.0 113.178 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -24.02 36.35 Favored Glycine 1 C--N 1.398 4.01 0 N-CA-C 116.846 1.499 . . . . 8.7599999999999998 116.846 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.406 HD23 HD12 ' A' ' 278' ' ' LEU . 87.9 mt -96.9 -45.77 6.49 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 120.093 1.947 . . . . 7.2000000000000002 113.971 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -50.53 130.06 23.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 8.1099999999999994 111.492 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.66 56.72 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.103 -0.57 . . . . 8.6400000000000006 113.987 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.3 ttt -50.58 147.15 4.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.797 0.298 . . . . 8.25 111.336 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -95.05 115.73 27.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 10.48 111.703 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.4 mm? -120.24 106.71 12.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.108 -1.071 . . . . 8.9499999999999993 108.108 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.06 -118.64 10.56 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.388 -1.485 . . . . 10.630000000000001 109.388 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.87 22.35 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 12.25 109.781 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -123.82 153.9 40.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.59 -0.732 . . . . 10.34 111.683 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.73 118.29 36.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.133 -1.062 . . . . 10.59 108.133 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.654 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.9 tp -62.99 143.1 58.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.413 0.625 . . . . 7.6500000000000004 112.663 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 94.8 mt -128.12 128.06 44.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.535 -1.211 . . . . 7.7599999999999998 108.917 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.5 t -137.98 123.93 25.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.927 -1.108 . . . . 6.4500000000000002 109.997 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -152.65 155.41 37.26 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.947 -1.72 . . . . 7.8799999999999999 109.5 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.495 ' HA ' HD21 ' A' ' 261' ' ' LEU . 98.8 mtt180 -58.69 122.49 13.63 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.459 -1.297 . . . . 9.1999999999999993 107.586 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.91 -11.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.757 1.391 . . . . 7.5199999999999996 114.757 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.3 m -119.41 -77.84 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.547 -0.461 . . . . 9.3599999999999994 111.362 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.662 ' HB3' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -161.81 149.24 14.45 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 122.97 0.508 . . . . 6.3499999999999996 111.526 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.498 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.4 mt -140.73 143.56 35.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 5.5099999999999998 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -96.54 125.14 40.8 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 6.8200000000000003 108.879 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.69 101.22 8.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.069 0.461 . . . . 5.0899999999999999 110.242 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.76 -179.2 34.86 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.033 -0.53 . . . . 6.2000000000000002 112.728 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.1 41.35 23.48 Favored 'General case' 0 CA--C 1.575 1.939 0 C-N-CA 125.175 1.39 . . . . 0.0 110.326 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.69 149.85 88.43 Favored Pre-proline 1 C--N 1.429 4.023 0 C-N-CA 123.726 0.81 . . . . 7.79 111.32 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.08 144.45 89.98 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.247 1.964 . . . . 8.9900000000000002 110.968 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.92 139.78 52.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 11.75 111.938 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.48 61.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.745 -0.661 . . . . 10.470000000000001 114.282 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 191' ' ' ILE . 11.0 tp -66.05 136.5 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.316 0.558 . . . . 8.9100000000000001 110.359 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.596 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 35.8 p -84.85 153.88 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.693 0.282 . . . . 9.9100000000000001 110.653 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.22 -43.07 96.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 7.7599999999999998 110.176 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -61.82 -45.99 91.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.971 -0.559 . . . . 9.8900000000000006 110.547 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.596 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.412 3.312 0 O-C-N 119.076 -2.265 . . . . 0.0 111.701 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.402 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.19 67.91 Favored 'General case' 1 C--N 1.429 4.059 0 O-C-N 123.934 0.771 . . . . 6.7800000000000002 111.731 171.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.451 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.5 -54.32 7.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.353 0.661 . . . . 6.9699999999999998 111.119 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.48 -33.75 60.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.388 -0.824 . . . . 8.8000000000000007 111.428 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.72 -53.7 17.25 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 120.612 -0.435 . . . . 7.8700000000000001 111.552 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.402 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.3 -48.21 82.4 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.18 0.437 . . . . 5.9400000000000004 112.18 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.41 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.77 -42.85 80.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.164 -0.614 . . . . 7.1200000000000001 109.594 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.98 -23.46 65.04 Favored 'General case' 0 C--N 1.406 3.042 0 O-C-N 120.279 -1.513 . . . . 0.0 111.31 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.3 -37.76 36.97 Favored 'General case' 1 C--N 1.428 4.014 0 CA-C-N 118.499 0.59 . . . . 7.9299999999999997 110.354 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.441 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.66 -36.82 83.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.589 -0.732 . . . . 7.7300000000000004 111.085 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -76.0 -43.13 45.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.349 0.5 . . . . 9.9600000000000009 112.349 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.5 mt -62.99 -37.74 88.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.272 0.558 . . . . 10.42 110.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.03 -16.45 74.7 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.224 -0.988 . . . . 9.2300000000000004 112.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.14 72.02 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.801 -0.92 . . . . 9.6099999999999994 110.801 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.96 5.33 51.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.865 0.691 . . . . 8.4600000000000009 112.865 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.516 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.6 p -82.62 143.46 30.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 9.1600000000000001 110.575 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.44 23.88 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.689 -0.232 . . . . 10.24 110.706 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.3 143.48 99.72 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.017 1.812 . . . . 11.43 110.834 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.33 161.55 20.56 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.534 -0.841 . . . . 9.4499999999999993 112.431 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.2 m-20 -75.26 134.52 73.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.02 0.378 . . . . 8.3300000000000001 112.02 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.516 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.28 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.553 2.169 . . . . 6.9699999999999998 111.327 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.451 ' O ' ' HE1' ' A' ' 166' ' ' MET . 22.0 t -69.63 105.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.118 -0.492 . . . . 5.8700000000000001 111.11 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 70.47 0.71 Allowed 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 124.752 1.221 . . . . 0.0 109.441 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.73 151.32 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 129.383 3.073 . . . . 0.0 112.78 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.52 130.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 129.47 3.108 . . . . 5.6699999999999999 109.273 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.743 -0.465 . . . . 6.6799999999999997 109.743 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 125.97 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 116.958 2.207 . . . . 7.0999999999999996 116.958 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.03 91.38 5.28 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 103.165 -2.902 . . . . 8.1600000000000001 103.165 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -57.39 8.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.606 1.706 . . . . 10.279999999999999 115.606 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.28 -48.67 76.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.845 0.683 . . . . 10.51 112.845 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.01 -9.12 50.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.726 0.298 . . . . 9.9399999999999995 111.803 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.1 36.07 15.44 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.556 1.317 . . . . 8.4499999999999993 114.556 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.42 168.7 19.2 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.134 -1.027 . . . . 7.25 111.703 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.69 161.09 41.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.235 -1.348 . . . . 5.1900000000000004 110.482 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.36 129.37 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.641 -0.874 . . . . 6.0899999999999999 108.641 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.92 137.58 33.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 4.2699999999999996 110.312 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.72 114.77 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.721 -0.474 . . . . 6.21 109.721 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.665 0.603 . . . . 6.1399999999999997 111.919 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.94 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 8.6899999999999995 111.411 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.452 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 89.3 p -128.94 159.57 35.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 8.3300000000000001 111.648 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.24 -41.78 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.751 . . . . 8.9600000000000009 112.232 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.71 -41.78 95.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.354 0.502 . . . . 9.2599999999999998 112.354 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.3 mt-10 -61.91 -43.86 97.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.248 -0.279 . . . . 7.6200000000000001 110.248 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.662 HG23 ' HB3' ' A' ' 149' ' ' ARG . 55.0 m -54.18 -53.87 47.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.261 1.029 . . . . 6.4199999999999999 108.261 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.1 m -55.06 -27.22 43.14 Favored 'General case' 0 C--N 1.424 3.845 0 C-N-CA 127.118 2.167 . . . . 0.0 109.888 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.35 -34.01 42.47 Favored 'General case' 0 C--N 1.421 3.682 0 N-CA-C 113.585 0.957 . . . . 8.75 113.585 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.58 -17.39 64.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.653 0.612 . . . . 5.9400000000000004 112.653 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.82 63.34 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.473 1.108 . . . . 7.1500000000000004 111.633 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.51 -9.21 52.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.355 . . . . 7.7000000000000002 111.611 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.83 16.16 14.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.564 -0.289 . . . . 7.4699999999999998 111.627 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.87 120.92 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.826 0.346 . . . . 7.3799999999999999 110.777 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.84 65.98 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.938 -0.648 . . . . 7.9199999999999999 113.577 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.06 142.38 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.936 0.368 . . . . 7.71 111.084 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.97 121.54 37.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.34 0.591 . . . . 10.0 111.262 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.29 107.76 7.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 8.4499999999999993 110.378 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.69 42.71 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 10.44 111.771 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.99 -5.35 54.21 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 115.195 0.838 . . . . 10.609999999999999 115.195 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.61 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.669 0.735 . . . . 10.279999999999999 112.469 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.44 10.83 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.56 -0.904 . . . . 8.8300000000000001 108.56 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.31 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.994 1.109 . . . . 6.9699999999999998 113.994 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.55 110.24 21.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.555 -1.276 . . . . 8.5099999999999998 107.555 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.93 126.89 58.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 6.1699999999999999 112.32 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.62 170.54 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 8.3000000000000007 110.03 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.14 154.76 49.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.537 -0.912 . . . . 8.1400000000000006 108.537 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.44 175.17 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.921 1.748 . . . . 7.79 112.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 66.9 m80 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.911 0.386 . . . . 11.33 110.782 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.767 ' HD3' ' HB2' ' A' ' 306' ' ' GLU . 7.0 tppt? -62.87 139.34 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 8.5 110.349 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 313' ' ' THR . 78.9 mt -109.75 143.99 38.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.006 -0.997 . . . . 6.5800000000000001 112.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -104.48 132.24 50.95 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.141 -1.429 . . . . 7.1399999999999997 107.141 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.99 121.15 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.603 -0.517 . . . . 5.6799999999999997 109.603 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.14 179.25 16.47 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 6.5700000000000003 112.72 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.53 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.555 -0.831 . . . . 8.0399999999999991 111.596 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 99.1 mt -70.86 135.3 85.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.192 . . . . 8.1600000000000001 111.496 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.3 Cg_exo -61.79 141.53 90.56 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.879 1.719 . . . . 9.4399999999999995 108.843 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -65.42 -14.86 61.84 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.752 1.39 . . . . 11.74 114.752 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -84.17 -23.14 30.71 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.781 1.401 . . . . 11.65 114.781 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.31 149.22 50.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.115 0.416 . . . . 9.3599999999999994 111.332 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.229 -0.286 . . . . 10.609999999999999 110.229 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 18.7 m-20 -53.55 -55.27 27.02 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 114.659 1.355 . . . . 10.07 114.659 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.67 -26.42 68.01 Favored 'General case' 0 C--N 1.405 3.009 0 C-N-CA 125.707 1.603 . . . . 0.0 112.461 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -80.02 -48.26 13.61 Favored 'General case' 1 C--N 1.431 4.119 0 CA-C-N 118.263 0.483 . . . . 10.289999999999999 111.455 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.74 -49.21 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.8 -0.636 . . . . 8.0 110.273 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 45.1 mtmt -54.25 -36.4 63.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 10.199999999999999 111.336 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.06 -53.26 57.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.092 0.472 . . . . 10.199999999999999 110.772 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.72 -33.21 33.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.964 -0.562 . . . . 7.6200000000000001 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.46 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.64 -41.66 19.17 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.549 0.574 . . . . 7.7400000000000002 112.549 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 32.3 m -56.92 -29.82 63.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.586 0.958 . . . . 10.390000000000001 113.586 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.1 m -49.9 -10.33 0.05 OUTLIER 'General case' 0 C--N 1.394 2.507 0 C-N-CA 124.846 1.258 . . . . 0.0 112.776 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -111.59 -11.99 13.98 Favored 'General case' 1 C--N 1.443 4.669 0 CA-C-N 118.341 0.519 . . . . 10.23 111.467 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.3 10.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.9 -0.667 . . . . 10.98 111.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 147.12 93.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.716 2.277 . . . . 12.75 112.689 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 81.6 mt -102.49 146.29 28.32 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.932 -0.576 . . . . 10.66 111.217 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -101.07 -22.58 14.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.271 -0.64 . . . . 11.630000000000001 109.271 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.58 126.13 5.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.174 -2.204 . . . . 0.0 109.172 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.528 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 50.1 t80 -143.41 134.68 25.92 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.792 0.437 . . . . 9.0099999999999998 112.028 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.12 13.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.797 0.332 . . . . 8.7300000000000004 111.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 60.7 tp -101.08 118.24 36.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.568 -1.271 . . . . 8.9399999999999995 107.568 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.6 t -74.14 122.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.44 0.904 . . . . 9.7400000000000002 113.44 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -119.18 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.353 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.6 t70 -58.9 141.19 54.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 13.83 110.98 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.4 m -49.75 -61.56 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.736 0.643 . . . . 14.779999999999999 112.736 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.21 -64.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.465 0.543 . . . . 16.440000000000001 112.465 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 9.0 m -42.59 -59.22 1.98 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.306 -0.406 . . . . 15.24 111.176 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.15 62.58 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.599 -0.81 . . . . 13.609999999999999 114.499 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 70.3 mt -88.24 167.67 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.401 0.601 . . . . 13.529999999999999 110.911 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 33.5 t -59.22 142.1 52.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 10.51 111.656 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.97 -9.43 53.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 11.73 109.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.5 -3.29 39.73 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.669 -0.696 . . . . 8.6300000000000008 113.935 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -143.01 146.4 33.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.038 0.919 . . . . 9.3900000000000006 112.827 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.13 46.73 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.037 -0.983 . . . . 6.5499999999999998 112.206 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.35 146.77 36.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.192 -0.913 . . . . 7.4299999999999997 110.415 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.528 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.6 p -157.78 156.29 31.3 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.969 -0.692 . . . . 6.7699999999999996 111.868 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.767 ' HB2' ' HD3' ' A' ' 260' ' ' LYS . 78.4 tt0 -145.35 127.05 15.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.737 -0.665 . . . . 9.5899999999999999 109.682 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 51.8 m-85 -82.42 164.87 20.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.953 0.406 . . . . 9.9100000000000001 112.007 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.53 -46.1 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.43 -0.952 . . . . 13.09 108.43 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.751 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.4 t70 -96.28 102.29 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.436 -1.32 . . . . 13.18 107.436 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.542 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 115.299 1.592 . . . . 12.48 115.299 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -56.92 -38.69 73.23 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.184 0.992 . . . . 13.4 108.966 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.64 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 112.358 -2.201 . . . . 11.43 109.613 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 91.6 m -54.71 -48.13 72.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.908 -0.775 . . . . 9.5 108.908 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -62.43 -42.89 99.78 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.285 -0.566 . . . . 10.31 110.473 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.7 -32.43 73.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 119.93 -0.708 . . . . 12.41 111.98 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.71 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.641 -1.618 . . . . 8.3900000000000006 113.076 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 72.8 mt -68.61 -51.39 46.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.354 0.597 . . . . 7.71 110.819 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.88 67.31 Favored 'General case' 0 C--N 1.42 3.668 0 C-N-CA 126.225 1.81 . . . . 0.0 113.13 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.02 -24.07 36.11 Favored Glycine 1 C--N 1.399 4.077 0 N-CA-C 116.762 1.465 . . . . 8.7599999999999998 116.762 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.403 ' O ' HD21 ' A' ' 330' ' ' LEU . 84.3 mt -96.86 -45.76 6.51 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 120.176 1.988 . . . . 7.2000000000000002 113.938 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -50.44 129.94 22.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 8.1099999999999994 111.526 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.69 56.7 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.108 -0.568 . . . . 8.6400000000000006 113.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.3 ttt -50.65 147.18 4.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.84 0.32 . . . . 8.25 111.337 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.01 115.64 27.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.407 . . . . 10.48 111.723 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.623 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.24 106.63 12.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.116 -1.068 . . . . 8.9499999999999993 108.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.2 -118.68 10.5 Favored Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 109.343 -1.503 . . . . 10.630000000000001 109.343 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -115.84 22.36 13.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 12.25 109.714 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -123.88 153.94 40.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.667 -0.697 . . . . 10.34 111.618 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -101.79 118.22 36.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.138 -1.06 . . . . 10.59 108.138 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.623 ' HB2' HD21 ' A' ' 325' ' ' LEU . 22.1 tp -63.0 143.15 58.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.545 0.688 . . . . 7.6500000000000004 112.637 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.23 127.92 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.469 -1.242 . . . . 7.7599999999999998 108.981 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.84 124.01 26.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 O-C-N 120.976 -1.078 . . . . 6.4500000000000002 110.011 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -152.78 155.4 37.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.042 -1.661 . . . . 7.8799999999999999 109.51 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.454 ' HA ' HD21 ' A' ' 261' ' ' LEU . 98.5 mtt180 -58.65 122.54 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 118.435 -1.306 . . . . 9.1999999999999993 107.58 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.78 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.795 1.406 . . . . 7.5199999999999996 114.795 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.3 m -119.36 -78.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.575 -0.45 . . . . 9.3599999999999994 111.212 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.819 -177.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.705 ' HB3' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -158.81 149.26 19.79 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 123.646 0.591 . . . . 6.3499999999999996 111.577 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.506 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.5 mt -140.81 143.64 34.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 5.5099999999999998 111.231 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -96.57 125.17 40.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.905 -0.776 . . . . 6.8200000000000003 108.905 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.82 101.23 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 5.0899999999999999 110.21 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.85 -179.32 34.68 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.07 -0.586 . . . . 6.2000000000000002 112.769 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.3 m120 49.95 41.6 23.21 Favored 'General case' 0 CA--C 1.574 1.899 0 C-N-CA 125.395 1.478 . . . . 0.0 110.292 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.43 149.87 89.01 Favored Pre-proline 1 C--N 1.43 4.07 0 C-N-CA 123.861 0.864 . . . . 7.79 111.355 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.15 144.44 90.35 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.317 2.011 . . . . 8.9900000000000002 110.977 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.96 139.77 52.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.929 0.395 . . . . 11.75 111.992 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.59 61.25 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.876 -0.602 . . . . 10.470000000000001 114.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.2 136.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 117.338 0.569 . . . . 8.9100000000000001 110.254 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.457 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 36.7 p -84.96 153.85 22.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 9.9100000000000001 110.637 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.09 -43.18 95.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 7.7599999999999998 110.185 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.74 -46.03 91.37 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.994 -0.548 . . . . 9.8900000000000006 110.54 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.457 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.56 -26.4 68.56 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.271 -2.143 . . . . 0.0 111.698 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.421 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.38 -34.08 67.68 Favored 'General case' 1 C--N 1.43 4.071 0 O-C-N 123.952 0.783 . . . . 6.7800000000000002 111.811 171.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.449 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.55 -54.29 7.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.442 0.697 . . . . 6.9699999999999998 111.078 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.411 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 61.5 m-20 -54.66 -33.64 61.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.419 -0.81 . . . . 8.8000000000000007 111.373 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.76 -53.6 17.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 120.634 -0.426 . . . . 7.8700000000000001 111.603 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.3 m-85 -61.25 -48.37 81.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.181 0.438 . . . . 5.9400000000000004 112.181 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.411 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.6 m-20 -56.74 -42.85 80.0 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.193 -0.603 . . . . 7.1200000000000001 109.606 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 167' ' ' ASP . . . -67.94 -23.4 65.07 Favored 'General case' 0 C--N 1.406 3.06 0 O-C-N 120.27 -1.519 . . . . 0.0 111.251 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.5 -37.66 36.21 Favored 'General case' 1 C--N 1.429 4.03 0 CA-C-N 118.576 0.625 . . . . 7.9299999999999997 110.332 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.45 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.82 83.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 7.7300000000000004 111.022 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.01 -43.07 45.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.437 0.532 . . . . 9.9600000000000009 112.437 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.02 -37.82 88.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 10.42 110.397 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.96 -16.52 74.67 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.309 -0.948 . . . . 9.2300000000000004 112.881 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.11 71.55 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.816 -0.914 . . . . 9.6099999999999994 110.816 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.01 5.28 52.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.816 0.672 . . . . 8.4600000000000009 112.816 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.501 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.5 p -82.59 143.44 31.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.565 0.221 . . . . 9.1600000000000001 110.598 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.157 0.429 . . . . 10.23 112.157 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.47 23.82 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.688 -0.233 . . . . 10.24 110.689 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.33 143.49 99.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.928 1.752 . . . . 11.43 110.797 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.57 20.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 9.4499999999999993 112.385 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.23 134.52 73.84 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.046 0.387 . . . . 8.3300000000000001 112.046 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.501 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.29 -50.91 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.564 2.176 . . . . 6.9699999999999998 111.358 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.449 ' O ' ' HE1' ' A' ' 166' ' ' MET . 22.0 t -69.79 105.43 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.183 -0.462 . . . . 5.8700000000000001 111.096 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -31.4 29.19 Favored 'General case' 0 N--CA 1.529 3.482 0 O-C-N 119.988 -1.695 . . . . 0.0 113.404 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.21 163.37 39.66 Favored 'General case' 0 C--N 1.391 2.372 0 C-N-CA 126.244 1.818 . . . . 0.0 110.798 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.27 130.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.376 1.752 0 C-N-CA 126.556 1.943 . . . . 5.6699999999999999 109.313 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.17 126.6 55.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.715 -0.476 . . . . 6.6799999999999997 109.715 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.535 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.2 mt -114.96 126.0 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 116.985 2.217 . . . . 7.0999999999999996 116.985 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.01 91.37 5.27 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 103.163 -2.902 . . . . 8.1600000000000001 103.163 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -57.36 8.09 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.634 1.716 . . . . 10.279999999999999 115.634 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.23 -48.75 75.87 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.891 0.7 . . . . 10.51 112.891 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.14 50.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.895 0.331 . . . . 9.9399999999999995 111.895 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.05 36.23 15.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.565 1.32 . . . . 8.4499999999999993 114.565 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.61 168.59 19.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.063 -1.055 . . . . 7.25 111.633 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.52 161.17 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.27 -1.332 . . . . 5.1900000000000004 110.413 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.46 129.4 51.2 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.556 -0.905 . . . . 6.0899999999999999 108.556 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.87 137.53 33.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.353 -0.385 . . . . 4.2699999999999996 110.33 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -114.74 114.7 25.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.678 -0.49 . . . . 6.21 109.678 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.428 ' HB2' ' HG1' ' A' ' 208' ' ' THR . 80.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.939 -0.573 . . . . 6.1399999999999997 111.93 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -25.99 22.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 8.6899999999999995 111.47 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.408 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 89.2 p -128.89 159.54 35.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.104 0.478 . . . . 8.3300000000000001 111.688 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.27 -41.78 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 8.9600000000000009 112.231 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.74 -41.68 95.75 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.385 0.513 . . . . 9.2599999999999998 112.385 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.5 mt-10 -61.83 -43.84 98.04 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.292 -0.262 . . . . 7.6200000000000001 110.292 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.705 HG23 ' HB3' ' A' ' 149' ' ' ARG . 55.2 m -54.17 -54.03 45.25 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.108 -1.071 . . . . 6.4199999999999999 108.108 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 m -54.99 -27.14 41.85 Favored 'General case' 1 C--N 1.429 4.039 0 C-N-CA 127.072 2.149 . . . . 0.0 109.905 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -34.1 42.69 Favored 'General case' 0 C--N 1.422 3.734 0 N-CA-C 113.586 0.958 . . . . 8.75 113.586 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.657 0.614 . . . . 5.9400000000000004 112.657 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.1 -19.83 63.39 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.451 1.095 . . . . 7.1500000000000004 111.602 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.26 52.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 7.7000000000000002 111.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.89 16.28 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.528 -0.305 . . . . 7.4699999999999998 111.584 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.97 14.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.869 0.366 . . . . 7.3799999999999999 110.715 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.9 65.98 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.89 -0.671 . . . . 7.9199999999999999 113.587 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.809 0.305 . . . . 7.71 111.121 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.91 121.54 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.271 0.558 . . . . 10.0 111.343 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.23 107.75 7.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 8.4499999999999993 110.354 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.7 13.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.064 -0.517 . . . . 10.44 111.751 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.53 53.6 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.234 0.854 . . . . 10.609999999999999 115.234 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.52 130.86 55.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.58 0.69 . . . . 10.279999999999999 112.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.68 101.51 10.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.52 -0.918 . . . . 8.8300000000000001 108.52 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.31 137.88 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.027 1.121 . . . . 6.9699999999999998 114.027 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.408 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.5 tttt -108.61 110.32 21.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.548 -1.279 . . . . 8.5099999999999998 107.548 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.05 126.92 58.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.129 0.49 . . . . 6.1699999999999999 112.288 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.408 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.63 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 8.3000000000000007 110.026 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.05 154.7 49.69 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.56 -0.904 . . . . 8.1400000000000006 108.56 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.4 175.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 121.89 1.726 . . . . 7.79 112.057 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m170 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.003 0.43 . . . . 11.33 110.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 260' ' ' LYS . 16.3 ttmt -62.9 139.34 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.5 110.323 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 313' ' ' THR . 64.4 mt -109.8 143.94 38.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.02 -0.991 . . . . 6.5800000000000001 112.806 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -104.47 132.12 51.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.19 -1.411 . . . . 7.1399999999999997 107.19 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.661 -0.496 . . . . 5.6799999999999997 109.661 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.504 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.17 179.25 16.48 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.537 -0.839 . . . . 6.5700000000000003 112.659 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.2 86.51 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.643 -0.789 . . . . 8.0399999999999991 111.554 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 95.2 mt -70.83 135.19 85.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.503 0.186 . . . . 8.1600000000000001 111.503 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.8 Cg_exo -61.78 141.6 90.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.883 1.722 . . . . 9.4399999999999995 108.843 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.37 -14.96 62.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.779 1.4 . . . . 11.74 114.779 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.08 -23.21 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.842 1.423 . . . . 11.65 114.842 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.29 149.19 50.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.159 0.436 . . . . 9.3599999999999994 111.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.42 ' O ' HG21 ' A' ' 275' ' ' VAL . 30.4 p-10 -114.5 -176.43 2.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 110.29 -0.263 . . . . 10.609999999999999 110.29 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.61 -55.2 27.85 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.618 1.34 . . . . 10.07 114.618 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.79 -26.34 68.04 Favored 'General case' 0 C--N 1.406 3.033 0 C-N-CA 125.669 1.588 . . . . 0.0 112.408 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -80.04 -48.3 13.52 Favored 'General case' 1 C--N 1.43 4.072 0 CA-C-N 118.301 0.5 . . . . 10.289999999999999 111.412 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 271' ' ' ASN . 67.6 t -62.63 -49.27 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 8.0 110.28 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -54.22 -36.46 63.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 10.199999999999999 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.0 -53.36 56.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.133 0.492 . . . . 10.199999999999999 110.709 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.417 ' O ' HD11 ' A' ' 278' ' ' LEU . 1.5 tm? -51.78 -33.14 33.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.081 -0.509 . . . . 7.6200000000000001 110.364 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.492 HD11 ' SG ' ' A' ' 305' ' ' CYS . 85.1 mt -82.66 -41.67 19.11 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.602 0.593 . . . . 7.7400000000000002 112.602 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.7 m -56.73 -29.9 62.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.567 0.951 . . . . 10.390000000000001 113.567 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 m -50.21 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.555 0 C-N-CA 124.796 1.238 . . . . 0.0 112.587 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -111.46 -12.06 14.03 Favored 'General case' 1 C--N 1.442 4.596 0 CA-C-N 118.379 0.536 . . . . 10.23 111.452 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.12 162.36 10.28 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.786 -0.643 . . . . 10.98 111.913 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.66 147.12 93.3 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.731 2.287 . . . . 12.75 112.712 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 84.1 mt -102.52 146.25 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.918 -0.583 . . . . 10.66 111.215 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.554 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.7 ptpt -100.99 -22.65 14.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.266 -0.642 . . . . 11.630000000000001 109.266 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.64 126.15 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 119.07 -2.269 . . . . 0.0 109.15 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.601 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 62.9 t80 -143.3 134.7 26.12 Favored 'General case' 0 C--N 1.362 1.142 0 C-N-CA 122.886 0.474 . . . . 9.0099999999999998 112.009 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.04 12.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.73 0.3 . . . . 8.7300000000000004 111.557 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 54.2 tp -101.01 118.3 36.73 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.552 -1.277 . . . . 8.9399999999999995 107.552 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.17 122.86 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.511 0.93 . . . . 9.7400000000000002 113.511 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -119.09 148.13 43.39 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 115.332 -0.849 . . . . 11.34 109.336 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 37.2 t70 -58.94 141.1 54.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 13.83 110.95 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.6 m -49.71 -61.66 1.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.625 0.602 . . . . 14.779999999999999 112.625 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.18 -63.95 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.493 0.553 . . . . 16.440000000000001 112.493 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.4 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.414 . . . . 15.24 111.179 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.07 62.69 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.607 -0.806 . . . . 13.609999999999999 114.557 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.33 167.64 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.34 0.57 . . . . 13.529999999999999 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.1 t -59.17 141.96 52.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 10.51 111.617 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.4 mmmp? -87.95 -9.42 53.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 11.73 109.574 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.37 39.53 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.727 . . . . 8.6300000000000008 113.875 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -142.92 146.43 33.99 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.051 0.925 . . . . 9.3900000000000006 112.846 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.13 46.72 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.004 -0.998 . . . . 6.5499999999999998 112.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.44 146.83 36.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.168 -0.924 . . . . 7.4299999999999997 110.449 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.601 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.6 p -157.72 156.24 31.32 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.003 -0.679 . . . . 6.7699999999999996 111.869 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.4 127.08 15.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.723 -0.671 . . . . 9.5899999999999999 109.649 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.554 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 53.2 m-85 -82.37 164.92 20.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.095 0.406 . . . . 9.9100000000000001 112.095 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.62 -46.08 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.343 -0.984 . . . . 13.09 108.343 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.741 ' O ' HG23 ' A' ' 312' ' ' VAL . 12.1 t70 -96.32 102.28 14.04 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.381 -1.34 . . . . 13.18 107.381 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.68 -35.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 115.337 1.606 . . . . 12.48 115.337 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -56.78 -38.73 72.89 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.259 1.028 . . . . 13.4 109.097 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.69 -22.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.306 -2.225 . . . . 11.43 109.529 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 94.5 m -54.64 -48.13 72.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.929 -0.767 . . . . 9.5 108.929 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.46 -42.89 99.8 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.308 -0.557 . . . . 10.31 110.467 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -63.8 -32.44 73.94 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 119.923 -0.711 . . . . 12.41 111.941 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.66 74.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.586 -1.643 . . . . 8.3900000000000006 113.103 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.61 -51.31 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.362 0.601 . . . . 7.71 110.876 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.88 -38.66 67.82 Favored 'General case' 0 C--N 1.419 3.596 0 C-N-CA 126.281 1.832 . . . . 0.0 113.151 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.431 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.11 -24.08 35.81 Favored Glycine 1 C--N 1.399 4.033 0 N-CA-C 116.778 1.471 . . . . 8.7599999999999998 116.778 177.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 99.1 mt -96.81 -45.81 6.5 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.107 1.954 . . . . 7.2000000000000002 113.946 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -50.47 130.04 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 8.1099999999999994 111.463 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.66 56.76 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.111 -0.566 . . . . 8.6400000000000006 113.948 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.431 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 18.7 mtt -50.65 147.21 4.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.783 0.325 . . . . 8.25 111.264 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -95.14 115.69 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.076 0.465 . . . . 10.48 111.715 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 330' ' ' LEU . 4.0 mm? -120.26 106.83 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.082 -1.081 . . . . 8.9499999999999993 108.082 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.1 -118.74 10.65 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.397 -1.481 . . . . 10.630000000000001 109.397 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -115.78 22.36 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 12.25 109.781 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.8 153.91 40.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.616 -0.72 . . . . 10.34 111.624 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.73 118.25 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.117 -1.068 . . . . 10.59 108.117 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.2 tp -63.09 143.09 58.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 7.6500000000000004 112.586 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 20.8 mt -128.12 128.0 44.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.504 -1.225 . . . . 7.7599999999999998 108.997 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.92 124.04 26.28 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 O-C-N 120.984 -1.073 . . . . 6.4500000000000002 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -152.76 155.33 36.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 119.987 -1.696 . . . . 7.8799999999999999 109.547 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.465 ' HA ' HD21 ' A' ' 261' ' ' LEU . 95.0 mtt180 -58.55 122.43 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.395 -1.322 . . . . 9.1999999999999993 107.626 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.94 -11.77 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.786 1.402 . . . . 7.5199999999999996 114.786 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.6 m -119.36 -77.84 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.55 -0.46 . . . . 9.3599999999999994 111.422 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.477 0.656 . . . . 0.0 110.581 178.139 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 149' ' ' ARG . 74.5 ttt180 . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.34 148.4 21.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.762 -1.108 . . . . 6.3499999999999996 111.36 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.6 mt -140.74 143.47 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 5.5099999999999998 111.205 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.55 125.14 40.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.901 -0.777 . . . . 6.8200000000000003 108.901 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.29 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.098 0.475 . . . . 5.0899999999999999 110.147 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.81 -179.32 34.73 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.964 -0.562 . . . . 6.2000000000000002 112.795 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.4 m120 50.28 41.31 24.14 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 125.258 1.423 . . . . 0.0 110.194 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.46 149.83 88.94 Favored Pre-proline 1 C--N 1.429 4.048 0 C-N-CA 123.832 0.853 . . . . 7.79 111.316 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.07 144.41 90.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.308 2.005 . . . . 8.9900000000000002 111.013 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.67 52.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.93 0.395 . . . . 11.75 111.964 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.33 6.42 61.52 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.470000000000001 114.319 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.11 136.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.31 0.555 . . . . 8.9100000000000001 110.276 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.6 p -84.86 153.91 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 9.9100000000000001 110.691 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.1 -43.19 95.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 7.7599999999999998 110.204 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.78 -45.92 91.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.901 -0.59 . . . . 9.8900000000000006 110.499 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.76 -26.38 68.68 Favored 'General case' 0 C--N 1.408 3.142 0 O-C-N 119.262 -2.149 . . . . 0.0 111.689 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.401 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.29 -34.1 67.92 Favored 'General case' 0 C--N 1.428 3.98 0 O-C-N 123.978 0.799 . . . . 6.7800000000000002 111.79 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.457 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.1 ttt -74.54 -54.22 7.92 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.412 0.685 . . . . 6.9699999999999998 111.132 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.73 -33.61 61.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 8.8000000000000007 111.353 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.83 -53.55 17.64 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.531 -0.468 . . . . 7.8700000000000001 111.61 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.31 -48.28 82.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.13 0.419 . . . . 5.9400000000000004 112.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.41 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.76 -42.85 80.08 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.277 -0.569 . . . . 7.1200000000000001 109.559 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.28 64.83 Favored 'General case' 0 C--N 1.405 3.001 0 O-C-N 120.199 -1.563 . . . . 0.0 111.234 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.72 36.7 Favored 'General case' 0 C--N 1.427 3.956 0 CA-C-N 118.528 0.604 . . . . 7.9299999999999997 110.354 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.445 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.75 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.577 -0.738 . . . . 7.7300000000000004 111.059 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -76.1 -42.94 45.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.413 0.523 . . . . 9.9600000000000009 112.413 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.259 0.552 . . . . 10.42 110.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.04 -16.52 74.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.322 -0.942 . . . . 9.2300000000000004 112.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.19 37.14 71.88 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.843 -0.903 . . . . 9.6099999999999994 110.843 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.35 51.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 8.4600000000000009 112.918 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.8 p -82.58 143.49 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 9.1600000000000001 110.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.47 21.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.18 0.437 . . . . 10.23 112.18 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.49 23.74 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.709 -0.223 . . . . 10.24 110.693 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.4 143.61 99.66 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.926 1.751 . . . . 11.43 110.825 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.22 161.63 20.69 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.639 -0.791 . . . . 9.4499999999999993 112.441 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.3 134.5 73.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.089 0.403 . . . . 8.3300000000000001 112.089 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.5 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.26 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.492 2.128 . . . . 6.9699999999999998 111.315 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.457 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.65 105.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.8700000000000001 111.135 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -35.05 33.28 Favored 'General case' 0 N--CA 1.53 3.525 0 O-C-N 120.279 -1.513 . . . . 0.0 113.277 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.84 163.95 39.18 Favored 'General case' 0 C--N 1.386 2.167 0 C-N-CA 126.05 1.74 . . . . 0.0 110.591 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.19 130.45 11.04 Favored 'Isoleucine or valine' 0 C--N 1.372 1.549 0 C-N-CA 126.534 1.934 . . . . 5.6699999999999999 109.297 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.06 126.7 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.798 -0.445 . . . . 6.6799999999999997 109.798 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.525 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.2 mt -115.06 125.98 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 116.904 2.187 . . . . 7.0999999999999996 116.904 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -98.05 91.38 5.27 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 103.193 -2.891 . . . . 8.1600000000000001 103.193 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -57.4 7.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.612 1.708 . . . . 10.279999999999999 115.612 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.76 75.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.839 0.681 . . . . 10.51 112.839 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.04 -9.11 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.834 0.309 . . . . 9.9399999999999995 111.834 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.15 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.495 1.294 . . . . 8.4499999999999993 114.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.64 168.56 19.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.184 -1.007 . . . . 7.25 111.663 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.525 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.51 161.17 41.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.27 -1.332 . . . . 5.1900000000000004 110.446 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.27 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.726 -0.842 . . . . 6.0899999999999999 108.726 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.0 mt -94.82 137.58 33.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.451 -0.34 . . . . 4.2699999999999996 110.337 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.73 25.98 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.702 -0.481 . . . . 6.21 109.702 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.7 164.78 11.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.928 -0.578 . . . . 6.1399999999999997 111.953 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.67 -25.87 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 8.6899999999999995 111.484 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 88.5 p -129.0 159.6 35.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.17 0.509 . . . . 8.3300000000000001 111.579 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.9 t -74.34 -41.73 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.523 -0.762 . . . . 8.9600000000000009 112.201 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.78 -41.72 95.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.32 0.489 . . . . 9.2599999999999998 112.32 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.451 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.2 mt-10 -61.91 -43.85 97.99 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.192 -0.299 . . . . 7.6200000000000001 110.192 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.529 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.15 -53.28 55.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.332 1.063 . . . . 6.4199999999999999 108.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.467 HG23 HH22 ' A' ' 228' ' ' ARG . 3.7 p -56.19 -26.15 49.64 Favored 'General case' 1 C--N 1.449 4.894 0 C-N-CA 126.15 1.78 . . . . 0.0 110.195 178.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -34.05 41.57 Favored 'General case' 0 C--N 1.428 3.995 0 N-CA-C 113.602 0.964 . . . . 8.75 113.602 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.36 64.14 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.72 0.637 . . . . 5.9400000000000004 112.72 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.02 -19.93 63.38 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.532 1.145 . . . . 7.1500000000000004 111.597 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.42 -9.27 52.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 7.7000000000000002 111.683 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.18 14.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 7.4699999999999998 111.704 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.86 120.99 14.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.886 0.374 . . . . 7.3799999999999999 110.803 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.86 -4.85 66.06 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.906 -0.664 . . . . 7.9199999999999999 113.584 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.858 0.329 . . . . 7.71 111.086 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.95 121.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.271 0.558 . . . . 10.0 111.286 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.64 7.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.698 -0.683 . . . . 8.4499999999999993 110.347 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.73 42.71 13.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 10.44 111.759 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.1 -5.5 54.08 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.186 0.834 . . . . 10.609999999999999 115.186 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.62 130.84 55.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.654 0.727 . . . . 10.279999999999999 112.405 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.72 101.49 10.91 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.535 -0.913 . . . . 8.8300000000000001 108.535 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.28 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.088 1.144 . . . . 6.9699999999999998 114.088 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.51 110.26 21.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.588 -1.264 . . . . 8.5099999999999998 107.588 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.92 126.95 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 6.1699999999999999 112.334 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.62 170.52 15.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 8.3000000000000007 110.047 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.467 HH22 HG23 ' A' ' 209' ' ' THR . 3.5 mtp180 -89.09 154.67 49.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.559 -0.904 . . . . 8.1400000000000006 108.559 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.38 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.97 1.78 . . . . 7.79 111.987 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.9 t60 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.961 0.41 . . . . 11.33 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.01 139.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.185 0.517 . . . . 8.5 110.278 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 334' ' ' ARG . 47.9 mt -109.73 143.86 38.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.032 -0.986 . . . . 6.5800000000000001 112.862 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -104.49 132.14 51.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.214 -1.402 . . . . 7.1399999999999997 107.214 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.0 121.21 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.54 -0.541 . . . . 5.6799999999999997 109.54 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.539 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.515 -0.85 . . . . 6.5700000000000003 112.722 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.19 86.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.656 -0.783 . . . . 8.0399999999999991 111.511 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.5 mt -70.86 135.25 85.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.154 . . . . 8.1600000000000001 111.409 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 35.4 Cg_exo -61.82 141.55 90.52 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.952 1.768 . . . . 9.4399999999999995 108.737 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.39 -14.94 62.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.703 1.371 . . . . 11.74 114.703 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -84.07 -23.27 30.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.811 1.412 . . . . 11.65 114.811 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.23 149.17 50.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.125 0.421 . . . . 9.3599999999999994 111.366 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.402 ' O ' HG21 ' A' ' 275' ' ' VAL . 20.5 p-10 -114.51 -176.46 2.91 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.293 -0.262 . . . . 10.609999999999999 110.293 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -53.55 -55.4 25.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 114.632 1.345 . . . . 10.07 114.632 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -26.46 67.89 Favored 'General case' 0 C--N 1.406 3.042 0 C-N-CA 125.639 1.576 . . . . 0.0 112.531 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -79.95 -48.34 13.55 Favored 'General case' 0 C--N 1.428 3.979 0 CA-C-N 118.307 0.503 . . . . 10.289999999999999 111.447 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 271' ' ' ASN . 79.5 t -62.67 -49.14 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 8.0 110.286 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 33.0 mtmm -54.28 -36.48 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 10.199999999999999 111.332 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.99 -53.38 56.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 10.199999999999999 110.716 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.77 -33.09 33.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.08 -0.509 . . . . 7.6200000000000001 110.393 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 305' ' ' CYS . 78.5 mt -82.62 -41.72 19.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.588 0.588 . . . . 7.7400000000000002 112.588 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 83.0 m -56.82 -29.9 63.22 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.523 0.935 . . . . 10.390000000000001 113.523 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 19.8 m -50.26 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.549 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 316' ' ' ALA . 33.8 m-85 -111.33 -11.95 14.1 Favored 'General case' 1 C--N 1.444 4.688 0 CA-C-N 118.372 0.533 . . . . 10.23 111.426 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.835 -0.621 . . . . 10.98 111.94 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.72 147.11 93.48 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.743 2.295 . . . . 12.75 112.627 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 82.5 mt -102.43 146.24 28.36 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.869 -0.605 . . . . 10.66 111.23 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.06 -22.48 14.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.308 -0.627 . . . . 11.630000000000001 109.308 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.33 127.66 5.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 119.294 -2.129 . . . . 0.0 109.099 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.546 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.0 t80 -144.56 134.65 24.07 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 122.852 0.461 . . . . 9.0099999999999998 112.008 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -144.73 124.14 13.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.764 0.316 . . . . 8.7300000000000004 111.513 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 57.3 tp -101.02 118.2 36.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.524 -1.287 . . . . 8.9399999999999995 107.524 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.22 122.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.465 0.913 . . . . 9.7400000000000002 113.465 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -119.19 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.436 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.2 t70 -58.89 141.15 54.27 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.966 0.412 . . . . 13.83 111.039 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.5 m -49.68 -61.7 1.97 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.616 . . . . 14.779999999999999 112.633 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.06 -64.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.476 0.547 . . . . 16.440000000000001 112.476 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.49 -59.33 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 15.24 111.18 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.07 62.55 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.567 -0.825 . . . . 13.609999999999999 114.554 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.29 167.64 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.394 0.597 . . . . 13.529999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.5 t -59.24 142.03 52.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 10.51 111.635 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.8 mmmp? -87.91 -9.46 53.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 11.73 109.573 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.42 39.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.644 -0.707 . . . . 8.6300000000000008 113.895 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -142.9 146.43 34.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.126 0.963 . . . . 9.3900000000000006 112.903 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.1 46.73 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.106 -0.952 . . . . 6.5499999999999998 112.23 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -111.39 146.93 36.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.221 -0.899 . . . . 7.4299999999999997 110.348 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.6 p -157.91 156.21 30.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.924 -0.711 . . . . 6.7699999999999996 111.919 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -145.31 127.1 15.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.68 -0.691 . . . . 9.5899999999999999 109.61 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.496 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 63.9 m-85 -82.55 164.87 20.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.417 . . . . 9.9100000000000001 112.041 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.5 -46.13 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.384 -0.969 . . . . 13.09 108.384 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.696 ' O ' HG23 ' A' ' 312' ' ' VAL . 15.1 t70 -96.28 102.35 14.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.355 -1.35 . . . . 13.18 107.355 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.522 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.05 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 115.303 1.594 . . . . 12.48 115.303 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -56.84 -38.71 73.05 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.264 1.03 . . . . 13.4 109.009 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.78 -22.63 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 112.265 -2.243 . . . . 11.43 109.549 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.62 -48.22 72.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.931 -0.766 . . . . 9.5 108.931 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.45 -42.81 99.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.184 -0.607 . . . . 10.31 110.52 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.8 -32.47 73.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 119.943 -0.703 . . . . 12.41 111.909 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . . . -69.43 -34.79 74.96 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.626 -1.624 . . . . 8.3900000000000006 113.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 74.7 mt -68.54 -51.3 47.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 121.403 0.621 . . . . 7.71 110.861 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.1 -38.63 68.38 Favored 'General case' 0 C--N 1.419 3.603 0 C-N-CA 126.141 1.776 . . . . 0.0 113.172 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -23.92 36.68 Favored Glycine 1 C--N 1.398 4.008 0 N-CA-C 116.845 1.498 . . . . 8.7599999999999998 116.845 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.415 ' O ' HD21 ' A' ' 330' ' ' LEU . 80.2 mt -96.9 -45.71 6.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 120.122 1.961 . . . . 7.2000000000000002 113.957 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -50.54 130.07 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 8.1099999999999994 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.16 -16.65 56.76 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.091 -0.576 . . . . 8.6400000000000006 113.955 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.2 ttt -50.67 147.19 4.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.755 0.312 . . . . 8.25 111.298 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -95.05 115.61 27.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 10.48 111.635 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.25 106.77 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.118 -1.068 . . . . 8.9499999999999993 108.118 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.08 -118.67 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.382 -1.487 . . . . 10.630000000000001 109.382 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -115.84 22.49 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.129 0.49 . . . . 12.25 109.749 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -123.9 153.83 40.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.673 -0.694 . . . . 10.34 111.612 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -101.79 118.3 36.64 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.071 -1.085 . . . . 10.59 108.071 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.695 ' HB2' HD21 ' A' ' 325' ' ' LEU . 23.8 tp -63.03 143.13 58.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.502 0.668 . . . . 7.6500000000000004 112.642 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.574 -1.193 . . . . 7.7599999999999998 108.977 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.96 123.98 26.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 O-C-N 120.939 -1.101 . . . . 6.4500000000000002 109.997 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.68 155.35 37.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 119.965 -1.709 . . . . 7.8799999999999999 109.502 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.505 ' HA ' HD21 ' A' ' 261' ' ' LEU . 82.1 mtt180 -58.63 122.53 13.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.403 -1.319 . . . . 9.1999999999999993 107.533 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.734 1.383 . . . . 7.5199999999999996 114.734 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.0 m -119.4 -78.29 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.623 -0.431 . . . . 9.3599999999999994 111.262 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.604 -178.398 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.665 0.269 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -156.22 148.61 23.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 6.3499999999999996 111.203 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.3 mt -140.8 143.56 34.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 5.5099999999999998 111.185 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.59 125.16 40.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.851 -0.796 . . . . 6.8200000000000003 108.851 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 198' ' ' ALA . 2.3 p -124.79 101.21 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.088 0.47 . . . . 5.0899999999999999 110.201 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -178.96 34.97 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.998 -0.547 . . . . 6.2000000000000002 112.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 50.53 40.71 24.09 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.122 1.369 . . . . 0.0 110.224 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.62 149.88 88.59 Favored Pre-proline 1 C--N 1.428 4.01 0 C-N-CA 123.595 0.758 . . . . 7.79 111.302 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.07 144.47 89.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.297 1.998 . . . . 8.9900000000000002 110.967 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.0 139.71 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.987 0.422 . . . . 11.75 111.94 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.19 6.56 61.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.792 -0.64 . . . . 10.470000000000001 114.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 191' ' ' ILE . 11.0 tp -66.17 136.47 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 117.331 0.566 . . . . 8.9100000000000001 110.283 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.3 p -84.9 153.99 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.517 -0.31 . . . . 9.9100000000000001 110.652 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.19 -43.21 96.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 7.7599999999999998 110.146 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.72 -45.96 91.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.979 -0.555 . . . . 9.8900000000000006 110.575 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.62 -26.35 68.57 Favored 'General case' 0 C--N 1.41 3.199 0 O-C-N 119.296 -2.127 . . . . 0.0 111.664 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.411 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.41 -34.17 67.66 Favored 'General case' 0 C--N 1.428 3.982 0 O-C-N 123.985 0.803 . . . . 6.7800000000000002 111.708 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.45 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.6 -54.24 7.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 123.47 0.708 . . . . 6.9699999999999998 111.102 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.54 -33.77 60.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.426 -0.806 . . . . 8.8000000000000007 111.391 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.75 -53.6 17.65 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.604 -0.438 . . . . 7.8700000000000001 111.572 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.411 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.39 -48.22 82.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 5.9400000000000004 112.139 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.412 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.79 -42.93 80.35 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.342 -0.543 . . . . 7.1200000000000001 109.591 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.2 -22.98 64.78 Favored 'General case' 0 C--N 1.406 3.038 0 O-C-N 120.181 -1.574 . . . . 0.0 111.302 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.63 -37.55 35.8 Favored 'General case' 0 C--N 1.427 3.961 0 CA-C-N 118.56 0.618 . . . . 7.9299999999999997 110.309 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.457 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.81 -36.67 82.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.614 -0.721 . . . . 7.7300000000000004 111.022 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -76.12 -43.03 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.375 0.509 . . . . 9.9600000000000009 112.375 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.99 -37.69 88.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.186 0.517 . . . . 10.42 110.471 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.44 74.58 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.196 -1.002 . . . . 9.2300000000000004 112.871 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.1 37.09 72.65 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.908 -0.877 . . . . 9.6099999999999994 110.908 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.8 5.22 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.945 0.72 . . . . 8.4600000000000009 112.945 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.3 p -82.65 143.46 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.591 0.234 . . . . 9.1600000000000001 110.524 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.525 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.69 -18.41 21.33 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.047 0.388 . . . . 10.23 112.047 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.44 23.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.704 -0.225 . . . . 10.24 110.674 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.31 143.46 99.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.033 1.822 . . . . 11.43 110.748 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.4 161.67 20.53 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.611 -0.804 . . . . 9.4499999999999993 112.355 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.36 134.42 73.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.003 0.372 . . . . 8.3300000000000001 112.003 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.492 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.24 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 6.9699999999999998 111.325 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.45 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.6 105.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.8700000000000001 111.174 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -33.78 29.67 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 120.212 -1.555 . . . . 0.0 113.418 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.17 40.58 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 126.054 1.742 . . . . 0.0 110.647 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.73 130.43 12.12 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 126.309 1.844 . . . . 5.6699999999999999 109.298 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.04 126.65 55.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.823 -0.436 . . . . 6.6799999999999997 109.823 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 198' ' ' ALA . 97.2 mt -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 116.875 2.176 . . . . 7.0999999999999996 116.875 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.11 91.32 5.22 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.186 -2.894 . . . . 8.1600000000000001 103.186 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.22 -57.43 7.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.619 1.711 . . . . 10.279999999999999 115.619 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.18 -48.73 75.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.884 0.698 . . . . 10.51 112.884 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.01 -9.13 50.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.74 0.305 . . . . 9.9399999999999995 111.764 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.14 15.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 114.516 1.302 . . . . 8.4499999999999993 114.516 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.58 168.64 19.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.11 -1.036 . . . . 7.25 111.632 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.05 41.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.149 -1.387 . . . . 5.1900000000000004 110.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.35 51.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.691 -0.855 . . . . 6.0899999999999999 108.691 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.87 137.6 33.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 4.2699999999999996 110.297 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.8 114.74 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.698 -0.482 . . . . 6.21 109.698 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.69 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.965 -0.561 . . . . 6.1399999999999997 111.935 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.68 -25.93 22.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.822 . . . . 8.6899999999999995 111.462 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.4 p -128.85 159.6 35.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 8.3300000000000001 111.687 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.29 -41.77 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 8.9600000000000009 112.247 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.7 -41.77 95.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.343 0.497 . . . . 9.2599999999999998 112.343 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.236 -0.283 . . . . 7.6200000000000001 110.236 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 151' ' ' LEU . 55.8 m -54.24 -53.9 47.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.317 1.056 . . . . 6.4199999999999999 108.15 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 m -55.03 -27.22 42.85 Favored 'General case' 1 C--N 1.429 4.041 0 C-N-CA 127.082 2.153 . . . . 0.0 109.859 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -34.21 42.78 Favored 'General case' 0 C--N 1.42 3.662 0 N-CA-C 113.578 0.955 . . . . 8.75 113.578 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.45 64.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.621 0.6 . . . . 5.9400000000000004 112.621 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.82 63.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.449 1.093 . . . . 7.1500000000000004 111.617 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.2 52.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 7.7000000000000002 111.62 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.91 16.2 14.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.529 -0.305 . . . . 7.4699999999999998 111.591 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.95 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 7.3799999999999999 110.767 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.81 -4.76 66.14 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.907 -0.663 . . . . 7.9199999999999999 113.619 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.37 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.877 0.338 . . . . 7.71 111.08 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.93 121.57 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.278 0.561 . . . . 10.0 111.31 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.31 107.81 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 8.4499999999999993 110.3 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.62 42.74 13.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.034 -0.53 . . . . 10.44 111.823 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.0 -5.47 53.71 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.225 0.85 . . . . 10.609999999999999 115.225 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.58 130.96 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.686 0.743 . . . . 10.279999999999999 112.405 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.56 10.96 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.507 -0.923 . . . . 8.8300000000000001 108.507 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.35 137.84 58.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.974 1.102 . . . . 6.9699999999999998 113.974 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.408 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.54 110.31 21.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.513 -1.291 . . . . 8.5099999999999998 107.513 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.99 126.88 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.35 0.5 . . . . 6.1699999999999999 112.35 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.408 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.6 170.44 15.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.474 -0.785 . . . . 8.3000000000000007 110.067 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.06 154.68 49.66 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.599 -0.889 . . . . 8.1400000000000006 108.599 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.31 174.9 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.795 1.663 . . . . 7.79 112.057 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.189 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.4 m80 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 120.968 0.414 . . . . 11.33 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.92 139.27 58.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.204 0.526 . . . . 8.5 110.367 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.481 HD21 ' HA ' ' A' ' 334' ' ' ARG . 59.4 mt -109.74 143.97 38.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.015 -0.993 . . . . 6.5800000000000001 112.829 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.4 132.17 50.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.147 -1.427 . . . . 7.1399999999999997 107.147 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.4 HD12 ' HG ' ' A' ' 305' ' ' CYS . 4.3 mp -127.04 121.29 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.565 -0.532 . . . . 5.6799999999999997 109.565 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.513 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.2 179.22 16.5 Favored Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.461 -0.876 . . . . 6.5700000000000003 112.693 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.12 86.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.634 -0.794 . . . . 8.0399999999999991 111.517 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 92.7 mt -70.79 135.27 85.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.48 0.178 . . . . 8.1600000000000001 111.48 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.6 Cg_exo -61.85 141.51 90.18 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.923 1.748 . . . . 9.4399999999999995 108.796 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -65.36 -14.86 61.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.763 1.394 . . . . 11.74 114.763 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -84.15 -23.17 30.75 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.77 1.396 . . . . 11.65 114.77 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 149.21 50.71 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.121 0.418 . . . . 9.3599999999999994 111.31 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.418 ' O ' HG21 ' A' ' 275' ' ' VAL . 10.0 p-10 -114.51 -176.39 2.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.578 -0.283 . . . . 10.609999999999999 110.296 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 10.8 m-20 -53.64 -55.21 27.9 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 114.622 1.341 . . . . 10.07 114.622 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.33 -26.77 68.03 Favored 'General case' 0 C--N 1.405 2.995 0 C-N-CA 125.697 1.599 . . . . 0.0 112.456 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.07 -48.22 13.61 Favored 'General case' 1 C--N 1.429 4.031 0 O-C-N 123.489 0.493 . . . . 10.289999999999999 111.398 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 271' ' ' ASN . 71.9 t -62.69 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 8.0 110.237 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 26.7 mtmm -54.27 -36.45 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.662 -0.699 . . . . 10.199999999999999 111.297 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.06 -53.3 57.37 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 10.199999999999999 110.7 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -51.73 -33.15 33.45 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 116.195 -0.457 . . . . 7.6200000000000001 110.322 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.494 HD11 ' SG ' ' A' ' 305' ' ' CYS . 84.9 mt -82.67 -41.67 19.08 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.568 0.581 . . . . 7.7400000000000002 112.568 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 53.1 m -56.86 -29.41 62.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.546 0.943 . . . . 10.390000000000001 113.546 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -50.11 -10.82 0.06 Allowed 'General case' 0 C--N 1.395 2.572 0 C-N-CA 125.062 1.345 . . . . 0.0 112.563 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.51 -12.03 14.01 Favored 'General case' 1 C--N 1.445 4.733 0 CA-C-N 118.174 0.443 . . . . 10.23 111.499 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.31 10.25 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.795 -0.638 . . . . 10.98 111.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.64 147.09 93.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.677 2.252 . . . . 12.75 112.681 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.3 mt -102.47 146.31 28.29 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.889 -0.596 . . . . 10.66 111.304 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.584 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 12.8 ptpt -101.11 -22.56 14.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 11.630000000000001 109.227 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.07 127.23 5.73 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 119.152 -2.217 . . . . 0.0 108.975 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.595 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 60.2 t80 -144.43 134.75 24.41 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 122.769 0.428 . . . . 9.0099999999999998 112.013 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -144.79 124.03 12.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.813 0.339 . . . . 8.7300000000000004 111.634 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 52.0 tp -100.88 118.27 36.6 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.592 -1.262 . . . . 8.9399999999999995 107.592 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.24 122.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.507 0.929 . . . . 9.7400000000000002 113.507 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.09 148.1 43.42 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.315 -0.857 . . . . 11.34 109.373 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.61 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 36.9 t70 -58.92 141.05 54.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.92 0.39 . . . . 13.83 110.958 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.6 m -49.59 -61.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.795 -0.638 . . . . 14.779999999999999 112.65 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.2 -64.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.422 0.527 . . . . 16.440000000000001 112.422 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 18.4 m -42.4 -59.39 1.86 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 15.24 111.209 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.65 -6.05 62.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.643 -0.789 . . . . 13.609999999999999 114.493 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.29 167.69 13.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.425 0.612 . . . . 13.529999999999999 110.913 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -59.25 142.01 52.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 10.51 111.572 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.618 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.96 -9.4 53.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.795 -0.639 . . . . 11.73 109.619 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.61 -3.4 39.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.597 -0.729 . . . . 8.6300000000000008 113.874 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.97 146.41 33.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.03 0.915 . . . . 9.3900000000000006 112.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.46 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.2 46.74 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.101 -0.954 . . . . 6.5499999999999998 112.242 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -111.42 146.84 36.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.186 -0.916 . . . . 7.4299999999999997 110.422 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.595 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.2 p -157.87 156.19 30.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 119.9 -0.72 . . . . 6.7699999999999996 111.875 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 37.5 tt0 -145.27 127.0 15.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.702 -0.681 . . . . 9.5899999999999999 109.713 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.584 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 56.4 m-85 -82.39 164.85 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.941 0.4 . . . . 9.9100000000000001 112.06 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.51 -46.11 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.428 -0.953 . . . . 13.09 108.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.727 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.1 t70 -96.32 102.39 14.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.391 -1.337 . . . . 13.18 107.391 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.561 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -52.76 -34.97 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 115.288 1.588 . . . . 12.48 115.288 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.84 -38.76 73.11 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 122.175 0.988 . . . . 13.4 108.979 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.7 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 112.366 -2.197 . . . . 11.43 109.552 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.67 -48.1 72.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.935 -0.765 . . . . 9.5 108.935 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -62.52 -42.77 99.74 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.205 -0.598 . . . . 10.31 110.486 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -63.88 -32.39 73.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.931 -0.708 . . . . 12.41 111.932 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.77 74.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.711 -1.586 . . . . 8.3900000000000006 113.036 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 313' ' ' THR . 63.6 mt -68.63 -51.3 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 7.71 110.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.03 67.59 Favored 'General case' 0 C--N 1.42 3.642 0 C-N-CA 126.185 1.794 . . . . 0.0 113.152 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.417 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -87.93 -23.9 36.92 Favored Glycine 1 C--N 1.399 4.055 0 N-CA-C 116.781 1.472 . . . . 8.7599999999999998 116.781 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.92 -45.7 6.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.214 2.007 . . . . 7.2000000000000002 114.039 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -50.45 129.98 22.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.845 0.355 . . . . 8.1099999999999994 111.426 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.65 56.79 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.145 -0.55 . . . . 8.6400000000000006 113.956 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.417 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 16.4 mtt -50.64 147.19 4.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.822 0.311 . . . . 8.25 111.267 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -95.09 115.65 27.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.03 0.443 . . . . 10.48 111.71 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.7 mm? -120.2 106.77 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.113 -1.069 . . . . 8.9499999999999993 108.113 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.14 -118.65 10.51 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.38 -1.488 . . . . 10.630000000000001 109.38 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -115.86 22.41 13.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.202 0.525 . . . . 12.25 109.818 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -123.82 153.91 40.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.599 -0.728 . . . . 10.34 111.629 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -101.7 118.41 36.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.115 -1.068 . . . . 10.59 108.115 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.6 tp -63.21 143.16 58.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.515 0.674 . . . . 7.6500000000000004 112.653 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.539 -1.209 . . . . 7.7599999999999998 108.942 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.96 124.02 26.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 O-C-N 120.935 -1.103 . . . . 6.4500000000000002 110.01 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -152.7 155.31 37.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.973 -1.704 . . . . 7.8799999999999999 109.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.481 ' HA ' HD21 ' A' ' 261' ' ' LEU . 84.6 mtt180 -58.66 122.44 13.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 118.463 -1.295 . . . . 9.1999999999999993 107.612 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.77 0.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.766 1.395 . . . . 7.5199999999999996 114.766 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.5 m -119.47 -79.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.539 -0.465 . . . . 9.3599999999999994 111.297 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.619 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.983 0.421 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -158.7 148.52 19.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.064 0.946 . . . . 6.3499999999999996 111.127 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 208' ' ' THR . 28.0 mt -140.67 143.55 35.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.541 . . . . 5.5099999999999998 111.282 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.61 125.19 40.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.854 -0.795 . . . . 6.8200000000000003 108.854 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.8 101.33 8.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 5.0899999999999999 110.196 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.77 -178.63 35.0 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.914 -0.585 . . . . 6.2000000000000002 112.792 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.25 40.83 23.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 124.969 1.308 . . . . 0.0 110.121 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.83 149.8 88.09 Favored Pre-proline 1 C--N 1.428 4.021 0 C-N-CA 123.477 0.711 . . . . 7.79 111.286 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.07 144.48 89.84 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.297 1.998 . . . . 8.9900000000000002 110.989 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.96 139.72 52.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 11.75 111.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.1 6.6 61.0 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.833 -0.621 . . . . 10.470000000000001 114.303 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.12 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.399 0.6 . . . . 8.9100000000000001 110.305 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.4 p -84.89 153.98 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.3 . . . . 9.9100000000000001 110.614 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -60.18 -43.31 95.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 7.7599999999999998 110.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.51 -46.22 90.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.106 -0.497 . . . . 9.8900000000000006 110.516 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.37 -26.39 68.43 Favored 'General case' 0 C--N 1.41 3.233 0 O-C-N 119.26 -2.15 . . . . 0.0 111.734 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.421 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.49 -34.08 67.41 Favored 'General case' 1 C--N 1.429 4.034 0 O-C-N 123.984 0.802 . . . . 6.7800000000000002 111.742 171.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.432 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.63 -54.31 7.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.424 0.69 . . . . 6.9699999999999998 111.057 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.61 -33.68 60.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.453 -0.794 . . . . 8.8000000000000007 111.345 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.76 -53.53 17.93 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 120.41 -0.516 . . . . 7.8700000000000001 111.611 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.2 m-85 -61.31 -48.27 82.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.18 0.437 . . . . 5.9400000000000004 112.18 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.411 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.82 -42.81 80.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.294 -0.562 . . . . 7.1200000000000001 109.64 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.57 65.16 Favored 'General case' 0 C--N 1.407 3.076 0 O-C-N 120.261 -1.524 . . . . 0.0 111.227 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.38 -37.66 36.77 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.528 0.604 . . . . 7.9299999999999997 110.319 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.463 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.8 -36.61 82.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.58 -0.736 . . . . 7.7300000000000004 111.079 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.17 -43.02 44.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.38 0.511 . . . . 9.9600000000000009 112.38 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.2 mt -63.0 -37.73 88.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.203 0.525 . . . . 10.42 110.415 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -16.46 74.61 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.225 -0.988 . . . . 9.2300000000000004 112.894 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.15 71.6 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.774 -0.93 . . . . 9.6099999999999994 110.774 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.9 5.27 51.95 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.939 0.718 . . . . 8.4600000000000009 112.939 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.0 p -82.6 143.42 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.183 -0.207 . . . . 9.1600000000000001 110.609 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.527 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.149 0.426 . . . . 10.23 112.149 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.5 23.71 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.731 -0.213 . . . . 10.24 110.688 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.37 143.56 99.68 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.915 1.743 . . . . 11.43 110.821 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.29 161.61 20.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.656 -0.783 . . . . 9.4499999999999993 112.467 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.25 134.48 73.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.025 0.38 . . . . 8.3300000000000001 112.025 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.503 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.4 Cg_exo -73.25 -50.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.573 2.182 . . . . 6.9699999999999998 111.368 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.432 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.71 105.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.151 -0.477 . . . . 5.8700000000000001 111.107 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -33.17 33.27 Favored 'General case' 0 N--CA 1.524 3.272 0 C-N-CA 124.878 1.271 . . . . 0.0 113.394 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 163.78 39.17 Favored 'General case' 0 C--N 1.386 2.181 0 C-N-CA 125.757 1.623 . . . . 0.0 110.577 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.45 130.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 C-N-CA 126.091 1.756 . . . . 5.6699999999999999 109.338 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.686 -0.487 . . . . 6.6799999999999997 109.686 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.512 HG12 ' HB1' ' A' ' 198' ' ' ALA . 97.1 mt -114.93 125.99 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 116.903 2.186 . . . . 7.0999999999999996 116.903 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.14 91.42 5.26 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 103.187 -2.894 . . . . 8.1600000000000001 103.187 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -57.46 7.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.645 1.72 . . . . 10.279999999999999 115.645 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.14 -48.78 75.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.853 0.686 . . . . 10.51 112.853 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.99 -9.07 50.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 9.9399999999999995 111.849 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.15 15.5 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.579 1.326 . . . . 8.4499999999999993 114.579 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.52 168.7 19.23 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.12 -1.032 . . . . 7.25 111.671 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.512 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -147.61 161.02 42.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.035 -1.438 . . . . 5.1900000000000004 110.515 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.35 51.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.624 -0.88 . . . . 6.0899999999999999 108.624 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.8 137.56 33.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.355 -0.384 . . . . 4.2699999999999996 110.351 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.83 114.82 26.05 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 6.21 109.645 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -99.77 164.67 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 6.1399999999999997 111.947 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -26.04 22.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.425 -0.807 . . . . 8.6899999999999995 111.461 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.1 p -128.86 159.64 35.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.1 0.476 . . . . 8.3300000000000001 111.646 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.569 -0.741 . . . . 8.9600000000000009 112.303 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.64 -41.79 95.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.364 0.505 . . . . 9.2599999999999998 112.364 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.77 98.17 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 110.298 -0.26 . . . . 7.6200000000000001 110.298 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.527 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.25 -54.48 39.49 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.13 -1.063 . . . . 6.4199999999999999 108.13 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.0 m -54.3 -27.56 36.26 Favored 'General case' 1 C--N 1.429 4.032 0 C-N-CA 127.029 2.132 . . . . 0.0 109.853 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -34.0 44.42 Favored 'General case' 0 C--N 1.426 3.897 0 N-CA-C 113.648 0.981 . . . . 8.75 113.648 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.55 -17.35 64.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.626 0.602 . . . . 5.9400000000000004 112.626 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.5 mtp -62.12 -19.86 63.46 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.29 0.994 . . . . 7.1500000000000004 111.569 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.24 52.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.383 -0.371 . . . . 7.7000000000000002 111.608 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.77 16.16 14.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.747 0.308 . . . . 7.4699999999999998 111.725 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.85 120.9 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 7.3799999999999999 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.84 65.95 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.859 -0.686 . . . . 7.9199999999999999 113.553 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.17 142.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.836 0.318 . . . . 7.71 111.066 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.94 121.57 37.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.271 0.558 . . . . 10.0 111.327 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.29 107.71 7.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 8.4499999999999993 110.354 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.72 42.62 13.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 10.44 111.771 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.34 54.53 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.229 0.851 . . . . 10.609999999999999 115.229 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.69 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.652 0.726 . . . . 10.279999999999999 112.475 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.71 101.58 10.96 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.486 -0.931 . . . . 8.8300000000000001 108.486 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.42 137.82 58.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.032 1.123 . . . . 6.9699999999999998 114.032 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.47 110.24 21.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.539 -1.282 . . . . 8.5099999999999998 107.539 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.5 mt -104.12 126.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.217 0.532 . . . . 6.1699999999999999 112.233 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.54 170.54 15.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.376 -0.829 . . . . 8.3000000000000007 110.079 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.13 154.7 49.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.535 -0.913 . . . . 8.1400000000000006 108.535 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.39 175.26 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.954 1.77 . . . . 7.79 112.038 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 t60 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.968 0.413 . . . . 11.33 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -62.98 139.4 58.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.276 0.56 . . . . 8.5 110.318 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 334' ' ' ARG . 65.9 mt -109.8 144.05 38.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.989 -1.005 . . . . 6.5800000000000001 112.789 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.44 132.03 51.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.214 -1.402 . . . . 7.1399999999999997 107.214 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.547 ' CD1' ' HG ' ' A' ' 305' ' ' CYS . 4.0 mp -127.02 121.23 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.618 -0.512 . . . . 5.6799999999999997 109.618 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.13 179.26 16.46 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.483 -0.865 . . . . 6.5700000000000003 112.719 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.08 86.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.625 -0.798 . . . . 8.0399999999999991 111.561 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.1 mt -70.79 135.27 85.7 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 111.522 0.193 . . . . 8.1600000000000001 111.522 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.1 Cg_exo -61.84 141.53 90.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.998 1.799 . . . . 9.4399999999999995 108.744 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.44 -14.86 61.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.724 1.379 . . . . 11.74 114.724 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -84.21 -22.98 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.827 1.417 . . . . 11.65 114.827 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.31 149.12 50.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.144 0.429 . . . . 9.3599999999999994 111.325 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -114.59 -176.49 2.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.233 -0.284 . . . . 10.609999999999999 110.233 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.54 -55.35 26.29 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.604 1.335 . . . . 10.07 114.604 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -61.4 -26.53 67.91 Favored 'General case' 0 C--N 1.405 3.006 0 C-N-CA 125.72 1.608 . . . . 0.0 112.51 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.12 -48.28 13.46 Favored 'General case' 1 C--N 1.43 4.086 0 CA-C-N 118.283 0.492 . . . . 10.289999999999999 111.385 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.7 -49.16 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.6 . . . . 8.0 110.318 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -54.3 -36.36 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.678 -0.692 . . . . 10.199999999999999 111.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.01 -53.43 55.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.167 0.508 . . . . 10.199999999999999 110.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.65 -33.28 32.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.115 -0.493 . . . . 7.6200000000000001 110.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.48 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.52 -41.6 19.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.649 0.611 . . . . 7.7400000000000002 112.649 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 43.5 m -56.94 -29.96 63.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.48 0.919 . . . . 10.390000000000001 113.48 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 17.1 m -50.25 -10.02 0.05 Allowed 'General case' 0 C--N 1.395 2.58 0 C-N-CA 124.753 1.221 . . . . 0.0 112.641 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.46 -12.02 14.04 Favored 'General case' 1 C--N 1.444 4.699 0 CA-C-N 118.379 0.536 . . . . 10.23 111.503 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.36 10.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.821 -0.627 . . . . 10.98 111.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.6 147.11 93.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.72 2.28 . . . . 12.75 112.65 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 89.7 mt -102.56 146.27 28.39 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.959 -0.564 . . . . 10.66 111.241 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.01 -22.53 14.73 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.273 -0.64 . . . . 11.630000000000001 109.273 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -157.32 129.25 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.483 -2.011 . . . . 0.0 108.836 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.576 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -146.21 134.72 22.04 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.654 0.382 . . . . 9.0099999999999998 111.98 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -144.86 124.11 12.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.866 0.365 . . . . 8.7300000000000004 111.566 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 57.3 tp -100.99 118.17 36.47 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.584 -1.265 . . . . 8.9399999999999995 107.584 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.18 122.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.515 0.931 . . . . 9.7400000000000002 113.515 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -119.13 148.14 43.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.262 -0.881 . . . . 11.34 109.413 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.587 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.9 t70 -58.92 141.12 54.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.921 0.391 . . . . 13.83 110.914 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 50.0 m -49.71 -61.72 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.863 -0.608 . . . . 14.779999999999999 112.6 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.08 -64.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.471 0.545 . . . . 16.440000000000001 112.471 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.48 -59.32 1.91 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.306 -0.407 . . . . 15.24 111.214 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.04 62.54 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.613 -0.804 . . . . 13.609999999999999 114.528 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.35 167.6 13.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.334 0.567 . . . . 13.529999999999999 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.0 t -59.19 142.07 52.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 10.51 111.624 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.531 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.95 -9.43 53.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.793 -0.64 . . . . 11.73 109.569 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.31 39.53 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.67 -0.695 . . . . 8.6300000000000008 113.942 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -143.01 146.41 33.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.979 0.889 . . . . 9.3900000000000006 112.845 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.61 155.16 46.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.078 -0.965 . . . . 6.5499999999999998 112.169 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.25 146.81 36.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.077 -0.965 . . . . 7.4299999999999997 110.394 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.576 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.4 p -157.89 156.21 30.95 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 119.983 -0.687 . . . . 6.7699999999999996 111.871 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -145.3 127.09 15.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 9.5899999999999999 109.608 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.516 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 52.9 m-85 -82.46 164.85 20.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.932 0.396 . . . . 9.9100000000000001 112.045 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.55 -46.1 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 108.4 -0.963 . . . . 13.09 108.4 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.9 t70 -96.34 102.37 14.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.361 -1.348 . . . . 13.18 107.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.02 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 115.291 1.589 . . . . 12.48 115.291 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -56.78 -38.86 73.08 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.294 1.045 . . . . 13.4 109.014 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.52 -22.92 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 112.402 -2.181 . . . . 11.43 109.519 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.53 -48.24 72.2 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.896 -0.779 . . . . 9.5 108.896 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.5 -42.71 99.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.187 -0.605 . . . . 10.31 110.513 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.82 -32.43 73.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 119.939 -0.704 . . . . 12.41 111.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.78 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.67 -1.605 . . . . 8.3900000000000006 113.027 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.6 -51.23 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.393 0.616 . . . . 7.71 110.833 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.69 -39.0 67.68 Favored 'General case' 0 C--N 1.42 3.649 0 C-N-CA 126.301 1.84 . . . . 0.0 113.171 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.9 -24.09 36.39 Favored Glycine 1 C--N 1.399 4.08 0 N-CA-C 116.817 1.487 . . . . 8.7599999999999998 116.817 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.89 -45.86 6.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 120.189 1.994 . . . . 7.2000000000000002 113.892 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -50.4 129.99 22.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.812 0.339 . . . . 8.1099999999999994 111.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.19 -16.69 56.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.11 -0.567 . . . . 8.6400000000000006 113.905 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.57 147.21 4.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.868 0.334 . . . . 8.25 111.337 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -95.2 115.67 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.053 0.454 . . . . 10.48 111.681 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -120.19 106.75 12.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.146 -1.057 . . . . 8.9499999999999993 108.146 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.15 -118.75 10.62 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 109.343 -1.503 . . . . 10.630000000000001 109.343 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -115.8 22.4 13.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.243 0.544 . . . . 12.25 109.786 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.9 154.0 40.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.597 -0.729 . . . . 10.34 111.642 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.8 118.2 36.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.086 -1.079 . . . . 10.59 108.086 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.58 ' HB2' HD21 ' A' ' 325' ' ' LEU . 22.2 tp -63.0 143.06 58.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.485 0.659 . . . . 7.6500000000000004 112.687 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.13 127.94 43.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.555 -1.202 . . . . 7.7599999999999998 108.971 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.4 t -137.91 123.98 26.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 O-C-N 121.044 -1.035 . . . . 6.4500000000000002 109.966 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -152.69 155.29 36.96 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.117 -1.614 . . . . 7.8799999999999999 109.587 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.485 ' HA ' HD21 ' A' ' 261' ' ' LEU . 92.2 mtt180 -58.56 122.45 13.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 118.544 -1.263 . . . . 9.1999999999999993 107.603 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.97 -11.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.808 1.41 . . . . 7.5199999999999996 114.808 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.5 m -119.37 -77.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.629 -0.428 . . . . 9.3599999999999994 111.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.523 0.677 . . . . 0.0 110.744 179.023 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.625 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 5.7 mmt-85 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -159.85 149.34 18.05 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 123.259 0.623 . . . . 6.3499999999999996 111.628 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.47 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.7 mt -140.71 143.65 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 5.5099999999999998 111.281 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.62 125.15 40.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.853 -0.795 . . . . 6.8200000000000003 108.853 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.406 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 5.0899999999999999 110.33 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.66 -179.07 35.07 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.86 -0.609 . . . . 6.2000000000000002 112.823 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 49.79 41.73 22.76 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 125.214 1.406 . . . . 0.0 110.268 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.85 149.75 88.01 Favored Pre-proline 0 C--N 1.426 3.935 0 C-N-CA 123.684 0.794 . . . . 7.79 111.312 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 144.41 89.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.283 1.989 . . . . 8.9900000000000002 111.032 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.93 139.66 52.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 11.75 111.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.27 6.5 61.46 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.799 -0.637 . . . . 10.470000000000001 114.259 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.05 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.363 0.581 . . . . 8.9100000000000001 110.271 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.99 153.89 22.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 9.9100000000000001 110.6 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.1 -43.16 95.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 7.7599999999999998 110.257 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.68 -46.03 91.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.963 -0.562 . . . . 9.8900000000000006 110.616 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -26.71 68.58 Favored 'General case' 0 C--N 1.409 3.159 0 O-C-N 119.264 -2.148 . . . . 0.0 111.661 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.413 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.42 -34.06 67.58 Favored 'General case' 0 C--N 1.428 3.979 0 O-C-N 123.967 0.792 . . . . 6.7800000000000002 111.737 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.5 -54.34 7.73 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.481 0.713 . . . . 6.9699999999999998 111.115 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.55 -33.72 60.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.367 -0.833 . . . . 8.8000000000000007 111.387 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.78 -53.57 17.67 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 120.543 -0.463 . . . . 7.8700000000000001 111.576 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.413 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.3 m-85 -61.3 -48.34 81.84 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.145 0.424 . . . . 5.9400000000000004 112.145 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.78 -42.6 79.72 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.258 -0.577 . . . . 7.1200000000000001 109.608 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.29 64.72 Favored 'General case' 0 C--N 1.405 3.004 0 O-C-N 120.388 -1.445 . . . . 0.0 111.21 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.5 -37.67 36.17 Favored 'General case' 1 C--N 1.428 4.019 0 CA-C-N 118.455 0.57 . . . . 7.9299999999999997 110.298 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.45 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.8 83.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 7.7300000000000004 111.009 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.15 -42.95 45.03 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.387 0.514 . . . . 9.9600000000000009 112.387 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.0 -37.75 88.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.259 0.552 . . . . 10.42 110.492 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.02 -16.56 74.46 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.273 -0.965 . . . . 9.2300000000000004 112.886 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.26 37.01 71.22 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 110.873 -0.891 . . . . 9.6099999999999994 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.97 5.35 51.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.92 0.711 . . . . 8.4600000000000009 112.92 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.9 p -82.61 143.48 30.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.586 0.232 . . . . 9.1600000000000001 110.593 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.528 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.45 21.37 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.176 0.435 . . . . 10.23 112.176 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.8 163.46 23.78 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.632 -0.258 . . . . 10.24 110.694 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.35 143.54 99.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.965 1.777 . . . . 11.43 110.793 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.58 20.58 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.677 -0.773 . . . . 9.4499999999999993 112.505 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.033 0.383 . . . . 8.3300000000000001 112.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.521 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.25 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.454 2.103 . . . . 6.9699999999999998 111.32 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.453 ' O ' ' HE1' ' A' ' 166' ' ' MET . 22.0 t -69.67 105.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.132 -0.485 . . . . 5.8700000000000001 111.134 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -36.33 37.92 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 125.37 1.468 . . . . 0.0 112.954 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.13 164.36 38.62 Favored 'General case' 0 C--N 1.386 2.173 0 C-N-CA 125.826 1.651 . . . . 0.0 110.959 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.9 130.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 125.999 1.72 . . . . 5.6699999999999999 109.337 175.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.93 126.64 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.765 -0.458 . . . . 6.6799999999999997 109.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 126.0 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 116.941 2.2 . . . . 7.0999999999999996 116.941 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.12 91.37 5.24 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.149 -2.908 . . . . 8.1600000000000001 103.149 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.21 -57.43 7.8 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.662 1.727 . . . . 10.279999999999999 115.662 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.24 -48.69 75.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.877 0.695 . . . . 10.51 112.877 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.97 -9.22 51.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.716 0.293 . . . . 9.9399999999999995 111.77 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 36.11 15.0 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.53 1.307 . . . . 8.4499999999999993 114.53 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.56 168.63 19.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.093 -1.043 . . . . 7.25 111.612 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.56 161.12 41.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.18 -1.373 . . . . 5.1900000000000004 110.486 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.38 129.31 51.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.73 -0.841 . . . . 6.0899999999999999 108.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.81 137.5 33.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.44 -0.345 . . . . 4.2699999999999996 110.364 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.71 114.73 26.02 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.718 -0.475 . . . . 6.21 109.718 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.73 164.66 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 6.1399999999999997 111.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.56 -25.98 22.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.515 -0.766 . . . . 8.6899999999999995 111.392 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.0 p -128.95 159.57 35.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.094 0.473 . . . . 8.3300000000000001 111.521 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.28 -41.74 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 8.9600000000000009 112.266 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.528 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.7 t70 -64.63 -41.79 95.92 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.396 0.517 . . . . 9.2599999999999998 112.396 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.28 -0.267 . . . . 7.6200000000000001 110.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' A' ' 149' ' ' ARG . 55.9 m -54.17 -53.97 46.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 6.4199999999999999 108.123 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.6 m -55.07 -27.3 43.78 Favored 'General case' 1 C--N 1.43 4.066 0 C-N-CA 126.953 2.101 . . . . 0.0 109.863 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -34.0 43.69 Favored 'General case' 0 C--N 1.422 3.743 0 N-CA-C 113.657 0.984 . . . . 8.75 113.657 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.33 64.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.651 0.611 . . . . 5.9400000000000004 112.651 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.09 -19.85 63.41 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.493 1.12 . . . . 7.1500000000000004 111.614 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.35 53.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 7.7000000000000002 111.613 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.22 14.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.585 -0.279 . . . . 7.4699999999999998 111.658 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.89 121.02 14.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.827 0.346 . . . . 7.3799999999999999 110.782 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.83 66.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.855 -0.688 . . . . 7.9199999999999999 113.587 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.23 142.39 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.87 0.335 . . . . 7.71 111.153 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.93 121.57 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.245 0.545 . . . . 10.0 111.278 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.23 107.69 7.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 8.4499999999999993 110.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.74 42.7 13.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 10.44 111.747 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.44 54.03 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 115.219 0.847 . . . . 10.609999999999999 115.219 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -110.69 130.89 55.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.574 0.687 . . . . 10.279999999999999 112.358 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.48 10.86 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.587 -0.894 . . . . 8.8300000000000001 108.587 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.83 58.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.088 . . . . 6.9699999999999998 113.939 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.51 110.24 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.602 -1.259 . . . . 8.5099999999999998 107.602 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.02 126.96 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.265 0.555 . . . . 6.1699999999999999 112.289 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.405 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.49 15.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.332 -0.849 . . . . 8.3000000000000007 110.041 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.04 154.71 49.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.614 -0.884 . . . . 8.1400000000000006 108.614 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.52 175.12 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.929 1.753 . . . . 7.79 112.007 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 79.9 m80 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.953 0.406 . . . . 11.33 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.0 139.4 58.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 8.5 110.33 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 313' ' ' THR . 67.4 mt -109.8 143.96 38.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.944 -1.026 . . . . 6.5800000000000001 112.788 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -104.38 132.06 51.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.219 -1.4 . . . . 7.1399999999999997 107.219 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.99 121.26 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 109.59 -0.522 . . . . 5.6799999999999997 109.59 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.522 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.21 179.27 16.47 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.436 -0.888 . . . . 6.5700000000000003 112.648 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.607 -0.806 . . . . 8.0399999999999991 111.573 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.78 135.25 85.72 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.835 -0.182 . . . . 8.1600000000000001 111.477 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.84 141.47 90.13 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.955 1.77 . . . . 9.4399999999999995 108.795 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.34 -14.86 61.77 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.803 1.408 . . . . 11.74 114.803 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -84.14 -23.19 30.77 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.816 1.413 . . . . 11.65 114.816 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.33 149.13 50.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.17 0.441 . . . . 9.3599999999999994 111.368 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.404 ' O ' HG21 ' A' ' 275' ' ' VAL . 18.9 p-10 -114.39 -176.41 2.89 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.284 -0.265 . . . . 10.609999999999999 110.284 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -53.59 -55.46 25.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.629 1.344 . . . . 10.07 114.629 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -25.94 67.79 Favored 'General case' 0 C--N 1.406 3.026 0 C-N-CA 125.596 1.558 . . . . 0.0 112.478 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.18 -48.3 13.36 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.363 0.529 . . . . 10.289999999999999 111.378 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 271' ' ' ASN . 78.5 t -62.66 -49.19 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 8.0 110.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -54.25 -36.41 63.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 10.199999999999999 111.312 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.13 -53.27 57.83 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.096 0.474 . . . . 10.199999999999999 110.699 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.73 -33.23 33.77 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.146 -0.479 . . . . 7.6200000000000001 110.318 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.469 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.7 mt -82.54 -41.8 19.16 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.572 0.582 . . . . 7.7400000000000002 112.572 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.2 m -56.75 -29.67 62.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.65 0.981 . . . . 10.390000000000001 113.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.2 m -50.42 -10.15 0.06 Allowed 'General case' 0 C--N 1.397 2.652 0 C-N-CA 124.846 1.258 . . . . 0.0 112.558 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -111.52 -12.03 14.01 Favored 'General case' 1 C--N 1.444 4.678 0 CA-C-N 118.335 0.516 . . . . 10.23 111.495 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.32 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.826 -0.625 . . . . 10.98 111.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.63 147.07 93.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.276 . . . . 12.75 112.716 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 83.0 mt -102.42 146.32 28.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.899 -0.591 . . . . 10.66 111.244 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 18.9 ptpt -101.05 -22.57 14.7 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.274 -0.639 . . . . 11.630000000000001 109.274 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.38 126.43 5.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.142 -2.224 . . . . 0.0 109.088 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.546 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 52.5 t80 -143.76 134.79 25.51 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 122.774 0.43 . . . . 9.0099999999999998 112.006 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.77 124.01 12.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.513 -0.312 . . . . 8.7300000000000004 111.595 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 61.0 tp -101.01 118.3 36.74 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.512 -1.292 . . . . 8.9399999999999995 107.512 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.23 122.8 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.509 0.929 . . . . 9.7400000000000002 113.509 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -119.13 148.06 43.48 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.31 -0.859 . . . . 11.34 109.353 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 38.7 t70 -58.81 141.13 53.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.922 0.391 . . . . 13.83 110.979 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.8 m -49.72 -61.71 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.816 -0.629 . . . . 14.779999999999999 112.649 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.04 -64.01 1.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.512 0.56 . . . . 16.440000000000001 112.512 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 12.8 m -42.55 -59.23 1.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.293 -0.412 . . . . 15.24 111.241 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.14 62.59 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.53 -0.843 . . . . 13.609999999999999 114.492 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.3 167.6 13.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.435 0.618 . . . . 13.529999999999999 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.9 t -59.22 142.07 52.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.526 . . . . 10.51 111.606 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 24.1 mmtp -87.95 -9.38 53.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.783 -0.644 . . . . 11.73 109.581 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.49 -3.43 39.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.674 -0.694 . . . . 8.6300000000000008 113.929 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -142.98 146.46 33.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.133 0.966 . . . . 9.3900000000000006 112.812 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.455 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.62 155.18 46.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.041 -0.982 . . . . 6.5499999999999998 112.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -111.38 146.81 36.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.17 -0.923 . . . . 7.4299999999999997 110.333 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.5 p -157.8 156.21 31.11 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.972 -0.691 . . . . 6.7699999999999996 111.903 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -145.23 127.07 15.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.708 . . . . 9.5899999999999999 109.656 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.475 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 55.4 m-85 -82.36 164.88 20.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.097 0.406 . . . . 9.9100000000000001 112.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.54 -46.09 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.413 -0.958 . . . . 13.09 108.413 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 312' ' ' VAL . 13.8 t70 -96.35 102.36 14.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.388 -1.338 . . . . 13.18 107.388 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.74 -34.97 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.305 1.595 . . . . 12.48 115.305 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -56.87 -38.71 73.11 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.238 1.018 . . . . 13.4 109.016 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.75 -22.58 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 112.243 -2.253 . . . . 11.43 109.594 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 88.5 m -54.67 -48.2 72.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.932 -0.766 . . . . 9.5 108.932 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.43 -42.83 99.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.245 -0.582 . . . . 10.31 110.52 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -63.83 -32.41 73.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.931 -0.708 . . . . 12.41 111.9 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.78 74.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.781 -1.554 . . . . 8.3900000000000006 113.052 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.63 -51.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.373 0.606 . . . . 7.71 110.857 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.8 -38.59 67.49 Favored 'General case' 0 C--N 1.421 3.678 0 C-N-CA 126.289 1.836 . . . . 0.0 113.166 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.03 -24.1 35.96 Favored Glycine 1 C--N 1.398 4.007 0 N-CA-C 116.847 1.499 . . . . 8.7599999999999998 116.847 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 330' ' ' LEU . 88.1 mt -96.84 -45.77 6.51 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.117 1.958 . . . . 7.2000000000000002 113.956 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -50.47 130.04 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.883 0.373 . . . . 8.1099999999999994 111.511 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.24 -16.79 56.56 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.056 -0.592 . . . . 8.6400000000000006 113.975 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.5 ttt -50.61 147.17 4.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.729 0.299 . . . . 8.25 111.324 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -95.08 115.55 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 10.48 111.751 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 330' ' ' LEU . 8.3 mp -120.16 106.74 12.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.127 -1.064 . . . . 8.9499999999999993 108.127 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.09 -118.64 10.53 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.408 -1.477 . . . . 10.630000000000001 109.408 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -115.9 22.51 12.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.169 0.509 . . . . 12.25 109.765 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -123.9 153.91 40.45 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.64 -0.709 . . . . 10.34 111.599 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.69 118.28 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.078 -1.082 . . . . 10.59 108.078 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 325' ' ' LEU . 22.4 tp -63.07 143.17 58.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.519 0.676 . . . . 7.6500000000000004 112.707 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 90.0 mt -128.14 127.97 43.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.593 -1.185 . . . . 7.7599999999999998 108.962 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.92 124.04 26.29 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 O-C-N 120.96 -1.088 . . . . 6.4500000000000002 109.999 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.71 155.34 37.04 Favored 'General case' 0 N--CA 1.432 -1.367 0 O-C-N 119.986 -1.696 . . . . 7.8799999999999999 109.561 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.477 ' HA ' HD21 ' A' ' 261' ' ' LEU . 83.3 mtt180 -58.61 122.44 13.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 118.453 -1.299 . . . . 9.1999999999999993 107.612 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.93 -11.76 0.1 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.794 1.405 . . . . 7.5199999999999996 114.794 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.9 m -119.45 -77.68 0.58 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.532 -0.467 . . . . 9.3599999999999994 111.156 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 8.2 m . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.33 0.586 . . . . 0.0 111.305 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.958 0.408 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.51 148.5 21.43 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.608 -0.724 . . . . 6.3499999999999996 111.196 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.558 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.7 mt -140.77 143.54 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 5.5099999999999998 111.218 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.52 125.21 40.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.855 -0.795 . . . . 6.8200000000000003 108.855 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.83 101.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.134 0.493 . . . . 5.0899999999999999 110.253 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.72 -178.86 35.03 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.921 -0.581 . . . . 6.2000000000000002 112.765 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.5 m120 51.17 39.97 24.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.993 1.317 . . . . 0.0 110.195 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.58 149.76 88.64 Favored Pre-proline 1 C--N 1.43 4.103 0 C-N-CA 123.525 0.73 . . . . 7.79 111.366 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.99 144.45 89.49 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.325 2.017 . . . . 8.9900000000000002 110.924 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -69.99 139.72 52.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.991 0.424 . . . . 11.75 111.916 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.22 6.49 61.26 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.755 -0.657 . . . . 10.470000000000001 114.277 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 117.395 0.597 . . . . 8.9100000000000001 110.281 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.559 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 36.1 p -84.82 153.88 22.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 9.9100000000000001 110.636 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.27 95.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 7.7599999999999998 110.203 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.55 -46.07 91.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.979 -0.555 . . . . 9.8900000000000006 110.568 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.559 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.73 -26.22 68.58 Favored 'General case' 0 C--N 1.41 3.22 0 O-C-N 119.25 -2.156 . . . . 0.0 111.658 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.416 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.39 -34.16 67.7 Favored 'General case' 1 C--N 1.429 4.046 0 O-C-N 123.949 0.781 . . . . 6.7800000000000002 111.758 171.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.47 -54.4 7.64 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.412 0.685 . . . . 6.9699999999999998 111.079 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.46 -33.76 60.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.397 -0.819 . . . . 8.8000000000000007 111.403 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.76 -53.66 17.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 120.472 -0.491 . . . . 7.8700000000000001 111.543 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.3 m-85 -61.22 -48.23 82.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 5.9400000000000004 112.255 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.75 -42.85 80.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.351 -0.54 . . . . 7.1200000000000001 109.579 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.1 -23.31 64.9 Favored 'General case' 0 C--N 1.407 3.09 0 O-C-N 120.279 -1.513 . . . . 0.0 111.276 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.4 -37.7 36.58 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.468 0.576 . . . . 7.9299999999999997 110.325 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.464 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.76 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.512 -0.767 . . . . 7.7300000000000004 111.062 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.6 mtt-85 -75.93 -43.36 45.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.377 0.51 . . . . 9.9600000000000009 112.377 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.73 -37.86 88.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.177 0.513 . . . . 10.42 110.47 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.9 -16.56 74.71 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.307 -0.949 . . . . 9.2300000000000004 112.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.29 36.95 70.83 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.809 -0.917 . . . . 9.6099999999999994 110.809 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.84 5.25 51.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.888 0.699 . . . . 8.4600000000000009 112.888 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.59 143.46 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.588 0.233 . . . . 9.1600000000000001 110.573 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.531 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.52 21.3 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.138 0.421 . . . . 10.23 112.138 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.56 23.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.722 -0.217 . . . . 10.24 110.735 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.41 143.54 99.68 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.947 1.765 . . . . 11.43 110.798 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.54 20.57 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 120.558 -0.83 . . . . 9.4499999999999993 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.36 73.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 8.3300000000000001 112.051 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.473 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.23 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.543 2.162 . . . . 6.9699999999999998 111.308 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.439 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.68 105.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.117 -0.492 . . . . 5.8700000000000001 111.161 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 71.39 0.74 Allowed 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 124.636 1.175 . . . . 0.0 109.31 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.13 151.1 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 129.44 3.096 . . . . 0.0 112.946 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.41 130.55 8.39 Favored 'Isoleucine or valine' 0 C--N 1.374 1.64 0 C-N-CA 129.288 3.035 . . . . 5.6699999999999999 109.31 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.19 126.55 55.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.772 -0.455 . . . . 6.6799999999999997 109.772 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.9 125.97 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 116.983 2.216 . . . . 7.0999999999999996 116.983 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.42 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 103.157 -2.905 . . . . 8.1600000000000001 103.157 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.28 -57.38 7.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.678 1.733 . . . . 10.279999999999999 115.678 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.82 75.48 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.852 0.686 . . . . 10.51 112.852 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.16 50.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 9.9399999999999995 111.847 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.18 36.05 15.22 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.548 1.314 . . . . 8.4499999999999993 114.548 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.44 168.67 19.27 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.081 -1.047 . . . . 7.25 111.629 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.6 161.06 41.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.022 -1.445 . . . . 5.1900000000000004 110.483 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.37 129.41 51.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.662 -0.866 . . . . 6.0899999999999999 108.662 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.361 -0.382 . . . . 4.2699999999999996 110.288 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.68 25.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.482 . . . . 6.21 109.697 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -99.73 164.69 11.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.016 -0.538 . . . . 6.1399999999999997 111.981 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.88 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.432 -0.804 . . . . 8.6899999999999995 111.46 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.8 p -128.91 159.61 35.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.114 0.483 . . . . 8.3300000000000001 111.612 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.74 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 8.9600000000000009 112.257 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.531 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.71 -41.76 95.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.424 0.527 . . . . 9.2599999999999998 112.424 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.86 98.0 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.268 -0.271 . . . . 7.6200000000000001 110.268 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.558 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.6 m -54.15 -54.0 45.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.125 -1.065 . . . . 6.4199999999999999 108.125 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.7 m -55.31 -26.93 43.58 Favored 'General case' 1 C--N 1.43 4.081 0 C-N-CA 126.977 2.111 . . . . 0.0 109.878 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.15 -34.14 43.49 Favored 'General case' 0 C--N 1.421 3.683 0 N-CA-C 113.642 0.979 . . . . 8.75 113.642 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.52 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.653 0.612 . . . . 5.9400000000000004 112.653 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.88 63.42 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.309 1.006 . . . . 7.1500000000000004 111.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.31 53.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.416 -0.357 . . . . 7.7000000000000002 111.647 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.19 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 7.4699999999999998 111.666 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.89 121.04 14.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 7.3799999999999999 110.751 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.71 -4.75 66.38 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 7.9199999999999999 113.615 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.855 0.327 . . . . 7.71 111.094 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.96 121.61 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.311 0.577 . . . . 10.0 111.332 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.76 7.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.4499999999999993 110.287 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.75 42.67 13.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.035 -0.53 . . . . 10.44 111.724 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.03 -5.47 53.88 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 115.247 0.859 . . . . 10.609999999999999 115.247 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.59 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.615 0.708 . . . . 10.279999999999999 112.417 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.88 101.49 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.542 -0.91 . . . . 8.8300000000000001 108.542 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.3 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.036 1.124 . . . . 6.9699999999999998 114.036 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.414 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.55 110.26 21.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.57 -1.27 . . . . 8.5099999999999998 107.57 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.98 126.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.405 0.52 . . . . 6.1699999999999999 112.405 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.414 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.52 170.5 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.48 -0.782 . . . . 8.3000000000000007 110.093 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.65 49.52 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.515 -0.92 . . . . 8.1400000000000006 108.515 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.43 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.953 1.769 . . . . 7.79 112.012 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 120.931 0.396 . . . . 11.33 110.862 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.94 139.33 58.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 8.5 110.365 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 334' ' ' ARG . 62.5 mt -109.79 144.07 38.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.076 -0.966 . . . . 6.5800000000000001 112.826 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -104.47 132.02 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.228 -1.397 . . . . 7.1399999999999997 107.228 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.95 121.2 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.608 -0.516 . . . . 5.6799999999999997 109.608 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.21 179.19 16.52 Favored Glycine 0 CA--C 1.508 -0.389 0 C-N-CA 120.446 -0.883 . . . . 6.5700000000000003 112.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.89 9.17 86.73 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.566 -0.826 . . . . 8.0399999999999991 111.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.85 135.3 85.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 111.427 0.158 . . . . 8.1600000000000001 111.427 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.85 141.48 90.14 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.962 1.775 . . . . 9.4399999999999995 108.833 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -65.39 -14.83 61.76 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.788 1.403 . . . . 11.74 114.788 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -84.18 -23.13 30.71 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.788 1.403 . . . . 11.65 114.788 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.33 149.18 50.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.112 0.415 . . . . 9.3599999999999994 111.344 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.403 ' O ' HG21 ' A' ' 275' ' ' VAL . 31.0 p-10 -114.43 -176.44 2.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.608 -0.269 . . . . 10.609999999999999 110.279 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.55 -55.11 28.36 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.624 1.342 . . . . 10.07 114.624 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.94 -27.74 68.45 Favored 'General case' 0 C--N 1.406 3.052 0 C-N-CA 125.873 1.669 . . . . 0.0 112.332 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -79.64 -48.28 14.0 Favored 'General case' 1 C--N 1.429 4.065 0 O-C-N 123.486 0.491 . . . . 10.289999999999999 111.388 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 271' ' ' ASN . 72.1 t -62.72 -49.17 84.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 8.0 110.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -54.24 -36.49 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 10.199999999999999 111.27 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.92 -53.39 56.44 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.156 0.503 . . . . 10.199999999999999 110.728 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 278' ' ' LEU . 0.8 OUTLIER -51.8 -33.14 34.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.064 -0.516 . . . . 7.6200000000000001 110.374 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.469 HD11 ' SG ' ' A' ' 305' ' ' CYS . 84.5 mt -82.62 -41.67 19.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.566 0.58 . . . . 7.7400000000000002 112.566 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.0 m -56.87 -29.65 63.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.6 0.963 . . . . 10.390000000000001 113.6 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.5 m -50.36 -10.33 0.06 Allowed 'General case' 0 C--N 1.395 2.552 0 C-N-CA 124.809 1.244 . . . . 0.0 112.544 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -111.42 -11.94 14.07 Favored 'General case' 1 C--N 1.442 4.618 0 CA-C-N 118.281 0.491 . . . . 10.23 111.521 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.08 162.24 10.2 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.78 -0.646 . . . . 10.98 111.932 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.56 147.05 93.38 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.694 2.263 . . . . 12.75 112.736 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.7 mt -102.44 146.3 28.29 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.862 -0.608 . . . . 10.66 111.25 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.545 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 15.4 ptpt -101.14 -21.51 14.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.2 -0.667 . . . . 11.630000000000001 109.2 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -159.94 128.56 4.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.213 -2.179 . . . . 0.0 108.798 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.2 t80 -145.07 134.69 23.34 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.084 0.553 . . . . 9.0099999999999998 112.005 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -144.8 124.09 13.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.809 0.338 . . . . 8.7300000000000004 111.536 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 59.5 tp -100.99 118.23 36.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.578 -1.267 . . . . 8.9399999999999995 107.578 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.17 122.91 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 9.7400000000000002 113.457 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -119.15 148.15 43.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.297 -0.865 . . . . 11.34 109.371 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 34.1 t70 -58.96 141.17 54.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.893 0.378 . . . . 13.83 110.943 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.1 m -49.73 -61.69 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.653 0.612 . . . . 14.779999999999999 112.653 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.11 -63.97 1.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.468 0.544 . . . . 16.440000000000001 112.468 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.1 m -42.51 -59.32 1.92 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.265 -0.425 . . . . 15.24 111.228 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.03 62.5 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 120.617 -0.801 . . . . 13.609999999999999 114.503 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 79.9 mt -88.38 167.63 13.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.339 0.57 . . . . 13.529999999999999 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -59.32 142.22 52.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.529 . . . . 10.51 111.684 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.404 ' NZ ' ' HB3' ' A' ' 300' ' ' LYS . 3.8 mmmp? -87.89 -9.51 53.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 11.73 109.561 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.62 -3.34 39.42 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.625 -0.716 . . . . 8.6300000000000008 113.89 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -143.06 146.35 33.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.055 0.927 . . . . 9.3900000000000006 112.814 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.444 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.21 46.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.085 -0.961 . . . . 6.5499999999999998 112.206 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.39 146.84 36.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.996 -1.002 . . . . 7.4299999999999997 110.395 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.561 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 20.4 p -157.84 156.22 31.06 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 119.929 -0.708 . . . . 6.7699999999999996 111.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -145.37 127.05 15.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.613 -0.722 . . . . 9.5899999999999999 109.628 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.545 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 51.2 m-85 -82.38 164.91 20.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.98 0.419 . . . . 9.9100000000000001 112.071 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.6 -46.05 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.463 -0.94 . . . . 13.09 108.463 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 312' ' ' VAL . 15.1 t70 -96.32 102.36 14.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.41 -1.33 . . . . 13.18 107.41 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.532 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.76 -34.96 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 N-CA-C 115.244 1.572 . . . . 12.48 115.244 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -56.77 -38.83 73.03 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 122.305 1.05 . . . . 13.4 109.048 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 309' ' ' ASP . 1.9 m -62.65 -22.81 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 112.283 -2.235 . . . . 11.43 109.518 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.5 m -54.52 -48.2 72.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.918 -0.771 . . . . 9.5 108.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.49 -42.8 99.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.239 -0.584 . . . . 10.31 110.521 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.89 -0.724 . . . . 12.41 111.974 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.73 74.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.647 -1.615 . . . . 8.3900000000000006 113.076 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.61 -51.29 47.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 7.71 110.864 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.39 67.71 Favored 'General case' 0 C--N 1.421 3.679 0 C-N-CA 126.211 1.805 . . . . 0.0 113.296 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.488 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.18 -24.0 35.85 Favored Glycine 1 C--N 1.4 4.125 0 N-CA-C 116.779 1.472 . . . . 8.7599999999999998 116.779 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.4 ' O ' HD21 ' A' ' 330' ' ' LEU . 98.1 mt -96.93 -45.69 6.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.193 1.997 . . . . 7.2000000000000002 113.957 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -50.52 130.03 23.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.844 0.354 . . . . 8.1099999999999994 111.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.22 -16.81 56.48 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.151 -0.547 . . . . 8.6400000000000006 113.977 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.488 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 19.0 mtt -50.53 147.15 4.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.723 0.297 . . . . 8.25 111.363 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -95.0 115.6 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.018 0.437 . . . . 10.48 111.759 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 330' ' ' LEU . 8.8 mp -120.25 106.72 12.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.094 -1.076 . . . . 8.9499999999999993 108.094 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.11 -118.75 10.65 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.347 -1.501 . . . . 10.630000000000001 109.347 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -115.8 22.45 13.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 12.25 109.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.83 153.95 40.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.682 -0.69 . . . . 10.34 111.685 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.74 118.26 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.139 -1.06 . . . . 10.59 108.139 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 325' ' ' LEU . 22.7 tp -63.11 143.08 58.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.547 0.689 . . . . 7.6500000000000004 112.601 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.08 128.0 44.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.563 -1.199 . . . . 7.7599999999999998 109.032 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.98 124.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 O-C-N 120.99 -1.069 . . . . 6.4500000000000002 109.945 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -152.79 155.33 36.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 120.126 -1.609 . . . . 7.8799999999999999 109.514 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.488 ' HA ' HD21 ' A' ' 261' ' ' LEU . 69.7 mtt85 -58.68 122.57 13.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 118.418 -1.313 . . . . 9.1999999999999993 107.617 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.98 -11.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.756 1.391 . . . . 7.5199999999999996 114.756 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.4 m -119.46 -78.18 0.58 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.641 -0.424 . . . . 9.3599999999999994 111.21 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.467 -179.681 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 120.843 0.354 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -155.83 148.44 23.96 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.072 0.949 . . . . 6.3499999999999996 111.087 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.7 mt -140.75 143.54 35.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 5.5099999999999998 111.171 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.62 125.18 40.91 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.891 -0.781 . . . . 6.8200000000000003 108.891 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.78 101.27 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.077 0.465 . . . . 5.0899999999999999 110.166 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.74 -178.57 35.06 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.895 -0.593 . . . . 6.2000000000000002 112.766 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.16 40.81 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.031 1.333 . . . . 0.0 110.151 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.79 149.85 88.2 Favored Pre-proline 1 C--N 1.429 4.062 0 C-N-CA 123.478 0.711 . . . . 7.79 111.33 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.01 144.43 89.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.251 1.967 . . . . 8.9900000000000002 111.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -69.91 139.66 53.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.429 . . . . 11.75 111.954 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.05 6.76 61.16 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.745 -0.661 . . . . 10.470000000000001 114.298 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 117.314 0.557 . . . . 8.9100000000000001 110.245 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.79 153.88 22.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 9.9100000000000001 110.692 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.25 95.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 7.7599999999999998 110.174 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.6 -46.12 91.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.064 -0.517 . . . . 9.8900000000000006 110.548 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.59 68.52 Favored 'General case' 0 C--N 1.409 3.179 0 O-C-N 119.261 -2.149 . . . . 0.0 111.675 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.417 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.4 -34.11 67.65 Favored 'General case' 0 C--N 1.427 3.975 0 O-C-N 123.889 0.743 . . . . 6.7800000000000002 111.727 172.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.437 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.61 -54.3 7.72 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.51 0.724 . . . . 6.9699999999999998 111.052 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.52 -33.73 60.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.43 -0.804 . . . . 8.8000000000000007 111.381 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.52 17.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 120.43 -0.508 . . . . 7.8700000000000001 111.617 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.417 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.114 0.413 . . . . 5.9400000000000004 112.114 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.0 m-20 -56.83 -43.0 80.63 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.547 -0.538 . . . . 7.1200000000000001 109.547 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -23.53 65.18 Favored 'General case' 0 C--N 1.406 3.026 0 O-C-N 120.192 -1.567 . . . . 0.0 111.231 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.35 -37.67 36.91 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.546 0.612 . . . . 7.9299999999999997 110.31 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.454 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.81 83.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.498 -0.774 . . . . 7.7300000000000004 111.033 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.4 mtt-85 -76.1 -43.03 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.37 0.507 . . . . 9.9600000000000009 112.37 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.99 -37.76 88.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.193 0.52 . . . . 10.42 110.388 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.11 -16.39 74.64 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.239 -0.981 . . . . 9.2300000000000004 112.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.98 71.59 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.888 -0.885 . . . . 9.6099999999999994 110.888 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.3 51.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.941 0.719 . . . . 8.4600000000000009 112.941 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.489 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.64 143.44 30.98 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.129 -0.228 . . . . 9.1600000000000001 110.665 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.527 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.51 21.34 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.45 23.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.691 -0.231 . . . . 10.24 110.722 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.32 143.45 99.73 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.997 1.798 . . . . 11.43 110.771 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.37 161.62 20.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.642 -0.789 . . . . 9.4499999999999993 112.465 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.8 m-20 -75.33 134.49 73.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 8.3300000000000001 112.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.33 -50.97 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.519 2.146 . . . . 6.9699999999999998 111.315 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.437 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.71 105.32 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.111 -0.495 . . . . 5.8700000000000001 111.146 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -37.59 40.47 Favored 'General case' 0 N--CA 1.533 3.68 0 C-N-CA 125.508 1.523 . . . . 0.0 112.848 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.38 164.48 38.09 Favored 'General case' 0 C--N 1.387 2.224 0 C-N-CA 125.938 1.695 . . . . 0.0 110.891 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.08 130.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.372 1.573 0 C-N-CA 126.291 1.836 . . . . 5.6699999999999999 109.329 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.12 126.65 55.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.475 . . . . 6.6799999999999997 109.716 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.91 125.92 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 116.937 2.199 . . . . 7.0999999999999996 116.937 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.34 5.24 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 103.182 -2.896 . . . . 8.1600000000000001 103.182 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.26 -57.34 8.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.676 1.732 . . . . 10.279999999999999 115.676 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.15 -48.87 75.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.831 0.678 . . . . 10.51 112.831 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.96 -9.12 50.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.768 0.285 . . . . 9.9399999999999995 111.768 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.07 36.17 15.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.547 1.314 . . . . 8.4499999999999993 114.547 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -143.5 168.73 19.16 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.118 -1.033 . . . . 7.25 111.661 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.63 161.03 41.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.031 -1.44 . . . . 5.1900000000000004 110.518 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.4 129.41 51.24 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.676 -0.861 . . . . 6.0899999999999999 108.676 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.75 137.58 33.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.361 . . . . 4.2699999999999996 110.359 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -114.86 114.68 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.703 -0.48 . . . . 6.21 109.703 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.68 164.65 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 6.1399999999999997 111.951 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.93 22.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.439 -0.8 . . . . 8.6899999999999995 111.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.2 p -128.92 159.59 35.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.155 0.503 . . . . 8.3300000000000001 111.607 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.21 -41.82 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.59 -0.732 . . . . 8.9600000000000009 112.247 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.7 -41.73 95.8 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.339 0.496 . . . . 9.2599999999999998 112.339 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.88 -43.89 97.93 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.202 -0.295 . . . . 7.6200000000000001 110.202 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 151' ' ' LEU . 56.0 m -54.17 -53.88 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.159 -1.052 . . . . 6.4199999999999999 108.159 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.47 ' HG1' HH22 ' A' ' 228' ' ' ARG . 16.1 m -55.1 -27.2 43.33 Favored 'General case' 1 C--N 1.429 4.051 0 C-N-CA 127.127 2.171 . . . . 0.0 109.739 178.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.46 -33.95 41.9 Favored 'General case' 0 C--N 1.423 3.779 0 N-CA-C 113.6 0.963 . . . . 8.75 113.6 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.62 -17.3 64.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 5.9400000000000004 112.638 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.12 -19.84 63.43 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.377 1.048 . . . . 7.1500000000000004 111.556 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.3 53.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.456 -0.338 . . . . 7.7000000000000002 111.656 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.85 16.18 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.466 -0.333 . . . . 7.4699999999999998 111.651 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.82 120.96 13.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 7.3799999999999999 110.75 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.83 -4.79 66.09 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.884 -0.674 . . . . 7.9199999999999999 113.579 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.833 0.316 . . . . 7.71 111.098 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.0 121.63 37.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.35 0.595 . . . . 10.0 111.286 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.36 107.67 7.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 8.4499999999999993 110.357 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.69 42.64 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 10.44 111.767 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.08 -5.45 54.18 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.248 0.859 . . . . 10.609999999999999 115.248 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.58 130.94 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.627 0.713 . . . . 10.279999999999999 112.375 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.53 10.95 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.506 -0.924 . . . . 8.8300000000000001 108.506 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.89 58.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.979 1.103 . . . . 6.9699999999999998 113.979 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.411 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.8 tttt -108.59 110.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.477 -1.305 . . . . 8.5099999999999998 107.477 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.98 126.89 58.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.36 0.504 . . . . 6.1699999999999999 112.36 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.61 170.46 15.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.388 -0.824 . . . . 8.3000000000000007 110.019 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.47 HH22 ' HG1' ' A' ' 209' ' ' THR . 3.5 mtp180 -89.02 154.67 49.74 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.635 -0.876 . . . . 8.1400000000000006 108.635 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.21 174.82 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.985 1.79 . . . . 7.79 111.982 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.4 t60 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.566 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.908 0.385 . . . . 11.33 110.791 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.91 139.37 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 8.5 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 334' ' ' ARG . 52.2 mt -109.77 143.95 38.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.019 -0.991 . . . . 6.5800000000000001 112.849 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -104.39 132.05 51.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.138 -1.43 . . . . 7.1399999999999997 107.138 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.425 HD12 ' HG ' ' A' ' 305' ' ' CYS . 4.1 mp -127.03 121.25 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.601 -0.518 . . . . 5.6799999999999997 109.601 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.524 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.17 179.2 16.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.444 -0.884 . . . . 6.5700000000000003 112.71 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.19 86.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.668 -0.777 . . . . 8.0399999999999991 111.532 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.3 mt -70.89 135.32 85.47 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 111.465 0.172 . . . . 8.1600000000000001 111.465 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.0 Cg_exo -61.79 141.54 90.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.95 1.767 . . . . 9.4399999999999995 108.792 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.39 -14.87 61.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.759 1.392 . . . . 11.74 114.759 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -84.15 -23.18 30.74 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.758 1.392 . . . . 11.65 114.758 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.26 149.18 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.165 0.439 . . . . 9.3599999999999994 111.388 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.403 ' O ' HG21 ' A' ' 275' ' ' VAL . 37.7 p-10 -114.59 -176.4 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.207 -0.294 . . . . 10.609999999999999 110.207 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.56 -55.3 26.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.617 1.34 . . . . 10.07 114.617 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -27.05 68.21 Favored 'General case' 0 C--N 1.407 3.084 0 C-N-CA 125.565 1.546 . . . . 0.0 112.392 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.59 -48.3 14.02 Favored 'General case' 1 C--N 1.429 4.024 0 CA-C-N 118.263 0.483 . . . . 10.289999999999999 111.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 271' ' ' ASN . 66.2 t -62.65 -49.26 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 8.0 110.285 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.25 -36.41 63.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.635 -0.711 . . . . 10.199999999999999 111.279 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.12 -53.35 56.63 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.052 0.453 . . . . 10.199999999999999 110.642 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.8 -33.17 34.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.889 0.476 . . . . 7.6200000000000001 110.283 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.506 HD11 ' SG ' ' A' ' 305' ' ' CYS . 85.2 mt -82.6 -41.7 19.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.552 0.575 . . . . 7.7400000000000002 112.552 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.6 m -56.82 -30.69 63.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.589 0.959 . . . . 10.390000000000001 113.589 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.6 m -52.4 -7.73 0.07 Allowed 'General case' 0 C--N 1.397 2.65 0 O-C-N 120.602 -1.311 . . . . 0.0 112.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -110.31 -12.05 14.48 Favored 'General case' 1 C--N 1.443 4.67 0 CA-C-N 118.413 0.552 . . . . 10.23 111.492 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.09 162.28 10.22 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.775 -0.648 . . . . 10.98 111.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.54 146.98 93.6 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.776 2.317 . . . . 12.75 112.746 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 73.0 mt -102.43 146.27 28.32 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.935 -0.575 . . . . 10.66 111.348 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.98 -22.73 14.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.256 -0.646 . . . . 11.630000000000001 109.256 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.15 5.08 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.155 -2.216 . . . . 0.0 109.159 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.612 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -143.39 134.68 25.94 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.785 0.434 . . . . 9.0099999999999998 111.98 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.75 124.05 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.547 -0.297 . . . . 8.7300000000000004 111.58 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 53.0 tp -101.06 118.21 36.55 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.634 -1.247 . . . . 8.9399999999999995 107.634 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.11 122.87 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.469 0.915 . . . . 9.7400000000000002 113.469 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.07 148.1 43.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.359 -0.837 . . . . 11.34 109.345 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.586 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.3 t70 -58.89 141.19 54.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.894 0.378 . . . . 13.83 110.984 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.5 m -49.82 -61.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.842 -0.617 . . . . 14.779999999999999 112.571 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.09 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.527 0.566 . . . . 16.440000000000001 112.527 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.4 m -42.5 -59.25 1.94 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 15.24 111.184 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.61 -6.08 62.66 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.62 -0.8 . . . . 13.609999999999999 114.493 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.35 167.64 13.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.415 0.608 . . . . 13.529999999999999 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.9 t -59.21 142.07 52.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 10.51 111.58 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.587 ' HB3' ' HZ3' ' A' ' 300' ' ' LYS . 4.1 mmmp? -87.91 -9.43 53.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.762 -0.653 . . . . 11.73 109.627 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.32 39.63 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.68 -0.691 . . . . 8.6300000000000008 113.892 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.96 146.33 33.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.054 0.927 . . . . 9.3900000000000006 112.92 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.19 46.71 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.158 -0.928 . . . . 6.5499999999999998 112.213 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.37 146.77 36.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 7.4299999999999997 110.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.612 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 23.1 p -157.73 156.18 31.2 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.906 -0.717 . . . . 6.7699999999999996 111.928 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -145.2 127.07 15.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.722 -0.672 . . . . 9.5899999999999999 109.716 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 54.8 m-85 -82.47 164.88 20.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.932 0.396 . . . . 9.9100000000000001 112.025 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.58 -46.12 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.369 -0.975 . . . . 13.09 108.369 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.9 t70 -96.3 102.37 14.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.385 -1.339 . . . . 13.18 107.385 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.04 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 115.293 1.59 . . . . 12.48 115.293 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -56.85 -38.68 73.02 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 122.263 1.03 . . . . 13.4 109.005 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.75 -22.65 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.322 -2.217 . . . . 11.43 109.578 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.9 m -54.72 -48.07 72.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.966 -0.753 . . . . 9.5 108.966 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.52 -42.67 99.67 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.138 -0.625 . . . . 10.31 110.554 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -63.94 -32.33 73.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.867 -0.733 . . . . 12.41 111.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.78 74.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.791 -1.55 . . . . 8.3900000000000006 113.021 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.58 -51.36 47.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.384 0.611 . . . . 7.71 110.872 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.7 67.78 Favored 'General case' 0 C--N 1.421 3.712 0 C-N-CA 126.273 1.829 . . . . 0.0 113.086 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.473 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.06 -23.97 36.33 Favored Glycine 1 C--N 1.401 4.188 0 N-CA-C 116.807 1.483 . . . . 8.7599999999999998 116.807 177.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.406 ' O ' HD21 ' A' ' 330' ' ' LEU . 99.0 mt -96.89 -45.75 6.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.19 1.995 . . . . 7.2000000000000002 113.984 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -50.47 130.14 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.851 0.358 . . . . 8.1099999999999994 111.468 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.04 -16.64 56.61 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.134 -0.555 . . . . 8.6400000000000006 113.983 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.473 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 17.2 mtt -50.61 147.19 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.836 0.318 . . . . 8.25 111.302 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -95.09 115.57 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 10.48 111.662 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.6 mm? -120.16 106.72 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.111 -1.07 . . . . 8.9499999999999993 108.111 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.13 -118.65 10.52 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.406 -1.477 . . . . 10.630000000000001 109.406 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -115.94 22.48 12.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.145 0.498 . . . . 12.25 109.741 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 328' ' ' LYS . 34.1 mtpt -123.89 153.91 40.46 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.597 -0.729 . . . . 10.34 111.583 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.76 118.28 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.116 -1.068 . . . . 10.59 108.116 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 325' ' ' LEU . 22.3 tp -63.11 143.22 57.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.537 0.684 . . . . 7.6500000000000004 112.612 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.5 tp -128.21 128.01 43.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.486 -1.234 . . . . 7.7599999999999998 108.961 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.02 124.0 25.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 O-C-N 121.038 -1.039 . . . . 6.4500000000000002 109.955 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.73 155.34 37.02 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.938 -1.726 . . . . 7.8799999999999999 109.488 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.504 ' HA ' HD21 ' A' ' 261' ' ' LEU . 99.2 mtt180 -58.62 122.51 13.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.422 -1.311 . . . . 9.1999999999999993 107.59 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.88 -11.82 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.795 1.406 . . . . 7.5199999999999996 114.795 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' SER . . . . . 0.498 ' O ' ' HB ' ' A' ' 337' ' ' VAL . 17.3 m -119.4 -75.9 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.613 -0.435 . . . . 9.3599999999999994 111.303 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 336' ' ' SER . 70.0 t . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.415 0.15 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.01 148.53 22.31 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.832 0.708 . . . . 6.3499999999999996 111.351 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.5 mt -140.65 143.54 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 5.5099999999999998 111.21 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -96.6 125.21 40.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 6.8200000000000003 108.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 198' ' ' ALA . 2.3 p -124.84 101.3 8.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.512 . . . . 5.0899999999999999 110.199 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.76 34.62 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.983 -0.553 . . . . 6.2000000000000002 112.734 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 m120 49.21 42.54 21.75 Favored 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.649 1.58 . . . . 0.0 110.391 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.28 149.84 89.35 Favored Pre-proline 0 C--N 1.426 3.929 0 CA-C-N 114.95 -1.023 . . . . 7.79 111.333 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.06 144.5 89.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.341 2.027 . . . . 8.9900000000000002 110.972 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.95 139.71 52.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 11.75 111.947 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.53 61.03 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.837 -0.619 . . . . 10.470000000000001 114.32 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.1 136.47 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.332 0.566 . . . . 8.9100000000000001 110.303 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.88 153.8 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.694 0.283 . . . . 9.9100000000000001 110.626 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.09 -43.1 95.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 7.7599999999999998 110.23 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.75 -45.88 92.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.012 -0.54 . . . . 9.8900000000000006 110.535 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.83 68.69 Favored 'General case' 0 C--N 1.41 3.217 0 O-C-N 119.408 -2.057 . . . . 0.0 111.606 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.415 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.27 -34.12 67.99 Favored 'General case' 1 C--N 1.429 4.043 0 O-C-N 123.978 0.799 . . . . 6.7800000000000002 111.875 172.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . 0.442 ' HE2' ' O ' ' A' ' 186' ' ' VAL . 22.3 ttt -74.53 -54.28 7.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.368 0.667 . . . . 6.9699999999999998 111.055 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.65 -33.69 61.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.434 -0.803 . . . . 8.8000000000000007 111.378 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.59 17.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.612 -0.435 . . . . 7.8700000000000001 111.555 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.415 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.2 m-85 -61.3 -48.26 82.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.175 0.435 . . . . 5.9400000000000004 112.175 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.412 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.7 79.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.196 -0.602 . . . . 7.1200000000000001 109.54 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.96 64.38 Favored 'General case' 0 C--N 1.404 2.965 0 O-C-N 120.213 -1.554 . . . . 0.0 111.246 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.69 36.78 Favored 'General case' 0 C--N 1.427 3.977 0 CA-C-N 118.502 0.592 . . . . 7.9299999999999997 110.291 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.446 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.75 -36.66 82.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.707 . . . . 7.7300000000000004 111.054 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.15 -42.88 45.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.386 0.514 . . . . 9.9600000000000009 112.386 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.22 -37.66 88.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.274 0.559 . . . . 10.42 110.399 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.12 -16.44 74.49 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.338 -0.934 . . . . 9.2300000000000004 112.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.15 37.04 72.19 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.871 -0.892 . . . . 9.6099999999999994 110.871 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.99 5.42 51.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.828 0.677 . . . . 8.4600000000000009 112.828 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.66 143.53 30.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.599 0.237 . . . . 9.1600000000000001 110.534 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.53 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.74 -18.4 21.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.105 0.409 . . . . 10.23 112.105 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.79 163.4 24.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.682 -0.235 . . . . 10.24 110.75 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.28 143.45 99.74 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.935 1.757 . . . . 11.43 110.853 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.56 20.53 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.606 -0.807 . . . . 9.4499999999999993 112.436 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.3 134.46 73.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 8.3300000000000001 111.982 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.537 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.31 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.493 2.129 . . . . 6.9699999999999998 111.298 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.442 ' O ' ' HE2' ' A' ' 166' ' ' MET . 21.9 t -69.67 106.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 5.8700000000000001 111.16 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -32.44 25.58 Favored 'General case' 0 N--CA 1.525 3.283 0 O-C-N 119.686 -1.884 . . . . 0.0 113.856 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.33 163.26 40.23 Favored 'General case' 0 C--N 1.384 2.07 0 C-N-CA 125.754 1.621 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.88 130.56 11.94 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 C-N-CA 126.529 1.931 . . . . 5.6699999999999999 109.31 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.11 126.57 55.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.776 -0.453 . . . . 6.6799999999999997 109.776 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.519 HG12 ' HB1' ' A' ' 198' ' ' ALA . 97.2 mt -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 116.893 2.183 . . . . 7.0999999999999996 116.893 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -97.9 91.35 5.29 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 103.234 -2.876 . . . . 8.1600000000000001 103.234 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.33 -57.47 7.83 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.566 1.691 . . . . 10.279999999999999 115.566 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.11 -48.77 75.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.9 0.704 . . . . 10.51 112.9 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -68.94 -9.18 50.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.855 0.317 . . . . 9.9399999999999995 111.855 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 35.87 15.13 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.55 1.315 . . . . 8.4499999999999993 114.55 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -143.38 168.79 18.99 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.116 -1.033 . . . . 7.25 111.612 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -147.7 161.14 41.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.23 -1.35 . . . . 5.1900000000000004 110.355 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.43 51.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.716 -0.846 . . . . 6.0899999999999999 108.716 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.6 mt -94.97 137.56 33.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.518 -0.31 . . . . 4.2699999999999996 110.349 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -114.83 114.72 25.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.674 -0.491 . . . . 6.21 109.674 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.68 164.68 11.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.876 -0.602 . . . . 6.1399999999999997 111.971 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.421 -0.809 . . . . 8.6899999999999995 111.427 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.3 p -128.96 159.6 35.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.115 0.483 . . . . 8.3300000000000001 111.666 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.25 -41.8 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.571 -0.74 . . . . 8.9600000000000009 112.272 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.53 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.66 -41.71 95.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.388 0.514 . . . . 9.2599999999999998 112.388 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.95 97.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.243 -0.281 . . . . 7.6200000000000001 110.243 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.529 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.4 m -54.13 -53.97 46.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.192 -1.04 . . . . 6.4199999999999999 108.192 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m -55.22 -27.11 43.83 Favored 'General case' 0 C--N 1.428 4.0 0 C-N-CA 127.001 2.12 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -34.11 43.47 Favored 'General case' 0 C--N 1.42 3.641 0 N-CA-C 113.613 0.968 . . . . 8.75 113.613 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.57 -17.32 64.11 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.654 0.613 . . . . 5.9400000000000004 112.654 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.05 -19.84 63.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.505 1.128 . . . . 7.1500000000000004 111.652 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.21 52.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 7.7000000000000002 111.654 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -93.8 16.25 14.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 7.4699999999999998 111.625 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.88 120.96 13.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 7.3799999999999999 110.765 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.87 -4.81 66.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.928 -0.653 . . . . 7.9199999999999999 113.599 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.845 0.323 . . . . 7.71 111.124 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.94 121.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.265 0.555 . . . . 10.0 111.333 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -135.34 107.74 7.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 8.4499999999999993 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.74 42.67 13.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 10.44 111.771 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.96 -5.33 54.2 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 115.201 0.84 . . . . 10.609999999999999 115.201 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.67 130.9 55.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.651 0.726 . . . . 10.279999999999999 112.356 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.67 101.46 10.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.556 -0.905 . . . . 8.8300000000000001 108.556 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.85 58.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.994 1.109 . . . . 6.9699999999999998 113.994 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.58 110.28 21.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.523 -1.288 . . . . 8.5099999999999998 107.523 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.4 mt -103.95 126.94 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 6.1699999999999999 112.338 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.403 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.56 15.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.384 -0.826 . . . . 8.3000000000000007 110.038 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.67 49.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.535 -0.913 . . . . 8.1400000000000006 108.535 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.16 174.78 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.988 1.792 . . . . 7.79 112.033 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.995 0.426 . . . . 11.33 110.745 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -63.01 139.36 58.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.211 0.529 . . . . 8.5 110.306 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 313' ' ' THR . 69.6 mt -109.74 144.0 38.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.957 -1.019 . . . . 6.5800000000000001 112.783 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.415 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 51.4 t80 -104.5 132.15 51.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.245 -1.391 . . . . 7.1399999999999997 107.245 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.22 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.531 -0.544 . . . . 5.6799999999999997 109.531 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . 0.507 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.2 179.21 16.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.516 -0.849 . . . . 6.5700000000000003 112.674 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.8 9.18 86.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.589 -0.815 . . . . 8.0399999999999991 111.552 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.85 135.27 85.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 111.446 0.165 . . . . 8.1600000000000001 111.446 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.77 141.54 90.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.832 1.688 . . . . 9.4399999999999995 108.832 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -65.39 -14.92 61.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.752 1.39 . . . . 11.74 114.752 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -84.1 -23.13 30.89 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.836 1.421 . . . . 11.65 114.836 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.34 149.2 50.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.105 0.411 . . . . 9.3599999999999994 111.333 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.244 -0.28 . . . . 10.609999999999999 110.244 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 4.5 m-20 -53.59 -55.54 24.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.611 1.338 . . . . 10.07 114.611 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.14 -26.83 67.96 Favored 'General case' 0 C--N 1.405 3.008 0 C-N-CA 125.724 1.61 . . . . 0.0 112.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -79.78 -48.35 13.74 Favored 'General case' 1 C--N 1.432 4.185 0 CA-C-N 118.3 0.5 . . . . 10.289999999999999 111.387 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.69 -49.15 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 8.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 31.8 mtmm -54.35 -36.3 63.67 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.616 -0.72 . . . . 10.199999999999999 111.362 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.06 -53.45 55.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.096 0.474 . . . . 10.199999999999999 110.644 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.73 -33.02 32.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.092 -0.503 . . . . 7.6200000000000001 110.447 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.447 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.76 -41.72 18.86 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.497 0.554 . . . . 7.7400000000000002 112.497 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 55.7 m -56.76 -30.08 63.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.583 0.957 . . . . 10.390000000000001 113.583 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.6 m -50.36 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.395 2.563 0 C-N-CA 124.78 1.232 . . . . 0.0 112.671 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -111.67 -12.05 13.93 Favored 'General case' 1 C--N 1.444 4.705 0 CA-C-N 118.388 0.54 . . . . 10.23 111.435 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.17 162.23 10.21 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.874 -0.603 . . . . 10.98 111.951 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 147.01 93.51 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.7 2.267 . . . . 12.75 112.78 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 76.1 mt -102.41 146.23 28.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.95 -0.568 . . . . 10.66 111.254 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.589 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.5 ptpt -101.0 -22.72 14.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 11.630000000000001 109.302 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.57 125.36 4.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.051 -2.281 . . . . 0.0 109.245 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.51 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 47.1 t80 -142.82 134.76 27.01 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 122.777 0.431 . . . . 9.0099999999999998 112.014 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -144.8 124.11 13.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.714 0.292 . . . . 8.7300000000000004 111.481 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 56.9 tp -101.04 118.24 36.6 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.55 -1.278 . . . . 8.9399999999999995 107.55 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 49.0 t -74.23 122.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.473 0.916 . . . . 9.7400000000000002 113.473 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -119.15 148.08 43.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.232 -0.894 . . . . 11.34 109.329 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 25.5 t70 -58.95 141.2 54.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.412 . . . . 13.83 110.894 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 18.7 m -49.78 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.802 -0.635 . . . . 14.779999999999999 112.606 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.07 -64.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.536 0.569 . . . . 16.440000000000001 112.536 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 3.9 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.254 -0.43 . . . . 15.24 111.21 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.72 -6.16 62.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.592 -0.814 . . . . 13.609999999999999 114.545 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.29 167.55 13.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.355 0.578 . . . . 13.529999999999999 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.0 t -59.15 142.08 52.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 10.51 111.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.42 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.4 mmmp? -87.94 -9.46 53.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.802 -0.636 . . . . 11.73 109.625 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.39 39.54 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.56 -0.746 . . . . 8.6300000000000008 113.857 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -142.96 146.46 33.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.146 0.973 . . . . 9.3900000000000006 112.75 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.59 155.13 46.66 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.094 -0.957 . . . . 6.5499999999999998 112.187 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' PHE . . . . . 0.415 ' CE1' ' HD1' ' A' ' 262' ' ' PHE . 88.9 m-85 -111.42 146.85 36.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.273 -0.876 . . . . 7.4299999999999997 110.422 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' CYS . . . . . 0.51 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.1 p -157.75 156.26 31.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.994 -0.683 . . . . 6.7699999999999996 111.903 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -145.41 127.08 15.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.738 -0.664 . . . . 9.5899999999999999 109.656 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.589 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 54.8 m-85 -82.46 164.9 20.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.081 0.467 . . . . 9.9100000000000001 112.027 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.55 -46.01 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.436 -0.95 . . . . 13.09 108.436 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASP . . . . . 0.709 ' O ' HG23 ' A' ' 312' ' ' VAL . 19.7 t70 -96.36 102.32 14.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.357 -1.349 . . . . 13.18 107.357 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ILE . . . . . 0.536 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.69 -34.98 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 115.326 1.602 . . . . 12.48 115.326 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -56.82 -38.82 73.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.236 1.017 . . . . 13.4 109.022 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.69 -22.57 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 112.268 -2.242 . . . . 11.43 109.61 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 97.8 m -54.66 -48.24 72.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.869 -0.789 . . . . 9.5 108.869 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.45 -42.82 99.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.3 -0.56 . . . . 10.31 110.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 119.871 -0.732 . . . . 12.41 111.993 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.76 74.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.597 -1.638 . . . . 8.3900000000000006 113.023 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.65 -51.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.316 0.579 . . . . 7.71 110.859 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.25 67.27 Favored 'General case' 0 C--N 1.419 3.589 0 C-N-CA 126.337 1.855 . . . . 0.0 113.2 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.438 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.25 -24.05 35.52 Favored Glycine 1 C--N 1.4 4.132 0 N-CA-C 116.815 1.486 . . . . 8.7599999999999998 116.815 177.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.87 -45.68 6.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 120.097 1.949 . . . . 7.2000000000000002 113.956 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -50.53 129.97 23.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.808 0.337 . . . . 8.1099999999999994 111.46 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.56 56.96 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.156 -0.545 . . . . 8.6400000000000006 113.978 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' MET . . . . . 0.438 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 18.3 mtt -50.71 147.18 4.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.846 0.323 . . . . 8.25 111.259 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.06 115.57 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.055 0.455 . . . . 10.48 111.712 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.581 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -120.18 106.85 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.146 -1.057 . . . . 8.9499999999999993 108.146 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 66.99 -118.64 10.63 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.373 -1.491 . . . . 10.630000000000001 109.373 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -115.84 22.4 13.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 12.25 109.752 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -123.83 153.98 40.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.609 -0.723 . . . . 10.34 111.617 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -101.79 118.27 36.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.083 -1.08 . . . . 10.59 108.083 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.581 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.2 tp -63.0 143.04 58.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.516 0.674 . . . . 7.6500000000000004 112.649 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 61.5 tp -128.14 127.94 43.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.597 -1.183 . . . . 7.7599999999999998 109.014 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.85 124.02 26.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 120.909 -1.119 . . . . 6.4500000000000002 109.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.8 155.31 36.89 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.961 -1.712 . . . . 7.8799999999999999 109.557 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.472 ' HA ' HD21 ' A' ' 261' ' ' LEU . 66.4 mtt180 -58.54 122.44 13.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 118.424 -1.31 . . . . 9.1999999999999993 107.577 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.92 -11.8 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.814 1.413 . . . . 7.5199999999999996 114.814 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.4 m -119.44 -77.59 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.522 -0.471 . . . . 9.3599999999999994 111.239 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.873 179.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.614 0.245 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.11 46.75 1.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.916 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -157.11 148.58 22.18 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 122.962 0.505 . . . . 6.3499999999999996 111.293 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.583 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.6 mt -140.8 143.55 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 5.5099999999999998 111.188 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.57 125.15 40.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.859 -0.793 . . . . 6.8200000000000003 108.859 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.78 101.22 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.097 0.475 . . . . 5.0899999999999999 110.24 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.78 -178.22 35.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.002 -0.618 . . . . 6.2000000000000002 112.763 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.87 40.76 21.43 Favored 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 125.065 1.346 . . . . 0.0 110.201 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.77 149.78 88.21 Favored Pre-proline 1 C--N 1.428 4.015 0 C-N-CA 123.448 0.699 . . . . 7.79 111.327 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.98 144.43 89.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.288 1.992 . . . . 8.9900000000000002 110.978 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.65 52.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.022 0.439 . . . . 11.75 111.934 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.56 61.18 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.818 -0.628 . . . . 10.470000000000001 114.313 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.07 136.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.307 0.553 . . . . 8.9100000000000001 110.306 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.534 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 36.1 p -84.84 153.92 22.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.697 0.284 . . . . 9.9100000000000001 110.645 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.13 -43.24 95.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 7.7599999999999998 110.192 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.7 -45.93 91.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.001 -0.545 . . . . 9.8900000000000006 110.562 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.3 -2.125 . . . . 0.0 111.724 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.417 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.11 67.84 Favored 'General case' 1 C--N 1.428 4.006 0 O-C-N 123.877 0.736 . . . . 6.7800000000000002 111.733 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.433 ' HE2' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.56 -54.35 7.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.449 0.699 . . . . 6.9699999999999998 111.074 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -54.48 -33.7 60.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.366 -0.834 . . . . 8.8000000000000007 111.41 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.79 -53.62 17.42 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.472 -0.491 . . . . 7.8700000000000001 111.58 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.417 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.1 m-85 -61.27 -48.29 82.09 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.139 0.422 . . . . 5.9400000000000004 112.139 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.97 80.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.265 -0.574 . . . . 7.1200000000000001 109.586 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.7 -23.58 65.3 Favored 'General case' 0 C--N 1.407 3.097 0 O-C-N 120.254 -1.529 . . . . 0.0 111.298 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.48 -37.62 36.4 Favored 'General case' 0 C--N 1.427 3.972 0 O-C-N 123.611 0.569 . . . . 7.9299999999999997 110.328 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.46 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.79 -36.79 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.595 -0.73 . . . . 7.7300000000000004 111.014 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -75.93 -43.12 46.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.429 0.529 . . . . 9.9600000000000009 112.429 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.03 -37.71 88.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.189 0.519 . . . . 10.42 110.447 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.15 -16.42 74.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.297 -0.954 . . . . 9.2300000000000004 112.814 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.02 72.03 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 110.878 -0.889 . . . . 9.6099999999999994 110.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.89 5.31 51.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.975 0.732 . . . . 8.4600000000000009 112.975 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.63 143.45 30.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.616 0.246 . . . . 9.1600000000000001 110.577 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.148 0.425 . . . . 10.23 112.148 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.4 24.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.646 -0.252 . . . . 10.24 110.714 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.29 143.51 99.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.946 1.764 . . . . 11.43 110.822 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.35 161.6 20.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.663 -0.779 . . . . 9.4499999999999993 112.43 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 112.117 0.414 . . . . 8.3300000000000001 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.519 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.21 -51.04 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.544 2.163 . . . . 6.9699999999999998 111.283 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.433 ' O ' ' HE2' ' A' ' 166' ' ' MET . 22.0 t -69.64 106.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.126 -0.488 . . . . 5.8700000000000001 111.075 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 -37.15 30.41 Favored 'General case' 0 N--CA 1.536 3.837 0 O-C-N 119.885 -1.76 . . . . 0.0 112.963 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.36 164.38 36.83 Favored 'General case' 0 C--N 1.382 1.983 0 C-N-CA 125.78 1.632 . . . . 0.0 110.736 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 130.45 10.53 Favored 'Isoleucine or valine' 0 C--N 1.37 1.499 0 C-N-CA 126.584 1.954 . . . . 5.6699999999999999 109.331 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -114.06 126.61 55.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.789 -0.449 . . . . 6.6799999999999997 109.789 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.2 mt -114.92 125.95 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 116.912 2.189 . . . . 7.0999999999999996 116.912 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.06 91.42 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 103.153 -2.906 . . . . 8.1600000000000001 103.153 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -57.37 7.99 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 115.73 1.752 . . . . 10.279999999999999 115.73 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.21 -48.78 75.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.812 0.671 . . . . 10.51 112.812 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.0 -9.06 50.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.832 0.308 . . . . 9.9399999999999995 111.832 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.21 15.49 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.528 1.307 . . . . 8.4499999999999993 114.528 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.59 168.68 19.29 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 119.074 -1.05 . . . . 7.25 111.601 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.542 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.04 41.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.143 -1.389 . . . . 5.1900000000000004 110.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.3 129.5 51.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.657 -0.868 . . . . 6.0899999999999999 108.657 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.94 137.56 33.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 4.2699999999999996 110.272 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.77 114.65 25.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.744 -0.465 . . . . 6.21 109.744 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -99.6 164.7 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.597 0.561 . . . . 6.1399999999999997 112.073 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.59 -25.98 22.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.473 -0.785 . . . . 8.6899999999999995 111.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 87.9 p -128.89 159.59 35.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.173 0.511 . . . . 8.3300000000000001 111.568 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.33 -41.71 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 8.9600000000000009 112.232 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.72 -41.79 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.325 0.491 . . . . 9.2599999999999998 112.325 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.4 mt-10 -61.84 -43.82 98.09 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.298 -0.26 . . . . 7.6200000000000001 110.298 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.583 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.2 m -54.19 -53.97 46.24 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.149 -1.056 . . . . 6.4199999999999999 108.149 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.5 m -55.18 -27.11 43.43 Favored 'General case' 0 C--N 1.428 3.98 0 C-N-CA 126.956 2.102 . . . . 0.0 109.86 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -34.03 43.12 Favored 'General case' 0 C--N 1.422 3.73 0 N-CA-C 113.606 0.965 . . . . 8.75 113.606 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.659 0.614 . . . . 5.9400000000000004 112.659 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.86 63.38 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.394 1.059 . . . . 7.1500000000000004 111.587 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.38 -9.37 53.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 7.7000000000000002 111.651 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.2 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.516 -0.311 . . . . 7.4699999999999998 111.619 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.84 120.92 13.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 7.3799999999999999 110.78 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.91 65.94 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.918 -0.658 . . . . 7.9199999999999999 113.559 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.07 142.36 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.854 0.327 . . . . 7.71 111.101 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.93 121.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.333 0.587 . . . . 10.0 111.266 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.28 107.73 7.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 8.4499999999999993 110.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.67 13.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 10.44 111.73 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.06 -5.47 54.01 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.169 0.828 . . . . 10.609999999999999 115.169 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.62 130.94 55.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.665 0.733 . . . . 10.279999999999999 112.381 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.79 101.55 11.0 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.449 -0.945 . . . . 8.8300000000000001 108.449 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.981 1.104 . . . . 6.9699999999999998 113.981 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 1.04 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.9 tttt -108.53 110.21 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.567 -1.272 . . . . 8.5099999999999998 107.567 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.91 126.91 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.349 0.5 . . . . 6.1699999999999999 112.349 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.406 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.57 170.53 15.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.413 -0.812 . . . . 8.3000000000000007 110.051 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.12 154.7 49.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.535 -0.913 . . . . 8.1400000000000006 108.535 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.38 175.04 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.942 1.761 . . . . 7.79 112.079 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -116.83 25.84 10.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.797 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.865 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 7.8 m-20 -68.76 -13.18 62.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.642 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -77.49 98.5 5.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.026 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -100.85 162.07 21.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.41 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.8 -29.35 80.68 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.547 2.165 . . . . 0.0 111.877 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.0 tp 62.01 82.81 0.21 Allowed Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.595 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.48 63.6 8.45 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.427 2.751 . . . . 0.0 112.123 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.43 -4.58 70.59 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.972 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.8 mmt 67.16 -174.77 0.19 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.818 0.447 . . . . 0.0 110.844 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 m 53.57 60.81 3.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.994 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -56.18 105.61 0.21 Allowed 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 27.1 t-20 -141.67 -56.32 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.21 175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 89.6 Cg_endo -82.36 9.89 3.8 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.927 1.751 . . . . 0.0 111.776 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.2 p -131.84 -88.33 0.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 247' ' ' PRO . 39.8 t 61.73 -81.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.219 0.608 . . . . 0.0 110.921 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -178.1 -61.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.183 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.652 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 50.6 t -77.29 -54.3 1.51 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.649 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 73.3 Cg_exo -50.54 117.43 3.23 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.406 2.07 . . . . 0.0 112.723 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.31 -30.74 7.11 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.95 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 249' ' ' VAL . 7.5 p -146.03 78.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.197 0.998 . . . . 0.0 110.3 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.633 HG23 HG13 ' A' ' 246' ' ' VAL . 48.4 t -94.34 -24.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.521 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t 70.44 104.02 0.06 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.593 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.0 m -56.07 -48.26 76.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.143 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.0 p -178.81 113.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.841 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 15.6 m -68.46 127.12 93.27 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 110.696 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 12.8 Cg_exo -70.84 163.08 40.39 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.814 2.343 . . . . 0.0 111.193 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.92 99.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.791 0.805 . . . . 0.0 109.895 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.3 m -150.65 179.32 8.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.412 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 62.01 85.48 0.12 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.768 0.667 . . . . 0.0 111.836 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -128.81 30.98 5.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.803 -0.635 . . . . 11.33 110.803 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.92 139.41 58.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 8.5 110.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.495 HD21 ' HA ' ' A' ' 334' ' ' ARG . 65.5 mt -109.88 143.94 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.114 -0.948 . . . . 6.5800000000000001 112.769 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -104.38 132.08 51.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.176 -1.416 . . . . 7.1399999999999997 107.176 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.421 HD12 ' HG ' ' A' ' 305' ' ' CYS . 4.1 mp -127.0 121.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.573 -0.529 . . . . 5.6799999999999997 109.573 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.456 -0.878 . . . . 6.5700000000000003 112.679 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.2 86.6 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 8.0399999999999991 111.506 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.6 mt -70.89 135.21 85.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.492 0.182 . . . . 8.1600000000000001 111.492 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 26.2 Cg_exo -61.82 141.56 90.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.93 1.753 . . . . 9.4399999999999995 108.76 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -65.36 -14.88 61.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.797 1.406 . . . . 11.74 114.797 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.16 -23.1 30.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.807 1.41 . . . . 11.65 114.807 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.35 149.12 50.86 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.169 0.44 . . . . 9.3599999999999994 111.306 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.403 ' O ' HG21 ' A' ' 275' ' ' VAL . 17.6 p-10 -114.53 -176.48 2.91 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.269 -0.271 . . . . 10.609999999999999 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 9.9 m-20 -53.46 -55.41 25.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 114.699 1.37 . . . . 10.07 114.699 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.66 -26.05 67.77 Favored 'General case' 0 C--N 1.406 3.023 0 C-N-CA 125.633 1.573 . . . . 0.0 112.559 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -80.28 -48.3 13.25 Favored 'General case' 1 C--N 1.429 4.064 0 CA-C-N 118.27 0.487 . . . . 10.289999999999999 111.414 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 271' ' ' ASN . 75.1 t -62.63 -49.16 84.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.784 -0.644 . . . . 8.0 110.329 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.6 mtmm -54.37 -36.44 63.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.647 -0.706 . . . . 10.199999999999999 111.312 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.97 -53.37 56.63 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.137 0.494 . . . . 10.199999999999999 110.701 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.406 HD12 HD23 ' A' ' 320' ' ' LEU . 3.1 tm? -51.74 -33.19 33.72 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.124 -0.489 . . . . 7.6200000000000001 110.328 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.476 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -82.64 -41.55 19.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.651 0.611 . . . . 7.7400000000000002 112.651 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.8 m -56.85 -29.57 63.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.566 0.95 . . . . 10.390000000000001 113.566 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 m -50.61 -9.99 0.06 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 124.873 1.269 . . . . 0.0 112.511 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.76 -11.96 13.9 Favored 'General case' 1 C--N 1.443 4.637 0 CA-C-N 118.398 0.544 . . . . 10.23 111.483 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 10.98 111.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.66 147.03 93.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.681 2.254 . . . . 12.75 112.744 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.4 mt -102.4 146.29 28.29 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.913 -0.585 . . . . 10.66 111.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.473 ' HD2' ' OE2' ' A' ' 306' ' ' GLU . 18.7 ptpt -101.02 -22.67 14.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.222 -0.658 . . . . 11.630000000000001 109.222 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.59 4.67 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.061 -2.274 . . . . 0.0 109.229 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.4 t80 -142.79 134.78 27.08 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 122.81 0.444 . . . . 9.0099999999999998 111.968 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.82 124.09 12.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.794 0.33 . . . . 8.7300000000000004 111.467 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 56.8 tp -101.03 118.13 36.4 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.634 -1.247 . . . . 8.9399999999999995 107.634 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.2 122.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.445 0.906 . . . . 9.7400000000000002 113.445 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.09 148.1 43.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.263 -0.88 . . . . 11.34 109.359 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.625 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.7 t70 -58.89 141.14 54.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.919 0.39 . . . . 13.83 111.039 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 38.0 m -49.59 -61.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.649 0.611 . . . . 14.779999999999999 112.649 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.16 -63.96 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.497 0.555 . . . . 16.440000000000001 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 14.9 m -42.46 -59.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.302 -0.408 . . . . 15.24 111.221 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.58 -6.04 62.7 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.65 -0.786 . . . . 13.609999999999999 114.531 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.32 167.56 13.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.411 0.606 . . . . 13.529999999999999 110.926 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.5 t -59.13 142.08 52.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 10.51 111.588 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 1.414 ' NZ ' HO2' ' B' ' 601' ' ' ' U' . 5.4 mmmp? -87.99 -9.47 53.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.771 -0.65 . . . . 11.73 109.566 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.55 -3.29 39.6 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.624 -0.716 . . . . 8.6300000000000008 113.908 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -143.02 146.4 33.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.04 0.92 . . . . 9.3900000000000006 112.837 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.63 155.14 46.62 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.131 -0.941 . . . . 6.5499999999999998 112.258 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.34 146.86 36.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.172 -0.922 . . . . 7.4299999999999997 110.405 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.568 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.3 p -157.91 156.18 30.87 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 119.903 -0.719 . . . . 6.7699999999999996 111.84 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 31.3 tt0 -145.26 127.16 15.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.585 -0.734 . . . . 9.5899999999999999 109.629 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 57.8 m-85 -82.5 164.89 20.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.042 0.386 . . . . 9.9100000000000001 112.042 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.463 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 64.0 t -71.59 -46.08 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.357 -0.979 . . . . 13.09 108.357 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.735 ' O ' HG23 ' A' ' 312' ' ' VAL . 15.3 t70 -96.35 102.35 14.13 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.442 -1.318 . . . . 13.18 107.442 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.521 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 115.27 1.582 . . . . 12.48 115.27 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -56.87 -38.69 73.08 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 122.246 1.022 . . . . 13.4 109.026 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.84 -22.57 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.296 -2.229 . . . . 11.43 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.61 -48.26 72.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.933 -0.766 . . . . 9.5 108.933 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.36 -42.82 99.71 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.252 -0.579 . . . . 10.31 110.554 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.82 -32.41 73.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.857 -0.737 . . . . 12.41 111.949 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.54 -34.78 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.671 -1.604 . . . . 8.3900000000000006 113.025 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 73.0 mt -68.57 -51.25 48.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 7.71 110.883 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.78 67.86 Favored 'General case' 0 C--N 1.419 3.611 0 C-N-CA 126.266 1.826 . . . . 0.0 113.178 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -24.02 36.35 Favored Glycine 1 C--N 1.398 4.01 0 N-CA-C 116.846 1.499 . . . . 8.7599999999999998 116.846 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.406 HD23 HD12 ' A' ' 278' ' ' LEU . 87.9 mt -96.9 -45.77 6.49 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 120.093 1.947 . . . . 7.2000000000000002 113.971 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -50.53 130.06 23.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 8.1099999999999994 111.492 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.66 56.72 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.103 -0.57 . . . . 8.6400000000000006 113.987 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.3 ttt -50.58 147.15 4.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.797 0.298 . . . . 8.25 111.336 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -95.05 115.73 27.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 10.48 111.703 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.654 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.4 mm? -120.24 106.71 12.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.108 -1.071 . . . . 8.9499999999999993 108.108 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.06 -118.64 10.56 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.388 -1.485 . . . . 10.630000000000001 109.388 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.87 22.35 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 12.25 109.781 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -123.82 153.9 40.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.59 -0.732 . . . . 10.34 111.683 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.73 118.29 36.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.133 -1.062 . . . . 10.59 108.133 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.654 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.9 tp -62.99 143.1 58.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.413 0.625 . . . . 7.6500000000000004 112.663 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.461 HD13 ' C2 ' ' B' ' 602' ' ' ' U' . 94.8 mt -128.12 128.06 44.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.535 -1.211 . . . . 7.7599999999999998 108.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.5 t -137.98 123.93 25.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.927 -1.108 . . . . 6.4500000000000002 109.997 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -152.65 155.41 37.26 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.947 -1.72 . . . . 7.8799999999999999 109.5 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.836 ' HD2' ' HA3' ' A' ' 338' ' ' GLY . 98.8 mtt180 -58.69 122.49 13.63 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.459 -1.297 . . . . 9.1999999999999993 107.586 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.91 -11.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.757 1.391 . . . . 7.5199999999999996 114.757 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.3 m -119.41 -77.84 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.547 -0.461 . . . . 9.3599999999999994 111.362 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.58 136.53 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . 0.836 ' HA3' ' HD2' ' A' ' 334' ' ' ARG . . . 125.89 53.41 0.16 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.504 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -97.81 -0.04 45.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -126.15 167.17 15.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.901 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -137.63 118.7 14.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.955 0.407 . . . . 0.0 110.688 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.835 177.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 1.414 HO2' ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.158 0 C3'-C2'-C1' 100.456 -1.16 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.461 ' C2 ' HD13 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 O4'-C1'-C2' 107.562 0.83 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.454 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.105 0 C4'-C3'-C2' 103.821 1.121 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 1.04 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 0 O3'--C3' 1.472 3.493 0 C3'-C2'-C1' 103.318 2.02 . 0.213 4g . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.684 6.402 1 P-O3'-C3' 124.824 4.27 . 0.0 OUTLIER '7D dist 9a' 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . 0.467 ' H6 ' ' OP2' ' B' ' 606' ' ' ' U' . . . . . . . . 0 C3'--C2' 1.538 1.216 0 C4'-C3'-C2' 105.583 2.883 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 0.865 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.546 1.81 0 O4'-C1'-C2' 107.841 1.03 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C3'-C2'-C1' 100.672 -0.92 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 O4'-C1'-C2' 107.358 0.684 . 0.025 0k . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.662 ' HB3' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -136.16 -150.21 0.36 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.4 -0.92 . . . . 0.0 112.827 173.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -161.81 149.24 14.45 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 122.97 0.508 . . . . 6.3499999999999996 111.526 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.498 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.4 mt -140.73 143.56 35.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 5.5099999999999998 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -96.54 125.14 40.8 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 6.8200000000000003 108.879 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.69 101.22 8.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.069 0.461 . . . . 5.0899999999999999 110.242 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.76 -179.2 34.86 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.033 -0.53 . . . . 6.2000000000000002 112.728 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.1 41.35 23.48 Favored 'General case' 0 CA--C 1.575 1.939 0 C-N-CA 125.175 1.39 . . . . 0.0 110.326 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.69 149.85 88.43 Favored Pre-proline 1 C--N 1.429 4.023 0 C-N-CA 123.726 0.81 . . . . 7.79 111.32 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.08 144.45 89.98 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.247 1.964 . . . . 8.9900000000000002 110.968 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.92 139.78 52.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 11.75 111.938 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.48 61.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.745 -0.661 . . . . 10.470000000000001 114.282 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 191' ' ' ILE . 11.0 tp -66.05 136.5 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.316 0.558 . . . . 8.9100000000000001 110.359 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.596 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 35.8 p -84.85 153.88 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.693 0.282 . . . . 9.9100000000000001 110.653 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.22 -43.07 96.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 7.7599999999999998 110.176 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -61.82 -45.99 91.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.971 -0.559 . . . . 9.8900000000000006 110.547 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.596 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.412 3.312 0 O-C-N 119.076 -2.265 . . . . 0.0 111.701 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.402 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.19 67.91 Favored 'General case' 1 C--N 1.429 4.059 0 O-C-N 123.934 0.771 . . . . 6.7800000000000002 111.731 171.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.451 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.5 -54.32 7.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.353 0.661 . . . . 6.9699999999999998 111.119 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.48 -33.75 60.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.388 -0.824 . . . . 8.8000000000000007 111.428 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.72 -53.7 17.25 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 120.612 -0.435 . . . . 7.8700000000000001 111.552 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.402 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.3 -48.21 82.4 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.18 0.437 . . . . 5.9400000000000004 112.18 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.41 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.77 -42.85 80.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.164 -0.614 . . . . 7.1200000000000001 109.594 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.98 -23.46 65.04 Favored 'General case' 0 C--N 1.406 3.042 0 O-C-N 120.279 -1.513 . . . . 0.0 111.31 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.3 -37.76 36.97 Favored 'General case' 1 C--N 1.428 4.014 0 CA-C-N 118.499 0.59 . . . . 7.9299999999999997 110.354 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.441 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.66 -36.82 83.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.589 -0.732 . . . . 7.7300000000000004 111.085 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -76.0 -43.13 45.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.349 0.5 . . . . 9.9600000000000009 112.349 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.5 mt -62.99 -37.74 88.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.272 0.558 . . . . 10.42 110.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.03 -16.45 74.7 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.224 -0.988 . . . . 9.2300000000000004 112.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.14 72.02 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.801 -0.92 . . . . 9.6099999999999994 110.801 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.96 5.33 51.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.865 0.691 . . . . 8.4600000000000009 112.865 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.516 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.6 p -82.62 143.46 30.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 9.1600000000000001 110.575 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.44 23.88 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.689 -0.232 . . . . 10.24 110.706 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.3 143.48 99.72 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.017 1.812 . . . . 11.43 110.834 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.33 161.55 20.56 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.534 -0.841 . . . . 9.4499999999999993 112.431 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.2 m-20 -75.26 134.52 73.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.02 0.378 . . . . 8.3300000000000001 112.02 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.516 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.28 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.553 2.169 . . . . 6.9699999999999998 111.327 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.451 ' O ' ' HE1' ' A' ' 166' ' ' MET . 22.0 t -69.63 105.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.118 -0.492 . . . . 5.8700000000000001 111.11 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 70.47 0.71 Allowed 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 124.752 1.221 . . . . 0.0 109.441 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.73 151.32 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 129.383 3.073 . . . . 0.0 112.78 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.52 130.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 129.47 3.108 . . . . 5.6699999999999999 109.273 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.743 -0.465 . . . . 6.6799999999999997 109.743 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 125.97 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 116.958 2.207 . . . . 7.0999999999999996 116.958 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.03 91.38 5.28 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 103.165 -2.902 . . . . 8.1600000000000001 103.165 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -57.39 8.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.606 1.706 . . . . 10.279999999999999 115.606 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.28 -48.67 76.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.845 0.683 . . . . 10.51 112.845 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.01 -9.12 50.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.726 0.298 . . . . 9.9399999999999995 111.803 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.1 36.07 15.44 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.556 1.317 . . . . 8.4499999999999993 114.556 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.42 168.7 19.2 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.134 -1.027 . . . . 7.25 111.703 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.69 161.09 41.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.235 -1.348 . . . . 5.1900000000000004 110.482 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.36 129.37 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.641 -0.874 . . . . 6.0899999999999999 108.641 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.92 137.58 33.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 4.2699999999999996 110.312 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.72 114.77 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.721 -0.474 . . . . 6.21 109.721 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.665 0.603 . . . . 6.1399999999999997 111.919 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.94 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 8.6899999999999995 111.411 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.452 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 89.3 p -128.94 159.57 35.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 8.3300000000000001 111.648 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.24 -41.78 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.751 . . . . 8.9600000000000009 112.232 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.71 -41.78 95.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.354 0.502 . . . . 9.2599999999999998 112.354 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.3 mt-10 -61.91 -43.86 97.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.248 -0.279 . . . . 7.6200000000000001 110.248 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.662 HG23 ' HB3' ' A' ' 149' ' ' ARG . 55.0 m -54.18 -53.87 47.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.261 1.029 . . . . 6.4199999999999999 108.261 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.1 m -55.06 -27.22 43.14 Favored 'General case' 0 C--N 1.424 3.845 0 C-N-CA 127.118 2.167 . . . . 0.0 109.888 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.35 -34.01 42.47 Favored 'General case' 0 C--N 1.421 3.682 0 N-CA-C 113.585 0.957 . . . . 8.75 113.585 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.58 -17.39 64.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.653 0.612 . . . . 5.9400000000000004 112.653 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.82 63.34 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.473 1.108 . . . . 7.1500000000000004 111.633 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.51 -9.21 52.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.355 . . . . 7.7000000000000002 111.611 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.83 16.16 14.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.564 -0.289 . . . . 7.4699999999999998 111.627 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.87 120.92 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.826 0.346 . . . . 7.3799999999999999 110.777 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.84 65.98 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.938 -0.648 . . . . 7.9199999999999999 113.577 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.06 142.38 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.936 0.368 . . . . 7.71 111.084 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.97 121.54 37.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.34 0.591 . . . . 10.0 111.262 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.29 107.76 7.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 8.4499999999999993 110.378 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.69 42.71 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 10.44 111.771 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.99 -5.35 54.21 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 115.195 0.838 . . . . 10.609999999999999 115.195 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.61 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.669 0.735 . . . . 10.279999999999999 112.469 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.44 10.83 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.56 -0.904 . . . . 8.8300000000000001 108.56 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.31 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.994 1.109 . . . . 6.9699999999999998 113.994 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.692 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.55 110.24 21.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.555 -1.276 . . . . 8.5099999999999998 107.555 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.93 126.89 58.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 6.1699999999999999 112.32 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.62 170.54 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 8.3000000000000007 110.03 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.14 154.76 49.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.537 -0.912 . . . . 8.1400000000000006 108.537 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.44 175.17 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.921 1.748 . . . . 7.79 112.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -103.39 -6.61 21.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 1.17 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 10.5 m-20 -85.29 15.89 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.274 172.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.44 150.11 44.43 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.29 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 10.5 pt20 -51.11 129.12 30.4 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.446 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 4.3 Cg_exo -80.68 -178.52 4.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.101 2.534 . . . . 0.0 111.016 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.78 125.72 90.37 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.13 138.97 88.35 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.707 2.271 . . . . 0.0 111.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.44 167.84 54.64 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.101 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 42.0 ttp 65.32 31.84 10.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.429 0.633 . . . . 0.0 110.225 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 41.1 m -102.56 96.14 6.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.518 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -121.83 -43.98 2.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.139 0.495 . . . . 0.0 110.168 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 16.7 m120 -100.23 115.19 65.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 20.5 Cg_exo -66.44 111.03 1.96 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.64 2.226 . . . . 0.0 112.238 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.3 m -71.19 -32.07 68.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 109.869 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.09 137.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.068 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -87.89 89.67 8.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.072 0.463 . . . . 0.0 110.142 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.8 158.08 34.12 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.703 ' HD2' HG23 ' A' ' 254' ' ' VAL . 31.6 Cg_exo -60.45 -42.35 41.62 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.898 2.398 . . . . 0.0 112.952 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.807 ' HA3' ' HB ' ' A' ' 252' ' ' THR . . . -111.59 -139.01 7.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.116 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.54 -68.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.8 0.3 . . . . 0.0 110.225 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.47 -44.65 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.051 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.5 m -129.64 2.28 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.132 0.492 . . . . 0.0 110.237 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.807 ' HB ' ' HA3' ' A' ' 248' ' ' GLY . 0.2 OUTLIER -59.92 121.95 13.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.127 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 4.3 p 50.77 22.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 112.082 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.703 HG23 ' HD2' ' A' ' 247' ' ' PRO . 90.7 t -80.48 117.8 69.44 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.39 113.47 2.48 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.73 2.287 . . . . 0.0 112.723 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -125.0 152.15 44.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t -73.61 90.86 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -142.82 54.46 1.39 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -80.32 30.98 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 11.33 110.782 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.767 ' HD3' ' HB2' ' A' ' 306' ' ' GLU . 7.0 tppt? -62.87 139.34 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 8.5 110.349 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 313' ' ' THR . 78.9 mt -109.75 143.99 38.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.006 -0.997 . . . . 6.5800000000000001 112.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -104.48 132.24 50.95 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.141 -1.429 . . . . 7.1399999999999997 107.141 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.99 121.15 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.603 -0.517 . . . . 5.6799999999999997 109.603 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.14 179.25 16.47 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 6.5700000000000003 112.72 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.53 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.555 -0.831 . . . . 8.0399999999999991 111.596 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 99.1 mt -70.86 135.3 85.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.192 . . . . 8.1600000000000001 111.496 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.3 Cg_exo -61.79 141.53 90.56 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.879 1.719 . . . . 9.4399999999999995 108.843 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -65.42 -14.86 61.84 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.752 1.39 . . . . 11.74 114.752 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -84.17 -23.14 30.71 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.781 1.401 . . . . 11.65 114.781 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.31 149.22 50.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.115 0.416 . . . . 9.3599999999999994 111.332 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.229 -0.286 . . . . 10.609999999999999 110.229 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 18.7 m-20 -53.55 -55.27 27.02 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 114.659 1.355 . . . . 10.07 114.659 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.67 -26.42 68.01 Favored 'General case' 0 C--N 1.405 3.009 0 C-N-CA 125.707 1.603 . . . . 0.0 112.461 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -80.02 -48.26 13.61 Favored 'General case' 1 C--N 1.431 4.119 0 CA-C-N 118.263 0.483 . . . . 10.289999999999999 111.455 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.74 -49.21 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.8 -0.636 . . . . 8.0 110.273 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 45.1 mtmt -54.25 -36.4 63.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 10.199999999999999 111.336 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.06 -53.26 57.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.092 0.472 . . . . 10.199999999999999 110.772 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.72 -33.21 33.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.964 -0.562 . . . . 7.6200000000000001 110.365 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.46 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.64 -41.66 19.17 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.549 0.574 . . . . 7.7400000000000002 112.549 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 32.3 m -56.92 -29.82 63.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.586 0.958 . . . . 10.390000000000001 113.586 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.1 m -49.9 -10.33 0.05 OUTLIER 'General case' 0 C--N 1.394 2.507 0 C-N-CA 124.846 1.258 . . . . 0.0 112.776 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -111.59 -11.99 13.98 Favored 'General case' 1 C--N 1.443 4.669 0 CA-C-N 118.341 0.519 . . . . 10.23 111.467 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.3 10.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.9 -0.667 . . . . 10.98 111.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 147.12 93.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.716 2.277 . . . . 12.75 112.689 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 81.6 mt -102.49 146.29 28.32 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.932 -0.576 . . . . 10.66 111.217 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -101.07 -22.58 14.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.271 -0.64 . . . . 11.630000000000001 109.271 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.58 126.13 5.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.174 -2.204 . . . . 0.0 109.172 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.528 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 50.1 t80 -143.41 134.68 25.92 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.792 0.437 . . . . 9.0099999999999998 112.028 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.12 13.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.797 0.332 . . . . 8.7300000000000004 111.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 60.7 tp -101.08 118.24 36.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.568 -1.271 . . . . 8.9399999999999995 107.568 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.6 t -74.14 122.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.44 0.904 . . . . 9.7400000000000002 113.44 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -119.18 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.353 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.6 t70 -58.9 141.19 54.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 13.83 110.98 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.678 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 14.4 m -49.75 -61.56 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.736 0.643 . . . . 14.779999999999999 112.736 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.21 -64.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.465 0.543 . . . . 16.440000000000001 112.465 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 9.0 m -42.59 -59.22 1.98 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.306 -0.406 . . . . 15.24 111.176 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.15 62.58 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.599 -0.81 . . . . 13.609999999999999 114.499 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 70.3 mt -88.24 167.67 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.401 0.601 . . . . 13.529999999999999 110.911 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 33.5 t -59.22 142.1 52.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 10.51 111.656 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 1.161 ' NZ ' HO2' ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.97 -9.43 53.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 11.73 109.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.5 -3.29 39.73 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.669 -0.696 . . . . 8.6300000000000008 113.935 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.44 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 38.2 p90 -143.01 146.4 33.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.038 0.919 . . . . 9.3900000000000006 112.827 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.13 46.73 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.037 -0.983 . . . . 6.5499999999999998 112.206 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.35 146.77 36.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.192 -0.913 . . . . 7.4299999999999997 110.415 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.528 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.6 p -157.78 156.29 31.3 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.969 -0.692 . . . . 6.7699999999999996 111.868 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.767 ' HB2' ' HD3' ' A' ' 260' ' ' LYS . 78.4 tt0 -145.35 127.05 15.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.737 -0.665 . . . . 9.5899999999999999 109.682 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 51.8 m-85 -82.42 164.87 20.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.953 0.406 . . . . 9.9100000000000001 112.007 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.53 -46.1 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.43 -0.952 . . . . 13.09 108.43 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.751 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.4 t70 -96.28 102.29 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.436 -1.32 . . . . 13.18 107.436 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.542 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 115.299 1.592 . . . . 12.48 115.299 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -56.92 -38.69 73.23 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.184 0.992 . . . . 13.4 108.966 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.64 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 112.358 -2.201 . . . . 11.43 109.613 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 91.6 m -54.71 -48.13 72.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.908 -0.775 . . . . 9.5 108.908 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -62.43 -42.89 99.78 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.285 -0.566 . . . . 10.31 110.473 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.7 -32.43 73.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 119.93 -0.708 . . . . 12.41 111.98 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.71 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.641 -1.618 . . . . 8.3900000000000006 113.076 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 72.8 mt -68.61 -51.39 46.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.354 0.597 . . . . 7.71 110.819 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.88 67.31 Favored 'General case' 0 C--N 1.42 3.668 0 C-N-CA 126.225 1.81 . . . . 0.0 113.13 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.02 -24.07 36.11 Favored Glycine 1 C--N 1.399 4.077 0 N-CA-C 116.762 1.465 . . . . 8.7599999999999998 116.762 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.403 ' O ' HD21 ' A' ' 330' ' ' LEU . 84.3 mt -96.86 -45.76 6.51 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 120.176 1.988 . . . . 7.2000000000000002 113.938 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -50.44 129.94 22.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 8.1099999999999994 111.526 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.69 56.7 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.108 -0.568 . . . . 8.6400000000000006 113.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.3 ttt -50.65 147.18 4.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.84 0.32 . . . . 8.25 111.337 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.01 115.64 27.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.407 . . . . 10.48 111.723 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.623 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.24 106.63 12.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.116 -1.068 . . . . 8.9499999999999993 108.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.2 -118.68 10.5 Favored Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 109.343 -1.503 . . . . 10.630000000000001 109.343 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -115.84 22.36 13.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 12.25 109.714 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -123.88 153.94 40.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.667 -0.697 . . . . 10.34 111.618 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -101.79 118.22 36.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.138 -1.06 . . . . 10.59 108.138 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.623 ' HB2' HD21 ' A' ' 325' ' ' LEU . 22.1 tp -63.0 143.15 58.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.545 0.688 . . . . 7.6500000000000004 112.637 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.23 127.92 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.469 -1.242 . . . . 7.7599999999999998 108.981 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.84 124.01 26.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 O-C-N 120.976 -1.078 . . . . 6.4500000000000002 110.011 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -152.78 155.4 37.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.042 -1.661 . . . . 7.8799999999999999 109.51 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.639 ' HD2' ' HA3' ' A' ' 338' ' ' GLY . 98.5 mtt180 -58.65 122.54 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 118.435 -1.306 . . . . 9.1999999999999993 107.58 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.78 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.795 1.406 . . . . 7.5199999999999996 114.795 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.3 m -119.36 -78.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.575 -0.45 . . . . 9.3599999999999994 111.212 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.71 146.42 24.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.819 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . 0.639 ' HA3' ' HD2' ' A' ' 334' ' ' ARG . . . 161.38 21.56 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.755 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.86 110.96 17.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.37 169.06 11.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.54 9.67 35.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.401 178.776 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 1.161 HO2' ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.509 -1.876 0 O4'-C1'-N19 109.424 1.224 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.409 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.933 0 O4'-C1'-C2' 107.545 0.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.444 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.933 0 C4'-C3'-C2' 103.496 0.796 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.692 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.498 5.385 0 C4'-C3'-C2' 98.948 -3.752 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.678 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.679 5.985 1 C4'-C3'-C2' 106.708 4.008 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 105.35 2.65 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 1.17 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.541 1.311 0 O4'-C1'-C2' 107.927 1.091 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.959 0 O4'-C1'-C2' 107.3 0.643 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.611 -0.988 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.705 ' HB3' HG23 ' A' ' 208' ' ' THR . 0.0 OUTLIER -144.11 -156.76 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.294 167.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -158.81 149.26 19.79 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 123.646 0.591 . . . . 6.3499999999999996 111.577 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.506 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.5 mt -140.81 143.64 34.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 5.5099999999999998 111.231 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -96.57 125.17 40.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.905 -0.776 . . . . 6.8200000000000003 108.905 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.82 101.23 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 5.0899999999999999 110.21 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.85 -179.32 34.68 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.07 -0.586 . . . . 6.2000000000000002 112.769 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.3 m120 49.95 41.6 23.21 Favored 'General case' 0 CA--C 1.574 1.899 0 C-N-CA 125.395 1.478 . . . . 0.0 110.292 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.43 149.87 89.01 Favored Pre-proline 1 C--N 1.43 4.07 0 C-N-CA 123.861 0.864 . . . . 7.79 111.355 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.15 144.44 90.35 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.317 2.011 . . . . 8.9900000000000002 110.977 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.96 139.77 52.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.929 0.395 . . . . 11.75 111.992 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.59 61.25 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.876 -0.602 . . . . 10.470000000000001 114.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.2 136.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 117.338 0.569 . . . . 8.9100000000000001 110.254 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.457 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 36.7 p -84.96 153.85 22.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 9.9100000000000001 110.637 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.09 -43.18 95.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 7.7599999999999998 110.185 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.74 -46.03 91.37 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.994 -0.548 . . . . 9.8900000000000006 110.54 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.457 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.56 -26.4 68.56 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.271 -2.143 . . . . 0.0 111.698 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.421 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.38 -34.08 67.68 Favored 'General case' 1 C--N 1.43 4.071 0 O-C-N 123.952 0.783 . . . . 6.7800000000000002 111.811 171.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.449 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.55 -54.29 7.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.442 0.697 . . . . 6.9699999999999998 111.078 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.411 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 61.5 m-20 -54.66 -33.64 61.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.419 -0.81 . . . . 8.8000000000000007 111.373 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.76 -53.6 17.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 120.634 -0.426 . . . . 7.8700000000000001 111.603 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.3 m-85 -61.25 -48.37 81.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.181 0.438 . . . . 5.9400000000000004 112.181 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.411 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.6 m-20 -56.74 -42.85 80.0 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.193 -0.603 . . . . 7.1200000000000001 109.606 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 167' ' ' ASP . . . -67.94 -23.4 65.07 Favored 'General case' 0 C--N 1.406 3.06 0 O-C-N 120.27 -1.519 . . . . 0.0 111.251 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.5 -37.66 36.21 Favored 'General case' 1 C--N 1.429 4.03 0 CA-C-N 118.576 0.625 . . . . 7.9299999999999997 110.332 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.45 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.82 83.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 7.7300000000000004 111.022 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.01 -43.07 45.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.437 0.532 . . . . 9.9600000000000009 112.437 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.02 -37.82 88.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 10.42 110.397 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.96 -16.52 74.67 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.309 -0.948 . . . . 9.2300000000000004 112.881 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.11 71.55 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.816 -0.914 . . . . 9.6099999999999994 110.816 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.01 5.28 52.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.816 0.672 . . . . 8.4600000000000009 112.816 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.501 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.5 p -82.59 143.44 31.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.565 0.221 . . . . 9.1600000000000001 110.598 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.157 0.429 . . . . 10.23 112.157 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.47 23.82 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.688 -0.233 . . . . 10.24 110.689 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.33 143.49 99.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.928 1.752 . . . . 11.43 110.797 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.57 20.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 9.4499999999999993 112.385 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.23 134.52 73.84 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.046 0.387 . . . . 8.3300000000000001 112.046 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.501 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.29 -50.91 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.564 2.176 . . . . 6.9699999999999998 111.358 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.449 ' O ' ' HE1' ' A' ' 166' ' ' MET . 22.0 t -69.79 105.43 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.183 -0.462 . . . . 5.8700000000000001 111.096 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -31.4 29.19 Favored 'General case' 0 N--CA 1.529 3.482 0 O-C-N 119.988 -1.695 . . . . 0.0 113.404 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.21 163.37 39.66 Favored 'General case' 0 C--N 1.391 2.372 0 C-N-CA 126.244 1.818 . . . . 0.0 110.798 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.27 130.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.376 1.752 0 C-N-CA 126.556 1.943 . . . . 5.6699999999999999 109.313 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.17 126.6 55.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.715 -0.476 . . . . 6.6799999999999997 109.715 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.535 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.2 mt -114.96 126.0 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 116.985 2.217 . . . . 7.0999999999999996 116.985 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.01 91.37 5.27 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 103.163 -2.902 . . . . 8.1600000000000001 103.163 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -57.36 8.09 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.634 1.716 . . . . 10.279999999999999 115.634 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.23 -48.75 75.87 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.891 0.7 . . . . 10.51 112.891 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.14 50.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.895 0.331 . . . . 9.9399999999999995 111.895 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.05 36.23 15.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.565 1.32 . . . . 8.4499999999999993 114.565 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.61 168.59 19.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.063 -1.055 . . . . 7.25 111.633 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.52 161.17 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.27 -1.332 . . . . 5.1900000000000004 110.413 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.46 129.4 51.2 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.556 -0.905 . . . . 6.0899999999999999 108.556 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.87 137.53 33.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.353 -0.385 . . . . 4.2699999999999996 110.33 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -114.74 114.7 25.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.678 -0.49 . . . . 6.21 109.678 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.428 ' HB2' ' HG1' ' A' ' 208' ' ' THR . 80.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.939 -0.573 . . . . 6.1399999999999997 111.93 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -25.99 22.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 8.6899999999999995 111.47 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.408 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 89.2 p -128.89 159.54 35.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.104 0.478 . . . . 8.3300000000000001 111.688 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.27 -41.78 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 8.9600000000000009 112.231 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.74 -41.68 95.75 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.385 0.513 . . . . 9.2599999999999998 112.385 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.5 mt-10 -61.83 -43.84 98.04 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.292 -0.262 . . . . 7.6200000000000001 110.292 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.705 HG23 ' HB3' ' A' ' 149' ' ' ARG . 55.2 m -54.17 -54.03 45.25 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.108 -1.071 . . . . 6.4199999999999999 108.108 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 m -54.99 -27.14 41.85 Favored 'General case' 1 C--N 1.429 4.039 0 C-N-CA 127.072 2.149 . . . . 0.0 109.905 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -34.1 42.69 Favored 'General case' 0 C--N 1.422 3.734 0 N-CA-C 113.586 0.958 . . . . 8.75 113.586 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.657 0.614 . . . . 5.9400000000000004 112.657 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.1 -19.83 63.39 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.451 1.095 . . . . 7.1500000000000004 111.602 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.26 52.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 7.7000000000000002 111.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.89 16.28 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.528 -0.305 . . . . 7.4699999999999998 111.584 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.97 14.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.869 0.366 . . . . 7.3799999999999999 110.715 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.9 65.98 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.89 -0.671 . . . . 7.9199999999999999 113.587 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.809 0.305 . . . . 7.71 111.121 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.91 121.54 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.271 0.558 . . . . 10.0 111.343 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.23 107.75 7.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 8.4499999999999993 110.354 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.7 13.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.064 -0.517 . . . . 10.44 111.751 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.53 53.6 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.234 0.854 . . . . 10.609999999999999 115.234 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.52 130.86 55.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.58 0.69 . . . . 10.279999999999999 112.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.68 101.51 10.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.52 -0.918 . . . . 8.8300000000000001 108.52 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.31 137.88 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.027 1.121 . . . . 6.9699999999999998 114.027 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.665 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.5 tttt -108.61 110.32 21.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.548 -1.279 . . . . 8.5099999999999998 107.548 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.05 126.92 58.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.129 0.49 . . . . 6.1699999999999999 112.288 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.408 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.63 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 8.3000000000000007 110.026 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.05 154.7 49.69 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.56 -0.904 . . . . 8.1400000000000006 108.56 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.4 175.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 121.89 1.726 . . . . 7.79 112.057 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -111.19 13.28 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.739 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 13.0 m-20 -64.43 116.19 5.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.264 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -76.37 135.12 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 57.74 82.72 0.23 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.111 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.5 97.48 0.96 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 112.042 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 99.2 mt 63.12 101.63 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.649 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.13 128.07 21.41 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.267 2.645 . . . . 0.0 113.049 -176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 150.24 38.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.053 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 240' ' ' GLU . 44.3 tpp -61.92 139.5 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 94.7 p 62.09 -9.61 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.918 1.287 . . . . 0.0 112.714 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 238' ' ' MET . 37.1 mt-10 -91.04 -40.38 11.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.824 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 90.5 m-20 -102.91 -57.55 0.1 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.739 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.824 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 12.6 Cg_exo -71.09 126.85 12.84 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.101 1.867 . . . . 0.0 111.53 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.5 p -79.28 90.35 4.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 0.0 111.025 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.28 3.08 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.814 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.2 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.9 m -100.47 132.91 21.75 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.845 0.355 . . . . 0.0 110.415 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.66 -63.48 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.593 2.195 . . . . 0.0 111.912 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -156.73 42.21 0.54 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.54 152.11 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.603 -0.298 . . . . 0.0 110.2 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.465 HG21 ' H ' ' A' ' 252' ' ' THR . 23.5 m -116.77 -172.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 74.3 m -75.47 8.55 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.465 ' H ' HG21 ' A' ' 250' ' ' VAL . 29.0 m -73.04 -38.44 66.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 254' ' ' VAL . 61.3 t -95.72 121.71 46.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.442 HG21 HG13 ' A' ' 253' ' ' VAL . 41.1 t 63.33 74.3 0.45 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.746 0.784 . . . . 0.0 109.545 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -90.51 -167.9 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.004 2.469 . . . . 0.0 112.198 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.75 102.24 14.64 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.9 t -75.72 103.68 5.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.191 0.519 . . . . 0.0 109.808 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -137.57 109.53 7.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.815 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -128.97 30.97 4.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.878 -0.601 . . . . 11.33 110.806 173.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 260' ' ' LYS . 16.3 ttmt -62.9 139.34 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.5 110.323 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 313' ' ' THR . 64.4 mt -109.8 143.94 38.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.02 -0.991 . . . . 6.5800000000000001 112.806 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -104.47 132.12 51.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.19 -1.411 . . . . 7.1399999999999997 107.19 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.661 -0.496 . . . . 5.6799999999999997 109.661 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.504 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.17 179.25 16.48 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.537 -0.839 . . . . 6.5700000000000003 112.659 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.2 86.51 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.643 -0.789 . . . . 8.0399999999999991 111.554 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 95.2 mt -70.83 135.19 85.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.503 0.186 . . . . 8.1600000000000001 111.503 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.8 Cg_exo -61.78 141.6 90.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.883 1.722 . . . . 9.4399999999999995 108.843 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.37 -14.96 62.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.779 1.4 . . . . 11.74 114.779 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.08 -23.21 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.842 1.423 . . . . 11.65 114.842 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.29 149.19 50.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.159 0.436 . . . . 9.3599999999999994 111.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.42 ' O ' HG21 ' A' ' 275' ' ' VAL . 30.4 p-10 -114.5 -176.43 2.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 110.29 -0.263 . . . . 10.609999999999999 110.29 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.61 -55.2 27.85 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.618 1.34 . . . . 10.07 114.618 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.79 -26.34 68.04 Favored 'General case' 0 C--N 1.406 3.033 0 C-N-CA 125.669 1.588 . . . . 0.0 112.408 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -80.04 -48.3 13.52 Favored 'General case' 1 C--N 1.43 4.072 0 CA-C-N 118.301 0.5 . . . . 10.289999999999999 111.412 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 271' ' ' ASN . 67.6 t -62.63 -49.27 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 8.0 110.28 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -54.22 -36.46 63.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 10.199999999999999 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.0 -53.36 56.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.133 0.492 . . . . 10.199999999999999 110.709 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.417 ' O ' HD11 ' A' ' 278' ' ' LEU . 1.5 tm? -51.78 -33.14 33.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.081 -0.509 . . . . 7.6200000000000001 110.364 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.492 HD11 ' SG ' ' A' ' 305' ' ' CYS . 85.1 mt -82.66 -41.67 19.11 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.602 0.593 . . . . 7.7400000000000002 112.602 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.7 m -56.73 -29.9 62.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.567 0.951 . . . . 10.390000000000001 113.567 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 m -50.21 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.555 0 C-N-CA 124.796 1.238 . . . . 0.0 112.587 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -111.46 -12.06 14.03 Favored 'General case' 1 C--N 1.442 4.596 0 CA-C-N 118.379 0.536 . . . . 10.23 111.452 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.12 162.36 10.28 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.786 -0.643 . . . . 10.98 111.913 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.66 147.12 93.3 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.731 2.287 . . . . 12.75 112.712 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 84.1 mt -102.52 146.25 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.918 -0.583 . . . . 10.66 111.215 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.554 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.7 ptpt -100.99 -22.65 14.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.266 -0.642 . . . . 11.630000000000001 109.266 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.64 126.15 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 119.07 -2.269 . . . . 0.0 109.15 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.601 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 62.9 t80 -143.3 134.7 26.12 Favored 'General case' 0 C--N 1.362 1.142 0 C-N-CA 122.886 0.474 . . . . 9.0099999999999998 112.009 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.04 12.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.73 0.3 . . . . 8.7300000000000004 111.557 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 54.2 tp -101.01 118.3 36.73 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.552 -1.277 . . . . 8.9399999999999995 107.552 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.17 122.86 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.511 0.93 . . . . 9.7400000000000002 113.511 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -119.09 148.13 43.39 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 115.332 -0.849 . . . . 11.34 109.336 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 37.2 t70 -58.94 141.1 54.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 13.83 110.95 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.671 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 5.6 m -49.71 -61.66 1.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.625 0.602 . . . . 14.779999999999999 112.625 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.18 -63.95 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.493 0.553 . . . . 16.440000000000001 112.493 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.4 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.414 . . . . 15.24 111.179 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.07 62.69 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.607 -0.806 . . . . 13.609999999999999 114.557 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.33 167.64 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.34 0.57 . . . . 13.529999999999999 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.1 t -59.17 141.96 52.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 10.51 111.617 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.681 ' NZ ' HO2' ' B' ' 601' ' ' ' U' . 4.4 mmmp? -87.95 -9.42 53.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 11.73 109.574 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.37 39.53 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.727 . . . . 8.6300000000000008 113.875 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.55 ' CE1' ' OP1' ' B' ' 603' ' ' ' U' . 55.3 p90 -142.92 146.43 33.99 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.051 0.925 . . . . 9.3900000000000006 112.846 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.13 46.72 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.004 -0.998 . . . . 6.5499999999999998 112.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -111.44 146.83 36.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.168 -0.924 . . . . 7.4299999999999997 110.449 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.601 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.6 p -157.72 156.24 31.32 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.003 -0.679 . . . . 6.7699999999999996 111.869 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.4 127.08 15.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.723 -0.671 . . . . 9.5899999999999999 109.649 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.554 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 53.2 m-85 -82.37 164.92 20.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.095 0.406 . . . . 9.9100000000000001 112.095 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.62 -46.08 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.343 -0.984 . . . . 13.09 108.343 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.741 ' O ' HG23 ' A' ' 312' ' ' VAL . 12.1 t70 -96.32 102.28 14.04 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.381 -1.34 . . . . 13.18 107.381 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.68 -35.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 115.337 1.606 . . . . 12.48 115.337 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -56.78 -38.73 72.89 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.259 1.028 . . . . 13.4 109.097 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.69 -22.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.306 -2.225 . . . . 11.43 109.529 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 94.5 m -54.64 -48.13 72.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.929 -0.767 . . . . 9.5 108.929 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.46 -42.89 99.8 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.308 -0.557 . . . . 10.31 110.467 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -63.8 -32.44 73.94 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 119.923 -0.711 . . . . 12.41 111.941 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.66 74.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.586 -1.643 . . . . 8.3900000000000006 113.103 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.61 -51.31 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.362 0.601 . . . . 7.71 110.876 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.88 -38.66 67.82 Favored 'General case' 0 C--N 1.419 3.596 0 C-N-CA 126.281 1.832 . . . . 0.0 113.151 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.431 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.11 -24.08 35.81 Favored Glycine 1 C--N 1.399 4.033 0 N-CA-C 116.778 1.471 . . . . 8.7599999999999998 116.778 177.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 99.1 mt -96.81 -45.81 6.5 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.107 1.954 . . . . 7.2000000000000002 113.946 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -50.47 130.04 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 8.1099999999999994 111.463 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.66 56.76 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.111 -0.566 . . . . 8.6400000000000006 113.948 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.431 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 18.7 mtt -50.65 147.21 4.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.783 0.325 . . . . 8.25 111.264 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -95.14 115.69 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.076 0.465 . . . . 10.48 111.715 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 330' ' ' LEU . 4.0 mm? -120.26 106.83 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.082 -1.081 . . . . 8.9499999999999993 108.082 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.1 -118.74 10.65 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.397 -1.481 . . . . 10.630000000000001 109.397 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -115.78 22.36 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 12.25 109.781 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.8 153.91 40.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.616 -0.72 . . . . 10.34 111.624 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.73 118.25 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.117 -1.068 . . . . 10.59 108.117 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.2 tp -63.09 143.09 58.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 7.6500000000000004 112.586 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.991 HD13 ' C2 ' ' B' ' 602' ' ' ' U' . 20.8 mt -128.12 128.0 44.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.504 -1.225 . . . . 7.7599999999999998 108.997 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.92 124.04 26.28 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 O-C-N 120.984 -1.073 . . . . 6.4500000000000002 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -152.76 155.33 36.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 119.987 -1.696 . . . . 7.8799999999999999 109.547 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.465 ' HA ' HD21 ' A' ' 261' ' ' LEU . 95.0 mtt180 -58.55 122.43 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.395 -1.322 . . . . 9.1999999999999993 107.626 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.94 -11.77 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.786 1.402 . . . . 7.5199999999999996 114.786 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.6 m -119.36 -77.84 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.55 -0.46 . . . . 9.3599999999999994 111.422 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.42 93.91 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.477 0.656 . . . . 0.0 110.581 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 167.84 136.59 2.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.012 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -166.01 -173.54 2.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.99 105.46 17.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.414 0.626 . . . . 0.0 110.181 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -97.53 -35.47 10.62 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.079 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.677 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 0.681 HO2' ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.101 0 C3'-C2'-C1' 100.208 -1.435 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.991 ' C2 ' HD13 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C1'-C2' 107.578 0.842 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.606 ' H6 ' " H5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.151 0 O4'-C1'-C2' 107.723 0.945 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.665 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.498 5.385 0 C4'-C3'-C2' 99.31 -3.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.671 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.677 5.823 0 C4'-C3'-C2' 106.672 3.972 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.08 0 C4'-C3'-C2' 105.18 2.48 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 0.739 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.54 1.186 0 O4'-C4'-C3' 103.912 -1.134 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . 0.402 H5'' " H2'" ' B' ' 607' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 O4'-C1'-C2' 107.604 0.86 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-C1' 100.785 -0.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.983 ' HB1' HG11 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.093 0.473 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 149' ' ' ARG . 74.5 ttt180 -179.66 16.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.018 -173.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.34 148.4 21.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.762 -1.108 . . . . 6.3499999999999996 111.36 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.6 mt -140.74 143.47 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 5.5099999999999998 111.205 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.55 125.14 40.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.901 -0.777 . . . . 6.8200000000000003 108.901 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.29 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.098 0.475 . . . . 5.0899999999999999 110.147 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.81 -179.32 34.73 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.964 -0.562 . . . . 6.2000000000000002 112.795 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.4 m120 50.28 41.31 24.14 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 125.258 1.423 . . . . 0.0 110.194 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.46 149.83 88.94 Favored Pre-proline 1 C--N 1.429 4.048 0 C-N-CA 123.832 0.853 . . . . 7.79 111.316 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.07 144.41 90.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.308 2.005 . . . . 8.9900000000000002 111.013 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.67 52.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.93 0.395 . . . . 11.75 111.964 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.33 6.42 61.52 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.838 -0.619 . . . . 10.470000000000001 114.319 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.11 136.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.31 0.555 . . . . 8.9100000000000001 110.276 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.6 p -84.86 153.91 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 9.9100000000000001 110.691 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.1 -43.19 95.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 7.7599999999999998 110.204 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.78 -45.92 91.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.901 -0.59 . . . . 9.8900000000000006 110.499 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.76 -26.38 68.68 Favored 'General case' 0 C--N 1.408 3.142 0 O-C-N 119.262 -2.149 . . . . 0.0 111.689 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.401 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.29 -34.1 67.92 Favored 'General case' 0 C--N 1.428 3.98 0 O-C-N 123.978 0.799 . . . . 6.7800000000000002 111.79 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.457 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.1 ttt -74.54 -54.22 7.92 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.412 0.685 . . . . 6.9699999999999998 111.132 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.73 -33.61 61.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 8.8000000000000007 111.353 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.83 -53.55 17.64 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.531 -0.468 . . . . 7.8700000000000001 111.61 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.31 -48.28 82.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.13 0.419 . . . . 5.9400000000000004 112.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.41 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.76 -42.85 80.08 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.277 -0.569 . . . . 7.1200000000000001 109.559 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.28 64.83 Favored 'General case' 0 C--N 1.405 3.001 0 O-C-N 120.199 -1.563 . . . . 0.0 111.234 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.72 36.7 Favored 'General case' 0 C--N 1.427 3.956 0 CA-C-N 118.528 0.604 . . . . 7.9299999999999997 110.354 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.445 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.75 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.577 -0.738 . . . . 7.7300000000000004 111.059 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -76.1 -42.94 45.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.413 0.523 . . . . 9.9600000000000009 112.413 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.259 0.552 . . . . 10.42 110.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.04 -16.52 74.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.322 -0.942 . . . . 9.2300000000000004 112.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.19 37.14 71.88 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.843 -0.903 . . . . 9.6099999999999994 110.843 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.35 51.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 8.4600000000000009 112.918 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.5 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.8 p -82.58 143.49 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 9.1600000000000001 110.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.529 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.47 21.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.18 0.437 . . . . 10.23 112.18 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.49 23.74 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.709 -0.223 . . . . 10.24 110.693 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.4 143.61 99.66 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.926 1.751 . . . . 11.43 110.825 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.22 161.63 20.69 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.639 -0.791 . . . . 9.4499999999999993 112.441 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.3 134.5 73.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.089 0.403 . . . . 8.3300000000000001 112.089 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.5 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.26 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.492 2.128 . . . . 6.9699999999999998 111.315 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.457 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.65 105.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.8700000000000001 111.135 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -35.05 33.28 Favored 'General case' 0 N--CA 1.53 3.525 0 O-C-N 120.279 -1.513 . . . . 0.0 113.277 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.84 163.95 39.18 Favored 'General case' 0 C--N 1.386 2.167 0 C-N-CA 126.05 1.74 . . . . 0.0 110.591 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.19 130.45 11.04 Favored 'Isoleucine or valine' 0 C--N 1.372 1.549 0 C-N-CA 126.534 1.934 . . . . 5.6699999999999999 109.297 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.06 126.7 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.798 -0.445 . . . . 6.6799999999999997 109.798 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.525 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.2 mt -115.06 125.98 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 116.904 2.187 . . . . 7.0999999999999996 116.904 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -98.05 91.38 5.27 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 103.193 -2.891 . . . . 8.1600000000000001 103.193 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -57.4 7.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.612 1.708 . . . . 10.279999999999999 115.612 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.76 75.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.839 0.681 . . . . 10.51 112.839 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.04 -9.11 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.834 0.309 . . . . 9.9399999999999995 111.834 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.15 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.495 1.294 . . . . 8.4499999999999993 114.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.64 168.56 19.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.184 -1.007 . . . . 7.25 111.663 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.525 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.51 161.17 41.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.27 -1.332 . . . . 5.1900000000000004 110.446 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.27 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.726 -0.842 . . . . 6.0899999999999999 108.726 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.0 mt -94.82 137.58 33.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.451 -0.34 . . . . 4.2699999999999996 110.337 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.73 25.98 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.702 -0.481 . . . . 6.21 109.702 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.7 164.78 11.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.928 -0.578 . . . . 6.1399999999999997 111.953 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.67 -25.87 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 8.6899999999999995 111.484 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 207' ' ' GLU . 88.5 p -129.0 159.6 35.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.17 0.509 . . . . 8.3300000000000001 111.579 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.983 HG11 ' HB1' ' A' ' 148' ' ' ALA . 40.9 t -74.34 -41.73 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.523 -0.762 . . . . 8.9600000000000009 112.201 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.78 -41.72 95.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.32 0.489 . . . . 9.2599999999999998 112.32 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.451 ' HB2' ' HG ' ' A' ' 204' ' ' SER . 61.2 mt-10 -61.91 -43.85 97.99 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.192 -0.299 . . . . 7.6200000000000001 110.192 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.529 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.15 -53.28 55.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.332 1.063 . . . . 6.4199999999999999 108.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.467 HG23 HH22 ' A' ' 228' ' ' ARG . 3.7 p -56.19 -26.15 49.64 Favored 'General case' 1 C--N 1.449 4.894 0 C-N-CA 126.15 1.78 . . . . 0.0 110.195 178.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -34.05 41.57 Favored 'General case' 0 C--N 1.428 3.995 0 N-CA-C 113.602 0.964 . . . . 8.75 113.602 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.36 64.14 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.72 0.637 . . . . 5.9400000000000004 112.72 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.02 -19.93 63.38 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.532 1.145 . . . . 7.1500000000000004 111.597 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.42 -9.27 52.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 7.7000000000000002 111.683 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.18 14.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 7.4699999999999998 111.704 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.86 120.99 14.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.886 0.374 . . . . 7.3799999999999999 110.803 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.86 -4.85 66.06 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.906 -0.664 . . . . 7.9199999999999999 113.584 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.858 0.329 . . . . 7.71 111.086 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.95 121.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.271 0.558 . . . . 10.0 111.286 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.64 7.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.698 -0.683 . . . . 8.4499999999999993 110.347 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.73 42.71 13.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 10.44 111.759 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.1 -5.5 54.08 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.186 0.834 . . . . 10.609999999999999 115.186 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.62 130.84 55.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.654 0.727 . . . . 10.279999999999999 112.405 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.72 101.49 10.91 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.535 -0.913 . . . . 8.8300000000000001 108.535 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.28 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.088 1.144 . . . . 6.9699999999999998 114.088 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.727 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.51 110.26 21.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.588 -1.264 . . . . 8.5099999999999998 107.588 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.92 126.95 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 6.1699999999999999 112.334 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.62 170.52 15.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 8.3000000000000007 110.047 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.467 HH22 HG23 ' A' ' 209' ' ' THR . 3.5 mtp180 -89.09 154.67 49.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.559 -0.904 . . . . 8.1400000000000006 108.559 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.38 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.97 1.78 . . . . 7.79 111.987 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -83.87 -30.39 26.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.9 p-10 -96.97 21.99 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.973 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -70.02 -22.53 63.09 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -111.43 100.7 48.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.09 19.8 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.908 2.405 . . . . 0.0 111.323 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 34.0 tp 58.75 75.41 0.52 Allowed Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.678 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.69 46.6 2.2 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.417 2.745 . . . . 0.0 112.351 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.17 57.11 6.4 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.692 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 26.2 ttt -101.81 -26.64 13.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.4 p -104.23 139.62 38.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.555 ' HG2' ' H ' ' A' ' 241' ' ' ASN . 34.3 tt0 -137.45 179.74 6.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.829 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 18.5 m120 -63.13 -54.56 44.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 121.352 -0.139 . . . . 0.0 110.938 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.829 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 8.5 Cg_endo -91.41 -175.25 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.673 2.249 . . . . 0.0 111.613 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 246' ' ' VAL . 45.8 m 62.09 27.17 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.204 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.73 -14.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -125.34 -48.43 1.7 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.098 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 243' ' ' SER . 5.5 m -126.24 133.25 24.77 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.51 31.29 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.985 2.456 . . . . 0.0 113.158 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 141.59 -157.77 26.34 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.6 t -75.68 -41.99 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.66 178.89 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.817 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.8 m -145.65 90.42 2.0 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.2 m -77.98 -42.19 33.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.651 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.03 86.85 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.348 0.594 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.36 136.46 22.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.617 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.59 119.92 5.67 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.611 2.208 . . . . 0.0 113.076 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.97 150.75 20.84 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 p -63.72 145.04 56.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.98 169.91 12.36 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -92.79 31.12 1.43 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.042 -0.663 . . . . 11.33 110.74 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.01 139.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.185 0.517 . . . . 8.5 110.278 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 334' ' ' ARG . 47.9 mt -109.73 143.86 38.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.032 -0.986 . . . . 6.5800000000000001 112.862 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -104.49 132.14 51.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.214 -1.402 . . . . 7.1399999999999997 107.214 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.0 121.21 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.54 -0.541 . . . . 5.6799999999999997 109.54 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.539 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.515 -0.85 . . . . 6.5700000000000003 112.722 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.19 86.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.656 -0.783 . . . . 8.0399999999999991 111.511 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.5 mt -70.86 135.25 85.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.154 . . . . 8.1600000000000001 111.409 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 35.4 Cg_exo -61.82 141.55 90.52 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.952 1.768 . . . . 9.4399999999999995 108.737 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.39 -14.94 62.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.703 1.371 . . . . 11.74 114.703 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -84.07 -23.27 30.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.811 1.412 . . . . 11.65 114.811 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.23 149.17 50.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.125 0.421 . . . . 9.3599999999999994 111.366 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.402 ' O ' HG21 ' A' ' 275' ' ' VAL . 20.5 p-10 -114.51 -176.46 2.91 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.293 -0.262 . . . . 10.609999999999999 110.293 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -53.55 -55.4 25.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 114.632 1.345 . . . . 10.07 114.632 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -26.46 67.89 Favored 'General case' 0 C--N 1.406 3.042 0 C-N-CA 125.639 1.576 . . . . 0.0 112.531 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -79.95 -48.34 13.55 Favored 'General case' 0 C--N 1.428 3.979 0 CA-C-N 118.307 0.503 . . . . 10.289999999999999 111.447 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 271' ' ' ASN . 79.5 t -62.67 -49.14 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 8.0 110.286 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 33.0 mtmm -54.28 -36.48 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 10.199999999999999 111.332 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.99 -53.38 56.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 10.199999999999999 110.716 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.77 -33.09 33.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.08 -0.509 . . . . 7.6200000000000001 110.393 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 305' ' ' CYS . 78.5 mt -82.62 -41.72 19.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.588 0.588 . . . . 7.7400000000000002 112.588 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 83.0 m -56.82 -29.9 63.22 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.523 0.935 . . . . 10.390000000000001 113.523 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 19.8 m -50.26 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.549 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.414 ' CD2' ' HA ' ' A' ' 316' ' ' ALA . 33.8 m-85 -111.33 -11.95 14.1 Favored 'General case' 1 C--N 1.444 4.688 0 CA-C-N 118.372 0.533 . . . . 10.23 111.426 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.835 -0.621 . . . . 10.98 111.94 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.72 147.11 93.48 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.743 2.295 . . . . 12.75 112.627 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 82.5 mt -102.43 146.24 28.36 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.869 -0.605 . . . . 10.66 111.23 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.06 -22.48 14.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.308 -0.627 . . . . 11.630000000000001 109.308 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.33 127.66 5.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 119.294 -2.129 . . . . 0.0 109.099 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.546 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.0 t80 -144.56 134.65 24.07 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 122.852 0.461 . . . . 9.0099999999999998 112.008 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -144.73 124.14 13.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.764 0.316 . . . . 8.7300000000000004 111.513 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 57.3 tp -101.02 118.2 36.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.524 -1.287 . . . . 8.9399999999999995 107.524 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.22 122.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.465 0.913 . . . . 9.7400000000000002 113.465 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -119.19 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.436 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.2 t70 -58.89 141.15 54.27 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.966 0.412 . . . . 13.83 111.039 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.615 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 15.5 m -49.68 -61.7 1.97 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.616 . . . . 14.779999999999999 112.633 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.06 -64.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.476 0.547 . . . . 16.440000000000001 112.476 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.49 -59.33 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 15.24 111.18 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.07 62.55 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.567 -0.825 . . . . 13.609999999999999 114.554 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.29 167.64 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.394 0.597 . . . . 13.529999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.5 t -59.24 142.03 52.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 10.51 111.635 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 1.075 ' NZ ' HO2' ' B' ' 601' ' ' ' U' . 4.8 mmmp? -87.91 -9.46 53.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 11.73 109.573 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.42 39.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.644 -0.707 . . . . 8.6300000000000008 113.895 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -142.9 146.43 34.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.126 0.963 . . . . 9.3900000000000006 112.903 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.1 46.73 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.106 -0.952 . . . . 6.5499999999999998 112.23 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -111.39 146.93 36.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.221 -0.899 . . . . 7.4299999999999997 110.348 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.6 p -157.91 156.21 30.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.924 -0.711 . . . . 6.7699999999999996 111.919 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -145.31 127.1 15.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.68 -0.691 . . . . 9.5899999999999999 109.61 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.496 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 63.9 m-85 -82.55 164.87 20.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.417 . . . . 9.9100000000000001 112.041 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.5 -46.13 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.384 -0.969 . . . . 13.09 108.384 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.696 ' O ' HG23 ' A' ' 312' ' ' VAL . 15.1 t70 -96.28 102.35 14.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.355 -1.35 . . . . 13.18 107.355 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.522 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.05 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 115.303 1.594 . . . . 12.48 115.303 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -56.84 -38.71 73.05 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.264 1.03 . . . . 13.4 109.009 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.78 -22.63 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 112.265 -2.243 . . . . 11.43 109.549 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.62 -48.22 72.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.931 -0.766 . . . . 9.5 108.931 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.45 -42.81 99.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.184 -0.607 . . . . 10.31 110.52 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.8 -32.47 73.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 119.943 -0.703 . . . . 12.41 111.909 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . . . -69.43 -34.79 74.96 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.626 -1.624 . . . . 8.3900000000000006 113.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 74.7 mt -68.54 -51.3 47.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 121.403 0.621 . . . . 7.71 110.861 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.1 -38.63 68.38 Favored 'General case' 0 C--N 1.419 3.603 0 C-N-CA 126.141 1.776 . . . . 0.0 113.172 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -23.92 36.68 Favored Glycine 1 C--N 1.398 4.008 0 N-CA-C 116.845 1.498 . . . . 8.7599999999999998 116.845 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.415 ' O ' HD21 ' A' ' 330' ' ' LEU . 80.2 mt -96.9 -45.71 6.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 120.122 1.961 . . . . 7.2000000000000002 113.957 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -50.54 130.07 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 8.1099999999999994 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.16 -16.65 56.76 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.091 -0.576 . . . . 8.6400000000000006 113.955 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.2 ttt -50.67 147.19 4.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.755 0.312 . . . . 8.25 111.298 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -95.05 115.61 27.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 10.48 111.635 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.25 106.77 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.118 -1.068 . . . . 8.9499999999999993 108.118 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.08 -118.67 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.382 -1.487 . . . . 10.630000000000001 109.382 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -115.84 22.49 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.129 0.49 . . . . 12.25 109.749 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -123.9 153.83 40.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.673 -0.694 . . . . 10.34 111.612 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -101.79 118.3 36.64 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.071 -1.085 . . . . 10.59 108.071 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.695 ' HB2' HD21 ' A' ' 325' ' ' LEU . 23.8 tp -63.03 143.13 58.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.502 0.668 . . . . 7.6500000000000004 112.642 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 1.446 ' CD1' ' H3 ' ' B' ' 602' ' ' ' U' . 3.7 mp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.574 -1.193 . . . . 7.7599999999999998 108.977 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.96 123.98 26.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 O-C-N 120.939 -1.101 . . . . 6.4500000000000002 109.997 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . 0.606 ' HB2' ' HB1' ' A' ' 339' ' ' ALA . 16.0 pt20 -152.68 155.35 37.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 119.965 -1.709 . . . . 7.8799999999999999 109.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.505 ' HA ' HD21 ' A' ' 261' ' ' LEU . 82.1 mtt180 -58.63 122.53 13.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.403 -1.319 . . . . 9.1999999999999993 107.533 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.734 1.383 . . . . 7.5199999999999996 114.734 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.0 m -119.4 -78.29 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.623 -0.431 . . . . 9.3599999999999994 111.262 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 30.0 m -126.75 141.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.604 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 152.05 -71.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 333' ' ' GLN . . . -102.05 112.84 25.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.078 0.466 . . . . 0.0 110.19 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -167.52 -56.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.965 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -93.32 -41.55 9.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.901 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 339' ' ' ALA . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 1.075 HO2' ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.176 0 O4'-C1'-N19 109.398 1.198 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 1.446 ' H3 ' ' CD1' ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 O4'-C1'-C2' 107.522 0.801 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.46 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.104 0 C4'-C3'-C2' 103.642 0.942 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.727 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 O3'--C3' 1.516 6.607 1 C4'-C3'-C2' 98.382 -4.318 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.615 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.696 7.456 0 C4'-C3'-C2' 106.662 3.962 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.975 0 C4'-C3'-C2' 105.54 2.84 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 0.61 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 O4'-C1'-C2' 107.589 0.849 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.964 0 C3'-C2'-C1' 100.84 -0.734 . 0.028 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-C1' 100.763 -0.819 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.502 ' HB2' HG12 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.634 0.254 . . . . 0.0 111.483 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -87.29 50.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 110.53 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -156.22 148.61 23.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 6.3499999999999996 111.203 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.3 mt -140.8 143.56 34.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 5.5099999999999998 111.185 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.59 125.16 40.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.851 -0.796 . . . . 6.8200000000000003 108.851 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 198' ' ' ALA . 2.3 p -124.79 101.21 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.088 0.47 . . . . 5.0899999999999999 110.201 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -178.96 34.97 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.998 -0.547 . . . . 6.2000000000000002 112.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 50.53 40.71 24.09 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.122 1.369 . . . . 0.0 110.224 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.62 149.88 88.59 Favored Pre-proline 1 C--N 1.428 4.01 0 C-N-CA 123.595 0.758 . . . . 7.79 111.302 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.07 144.47 89.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.297 1.998 . . . . 8.9900000000000002 110.967 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.0 139.71 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.987 0.422 . . . . 11.75 111.94 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.19 6.56 61.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.792 -0.64 . . . . 10.470000000000001 114.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 191' ' ' ILE . 11.0 tp -66.17 136.47 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 117.331 0.566 . . . . 8.9100000000000001 110.283 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.3 p -84.9 153.99 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.517 -0.31 . . . . 9.9100000000000001 110.652 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.19 -43.21 96.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 7.7599999999999998 110.146 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.72 -45.96 91.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.979 -0.555 . . . . 9.8900000000000006 110.575 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.62 -26.35 68.57 Favored 'General case' 0 C--N 1.41 3.199 0 O-C-N 119.296 -2.127 . . . . 0.0 111.664 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.411 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.41 -34.17 67.66 Favored 'General case' 0 C--N 1.428 3.982 0 O-C-N 123.985 0.803 . . . . 6.7800000000000002 111.708 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.45 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.6 -54.24 7.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 123.47 0.708 . . . . 6.9699999999999998 111.102 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.54 -33.77 60.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.426 -0.806 . . . . 8.8000000000000007 111.391 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.75 -53.6 17.65 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.604 -0.438 . . . . 7.8700000000000001 111.572 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.411 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.39 -48.22 82.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 5.9400000000000004 112.139 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.412 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.79 -42.93 80.35 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.342 -0.543 . . . . 7.1200000000000001 109.591 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.2 -22.98 64.78 Favored 'General case' 0 C--N 1.406 3.038 0 O-C-N 120.181 -1.574 . . . . 0.0 111.302 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.63 -37.55 35.8 Favored 'General case' 0 C--N 1.427 3.961 0 CA-C-N 118.56 0.618 . . . . 7.9299999999999997 110.309 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.457 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.81 -36.67 82.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.614 -0.721 . . . . 7.7300000000000004 111.022 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -76.12 -43.03 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.375 0.509 . . . . 9.9600000000000009 112.375 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.99 -37.69 88.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.186 0.517 . . . . 10.42 110.471 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.44 74.58 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.196 -1.002 . . . . 9.2300000000000004 112.871 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.1 37.09 72.65 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.908 -0.877 . . . . 9.6099999999999994 110.908 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.8 5.22 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.945 0.72 . . . . 8.4600000000000009 112.945 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.492 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.3 p -82.65 143.46 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.591 0.234 . . . . 9.1600000000000001 110.524 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.525 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.69 -18.41 21.33 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.047 0.388 . . . . 10.23 112.047 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.44 23.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.704 -0.225 . . . . 10.24 110.674 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.31 143.46 99.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.033 1.822 . . . . 11.43 110.748 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.4 161.67 20.53 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.611 -0.804 . . . . 9.4499999999999993 112.355 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.36 134.42 73.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.003 0.372 . . . . 8.3300000000000001 112.003 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.492 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.24 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 6.9699999999999998 111.325 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.45 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.6 105.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.8700000000000001 111.174 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -33.78 29.67 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 120.212 -1.555 . . . . 0.0 113.418 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.17 40.58 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 126.054 1.742 . . . . 0.0 110.647 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.73 130.43 12.12 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 126.309 1.844 . . . . 5.6699999999999999 109.298 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.04 126.65 55.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.823 -0.436 . . . . 6.6799999999999997 109.823 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.526 HG12 ' HB1' ' A' ' 198' ' ' ALA . 97.2 mt -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 116.875 2.176 . . . . 7.0999999999999996 116.875 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.11 91.32 5.22 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.186 -2.894 . . . . 8.1600000000000001 103.186 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.22 -57.43 7.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.619 1.711 . . . . 10.279999999999999 115.619 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.18 -48.73 75.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.884 0.698 . . . . 10.51 112.884 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.01 -9.13 50.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.74 0.305 . . . . 9.9399999999999995 111.764 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.14 15.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 114.516 1.302 . . . . 8.4499999999999993 114.516 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.418 ' CD2' ' OP1' ' B' ' 606' ' ' ' U' . 13.2 p90 -143.58 168.64 19.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.11 -1.036 . . . . 7.25 111.632 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.526 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.05 41.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.149 -1.387 . . . . 5.1900000000000004 110.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.35 51.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.691 -0.855 . . . . 6.0899999999999999 108.691 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.87 137.6 33.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 4.2699999999999996 110.297 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.8 114.74 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.698 -0.482 . . . . 6.21 109.698 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.69 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.965 -0.561 . . . . 6.1399999999999997 111.935 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.68 -25.93 22.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.822 . . . . 8.6899999999999995 111.462 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.4 p -128.85 159.6 35.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 8.3300000000000001 111.687 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 148' ' ' ALA . 40.6 t -74.29 -41.77 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 8.9600000000000009 112.247 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.7 -41.77 95.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.343 0.497 . . . . 9.2599999999999998 112.343 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.236 -0.283 . . . . 7.6200000000000001 110.236 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.489 HG22 ' HG ' ' A' ' 151' ' ' LEU . 55.8 m -54.24 -53.9 47.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.317 1.056 . . . . 6.4199999999999999 108.15 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 m -55.03 -27.22 42.85 Favored 'General case' 1 C--N 1.429 4.041 0 C-N-CA 127.082 2.153 . . . . 0.0 109.859 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -34.21 42.78 Favored 'General case' 0 C--N 1.42 3.662 0 N-CA-C 113.578 0.955 . . . . 8.75 113.578 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.45 64.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.621 0.6 . . . . 5.9400000000000004 112.621 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.82 63.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.449 1.093 . . . . 7.1500000000000004 111.617 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.2 52.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 7.7000000000000002 111.62 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.91 16.2 14.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.529 -0.305 . . . . 7.4699999999999998 111.591 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.95 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 7.3799999999999999 110.767 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.81 -4.76 66.14 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.907 -0.663 . . . . 7.9199999999999999 113.619 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.37 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.877 0.338 . . . . 7.71 111.08 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.93 121.57 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.278 0.561 . . . . 10.0 111.31 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.31 107.81 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 8.4499999999999993 110.3 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.62 42.74 13.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.034 -0.53 . . . . 10.44 111.823 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.0 -5.47 53.71 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.225 0.85 . . . . 10.609999999999999 115.225 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.58 130.96 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.686 0.743 . . . . 10.279999999999999 112.405 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.56 10.96 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.507 -0.923 . . . . 8.8300000000000001 108.507 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.35 137.84 58.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.974 1.102 . . . . 6.9699999999999998 113.974 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.638 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.54 110.31 21.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.513 -1.291 . . . . 8.5099999999999998 107.513 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.99 126.88 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.35 0.5 . . . . 6.1699999999999999 112.35 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.408 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.6 170.44 15.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.474 -0.785 . . . . 8.3000000000000007 110.067 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.06 154.68 49.66 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.599 -0.889 . . . . 8.1400000000000006 108.599 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.31 174.9 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.795 1.663 . . . . 7.79 112.057 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -104.29 -80.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 1.175 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 3.7 m-20 46.28 -98.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.903 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.13 -72.55 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -160.45 129.1 3.01 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.922 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.53 -45.31 41.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.841 2.361 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.0 tp -114.3 99.53 51.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.409 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.69 117.14 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.605 2.203 . . . . 0.0 112.441 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.56 -43.19 4.01 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -148.35 165.5 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 70.4 m -120.41 -58.5 1.84 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.5 0.19 . . . . 0.0 110.922 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -18.48 1.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.901 0.381 . . . . 0.0 110.994 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -105.04 147.69 34.91 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.49 -49.97 14.26 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.926 2.417 . . . . 0.0 112.505 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m 69.71 161.42 0.21 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.909 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.6 t 67.37 99.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.804 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -96.33 -47.74 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.117 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 18.4 m -91.34 140.2 25.54 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.243 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 36.5 Cg_exo -57.44 -50.57 10.51 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.057 2.504 . . . . 0.0 112.884 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 68.53 38.26 86.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.686 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.74 -14.99 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.476 0.655 . . . . 0.0 110.108 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.46 165.28 2.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.233 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 27.5 p 50.66 85.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.453 0.701 . . . . 0.0 111.487 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 48.1 m -64.8 100.53 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.211 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.02 -51.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.727 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.4 t 63.6 89.22 0.11 Allowed Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.311 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.08 -45.53 15.72 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.787 2.325 . . . . 0.0 112.022 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.52 88.49 7.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 110.102 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.2 t -141.97 150.01 40.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.419 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . 0.645 ' O ' ' HB2' ' A' ' 259' ' ' HIS . . . -146.62 -69.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.275 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.645 ' HB2' ' O ' ' A' ' 258' ' ' ALA . 59.4 m80 89.65 30.43 0.02 OUTLIER 'General case' 0 C--N 1.344 0.326 0 O-C-N 124.456 1.097 . . . . 11.33 110.958 -172.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.92 139.27 58.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.204 0.526 . . . . 8.5 110.367 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.481 HD21 ' HA ' ' A' ' 334' ' ' ARG . 59.4 mt -109.74 143.97 38.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.015 -0.993 . . . . 6.5800000000000001 112.829 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.4 132.17 50.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.147 -1.427 . . . . 7.1399999999999997 107.147 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.4 HD12 ' HG ' ' A' ' 305' ' ' CYS . 4.3 mp -127.04 121.29 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.565 -0.532 . . . . 5.6799999999999997 109.565 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.513 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.2 179.22 16.5 Favored Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.461 -0.876 . . . . 6.5700000000000003 112.693 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.12 86.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.634 -0.794 . . . . 8.0399999999999991 111.517 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 92.7 mt -70.79 135.27 85.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.48 0.178 . . . . 8.1600000000000001 111.48 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.6 Cg_exo -61.85 141.51 90.18 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.923 1.748 . . . . 9.4399999999999995 108.796 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -65.36 -14.86 61.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.763 1.394 . . . . 11.74 114.763 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -84.15 -23.17 30.75 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.77 1.396 . . . . 11.65 114.77 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 149.21 50.71 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.121 0.418 . . . . 9.3599999999999994 111.31 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.418 ' O ' HG21 ' A' ' 275' ' ' VAL . 10.0 p-10 -114.51 -176.39 2.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.578 -0.283 . . . . 10.609999999999999 110.296 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 10.8 m-20 -53.64 -55.21 27.9 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 114.622 1.341 . . . . 10.07 114.622 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.33 -26.77 68.03 Favored 'General case' 0 C--N 1.405 2.995 0 C-N-CA 125.697 1.599 . . . . 0.0 112.456 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.07 -48.22 13.61 Favored 'General case' 1 C--N 1.429 4.031 0 O-C-N 123.489 0.493 . . . . 10.289999999999999 111.398 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 271' ' ' ASN . 71.9 t -62.69 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 8.0 110.237 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 26.7 mtmm -54.27 -36.45 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.662 -0.699 . . . . 10.199999999999999 111.297 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.06 -53.3 57.37 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 10.199999999999999 110.7 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -51.73 -33.15 33.45 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 116.195 -0.457 . . . . 7.6200000000000001 110.322 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.494 HD11 ' SG ' ' A' ' 305' ' ' CYS . 84.9 mt -82.67 -41.67 19.08 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.568 0.581 . . . . 7.7400000000000002 112.568 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 53.1 m -56.86 -29.41 62.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.546 0.943 . . . . 10.390000000000001 113.546 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -50.11 -10.82 0.06 Allowed 'General case' 0 C--N 1.395 2.572 0 C-N-CA 125.062 1.345 . . . . 0.0 112.563 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.51 -12.03 14.01 Favored 'General case' 1 C--N 1.445 4.733 0 CA-C-N 118.174 0.443 . . . . 10.23 111.499 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.31 10.25 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.795 -0.638 . . . . 10.98 111.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.64 147.09 93.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.677 2.252 . . . . 12.75 112.681 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.3 mt -102.47 146.31 28.29 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.889 -0.596 . . . . 10.66 111.304 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.584 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 12.8 ptpt -101.11 -22.56 14.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 11.630000000000001 109.227 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.07 127.23 5.73 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 119.152 -2.217 . . . . 0.0 108.975 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.595 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 60.2 t80 -144.43 134.75 24.41 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 122.769 0.428 . . . . 9.0099999999999998 112.013 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -144.79 124.03 12.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.813 0.339 . . . . 8.7300000000000004 111.634 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 52.0 tp -100.88 118.27 36.6 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.592 -1.262 . . . . 8.9399999999999995 107.592 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.24 122.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.507 0.929 . . . . 9.7400000000000002 113.507 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.09 148.1 43.42 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.315 -0.857 . . . . 11.34 109.373 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.61 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 36.9 t70 -58.92 141.05 54.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.92 0.39 . . . . 13.83 110.958 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.743 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 14.6 m -49.59 -61.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.795 -0.638 . . . . 14.779999999999999 112.65 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.2 -64.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.422 0.527 . . . . 16.440000000000001 112.422 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 18.4 m -42.4 -59.39 1.86 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 15.24 111.209 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.65 -6.05 62.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.643 -0.789 . . . . 13.609999999999999 114.493 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.29 167.69 13.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.425 0.612 . . . . 13.529999999999999 110.913 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -59.25 142.01 52.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 10.51 111.572 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 1.282 ' NZ ' HO2' ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.96 -9.4 53.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.795 -0.639 . . . . 11.73 109.619 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.61 -3.4 39.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.597 -0.729 . . . . 8.6300000000000008 113.874 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.97 146.41 33.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.03 0.915 . . . . 9.3900000000000006 112.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.46 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.2 46.74 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.101 -0.954 . . . . 6.5499999999999998 112.242 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -111.42 146.84 36.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.186 -0.916 . . . . 7.4299999999999997 110.422 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.595 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.2 p -157.87 156.19 30.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 119.9 -0.72 . . . . 6.7699999999999996 111.875 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 37.5 tt0 -145.27 127.0 15.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.702 -0.681 . . . . 9.5899999999999999 109.713 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.584 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 56.4 m-85 -82.39 164.85 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.941 0.4 . . . . 9.9100000000000001 112.06 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.51 -46.11 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.428 -0.953 . . . . 13.09 108.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.727 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.1 t70 -96.32 102.39 14.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.391 -1.337 . . . . 13.18 107.391 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.561 ' H ' HD11 ' A' ' 310' ' ' ILE . 0.2 OUTLIER -52.76 -34.97 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 115.288 1.588 . . . . 12.48 115.288 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.84 -38.76 73.11 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 122.175 0.988 . . . . 13.4 108.979 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.7 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 112.366 -2.197 . . . . 11.43 109.552 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.67 -48.1 72.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.935 -0.765 . . . . 9.5 108.935 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -62.52 -42.77 99.74 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.205 -0.598 . . . . 10.31 110.486 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -63.88 -32.39 73.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.931 -0.708 . . . . 12.41 111.932 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.77 74.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.711 -1.586 . . . . 8.3900000000000006 113.036 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 313' ' ' THR . 63.6 mt -68.63 -51.3 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 7.71 110.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.03 67.59 Favored 'General case' 0 C--N 1.42 3.642 0 C-N-CA 126.185 1.794 . . . . 0.0 113.152 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.417 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -87.93 -23.9 36.92 Favored Glycine 1 C--N 1.399 4.055 0 N-CA-C 116.781 1.472 . . . . 8.7599999999999998 116.781 177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 96.9 mt -96.92 -45.7 6.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.214 2.007 . . . . 7.2000000000000002 114.039 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -50.45 129.98 22.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.845 0.355 . . . . 8.1099999999999994 111.426 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.65 56.79 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.145 -0.55 . . . . 8.6400000000000006 113.956 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.417 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 16.4 mtt -50.64 147.19 4.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.822 0.311 . . . . 8.25 111.267 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -95.09 115.65 27.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.03 0.443 . . . . 10.48 111.71 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.7 mm? -120.2 106.77 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.113 -1.069 . . . . 8.9499999999999993 108.113 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.14 -118.65 10.51 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.38 -1.488 . . . . 10.630000000000001 109.38 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -115.86 22.41 13.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.202 0.525 . . . . 12.25 109.818 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -123.82 153.91 40.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.599 -0.728 . . . . 10.34 111.629 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -101.7 118.41 36.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.115 -1.068 . . . . 10.59 108.115 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.587 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.6 tp -63.21 143.16 58.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.515 0.674 . . . . 7.6500000000000004 112.653 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.539 -1.209 . . . . 7.7599999999999998 108.942 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.96 124.02 26.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 O-C-N 120.935 -1.103 . . . . 6.4500000000000002 110.01 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -152.7 155.31 37.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.973 -1.704 . . . . 7.8799999999999999 109.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.669 ' HD2' ' HA2' ' A' ' 338' ' ' GLY . 84.6 mtt180 -58.66 122.44 13.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 118.463 -1.295 . . . . 9.1999999999999993 107.612 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.77 0.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.766 1.395 . . . . 7.5199999999999996 114.766 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.5 m -119.47 -79.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.539 -0.465 . . . . 9.3599999999999994 111.297 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.02 158.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.619 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . 0.669 ' HA2' ' HD2' ' A' ' 334' ' ' ARG . . . -85.51 63.41 4.31 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.911 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -69.87 100.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.961 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -126.42 144.03 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.363 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.74 100.7 0.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.987 0.804 . . . . 0.0 110.91 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.724 179.181 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 1.282 HO2' ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.505 -2.264 0 C3'-C2'-C1' 100.424 -1.196 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.412 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.907 0 O4'-C1'-C2' 107.514 0.796 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.452 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C4'-C3'-C2' 103.427 0.727 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.638 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.503 5.738 0 C4'-C3'-C2' 99.205 -3.495 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.743 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.683 6.373 0 C4'-C3'-C2' 106.186 3.486 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . 0.418 ' OP1' ' CD2' ' A' ' 197' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.012 0 C4'-C3'-C2' 105.671 2.971 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 1.175 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.035 0 O4'-C1'-C2' 107.645 0.889 . 0.075 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 O4'-C1'-C2' 107.135 0.525 . 0.105 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 O4'-C1'-C2' 107.197 0.569 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 56.09 46.1 22.27 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.581 0.55 . . . . 0.0 111.438 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -158.7 148.52 19.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.064 0.946 . . . . 6.3499999999999996 111.127 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 208' ' ' THR . 28.0 mt -140.67 143.55 35.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.541 . . . . 5.5099999999999998 111.282 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.61 125.19 40.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.854 -0.795 . . . . 6.8200000000000003 108.854 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.8 101.33 8.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 5.0899999999999999 110.196 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.77 -178.63 35.0 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.914 -0.585 . . . . 6.2000000000000002 112.792 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.25 40.83 23.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 124.969 1.308 . . . . 0.0 110.121 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.83 149.8 88.09 Favored Pre-proline 1 C--N 1.428 4.021 0 C-N-CA 123.477 0.711 . . . . 7.79 111.286 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.07 144.48 89.84 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.297 1.998 . . . . 8.9900000000000002 110.989 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.96 139.72 52.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 11.75 111.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.1 6.6 61.0 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.833 -0.621 . . . . 10.470000000000001 114.303 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.12 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.399 0.6 . . . . 8.9100000000000001 110.305 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.4 p -84.89 153.98 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.3 . . . . 9.9100000000000001 110.614 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -60.18 -43.31 95.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 7.7599999999999998 110.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.51 -46.22 90.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.106 -0.497 . . . . 9.8900000000000006 110.516 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.37 -26.39 68.43 Favored 'General case' 0 C--N 1.41 3.233 0 O-C-N 119.26 -2.15 . . . . 0.0 111.734 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.421 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.49 -34.08 67.41 Favored 'General case' 1 C--N 1.429 4.034 0 O-C-N 123.984 0.802 . . . . 6.7800000000000002 111.742 171.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.432 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.63 -54.31 7.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.424 0.69 . . . . 6.9699999999999998 111.057 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.61 -33.68 60.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.453 -0.794 . . . . 8.8000000000000007 111.345 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.76 -53.53 17.93 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 120.41 -0.516 . . . . 7.8700000000000001 111.611 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.2 m-85 -61.31 -48.27 82.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.18 0.437 . . . . 5.9400000000000004 112.18 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.411 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.82 -42.81 80.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.294 -0.562 . . . . 7.1200000000000001 109.64 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.57 65.16 Favored 'General case' 0 C--N 1.407 3.076 0 O-C-N 120.261 -1.524 . . . . 0.0 111.227 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.38 -37.66 36.77 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.528 0.604 . . . . 7.9299999999999997 110.319 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.463 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.8 -36.61 82.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.58 -0.736 . . . . 7.7300000000000004 111.079 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.17 -43.02 44.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.38 0.511 . . . . 9.9600000000000009 112.38 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.2 mt -63.0 -37.73 88.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.203 0.525 . . . . 10.42 110.415 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -16.46 74.61 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.225 -0.988 . . . . 9.2300000000000004 112.894 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.15 71.6 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.774 -0.93 . . . . 9.6099999999999994 110.774 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.9 5.27 51.95 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.939 0.718 . . . . 8.4600000000000009 112.939 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.0 p -82.6 143.42 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.183 -0.207 . . . . 9.1600000000000001 110.609 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.527 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.149 0.426 . . . . 10.23 112.149 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.5 23.71 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.731 -0.213 . . . . 10.24 110.688 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.37 143.56 99.68 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.915 1.743 . . . . 11.43 110.821 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.29 161.61 20.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.656 -0.783 . . . . 9.4499999999999993 112.467 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.25 134.48 73.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.025 0.38 . . . . 8.3300000000000001 112.025 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.503 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.4 Cg_exo -73.25 -50.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.573 2.182 . . . . 6.9699999999999998 111.368 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.432 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.71 105.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.151 -0.477 . . . . 5.8700000000000001 111.107 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -33.17 33.27 Favored 'General case' 0 N--CA 1.524 3.272 0 C-N-CA 124.878 1.271 . . . . 0.0 113.394 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 163.78 39.17 Favored 'General case' 0 C--N 1.386 2.181 0 C-N-CA 125.757 1.623 . . . . 0.0 110.577 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.45 130.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 C-N-CA 126.091 1.756 . . . . 5.6699999999999999 109.338 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.686 -0.487 . . . . 6.6799999999999997 109.686 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.512 HG12 ' HB1' ' A' ' 198' ' ' ALA . 97.1 mt -114.93 125.99 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 116.903 2.186 . . . . 7.0999999999999996 116.903 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.14 91.42 5.26 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 103.187 -2.894 . . . . 8.1600000000000001 103.187 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -57.46 7.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.645 1.72 . . . . 10.279999999999999 115.645 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.14 -48.78 75.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.853 0.686 . . . . 10.51 112.853 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.537 ' HD3' " O2'" ' B' ' 605' ' ' ' U' . 9.5 mmtm -68.99 -9.07 50.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 9.9399999999999995 111.849 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.15 15.5 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.579 1.326 . . . . 8.4499999999999993 114.579 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.52 168.7 19.23 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.12 -1.032 . . . . 7.25 111.671 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.512 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -147.61 161.02 42.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.035 -1.438 . . . . 5.1900000000000004 110.515 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.35 51.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.624 -0.88 . . . . 6.0899999999999999 108.624 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.8 137.56 33.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.355 -0.384 . . . . 4.2699999999999996 110.351 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.83 114.82 26.05 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 6.21 109.645 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -99.77 164.67 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 6.1399999999999997 111.947 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -26.04 22.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.425 -0.807 . . . . 8.6899999999999995 111.461 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.1 p -128.86 159.64 35.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.1 0.476 . . . . 8.3300000000000001 111.646 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.569 -0.741 . . . . 8.9600000000000009 112.303 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.64 -41.79 95.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.364 0.505 . . . . 9.2599999999999998 112.364 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.77 98.17 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 110.298 -0.26 . . . . 7.6200000000000001 110.298 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.527 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.25 -54.48 39.49 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.13 -1.063 . . . . 6.4199999999999999 108.13 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.0 m -54.3 -27.56 36.26 Favored 'General case' 1 C--N 1.429 4.032 0 C-N-CA 127.029 2.132 . . . . 0.0 109.853 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -34.0 44.42 Favored 'General case' 0 C--N 1.426 3.897 0 N-CA-C 113.648 0.981 . . . . 8.75 113.648 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.55 -17.35 64.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.626 0.602 . . . . 5.9400000000000004 112.626 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.5 mtp -62.12 -19.86 63.46 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.29 0.994 . . . . 7.1500000000000004 111.569 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.24 52.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.383 -0.371 . . . . 7.7000000000000002 111.608 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.77 16.16 14.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.747 0.308 . . . . 7.4699999999999998 111.725 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.85 120.9 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 7.3799999999999999 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.84 65.95 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.859 -0.686 . . . . 7.9199999999999999 113.553 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.17 142.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.836 0.318 . . . . 7.71 111.066 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.94 121.57 37.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.271 0.558 . . . . 10.0 111.327 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.29 107.71 7.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 8.4499999999999993 110.354 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.72 42.62 13.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 10.44 111.771 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.34 54.53 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.229 0.851 . . . . 10.609999999999999 115.229 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.69 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.652 0.726 . . . . 10.279999999999999 112.475 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.71 101.58 10.96 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.486 -0.931 . . . . 8.8300000000000001 108.486 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.42 137.82 58.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.032 1.123 . . . . 6.9699999999999998 114.032 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.731 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.47 110.24 21.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.539 -1.282 . . . . 8.5099999999999998 107.539 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.5 mt -104.12 126.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.217 0.532 . . . . 6.1699999999999999 112.233 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.54 170.54 15.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.376 -0.829 . . . . 8.3000000000000007 110.079 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.13 154.7 49.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.535 -0.913 . . . . 8.1400000000000006 108.535 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.39 175.26 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.954 1.77 . . . . 7.79 112.038 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -98.09 -23.6 15.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.87 137.14 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 233' ' ' GLN . 37.7 t80 -96.17 -53.16 3.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.956 0.408 . . . . 0.0 110.511 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.461 ' HB3' ' HG2' ' A' ' 236' ' ' PRO . 27.2 mm-40 -130.61 154.36 81.7 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.84 -66.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.755 2.303 . . . . 0.0 112.507 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.471 ' HB2' ' HD3' ' A' ' 236' ' ' PRO . 81.6 mt -92.69 -55.31 0.24 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 235' ' ' LEU . 46.3 Cg_endo -69.29 148.2 67.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.908 1.739 . . . . 0.0 112.972 -176.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -156.42 53.1 0.42 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -139.58 153.33 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.624 0.25 . . . . 0.0 110.335 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 47.6 m -127.22 114.28 17.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 111.301 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.6 -48.54 69.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.352 0.596 . . . . 0.0 109.51 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -127.33 99.69 27.32 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.446 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.89 113.19 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.879 2.386 . . . . 0.0 112.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -106.5 115.49 30.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.79 -30.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.762 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -152.49 102.01 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.265 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.33 130.9 23.9 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.176 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.08 119.54 6.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.78 2.32 . . . . 0.0 112.124 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 137.88 -176.33 20.73 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 95.9 t 62.45 96.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 111.162 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.9 m -79.35 153.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.486 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.0 t -124.42 -77.62 0.59 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.9 m 67.83 -69.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.512 0.508 . . . . 0.0 111.306 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.3 p -152.94 105.41 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.44 0.638 . . . . 0.0 109.618 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.95 151.3 50.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.95 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.54 12.68 2.8 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.774 2.316 . . . . 0.0 112.355 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.13 156.13 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.586 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 13.1 m -74.91 76.15 2.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -149.03 72.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.484 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -140.05 30.95 1.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 11.33 110.793 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -62.98 139.4 58.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.276 0.56 . . . . 8.5 110.318 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' A' ' 334' ' ' ARG . 65.9 mt -109.8 144.05 38.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.989 -1.005 . . . . 6.5800000000000001 112.789 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.44 132.03 51.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.214 -1.402 . . . . 7.1399999999999997 107.214 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.547 ' CD1' ' HG ' ' A' ' 305' ' ' CYS . 4.0 mp -127.02 121.23 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.618 -0.512 . . . . 5.6799999999999997 109.618 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.521 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.13 179.26 16.46 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.483 -0.865 . . . . 6.5700000000000003 112.719 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.08 86.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.625 -0.798 . . . . 8.0399999999999991 111.561 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.1 mt -70.79 135.27 85.7 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 111.522 0.193 . . . . 8.1600000000000001 111.522 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.1 Cg_exo -61.84 141.53 90.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.998 1.799 . . . . 9.4399999999999995 108.744 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.44 -14.86 61.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.724 1.379 . . . . 11.74 114.724 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -84.21 -22.98 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.827 1.417 . . . . 11.65 114.827 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.31 149.12 50.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.144 0.429 . . . . 9.3599999999999994 111.325 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -114.59 -176.49 2.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.233 -0.284 . . . . 10.609999999999999 110.233 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.54 -55.35 26.29 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.604 1.335 . . . . 10.07 114.604 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -61.4 -26.53 67.91 Favored 'General case' 0 C--N 1.405 3.006 0 C-N-CA 125.72 1.608 . . . . 0.0 112.51 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.12 -48.28 13.46 Favored 'General case' 1 C--N 1.43 4.086 0 CA-C-N 118.283 0.492 . . . . 10.289999999999999 111.385 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.7 -49.16 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.6 . . . . 8.0 110.318 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -54.3 -36.36 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.678 -0.692 . . . . 10.199999999999999 111.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.01 -53.43 55.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.167 0.508 . . . . 10.199999999999999 110.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.65 -33.28 32.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.115 -0.493 . . . . 7.6200000000000001 110.365 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.48 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.52 -41.6 19.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.649 0.611 . . . . 7.7400000000000002 112.649 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 43.5 m -56.94 -29.96 63.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.48 0.919 . . . . 10.390000000000001 113.48 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 17.1 m -50.25 -10.02 0.05 Allowed 'General case' 0 C--N 1.395 2.58 0 C-N-CA 124.753 1.221 . . . . 0.0 112.641 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.46 -12.02 14.04 Favored 'General case' 1 C--N 1.444 4.699 0 CA-C-N 118.379 0.536 . . . . 10.23 111.503 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.36 10.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.821 -0.627 . . . . 10.98 111.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.6 147.11 93.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.72 2.28 . . . . 12.75 112.65 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 89.7 mt -102.56 146.27 28.39 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.959 -0.564 . . . . 10.66 111.241 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.01 -22.53 14.73 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.273 -0.64 . . . . 11.630000000000001 109.273 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -157.32 129.25 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.483 -2.011 . . . . 0.0 108.836 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.576 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -146.21 134.72 22.04 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.654 0.382 . . . . 9.0099999999999998 111.98 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -144.86 124.11 12.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.866 0.365 . . . . 8.7300000000000004 111.566 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 57.3 tp -100.99 118.17 36.47 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.584 -1.265 . . . . 8.9399999999999995 107.584 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.18 122.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.515 0.931 . . . . 9.7400000000000002 113.515 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -119.13 148.14 43.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.262 -0.881 . . . . 11.34 109.413 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.587 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.9 t70 -58.92 141.12 54.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.921 0.391 . . . . 13.83 110.914 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.517 ' HB3' ' N3 ' ' B' ' 605' ' ' ' U' . 50.0 m -49.71 -61.72 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.863 -0.608 . . . . 14.779999999999999 112.6 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.08 -64.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.471 0.545 . . . . 16.440000000000001 112.471 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.48 -59.32 1.91 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.306 -0.407 . . . . 15.24 111.214 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.04 62.54 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.613 -0.804 . . . . 13.609999999999999 114.528 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.35 167.6 13.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.334 0.567 . . . . 13.529999999999999 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.0 t -59.19 142.07 52.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 10.51 111.624 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.619 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.95 -9.43 53.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.793 -0.64 . . . . 11.73 109.569 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.31 39.53 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.67 -0.695 . . . . 8.6300000000000008 113.942 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.815 ' HH ' " H4'" ' B' ' 603' ' ' ' U' . 27.2 p90 -143.01 146.41 33.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.979 0.889 . . . . 9.3900000000000006 112.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.61 155.16 46.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.078 -0.965 . . . . 6.5499999999999998 112.169 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.25 146.81 36.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.077 -0.965 . . . . 7.4299999999999997 110.394 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.576 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.4 p -157.89 156.21 30.95 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 119.983 -0.687 . . . . 6.7699999999999996 111.871 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -145.3 127.09 15.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 9.5899999999999999 109.608 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.516 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 52.9 m-85 -82.46 164.85 20.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.932 0.396 . . . . 9.9100000000000001 112.045 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.55 -46.1 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 108.4 -0.963 . . . . 13.09 108.4 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.9 t70 -96.34 102.37 14.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.361 -1.348 . . . . 13.18 107.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.02 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 115.291 1.589 . . . . 12.48 115.291 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -56.78 -38.86 73.08 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.294 1.045 . . . . 13.4 109.014 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.52 -22.92 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 112.402 -2.181 . . . . 11.43 109.519 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.53 -48.24 72.2 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.896 -0.779 . . . . 9.5 108.896 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.5 -42.71 99.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.187 -0.605 . . . . 10.31 110.513 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.82 -32.43 73.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 119.939 -0.704 . . . . 12.41 111.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.78 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.67 -1.605 . . . . 8.3900000000000006 113.027 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.6 -51.23 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.393 0.616 . . . . 7.71 110.833 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.69 -39.0 67.68 Favored 'General case' 0 C--N 1.42 3.649 0 C-N-CA 126.301 1.84 . . . . 0.0 113.171 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.9 -24.09 36.39 Favored Glycine 1 C--N 1.399 4.08 0 N-CA-C 116.817 1.487 . . . . 8.7599999999999998 116.817 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.89 -45.86 6.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 120.189 1.994 . . . . 7.2000000000000002 113.892 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -50.4 129.99 22.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.812 0.339 . . . . 8.1099999999999994 111.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.19 -16.69 56.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.11 -0.567 . . . . 8.6400000000000006 113.905 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.57 147.21 4.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.868 0.334 . . . . 8.25 111.337 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -95.2 115.67 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.053 0.454 . . . . 10.48 111.681 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.58 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -120.19 106.75 12.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.146 -1.057 . . . . 8.9499999999999993 108.146 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.15 -118.75 10.62 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 109.343 -1.503 . . . . 10.630000000000001 109.343 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -115.8 22.4 13.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.243 0.544 . . . . 12.25 109.786 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.9 154.0 40.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.597 -0.729 . . . . 10.34 111.642 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.8 118.2 36.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.086 -1.079 . . . . 10.59 108.086 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.58 ' HB2' HD21 ' A' ' 325' ' ' LEU . 22.2 tp -63.0 143.06 58.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.485 0.659 . . . . 7.6500000000000004 112.687 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 1.459 ' CD1' ' H3 ' ' B' ' 602' ' ' ' U' . 3.1 mp -128.13 127.94 43.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.555 -1.202 . . . . 7.7599999999999998 108.971 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.4 t -137.91 123.98 26.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 O-C-N 121.044 -1.035 . . . . 6.4500000000000002 109.966 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -152.69 155.29 36.96 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.117 -1.614 . . . . 7.8799999999999999 109.587 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.485 ' HA ' HD21 ' A' ' 261' ' ' LEU . 92.2 mtt180 -58.56 122.45 13.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 118.544 -1.263 . . . . 9.1999999999999993 107.603 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.97 -11.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.808 1.41 . . . . 7.5199999999999996 114.808 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.5 m -119.37 -77.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.629 -0.428 . . . . 9.3599999999999994 111.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 4.7 m -101.12 79.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.523 0.677 . . . . 0.0 110.744 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -75.77 148.43 36.67 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.813 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.95 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.177 0.513 . . . . 0.0 110.677 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -102.0 136.41 41.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.224 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.03 101.87 13.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.927 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.319 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 0.619 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.079 0 O4'-C1'-N19 109.358 1.158 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 1.459 ' H3 ' ' CD1' ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 O4'-C1'-C2' 107.604 0.86 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.815 " H4'" ' HH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.421 -1.191 0 C4'-C3'-C2' 103.984 1.284 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.731 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 C4'--C3' 1.581 5.153 1 C3'-C2'-C1' 105.204 4.116 . 0.077 4g . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.639 " O2'" ' P ' ' B' ' 606' ' ' ' U' . . . . . . . . 1 P--O3' 1.702 7.89 1 P-O3'-C3' 126.116 5.347 OUTLIER-EPSILON 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 5 4 . 1 . 006 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . 0.639 ' P ' " O2'" ' B' ' 605' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.414 -1.625 0 P-O3'-C3' 122.833 2.611 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.541 1.265 0 O4'-C1'-C2' 107.899 1.07 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C3'-C2'-C1' 100.74 -0.844 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-C1' 100.656 -0.938 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 119.876 -0.107 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.625 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 5.7 mmt-85 -127.73 -152.26 0.51 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.074 164.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -159.85 149.34 18.05 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 123.259 0.623 . . . . 6.3499999999999996 111.628 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.47 ' HG ' HG22 ' A' ' 208' ' ' THR . 27.7 mt -140.71 143.65 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 5.5099999999999998 111.281 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.62 125.15 40.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.853 -0.795 . . . . 6.8200000000000003 108.853 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.406 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 5.0899999999999999 110.33 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.66 -179.07 35.07 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.86 -0.609 . . . . 6.2000000000000002 112.823 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 49.79 41.73 22.76 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 125.214 1.406 . . . . 0.0 110.268 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.85 149.75 88.01 Favored Pre-proline 0 C--N 1.426 3.935 0 C-N-CA 123.684 0.794 . . . . 7.79 111.312 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 144.41 89.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.283 1.989 . . . . 8.9900000000000002 111.032 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.93 139.66 52.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 11.75 111.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.27 6.5 61.46 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.799 -0.637 . . . . 10.470000000000001 114.259 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.05 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.363 0.581 . . . . 8.9100000000000001 110.271 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.99 153.89 22.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 9.9100000000000001 110.6 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.1 -43.16 95.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 7.7599999999999998 110.257 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.68 -46.03 91.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.963 -0.562 . . . . 9.8900000000000006 110.616 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -26.71 68.58 Favored 'General case' 0 C--N 1.409 3.159 0 O-C-N 119.264 -2.148 . . . . 0.0 111.661 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.413 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.42 -34.06 67.58 Favored 'General case' 0 C--N 1.428 3.979 0 O-C-N 123.967 0.792 . . . . 6.7800000000000002 111.737 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.453 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.5 -54.34 7.73 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.481 0.713 . . . . 6.9699999999999998 111.115 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.55 -33.72 60.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.367 -0.833 . . . . 8.8000000000000007 111.387 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.78 -53.57 17.67 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 120.543 -0.463 . . . . 7.8700000000000001 111.576 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.413 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.3 m-85 -61.3 -48.34 81.84 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.145 0.424 . . . . 5.9400000000000004 112.145 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.78 -42.6 79.72 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.258 -0.577 . . . . 7.1200000000000001 109.608 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.29 64.72 Favored 'General case' 0 C--N 1.405 3.004 0 O-C-N 120.388 -1.445 . . . . 0.0 111.21 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.5 -37.67 36.17 Favored 'General case' 1 C--N 1.428 4.019 0 CA-C-N 118.455 0.57 . . . . 7.9299999999999997 110.298 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.45 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.8 83.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 7.7300000000000004 111.009 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.15 -42.95 45.03 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.387 0.514 . . . . 9.9600000000000009 112.387 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.0 -37.75 88.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.259 0.552 . . . . 10.42 110.492 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.02 -16.56 74.46 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.273 -0.965 . . . . 9.2300000000000004 112.886 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.26 37.01 71.22 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 110.873 -0.891 . . . . 9.6099999999999994 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.97 5.35 51.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.92 0.711 . . . . 8.4600000000000009 112.92 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.9 p -82.61 143.48 30.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.586 0.232 . . . . 9.1600000000000001 110.593 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.528 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.45 21.37 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.176 0.435 . . . . 10.23 112.176 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.8 163.46 23.78 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.632 -0.258 . . . . 10.24 110.694 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.35 143.54 99.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.965 1.777 . . . . 11.43 110.793 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.58 20.58 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.677 -0.773 . . . . 9.4499999999999993 112.505 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.033 0.383 . . . . 8.3300000000000001 112.033 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.521 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.25 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.454 2.103 . . . . 6.9699999999999998 111.32 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.453 ' O ' ' HE1' ' A' ' 166' ' ' MET . 22.0 t -69.67 105.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.132 -0.485 . . . . 5.8700000000000001 111.134 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -36.33 37.92 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 125.37 1.468 . . . . 0.0 112.954 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.13 164.36 38.62 Favored 'General case' 0 C--N 1.386 2.173 0 C-N-CA 125.826 1.651 . . . . 0.0 110.959 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.9 130.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 125.999 1.72 . . . . 5.6699999999999999 109.337 175.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.93 126.64 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.765 -0.458 . . . . 6.6799999999999997 109.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 126.0 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 116.941 2.2 . . . . 7.0999999999999996 116.941 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.12 91.37 5.24 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.149 -2.908 . . . . 8.1600000000000001 103.149 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.21 -57.43 7.8 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.662 1.727 . . . . 10.279999999999999 115.662 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.24 -48.69 75.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.877 0.695 . . . . 10.51 112.877 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.459 ' HD3' " O2'" ' B' ' 605' ' ' ' U' . 9.5 mmtm -68.97 -9.22 51.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.716 0.293 . . . . 9.9399999999999995 111.77 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 36.11 15.0 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.53 1.307 . . . . 8.4499999999999993 114.53 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.56 168.63 19.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.093 -1.043 . . . . 7.25 111.612 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.544 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.56 161.12 41.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.18 -1.373 . . . . 5.1900000000000004 110.486 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.38 129.31 51.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.73 -0.841 . . . . 6.0899999999999999 108.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.81 137.5 33.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.44 -0.345 . . . . 4.2699999999999996 110.364 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.71 114.73 26.02 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.718 -0.475 . . . . 6.21 109.718 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.73 164.66 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 6.1399999999999997 111.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.56 -25.98 22.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.515 -0.766 . . . . 8.6899999999999995 111.392 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.0 p -128.95 159.57 35.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.094 0.473 . . . . 8.3300000000000001 111.521 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.28 -41.74 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 8.9600000000000009 112.266 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.528 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.7 t70 -64.63 -41.79 95.92 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.396 0.517 . . . . 9.2599999999999998 112.396 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.28 -0.267 . . . . 7.6200000000000001 110.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' A' ' 149' ' ' ARG . 55.9 m -54.17 -53.97 46.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 6.4199999999999999 108.123 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.6 m -55.07 -27.3 43.78 Favored 'General case' 1 C--N 1.43 4.066 0 C-N-CA 126.953 2.101 . . . . 0.0 109.863 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -34.0 43.69 Favored 'General case' 0 C--N 1.422 3.743 0 N-CA-C 113.657 0.984 . . . . 8.75 113.657 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.33 64.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.651 0.611 . . . . 5.9400000000000004 112.651 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.09 -19.85 63.41 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.493 1.12 . . . . 7.1500000000000004 111.614 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.35 53.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 7.7000000000000002 111.613 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.22 14.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.585 -0.279 . . . . 7.4699999999999998 111.658 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.89 121.02 14.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.827 0.346 . . . . 7.3799999999999999 110.782 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.83 66.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.855 -0.688 . . . . 7.9199999999999999 113.587 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.23 142.39 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.87 0.335 . . . . 7.71 111.153 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.93 121.57 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.245 0.545 . . . . 10.0 111.278 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.23 107.69 7.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 8.4499999999999993 110.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.74 42.7 13.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 10.44 111.747 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.44 54.03 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 115.219 0.847 . . . . 10.609999999999999 115.219 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -110.69 130.89 55.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.574 0.687 . . . . 10.279999999999999 112.358 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.48 10.86 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.587 -0.894 . . . . 8.8300000000000001 108.587 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.83 58.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.088 . . . . 6.9699999999999998 113.939 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.678 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.51 110.24 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.602 -1.259 . . . . 8.5099999999999998 107.602 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.02 126.96 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.265 0.555 . . . . 6.1699999999999999 112.289 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.405 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.49 15.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.332 -0.849 . . . . 8.3000000000000007 110.041 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.04 154.71 49.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.614 -0.884 . . . . 8.1400000000000006 108.614 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.52 175.12 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.929 1.753 . . . . 7.79 112.007 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -93.74 -9.56 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.946 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.3 p-10 -93.41 9.22 37.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.917 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -55.44 -52.47 63.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.221 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.97 134.3 22.51 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.122 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.01 133.98 28.98 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.062 2.508 . . . . 0.0 112.026 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.82 142.02 90.51 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.606 -177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.14 125.1 15.65 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.672 2.248 . . . . 0.0 111.959 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -171.59 -67.33 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -131.72 164.05 26.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 14.2 m -130.47 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.79 -88.57 0.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.83 95.67 49.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.08 -66.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.46 2.107 . . . . 0.0 111.913 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.6 t 51.79 63.58 2.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.398 0.618 . . . . 0.0 110.082 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.8 96.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.848 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -145.52 104.29 3.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.244 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.5 m -96.87 154.84 38.16 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.221 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.38 -33.29 97.54 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.516 2.144 . . . . 0.0 111.81 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 72.55 31.86 62.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.647 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.85 101.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.4 t 65.26 -77.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.762 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 69.3 m -154.67 105.64 2.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.377 . . . . 0.0 110.181 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.8 m -71.61 -29.02 64.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.419 0.628 . . . . 0.0 109.853 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 138.03 26.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.053 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 88.6 t -120.5 117.04 31.73 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.366 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.77 140.09 65.88 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.497 2.131 . . . . 0.0 111.343 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.35 136.33 57.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.034 0.445 . . . . 0.0 111.155 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.5 p -135.2 111.69 9.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -95.49 159.12 15.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -93.83 31.02 1.68 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 11.33 110.727 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.0 139.4 58.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 8.5 110.33 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.487 HD12 HG21 ' A' ' 313' ' ' THR . 67.4 mt -109.8 143.96 38.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.944 -1.026 . . . . 6.5800000000000001 112.788 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -104.38 132.06 51.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.219 -1.4 . . . . 7.1399999999999997 107.219 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.99 121.26 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 109.59 -0.522 . . . . 5.6799999999999997 109.59 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.522 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.21 179.27 16.47 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.436 -0.888 . . . . 6.5700000000000003 112.648 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.607 -0.806 . . . . 8.0399999999999991 111.573 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.78 135.25 85.72 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.835 -0.182 . . . . 8.1600000000000001 111.477 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.84 141.47 90.13 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.955 1.77 . . . . 9.4399999999999995 108.795 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.34 -14.86 61.77 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.803 1.408 . . . . 11.74 114.803 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -84.14 -23.19 30.77 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.816 1.413 . . . . 11.65 114.816 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.33 149.13 50.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.17 0.441 . . . . 9.3599999999999994 111.368 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.404 ' O ' HG21 ' A' ' 275' ' ' VAL . 18.9 p-10 -114.39 -176.41 2.89 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.284 -0.265 . . . . 10.609999999999999 110.284 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -53.59 -55.46 25.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.629 1.344 . . . . 10.07 114.629 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -25.94 67.79 Favored 'General case' 0 C--N 1.406 3.026 0 C-N-CA 125.596 1.558 . . . . 0.0 112.478 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.18 -48.3 13.36 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.363 0.529 . . . . 10.289999999999999 111.378 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 271' ' ' ASN . 78.5 t -62.66 -49.19 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 8.0 110.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -54.25 -36.41 63.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 10.199999999999999 111.312 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.13 -53.27 57.83 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.096 0.474 . . . . 10.199999999999999 110.699 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.73 -33.23 33.77 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.146 -0.479 . . . . 7.6200000000000001 110.318 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.469 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.7 mt -82.54 -41.8 19.16 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.572 0.582 . . . . 7.7400000000000002 112.572 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.2 m -56.75 -29.67 62.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.65 0.981 . . . . 10.390000000000001 113.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.2 m -50.42 -10.15 0.06 Allowed 'General case' 0 C--N 1.397 2.652 0 C-N-CA 124.846 1.258 . . . . 0.0 112.558 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -111.52 -12.03 14.01 Favored 'General case' 1 C--N 1.444 4.678 0 CA-C-N 118.335 0.516 . . . . 10.23 111.495 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.32 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.826 -0.625 . . . . 10.98 111.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.63 147.07 93.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.276 . . . . 12.75 112.716 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 83.0 mt -102.42 146.32 28.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.899 -0.591 . . . . 10.66 111.244 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 18.9 ptpt -101.05 -22.57 14.7 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.274 -0.639 . . . . 11.630000000000001 109.274 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.38 126.43 5.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.142 -2.224 . . . . 0.0 109.088 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.546 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 52.5 t80 -143.76 134.79 25.51 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 122.774 0.43 . . . . 9.0099999999999998 112.006 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.77 124.01 12.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.513 -0.312 . . . . 8.7300000000000004 111.595 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 61.0 tp -101.01 118.3 36.74 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.512 -1.292 . . . . 8.9399999999999995 107.512 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.23 122.8 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.509 0.929 . . . . 9.7400000000000002 113.509 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -119.13 148.06 43.48 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.31 -0.859 . . . . 11.34 109.353 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 38.7 t70 -58.81 141.13 53.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.922 0.391 . . . . 13.83 110.979 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.637 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 52.8 m -49.72 -61.71 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.816 -0.629 . . . . 14.779999999999999 112.649 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.04 -64.01 1.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.512 0.56 . . . . 16.440000000000001 112.512 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 12.8 m -42.55 -59.23 1.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.293 -0.412 . . . . 15.24 111.241 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.14 62.59 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.53 -0.843 . . . . 13.609999999999999 114.492 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.3 167.6 13.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.435 0.618 . . . . 13.529999999999999 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.9 t -59.22 142.07 52.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.526 . . . . 10.51 111.606 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 24.1 mmtp -87.95 -9.38 53.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.783 -0.644 . . . . 11.73 109.581 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.49 -3.43 39.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.674 -0.694 . . . . 8.6300000000000008 113.929 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.467 ' HE1' ' OP2' ' B' ' 604' ' ' ' U' . 46.0 p90 -142.98 146.46 33.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.133 0.966 . . . . 9.3900000000000006 112.812 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.455 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.62 155.18 46.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.041 -0.982 . . . . 6.5499999999999998 112.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.427 ' HZ ' " H1'" ' B' ' 603' ' ' ' U' . 94.1 m-85 -111.38 146.81 36.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.17 -0.923 . . . . 7.4299999999999997 110.333 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.546 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.5 p -157.8 156.21 31.11 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.972 -0.691 . . . . 6.7699999999999996 111.903 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -145.23 127.07 15.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.708 . . . . 9.5899999999999999 109.656 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.475 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 55.4 m-85 -82.36 164.88 20.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.097 0.406 . . . . 9.9100000000000001 112.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.54 -46.09 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.413 -0.958 . . . . 13.09 108.413 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.683 ' O ' HG23 ' A' ' 312' ' ' VAL . 13.8 t70 -96.35 102.36 14.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.388 -1.338 . . . . 13.18 107.388 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.74 -34.97 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.305 1.595 . . . . 12.48 115.305 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -56.87 -38.71 73.11 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.238 1.018 . . . . 13.4 109.016 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.75 -22.58 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 112.243 -2.253 . . . . 11.43 109.594 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 88.5 m -54.67 -48.2 72.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.932 -0.766 . . . . 9.5 108.932 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.43 -42.83 99.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.245 -0.582 . . . . 10.31 110.52 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -63.83 -32.41 73.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.931 -0.708 . . . . 12.41 111.9 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.78 74.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.781 -1.554 . . . . 8.3900000000000006 113.052 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.63 -51.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.373 0.606 . . . . 7.71 110.857 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.8 -38.59 67.49 Favored 'General case' 0 C--N 1.421 3.678 0 C-N-CA 126.289 1.836 . . . . 0.0 113.166 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.03 -24.1 35.96 Favored Glycine 1 C--N 1.398 4.007 0 N-CA-C 116.847 1.499 . . . . 8.7599999999999998 116.847 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 330' ' ' LEU . 88.1 mt -96.84 -45.77 6.51 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.117 1.958 . . . . 7.2000000000000002 113.956 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -50.47 130.04 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.883 0.373 . . . . 8.1099999999999994 111.511 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.24 -16.79 56.56 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.056 -0.592 . . . . 8.6400000000000006 113.975 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.5 ttt -50.61 147.17 4.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.729 0.299 . . . . 8.25 111.324 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -95.08 115.55 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 10.48 111.751 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 330' ' ' LEU . 8.3 mp -120.16 106.74 12.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.127 -1.064 . . . . 8.9499999999999993 108.127 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.09 -118.64 10.53 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.408 -1.477 . . . . 10.630000000000001 109.408 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -115.9 22.51 12.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.169 0.509 . . . . 12.25 109.765 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -123.9 153.91 40.45 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.64 -0.709 . . . . 10.34 111.599 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.69 118.28 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.078 -1.082 . . . . 10.59 108.078 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.64 ' HB2' HD11 ' A' ' 325' ' ' LEU . 22.4 tp -63.07 143.17 58.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.519 0.676 . . . . 7.6500000000000004 112.707 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.467 HD13 ' C2 ' ' B' ' 602' ' ' ' U' . 90.0 mt -128.14 127.97 43.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.593 -1.185 . . . . 7.7599999999999998 108.962 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.92 124.04 26.29 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 O-C-N 120.96 -1.088 . . . . 6.4500000000000002 109.999 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.71 155.34 37.04 Favored 'General case' 0 N--CA 1.432 -1.367 0 O-C-N 119.986 -1.696 . . . . 7.8799999999999999 109.561 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.477 ' HA ' HD21 ' A' ' 261' ' ' LEU . 83.3 mtt180 -58.61 122.44 13.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 118.453 -1.299 . . . . 9.1999999999999993 107.612 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.93 -11.76 0.1 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.794 1.405 . . . . 7.5199999999999996 114.794 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.9 m -119.45 -77.68 0.58 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.532 -0.467 . . . . 9.3599999999999994 111.156 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 8.2 m -89.85 108.02 18.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.33 0.586 . . . . 0.0 111.305 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -84.4 139.07 17.83 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.386 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -74.96 110.6 9.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.28 -42.95 61.85 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -113.27 107.29 15.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.79 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.845 -179.314 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 0.412 ' O2 ' ' HE2' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.207 0 O4'-C1'-N19 109.38 1.18 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.467 ' C2 ' HD13 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.425 -0.916 0 O4'-C1'-C2' 107.487 0.777 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.531 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O3'--C3' 1.446 1.618 0 C1'-O4'-C4' 110.61 1.122 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.678 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.509 6.162 0 C4'-C3'-C2' 99.165 -3.535 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.637 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.689 6.868 0 C3'-C2'-C1' 104.602 3.446 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . 0.586 ' P ' " O2'" ' B' ' 605' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.541 1.307 0 C4'-C3'-C2' 105.421 2.721 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 0.946 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 O4'-C1'-C2' 107.589 0.849 . 0.01 3a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.962 0 O4'-C1'-C2' 107.131 0.522 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-C1' 100.838 -0.736 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -91.75 57.47 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.401 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.51 148.5 21.43 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.608 -0.724 . . . . 6.3499999999999996 111.196 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.558 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.7 mt -140.77 143.54 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 5.5099999999999998 111.218 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.52 125.21 40.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.855 -0.795 . . . . 6.8200000000000003 108.855 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' A' ' 198' ' ' ALA . 2.3 p -124.83 101.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.134 0.493 . . . . 5.0899999999999999 110.253 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.72 -178.86 35.03 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.921 -0.581 . . . . 6.2000000000000002 112.765 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.5 m120 51.17 39.97 24.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.993 1.317 . . . . 0.0 110.195 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.58 149.76 88.64 Favored Pre-proline 1 C--N 1.43 4.103 0 C-N-CA 123.525 0.73 . . . . 7.79 111.366 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.99 144.45 89.49 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.325 2.017 . . . . 8.9900000000000002 110.924 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -69.99 139.72 52.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.991 0.424 . . . . 11.75 111.916 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.22 6.49 61.26 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.755 -0.657 . . . . 10.470000000000001 114.277 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 117.395 0.597 . . . . 8.9100000000000001 110.281 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.559 ' HG1' ' H ' ' A' ' 164' ' ' ALA . 36.1 p -84.82 153.88 22.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 9.9100000000000001 110.636 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.27 95.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 7.7599999999999998 110.203 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.55 -46.07 91.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.979 -0.555 . . . . 9.8900000000000006 110.568 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.559 ' H ' ' HG1' ' A' ' 161' ' ' THR . . . -62.73 -26.22 68.58 Favored 'General case' 0 C--N 1.41 3.22 0 O-C-N 119.25 -2.156 . . . . 0.0 111.658 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.416 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.39 -34.16 67.7 Favored 'General case' 1 C--N 1.429 4.046 0 O-C-N 123.949 0.781 . . . . 6.7800000000000002 111.758 171.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.47 -54.4 7.64 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.412 0.685 . . . . 6.9699999999999998 111.079 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.46 -33.76 60.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.397 -0.819 . . . . 8.8000000000000007 111.403 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.76 -53.66 17.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 120.472 -0.491 . . . . 7.8700000000000001 111.543 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.3 m-85 -61.22 -48.23 82.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 5.9400000000000004 112.255 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.75 -42.85 80.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.351 -0.54 . . . . 7.1200000000000001 109.579 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.1 -23.31 64.9 Favored 'General case' 0 C--N 1.407 3.09 0 O-C-N 120.279 -1.513 . . . . 0.0 111.276 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.4 -37.7 36.58 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.468 0.576 . . . . 7.9299999999999997 110.325 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.464 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.76 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.512 -0.767 . . . . 7.7300000000000004 111.062 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.6 mtt-85 -75.93 -43.36 45.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.377 0.51 . . . . 9.9600000000000009 112.377 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.73 -37.86 88.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.177 0.513 . . . . 10.42 110.47 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.9 -16.56 74.71 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.307 -0.949 . . . . 9.2300000000000004 112.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.29 36.95 70.83 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.809 -0.917 . . . . 9.6099999999999994 110.809 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.84 5.25 51.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.888 0.699 . . . . 8.4600000000000009 112.888 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.59 143.46 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.588 0.233 . . . . 9.1600000000000001 110.573 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.531 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.52 21.3 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.138 0.421 . . . . 10.23 112.138 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.56 23.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.722 -0.217 . . . . 10.24 110.735 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.41 143.54 99.68 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.947 1.765 . . . . 11.43 110.798 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.54 20.57 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 120.558 -0.83 . . . . 9.4499999999999993 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.36 73.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 8.3300000000000001 112.051 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.473 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.23 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.543 2.162 . . . . 6.9699999999999998 111.308 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.439 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.68 105.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.117 -0.492 . . . . 5.8700000000000001 111.161 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 71.39 0.74 Allowed 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 124.636 1.175 . . . . 0.0 109.31 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.13 151.1 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 129.44 3.096 . . . . 0.0 112.946 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.41 130.55 8.39 Favored 'Isoleucine or valine' 0 C--N 1.374 1.64 0 C-N-CA 129.288 3.035 . . . . 5.6699999999999999 109.31 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.19 126.55 55.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.772 -0.455 . . . . 6.6799999999999997 109.772 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.9 125.97 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 116.983 2.216 . . . . 7.0999999999999996 116.983 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.42 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 103.157 -2.905 . . . . 8.1600000000000001 103.157 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.28 -57.38 7.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.678 1.733 . . . . 10.279999999999999 115.678 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.82 75.48 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.852 0.686 . . . . 10.51 112.852 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.16 50.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 9.9399999999999995 111.847 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.18 36.05 15.22 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.548 1.314 . . . . 8.4499999999999993 114.548 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.44 168.67 19.27 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.081 -1.047 . . . . 7.25 111.629 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.6 161.06 41.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.022 -1.445 . . . . 5.1900000000000004 110.483 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.37 129.41 51.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.662 -0.866 . . . . 6.0899999999999999 108.662 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.361 -0.382 . . . . 4.2699999999999996 110.288 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.68 25.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.482 . . . . 6.21 109.697 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -99.73 164.69 11.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.016 -0.538 . . . . 6.1399999999999997 111.981 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.88 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.432 -0.804 . . . . 8.6899999999999995 111.46 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.8 p -128.91 159.61 35.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.114 0.483 . . . . 8.3300000000000001 111.612 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.74 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 8.9600000000000009 112.257 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.531 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.71 -41.76 95.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.424 0.527 . . . . 9.2599999999999998 112.424 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.86 98.0 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.268 -0.271 . . . . 7.6200000000000001 110.268 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.558 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.6 m -54.15 -54.0 45.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.125 -1.065 . . . . 6.4199999999999999 108.125 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.7 m -55.31 -26.93 43.58 Favored 'General case' 1 C--N 1.43 4.081 0 C-N-CA 126.977 2.111 . . . . 0.0 109.878 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.15 -34.14 43.49 Favored 'General case' 0 C--N 1.421 3.683 0 N-CA-C 113.642 0.979 . . . . 8.75 113.642 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.52 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.653 0.612 . . . . 5.9400000000000004 112.653 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.88 63.42 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.309 1.006 . . . . 7.1500000000000004 111.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.31 53.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.416 -0.357 . . . . 7.7000000000000002 111.647 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.19 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 7.4699999999999998 111.666 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.89 121.04 14.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 7.3799999999999999 110.751 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.71 -4.75 66.38 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 7.9199999999999999 113.615 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.855 0.327 . . . . 7.71 111.094 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.96 121.61 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.311 0.577 . . . . 10.0 111.332 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.76 7.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.4499999999999993 110.287 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.75 42.67 13.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.035 -0.53 . . . . 10.44 111.724 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.03 -5.47 53.88 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 115.247 0.859 . . . . 10.609999999999999 115.247 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.59 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.615 0.708 . . . . 10.279999999999999 112.417 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.88 101.49 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.542 -0.91 . . . . 8.8300000000000001 108.542 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.3 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.036 1.124 . . . . 6.9699999999999998 114.036 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.994 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.55 110.26 21.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.57 -1.27 . . . . 8.5099999999999998 107.57 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.98 126.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.405 0.52 . . . . 6.1699999999999999 112.405 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.414 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.52 170.5 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.48 -0.782 . . . . 8.3000000000000007 110.093 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.65 49.52 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.515 -0.92 . . . . 8.1400000000000006 108.515 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 46.3 Cg_exo -57.43 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.953 1.769 . . . . 7.79 112.012 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -115.06 27.49 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 1.083 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 5.9 m-20 -75.33 126.57 31.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.326 174.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 65.71 106.54 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.625 0.726 . . . . 0.0 111.08 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 15.9 pt20 -63.03 141.89 97.7 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.71 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 29.8 Cg_exo -62.36 -35.14 74.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.147 2.565 . . . . 0.0 112.401 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 236' ' ' PRO . 9.5 mp -88.15 135.64 32.97 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.243 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 13.9 Cg_exo -69.48 175.84 7.34 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.97 2.447 . . . . 0.0 112.221 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.69 -178.33 51.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.924 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 26.8 ptm -140.2 174.55 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.75 0.275 . . . . 0.0 110.484 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.2 t -113.63 163.6 14.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.69 94.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -130.1 139.53 35.92 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.245 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.97 106.34 1.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.562 2.175 . . . . 0.0 111.522 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.3 m -134.85 116.83 15.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.819 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.18 11.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 49.4 t80 62.59 83.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.035 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.599 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 57.8 t -82.25 -62.49 0.31 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.316 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 48.6 Cg_endo -69.46 110.41 2.49 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.763 1.642 . . . . 0.0 111.972 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.04 -6.88 88.5 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.372 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.9 m -113.27 129.38 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 0.0 110.97 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.34 143.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.556 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.7 m -115.75 101.62 8.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.276 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.7 t -162.53 162.43 27.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 41.5 t 65.05 95.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.307 0.643 . . . . 0.0 111.199 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.48 119.7 18.53 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.202 0.525 . . . . 0.0 110.891 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.34 -149.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.012 2.474 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.474 ' CG ' ' HZ1' ' A' ' 260' ' ' LYS . 12.8 p-10 -69.8 104.66 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.0 m -149.5 100.59 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.777 -173.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -124.77 -71.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.875 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -140.56 31.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.996 -0.547 . . . . 11.33 110.862 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.501 ' NZ ' ' O4 ' ' B' ' 604' ' ' ' U' . 39.1 ttpt -62.94 139.33 58.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 8.5 110.365 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 334' ' ' ARG . 62.5 mt -109.79 144.07 38.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.076 -0.966 . . . . 6.5800000000000001 112.826 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -104.47 132.02 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.228 -1.397 . . . . 7.1399999999999997 107.228 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.95 121.2 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.608 -0.516 . . . . 5.6799999999999997 109.608 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.21 179.19 16.52 Favored Glycine 0 CA--C 1.508 -0.389 0 C-N-CA 120.446 -0.883 . . . . 6.5700000000000003 112.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.89 9.17 86.73 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.566 -0.826 . . . . 8.0399999999999991 111.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.85 135.3 85.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 111.427 0.158 . . . . 8.1600000000000001 111.427 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.85 141.48 90.14 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.962 1.775 . . . . 9.4399999999999995 108.833 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -65.39 -14.83 61.76 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.788 1.403 . . . . 11.74 114.788 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -84.18 -23.13 30.71 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.788 1.403 . . . . 11.65 114.788 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.33 149.18 50.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.112 0.415 . . . . 9.3599999999999994 111.344 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.403 ' O ' HG21 ' A' ' 275' ' ' VAL . 31.0 p-10 -114.43 -176.44 2.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.608 -0.269 . . . . 10.609999999999999 110.279 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.55 -55.11 28.36 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.624 1.342 . . . . 10.07 114.624 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.94 -27.74 68.45 Favored 'General case' 0 C--N 1.406 3.052 0 C-N-CA 125.873 1.669 . . . . 0.0 112.332 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -79.64 -48.28 14.0 Favored 'General case' 1 C--N 1.429 4.065 0 O-C-N 123.486 0.491 . . . . 10.289999999999999 111.388 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 271' ' ' ASN . 72.1 t -62.72 -49.17 84.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 8.0 110.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -54.24 -36.49 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 10.199999999999999 111.27 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.92 -53.39 56.44 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.156 0.503 . . . . 10.199999999999999 110.728 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 278' ' ' LEU . 0.8 OUTLIER -51.8 -33.14 34.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.064 -0.516 . . . . 7.6200000000000001 110.374 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.469 HD11 ' SG ' ' A' ' 305' ' ' CYS . 84.5 mt -82.62 -41.67 19.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.566 0.58 . . . . 7.7400000000000002 112.566 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.0 m -56.87 -29.65 63.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.6 0.963 . . . . 10.390000000000001 113.6 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.5 m -50.36 -10.33 0.06 Allowed 'General case' 0 C--N 1.395 2.552 0 C-N-CA 124.809 1.244 . . . . 0.0 112.544 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -111.42 -11.94 14.07 Favored 'General case' 1 C--N 1.442 4.618 0 CA-C-N 118.281 0.491 . . . . 10.23 111.521 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.08 162.24 10.2 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.78 -0.646 . . . . 10.98 111.932 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.56 147.05 93.38 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.694 2.263 . . . . 12.75 112.736 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.7 mt -102.44 146.3 28.29 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.862 -0.608 . . . . 10.66 111.25 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.545 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 15.4 ptpt -101.14 -21.51 14.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.2 -0.667 . . . . 11.630000000000001 109.2 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -159.94 128.56 4.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.213 -2.179 . . . . 0.0 108.798 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.2 t80 -145.07 134.69 23.34 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.084 0.553 . . . . 9.0099999999999998 112.005 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -144.8 124.09 13.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.809 0.338 . . . . 8.7300000000000004 111.536 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 59.5 tp -100.99 118.23 36.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.578 -1.267 . . . . 8.9399999999999995 107.578 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.17 122.91 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 9.7400000000000002 113.457 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -119.15 148.15 43.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.297 -0.865 . . . . 11.34 109.371 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.595 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 34.1 t70 -58.96 141.17 54.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.893 0.378 . . . . 13.83 110.943 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.401 ' HB3' ' N3 ' ' B' ' 605' ' ' ' U' . 40.1 m -49.73 -61.69 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.653 0.612 . . . . 14.779999999999999 112.653 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.11 -63.97 1.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.468 0.544 . . . . 16.440000000000001 112.468 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.595 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.1 m -42.51 -59.32 1.92 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.265 -0.425 . . . . 15.24 111.228 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.03 62.5 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 120.617 -0.801 . . . . 13.609999999999999 114.503 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 79.9 mt -88.38 167.63 13.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.339 0.57 . . . . 13.529999999999999 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -59.32 142.22 52.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.529 . . . . 10.51 111.684 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.581 ' HZ1' HO2' ' B' ' 601' ' ' ' U' . 3.8 mmmp? -87.89 -9.51 53.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 11.73 109.561 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.62 -3.34 39.42 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.625 -0.716 . . . . 8.6300000000000008 113.89 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -143.06 146.35 33.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.055 0.927 . . . . 9.3900000000000006 112.814 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.444 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.21 46.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.085 -0.961 . . . . 6.5499999999999998 112.206 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.39 146.84 36.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.996 -1.002 . . . . 7.4299999999999997 110.395 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.561 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 20.4 p -157.84 156.22 31.06 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 119.929 -0.708 . . . . 6.7699999999999996 111.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -145.37 127.05 15.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.613 -0.722 . . . . 9.5899999999999999 109.628 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.545 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 51.2 m-85 -82.38 164.91 20.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.98 0.419 . . . . 9.9100000000000001 112.071 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.6 -46.05 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.463 -0.94 . . . . 13.09 108.463 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 312' ' ' VAL . 15.1 t70 -96.32 102.36 14.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.41 -1.33 . . . . 13.18 107.41 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.532 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.76 -34.96 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 N-CA-C 115.244 1.572 . . . . 12.48 115.244 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -56.77 -38.83 73.03 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 122.305 1.05 . . . . 13.4 109.048 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 309' ' ' ASP . 1.9 m -62.65 -22.81 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 112.283 -2.235 . . . . 11.43 109.518 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.5 m -54.52 -48.2 72.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.918 -0.771 . . . . 9.5 108.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.49 -42.8 99.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.239 -0.584 . . . . 10.31 110.521 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.89 -0.724 . . . . 12.41 111.974 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.73 74.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.647 -1.615 . . . . 8.3900000000000006 113.076 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.61 -51.29 47.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 7.71 110.864 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.39 67.71 Favored 'General case' 0 C--N 1.421 3.679 0 C-N-CA 126.211 1.805 . . . . 0.0 113.296 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.488 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.18 -24.0 35.85 Favored Glycine 1 C--N 1.4 4.125 0 N-CA-C 116.779 1.472 . . . . 8.7599999999999998 116.779 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.4 ' O ' HD21 ' A' ' 330' ' ' LEU . 98.1 mt -96.93 -45.69 6.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.193 1.997 . . . . 7.2000000000000002 113.957 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -50.52 130.03 23.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.844 0.354 . . . . 8.1099999999999994 111.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.22 -16.81 56.48 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.151 -0.547 . . . . 8.6400000000000006 113.977 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.488 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 19.0 mtt -50.53 147.15 4.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.723 0.297 . . . . 8.25 111.363 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -95.0 115.6 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.018 0.437 . . . . 10.48 111.759 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 330' ' ' LEU . 8.8 mp -120.25 106.72 12.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.094 -1.076 . . . . 8.9499999999999993 108.094 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.11 -118.75 10.65 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.347 -1.501 . . . . 10.630000000000001 109.347 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -115.8 22.45 13.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 12.25 109.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.83 153.95 40.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.682 -0.69 . . . . 10.34 111.685 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.74 118.26 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.139 -1.06 . . . . 10.59 108.139 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 325' ' ' LEU . 22.7 tp -63.11 143.08 58.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.547 0.689 . . . . 7.6500000000000004 112.601 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . 0.471 HD13 ' C2 ' ' B' ' 602' ' ' ' U' . 88.1 mt -128.08 128.0 44.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.563 -1.199 . . . . 7.7599999999999998 109.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.98 124.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 O-C-N 120.99 -1.069 . . . . 6.4500000000000002 109.945 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -152.79 155.33 36.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 120.126 -1.609 . . . . 7.8799999999999999 109.514 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.488 ' HA ' HD21 ' A' ' 261' ' ' LEU . 69.7 mtt85 -58.68 122.57 13.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 118.418 -1.313 . . . . 9.1999999999999993 107.617 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.98 -11.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.756 1.391 . . . . 7.5199999999999996 114.756 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.4 m -119.46 -78.18 0.58 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.641 -0.424 . . . . 9.3599999999999994 111.21 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.6 p -168.36 -42.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.467 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 176.15 -121.76 0.82 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.008 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -161.16 -164.94 1.24 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.32 118.95 9.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.049 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.946 -179.657 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 0.581 HO2' ' HZ1' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.508 -2.049 0 O4'-C1'-N19 109.397 1.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.471 ' C2 ' HD13 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.427 -0.791 0 O4'-C1'-C2' 107.546 0.819 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.442 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C4'-C3'-C2' 103.728 1.028 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.994 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 0 O3'--C3' 1.475 3.717 1 C3'-C2'-C1' 106.1 5.111 . 0.0 OUTLIER '7D dist 4g' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.401 ' N3 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.686 6.568 0 P-O3'-C3' 122.926 2.689 . 0.046 9a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . 0.41 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 C3'--C2' 1.54 1.332 0 C4'-C3'-C2' 105.502 2.802 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 1.083 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C1'-C2' 107.611 0.865 . 0.0 OUTLIER '7D dist 3a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . 0.424 " H5'" " H2'" ' B' ' 607' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.965 0 C3'-C2'-C1' 100.848 -0.724 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 O4'-C1'-C2' 107.23 0.593 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 235' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.168 0.508 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -120.33 45.2 2.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.575 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -155.83 148.44 23.96 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.072 0.949 . . . . 6.3499999999999996 111.087 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.7 mt -140.75 143.54 35.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 5.5099999999999998 111.171 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.62 125.18 40.91 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.891 -0.781 . . . . 6.8200000000000003 108.891 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.78 101.27 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.077 0.465 . . . . 5.0899999999999999 110.166 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.74 -178.57 35.06 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.895 -0.593 . . . . 6.2000000000000002 112.766 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.16 40.81 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.031 1.333 . . . . 0.0 110.151 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.79 149.85 88.2 Favored Pre-proline 1 C--N 1.429 4.062 0 C-N-CA 123.478 0.711 . . . . 7.79 111.33 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.01 144.43 89.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.251 1.967 . . . . 8.9900000000000002 111.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -69.91 139.66 53.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.429 . . . . 11.75 111.954 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.05 6.76 61.16 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.745 -0.661 . . . . 10.470000000000001 114.298 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 117.314 0.557 . . . . 8.9100000000000001 110.245 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.79 153.88 22.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 9.9100000000000001 110.692 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.25 95.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 7.7599999999999998 110.174 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.6 -46.12 91.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.064 -0.517 . . . . 9.8900000000000006 110.548 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.59 68.52 Favored 'General case' 0 C--N 1.409 3.179 0 O-C-N 119.261 -2.149 . . . . 0.0 111.675 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.417 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.4 -34.11 67.65 Favored 'General case' 0 C--N 1.427 3.975 0 O-C-N 123.889 0.743 . . . . 6.7800000000000002 111.727 172.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.437 ' HE1' ' O ' ' A' ' 186' ' ' VAL . 22.2 ttt -74.61 -54.3 7.72 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.51 0.724 . . . . 6.9699999999999998 111.052 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.52 -33.73 60.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.43 -0.804 . . . . 8.8000000000000007 111.381 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.52 17.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 120.43 -0.508 . . . . 7.8700000000000001 111.617 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.417 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.0 m-85 -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.114 0.413 . . . . 5.9400000000000004 112.114 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.0 m-20 -56.83 -43.0 80.63 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.547 -0.538 . . . . 7.1200000000000001 109.547 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -23.53 65.18 Favored 'General case' 0 C--N 1.406 3.026 0 O-C-N 120.192 -1.567 . . . . 0.0 111.231 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.35 -37.67 36.91 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.546 0.612 . . . . 7.9299999999999997 110.31 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.454 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.81 83.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.498 -0.774 . . . . 7.7300000000000004 111.033 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.4 mtt-85 -76.1 -43.03 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.37 0.507 . . . . 9.9600000000000009 112.37 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.99 -37.76 88.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.193 0.52 . . . . 10.42 110.388 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.11 -16.39 74.64 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.239 -0.981 . . . . 9.2300000000000004 112.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.98 71.59 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.888 -0.885 . . . . 9.6099999999999994 110.888 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.3 51.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.941 0.719 . . . . 8.4600000000000009 112.941 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.489 HG23 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.64 143.44 30.98 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.129 -0.228 . . . . 9.1600000000000001 110.665 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.527 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.51 21.34 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.45 23.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.691 -0.231 . . . . 10.24 110.722 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.32 143.45 99.73 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.997 1.798 . . . . 11.43 110.771 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.37 161.62 20.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.642 -0.789 . . . . 9.4499999999999993 112.465 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.8 m-20 -75.33 134.49 73.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 8.3300000000000001 112.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.489 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.33 -50.97 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.519 2.146 . . . . 6.9699999999999998 111.315 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.437 ' O ' ' HE1' ' A' ' 166' ' ' MET . 21.9 t -69.71 105.32 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.111 -0.495 . . . . 5.8700000000000001 111.146 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -37.59 40.47 Favored 'General case' 0 N--CA 1.533 3.68 0 C-N-CA 125.508 1.523 . . . . 0.0 112.848 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.38 164.48 38.09 Favored 'General case' 0 C--N 1.387 2.224 0 C-N-CA 125.938 1.695 . . . . 0.0 110.891 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.08 130.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.372 1.573 0 C-N-CA 126.291 1.836 . . . . 5.6699999999999999 109.329 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.12 126.65 55.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.475 . . . . 6.6799999999999997 109.716 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' A' ' 198' ' ' ALA . 97.3 mt -114.91 125.92 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 116.937 2.199 . . . . 7.0999999999999996 116.937 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.34 5.24 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 103.182 -2.896 . . . . 8.1600000000000001 103.182 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.26 -57.34 8.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.676 1.732 . . . . 10.279999999999999 115.676 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.15 -48.87 75.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.831 0.678 . . . . 10.51 112.831 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.96 -9.12 50.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.768 0.285 . . . . 9.9399999999999995 111.768 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.07 36.17 15.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.547 1.314 . . . . 8.4499999999999993 114.547 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -143.5 168.73 19.16 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.118 -1.033 . . . . 7.25 111.661 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' A' ' 191' ' ' ILE . . . -147.63 161.03 41.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.031 -1.44 . . . . 5.1900000000000004 110.518 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.4 129.41 51.24 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.676 -0.861 . . . . 6.0899999999999999 108.676 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.75 137.58 33.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.361 . . . . 4.2699999999999996 110.359 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -114.86 114.68 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.703 -0.48 . . . . 6.21 109.703 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.68 164.65 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 6.1399999999999997 111.951 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.93 22.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.439 -0.8 . . . . 8.6899999999999995 111.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.2 p -128.92 159.59 35.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.155 0.503 . . . . 8.3300000000000001 111.607 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.21 -41.82 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.59 -0.732 . . . . 8.9600000000000009 112.247 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.7 -41.73 95.8 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.339 0.496 . . . . 9.2599999999999998 112.339 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.88 -43.89 97.93 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.202 -0.295 . . . . 7.6200000000000001 110.202 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 151' ' ' LEU . 56.0 m -54.17 -53.88 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.159 -1.052 . . . . 6.4199999999999999 108.159 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.47 ' HG1' HH22 ' A' ' 228' ' ' ARG . 16.1 m -55.1 -27.2 43.33 Favored 'General case' 1 C--N 1.429 4.051 0 C-N-CA 127.127 2.171 . . . . 0.0 109.739 178.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.46 -33.95 41.9 Favored 'General case' 0 C--N 1.423 3.779 0 N-CA-C 113.6 0.963 . . . . 8.75 113.6 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.62 -17.3 64.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 5.9400000000000004 112.638 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.12 -19.84 63.43 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.377 1.048 . . . . 7.1500000000000004 111.556 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.3 53.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.456 -0.338 . . . . 7.7000000000000002 111.656 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.85 16.18 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.466 -0.333 . . . . 7.4699999999999998 111.651 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.82 120.96 13.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 7.3799999999999999 110.75 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.83 -4.79 66.09 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.884 -0.674 . . . . 7.9199999999999999 113.579 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.833 0.316 . . . . 7.71 111.098 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -85.0 121.63 37.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.35 0.595 . . . . 10.0 111.286 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.36 107.67 7.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 8.4499999999999993 110.357 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.69 42.64 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 10.44 111.767 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.08 -5.45 54.18 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.248 0.859 . . . . 10.609999999999999 115.248 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.58 130.94 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.627 0.713 . . . . 10.279999999999999 112.375 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.53 10.95 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.506 -0.924 . . . . 8.8300000000000001 108.506 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.89 58.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.979 1.103 . . . . 6.9699999999999998 113.979 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.871 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.8 tttt -108.59 110.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.477 -1.305 . . . . 8.5099999999999998 107.477 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.98 126.89 58.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.36 0.504 . . . . 6.1699999999999999 112.36 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.411 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.61 170.46 15.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.388 -0.824 . . . . 8.3000000000000007 110.019 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.47 HH22 ' HG1' ' A' ' 209' ' ' THR . 3.5 mtp180 -89.02 154.67 49.74 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.635 -0.876 . . . . 8.1400000000000006 108.635 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.437 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.7 Cg_exo -57.21 174.82 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.985 1.79 . . . . 7.79 111.982 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -113.08 23.72 13.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.566 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.726 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 7.3 m-20 -64.07 149.7 47.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.01 0.433 . . . . 0.0 111.647 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.07 113.81 2.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.88 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 62.01 93.75 0.06 OUTLIER Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.04 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.54 -179.43 3.68 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.674 2.25 . . . . 0.0 111.489 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 148' ' ' ALA . 10.8 mp -72.5 142.31 83.89 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.964 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.01 119.34 5.93 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.98 2.453 . . . . 0.0 112.765 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.91 143.49 11.72 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 95.6 mmm -122.02 9.99 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.861 0.331 . . . . 0.0 111.046 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.0 m 58.88 23.58 11.52 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 110.782 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -98.44 16.5 21.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.908 -175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 25.3 t-20 -50.59 -54.2 38.1 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.652 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 67.0 Cg_endo -91.09 16.81 1.51 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.151 1.901 . . . . 0.0 112.13 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t 68.35 146.62 0.05 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.748 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 31.2 m -114.49 166.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.931 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.823 ' HA ' HG23 ' A' ' 249' ' ' VAL . 37.7 t80 71.29 12.64 6.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.443 0.639 . . . . 0.0 110.055 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.622 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 58.8 t -67.13 -59.04 8.03 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.72 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 81.0 Cg_endo -77.97 9.16 3.13 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.107 1.872 . . . . 0.0 113.138 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.75 79.49 1.01 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.094 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . 0.823 HG23 ' HA ' ' A' ' 245' ' ' TYR . 32.0 m -110.31 -172.72 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.29 115.88 50.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 50.6 m 71.54 170.55 0.32 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.233 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.8 t -74.88 -13.86 60.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.174 0.511 . . . . 0.0 110.763 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.7 117.7 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.351 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 256' ' ' ASP . 5.7 p -125.75 126.38 24.92 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 339' ' ' ALA . 12.4 Cg_exo -71.5 15.52 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.368 2.712 . . . . 0.0 113.715 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.474 ' H ' HG23 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -96.64 -8.63 31.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.3 m -61.75 138.46 58.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.998 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 70.32 105.69 0.06 Allowed 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.991 0.807 . . . . 0.0 110.35 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -98.21 31.02 2.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.213 -0.903 . . . . 11.33 110.791 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.91 139.37 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 8.5 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 334' ' ' ARG . 52.2 mt -109.77 143.95 38.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.019 -0.991 . . . . 6.5800000000000001 112.849 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -104.39 132.05 51.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.138 -1.43 . . . . 7.1399999999999997 107.138 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.425 HD12 ' HG ' ' A' ' 305' ' ' CYS . 4.1 mp -127.03 121.25 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.601 -0.518 . . . . 5.6799999999999997 109.601 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.524 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.17 179.2 16.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.444 -0.884 . . . . 6.5700000000000003 112.71 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.19 86.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.668 -0.777 . . . . 8.0399999999999991 111.532 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.3 mt -70.89 135.32 85.47 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 111.465 0.172 . . . . 8.1600000000000001 111.465 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.0 Cg_exo -61.79 141.54 90.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.95 1.767 . . . . 9.4399999999999995 108.792 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.39 -14.87 61.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.759 1.392 . . . . 11.74 114.759 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -84.15 -23.18 30.74 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.758 1.392 . . . . 11.65 114.758 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.26 149.18 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.165 0.439 . . . . 9.3599999999999994 111.388 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.403 ' O ' HG21 ' A' ' 275' ' ' VAL . 37.7 p-10 -114.59 -176.4 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.207 -0.294 . . . . 10.609999999999999 110.207 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.56 -55.3 26.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.617 1.34 . . . . 10.07 114.617 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -27.05 68.21 Favored 'General case' 0 C--N 1.407 3.084 0 C-N-CA 125.565 1.546 . . . . 0.0 112.392 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.59 -48.3 14.02 Favored 'General case' 1 C--N 1.429 4.024 0 CA-C-N 118.263 0.483 . . . . 10.289999999999999 111.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 271' ' ' ASN . 66.2 t -62.65 -49.26 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 8.0 110.285 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.25 -36.41 63.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.635 -0.711 . . . . 10.199999999999999 111.279 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.12 -53.35 56.63 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.052 0.453 . . . . 10.199999999999999 110.642 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.8 -33.17 34.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.889 0.476 . . . . 7.6200000000000001 110.283 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.506 HD11 ' SG ' ' A' ' 305' ' ' CYS . 85.2 mt -82.6 -41.7 19.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.552 0.575 . . . . 7.7400000000000002 112.552 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.6 m -56.82 -30.69 63.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.589 0.959 . . . . 10.390000000000001 113.589 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.6 m -52.4 -7.73 0.07 Allowed 'General case' 0 C--N 1.397 2.65 0 O-C-N 120.602 -1.311 . . . . 0.0 112.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -110.31 -12.05 14.48 Favored 'General case' 1 C--N 1.443 4.67 0 CA-C-N 118.413 0.552 . . . . 10.23 111.492 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.09 162.28 10.22 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.775 -0.648 . . . . 10.98 111.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.54 146.98 93.6 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.776 2.317 . . . . 12.75 112.746 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 73.0 mt -102.43 146.27 28.32 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.935 -0.575 . . . . 10.66 111.348 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.98 -22.73 14.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.256 -0.646 . . . . 11.630000000000001 109.256 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.15 5.08 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.155 -2.216 . . . . 0.0 109.159 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.612 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -143.39 134.68 25.94 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.785 0.434 . . . . 9.0099999999999998 111.98 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.75 124.05 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.547 -0.297 . . . . 8.7300000000000004 111.58 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 53.0 tp -101.06 118.21 36.55 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.634 -1.247 . . . . 8.9399999999999995 107.634 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.11 122.87 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.469 0.915 . . . . 9.7400000000000002 113.469 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.07 148.1 43.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.359 -0.837 . . . . 11.34 109.345 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.586 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.3 t70 -58.89 141.19 54.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.894 0.378 . . . . 13.83 110.984 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.5 m -49.82 -61.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.842 -0.617 . . . . 14.779999999999999 112.571 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.09 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.527 0.566 . . . . 16.440000000000001 112.527 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.4 m -42.5 -59.25 1.94 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 15.24 111.184 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.61 -6.08 62.66 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.62 -0.8 . . . . 13.609999999999999 114.493 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.35 167.64 13.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.415 0.608 . . . . 13.529999999999999 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.9 t -59.21 142.07 52.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 10.51 111.58 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.814 ' HZ1' HO2' ' B' ' 601' ' ' ' U' . 4.1 mmmp? -87.91 -9.43 53.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.762 -0.653 . . . . 11.73 109.627 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.32 39.63 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.68 -0.691 . . . . 8.6300000000000008 113.892 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.694 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 26.4 p90 -142.96 146.33 33.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.054 0.927 . . . . 9.3900000000000006 112.92 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.454 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.19 46.71 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.158 -0.928 . . . . 6.5499999999999998 112.213 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.37 146.77 36.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 7.4299999999999997 110.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.612 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 23.1 p -157.73 156.18 31.2 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.906 -0.717 . . . . 6.7699999999999996 111.928 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -145.2 127.07 15.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.722 -0.672 . . . . 9.5899999999999999 109.716 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 54.8 m-85 -82.47 164.88 20.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.932 0.396 . . . . 9.9100000000000001 112.025 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.58 -46.12 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.369 -0.975 . . . . 13.09 108.369 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.733 ' O ' HG23 ' A' ' 312' ' ' VAL . 16.9 t70 -96.3 102.37 14.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.385 -1.339 . . . . 13.18 107.385 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.04 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 115.293 1.59 . . . . 12.48 115.293 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -56.85 -38.68 73.02 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 122.263 1.03 . . . . 13.4 109.005 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.75 -22.65 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.322 -2.217 . . . . 11.43 109.578 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.9 m -54.72 -48.07 72.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.966 -0.753 . . . . 9.5 108.966 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.52 -42.67 99.67 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.138 -0.625 . . . . 10.31 110.554 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -63.94 -32.33 73.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.867 -0.733 . . . . 12.41 111.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.78 74.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.791 -1.55 . . . . 8.3900000000000006 113.021 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.58 -51.36 47.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.384 0.611 . . . . 7.71 110.872 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.7 67.78 Favored 'General case' 0 C--N 1.421 3.712 0 C-N-CA 126.273 1.829 . . . . 0.0 113.086 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.473 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.06 -23.97 36.33 Favored Glycine 1 C--N 1.401 4.188 0 N-CA-C 116.807 1.483 . . . . 8.7599999999999998 116.807 177.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.406 ' O ' HD21 ' A' ' 330' ' ' LEU . 99.0 mt -96.89 -45.75 6.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.19 1.995 . . . . 7.2000000000000002 113.984 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -50.47 130.14 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.851 0.358 . . . . 8.1099999999999994 111.468 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.04 -16.64 56.61 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.134 -0.555 . . . . 8.6400000000000006 113.983 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.473 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 17.2 mtt -50.61 147.19 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.836 0.318 . . . . 8.25 111.302 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -95.09 115.57 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 10.48 111.662 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.6 mm? -120.16 106.72 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.111 -1.07 . . . . 8.9499999999999993 108.111 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.13 -118.65 10.52 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.406 -1.477 . . . . 10.630000000000001 109.406 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -115.94 22.48 12.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.145 0.498 . . . . 12.25 109.741 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 328' ' ' LYS . 34.1 mtpt -123.89 153.91 40.46 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.597 -0.729 . . . . 10.34 111.583 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.76 118.28 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.116 -1.068 . . . . 10.59 108.116 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.617 ' HB2' HD21 ' A' ' 325' ' ' LEU . 22.3 tp -63.11 143.22 57.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.537 0.684 . . . . 7.6500000000000004 112.612 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.5 tp -128.21 128.01 43.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.486 -1.234 . . . . 7.7599999999999998 108.961 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.02 124.0 25.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 O-C-N 121.038 -1.039 . . . . 6.4500000000000002 109.955 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.73 155.34 37.02 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.938 -1.726 . . . . 7.8799999999999999 109.488 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.504 ' HA ' HD21 ' A' ' 261' ' ' LEU . 99.2 mtt180 -58.62 122.51 13.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.422 -1.311 . . . . 9.1999999999999993 107.59 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.88 -11.82 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.795 1.406 . . . . 7.5199999999999996 114.795 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' SER . . . . . 0.498 ' O ' ' HB ' ' A' ' 337' ' ' VAL . 17.3 m -119.4 -75.9 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.613 -0.435 . . . . 9.3599999999999994 111.303 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 336' ' ' SER . 70.0 t 79.04 120.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -167.52 -53.48 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.894 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . 0.629 ' HB3' ' HD2' ' A' ' 255' ' ' PRO . . . -101.35 96.13 6.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.899 0.381 . . . . 0.0 111.028 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -128.46 -49.5 1.28 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.638 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -127.03 -3.63 6.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.047 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.545 178.38 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 0.814 HO2' ' HZ1' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.07 0 O4'-C1'-N19 109.397 1.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.411 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.949 0 O4'-C1'-C2' 107.714 0.939 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.694 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.423 -1.039 0 C1'-O4'-C4' 110.243 0.714 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.871 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 C4'--C3' 1.569 4.07 1 C3'-C2'-C1' 105.705 4.672 . 0.0 OUTLIER '7D dist 4g' 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.688 6.782 0 P-O3'-C3' 124.066 3.638 . 0.01 9a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . 0.437 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O4'--C1' 1.402 -1.024 0 C4'-C3'-C2' 105.74 3.04 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 0.726 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 O4'-C1'-C2' 107.444 0.746 . 0.02 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C1'-C2' 107.281 0.63 . 0.01 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.986 0 C3'-C2'-C1' 100.714 -0.873 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.599 0.238 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -126.49 53.92 1.62 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.371 -0.206 . . . . 0.0 111.039 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.01 148.53 22.31 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.832 0.708 . . . . 6.3499999999999996 111.351 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 208' ' ' THR . 27.5 mt -140.65 143.54 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 5.5099999999999998 111.21 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -96.6 125.21 40.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 6.8200000000000003 108.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 198' ' ' ALA . 2.3 p -124.84 101.3 8.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.512 . . . . 5.0899999999999999 110.199 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.76 34.62 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.983 -0.553 . . . . 6.2000000000000002 112.734 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 m120 49.21 42.54 21.75 Favored 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.649 1.58 . . . . 0.0 110.391 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.28 149.84 89.35 Favored Pre-proline 0 C--N 1.426 3.929 0 CA-C-N 114.95 -1.023 . . . . 7.79 111.333 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.06 144.5 89.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.341 2.027 . . . . 8.9900000000000002 110.972 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.95 139.71 52.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 11.75 111.947 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.53 61.03 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.837 -0.619 . . . . 10.470000000000001 114.32 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 191' ' ' ILE . 10.9 tp -66.1 136.47 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.332 0.566 . . . . 8.9100000000000001 110.303 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.88 153.8 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.694 0.283 . . . . 9.9100000000000001 110.626 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.09 -43.1 95.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 7.7599999999999998 110.23 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.75 -45.88 92.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.012 -0.54 . . . . 9.8900000000000006 110.535 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.83 68.69 Favored 'General case' 0 C--N 1.41 3.217 0 O-C-N 119.408 -2.057 . . . . 0.0 111.606 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.415 ' HE3' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.27 -34.12 67.99 Favored 'General case' 1 C--N 1.429 4.043 0 O-C-N 123.978 0.799 . . . . 6.7800000000000002 111.875 172.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.442 ' HE2' ' O ' ' A' ' 186' ' ' VAL . 22.3 ttt -74.53 -54.28 7.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.368 0.667 . . . . 6.9699999999999998 111.055 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.65 -33.69 61.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.434 -0.803 . . . . 8.8000000000000007 111.378 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.59 17.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.612 -0.435 . . . . 7.8700000000000001 111.555 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.415 ' HE2' ' HE3' ' A' ' 165' ' ' MET . 29.2 m-85 -61.3 -48.26 82.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.175 0.435 . . . . 5.9400000000000004 112.175 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.412 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.7 79.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.196 -0.602 . . . . 7.1200000000000001 109.54 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.96 64.38 Favored 'General case' 0 C--N 1.404 2.965 0 O-C-N 120.213 -1.554 . . . . 0.0 111.246 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.69 36.78 Favored 'General case' 0 C--N 1.427 3.977 0 CA-C-N 118.502 0.592 . . . . 7.9299999999999997 110.291 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.446 ' HA ' ' HE1' ' A' ' 173' ' ' MET . 4.0 mmt -66.75 -36.66 82.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.707 . . . . 7.7300000000000004 111.054 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.15 -42.88 45.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.386 0.514 . . . . 9.9600000000000009 112.386 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.22 -37.66 88.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.274 0.559 . . . . 10.42 110.399 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.12 -16.44 74.49 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.338 -0.934 . . . . 9.2300000000000004 112.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.15 37.04 72.19 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.871 -0.892 . . . . 9.6099999999999994 110.871 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.99 5.42 51.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.828 0.677 . . . . 8.4600000000000009 112.828 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.66 143.53 30.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.599 0.237 . . . . 9.1600000000000001 110.534 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.53 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.74 -18.4 21.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.105 0.409 . . . . 10.23 112.105 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.79 163.4 24.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.682 -0.235 . . . . 10.24 110.75 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.28 143.45 99.74 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.935 1.757 . . . . 11.43 110.853 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.56 20.53 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.606 -0.807 . . . . 9.4499999999999993 112.436 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.3 134.46 73.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 8.3300000000000001 111.982 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.537 ' HG3' HG23 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.31 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.493 2.129 . . . . 6.9699999999999998 111.298 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.442 ' O ' ' HE2' ' A' ' 166' ' ' MET . 21.9 t -69.67 106.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 5.8700000000000001 111.16 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -32.44 25.58 Favored 'General case' 0 N--CA 1.525 3.283 0 O-C-N 119.686 -1.884 . . . . 0.0 113.856 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.33 163.26 40.23 Favored 'General case' 0 C--N 1.384 2.07 0 C-N-CA 125.754 1.621 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.88 130.56 11.94 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 C-N-CA 126.529 1.931 . . . . 5.6699999999999999 109.31 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.11 126.57 55.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.776 -0.453 . . . . 6.6799999999999997 109.776 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.519 HG12 ' HB1' ' A' ' 198' ' ' ALA . 97.2 mt -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 116.893 2.183 . . . . 7.0999999999999996 116.893 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -97.9 91.35 5.29 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 103.234 -2.876 . . . . 8.1600000000000001 103.234 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.33 -57.47 7.83 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.566 1.691 . . . . 10.279999999999999 115.566 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.11 -48.77 75.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.9 0.704 . . . . 10.51 112.9 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -68.94 -9.18 50.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.855 0.317 . . . . 9.9399999999999995 111.855 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 35.87 15.13 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.55 1.315 . . . . 8.4499999999999993 114.55 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -143.38 168.79 18.99 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.116 -1.033 . . . . 7.25 111.612 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.519 ' HB1' HG12 ' A' ' 191' ' ' ILE . . . -147.7 161.14 41.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.23 -1.35 . . . . 5.1900000000000004 110.355 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.43 51.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.716 -0.846 . . . . 6.0899999999999999 108.716 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.6 mt -94.97 137.56 33.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.518 -0.31 . . . . 4.2699999999999996 110.349 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -114.83 114.72 25.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.674 -0.491 . . . . 6.21 109.674 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.68 164.68 11.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.876 -0.602 . . . . 6.1399999999999997 111.971 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.421 -0.809 . . . . 8.6899999999999995 111.427 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.3 p -128.96 159.6 35.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.115 0.483 . . . . 8.3300000000000001 111.666 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.25 -41.8 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.571 -0.74 . . . . 8.9600000000000009 112.272 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.53 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.66 -41.71 95.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.388 0.514 . . . . 9.2599999999999998 112.388 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.95 97.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.243 -0.281 . . . . 7.6200000000000001 110.243 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.529 HG21 ' HG ' ' A' ' 151' ' ' LEU . 55.4 m -54.13 -53.97 46.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.192 -1.04 . . . . 6.4199999999999999 108.192 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m -55.22 -27.11 43.83 Favored 'General case' 0 C--N 1.428 4.0 0 C-N-CA 127.001 2.12 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -34.11 43.47 Favored 'General case' 0 C--N 1.42 3.641 0 N-CA-C 113.613 0.968 . . . . 8.75 113.613 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.57 -17.32 64.11 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.654 0.613 . . . . 5.9400000000000004 112.654 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.05 -19.84 63.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.505 1.128 . . . . 7.1500000000000004 111.652 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.21 52.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 7.7000000000000002 111.654 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -93.8 16.25 14.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 7.4699999999999998 111.625 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.88 120.96 13.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 7.3799999999999999 110.765 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.87 -4.81 66.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.928 -0.653 . . . . 7.9199999999999999 113.599 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.845 0.323 . . . . 7.71 111.124 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 10.0 tp -84.94 121.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.265 0.555 . . . . 10.0 111.333 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -135.34 107.74 7.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 8.4499999999999993 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.74 42.67 13.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 10.44 111.771 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.96 -5.33 54.2 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 115.201 0.84 . . . . 10.609999999999999 115.201 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.67 130.9 55.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.651 0.726 . . . . 10.279999999999999 112.356 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.67 101.46 10.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.556 -0.905 . . . . 8.8300000000000001 108.556 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.85 58.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.994 1.109 . . . . 6.9699999999999998 113.994 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.731 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.58 110.28 21.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.523 -1.288 . . . . 8.5099999999999998 107.523 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.4 mt -103.95 126.94 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 6.1699999999999999 112.338 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.403 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.56 15.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.384 -0.826 . . . . 8.3000000000000007 110.038 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.67 49.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.535 -0.913 . . . . 8.1400000000000006 108.535 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.16 174.78 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.988 1.792 . . . . 7.79 112.033 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.13 -46.88 13.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 1.207 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.7 p-10 -79.85 174.48 11.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.335 166.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.16 -36.18 1.76 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.04 0.448 . . . . 0.0 109.912 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -140.21 153.36 68.92 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.569 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.18 -23.11 73.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.611 2.207 . . . . 0.0 112.085 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.24 142.88 30.24 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.57 111.81 1.27 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.879 2.386 . . . . 0.0 112.764 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -138.35 66.41 0.53 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.919 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.5 ttt -109.62 -60.48 1.77 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 t -110.76 -38.09 5.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.811 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -83.8 101.34 11.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.101 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.562 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 27.5 t-20 -143.83 132.28 11.11 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.124 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.91 104.52 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.198 2.599 . . . . 0.0 113.566 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.3 m 60.41 29.67 19.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.052 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 241' ' ' ASN . 7.3 p -64.35 110.98 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.553 0.692 . . . . 0.0 112.023 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -169.8 129.81 0.99 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.104 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.2 m -111.71 144.95 31.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.608 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.84 109.76 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.804 2.336 . . . . 0.0 111.561 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.75 94.49 1.44 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.552 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.8 m -76.3 -17.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 111.279 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.04 -46.95 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.36 0.6 . . . . 0.0 109.418 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 t -114.6 92.26 3.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.555 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.0 m -87.31 -13.36 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.052 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t 62.64 72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.894 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.551 ' HB ' ' HD2' ' A' ' 255' ' ' PRO . 30.0 m -115.99 164.26 18.4 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.337 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 254' ' ' VAL . 18.9 Cg_endo -61.52 -22.32 74.19 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.149 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -74.11 101.91 4.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 p -134.35 98.59 4.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.362 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -86.4 154.48 21.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.853 0.835 . . . . 0.0 112.477 -171.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -135.16 31.07 3.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.334 -1.303 . . . . 11.33 110.745 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -63.01 139.36 58.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.211 0.529 . . . . 8.5 110.306 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 313' ' ' THR . 69.6 mt -109.74 144.0 38.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.957 -1.019 . . . . 6.5800000000000001 112.783 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.415 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 51.4 t80 -104.5 132.15 51.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.245 -1.391 . . . . 7.1399999999999997 107.245 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.22 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.531 -0.544 . . . . 5.6799999999999997 109.531 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . 0.507 ' O ' HD13 ' A' ' 330' ' ' LEU . . . -127.2 179.21 16.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.516 -0.849 . . . . 6.5700000000000003 112.674 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.8 9.18 86.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.589 -0.815 . . . . 8.0399999999999991 111.552 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.85 135.27 85.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 111.446 0.165 . . . . 8.1600000000000001 111.446 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.77 141.54 90.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.832 1.688 . . . . 9.4399999999999995 108.832 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -65.39 -14.92 61.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.752 1.39 . . . . 11.74 114.752 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -84.1 -23.13 30.89 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.836 1.421 . . . . 11.65 114.836 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.34 149.2 50.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.105 0.411 . . . . 9.3599999999999994 111.333 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.244 -0.28 . . . . 10.609999999999999 110.244 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 4.5 m-20 -53.59 -55.54 24.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.611 1.338 . . . . 10.07 114.611 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.14 -26.83 67.96 Favored 'General case' 0 C--N 1.405 3.008 0 C-N-CA 125.724 1.61 . . . . 0.0 112.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -79.78 -48.35 13.74 Favored 'General case' 1 C--N 1.432 4.185 0 CA-C-N 118.3 0.5 . . . . 10.289999999999999 111.387 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.69 -49.15 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 8.0 110.315 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 31.8 mtmm -54.35 -36.3 63.67 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.616 -0.72 . . . . 10.199999999999999 111.362 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.06 -53.45 55.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.096 0.474 . . . . 10.199999999999999 110.644 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.73 -33.02 32.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.092 -0.503 . . . . 7.6200000000000001 110.447 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.447 HD11 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.76 -41.72 18.86 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.497 0.554 . . . . 7.7400000000000002 112.497 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 55.7 m -56.76 -30.08 63.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.583 0.957 . . . . 10.390000000000001 113.583 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.6 m -50.36 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.395 2.563 0 C-N-CA 124.78 1.232 . . . . 0.0 112.671 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -111.67 -12.05 13.93 Favored 'General case' 1 C--N 1.444 4.705 0 CA-C-N 118.388 0.54 . . . . 10.23 111.435 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.17 162.23 10.21 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.874 -0.603 . . . . 10.98 111.951 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 147.01 93.51 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.7 2.267 . . . . 12.75 112.78 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 76.1 mt -102.41 146.23 28.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.95 -0.568 . . . . 10.66 111.254 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.589 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.5 ptpt -101.0 -22.72 14.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 11.630000000000001 109.302 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.57 125.36 4.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.051 -2.281 . . . . 0.0 109.245 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.51 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 47.1 t80 -142.82 134.76 27.01 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 122.777 0.431 . . . . 9.0099999999999998 112.014 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -144.8 124.11 13.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.714 0.292 . . . . 8.7300000000000004 111.481 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 303' ' ' ALA . 56.9 tp -101.04 118.24 36.6 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.55 -1.278 . . . . 8.9399999999999995 107.55 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 49.0 t -74.23 122.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.473 0.916 . . . . 9.7400000000000002 113.473 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -119.15 148.08 43.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.232 -0.894 . . . . 11.34 109.329 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 25.5 t70 -58.95 141.2 54.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.412 . . . . 13.83 110.894 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.595 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 18.7 m -49.78 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.802 -0.635 . . . . 14.779999999999999 112.606 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.07 -64.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.536 0.569 . . . . 16.440000000000001 112.536 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 3.9 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.254 -0.43 . . . . 15.24 111.21 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.72 -6.16 62.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.592 -0.814 . . . . 13.609999999999999 114.545 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.29 167.55 13.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.355 0.578 . . . . 13.529999999999999 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.0 t -59.15 142.08 52.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 10.51 111.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 1.405 ' NZ ' HO2' ' B' ' 601' ' ' ' U' . 4.4 mmmp? -87.94 -9.46 53.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.802 -0.636 . . . . 11.73 109.625 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.39 39.54 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.56 -0.746 . . . . 8.6300000000000008 113.857 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.947 ' HH ' " H4'" ' B' ' 603' ' ' ' U' . 42.7 p90 -142.96 146.46 33.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.146 0.973 . . . . 9.3900000000000006 112.75 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' A' ' 290' ' ' LEU . . . -140.59 155.13 46.66 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.094 -0.957 . . . . 6.5499999999999998 112.187 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' PHE . . . . . 0.415 ' CE1' ' HD1' ' A' ' 262' ' ' PHE . 88.9 m-85 -111.42 146.85 36.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.273 -0.876 . . . . 7.4299999999999997 110.422 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' CYS . . . . . 0.51 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.1 p -157.75 156.26 31.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.994 -0.683 . . . . 6.7699999999999996 111.903 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -145.41 127.08 15.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.738 -0.664 . . . . 9.5899999999999999 109.656 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.589 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 54.8 m-85 -82.46 164.9 20.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.081 0.467 . . . . 9.9100000000000001 112.027 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.55 -46.01 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.436 -0.95 . . . . 13.09 108.436 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASP . . . . . 0.709 ' O ' HG23 ' A' ' 312' ' ' VAL . 19.7 t70 -96.36 102.32 14.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.357 -1.349 . . . . 13.18 107.357 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ILE . . . . . 0.536 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.69 -34.98 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 115.326 1.602 . . . . 12.48 115.326 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -56.82 -38.82 73.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.236 1.017 . . . . 13.4 109.022 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.69 -22.57 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 112.268 -2.242 . . . . 11.43 109.61 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 97.8 m -54.66 -48.24 72.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.869 -0.789 . . . . 9.5 108.869 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.45 -42.82 99.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.3 -0.56 . . . . 10.31 110.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 119.871 -0.732 . . . . 12.41 111.993 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.76 74.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.597 -1.638 . . . . 8.3900000000000006 113.023 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.65 -51.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.316 0.579 . . . . 7.71 110.859 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.25 67.27 Favored 'General case' 0 C--N 1.419 3.589 0 C-N-CA 126.337 1.855 . . . . 0.0 113.2 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.438 ' O ' ' HE1' ' A' ' 323' ' ' MET . . . -88.25 -24.05 35.52 Favored Glycine 1 C--N 1.4 4.132 0 N-CA-C 116.815 1.486 . . . . 8.7599999999999998 116.815 177.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.87 -45.68 6.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 120.097 1.949 . . . . 7.2000000000000002 113.956 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -50.53 129.97 23.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.808 0.337 . . . . 8.1099999999999994 111.46 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.56 56.96 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.156 -0.545 . . . . 8.6400000000000006 113.978 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' MET . . . . . 0.438 ' HE1' ' O ' ' A' ' 319' ' ' GLY . 18.3 mtt -50.71 147.18 4.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.846 0.323 . . . . 8.25 111.259 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.06 115.57 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.055 0.455 . . . . 10.48 111.712 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.581 HD21 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -120.18 106.85 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.146 -1.057 . . . . 8.9499999999999993 108.146 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 66.99 -118.64 10.63 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.373 -1.491 . . . . 10.630000000000001 109.373 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -115.84 22.4 13.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 12.25 109.752 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -123.83 153.98 40.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.609 -0.723 . . . . 10.34 111.617 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -101.79 118.27 36.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.083 -1.08 . . . . 10.59 108.083 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.581 ' HB2' HD21 ' A' ' 325' ' ' LEU . 21.2 tp -63.0 143.04 58.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.516 0.674 . . . . 7.6500000000000004 112.649 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 61.5 tp -128.14 127.94 43.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.597 -1.183 . . . . 7.7599999999999998 109.014 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.85 124.02 26.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 120.909 -1.119 . . . . 6.4500000000000002 109.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.8 155.31 36.89 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.961 -1.712 . . . . 7.8799999999999999 109.557 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.472 ' HA ' HD21 ' A' ' 261' ' ' LEU . 66.4 mtt180 -58.54 122.44 13.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 118.424 -1.31 . . . . 9.1999999999999993 107.577 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.92 -11.8 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.814 1.413 . . . . 7.5199999999999996 114.814 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.4 m -119.44 -77.59 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.522 -0.471 . . . . 9.3599999999999994 111.239 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 7.3 p -166.53 134.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.873 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -83.35 60.45 4.88 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -65.18 105.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 111.937 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.47 90.71 3.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.504 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -107.21 113.4 26.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.177 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.601 179.4 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 601' ' ' ' U' . . . . . 1.405 HO2' ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.102 0 O4'-C1'-N19 109.29 1.09 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 602' ' ' ' U' . . . . . 0.417 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 O4'-C1'-C2' 107.57 0.836 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 603' ' ' ' U' . . . . . 0.947 " H4'" ' HH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C4'-C3'-C2' 103.511 0.811 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 604' ' ' ' U' . . . . . 0.731 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.501 5.57 0 C4'-C3'-C2' 99.077 -3.623 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 605' ' ' ' U' . . . . . 0.595 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.68 6.051 1 C4'-C3'-C2' 106.717 4.017 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.401 -1.093 0 C4'-C3'-C2' 105.707 3.007 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 607' ' ' ' U' . . . . . 1.207 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.053 0 O4'-C1'-C2' 107.617 0.869 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C3'-C2'-C1' 100.613 -0.986 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.518 -0.961 0 C3'-C2'-C1' 100.75 -0.833 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.554 0.216 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -157.11 148.58 22.18 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 122.962 0.505 . . . . 5.88 111.293 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.8 143.55 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 5.25 111.188 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.57 125.15 40.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.859 -0.793 . . . . 6.58 108.859 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.22 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.097 0.475 . . . . 5.06 110.24 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.78 -178.22 35.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.002 -0.618 . . . . 6.2 112.763 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.87 40.76 21.43 Favored 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 125.065 1.346 . . . . 0.0 110.201 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.77 149.78 88.21 Favored Pre-proline 1 C--N 1.428 4.015 0 C-N-CA 123.448 0.699 . . . . 7.79 111.327 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.98 144.43 89.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.288 1.992 . . . . 8.57 110.978 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.65 52.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.022 0.439 . . . . 11.37 111.934 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.56 61.18 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.818 -0.628 . . . . 9.94 114.313 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.07 136.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.307 0.553 . . . . 8.91 110.306 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.84 153.92 22.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.697 0.284 . . . . 9.64 110.645 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.13 -43.24 95.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 7.44 110.192 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.7 -45.93 91.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.001 -0.545 . . . . 9.89 110.562 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.3 -2.125 . . . . 0.0 111.724 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.48 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.11 67.84 Favored 'General case' 1 C--N 1.428 4.006 0 O-C-N 123.877 0.736 . . . . 6.64 111.733 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.56 -54.35 7.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.449 0.699 . . . . 6.69 111.074 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -54.48 -33.7 60.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.366 -0.834 . . . . 8.8 111.41 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.79 -53.62 17.42 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.58 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.1 m-85 -61.27 -48.29 82.09 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.97 80.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.265 -0.574 . . . . 7.12 109.586 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.7 -23.58 65.3 Favored 'General case' 0 C--N 1.407 3.097 0 O-C-N 120.254 -1.529 . . . . 0.0 111.298 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -79.48 -37.62 36.4 Favored 'General case' 0 C--N 1.427 3.972 0 O-C-N 123.611 0.569 . . . . 7.79 110.328 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.79 -36.79 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.595 -0.73 . . . . 7.73 111.014 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -75.93 -43.12 46.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.429 0.529 . . . . 9.61 112.429 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.03 -37.71 88.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.189 0.519 . . . . 10.06 110.447 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.15 -16.42 74.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.297 -0.954 . . . . 9.23 112.814 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.02 72.03 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 110.878 -0.889 . . . . 9.25 110.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.89 5.31 51.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.975 0.732 . . . . 8.31 112.975 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.63 143.45 30.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.616 0.246 . . . . 9.16 110.577 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.148 0.425 . . . . 10.23 112.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.4 24.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.646 -0.252 . . . . 9.89 110.714 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.29 143.51 99.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.946 1.764 . . . . 11.04 110.822 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.35 161.6 20.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.663 -0.779 . . . . 9.31 112.43 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 112.117 0.414 . . . . 7.97 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.21 -51.04 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.544 2.163 . . . . 6.59 111.283 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.64 106.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.126 -0.488 . . . . 5.87 111.075 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 -37.15 30.41 Favored 'General case' 0 N--CA 1.536 3.837 0 O-C-N 119.885 -1.76 . . . . 0.0 112.963 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.36 164.38 36.83 Favored 'General case' 0 C--N 1.382 1.983 0 C-N-CA 125.78 1.632 . . . . 0.0 110.736 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 130.45 10.53 Favored 'Isoleucine or valine' 0 C--N 1.37 1.499 0 C-N-CA 126.584 1.954 . . . . 5.67 109.331 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -114.06 126.61 55.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.789 -0.449 . . . . 6.47 109.789 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.92 125.95 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 116.912 2.189 . . . . 7.1 116.912 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.06 91.42 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 103.153 -2.906 . . . . 8.1 103.153 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -57.37 7.99 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 115.73 1.752 . . . . 10.19 115.73 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.21 -48.78 75.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.812 0.671 . . . . 10.51 112.812 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.0 -9.06 50.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.832 0.308 . . . . 9.72 111.832 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.21 15.49 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.528 1.307 . . . . 8.04 114.528 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.59 168.68 19.29 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 119.074 -1.05 . . . . 6.83 111.601 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.04 41.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.143 -1.389 . . . . 5.19 110.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.3 129.5 51.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.657 -0.868 . . . . 5.71 108.657 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.94 137.56 33.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 4.27 110.272 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.77 114.65 25.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.744 -0.465 . . . . 6.21 109.744 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -99.6 164.7 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.597 0.561 . . . . 6.14 112.073 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.59 -25.98 22.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.473 -0.785 . . . . 8.37 111.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.9 p -128.89 159.59 35.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.173 0.511 . . . . 7.92 111.568 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.33 -41.71 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 8.77 112.232 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.72 -41.79 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.325 0.491 . . . . 9.08 112.325 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.82 98.09 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.2 m -54.19 -53.97 46.24 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.149 -1.056 . . . . 6.18 108.149 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.5 m -55.18 -27.11 43.43 Favored 'General case' 0 C--N 1.428 3.98 0 C-N-CA 126.956 2.102 . . . . 0.0 109.86 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.23 -34.03 43.12 Favored 'General case' 0 C--N 1.422 3.73 0 N-CA-C 113.606 0.965 . . . . 8.7 113.606 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.659 0.614 . . . . 5.94 112.659 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.86 63.38 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.394 1.059 . . . . 6.89 111.587 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.38 -9.37 53.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 7.4 111.651 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.2 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.516 -0.311 . . . . 6.97 111.619 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.84 120.92 13.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 7.38 110.78 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.91 65.94 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.918 -0.658 . . . . 7.92 113.559 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.07 142.36 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.854 0.327 . . . . 7.5 111.101 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.333 0.587 . . . . 9.49 111.266 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.28 107.73 7.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 8.45 110.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.67 13.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 10.44 111.73 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.06 -5.47 54.01 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.169 0.828 . . . . 10.21 115.169 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.62 130.94 55.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.665 0.733 . . . . 9.94 112.381 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.79 101.55 11.0 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.449 -0.945 . . . . 8.4 108.449 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.981 1.104 . . . . 6.9 113.981 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.9 tttt -108.53 110.21 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.567 -1.272 . . . . 8.29 107.567 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.91 126.91 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.349 0.5 . . . . 6.17 112.349 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.57 170.53 15.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.413 -0.812 . . . . 7.99 110.051 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.12 154.7 49.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.38 175.04 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.942 1.761 . . . . 7.79 112.079 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.797 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.004 0.43 . . . . 10.8 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.92 139.41 58.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 8.21 110.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.5 mt -109.88 143.94 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.114 -0.948 . . . . 6.33 112.769 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -104.38 132.08 51.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.176 -1.416 . . . . 6.75 107.176 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.573 -0.529 . . . . 5.68 109.573 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.456 -0.878 . . . . 6.53 112.679 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.2 86.6 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 7.67 111.506 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.6 mt -70.89 135.21 85.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.492 0.182 . . . . 8.16 111.492 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 26.2 Cg_exo -61.82 141.56 90.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.93 1.753 . . . . 8.96 108.76 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -65.36 -14.88 61.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.797 1.406 . . . . 11.61 114.797 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.16 -23.1 30.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.807 1.41 . . . . 11.06 114.807 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.35 149.12 50.86 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.169 0.44 . . . . 9.36 111.306 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 17.6 p-10 -114.53 -176.48 2.91 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.269 -0.271 . . . . 10.46 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 9.9 m-20 -53.46 -55.41 25.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 114.699 1.37 . . . . 9.92 114.699 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.66 -26.05 67.77 Favored 'General case' 0 C--N 1.406 3.023 0 C-N-CA 125.633 1.573 . . . . 0.0 112.559 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -80.28 -48.3 13.25 Favored 'General case' 1 C--N 1.429 4.064 0 CA-C-N 118.27 0.487 . . . . 10.06 111.414 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 75.1 t -62.63 -49.16 84.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.784 -0.644 . . . . 7.76 110.329 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.6 mtmm -54.37 -36.44 63.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.647 -0.706 . . . . 9.67 111.312 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.97 -53.37 56.63 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.137 0.494 . . . . 10.2 110.701 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 320' ' ' LEU . 3.1 tm? -51.74 -33.19 33.72 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.124 -0.489 . . . . 7.62 110.328 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -82.64 -41.55 19.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.651 0.611 . . . . 7.74 112.651 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.8 m -56.85 -29.57 63.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.566 0.95 . . . . 10.09 113.566 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 m -50.61 -9.99 0.06 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 124.873 1.269 . . . . 0.0 112.511 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.76 -11.96 13.9 Favored 'General case' 1 C--N 1.443 4.637 0 CA-C-N 118.398 0.544 . . . . 10.23 111.483 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 10.4 111.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.66 147.03 93.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.681 2.254 . . . . 12.19 112.744 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.4 mt -102.4 146.29 28.29 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.913 -0.585 . . . . 10.66 111.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.488 ' HD2' ' OE2' ' A' ' 306' ' ' GLU . 18.7 ptpt -101.02 -22.67 14.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.222 -0.658 . . . . 11.41 109.222 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.59 4.67 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.061 -2.274 . . . . 0.0 109.229 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.594 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.4 t80 -142.79 134.78 27.08 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 122.81 0.444 . . . . 8.77 111.968 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.82 124.09 12.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.794 0.33 . . . . 8.38 111.467 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.8 tp -101.03 118.13 36.4 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.2 122.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.445 0.906 . . . . 9.37 113.445 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.09 148.1 43.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.263 -0.88 . . . . 11.34 109.359 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.7 t70 -58.89 141.14 54.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.919 0.39 . . . . 13.83 111.039 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 38.0 m -49.59 -61.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.649 0.611 . . . . 14.58 112.649 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.16 -63.96 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.497 0.555 . . . . 16.19 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 14.9 m -42.46 -59.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.302 -0.408 . . . . 14.94 111.221 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.58 -6.04 62.7 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.65 -0.786 . . . . 13.57 114.531 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.32 167.56 13.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.411 0.606 . . . . 13.28 110.926 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.5 t -59.13 142.08 52.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 10.43 111.588 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 5.4 mmmp? -87.99 -9.47 53.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.771 -0.65 . . . . 11.2 109.566 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.55 -3.29 39.6 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.624 -0.716 . . . . 8.63 113.908 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -143.02 146.4 33.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.04 0.92 . . . . 9.19 112.837 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.63 155.14 46.62 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.131 -0.941 . . . . 6.21 112.258 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.34 146.86 36.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.172 -0.922 . . . . 7.09 110.405 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.594 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.3 p -157.91 156.18 30.87 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 119.903 -0.719 . . . . 6.77 111.84 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 31.3 tt0 -145.26 127.16 15.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.585 -0.734 . . . . 9.59 109.629 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 57.8 m-85 -82.5 164.89 20.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.042 0.386 . . . . 9.91 112.042 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' VAL . . . . . 0.475 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 64.0 t -71.59 -46.08 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.357 -0.979 . . . . 12.81 108.357 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.3 t70 -96.35 102.35 14.13 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.442 -1.318 . . . . 13.18 107.442 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 115.27 1.582 . . . . 12.23 115.27 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -56.87 -38.69 73.08 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 122.246 1.022 . . . . 13.04 109.026 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.84 -22.57 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.296 -2.229 . . . . 11.08 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.61 -48.26 72.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.933 -0.766 . . . . 9.11 108.933 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.36 -42.82 99.71 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.252 -0.579 . . . . 10.31 110.554 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.82 -32.41 73.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.857 -0.737 . . . . 11.98 111.949 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.54 -34.78 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.671 -1.604 . . . . 8.25 113.025 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 73.0 mt -68.57 -51.25 48.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 7.4 110.883 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.78 67.86 Favored 'General case' 0 C--N 1.419 3.611 0 C-N-CA 126.266 1.826 . . . . 0.0 113.178 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -24.02 36.35 Favored Glycine 1 C--N 1.398 4.01 0 N-CA-C 116.846 1.499 . . . . 8.35 116.846 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 278' ' ' LEU . 87.9 mt -96.9 -45.77 6.49 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 120.093 1.947 . . . . 7.2 113.971 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -50.53 130.06 23.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 7.86 111.492 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.66 56.72 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.103 -0.57 . . . . 8.64 113.987 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.3 ttt -50.58 147.15 4.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.797 0.298 . . . . 8.0 111.336 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -95.05 115.73 27.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 10.39 111.703 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.4 mm? -120.24 106.71 12.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.108 -1.071 . . . . 8.95 108.108 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.06 -118.64 10.56 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.388 -1.485 . . . . 10.63 109.388 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.87 22.35 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 12.25 109.781 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -123.82 153.9 40.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.59 -0.732 . . . . 9.98 111.683 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.73 118.29 36.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.133 -1.062 . . . . 10.14 108.133 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.67 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.9 tp -62.99 143.1 58.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.413 0.625 . . . . 7.52 112.663 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 94.8 mt -128.12 128.06 44.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.535 -1.211 . . . . 7.48 108.917 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.5 t -137.98 123.93 25.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.927 -1.108 . . . . 6.45 109.997 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -152.65 155.41 37.26 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.947 -1.72 . . . . 7.66 109.5 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.515 ' HA ' HD23 ' A' ' 261' ' ' LEU . 98.8 mtt180 -58.69 122.49 13.63 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.459 -1.297 . . . . 8.94 107.586 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.91 -11.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.757 1.391 . . . . 7.52 114.757 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.3 m -119.41 -77.84 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.547 -0.461 . . . . 9.07 111.362 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.554 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.725 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -161.81 149.24 14.45 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 122.97 0.508 . . . . 5.88 111.526 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.4 mt -140.73 143.56 35.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 5.25 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -96.54 125.14 40.8 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 6.58 108.879 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.69 101.22 8.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.069 0.461 . . . . 5.06 110.242 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.76 -179.2 34.86 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.033 -0.53 . . . . 6.2 112.728 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.1 41.35 23.48 Favored 'General case' 0 CA--C 1.575 1.939 0 C-N-CA 125.175 1.39 . . . . 0.0 110.326 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.69 149.85 88.43 Favored Pre-proline 1 C--N 1.429 4.023 0 C-N-CA 123.726 0.81 . . . . 7.79 111.32 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.08 144.45 89.98 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.247 1.964 . . . . 8.57 110.968 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.92 139.78 52.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 11.37 111.938 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.48 61.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.282 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.05 136.5 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.316 0.558 . . . . 8.91 110.359 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.85 153.88 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.693 0.282 . . . . 9.64 110.653 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.22 -43.07 96.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.176 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -61.82 -45.99 91.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.971 -0.559 . . . . 9.89 110.547 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.412 3.312 0 O-C-N 119.076 -2.265 . . . . 0.0 111.701 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.19 67.91 Favored 'General case' 1 C--N 1.429 4.059 0 O-C-N 123.934 0.771 . . . . 6.64 111.731 171.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.32 7.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.353 0.661 . . . . 6.69 111.119 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.48 -33.75 60.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.388 -0.824 . . . . 8.8 111.428 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.72 -53.7 17.25 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.552 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.3 -48.21 82.4 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.77 -42.85 80.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.164 -0.614 . . . . 7.12 109.594 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.98 -23.46 65.04 Favored 'General case' 0 C--N 1.406 3.042 0 O-C-N 120.279 -1.513 . . . . 0.0 111.31 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -79.3 -37.76 36.97 Favored 'General case' 1 C--N 1.428 4.014 0 CA-C-N 118.499 0.59 . . . . 7.79 110.354 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.66 -36.82 83.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.589 -0.732 . . . . 7.73 111.085 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -76.0 -43.13 45.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.349 0.5 . . . . 9.61 112.349 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.5 mt -62.99 -37.74 88.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.272 0.558 . . . . 10.06 110.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.03 -16.45 74.7 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.224 -0.988 . . . . 9.23 112.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.14 72.02 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.801 -0.92 . . . . 9.25 110.801 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.96 5.33 51.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.865 0.691 . . . . 8.31 112.865 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 p -82.62 143.46 30.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 9.16 110.575 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.44 23.88 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.689 -0.232 . . . . 9.89 110.706 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.3 143.48 99.72 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.017 1.812 . . . . 11.04 110.834 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.33 161.55 20.56 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.534 -0.841 . . . . 9.31 112.431 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.2 m-20 -75.26 134.52 73.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.02 0.378 . . . . 7.97 112.02 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.28 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.553 2.169 . . . . 6.59 111.327 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.63 105.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.118 -0.492 . . . . 5.87 111.11 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 70.47 0.71 Allowed 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 124.752 1.221 . . . . 0.0 109.441 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.73 151.32 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 129.383 3.073 . . . . 0.0 112.78 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.52 130.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 129.47 3.108 . . . . 5.67 109.273 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.743 -0.465 . . . . 6.47 109.743 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 125.97 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 116.958 2.207 . . . . 7.1 116.958 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.03 91.38 5.28 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 103.165 -2.902 . . . . 8.1 103.165 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -57.39 8.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.606 1.706 . . . . 10.19 115.606 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.28 -48.67 76.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.845 0.683 . . . . 10.51 112.845 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.01 -9.12 50.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.726 0.298 . . . . 9.72 111.803 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.1 36.07 15.44 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.556 1.317 . . . . 8.04 114.556 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.42 168.7 19.2 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.134 -1.027 . . . . 6.83 111.703 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.69 161.09 41.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.235 -1.348 . . . . 5.19 110.482 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.36 129.37 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.641 -0.874 . . . . 5.71 108.641 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.92 137.58 33.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 4.27 110.312 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.72 114.77 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.721 -0.474 . . . . 6.21 109.721 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.665 0.603 . . . . 6.14 111.919 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.94 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 8.37 111.411 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.3 p -128.94 159.57 35.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 7.92 111.648 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.24 -41.78 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.751 . . . . 8.77 112.232 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.71 -41.78 95.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.354 0.502 . . . . 9.08 112.354 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.91 -43.86 97.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.248 -0.279 . . . . 7.46 110.248 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.0 m -54.18 -53.87 47.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.261 1.029 . . . . 6.18 108.261 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.1 m -55.06 -27.22 43.14 Favored 'General case' 0 C--N 1.424 3.845 0 C-N-CA 127.118 2.167 . . . . 0.0 109.888 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.35 -34.01 42.47 Favored 'General case' 0 C--N 1.421 3.682 0 N-CA-C 113.585 0.957 . . . . 8.7 113.585 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.58 -17.39 64.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.82 63.34 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.473 1.108 . . . . 6.89 111.633 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.51 -9.21 52.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.355 . . . . 7.4 111.611 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.83 16.16 14.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.564 -0.289 . . . . 6.97 111.627 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.87 120.92 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.826 0.346 . . . . 7.38 110.777 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.84 65.98 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.938 -0.648 . . . . 7.92 113.577 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.06 142.38 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.936 0.368 . . . . 7.5 111.084 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.97 121.54 37.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.34 0.591 . . . . 9.49 111.262 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.29 107.76 7.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 8.45 110.378 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.69 42.71 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 10.44 111.771 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.99 -5.35 54.21 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 115.195 0.838 . . . . 10.21 115.195 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.61 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.669 0.735 . . . . 9.94 112.469 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.44 10.83 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.56 -0.904 . . . . 8.4 108.56 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.31 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.434 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.55 110.24 21.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.555 -1.276 . . . . 8.29 107.555 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.93 126.89 58.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 6.17 112.32 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.434 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.62 170.54 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.03 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.14 154.76 49.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.537 -0.912 . . . . 7.86 108.537 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.44 175.17 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.921 1.748 . . . . 7.79 112.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 66.9 m80 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.911 0.386 . . . . 10.8 110.782 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 306' ' ' GLU . 7.0 tppt? -62.87 139.34 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 8.21 110.349 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 313' ' ' THR . 78.9 mt -109.75 143.99 38.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.006 -0.997 . . . . 6.33 112.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -104.48 132.24 50.95 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.141 -1.429 . . . . 6.75 107.141 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.99 121.15 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.603 -0.517 . . . . 5.68 109.603 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.14 179.25 16.47 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.72 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.53 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.555 -0.831 . . . . 7.67 111.596 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 99.1 mt -70.86 135.3 85.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.192 . . . . 8.16 111.496 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.3 Cg_exo -61.79 141.53 90.56 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.879 1.719 . . . . 8.96 108.843 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -65.42 -14.86 61.84 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -84.17 -23.14 30.71 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.781 1.401 . . . . 11.06 114.781 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.31 149.22 50.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.115 0.416 . . . . 9.36 111.332 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 275' ' ' VAL . 27.4 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.229 -0.286 . . . . 10.46 110.229 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 18.7 m-20 -53.55 -55.27 27.02 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 114.659 1.355 . . . . 9.92 114.659 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.67 -26.42 68.01 Favored 'General case' 0 C--N 1.405 3.009 0 C-N-CA 125.707 1.603 . . . . 0.0 112.461 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -80.02 -48.26 13.61 Favored 'General case' 1 C--N 1.431 4.119 0 CA-C-N 118.263 0.483 . . . . 10.06 111.455 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 271' ' ' ASN . 84.4 t -62.74 -49.21 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.8 -0.636 . . . . 7.76 110.273 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 45.1 mtmt -54.25 -36.4 63.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 9.67 111.336 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.06 -53.26 57.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.092 0.472 . . . . 10.2 110.772 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.401 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.72 -33.21 33.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.964 -0.562 . . . . 7.62 110.365 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.64 -41.66 19.17 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.549 0.574 . . . . 7.74 112.549 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 32.3 m -56.92 -29.82 63.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.586 0.958 . . . . 10.09 113.586 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.1 m -49.9 -10.33 0.05 OUTLIER 'General case' 0 C--N 1.394 2.507 0 C-N-CA 124.846 1.258 . . . . 0.0 112.776 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -111.59 -11.99 13.98 Favored 'General case' 1 C--N 1.443 4.669 0 CA-C-N 118.341 0.519 . . . . 10.23 111.467 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.3 10.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.9 -0.667 . . . . 10.4 111.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 147.12 93.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.716 2.277 . . . . 12.19 112.689 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 81.6 mt -102.49 146.29 28.32 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.932 -0.576 . . . . 10.66 111.217 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -101.07 -22.58 14.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.271 -0.64 . . . . 11.41 109.271 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.58 126.13 5.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.174 -2.204 . . . . 0.0 109.172 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.547 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 50.1 t80 -143.41 134.68 25.92 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.792 0.437 . . . . 8.77 112.028 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.12 13.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.797 0.332 . . . . 8.38 111.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 60.7 tp -101.08 118.24 36.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.568 -1.271 . . . . 8.94 107.568 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.6 t -74.14 122.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.44 0.904 . . . . 9.37 113.44 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -119.18 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.353 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.6 t70 -58.9 141.19 54.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 13.83 110.98 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.4 m -49.75 -61.56 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.736 0.643 . . . . 14.58 112.736 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.21 -64.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.465 0.543 . . . . 16.19 112.465 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 9.0 m -42.59 -59.22 1.98 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.306 -0.406 . . . . 14.94 111.176 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.15 62.58 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.599 -0.81 . . . . 13.57 114.499 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 70.3 mt -88.24 167.67 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.401 0.601 . . . . 13.28 110.911 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 33.5 t -59.22 142.1 52.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 10.43 111.656 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.97 -9.43 53.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 11.2 109.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.5 -3.29 39.73 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.669 -0.696 . . . . 8.63 113.935 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -143.01 146.4 33.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.038 0.919 . . . . 9.19 112.827 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.13 46.73 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.037 -0.983 . . . . 6.21 112.206 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.35 146.77 36.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.192 -0.913 . . . . 7.09 110.415 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.547 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.6 p -157.78 156.29 31.3 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.969 -0.692 . . . . 6.77 111.868 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.796 ' HB2' ' HD3' ' A' ' 260' ' ' LYS . 78.4 tt0 -145.35 127.05 15.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.737 -0.665 . . . . 9.59 109.682 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 51.8 m-85 -82.42 164.87 20.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.953 0.406 . . . . 9.91 112.007 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.53 -46.1 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.43 -0.952 . . . . 12.81 108.43 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.4 t70 -96.28 102.29 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.436 -1.32 . . . . 13.18 107.436 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 115.299 1.592 . . . . 12.23 115.299 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -56.92 -38.69 73.23 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.184 0.992 . . . . 13.04 108.966 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.64 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 112.358 -2.201 . . . . 11.08 109.613 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 91.6 m -54.71 -48.13 72.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.908 -0.775 . . . . 9.11 108.908 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -62.43 -42.89 99.78 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.285 -0.566 . . . . 10.31 110.473 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.7 -32.43 73.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 119.93 -0.708 . . . . 11.98 111.98 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.71 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.641 -1.618 . . . . 8.25 113.076 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 72.8 mt -68.61 -51.39 46.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.354 0.597 . . . . 7.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.88 67.31 Favored 'General case' 0 C--N 1.42 3.668 0 C-N-CA 126.225 1.81 . . . . 0.0 113.13 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.02 -24.07 36.11 Favored Glycine 1 C--N 1.399 4.077 0 N-CA-C 116.762 1.465 . . . . 8.35 116.762 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 330' ' ' LEU . 84.3 mt -96.86 -45.76 6.51 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 120.176 1.988 . . . . 7.2 113.938 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -50.44 129.94 22.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 7.86 111.526 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.69 56.7 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.108 -0.568 . . . . 8.64 113.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.3 ttt -50.65 147.18 4.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.84 0.32 . . . . 8.0 111.337 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.01 115.64 27.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.407 . . . . 10.39 111.723 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.24 106.63 12.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.116 -1.068 . . . . 8.95 108.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.2 -118.68 10.5 Favored Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -115.84 22.36 13.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 12.25 109.714 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -123.88 153.94 40.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.667 -0.697 . . . . 9.98 111.618 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -101.79 118.22 36.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.138 -1.06 . . . . 10.14 108.138 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.643 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.1 tp -63.0 143.15 58.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.545 0.688 . . . . 7.52 112.637 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.23 127.92 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.469 -1.242 . . . . 7.48 108.981 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.84 124.01 26.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 O-C-N 120.976 -1.078 . . . . 6.45 110.011 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -152.78 155.4 37.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.042 -1.661 . . . . 7.66 109.51 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.463 ' HA ' HD23 ' A' ' 261' ' ' LEU . 98.5 mtt180 -58.65 122.54 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 118.435 -1.306 . . . . 8.94 107.58 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.78 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.3 m -119.36 -78.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.575 -0.45 . . . . 9.07 111.212 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.819 -177.95 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.758 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -158.81 149.26 19.79 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 123.646 0.591 . . . . 5.88 111.577 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.81 143.64 34.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 5.25 111.231 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -96.57 125.17 40.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.905 -0.776 . . . . 6.58 108.905 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.82 101.23 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 5.06 110.21 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.85 -179.32 34.68 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.07 -0.586 . . . . 6.2 112.769 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.3 m120 49.95 41.6 23.21 Favored 'General case' 0 CA--C 1.574 1.899 0 C-N-CA 125.395 1.478 . . . . 0.0 110.292 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.43 149.87 89.01 Favored Pre-proline 1 C--N 1.43 4.07 0 C-N-CA 123.861 0.864 . . . . 7.79 111.355 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.15 144.44 90.35 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.317 2.011 . . . . 8.57 110.977 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.96 139.77 52.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.929 0.395 . . . . 11.37 111.992 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.59 61.25 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.876 -0.602 . . . . 9.94 114.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.2 136.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 117.338 0.569 . . . . 8.91 110.254 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.7 p -84.96 153.85 22.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 9.64 110.637 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.09 -43.18 95.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 7.44 110.185 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.74 -46.03 91.37 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.994 -0.548 . . . . 9.89 110.54 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.56 -26.4 68.56 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.271 -2.143 . . . . 0.0 111.698 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.478 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.38 -34.08 67.68 Favored 'General case' 1 C--N 1.43 4.071 0 O-C-N 123.952 0.783 . . . . 6.64 111.811 171.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.55 -54.29 7.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.442 0.697 . . . . 6.69 111.078 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.66 -33.64 61.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.419 -0.81 . . . . 8.8 111.373 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.76 -53.6 17.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 120.634 -0.426 . . . . 7.44 111.603 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.25 -48.37 81.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.181 0.438 . . . . 5.94 112.181 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.6 m-20 -56.74 -42.85 80.0 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.193 -0.603 . . . . 7.12 109.606 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.4 65.07 Favored 'General case' 0 C--N 1.406 3.06 0 O-C-N 120.27 -1.519 . . . . 0.0 111.251 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.5 -37.66 36.21 Favored 'General case' 1 C--N 1.429 4.03 0 CA-C-N 118.576 0.625 . . . . 7.79 110.332 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.82 83.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 7.73 111.022 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.01 -43.07 45.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.437 0.532 . . . . 9.61 112.437 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.02 -37.82 88.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 10.06 110.397 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.96 -16.52 74.67 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.309 -0.948 . . . . 9.23 112.881 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.11 71.55 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.816 -0.914 . . . . 9.25 110.816 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.01 5.28 52.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.816 0.672 . . . . 8.31 112.816 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.5 p -82.59 143.44 31.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.565 0.221 . . . . 9.16 110.598 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.157 0.429 . . . . 10.23 112.157 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.47 23.82 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.688 -0.233 . . . . 9.89 110.689 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.33 143.49 99.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.928 1.752 . . . . 11.04 110.797 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.57 20.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 9.31 112.385 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.23 134.52 73.84 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.046 0.387 . . . . 7.97 112.046 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.29 -50.91 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.564 2.176 . . . . 6.59 111.358 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.79 105.43 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.183 -0.462 . . . . 5.87 111.096 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -31.4 29.19 Favored 'General case' 0 N--CA 1.529 3.482 0 O-C-N 119.988 -1.695 . . . . 0.0 113.404 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.21 163.37 39.66 Favored 'General case' 0 C--N 1.391 2.372 0 C-N-CA 126.244 1.818 . . . . 0.0 110.798 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.27 130.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.376 1.752 0 C-N-CA 126.556 1.943 . . . . 5.67 109.313 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.17 126.6 55.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.715 -0.476 . . . . 6.47 109.715 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.96 126.0 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 116.985 2.217 . . . . 7.1 116.985 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.01 91.37 5.27 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 103.163 -2.902 . . . . 8.1 103.163 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -57.36 8.09 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.634 1.716 . . . . 10.19 115.634 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.23 -48.75 75.87 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.891 0.7 . . . . 10.51 112.891 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.14 50.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.895 0.331 . . . . 9.72 111.895 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.05 36.23 15.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.565 1.32 . . . . 8.04 114.565 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.61 168.59 19.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.063 -1.055 . . . . 6.83 111.633 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.52 161.17 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.413 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.46 129.4 51.2 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.556 -0.905 . . . . 5.71 108.556 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.87 137.53 33.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.353 -0.385 . . . . 4.27 110.33 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -114.74 114.7 25.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.678 -0.49 . . . . 6.21 109.678 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.939 -0.573 . . . . 6.14 111.93 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -25.99 22.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 8.37 111.47 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.2 p -128.89 159.54 35.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.104 0.478 . . . . 7.92 111.688 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.27 -41.78 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 8.77 112.231 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.74 -41.68 95.75 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.385 0.513 . . . . 9.08 112.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.83 -43.84 98.04 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.292 -0.262 . . . . 7.46 110.292 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.2 m -54.17 -54.03 45.25 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.108 -1.071 . . . . 6.18 108.108 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 m -54.99 -27.14 41.85 Favored 'General case' 1 C--N 1.429 4.039 0 C-N-CA 127.072 2.149 . . . . 0.0 109.905 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.3 -34.1 42.69 Favored 'General case' 0 C--N 1.422 3.734 0 N-CA-C 113.586 0.958 . . . . 8.7 113.586 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.657 0.614 . . . . 5.94 112.657 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.1 -19.83 63.39 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.451 1.095 . . . . 6.89 111.602 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.26 52.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 7.4 111.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.89 16.28 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.528 -0.305 . . . . 6.97 111.584 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.97 14.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.869 0.366 . . . . 7.38 110.715 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.9 65.98 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.89 -0.671 . . . . 7.92 113.587 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.809 0.305 . . . . 7.5 111.121 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.91 121.54 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.271 0.558 . . . . 9.49 111.343 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.23 107.75 7.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 8.45 110.354 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.7 13.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.064 -0.517 . . . . 10.44 111.751 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.53 53.6 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.234 0.854 . . . . 10.21 115.234 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.52 130.86 55.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.58 0.69 . . . . 9.94 112.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.68 101.51 10.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.52 -0.918 . . . . 8.4 108.52 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.31 137.88 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.027 1.121 . . . . 6.9 114.027 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.5 tttt -108.61 110.32 21.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.548 -1.279 . . . . 8.29 107.548 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.05 126.92 58.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.129 0.49 . . . . 6.17 112.288 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.63 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 7.99 110.026 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.05 154.7 49.69 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.56 -0.904 . . . . 7.86 108.56 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.4 175.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 121.89 1.726 . . . . 7.79 112.057 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m170 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.003 0.43 . . . . 10.8 110.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 260' ' ' LYS . 16.3 ttmt -62.9 139.34 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.21 110.323 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 313' ' ' THR . 64.4 mt -109.8 143.94 38.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.02 -0.991 . . . . 6.33 112.806 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -104.47 132.12 51.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.19 -1.411 . . . . 6.75 107.19 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.661 -0.496 . . . . 5.68 109.661 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.25 16.48 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.537 -0.839 . . . . 6.53 112.659 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.2 86.51 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.643 -0.789 . . . . 7.67 111.554 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 95.2 mt -70.83 135.19 85.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.503 0.186 . . . . 8.16 111.503 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.8 Cg_exo -61.78 141.6 90.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.883 1.722 . . . . 8.96 108.843 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.37 -14.96 62.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.779 1.4 . . . . 11.61 114.779 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.08 -23.21 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.842 1.423 . . . . 11.06 114.842 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.29 149.19 50.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.159 0.436 . . . . 9.36 111.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.4 p-10 -114.5 -176.43 2.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 110.29 -0.263 . . . . 10.46 110.29 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.61 -55.2 27.85 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.618 1.34 . . . . 9.92 114.618 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.79 -26.34 68.04 Favored 'General case' 0 C--N 1.406 3.033 0 C-N-CA 125.669 1.588 . . . . 0.0 112.408 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -80.04 -48.3 13.52 Favored 'General case' 1 C--N 1.43 4.072 0 CA-C-N 118.301 0.5 . . . . 10.06 111.412 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 271' ' ' ASN . 67.6 t -62.63 -49.27 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 7.76 110.28 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -54.22 -36.46 63.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 9.67 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.0 -53.36 56.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.133 0.492 . . . . 10.2 110.709 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 278' ' ' LEU . 1.5 tm? -51.78 -33.14 33.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.081 -0.509 . . . . 7.62 110.364 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.1 mt -82.66 -41.67 19.11 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.602 0.593 . . . . 7.74 112.602 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.7 m -56.73 -29.9 62.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.567 0.951 . . . . 10.09 113.567 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 m -50.21 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.555 0 C-N-CA 124.796 1.238 . . . . 0.0 112.587 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -111.46 -12.06 14.03 Favored 'General case' 1 C--N 1.442 4.596 0 CA-C-N 118.379 0.536 . . . . 10.23 111.452 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.12 162.36 10.28 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.786 -0.643 . . . . 10.4 111.913 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.66 147.12 93.3 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.731 2.287 . . . . 12.19 112.712 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 84.1 mt -102.52 146.25 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.918 -0.583 . . . . 10.66 111.215 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.7 ptpt -100.99 -22.65 14.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.266 -0.642 . . . . 11.41 109.266 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.64 126.15 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 119.07 -2.269 . . . . 0.0 109.15 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 62.9 t80 -143.3 134.7 26.12 Favored 'General case' 0 C--N 1.362 1.142 0 C-N-CA 122.886 0.474 . . . . 8.77 112.009 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 4.2 p-10 -144.78 124.04 12.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.73 0.3 . . . . 8.38 111.557 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 54.2 tp -101.01 118.3 36.73 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.552 -1.277 . . . . 8.94 107.552 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.17 122.86 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.511 0.93 . . . . 9.37 113.511 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -119.09 148.13 43.39 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 115.332 -0.849 . . . . 11.34 109.336 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 37.2 t70 -58.94 141.1 54.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 13.83 110.95 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.6 m -49.71 -61.66 1.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.625 0.602 . . . . 14.58 112.625 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.18 -63.95 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.493 0.553 . . . . 16.19 112.493 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.4 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.414 . . . . 14.94 111.179 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.07 62.69 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.607 -0.806 . . . . 13.57 114.557 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.33 167.64 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.34 0.57 . . . . 13.28 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.1 t -59.17 141.96 52.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 10.43 111.617 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.419 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.4 mmmp? -87.95 -9.42 53.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 11.2 109.574 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.37 39.53 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.727 . . . . 8.63 113.875 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -142.92 146.43 33.99 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.051 0.925 . . . . 9.19 112.846 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.13 46.72 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.004 -0.998 . . . . 6.21 112.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 97.5 m-85 -111.44 146.83 36.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.168 -0.924 . . . . 7.09 110.449 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.6 p -157.72 156.24 31.32 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.003 -0.679 . . . . 6.77 111.869 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.4 127.08 15.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.723 -0.671 . . . . 9.59 109.649 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.568 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 53.2 m-85 -82.37 164.92 20.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.095 0.406 . . . . 9.91 112.095 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.62 -46.08 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.343 -0.984 . . . . 12.81 108.343 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 312' ' ' VAL . 12.1 t70 -96.32 102.28 14.04 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.381 -1.34 . . . . 13.18 107.381 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.68 -35.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 115.337 1.606 . . . . 12.23 115.337 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -56.78 -38.73 72.89 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.259 1.028 . . . . 13.04 109.097 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.69 -22.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.306 -2.225 . . . . 11.08 109.529 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 94.5 m -54.64 -48.13 72.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.929 -0.767 . . . . 9.11 108.929 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.46 -42.89 99.8 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.308 -0.557 . . . . 10.31 110.467 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -63.8 -32.44 73.94 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 119.923 -0.711 . . . . 11.98 111.941 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.66 74.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.586 -1.643 . . . . 8.25 113.103 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.61 -51.31 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.362 0.601 . . . . 7.4 110.876 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.88 -38.66 67.82 Favored 'General case' 0 C--N 1.419 3.596 0 C-N-CA 126.281 1.832 . . . . 0.0 113.151 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.11 -24.08 35.81 Favored Glycine 1 C--N 1.399 4.033 0 N-CA-C 116.778 1.471 . . . . 8.35 116.778 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 99.1 mt -96.81 -45.81 6.5 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.107 1.954 . . . . 7.2 113.946 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -50.47 130.04 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 7.86 111.463 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.66 56.76 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.111 -0.566 . . . . 8.64 113.948 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.7 mtt -50.65 147.21 4.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.783 0.325 . . . . 8.0 111.264 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -95.14 115.69 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.076 0.465 . . . . 10.39 111.715 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.0 mm? -120.26 106.83 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.082 -1.081 . . . . 8.95 108.082 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.1 -118.74 10.65 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.397 -1.481 . . . . 10.63 109.397 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -115.78 22.36 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 12.25 109.781 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.8 153.91 40.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.616 -0.72 . . . . 9.98 111.624 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.73 118.25 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.117 -1.068 . . . . 10.14 108.117 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.09 143.09 58.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 7.52 112.586 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 20.8 mt -128.12 128.0 44.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.504 -1.225 . . . . 7.48 108.997 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.92 124.04 26.28 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 O-C-N 120.984 -1.073 . . . . 6.45 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -152.76 155.33 36.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 119.987 -1.696 . . . . 7.66 109.547 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.488 ' HA ' HD23 ' A' ' 261' ' ' LEU . 95.0 mtt180 -58.55 122.43 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.395 -1.322 . . . . 8.94 107.626 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.94 -11.77 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.786 1.402 . . . . 7.52 114.786 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.6 m -119.36 -77.84 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.55 -0.46 . . . . 9.07 111.422 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.477 0.656 . . . . 0.0 110.581 178.139 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 74.5 ttt180 . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.34 148.4 21.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.762 -1.108 . . . . 5.88 111.36 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.74 143.47 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 5.25 111.205 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.55 125.14 40.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.901 -0.777 . . . . 6.58 108.901 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.77 101.29 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.098 0.475 . . . . 5.06 110.147 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.81 -179.32 34.73 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.964 -0.562 . . . . 6.2 112.795 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.4 m120 50.28 41.31 24.14 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 125.258 1.423 . . . . 0.0 110.194 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.46 149.83 88.94 Favored Pre-proline 1 C--N 1.429 4.048 0 C-N-CA 123.832 0.853 . . . . 7.79 111.316 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.07 144.41 90.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.308 2.005 . . . . 8.57 111.013 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.67 52.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.93 0.395 . . . . 11.37 111.964 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.33 6.42 61.52 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.838 -0.619 . . . . 9.94 114.319 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.11 136.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.31 0.555 . . . . 8.91 110.276 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.6 p -84.86 153.91 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 9.64 110.691 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.1 -43.19 95.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 7.44 110.204 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.78 -45.92 91.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.901 -0.59 . . . . 9.89 110.499 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.76 -26.38 68.68 Favored 'General case' 0 C--N 1.408 3.142 0 O-C-N 119.262 -2.149 . . . . 0.0 111.689 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.29 -34.1 67.92 Favored 'General case' 0 C--N 1.428 3.98 0 O-C-N 123.978 0.799 . . . . 6.64 111.79 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.54 -54.22 7.92 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.412 0.685 . . . . 6.69 111.132 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.73 -33.61 61.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 8.8 111.353 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.83 -53.55 17.64 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.531 -0.468 . . . . 7.44 111.61 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.31 -48.28 82.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.13 0.419 . . . . 5.94 112.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.76 -42.85 80.08 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.277 -0.569 . . . . 7.12 109.559 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.28 64.83 Favored 'General case' 0 C--N 1.405 3.001 0 O-C-N 120.199 -1.563 . . . . 0.0 111.234 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.37 -37.72 36.7 Favored 'General case' 0 C--N 1.427 3.956 0 CA-C-N 118.528 0.604 . . . . 7.79 110.354 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.75 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.577 -0.738 . . . . 7.73 111.059 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -76.1 -42.94 45.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.413 0.523 . . . . 9.61 112.413 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.259 0.552 . . . . 10.06 110.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.04 -16.52 74.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.322 -0.942 . . . . 9.23 112.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.19 37.14 71.88 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.843 -0.903 . . . . 9.25 110.843 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.35 51.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 8.31 112.918 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.8 p -82.58 143.49 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 9.16 110.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.61 -18.47 21.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.18 0.437 . . . . 10.23 112.18 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.49 23.74 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.709 -0.223 . . . . 9.89 110.693 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.4 143.61 99.66 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.926 1.751 . . . . 11.04 110.825 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.22 161.63 20.69 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.639 -0.791 . . . . 9.31 112.441 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.3 134.5 73.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.089 0.403 . . . . 7.97 112.089 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.26 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.492 2.128 . . . . 6.59 111.315 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.65 105.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.135 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -35.05 33.28 Favored 'General case' 0 N--CA 1.53 3.525 0 O-C-N 120.279 -1.513 . . . . 0.0 113.277 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.84 163.95 39.18 Favored 'General case' 0 C--N 1.386 2.167 0 C-N-CA 126.05 1.74 . . . . 0.0 110.591 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.19 130.45 11.04 Favored 'Isoleucine or valine' 0 C--N 1.372 1.549 0 C-N-CA 126.534 1.934 . . . . 5.67 109.297 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.06 126.7 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.798 -0.445 . . . . 6.47 109.798 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -115.06 125.98 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 116.904 2.187 . . . . 7.1 116.904 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -98.05 91.38 5.27 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 103.193 -2.891 . . . . 8.1 103.193 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -57.4 7.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.612 1.708 . . . . 10.19 115.612 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.76 75.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.839 0.681 . . . . 10.51 112.839 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.04 -9.11 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.834 0.309 . . . . 9.72 111.834 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.15 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.495 1.294 . . . . 8.04 114.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.64 168.56 19.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.184 -1.007 . . . . 6.83 111.663 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.51 161.17 41.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.446 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.27 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.726 -0.842 . . . . 5.71 108.726 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.0 mt -94.82 137.58 33.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.451 -0.34 . . . . 4.27 110.337 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.73 25.98 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.702 -0.481 . . . . 6.21 109.702 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.7 164.78 11.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.928 -0.578 . . . . 6.14 111.953 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.67 -25.87 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 8.37 111.484 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.5 p -129.0 159.6 35.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.17 0.509 . . . . 7.92 111.579 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 209' ' ' THR . 40.9 t -74.34 -41.73 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.523 -0.762 . . . . 8.77 112.201 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.78 -41.72 95.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.32 0.489 . . . . 9.08 112.32 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.91 -43.85 97.99 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.192 -0.299 . . . . 7.46 110.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.15 -53.28 55.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.332 1.063 . . . . 6.18 108.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.619 HG22 HH22 ' A' ' 228' ' ' ARG . 3.7 p -56.19 -26.15 49.64 Favored 'General case' 1 C--N 1.449 4.894 0 C-N-CA 126.15 1.78 . . . . 0.0 110.195 178.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.51 -34.05 41.57 Favored 'General case' 0 C--N 1.428 3.995 0 N-CA-C 113.602 0.964 . . . . 8.7 113.602 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.36 64.14 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.72 0.637 . . . . 5.94 112.72 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.02 -19.93 63.38 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.532 1.145 . . . . 6.89 111.597 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.42 -9.27 52.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 7.4 111.683 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.18 14.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 6.97 111.704 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.86 120.99 14.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.886 0.374 . . . . 7.38 110.803 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.86 -4.85 66.06 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.906 -0.664 . . . . 7.92 113.584 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.858 0.329 . . . . 7.5 111.086 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.95 121.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.271 0.558 . . . . 9.49 111.286 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.64 7.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.698 -0.683 . . . . 8.45 110.347 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.73 42.71 13.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 10.44 111.759 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.1 -5.5 54.08 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.186 0.834 . . . . 10.21 115.186 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.62 130.84 55.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.654 0.727 . . . . 9.94 112.405 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.72 101.49 10.91 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.535 -0.913 . . . . 8.4 108.535 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.28 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.088 1.144 . . . . 6.9 114.088 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.51 110.26 21.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.588 -1.264 . . . . 8.29 107.588 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.92 126.95 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 6.17 112.334 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.62 170.52 15.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.047 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 209' ' ' THR . 3.5 mtp180 -89.09 154.67 49.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.559 -0.904 . . . . 7.86 108.559 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.38 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.97 1.78 . . . . 7.79 111.987 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.9 t60 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.961 0.41 . . . . 10.8 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.01 139.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.185 0.517 . . . . 8.21 110.278 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 334' ' ' ARG . 47.9 mt -109.73 143.86 38.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.032 -0.986 . . . . 6.33 112.862 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -104.49 132.14 51.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.0 121.21 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.54 -0.541 . . . . 5.68 109.54 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.722 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.19 86.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.656 -0.783 . . . . 7.67 111.511 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.5 mt -70.86 135.25 85.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.154 . . . . 8.16 111.409 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 35.4 Cg_exo -61.82 141.55 90.52 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.952 1.768 . . . . 8.96 108.737 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.39 -14.94 62.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.703 1.371 . . . . 11.61 114.703 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -84.07 -23.27 30.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.811 1.412 . . . . 11.06 114.811 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.23 149.17 50.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.125 0.421 . . . . 9.36 111.366 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.5 p-10 -114.51 -176.46 2.91 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.293 -0.262 . . . . 10.46 110.293 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -53.55 -55.4 25.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 114.632 1.345 . . . . 9.92 114.632 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -26.46 67.89 Favored 'General case' 0 C--N 1.406 3.042 0 C-N-CA 125.639 1.576 . . . . 0.0 112.531 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -79.95 -48.34 13.55 Favored 'General case' 0 C--N 1.428 3.979 0 CA-C-N 118.307 0.503 . . . . 10.06 111.447 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 79.5 t -62.67 -49.14 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 7.76 110.286 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 33.0 mtmm -54.28 -36.48 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 9.67 111.332 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.99 -53.38 56.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 10.2 110.716 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.77 -33.09 33.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.08 -0.509 . . . . 7.62 110.393 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.469 HD13 ' SG ' ' A' ' 305' ' ' CYS . 78.5 mt -82.62 -41.72 19.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.588 0.588 . . . . 7.74 112.588 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 83.0 m -56.82 -29.9 63.22 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.523 0.935 . . . . 10.09 113.523 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 19.8 m -50.26 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.549 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 316' ' ' ALA . 33.8 m-85 -111.33 -11.95 14.1 Favored 'General case' 1 C--N 1.444 4.688 0 CA-C-N 118.372 0.533 . . . . 10.23 111.426 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.835 -0.621 . . . . 10.4 111.94 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.72 147.11 93.48 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.743 2.295 . . . . 12.19 112.627 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 82.5 mt -102.43 146.24 28.36 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.869 -0.605 . . . . 10.66 111.23 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.06 -22.48 14.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.308 -0.627 . . . . 11.41 109.308 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.33 127.66 5.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 119.294 -2.129 . . . . 0.0 109.099 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.0 t80 -144.56 134.65 24.07 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 122.852 0.461 . . . . 8.77 112.008 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -144.73 124.14 13.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.764 0.316 . . . . 8.38 111.513 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -101.02 118.2 36.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.524 -1.287 . . . . 8.94 107.524 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.22 122.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.465 0.913 . . . . 9.37 113.465 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -119.19 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.436 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.2 t70 -58.89 141.15 54.27 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.966 0.412 . . . . 13.83 111.039 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.5 m -49.68 -61.7 1.97 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.616 . . . . 14.58 112.633 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.06 -64.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.476 0.547 . . . . 16.19 112.476 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.49 -59.33 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 14.94 111.18 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.07 62.55 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.567 -0.825 . . . . 13.57 114.554 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.29 167.64 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.394 0.597 . . . . 13.28 110.886 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.5 t -59.24 142.03 52.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 10.43 111.635 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 4.8 mmmp? -87.91 -9.46 53.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 11.2 109.573 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.42 39.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.644 -0.707 . . . . 8.63 113.895 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -142.9 146.43 34.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.126 0.963 . . . . 9.19 112.903 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.1 46.73 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.106 -0.952 . . . . 6.21 112.23 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -111.39 146.93 36.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.221 -0.899 . . . . 7.09 110.348 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.568 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.6 p -157.91 156.21 30.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.924 -0.711 . . . . 6.77 111.919 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -145.31 127.1 15.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.68 -0.691 . . . . 9.59 109.61 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 63.9 m-85 -82.55 164.87 20.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.417 . . . . 9.91 112.041 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.5 -46.13 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.384 -0.969 . . . . 12.81 108.384 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.705 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.28 102.35 14.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.355 -1.35 . . . . 13.18 107.355 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.05 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 115.303 1.594 . . . . 12.23 115.303 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -56.84 -38.71 73.05 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.264 1.03 . . . . 13.04 109.009 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.78 -22.63 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 112.265 -2.243 . . . . 11.08 109.549 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.62 -48.22 72.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.931 -0.766 . . . . 9.11 108.931 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.45 -42.81 99.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.184 -0.607 . . . . 10.31 110.52 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.8 -32.47 73.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 119.943 -0.703 . . . . 11.98 111.909 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . . . -69.43 -34.79 74.96 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.626 -1.624 . . . . 8.25 113.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 74.7 mt -68.54 -51.3 47.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 121.403 0.621 . . . . 7.4 110.861 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.1 -38.63 68.38 Favored 'General case' 0 C--N 1.419 3.603 0 C-N-CA 126.141 1.776 . . . . 0.0 113.172 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -23.92 36.68 Favored Glycine 1 C--N 1.398 4.008 0 N-CA-C 116.845 1.498 . . . . 8.35 116.845 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 330' ' ' LEU . 80.2 mt -96.9 -45.71 6.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 120.122 1.961 . . . . 7.2 113.957 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -50.54 130.07 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 7.86 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.16 -16.65 56.76 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.091 -0.576 . . . . 8.64 113.955 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.2 ttt -50.67 147.19 4.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.755 0.312 . . . . 8.0 111.298 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -95.05 115.61 27.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 10.39 111.635 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.25 106.77 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.118 -1.068 . . . . 8.95 108.118 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.08 -118.67 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.382 -1.487 . . . . 10.63 109.382 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -115.84 22.49 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.129 0.49 . . . . 12.25 109.749 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -123.9 153.83 40.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.673 -0.694 . . . . 9.98 111.612 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -101.79 118.3 36.64 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.071 -1.085 . . . . 10.14 108.071 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.711 ' HB2' HD23 ' A' ' 325' ' ' LEU . 23.8 tp -63.03 143.13 58.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.502 0.668 . . . . 7.52 112.642 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.574 -1.193 . . . . 7.48 108.977 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.96 123.98 26.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 O-C-N 120.939 -1.101 . . . . 6.45 109.997 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.68 155.35 37.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 119.965 -1.709 . . . . 7.66 109.502 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.541 ' HA ' HD23 ' A' ' 261' ' ' LEU . 82.1 mtt180 -58.63 122.53 13.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.403 -1.319 . . . . 8.94 107.533 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.734 1.383 . . . . 7.52 114.734 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.0 m -119.4 -78.29 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.623 -0.431 . . . . 9.07 111.262 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.604 -178.398 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.665 0.269 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -156.22 148.61 23.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 5.88 111.203 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.3 mt -140.8 143.56 34.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 5.25 111.185 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.59 125.16 40.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.851 -0.796 . . . . 6.58 108.851 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.79 101.21 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.088 0.47 . . . . 5.06 110.201 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -178.96 34.97 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.998 -0.547 . . . . 6.2 112.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 50.53 40.71 24.09 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.122 1.369 . . . . 0.0 110.224 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.62 149.88 88.59 Favored Pre-proline 1 C--N 1.428 4.01 0 C-N-CA 123.595 0.758 . . . . 7.79 111.302 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.07 144.47 89.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.297 1.998 . . . . 8.57 110.967 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.0 139.71 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.987 0.422 . . . . 11.37 111.94 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.19 6.56 61.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.792 -0.64 . . . . 9.94 114.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.17 136.47 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 117.331 0.566 . . . . 8.91 110.283 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.3 p -84.9 153.99 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.517 -0.31 . . . . 9.64 110.652 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.19 -43.21 96.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 7.44 110.146 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.72 -45.96 91.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.575 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.62 -26.35 68.57 Favored 'General case' 0 C--N 1.41 3.199 0 O-C-N 119.296 -2.127 . . . . 0.0 111.664 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.41 -34.17 67.66 Favored 'General case' 0 C--N 1.428 3.982 0 O-C-N 123.985 0.803 . . . . 6.64 111.708 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.6 -54.24 7.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 123.47 0.708 . . . . 6.69 111.102 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.54 -33.77 60.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.426 -0.806 . . . . 8.8 111.391 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.75 -53.6 17.65 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.604 -0.438 . . . . 7.44 111.572 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.39 -48.22 82.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.79 -42.93 80.35 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.342 -0.543 . . . . 7.12 109.591 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.2 -22.98 64.78 Favored 'General case' 0 C--N 1.406 3.038 0 O-C-N 120.181 -1.574 . . . . 0.0 111.302 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.63 -37.55 35.8 Favored 'General case' 0 C--N 1.427 3.961 0 CA-C-N 118.56 0.618 . . . . 7.79 110.309 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.81 -36.67 82.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.614 -0.721 . . . . 7.73 111.022 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -76.12 -43.03 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.375 0.509 . . . . 9.61 112.375 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.99 -37.69 88.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.186 0.517 . . . . 10.06 110.471 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.44 74.58 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.196 -1.002 . . . . 9.23 112.871 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.1 37.09 72.65 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.908 -0.877 . . . . 9.25 110.908 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.8 5.22 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.945 0.72 . . . . 8.31 112.945 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.3 p -82.65 143.46 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.591 0.234 . . . . 9.16 110.524 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.69 -18.41 21.33 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.047 0.388 . . . . 10.23 112.047 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.44 23.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.704 -0.225 . . . . 9.89 110.674 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.31 143.46 99.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.033 1.822 . . . . 11.04 110.748 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.4 161.67 20.53 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.611 -0.804 . . . . 9.31 112.355 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.36 134.42 73.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.003 0.372 . . . . 7.97 112.003 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.24 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 6.59 111.325 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.6 105.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.174 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -33.78 29.67 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 120.212 -1.555 . . . . 0.0 113.418 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.17 40.58 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 126.054 1.742 . . . . 0.0 110.647 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.73 130.43 12.12 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 126.309 1.844 . . . . 5.67 109.298 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.04 126.65 55.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.823 -0.436 . . . . 6.47 109.823 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 116.875 2.176 . . . . 7.1 116.875 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.11 91.32 5.22 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.186 -2.894 . . . . 8.1 103.186 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.22 -57.43 7.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.619 1.711 . . . . 10.19 115.619 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.18 -48.73 75.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.884 0.698 . . . . 10.51 112.884 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.01 -9.13 50.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.74 0.305 . . . . 9.72 111.764 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.14 15.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 114.516 1.302 . . . . 8.04 114.516 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.58 168.64 19.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.11 -1.036 . . . . 6.83 111.632 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.604 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.05 41.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.149 -1.387 . . . . 5.19 110.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.35 51.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.691 -0.855 . . . . 5.71 108.691 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.87 137.6 33.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 4.27 110.297 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.8 114.74 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.698 -0.482 . . . . 6.21 109.698 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.69 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.965 -0.561 . . . . 6.14 111.935 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.68 -25.93 22.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.822 . . . . 8.37 111.462 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.4 p -128.85 159.6 35.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 7.92 111.687 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.29 -41.77 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 8.77 112.247 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.7 -41.77 95.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.343 0.497 . . . . 9.08 112.343 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.236 -0.283 . . . . 7.46 110.236 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.8 m -54.24 -53.9 47.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.317 1.056 . . . . 6.18 108.15 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 m -55.03 -27.22 42.85 Favored 'General case' 1 C--N 1.429 4.041 0 C-N-CA 127.082 2.153 . . . . 0.0 109.859 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.27 -34.21 42.78 Favored 'General case' 0 C--N 1.42 3.662 0 N-CA-C 113.578 0.955 . . . . 8.7 113.578 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.45 64.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.621 0.6 . . . . 5.94 112.621 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.82 63.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.449 1.093 . . . . 6.89 111.617 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.2 52.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 7.4 111.62 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.91 16.2 14.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.529 -0.305 . . . . 6.97 111.591 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.95 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 7.38 110.767 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.81 -4.76 66.14 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.907 -0.663 . . . . 7.92 113.619 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.37 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.877 0.338 . . . . 7.5 111.08 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.278 0.561 . . . . 9.49 111.31 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.31 107.81 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 8.45 110.3 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.62 42.74 13.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.034 -0.53 . . . . 10.44 111.823 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.0 -5.47 53.71 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.225 0.85 . . . . 10.21 115.225 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.58 130.96 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.686 0.743 . . . . 9.94 112.405 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.56 10.96 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.507 -0.923 . . . . 8.4 108.507 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.35 137.84 58.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.974 1.102 . . . . 6.9 113.974 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.43 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.54 110.31 21.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.513 -1.291 . . . . 8.29 107.513 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.99 126.88 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.35 0.5 . . . . 6.17 112.35 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.43 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.6 170.44 15.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.474 -0.785 . . . . 7.99 110.067 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.06 154.68 49.66 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.599 -0.889 . . . . 7.86 108.599 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.31 174.9 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.795 1.663 . . . . 7.79 112.057 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.189 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.4 m80 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 120.968 0.414 . . . . 10.8 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.92 139.27 58.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.204 0.526 . . . . 8.21 110.367 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 334' ' ' ARG . 59.4 mt -109.74 143.97 38.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.015 -0.993 . . . . 6.33 112.829 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.4 132.17 50.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.147 -1.427 . . . . 6.75 107.147 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.04 121.29 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.565 -0.532 . . . . 5.68 109.565 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.22 16.5 Favored Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.461 -0.876 . . . . 6.53 112.693 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.12 86.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.634 -0.794 . . . . 7.67 111.517 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 92.7 mt -70.79 135.27 85.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.48 0.178 . . . . 8.16 111.48 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.6 Cg_exo -61.85 141.51 90.18 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.923 1.748 . . . . 8.96 108.796 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -65.36 -14.86 61.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.763 1.394 . . . . 11.61 114.763 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -84.15 -23.17 30.75 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.77 1.396 . . . . 11.06 114.77 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 149.21 50.71 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.121 0.418 . . . . 9.36 111.31 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 10.0 p-10 -114.51 -176.39 2.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.578 -0.283 . . . . 10.46 110.296 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 10.8 m-20 -53.64 -55.21 27.9 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 114.622 1.341 . . . . 9.92 114.622 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.33 -26.77 68.03 Favored 'General case' 0 C--N 1.405 2.995 0 C-N-CA 125.697 1.599 . . . . 0.0 112.456 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.07 -48.22 13.61 Favored 'General case' 1 C--N 1.429 4.031 0 O-C-N 123.489 0.493 . . . . 10.06 111.398 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 71.9 t -62.69 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 7.76 110.237 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 26.7 mtmm -54.27 -36.45 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.662 -0.699 . . . . 9.67 111.297 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.06 -53.3 57.37 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 10.2 110.7 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -51.73 -33.15 33.45 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 116.195 -0.457 . . . . 7.62 110.322 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.499 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.9 mt -82.67 -41.67 19.08 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.568 0.581 . . . . 7.74 112.568 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 53.1 m -56.86 -29.41 62.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.546 0.943 . . . . 10.09 113.546 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -50.11 -10.82 0.06 Allowed 'General case' 0 C--N 1.395 2.572 0 C-N-CA 125.062 1.345 . . . . 0.0 112.563 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.51 -12.03 14.01 Favored 'General case' 1 C--N 1.445 4.733 0 CA-C-N 118.174 0.443 . . . . 10.23 111.499 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.31 10.25 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.795 -0.638 . . . . 10.4 111.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.64 147.09 93.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.677 2.252 . . . . 12.19 112.681 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.3 mt -102.47 146.31 28.29 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.889 -0.596 . . . . 10.66 111.304 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.6 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 12.8 ptpt -101.11 -22.56 14.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 11.41 109.227 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.07 127.23 5.73 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 119.152 -2.217 . . . . 0.0 108.975 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.618 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 60.2 t80 -144.43 134.75 24.41 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 122.769 0.428 . . . . 8.77 112.013 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -144.79 124.03 12.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.813 0.339 . . . . 8.38 111.634 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 52.0 tp -100.88 118.27 36.6 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.592 -1.262 . . . . 8.94 107.592 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.24 122.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.507 0.929 . . . . 9.37 113.507 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.09 148.1 43.42 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.315 -0.857 . . . . 11.34 109.373 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 36.9 t70 -58.92 141.05 54.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.92 0.39 . . . . 13.83 110.958 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.6 m -49.59 -61.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.795 -0.638 . . . . 14.58 112.65 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.2 -64.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.422 0.527 . . . . 16.19 112.422 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.621 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 18.4 m -42.4 -59.39 1.86 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 14.94 111.209 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.65 -6.05 62.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.643 -0.789 . . . . 13.57 114.493 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.29 167.69 13.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.425 0.612 . . . . 13.28 110.913 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -59.25 142.01 52.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 10.43 111.572 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 4.7 mmmp? -87.96 -9.4 53.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.795 -0.639 . . . . 11.2 109.619 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.61 -3.4 39.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.597 -0.729 . . . . 8.63 113.874 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.97 146.41 33.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.03 0.915 . . . . 9.19 112.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.2 46.74 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.101 -0.954 . . . . 6.21 112.242 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -111.42 146.84 36.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.186 -0.916 . . . . 7.09 110.422 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.618 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.2 p -157.87 156.19 30.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 119.9 -0.72 . . . . 6.77 111.875 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.404 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 37.5 tt0 -145.27 127.0 15.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.702 -0.681 . . . . 9.59 109.713 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.6 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 56.4 m-85 -82.39 164.85 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.941 0.4 . . . . 9.91 112.06 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.51 -46.11 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.428 -0.953 . . . . 12.81 108.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.1 t70 -96.32 102.39 14.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.391 -1.337 . . . . 13.18 107.391 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -52.76 -34.97 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 115.288 1.588 . . . . 12.23 115.288 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.84 -38.76 73.11 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 122.175 0.988 . . . . 13.04 108.979 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.7 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 112.366 -2.197 . . . . 11.08 109.552 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.67 -48.1 72.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.935 -0.765 . . . . 9.11 108.935 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -62.52 -42.77 99.74 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.205 -0.598 . . . . 10.31 110.486 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -63.88 -32.39 73.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.932 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.77 74.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.711 -1.586 . . . . 8.25 113.036 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 313' ' ' THR . 63.6 mt -68.63 -51.3 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 7.4 110.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.03 67.59 Favored 'General case' 0 C--N 1.42 3.642 0 C-N-CA 126.185 1.794 . . . . 0.0 113.152 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.93 -23.9 36.92 Favored Glycine 1 C--N 1.399 4.055 0 N-CA-C 116.781 1.472 . . . . 8.35 116.781 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 330' ' ' LEU . 96.9 mt -96.92 -45.7 6.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.214 2.007 . . . . 7.2 114.039 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -50.45 129.98 22.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.845 0.355 . . . . 7.86 111.426 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.65 56.79 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.145 -0.55 . . . . 8.64 113.956 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 16.4 mtt -50.64 147.19 4.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.822 0.311 . . . . 8.0 111.267 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -95.09 115.65 27.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.03 0.443 . . . . 10.39 111.71 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.7 mm? -120.2 106.77 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.113 -1.069 . . . . 8.95 108.113 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.14 -118.65 10.51 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.38 -1.488 . . . . 10.63 109.38 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -115.86 22.41 13.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.202 0.525 . . . . 12.25 109.818 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -123.82 153.91 40.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.599 -0.728 . . . . 9.98 111.629 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -101.7 118.41 36.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.115 -1.068 . . . . 10.14 108.115 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.601 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.6 tp -63.21 143.16 58.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.515 0.674 . . . . 7.52 112.653 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.539 -1.209 . . . . 7.48 108.942 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.96 124.02 26.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 O-C-N 120.935 -1.103 . . . . 6.45 110.01 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -152.7 155.31 37.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.973 -1.704 . . . . 7.66 109.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.507 ' HA ' HD23 ' A' ' 261' ' ' LEU . 84.6 mtt180 -58.66 122.44 13.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 118.463 -1.295 . . . . 8.94 107.612 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.77 0.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.766 1.395 . . . . 7.52 114.766 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.5 m -119.47 -79.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.539 -0.465 . . . . 9.07 111.297 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.619 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.983 0.421 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -158.7 148.52 19.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.064 0.946 . . . . 5.88 111.127 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 28.0 mt -140.67 143.55 35.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.541 . . . . 5.25 111.282 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.61 125.19 40.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.854 -0.795 . . . . 6.58 108.854 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.8 101.33 8.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 5.06 110.196 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.77 -178.63 35.0 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.914 -0.585 . . . . 6.2 112.792 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.25 40.83 23.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 124.969 1.308 . . . . 0.0 110.121 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.83 149.8 88.09 Favored Pre-proline 1 C--N 1.428 4.021 0 C-N-CA 123.477 0.711 . . . . 7.79 111.286 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.07 144.48 89.84 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.297 1.998 . . . . 8.57 110.989 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.96 139.72 52.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 11.37 111.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.1 6.6 61.0 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.833 -0.621 . . . . 9.94 114.303 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.12 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.399 0.6 . . . . 8.91 110.305 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.4 p -84.89 153.98 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.614 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -60.18 -43.31 95.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 7.44 110.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.51 -46.22 90.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.106 -0.497 . . . . 9.89 110.516 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.37 -26.39 68.43 Favored 'General case' 0 C--N 1.41 3.233 0 O-C-N 119.26 -2.15 . . . . 0.0 111.734 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.484 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.49 -34.08 67.41 Favored 'General case' 1 C--N 1.429 4.034 0 O-C-N 123.984 0.802 . . . . 6.64 111.742 171.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.63 -54.31 7.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.424 0.69 . . . . 6.69 111.057 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.61 -33.68 60.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.453 -0.794 . . . . 8.8 111.345 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.76 -53.53 17.93 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 120.41 -0.516 . . . . 7.44 111.611 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.31 -48.27 82.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.82 -42.81 80.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.294 -0.562 . . . . 7.12 109.64 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.57 65.16 Favored 'General case' 0 C--N 1.407 3.076 0 O-C-N 120.261 -1.524 . . . . 0.0 111.227 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.38 -37.66 36.77 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.528 0.604 . . . . 7.79 110.319 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.8 -36.61 82.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.58 -0.736 . . . . 7.73 111.079 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HD3' HH11 ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.17 -43.02 44.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.38 0.511 . . . . 9.61 112.38 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.2 mt -63.0 -37.73 88.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.203 0.525 . . . . 10.06 110.415 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -16.46 74.61 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.225 -0.988 . . . . 9.23 112.894 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.15 71.6 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.774 -0.93 . . . . 9.25 110.774 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.9 5.27 51.95 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.939 0.718 . . . . 8.31 112.939 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.0 p -82.6 143.42 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.183 -0.207 . . . . 9.16 110.609 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.149 0.426 . . . . 10.23 112.149 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.5 23.71 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.731 -0.213 . . . . 9.89 110.688 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.37 143.56 99.68 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.915 1.743 . . . . 11.04 110.821 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.29 161.61 20.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.656 -0.783 . . . . 9.31 112.467 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.25 134.48 73.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.025 0.38 . . . . 7.97 112.025 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.4 Cg_exo -73.25 -50.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.573 2.182 . . . . 6.59 111.368 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.151 -0.477 . . . . 5.87 111.107 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -33.17 33.27 Favored 'General case' 0 N--CA 1.524 3.272 0 C-N-CA 124.878 1.271 . . . . 0.0 113.394 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 163.78 39.17 Favored 'General case' 0 C--N 1.386 2.181 0 C-N-CA 125.757 1.623 . . . . 0.0 110.577 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.45 130.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 C-N-CA 126.091 1.756 . . . . 5.67 109.338 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.686 -0.487 . . . . 6.47 109.686 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.1 mt -114.93 125.99 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 116.903 2.186 . . . . 7.1 116.903 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.14 91.42 5.26 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 103.187 -2.894 . . . . 8.1 103.187 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -57.46 7.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.645 1.72 . . . . 10.19 115.645 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.14 -48.78 75.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.853 0.686 . . . . 10.51 112.853 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.99 -9.07 50.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 9.72 111.849 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.15 15.5 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.579 1.326 . . . . 8.04 114.579 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.52 168.7 19.23 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.12 -1.032 . . . . 6.83 111.671 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.61 161.02 42.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.035 -1.438 . . . . 5.19 110.515 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.35 51.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.624 -0.88 . . . . 5.71 108.624 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.8 137.56 33.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.355 -0.384 . . . . 4.27 110.351 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.83 114.82 26.05 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 6.21 109.645 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -99.77 164.67 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 6.14 111.947 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -26.04 22.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.425 -0.807 . . . . 8.37 111.461 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.1 p -128.86 159.64 35.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.1 0.476 . . . . 7.92 111.646 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.569 -0.741 . . . . 8.77 112.303 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.64 -41.79 95.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.364 0.505 . . . . 9.08 112.364 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.77 98.17 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.25 -54.48 39.49 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.13 -1.063 . . . . 6.18 108.13 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.0 m -54.3 -27.56 36.26 Favored 'General case' 1 C--N 1.429 4.032 0 C-N-CA 127.029 2.132 . . . . 0.0 109.853 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.01 -34.0 44.42 Favored 'General case' 0 C--N 1.426 3.897 0 N-CA-C 113.648 0.981 . . . . 8.7 113.648 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.55 -17.35 64.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.626 0.602 . . . . 5.94 112.626 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.5 mtp -62.12 -19.86 63.46 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.29 0.994 . . . . 6.89 111.569 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.24 52.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.383 -0.371 . . . . 7.4 111.608 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.77 16.16 14.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.747 0.308 . . . . 6.97 111.725 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.85 120.9 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 7.38 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.84 65.95 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.859 -0.686 . . . . 7.92 113.553 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.17 142.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.836 0.318 . . . . 7.5 111.066 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.57 37.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.271 0.558 . . . . 9.49 111.327 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.29 107.71 7.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 8.45 110.354 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.72 42.62 13.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 10.44 111.771 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.34 54.53 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.229 0.851 . . . . 10.21 115.229 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.69 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.652 0.726 . . . . 9.94 112.475 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.71 101.58 10.96 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.486 -0.931 . . . . 8.4 108.486 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.42 137.82 58.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.032 1.123 . . . . 6.9 114.032 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.433 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.47 110.24 21.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.539 -1.282 . . . . 8.29 107.539 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.5 mt -104.12 126.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.217 0.532 . . . . 6.17 112.233 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.433 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.54 170.54 15.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.376 -0.829 . . . . 7.99 110.079 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.13 154.7 49.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.39 175.26 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.954 1.77 . . . . 7.79 112.038 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 t60 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.899 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.968 0.413 . . . . 10.8 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -62.98 139.4 58.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.276 0.56 . . . . 8.21 110.318 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.9 mt -109.8 144.05 38.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.989 -1.005 . . . . 6.33 112.789 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.44 132.03 51.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.02 121.23 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.618 -0.512 . . . . 5.68 109.618 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.13 179.26 16.46 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.483 -0.865 . . . . 6.53 112.719 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.08 86.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.625 -0.798 . . . . 7.67 111.561 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.1 mt -70.79 135.27 85.7 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 111.522 0.193 . . . . 8.16 111.522 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.1 Cg_exo -61.84 141.53 90.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.998 1.799 . . . . 8.96 108.744 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.44 -14.86 61.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.724 1.379 . . . . 11.61 114.724 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -84.21 -22.98 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.827 1.417 . . . . 11.06 114.827 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.31 149.12 50.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.144 0.429 . . . . 9.36 111.325 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.9 p-10 -114.59 -176.49 2.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.233 -0.284 . . . . 10.46 110.233 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.54 -55.35 26.29 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.604 1.335 . . . . 9.92 114.604 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -61.4 -26.53 67.91 Favored 'General case' 0 C--N 1.405 3.006 0 C-N-CA 125.72 1.608 . . . . 0.0 112.51 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.12 -48.28 13.46 Favored 'General case' 1 C--N 1.43 4.086 0 CA-C-N 118.283 0.492 . . . . 10.06 111.385 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.9 t -62.7 -49.16 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.6 . . . . 7.76 110.318 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -54.3 -36.36 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.678 -0.692 . . . . 9.67 111.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.01 -53.43 55.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.167 0.508 . . . . 10.2 110.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 320' ' ' LEU . 3.2 tm? -51.65 -33.28 32.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.115 -0.493 . . . . 7.62 110.365 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.496 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.52 -41.6 19.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.649 0.611 . . . . 7.74 112.649 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 43.5 m -56.94 -29.96 63.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.48 0.919 . . . . 10.09 113.48 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 17.1 m -50.25 -10.02 0.05 Allowed 'General case' 0 C--N 1.395 2.58 0 C-N-CA 124.753 1.221 . . . . 0.0 112.641 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.46 -12.02 14.04 Favored 'General case' 1 C--N 1.444 4.699 0 CA-C-N 118.379 0.536 . . . . 10.23 111.503 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.36 10.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.821 -0.627 . . . . 10.4 111.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.6 147.11 93.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.72 2.28 . . . . 12.19 112.65 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 89.7 mt -102.56 146.27 28.39 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.959 -0.564 . . . . 10.66 111.241 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.01 -22.53 14.73 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.273 -0.64 . . . . 11.41 109.273 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -157.32 129.25 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.483 -2.011 . . . . 0.0 108.836 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -146.21 134.72 22.04 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.654 0.382 . . . . 8.77 111.98 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -144.86 124.11 12.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.866 0.365 . . . . 8.38 111.566 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -100.99 118.17 36.47 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.584 -1.265 . . . . 8.94 107.584 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.18 122.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.515 0.931 . . . . 9.37 113.515 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -119.13 148.14 43.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.262 -0.881 . . . . 11.34 109.413 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.9 t70 -58.92 141.12 54.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.921 0.391 . . . . 13.83 110.914 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 50.0 m -49.71 -61.72 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.863 -0.608 . . . . 14.58 112.6 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.08 -64.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.471 0.545 . . . . 16.19 112.471 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.48 -59.32 1.91 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.306 -0.407 . . . . 14.94 111.214 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.04 62.54 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.613 -0.804 . . . . 13.57 114.528 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.35 167.6 13.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.334 0.567 . . . . 13.28 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.0 t -59.19 142.07 52.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 10.43 111.624 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.95 -9.43 53.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.793 -0.64 . . . . 11.2 109.569 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.31 39.53 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.67 -0.695 . . . . 8.63 113.942 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -143.01 146.41 33.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.979 0.889 . . . . 9.19 112.845 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.61 155.16 46.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.078 -0.965 . . . . 6.21 112.169 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.25 146.81 36.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.077 -0.965 . . . . 7.09 110.394 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.597 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.4 p -157.89 156.21 30.95 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 119.983 -0.687 . . . . 6.77 111.871 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -145.3 127.09 15.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 9.59 109.608 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.531 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 52.9 m-85 -82.46 164.85 20.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.932 0.396 . . . . 9.91 112.045 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.55 -46.1 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 108.4 -0.963 . . . . 12.81 108.4 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.34 102.37 14.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.361 -1.348 . . . . 13.18 107.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.02 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 115.291 1.589 . . . . 12.23 115.291 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -56.78 -38.86 73.08 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.294 1.045 . . . . 13.04 109.014 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.52 -22.92 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 112.402 -2.181 . . . . 11.08 109.519 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.53 -48.24 72.2 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.896 -0.779 . . . . 9.11 108.896 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.5 -42.71 99.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.187 -0.605 . . . . 10.31 110.513 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.82 -32.43 73.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 119.939 -0.704 . . . . 11.98 111.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.78 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.67 -1.605 . . . . 8.25 113.027 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.6 -51.23 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.393 0.616 . . . . 7.4 110.833 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.69 -39.0 67.68 Favored 'General case' 0 C--N 1.42 3.649 0 C-N-CA 126.301 1.84 . . . . 0.0 113.171 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.9 -24.09 36.39 Favored Glycine 1 C--N 1.399 4.08 0 N-CA-C 116.817 1.487 . . . . 8.35 116.817 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 278' ' ' LEU . 78.9 mt -96.89 -45.86 6.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 120.189 1.994 . . . . 7.2 113.892 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -50.4 129.99 22.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.812 0.339 . . . . 7.86 111.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.19 -16.69 56.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.11 -0.567 . . . . 8.64 113.905 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.57 147.21 4.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.868 0.334 . . . . 8.0 111.337 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -95.2 115.67 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.053 0.454 . . . . 10.39 111.681 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.595 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -120.19 106.75 12.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.15 -118.75 10.62 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -115.8 22.4 13.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.243 0.544 . . . . 12.25 109.786 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.9 154.0 40.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.642 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.8 118.2 36.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.086 -1.079 . . . . 10.14 108.086 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.595 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.2 tp -63.0 143.06 58.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.485 0.659 . . . . 7.52 112.687 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.13 127.94 43.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.555 -1.202 . . . . 7.48 108.971 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.4 t -137.91 123.98 26.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 O-C-N 121.044 -1.035 . . . . 6.45 109.966 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -152.69 155.29 36.96 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.117 -1.614 . . . . 7.66 109.587 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.51 ' HA ' HD23 ' A' ' 261' ' ' LEU . 92.2 mtt180 -58.56 122.45 13.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 118.544 -1.263 . . . . 8.94 107.603 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.97 -11.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.808 1.41 . . . . 7.52 114.808 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.5 m -119.37 -77.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.629 -0.428 . . . . 9.07 111.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.523 0.677 . . . . 0.0 110.744 179.023 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.734 ' HB3' HG21 ' A' ' 208' ' ' THR . 5.7 mmt-85 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -159.85 149.34 18.05 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 123.259 0.623 . . . . 5.88 111.628 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.71 143.65 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 5.25 111.281 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.62 125.15 40.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.853 -0.795 . . . . 6.58 108.853 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 5.06 110.33 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.66 -179.07 35.07 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.86 -0.609 . . . . 6.2 112.823 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 49.79 41.73 22.76 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 125.214 1.406 . . . . 0.0 110.268 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.85 149.75 88.01 Favored Pre-proline 0 C--N 1.426 3.935 0 C-N-CA 123.684 0.794 . . . . 7.79 111.312 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 144.41 89.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.283 1.989 . . . . 8.57 111.032 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.93 139.66 52.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 11.37 111.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.27 6.5 61.46 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.799 -0.637 . . . . 9.94 114.259 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.05 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.363 0.581 . . . . 8.91 110.271 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.99 153.89 22.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 9.64 110.6 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.1 -43.16 95.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 7.44 110.257 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.68 -46.03 91.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.963 -0.562 . . . . 9.89 110.616 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -26.71 68.58 Favored 'General case' 0 C--N 1.409 3.159 0 O-C-N 119.264 -2.148 . . . . 0.0 111.661 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.42 -34.06 67.58 Favored 'General case' 0 C--N 1.428 3.979 0 O-C-N 123.967 0.792 . . . . 6.64 111.737 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.34 7.73 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.481 0.713 . . . . 6.69 111.115 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.55 -33.72 60.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.367 -0.833 . . . . 8.8 111.387 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.78 -53.57 17.67 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 120.543 -0.463 . . . . 7.44 111.576 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.3 -48.34 81.84 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.145 0.424 . . . . 5.94 112.145 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.78 -42.6 79.72 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.258 -0.577 . . . . 7.12 109.608 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.29 64.72 Favored 'General case' 0 C--N 1.405 3.004 0 O-C-N 120.388 -1.445 . . . . 0.0 111.21 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -79.5 -37.67 36.17 Favored 'General case' 1 C--N 1.428 4.019 0 CA-C-N 118.455 0.57 . . . . 7.79 110.298 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.8 83.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 7.73 111.009 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.15 -42.95 45.03 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.387 0.514 . . . . 9.61 112.387 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.0 -37.75 88.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.259 0.552 . . . . 10.06 110.492 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.02 -16.56 74.46 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.273 -0.965 . . . . 9.23 112.886 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.26 37.01 71.22 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 110.873 -0.891 . . . . 9.25 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.97 5.35 51.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.92 0.711 . . . . 8.31 112.92 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.9 p -82.61 143.48 30.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.586 0.232 . . . . 9.16 110.593 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.61 -18.45 21.37 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.176 0.435 . . . . 10.23 112.176 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.8 163.46 23.78 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.632 -0.258 . . . . 9.89 110.694 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.35 143.54 99.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.965 1.777 . . . . 11.04 110.793 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.58 20.58 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.677 -0.773 . . . . 9.31 112.505 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.033 0.383 . . . . 7.97 112.033 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.558 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.25 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.454 2.103 . . . . 6.59 111.32 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.67 105.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.132 -0.485 . . . . 5.87 111.134 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -36.33 37.92 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 125.37 1.468 . . . . 0.0 112.954 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.13 164.36 38.62 Favored 'General case' 0 C--N 1.386 2.173 0 C-N-CA 125.826 1.651 . . . . 0.0 110.959 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.9 130.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 125.999 1.72 . . . . 5.67 109.337 175.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.93 126.64 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.765 -0.458 . . . . 6.47 109.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 126.0 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 116.941 2.2 . . . . 7.1 116.941 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.12 91.37 5.24 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.149 -2.908 . . . . 8.1 103.149 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.21 -57.43 7.8 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.662 1.727 . . . . 10.19 115.662 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.24 -48.69 75.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.877 0.695 . . . . 10.51 112.877 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.97 -9.22 51.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.716 0.293 . . . . 9.72 111.77 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 36.11 15.0 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.53 1.307 . . . . 8.04 114.53 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.56 168.63 19.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.093 -1.043 . . . . 6.83 111.612 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.56 161.12 41.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.18 -1.373 . . . . 5.19 110.486 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.38 129.31 51.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.73 -0.841 . . . . 5.71 108.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.81 137.5 33.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.44 -0.345 . . . . 4.27 110.364 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.71 114.73 26.02 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.718 -0.475 . . . . 6.21 109.718 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.73 164.66 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 6.14 111.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.56 -25.98 22.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.515 -0.766 . . . . 8.37 111.392 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.0 p -128.95 159.57 35.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.094 0.473 . . . . 7.92 111.521 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.28 -41.74 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 8.77 112.266 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.63 -41.79 95.92 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.396 0.517 . . . . 9.08 112.396 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.28 -0.267 . . . . 7.46 110.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.9 m -54.17 -53.97 46.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 6.18 108.123 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.6 m -55.07 -27.3 43.78 Favored 'General case' 1 C--N 1.43 4.066 0 C-N-CA 126.953 2.101 . . . . 0.0 109.863 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.14 -34.0 43.69 Favored 'General case' 0 C--N 1.422 3.743 0 N-CA-C 113.657 0.984 . . . . 8.7 113.657 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.33 64.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.651 0.611 . . . . 5.94 112.651 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.09 -19.85 63.41 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.493 1.12 . . . . 6.89 111.614 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.35 53.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 7.4 111.613 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.22 14.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.585 -0.279 . . . . 6.97 111.658 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.89 121.02 14.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.827 0.346 . . . . 7.38 110.782 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.83 66.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.855 -0.688 . . . . 7.92 113.587 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.23 142.39 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.87 0.335 . . . . 7.5 111.153 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.245 0.545 . . . . 9.49 111.278 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.23 107.69 7.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 8.45 110.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.74 42.7 13.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 10.44 111.747 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.44 54.03 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 115.219 0.847 . . . . 10.21 115.219 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.69 130.89 55.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.574 0.687 . . . . 9.94 112.358 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.48 10.86 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.587 -0.894 . . . . 8.4 108.587 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.83 58.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.088 . . . . 6.9 113.939 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.428 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.51 110.24 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.602 -1.259 . . . . 8.29 107.602 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.02 126.96 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.265 0.555 . . . . 6.17 112.289 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.428 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.49 15.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.332 -0.849 . . . . 7.99 110.041 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.04 154.71 49.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.614 -0.884 . . . . 7.86 108.614 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.52 175.12 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.929 1.753 . . . . 7.79 112.007 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 79.9 m80 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.953 0.406 . . . . 10.8 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.0 139.4 58.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 8.21 110.33 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 334' ' ' ARG . 67.4 mt -109.8 143.96 38.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.944 -1.026 . . . . 6.33 112.788 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -104.38 132.06 51.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.219 -1.4 . . . . 6.75 107.219 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.99 121.26 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 109.59 -0.522 . . . . 5.68 109.59 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.27 16.47 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.436 -0.888 . . . . 6.53 112.648 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.607 -0.806 . . . . 7.67 111.573 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 90.8 mt -70.78 135.25 85.72 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.835 -0.182 . . . . 8.16 111.477 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.4 Cg_exo -61.84 141.47 90.13 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.955 1.77 . . . . 8.96 108.795 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.34 -14.86 61.77 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.803 1.408 . . . . 11.61 114.803 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -84.14 -23.19 30.77 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.816 1.413 . . . . 11.06 114.816 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.33 149.13 50.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.17 0.441 . . . . 9.36 111.368 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 18.9 p-10 -114.39 -176.41 2.89 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.284 -0.265 . . . . 10.46 110.284 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -53.59 -55.46 25.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.629 1.344 . . . . 9.92 114.629 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -25.94 67.79 Favored 'General case' 0 C--N 1.406 3.026 0 C-N-CA 125.596 1.558 . . . . 0.0 112.478 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.18 -48.3 13.36 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.363 0.529 . . . . 10.06 111.378 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 78.5 t -62.66 -49.19 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 7.76 110.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -54.25 -36.41 63.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.312 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.13 -53.27 57.83 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.096 0.474 . . . . 10.2 110.699 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.403 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.73 -33.23 33.77 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.146 -0.479 . . . . 7.62 110.318 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.479 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.7 mt -82.54 -41.8 19.16 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.572 0.582 . . . . 7.74 112.572 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.2 m -56.75 -29.67 62.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.65 0.981 . . . . 10.09 113.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.2 m -50.42 -10.15 0.06 Allowed 'General case' 0 C--N 1.397 2.652 0 C-N-CA 124.846 1.258 . . . . 0.0 112.558 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -111.52 -12.03 14.01 Favored 'General case' 1 C--N 1.444 4.678 0 CA-C-N 118.335 0.516 . . . . 10.23 111.495 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.32 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.826 -0.625 . . . . 10.4 111.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.63 147.07 93.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.276 . . . . 12.19 112.716 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 83.0 mt -102.42 146.32 28.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.899 -0.591 . . . . 10.66 111.244 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 18.9 ptpt -101.05 -22.57 14.7 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.274 -0.639 . . . . 11.41 109.274 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.38 126.43 5.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.142 -2.224 . . . . 0.0 109.088 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 52.5 t80 -143.76 134.79 25.51 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 122.774 0.43 . . . . 8.77 112.006 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.77 124.01 12.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.513 -0.312 . . . . 8.38 111.595 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 61.0 tp -101.01 118.3 36.74 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.512 -1.292 . . . . 8.94 107.512 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.23 122.8 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.509 0.929 . . . . 9.37 113.509 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -119.13 148.06 43.48 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.31 -0.859 . . . . 11.34 109.353 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 38.7 t70 -58.81 141.13 53.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.922 0.391 . . . . 13.83 110.979 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.8 m -49.72 -61.71 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.816 -0.629 . . . . 14.58 112.649 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.04 -64.01 1.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.512 0.56 . . . . 16.19 112.512 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 12.8 m -42.55 -59.23 1.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.293 -0.412 . . . . 14.94 111.241 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.14 62.59 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.53 -0.843 . . . . 13.57 114.492 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.3 167.6 13.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.435 0.618 . . . . 13.28 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.9 t -59.22 142.07 52.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.526 . . . . 10.43 111.606 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 24.1 mmtp -87.95 -9.38 53.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.783 -0.644 . . . . 11.2 109.581 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.49 -3.43 39.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.674 -0.694 . . . . 8.63 113.929 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -142.98 146.46 33.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.133 0.966 . . . . 9.19 112.812 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.62 155.18 46.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.041 -0.982 . . . . 6.21 112.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -111.38 146.81 36.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.17 -0.923 . . . . 7.09 110.333 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.57 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.5 p -157.8 156.21 31.11 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.972 -0.691 . . . . 6.77 111.903 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -145.23 127.07 15.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.708 . . . . 9.59 109.656 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.489 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 55.4 m-85 -82.36 164.88 20.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.097 0.406 . . . . 9.91 112.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.54 -46.09 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.413 -0.958 . . . . 12.81 108.413 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.692 ' O ' HG22 ' A' ' 312' ' ' VAL . 13.8 t70 -96.35 102.36 14.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.388 -1.338 . . . . 13.18 107.388 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.526 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.74 -34.97 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.305 1.595 . . . . 12.23 115.305 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -56.87 -38.71 73.11 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.238 1.018 . . . . 13.04 109.016 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.75 -22.58 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 112.243 -2.253 . . . . 11.08 109.594 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 88.5 m -54.67 -48.2 72.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.932 -0.766 . . . . 9.11 108.932 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.43 -42.83 99.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.245 -0.582 . . . . 10.31 110.52 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -63.83 -32.41 73.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.9 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.78 74.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.781 -1.554 . . . . 8.25 113.052 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.63 -51.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.373 0.606 . . . . 7.4 110.857 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.8 -38.59 67.49 Favored 'General case' 0 C--N 1.421 3.678 0 C-N-CA 126.289 1.836 . . . . 0.0 113.166 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.03 -24.1 35.96 Favored Glycine 1 C--N 1.398 4.007 0 N-CA-C 116.847 1.499 . . . . 8.35 116.847 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 330' ' ' LEU . 88.1 mt -96.84 -45.77 6.51 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.117 1.958 . . . . 7.2 113.956 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -50.47 130.04 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.883 0.373 . . . . 7.86 111.511 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.24 -16.79 56.56 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.056 -0.592 . . . . 8.64 113.975 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.5 ttt -50.61 147.17 4.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.729 0.299 . . . . 8.0 111.324 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -95.08 115.55 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 10.39 111.751 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.3 mp -120.16 106.74 12.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.127 -1.064 . . . . 8.95 108.127 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.09 -118.64 10.53 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.408 -1.477 . . . . 10.63 109.408 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -115.9 22.51 12.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.169 0.509 . . . . 12.25 109.765 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -123.9 153.91 40.45 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.64 -0.709 . . . . 9.98 111.599 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.69 118.28 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.078 -1.082 . . . . 10.14 108.078 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.66 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.4 tp -63.07 143.17 58.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.519 0.676 . . . . 7.52 112.707 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 90.0 mt -128.14 127.97 43.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.593 -1.185 . . . . 7.48 108.962 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.92 124.04 26.29 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 O-C-N 120.96 -1.088 . . . . 6.45 109.999 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.71 155.34 37.04 Favored 'General case' 0 N--CA 1.432 -1.367 0 O-C-N 119.986 -1.696 . . . . 7.66 109.561 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.508 ' HA ' HD23 ' A' ' 261' ' ' LEU . 83.3 mtt180 -58.61 122.44 13.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 118.453 -1.299 . . . . 8.94 107.612 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.93 -11.76 0.1 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.794 1.405 . . . . 7.52 114.794 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.9 m -119.45 -77.68 0.58 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.532 -0.467 . . . . 9.07 111.156 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 8.2 m . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.33 0.586 . . . . 0.0 111.305 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.958 0.408 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.51 148.5 21.43 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.608 -0.724 . . . . 5.88 111.196 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.577 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.77 143.54 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 5.25 111.218 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.52 125.21 40.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.855 -0.795 . . . . 6.58 108.855 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.83 101.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.134 0.493 . . . . 5.06 110.253 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.72 -178.86 35.03 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.921 -0.581 . . . . 6.2 112.765 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.5 m120 51.17 39.97 24.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.993 1.317 . . . . 0.0 110.195 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.58 149.76 88.64 Favored Pre-proline 1 C--N 1.43 4.103 0 C-N-CA 123.525 0.73 . . . . 7.79 111.366 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.99 144.45 89.49 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.325 2.017 . . . . 8.57 110.924 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -69.99 139.72 52.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.991 0.424 . . . . 11.37 111.916 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.22 6.49 61.26 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.755 -0.657 . . . . 9.94 114.277 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 117.395 0.597 . . . . 8.91 110.281 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.82 153.88 22.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.636 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.27 95.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.203 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.55 -46.07 91.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.568 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.73 -26.22 68.58 Favored 'General case' 0 C--N 1.41 3.22 0 O-C-N 119.25 -2.156 . . . . 0.0 111.658 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.492 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.39 -34.16 67.7 Favored 'General case' 1 C--N 1.429 4.046 0 O-C-N 123.949 0.781 . . . . 6.64 111.758 171.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.47 -54.4 7.64 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.412 0.685 . . . . 6.69 111.079 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.46 -33.76 60.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.397 -0.819 . . . . 8.8 111.403 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.76 -53.66 17.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.543 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.492 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.22 -48.23 82.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 5.94 112.255 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.75 -42.85 80.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.351 -0.54 . . . . 7.12 109.579 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.1 -23.31 64.9 Favored 'General case' 0 C--N 1.407 3.09 0 O-C-N 120.279 -1.513 . . . . 0.0 111.276 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.4 -37.7 36.58 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.468 0.576 . . . . 7.79 110.325 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.76 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.512 -0.767 . . . . 7.73 111.062 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.6 mtt-85 -75.93 -43.36 45.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.377 0.51 . . . . 9.61 112.377 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.73 -37.86 88.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.177 0.513 . . . . 10.06 110.47 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.9 -16.56 74.71 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.307 -0.949 . . . . 9.23 112.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.29 36.95 70.83 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.809 -0.917 . . . . 9.25 110.809 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.84 5.25 51.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.888 0.699 . . . . 8.31 112.888 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.549 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.59 143.46 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.588 0.233 . . . . 9.16 110.573 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.6 -18.52 21.3 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.138 0.421 . . . . 10.23 112.138 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.56 23.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.722 -0.217 . . . . 9.89 110.735 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.41 143.54 99.68 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.947 1.765 . . . . 11.04 110.798 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.54 20.57 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 120.558 -0.83 . . . . 9.31 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.36 73.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 7.97 112.051 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.549 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.23 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.543 2.162 . . . . 6.59 111.308 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.68 105.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.117 -0.492 . . . . 5.87 111.161 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 71.39 0.74 Allowed 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 124.636 1.175 . . . . 0.0 109.31 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.13 151.1 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 129.44 3.096 . . . . 0.0 112.946 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.41 130.55 8.39 Favored 'Isoleucine or valine' 0 C--N 1.374 1.64 0 C-N-CA 129.288 3.035 . . . . 5.67 109.31 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.19 126.55 55.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.772 -0.455 . . . . 6.47 109.772 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.599 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.9 125.97 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 116.983 2.216 . . . . 7.1 116.983 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.42 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 103.157 -2.905 . . . . 8.1 103.157 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.28 -57.38 7.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.678 1.733 . . . . 10.19 115.678 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.82 75.48 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.852 0.686 . . . . 10.51 112.852 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.16 50.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 9.72 111.847 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.18 36.05 15.22 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.548 1.314 . . . . 8.04 114.548 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.44 168.67 19.27 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.081 -1.047 . . . . 6.83 111.629 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.599 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.6 161.06 41.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.022 -1.445 . . . . 5.19 110.483 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.37 129.41 51.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.662 -0.866 . . . . 5.71 108.662 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.361 -0.382 . . . . 4.27 110.288 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.68 25.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.482 . . . . 6.21 109.697 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -99.73 164.69 11.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.016 -0.538 . . . . 6.14 111.981 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.88 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.432 -0.804 . . . . 8.37 111.46 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.8 p -128.91 159.61 35.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.114 0.483 . . . . 7.92 111.612 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.74 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 8.77 112.257 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.71 -41.76 95.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.424 0.527 . . . . 9.08 112.424 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.86 98.0 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.268 -0.271 . . . . 7.46 110.268 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.577 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.6 m -54.15 -54.0 45.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.125 -1.065 . . . . 6.18 108.125 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.7 m -55.31 -26.93 43.58 Favored 'General case' 1 C--N 1.43 4.081 0 C-N-CA 126.977 2.111 . . . . 0.0 109.878 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.15 -34.14 43.49 Favored 'General case' 0 C--N 1.421 3.683 0 N-CA-C 113.642 0.979 . . . . 8.7 113.642 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.52 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.88 63.42 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.309 1.006 . . . . 6.89 111.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.31 53.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.416 -0.357 . . . . 7.4 111.647 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.19 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 6.97 111.666 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.89 121.04 14.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 7.38 110.751 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.71 -4.75 66.38 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 7.92 113.615 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.855 0.327 . . . . 7.5 111.094 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.96 121.61 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.311 0.577 . . . . 9.49 111.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.76 7.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.45 110.287 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.75 42.67 13.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.035 -0.53 . . . . 10.44 111.724 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.03 -5.47 53.88 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 115.247 0.859 . . . . 10.21 115.247 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.59 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.615 0.708 . . . . 9.94 112.417 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.88 101.49 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.542 -0.91 . . . . 8.4 108.542 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.3 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.036 1.124 . . . . 6.9 114.036 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.436 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.55 110.26 21.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.57 -1.27 . . . . 8.29 107.57 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.98 126.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.405 0.52 . . . . 6.17 112.405 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.52 170.5 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.48 -0.782 . . . . 7.99 110.093 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.65 49.52 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.515 -0.92 . . . . 7.86 108.515 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.43 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.953 1.769 . . . . 7.79 112.012 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 120.931 0.396 . . . . 10.8 110.862 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.94 139.33 58.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 8.21 110.365 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 334' ' ' ARG . 62.5 mt -109.79 144.07 38.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.076 -0.966 . . . . 6.33 112.826 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -104.47 132.02 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.228 -1.397 . . . . 6.75 107.228 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.95 121.2 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.608 -0.516 . . . . 5.68 109.608 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.19 16.52 Favored Glycine 0 CA--C 1.508 -0.389 0 C-N-CA 120.446 -0.883 . . . . 6.53 112.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.89 9.17 86.73 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.566 -0.826 . . . . 7.67 111.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.85 135.3 85.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 111.427 0.158 . . . . 8.16 111.427 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.85 141.48 90.14 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.962 1.775 . . . . 8.96 108.833 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -65.39 -14.83 61.76 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.788 1.403 . . . . 11.61 114.788 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -84.18 -23.13 30.71 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.788 1.403 . . . . 11.06 114.788 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.33 149.18 50.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.112 0.415 . . . . 9.36 111.344 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 31.0 p-10 -114.43 -176.44 2.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.608 -0.269 . . . . 10.46 110.279 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.55 -55.11 28.36 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.624 1.342 . . . . 9.92 114.624 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.94 -27.74 68.45 Favored 'General case' 0 C--N 1.406 3.052 0 C-N-CA 125.873 1.669 . . . . 0.0 112.332 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -79.64 -48.28 14.0 Favored 'General case' 1 C--N 1.429 4.065 0 O-C-N 123.486 0.491 . . . . 10.06 111.388 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.1 t -62.72 -49.17 84.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 7.76 110.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -54.24 -36.49 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 9.67 111.27 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.92 -53.39 56.44 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.156 0.503 . . . . 10.2 110.728 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.8 OUTLIER -51.8 -33.14 34.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.064 -0.516 . . . . 7.62 110.374 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.5 mt -82.62 -41.67 19.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.566 0.58 . . . . 7.74 112.566 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.0 m -56.87 -29.65 63.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.6 0.963 . . . . 10.09 113.6 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.5 m -50.36 -10.33 0.06 Allowed 'General case' 0 C--N 1.395 2.552 0 C-N-CA 124.809 1.244 . . . . 0.0 112.544 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -111.42 -11.94 14.07 Favored 'General case' 1 C--N 1.442 4.618 0 CA-C-N 118.281 0.491 . . . . 10.23 111.521 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.08 162.24 10.2 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.78 -0.646 . . . . 10.4 111.932 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.56 147.05 93.38 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.694 2.263 . . . . 12.19 112.736 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.7 mt -102.44 146.3 28.29 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.862 -0.608 . . . . 10.66 111.25 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 15.4 ptpt -101.14 -21.51 14.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.2 -0.667 . . . . 11.41 109.2 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -159.94 128.56 4.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.213 -2.179 . . . . 0.0 108.798 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.583 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.2 t80 -145.07 134.69 23.34 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.084 0.553 . . . . 8.77 112.005 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -144.8 124.09 13.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.809 0.338 . . . . 8.38 111.536 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 59.5 tp -100.99 118.23 36.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.578 -1.267 . . . . 8.94 107.578 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.17 122.91 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 9.37 113.457 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -119.15 148.15 43.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.297 -0.865 . . . . 11.34 109.371 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 34.1 t70 -58.96 141.17 54.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.893 0.378 . . . . 13.83 110.943 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.1 m -49.73 -61.69 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.653 0.612 . . . . 14.58 112.653 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.11 -63.97 1.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.468 0.544 . . . . 16.19 112.468 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.1 m -42.51 -59.32 1.92 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.265 -0.425 . . . . 14.94 111.228 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.03 62.5 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 120.617 -0.801 . . . . 13.57 114.503 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 79.9 mt -88.38 167.63 13.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.339 0.57 . . . . 13.28 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -59.32 142.22 52.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.529 . . . . 10.43 111.684 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 300' ' ' LYS . 3.8 mmmp? -87.89 -9.51 53.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 11.2 109.561 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.62 -3.34 39.42 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.625 -0.716 . . . . 8.63 113.89 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -143.06 146.35 33.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.055 0.927 . . . . 9.19 112.814 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.21 46.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.085 -0.961 . . . . 6.21 112.206 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.39 146.84 36.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.996 -1.002 . . . . 7.09 110.395 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.583 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 20.4 p -157.84 156.22 31.06 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 119.929 -0.708 . . . . 6.77 111.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -145.37 127.05 15.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.613 -0.722 . . . . 9.59 109.628 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.56 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 51.2 m-85 -82.38 164.91 20.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.98 0.419 . . . . 9.91 112.071 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.6 -46.05 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.463 -0.94 . . . . 12.81 108.463 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.32 102.36 14.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.41 -1.33 . . . . 13.18 107.41 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.76 -34.96 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 N-CA-C 115.244 1.572 . . . . 12.23 115.244 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -56.77 -38.83 73.03 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 122.305 1.05 . . . . 13.04 109.048 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 309' ' ' ASP . 1.9 m -62.65 -22.81 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 112.283 -2.235 . . . . 11.08 109.518 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.5 m -54.52 -48.2 72.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.918 -0.771 . . . . 9.11 108.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.49 -42.8 99.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.239 -0.584 . . . . 10.31 110.521 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.89 -0.724 . . . . 11.98 111.974 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.73 74.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.647 -1.615 . . . . 8.25 113.076 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.61 -51.29 47.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 7.4 110.864 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.39 67.71 Favored 'General case' 0 C--N 1.421 3.679 0 C-N-CA 126.211 1.805 . . . . 0.0 113.296 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.18 -24.0 35.85 Favored Glycine 1 C--N 1.4 4.125 0 N-CA-C 116.779 1.472 . . . . 8.35 116.779 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 330' ' ' LEU . 98.1 mt -96.93 -45.69 6.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.193 1.997 . . . . 7.2 113.957 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -50.52 130.03 23.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.844 0.354 . . . . 7.86 111.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.22 -16.81 56.48 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.151 -0.547 . . . . 8.64 113.977 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 19.0 mtt -50.53 147.15 4.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.723 0.297 . . . . 8.0 111.363 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -95.0 115.6 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.018 0.437 . . . . 10.39 111.759 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.8 mp -120.25 106.72 12.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.094 -1.076 . . . . 8.95 108.094 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.11 -118.75 10.65 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.347 -1.501 . . . . 10.63 109.347 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -115.8 22.45 13.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 12.25 109.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.83 153.95 40.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.682 -0.69 . . . . 9.98 111.685 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.74 118.26 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.139 -1.06 . . . . 10.14 108.139 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.7 tp -63.11 143.08 58.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.547 0.689 . . . . 7.52 112.601 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.08 128.0 44.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.563 -1.199 . . . . 7.48 109.032 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.98 124.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 O-C-N 120.99 -1.069 . . . . 6.45 109.945 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -152.79 155.33 36.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 120.126 -1.609 . . . . 7.66 109.514 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.516 ' HA ' HD23 ' A' ' 261' ' ' LEU . 69.7 mtt85 -58.68 122.57 13.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 118.418 -1.313 . . . . 8.94 107.617 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.98 -11.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.756 1.391 . . . . 7.52 114.756 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.4 m -119.46 -78.18 0.58 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.641 -0.424 . . . . 9.07 111.21 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.467 -179.681 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 120.843 0.354 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -155.83 148.44 23.96 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.072 0.949 . . . . 5.88 111.087 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.568 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.75 143.54 35.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 5.25 111.171 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.62 125.18 40.91 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.891 -0.781 . . . . 6.58 108.891 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.27 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.077 0.465 . . . . 5.06 110.166 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.74 -178.57 35.06 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.895 -0.593 . . . . 6.2 112.766 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.16 40.81 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.031 1.333 . . . . 0.0 110.151 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.79 149.85 88.2 Favored Pre-proline 1 C--N 1.429 4.062 0 C-N-CA 123.478 0.711 . . . . 7.79 111.33 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.01 144.43 89.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.251 1.967 . . . . 8.57 111.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -69.91 139.66 53.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.429 . . . . 11.37 111.954 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.05 6.76 61.16 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.298 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 117.314 0.557 . . . . 8.91 110.245 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.79 153.88 22.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 9.64 110.692 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.25 95.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 7.44 110.174 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.6 -46.12 91.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.064 -0.517 . . . . 9.89 110.548 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.59 68.52 Favored 'General case' 0 C--N 1.409 3.179 0 O-C-N 119.261 -2.149 . . . . 0.0 111.675 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.483 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.4 -34.11 67.65 Favored 'General case' 0 C--N 1.427 3.975 0 O-C-N 123.889 0.743 . . . . 6.64 111.727 172.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.61 -54.3 7.72 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.51 0.724 . . . . 6.69 111.052 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.52 -33.73 60.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.43 -0.804 . . . . 8.8 111.381 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.52 17.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 120.43 -0.508 . . . . 7.44 111.617 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.114 0.413 . . . . 5.94 112.114 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.0 m-20 -56.83 -43.0 80.63 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.547 -0.538 . . . . 7.12 109.547 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -23.53 65.18 Favored 'General case' 0 C--N 1.406 3.026 0 O-C-N 120.192 -1.567 . . . . 0.0 111.231 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -79.35 -37.67 36.91 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.546 0.612 . . . . 7.79 110.31 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.81 83.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.498 -0.774 . . . . 7.73 111.033 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.4 mtt-85 -76.1 -43.03 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.37 0.507 . . . . 9.61 112.37 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.99 -37.76 88.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.193 0.52 . . . . 10.06 110.388 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.11 -16.39 74.64 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.239 -0.981 . . . . 9.23 112.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.98 71.59 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.888 -0.885 . . . . 9.25 110.888 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.3 51.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.941 0.719 . . . . 8.31 112.941 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.64 143.44 30.98 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.129 -0.228 . . . . 9.16 110.665 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.57 -18.51 21.34 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.45 23.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.691 -0.231 . . . . 9.89 110.722 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.32 143.45 99.73 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.997 1.798 . . . . 11.04 110.771 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.37 161.62 20.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.642 -0.789 . . . . 9.31 112.465 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.8 m-20 -75.33 134.49 73.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 7.97 112.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.33 -50.97 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.519 2.146 . . . . 6.59 111.315 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.32 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.111 -0.495 . . . . 5.87 111.146 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -37.59 40.47 Favored 'General case' 0 N--CA 1.533 3.68 0 C-N-CA 125.508 1.523 . . . . 0.0 112.848 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.38 164.48 38.09 Favored 'General case' 0 C--N 1.387 2.224 0 C-N-CA 125.938 1.695 . . . . 0.0 110.891 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.08 130.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.372 1.573 0 C-N-CA 126.291 1.836 . . . . 5.67 109.329 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.12 126.65 55.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.475 . . . . 6.47 109.716 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.91 125.92 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 116.937 2.199 . . . . 7.1 116.937 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.34 5.24 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 103.182 -2.896 . . . . 8.1 103.182 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.26 -57.34 8.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.676 1.732 . . . . 10.19 115.676 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.15 -48.87 75.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.831 0.678 . . . . 10.51 112.831 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.96 -9.12 50.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.768 0.285 . . . . 9.72 111.768 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.07 36.17 15.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.547 1.314 . . . . 8.04 114.547 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -143.5 168.73 19.16 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.118 -1.033 . . . . 6.83 111.661 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.6 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.63 161.03 41.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.031 -1.44 . . . . 5.19 110.518 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.4 129.41 51.24 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.676 -0.861 . . . . 5.71 108.676 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.75 137.58 33.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.361 . . . . 4.27 110.359 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -114.86 114.68 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.703 -0.48 . . . . 6.21 109.703 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.68 164.65 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 6.14 111.951 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.93 22.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.439 -0.8 . . . . 8.37 111.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.2 p -128.92 159.59 35.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.155 0.503 . . . . 7.92 111.607 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.21 -41.82 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.59 -0.732 . . . . 8.77 112.247 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.7 -41.73 95.8 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.339 0.496 . . . . 9.08 112.339 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.88 -43.89 97.93 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.202 -0.295 . . . . 7.46 110.202 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.568 HG23 ' HG ' ' A' ' 151' ' ' LEU . 56.0 m -54.17 -53.88 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.159 -1.052 . . . . 6.18 108.159 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.1 m -55.1 -27.2 43.33 Favored 'General case' 1 C--N 1.429 4.051 0 C-N-CA 127.127 2.171 . . . . 0.0 109.739 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.46 -33.95 41.9 Favored 'General case' 0 C--N 1.423 3.779 0 N-CA-C 113.6 0.963 . . . . 8.7 113.6 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.62 -17.3 64.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 5.94 112.638 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.12 -19.84 63.43 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.377 1.048 . . . . 6.89 111.556 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.3 53.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.456 -0.338 . . . . 7.4 111.656 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.85 16.18 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.466 -0.333 . . . . 6.97 111.651 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.82 120.96 13.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 7.38 110.75 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.83 -4.79 66.09 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.884 -0.674 . . . . 7.92 113.579 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.833 0.316 . . . . 7.5 111.098 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -85.0 121.63 37.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.35 0.595 . . . . 9.49 111.286 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.36 107.67 7.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 8.45 110.357 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.69 42.64 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 10.44 111.767 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.08 -5.45 54.18 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.248 0.859 . . . . 10.21 115.248 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.58 130.94 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.627 0.713 . . . . 9.94 112.375 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.53 10.95 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.506 -0.924 . . . . 8.4 108.506 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.89 58.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.979 1.103 . . . . 6.9 113.979 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.8 tttt -108.59 110.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.477 -1.305 . . . . 8.29 107.477 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.98 126.89 58.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.36 0.504 . . . . 6.17 112.36 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.61 170.46 15.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.388 -0.824 . . . . 7.99 110.019 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.02 154.67 49.74 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.635 -0.876 . . . . 7.86 108.635 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.21 174.82 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.985 1.79 . . . . 7.79 111.982 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.4 t60 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.566 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.908 0.385 . . . . 10.8 110.791 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.91 139.37 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 8.21 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 334' ' ' ARG . 52.2 mt -109.77 143.95 38.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.019 -0.991 . . . . 6.33 112.849 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -104.39 132.05 51.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.138 -1.43 . . . . 6.75 107.138 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.03 121.25 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.601 -0.518 . . . . 5.68 109.601 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.2 16.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.444 -0.884 . . . . 6.53 112.71 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.19 86.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.668 -0.777 . . . . 7.67 111.532 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.3 mt -70.89 135.32 85.47 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 111.465 0.172 . . . . 8.16 111.465 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.0 Cg_exo -61.79 141.54 90.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.95 1.767 . . . . 8.96 108.792 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.39 -14.87 61.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.759 1.392 . . . . 11.61 114.759 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -84.15 -23.18 30.74 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.758 1.392 . . . . 11.06 114.758 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.26 149.18 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.165 0.439 . . . . 9.36 111.388 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 37.7 p-10 -114.59 -176.4 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.207 -0.294 . . . . 10.46 110.207 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.56 -55.3 26.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.617 1.34 . . . . 9.92 114.617 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -27.05 68.21 Favored 'General case' 0 C--N 1.407 3.084 0 C-N-CA 125.565 1.546 . . . . 0.0 112.392 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.59 -48.3 14.02 Favored 'General case' 1 C--N 1.429 4.024 0 CA-C-N 118.263 0.483 . . . . 10.06 111.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 66.2 t -62.65 -49.26 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 7.76 110.285 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.25 -36.41 63.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.279 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.12 -53.35 56.63 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.052 0.453 . . . . 10.2 110.642 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.8 -33.17 34.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.889 0.476 . . . . 7.62 110.283 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.517 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.2 mt -82.6 -41.7 19.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.552 0.575 . . . . 7.74 112.552 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.6 m -56.82 -30.69 63.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.589 0.959 . . . . 10.09 113.589 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.6 m -52.4 -7.73 0.07 Allowed 'General case' 0 C--N 1.397 2.65 0 O-C-N 120.602 -1.311 . . . . 0.0 112.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -110.31 -12.05 14.48 Favored 'General case' 1 C--N 1.443 4.67 0 CA-C-N 118.413 0.552 . . . . 10.23 111.492 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.09 162.28 10.22 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.775 -0.648 . . . . 10.4 111.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.54 146.98 93.6 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.776 2.317 . . . . 12.19 112.746 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 73.0 mt -102.43 146.27 28.32 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.935 -0.575 . . . . 10.66 111.348 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.98 -22.73 14.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.256 -0.646 . . . . 11.41 109.256 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.15 5.08 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.155 -2.216 . . . . 0.0 109.159 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.631 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -143.39 134.68 25.94 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.785 0.434 . . . . 8.77 111.98 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.75 124.05 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.547 -0.297 . . . . 8.38 111.58 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 53.0 tp -101.06 118.21 36.55 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.413 HG12 ' HG3' ' A' ' 300' ' ' LYS . 41.2 t -74.11 122.87 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.469 0.915 . . . . 9.37 113.469 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.07 148.1 43.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.359 -0.837 . . . . 11.34 109.345 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.3 t70 -58.89 141.19 54.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.894 0.378 . . . . 13.83 110.984 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.5 m -49.82 -61.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.842 -0.617 . . . . 14.58 112.571 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.09 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.527 0.566 . . . . 16.19 112.527 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.4 m -42.5 -59.25 1.94 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 14.94 111.184 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.61 -6.08 62.66 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.62 -0.8 . . . . 13.57 114.493 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.35 167.64 13.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.415 0.608 . . . . 13.28 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.9 t -59.21 142.07 52.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 10.43 111.58 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.413 ' HG3' HG12 ' A' ' 291' ' ' VAL . 4.1 mmmp? -87.91 -9.43 53.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.762 -0.653 . . . . 11.2 109.627 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.32 39.63 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.68 -0.691 . . . . 8.63 113.892 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.96 146.33 33.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.054 0.927 . . . . 9.19 112.92 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.19 46.71 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.158 -0.928 . . . . 6.21 112.213 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.37 146.77 36.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 7.09 110.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.631 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 23.1 p -157.73 156.18 31.2 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.906 -0.717 . . . . 6.77 111.928 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -145.2 127.07 15.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.722 -0.672 . . . . 9.59 109.716 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 54.8 m-85 -82.47 164.88 20.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.932 0.396 . . . . 9.91 112.025 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.58 -46.12 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.369 -0.975 . . . . 12.81 108.369 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.3 102.37 14.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.385 -1.339 . . . . 13.18 107.385 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.04 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 115.293 1.59 . . . . 12.23 115.293 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -56.85 -38.68 73.02 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 122.263 1.03 . . . . 13.04 109.005 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.75 -22.65 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.322 -2.217 . . . . 11.08 109.578 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.9 m -54.72 -48.07 72.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.966 -0.753 . . . . 9.11 108.966 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.52 -42.67 99.67 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.138 -0.625 . . . . 10.31 110.554 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -63.94 -32.33 73.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.867 -0.733 . . . . 11.98 111.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.78 74.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.791 -1.55 . . . . 8.25 113.021 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.58 -51.36 47.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.384 0.611 . . . . 7.4 110.872 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.7 67.78 Favored 'General case' 0 C--N 1.421 3.712 0 C-N-CA 126.273 1.829 . . . . 0.0 113.086 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.06 -23.97 36.33 Favored Glycine 1 C--N 1.401 4.188 0 N-CA-C 116.807 1.483 . . . . 8.35 116.807 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 330' ' ' LEU . 99.0 mt -96.89 -45.75 6.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.19 1.995 . . . . 7.2 113.984 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -50.47 130.14 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.851 0.358 . . . . 7.86 111.468 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.04 -16.64 56.61 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.134 -0.555 . . . . 8.64 113.983 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 17.2 mtt -50.61 147.19 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.836 0.318 . . . . 8.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -95.09 115.57 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 10.39 111.662 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.6 mm? -120.16 106.72 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.111 -1.07 . . . . 8.95 108.111 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.13 -118.65 10.52 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.406 -1.477 . . . . 10.63 109.406 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -115.94 22.48 12.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.145 0.498 . . . . 12.25 109.741 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 328' ' ' LYS . 34.1 mtpt -123.89 153.91 40.46 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.583 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.76 118.28 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.116 -1.068 . . . . 10.14 108.116 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.629 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.3 tp -63.11 143.22 57.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.537 0.684 . . . . 7.52 112.612 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.5 tp -128.21 128.01 43.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.486 -1.234 . . . . 7.48 108.961 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.02 124.0 25.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 O-C-N 121.038 -1.039 . . . . 6.45 109.955 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.73 155.34 37.02 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.938 -1.726 . . . . 7.66 109.488 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.539 ' HA ' HD23 ' A' ' 261' ' ' LEU . 99.2 mtt180 -58.62 122.51 13.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.422 -1.311 . . . . 8.94 107.59 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.88 -11.82 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 337' ' ' VAL . 17.3 m -119.4 -75.9 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.613 -0.435 . . . . 9.07 111.303 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 336' ' ' SER . 70.0 t . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.415 0.15 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.01 148.53 22.31 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.832 0.708 . . . . 5.88 111.351 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.65 143.54 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 5.25 111.21 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -96.6 125.21 40.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 6.58 108.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.84 101.3 8.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.512 . . . . 5.06 110.199 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.76 34.62 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.983 -0.553 . . . . 6.2 112.734 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 m120 49.21 42.54 21.75 Favored 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.649 1.58 . . . . 0.0 110.391 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.28 149.84 89.35 Favored Pre-proline 0 C--N 1.426 3.929 0 CA-C-N 114.95 -1.023 . . . . 7.79 111.333 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.06 144.5 89.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.341 2.027 . . . . 8.57 110.972 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.95 139.71 52.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 11.37 111.947 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.53 61.03 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.837 -0.619 . . . . 9.94 114.32 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.1 136.47 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.332 0.566 . . . . 8.91 110.303 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.88 153.8 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.694 0.283 . . . . 9.64 110.626 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.09 -43.1 95.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 7.44 110.23 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.75 -45.88 92.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.012 -0.54 . . . . 9.89 110.535 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.83 68.69 Favored 'General case' 0 C--N 1.41 3.217 0 O-C-N 119.408 -2.057 . . . . 0.0 111.606 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.479 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.27 -34.12 67.99 Favored 'General case' 1 C--N 1.429 4.043 0 O-C-N 123.978 0.799 . . . . 6.64 111.875 172.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ttt -74.53 -54.28 7.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.368 0.667 . . . . 6.69 111.055 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.65 -33.69 61.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.434 -0.803 . . . . 8.8 111.378 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.59 17.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.555 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.479 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.3 -48.26 82.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.175 0.435 . . . . 5.94 112.175 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.7 79.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.196 -0.602 . . . . 7.12 109.54 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.96 64.38 Favored 'General case' 0 C--N 1.404 2.965 0 O-C-N 120.213 -1.554 . . . . 0.0 111.246 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.37 -37.69 36.78 Favored 'General case' 0 C--N 1.427 3.977 0 CA-C-N 118.502 0.592 . . . . 7.79 110.291 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.541 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.75 -36.66 82.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.707 . . . . 7.73 111.054 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.15 -42.88 45.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.386 0.514 . . . . 9.61 112.386 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.22 -37.66 88.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.274 0.559 . . . . 10.06 110.399 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.12 -16.44 74.49 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.338 -0.934 . . . . 9.23 112.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.15 37.04 72.19 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.871 -0.892 . . . . 9.25 110.871 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.99 5.42 51.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.828 0.677 . . . . 8.31 112.828 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.66 143.53 30.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.599 0.237 . . . . 9.16 110.534 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.74 -18.4 21.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.105 0.409 . . . . 10.23 112.105 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.79 163.4 24.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.682 -0.235 . . . . 9.89 110.75 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.28 143.45 99.74 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.935 1.757 . . . . 11.04 110.853 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.56 20.53 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.606 -0.807 . . . . 9.31 112.436 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.3 134.46 73.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 7.97 111.982 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.31 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.493 2.129 . . . . 6.59 111.298 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.67 106.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 5.87 111.16 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -32.44 25.58 Favored 'General case' 0 N--CA 1.525 3.283 0 O-C-N 119.686 -1.884 . . . . 0.0 113.856 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.33 163.26 40.23 Favored 'General case' 0 C--N 1.384 2.07 0 C-N-CA 125.754 1.621 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.88 130.56 11.94 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 C-N-CA 126.529 1.931 . . . . 5.67 109.31 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.11 126.57 55.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.776 -0.453 . . . . 6.47 109.776 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 116.893 2.183 . . . . 7.1 116.893 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -97.9 91.35 5.29 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 103.234 -2.876 . . . . 8.1 103.234 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.33 -57.47 7.83 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.566 1.691 . . . . 10.19 115.566 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.11 -48.77 75.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.9 0.704 . . . . 10.51 112.9 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -68.94 -9.18 50.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.855 0.317 . . . . 9.72 111.855 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 35.87 15.13 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.55 1.315 . . . . 8.04 114.55 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -143.38 168.79 18.99 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.116 -1.033 . . . . 6.83 111.612 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.605 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.7 161.14 41.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.23 -1.35 . . . . 5.19 110.355 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.43 51.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.716 -0.846 . . . . 5.71 108.716 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.6 mt -94.97 137.56 33.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.518 -0.31 . . . . 4.27 110.349 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -114.83 114.72 25.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.674 -0.491 . . . . 6.21 109.674 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.68 164.68 11.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.876 -0.602 . . . . 6.14 111.971 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.421 -0.809 . . . . 8.37 111.427 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.3 p -128.96 159.6 35.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.115 0.483 . . . . 7.92 111.666 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.25 -41.8 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.571 -0.74 . . . . 8.77 112.272 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.66 -41.71 95.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.388 0.514 . . . . 9.08 112.388 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.95 97.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.243 -0.281 . . . . 7.46 110.243 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.56 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.4 m -54.13 -53.97 46.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.192 -1.04 . . . . 6.18 108.192 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m -55.22 -27.11 43.83 Favored 'General case' 0 C--N 1.428 4.0 0 C-N-CA 127.001 2.12 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.16 -34.11 43.47 Favored 'General case' 0 C--N 1.42 3.641 0 N-CA-C 113.613 0.968 . . . . 8.7 113.613 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.57 -17.32 64.11 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.654 0.613 . . . . 5.94 112.654 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.05 -19.84 63.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.505 1.128 . . . . 6.89 111.652 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.21 52.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 7.4 111.654 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -93.8 16.25 14.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 6.97 111.625 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.88 120.96 13.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 7.38 110.765 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.87 -4.81 66.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.928 -0.653 . . . . 7.92 113.599 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.845 0.323 . . . . 7.5 111.124 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.265 0.555 . . . . 9.49 111.333 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -135.34 107.74 7.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 8.45 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.74 42.67 13.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 10.44 111.771 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.96 -5.33 54.2 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 115.201 0.84 . . . . 10.21 115.201 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.67 130.9 55.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.651 0.726 . . . . 9.94 112.356 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.67 101.46 10.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.556 -0.905 . . . . 8.4 108.556 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.85 58.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.427 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.58 110.28 21.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.523 -1.288 . . . . 8.29 107.523 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.4 mt -103.95 126.94 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 6.17 112.338 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.427 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.56 15.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.384 -0.826 . . . . 7.99 110.038 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.67 49.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.16 174.78 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.988 1.792 . . . . 7.79 112.033 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.995 0.426 . . . . 10.8 110.745 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -63.01 139.36 58.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.211 0.529 . . . . 8.21 110.306 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 334' ' ' ARG . 69.6 mt -109.74 144.0 38.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.957 -1.019 . . . . 6.33 112.783 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.414 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 51.4 t80 -104.5 132.15 51.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.245 -1.391 . . . . 6.75 107.245 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.22 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.531 -0.544 . . . . 5.68 109.531 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.21 16.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.516 -0.849 . . . . 6.53 112.674 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.8 9.18 86.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.589 -0.815 . . . . 7.67 111.552 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.85 135.27 85.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 111.446 0.165 . . . . 8.16 111.446 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.77 141.54 90.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.832 1.688 . . . . 8.96 108.832 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -65.39 -14.92 61.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -84.1 -23.13 30.89 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.836 1.421 . . . . 11.06 114.836 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.34 149.2 50.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.105 0.411 . . . . 9.36 111.333 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 25.1 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.244 -0.28 . . . . 10.46 110.244 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 4.5 m-20 -53.59 -55.54 24.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.611 1.338 . . . . 9.92 114.611 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.14 -26.83 67.96 Favored 'General case' 0 C--N 1.405 3.008 0 C-N-CA 125.724 1.61 . . . . 0.0 112.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -79.78 -48.35 13.74 Favored 'General case' 1 C--N 1.432 4.185 0 CA-C-N 118.3 0.5 . . . . 10.06 111.387 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 88.9 t -62.69 -49.15 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 7.76 110.315 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 31.8 mtmm -54.35 -36.3 63.67 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.616 -0.72 . . . . 9.67 111.362 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.06 -53.45 55.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.096 0.474 . . . . 10.2 110.644 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.73 -33.02 32.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.092 -0.503 . . . . 7.62 110.447 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.461 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.76 -41.72 18.86 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.497 0.554 . . . . 7.74 112.497 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 55.7 m -56.76 -30.08 63.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.583 0.957 . . . . 10.09 113.583 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.6 m -50.36 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.395 2.563 0 C-N-CA 124.78 1.232 . . . . 0.0 112.671 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -111.67 -12.05 13.93 Favored 'General case' 1 C--N 1.444 4.705 0 CA-C-N 118.388 0.54 . . . . 10.23 111.435 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.17 162.23 10.21 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.874 -0.603 . . . . 10.4 111.951 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 147.01 93.51 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.7 2.267 . . . . 12.19 112.78 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 76.1 mt -102.41 146.23 28.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.95 -0.568 . . . . 10.66 111.254 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.5 ptpt -101.0 -22.72 14.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 11.41 109.302 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.57 125.36 4.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.051 -2.281 . . . . 0.0 109.245 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.53 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 47.1 t80 -142.82 134.76 27.01 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 122.777 0.431 . . . . 8.77 112.014 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -144.8 124.11 13.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.714 0.292 . . . . 8.38 111.481 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.9 tp -101.04 118.24 36.6 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.55 -1.278 . . . . 8.94 107.55 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 49.0 t -74.23 122.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.473 0.916 . . . . 9.37 113.473 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -119.15 148.08 43.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.232 -0.894 . . . . 11.34 109.329 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 25.5 t70 -58.95 141.2 54.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.412 . . . . 13.83 110.894 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 18.7 m -49.78 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.802 -0.635 . . . . 14.58 112.606 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.07 -64.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.536 0.569 . . . . 16.19 112.536 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 3.9 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.254 -0.43 . . . . 14.94 111.21 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.72 -6.16 62.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.592 -0.814 . . . . 13.57 114.545 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.29 167.55 13.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.355 0.578 . . . . 13.28 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.0 t -59.15 142.08 52.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 10.43 111.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.4 mmmp? -87.94 -9.46 53.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.802 -0.636 . . . . 11.2 109.625 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.39 39.54 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.56 -0.746 . . . . 8.63 113.857 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -142.96 146.46 33.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.146 0.973 . . . . 9.19 112.75 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.59 155.13 46.66 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.094 -0.957 . . . . 6.21 112.187 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' PHE . . . . . 0.414 ' CE1' ' HD1' ' A' ' 262' ' ' PHE . 88.9 m-85 -111.42 146.85 36.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.273 -0.876 . . . . 7.09 110.422 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' CYS . . . . . 0.53 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.1 p -157.75 156.26 31.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.994 -0.683 . . . . 6.77 111.903 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -145.41 127.08 15.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.738 -0.664 . . . . 9.59 109.656 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.602 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 54.8 m-85 -82.46 164.9 20.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.081 0.467 . . . . 9.91 112.027 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.55 -46.01 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.436 -0.95 . . . . 12.81 108.436 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 312' ' ' VAL . 19.7 t70 -96.36 102.32 14.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.357 -1.349 . . . . 13.18 107.357 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ILE . . . . . 0.533 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.69 -34.98 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 115.326 1.602 . . . . 12.23 115.326 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -56.82 -38.82 73.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.236 1.017 . . . . 13.04 109.022 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.69 -22.57 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 112.268 -2.242 . . . . 11.08 109.61 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 97.8 m -54.66 -48.24 72.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.869 -0.789 . . . . 9.11 108.869 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.45 -42.82 99.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.3 -0.56 . . . . 10.31 110.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 119.871 -0.732 . . . . 11.98 111.993 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.76 74.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.597 -1.638 . . . . 8.25 113.023 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.65 -51.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.316 0.579 . . . . 7.4 110.859 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.25 67.27 Favored 'General case' 0 C--N 1.419 3.589 0 C-N-CA 126.337 1.855 . . . . 0.0 113.2 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.25 -24.05 35.52 Favored Glycine 1 C--N 1.4 4.132 0 N-CA-C 116.815 1.486 . . . . 8.35 116.815 177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.87 -45.68 6.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 120.097 1.949 . . . . 7.2 113.956 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -50.53 129.97 23.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.808 0.337 . . . . 7.86 111.46 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.56 56.96 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.156 -0.545 . . . . 8.64 113.978 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.3 mtt -50.71 147.18 4.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.846 0.323 . . . . 8.0 111.259 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.06 115.57 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.055 0.455 . . . . 10.39 111.712 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -120.18 106.85 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 66.99 -118.64 10.63 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.373 -1.491 . . . . 10.63 109.373 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -115.84 22.4 13.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 12.25 109.752 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -123.83 153.98 40.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.609 -0.723 . . . . 9.98 111.617 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -101.79 118.27 36.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.083 -1.08 . . . . 10.14 108.083 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.0 143.04 58.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.516 0.674 . . . . 7.52 112.649 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 61.5 tp -128.14 127.94 43.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.597 -1.183 . . . . 7.48 109.014 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.85 124.02 26.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 120.909 -1.119 . . . . 6.45 109.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.8 155.31 36.89 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.961 -1.712 . . . . 7.66 109.557 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.49 ' HA ' HD23 ' A' ' 261' ' ' LEU . 66.4 mtt180 -58.54 122.44 13.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 118.424 -1.31 . . . . 8.94 107.577 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.92 -11.8 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.814 1.413 . . . . 7.52 114.814 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.4 m -119.44 -77.59 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.522 -0.471 . . . . 9.07 111.239 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.873 179.801 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.614 0.245 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.11 46.75 1.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.916 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -157.11 148.58 22.18 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 122.962 0.505 . . . . 5.88 111.293 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.8 143.55 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 5.25 111.188 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.57 125.15 40.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.859 -0.793 . . . . 6.58 108.859 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.22 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.097 0.475 . . . . 5.06 110.24 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.78 -178.22 35.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.002 -0.618 . . . . 6.2 112.763 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.87 40.76 21.43 Favored 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 125.065 1.346 . . . . 0.0 110.201 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.77 149.78 88.21 Favored Pre-proline 1 C--N 1.428 4.015 0 C-N-CA 123.448 0.699 . . . . 7.79 111.327 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.98 144.43 89.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.288 1.992 . . . . 8.57 110.978 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.65 52.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.022 0.439 . . . . 11.37 111.934 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.56 61.18 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.818 -0.628 . . . . 9.94 114.313 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.07 136.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.307 0.553 . . . . 8.91 110.306 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.84 153.92 22.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.697 0.284 . . . . 9.64 110.645 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.13 -43.24 95.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 7.44 110.192 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.7 -45.93 91.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.001 -0.545 . . . . 9.89 110.562 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.3 -2.125 . . . . 0.0 111.724 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.48 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.11 67.84 Favored 'General case' 1 C--N 1.428 4.006 0 O-C-N 123.877 0.736 . . . . 6.64 111.733 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.56 -54.35 7.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.449 0.699 . . . . 6.69 111.074 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -54.48 -33.7 60.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.366 -0.834 . . . . 8.8 111.41 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.79 -53.62 17.42 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.58 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.1 m-85 -61.27 -48.29 82.09 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.97 80.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.265 -0.574 . . . . 7.12 109.586 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.7 -23.58 65.3 Favored 'General case' 0 C--N 1.407 3.097 0 O-C-N 120.254 -1.529 . . . . 0.0 111.298 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -79.48 -37.62 36.4 Favored 'General case' 0 C--N 1.427 3.972 0 O-C-N 123.611 0.569 . . . . 7.79 110.328 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.79 -36.79 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.595 -0.73 . . . . 7.73 111.014 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -75.93 -43.12 46.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.429 0.529 . . . . 9.61 112.429 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.03 -37.71 88.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.189 0.519 . . . . 10.06 110.447 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.15 -16.42 74.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.297 -0.954 . . . . 9.23 112.814 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.02 72.03 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 110.878 -0.889 . . . . 9.25 110.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.89 5.31 51.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.975 0.732 . . . . 8.31 112.975 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.63 143.45 30.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.616 0.246 . . . . 9.16 110.577 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.148 0.425 . . . . 10.23 112.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.4 24.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.646 -0.252 . . . . 9.89 110.714 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.29 143.51 99.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.946 1.764 . . . . 11.04 110.822 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.35 161.6 20.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.663 -0.779 . . . . 9.31 112.43 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 112.117 0.414 . . . . 7.97 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.21 -51.04 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.544 2.163 . . . . 6.59 111.283 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.64 106.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.126 -0.488 . . . . 5.87 111.075 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 -37.15 30.41 Favored 'General case' 0 N--CA 1.536 3.837 0 O-C-N 119.885 -1.76 . . . . 0.0 112.963 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.36 164.38 36.83 Favored 'General case' 0 C--N 1.382 1.983 0 C-N-CA 125.78 1.632 . . . . 0.0 110.736 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 130.45 10.53 Favored 'Isoleucine or valine' 0 C--N 1.37 1.499 0 C-N-CA 126.584 1.954 . . . . 5.67 109.331 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -114.06 126.61 55.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.789 -0.449 . . . . 6.47 109.789 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.92 125.95 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 116.912 2.189 . . . . 7.1 116.912 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.06 91.42 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 103.153 -2.906 . . . . 8.1 103.153 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -57.37 7.99 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 115.73 1.752 . . . . 10.19 115.73 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.21 -48.78 75.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.812 0.671 . . . . 10.51 112.812 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.0 -9.06 50.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.832 0.308 . . . . 9.72 111.832 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.21 15.49 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.528 1.307 . . . . 8.04 114.528 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.59 168.68 19.29 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 119.074 -1.05 . . . . 6.83 111.601 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.04 41.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.143 -1.389 . . . . 5.19 110.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.3 129.5 51.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.657 -0.868 . . . . 5.71 108.657 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.94 137.56 33.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 4.27 110.272 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.77 114.65 25.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.744 -0.465 . . . . 6.21 109.744 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -99.6 164.7 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.597 0.561 . . . . 6.14 112.073 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.59 -25.98 22.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.473 -0.785 . . . . 8.37 111.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.9 p -128.89 159.59 35.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.173 0.511 . . . . 7.92 111.568 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.33 -41.71 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 8.77 112.232 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.72 -41.79 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.325 0.491 . . . . 9.08 112.325 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.82 98.09 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.2 m -54.19 -53.97 46.24 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.149 -1.056 . . . . 6.18 108.149 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.5 m -55.18 -27.11 43.43 Favored 'General case' 0 C--N 1.428 3.98 0 C-N-CA 126.956 2.102 . . . . 0.0 109.86 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.23 -34.03 43.12 Favored 'General case' 0 C--N 1.422 3.73 0 N-CA-C 113.606 0.965 . . . . 8.7 113.606 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.659 0.614 . . . . 5.94 112.659 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.86 63.38 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.394 1.059 . . . . 6.89 111.587 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.38 -9.37 53.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 7.4 111.651 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.2 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.516 -0.311 . . . . 6.97 111.619 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.84 120.92 13.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 7.38 110.78 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.91 65.94 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.918 -0.658 . . . . 7.92 113.559 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.07 142.36 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.854 0.327 . . . . 7.5 111.101 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.333 0.587 . . . . 9.49 111.266 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.28 107.73 7.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 8.45 110.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.67 13.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 10.44 111.73 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.06 -5.47 54.01 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.169 0.828 . . . . 10.21 115.169 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.62 130.94 55.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.665 0.733 . . . . 9.94 112.381 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.79 101.55 11.0 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.449 -0.945 . . . . 8.4 108.449 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.981 1.104 . . . . 6.9 113.981 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 1.011 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.9 tttt -108.53 110.21 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.567 -1.272 . . . . 8.29 107.567 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.91 126.91 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.349 0.5 . . . . 6.17 112.349 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.57 170.53 15.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.413 -0.812 . . . . 7.99 110.051 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.12 154.7 49.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.448 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.8 Cg_exo -57.38 175.04 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.942 1.761 . . . . 7.79 112.079 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -116.83 25.84 10.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.797 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.865 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 7.8 m-20 -68.76 -13.18 62.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.642 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -77.49 98.5 5.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.026 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -100.85 162.07 21.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.41 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.8 -29.35 80.68 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.547 2.165 . . . . 0.0 111.877 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.0 tp 62.01 82.81 0.21 Allowed Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.595 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.48 63.6 8.45 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.427 2.751 . . . . 0.0 112.123 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.43 -4.58 70.59 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.972 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.8 mmt 67.16 -174.77 0.19 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.818 0.447 . . . . 0.0 110.844 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 m 53.57 60.81 3.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.994 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -56.18 105.61 0.21 Allowed 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.667 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 27.1 t-20 -141.67 -56.32 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.21 175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 89.6 Cg_endo -82.36 9.89 3.8 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.927 1.751 . . . . 0.0 111.776 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.2 p -131.84 -88.33 0.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 247' ' ' PRO . 39.8 t 61.73 -81.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.219 0.608 . . . . 0.0 110.921 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -178.1 -61.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.183 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 50.6 t -77.29 -54.3 1.51 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.649 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 73.3 Cg_exo -50.54 117.43 3.23 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.406 2.07 . . . . 0.0 112.723 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.31 -30.74 7.11 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.95 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 249' ' ' VAL . 7.5 p -146.03 78.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.197 0.998 . . . . 0.0 110.3 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 246' ' ' VAL . 48.4 t -94.34 -24.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.521 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t 70.44 104.02 0.06 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.593 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.0 m -56.07 -48.26 76.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.143 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.0 p -178.81 113.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.841 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 15.6 m -68.46 127.12 93.27 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 110.696 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 12.8 Cg_exo -70.84 163.08 40.39 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.814 2.343 . . . . 0.0 111.193 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.92 99.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.791 0.805 . . . . 0.0 109.895 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.3 m -150.65 179.32 8.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.412 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 62.01 85.48 0.12 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.768 0.667 . . . . 0.0 111.836 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -128.81 30.98 5.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.803 -0.635 . . . . 10.8 110.803 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.92 139.41 58.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 8.21 110.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.5 mt -109.88 143.94 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.114 -0.948 . . . . 6.33 112.769 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -104.38 132.08 51.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.176 -1.416 . . . . 6.75 107.176 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.573 -0.529 . . . . 5.68 109.573 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.456 -0.878 . . . . 6.53 112.679 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.2 86.6 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 7.67 111.506 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.6 mt -70.89 135.21 85.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.492 0.182 . . . . 8.16 111.492 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 26.2 Cg_exo -61.82 141.56 90.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.93 1.753 . . . . 8.96 108.76 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -65.36 -14.88 61.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.797 1.406 . . . . 11.61 114.797 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.16 -23.1 30.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.807 1.41 . . . . 11.06 114.807 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.35 149.12 50.86 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.169 0.44 . . . . 9.36 111.306 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 17.6 p-10 -114.53 -176.48 2.91 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.269 -0.271 . . . . 10.46 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 9.9 m-20 -53.46 -55.41 25.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 114.699 1.37 . . . . 9.92 114.699 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.66 -26.05 67.77 Favored 'General case' 0 C--N 1.406 3.023 0 C-N-CA 125.633 1.573 . . . . 0.0 112.559 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -80.28 -48.3 13.25 Favored 'General case' 1 C--N 1.429 4.064 0 CA-C-N 118.27 0.487 . . . . 10.06 111.414 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 75.1 t -62.63 -49.16 84.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.784 -0.644 . . . . 7.76 110.329 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.6 mtmm -54.37 -36.44 63.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.647 -0.706 . . . . 9.67 111.312 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.97 -53.37 56.63 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.137 0.494 . . . . 10.2 110.701 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 320' ' ' LEU . 3.1 tm? -51.74 -33.19 33.72 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.124 -0.489 . . . . 7.62 110.328 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -82.64 -41.55 19.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.651 0.611 . . . . 7.74 112.651 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.8 m -56.85 -29.57 63.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.566 0.95 . . . . 10.09 113.566 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 m -50.61 -9.99 0.06 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 124.873 1.269 . . . . 0.0 112.511 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.76 -11.96 13.9 Favored 'General case' 1 C--N 1.443 4.637 0 CA-C-N 118.398 0.544 . . . . 10.23 111.483 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 10.4 111.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.66 147.03 93.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.681 2.254 . . . . 12.19 112.744 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.4 mt -102.4 146.29 28.29 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.913 -0.585 . . . . 10.66 111.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.488 ' HD2' ' OE2' ' A' ' 306' ' ' GLU . 18.7 ptpt -101.02 -22.67 14.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.222 -0.658 . . . . 11.41 109.222 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.59 4.67 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.061 -2.274 . . . . 0.0 109.229 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.594 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.4 t80 -142.79 134.78 27.08 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 122.81 0.444 . . . . 8.77 111.968 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.82 124.09 12.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.794 0.33 . . . . 8.38 111.467 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.8 tp -101.03 118.13 36.4 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.2 122.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.445 0.906 . . . . 9.37 113.445 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.09 148.1 43.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.263 -0.88 . . . . 11.34 109.359 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.7 t70 -58.89 141.14 54.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.919 0.39 . . . . 13.83 111.039 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 38.0 m -49.59 -61.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.649 0.611 . . . . 14.58 112.649 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.16 -63.96 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.497 0.555 . . . . 16.19 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 14.9 m -42.46 -59.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.302 -0.408 . . . . 14.94 111.221 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.58 -6.04 62.7 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.65 -0.786 . . . . 13.57 114.531 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.32 167.56 13.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.411 0.606 . . . . 13.28 110.926 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.5 t -59.13 142.08 52.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 10.43 111.588 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.986 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 5.4 mmmp? -87.99 -9.47 53.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.771 -0.65 . . . . 11.2 109.566 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.55 -3.29 39.6 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.624 -0.716 . . . . 8.63 113.908 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.413 ' HH ' " H4'" ' B' ' 603' ' ' ' U' . 37.8 p90 -143.02 146.4 33.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.04 0.92 . . . . 9.19 112.837 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.63 155.14 46.62 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.131 -0.941 . . . . 6.21 112.258 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.34 146.86 36.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.172 -0.922 . . . . 7.09 110.405 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.594 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.3 p -157.91 156.18 30.87 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 119.903 -0.719 . . . . 6.77 111.84 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 31.3 tt0 -145.26 127.16 15.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.585 -0.734 . . . . 9.59 109.629 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 57.8 m-85 -82.5 164.89 20.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.042 0.386 . . . . 9.91 112.042 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.475 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 64.0 t -71.59 -46.08 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.357 -0.979 . . . . 12.81 108.357 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.3 t70 -96.35 102.35 14.13 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.442 -1.318 . . . . 13.18 107.442 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 115.27 1.582 . . . . 12.23 115.27 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -56.87 -38.69 73.08 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 122.246 1.022 . . . . 13.04 109.026 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.84 -22.57 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.296 -2.229 . . . . 11.08 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.61 -48.26 72.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.933 -0.766 . . . . 9.11 108.933 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.36 -42.82 99.71 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.252 -0.579 . . . . 10.31 110.554 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.82 -32.41 73.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.857 -0.737 . . . . 11.98 111.949 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.54 -34.78 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.671 -1.604 . . . . 8.25 113.025 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 73.0 mt -68.57 -51.25 48.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 7.4 110.883 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.78 67.86 Favored 'General case' 0 C--N 1.419 3.611 0 C-N-CA 126.266 1.826 . . . . 0.0 113.178 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -24.02 36.35 Favored Glycine 1 C--N 1.398 4.01 0 N-CA-C 116.846 1.499 . . . . 8.35 116.846 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 278' ' ' LEU . 87.9 mt -96.9 -45.77 6.49 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 120.093 1.947 . . . . 7.2 113.971 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -50.53 130.06 23.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 7.86 111.492 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.66 56.72 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.103 -0.57 . . . . 8.64 113.987 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.3 ttt -50.58 147.15 4.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.797 0.298 . . . . 8.0 111.336 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -95.05 115.73 27.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 10.39 111.703 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.4 mm? -120.24 106.71 12.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.108 -1.071 . . . . 8.95 108.108 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.06 -118.64 10.56 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.388 -1.485 . . . . 10.63 109.388 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.87 22.35 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 12.25 109.781 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -123.82 153.9 40.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.59 -0.732 . . . . 9.98 111.683 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.73 118.29 36.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.133 -1.062 . . . . 10.14 108.133 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.67 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.9 tp -62.99 143.1 58.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.413 0.625 . . . . 7.52 112.663 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.471 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 94.8 mt -128.12 128.06 44.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.535 -1.211 . . . . 7.48 108.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.5 t -137.98 123.93 25.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.927 -1.108 . . . . 6.45 109.997 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -152.65 155.41 37.26 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.947 -1.72 . . . . 7.66 109.5 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.843 ' HD2' ' HA3' ' A' ' 338' ' ' GLY . 98.8 mtt180 -58.69 122.49 13.63 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.459 -1.297 . . . . 8.94 107.586 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.91 -11.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.757 1.391 . . . . 7.52 114.757 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.3 m -119.41 -77.84 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.547 -0.461 . . . . 9.07 111.362 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.58 136.53 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . 0.843 ' HA3' ' HD2' ' A' ' 334' ' ' ARG . . . 125.89 53.41 0.16 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.504 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -97.81 -0.04 45.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -126.15 167.17 15.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.901 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -137.63 118.7 14.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.955 0.407 . . . . 0.0 110.688 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.835 177.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.986 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.158 0 C3'-C2'-C1' 100.456 -1.16 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 0.471 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 O4'-C1'-C2' 107.562 0.83 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.446 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.105 0 C4'-C3'-C2' 103.821 1.121 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 1.011 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 0 O3'--C3' 1.472 3.493 0 C3'-C2'-C1' 103.318 2.02 . 0.213 4g . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.684 6.402 1 P-O3'-C3' 124.824 4.27 . 0.0 OUTLIER '7D dist 9a' 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.461 ' H6 ' ' OP2' ' B' ' 606' ' ' ' U' . . . . . . . . 0 C3'--C2' 1.538 1.216 0 C4'-C3'-C2' 105.583 2.883 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 0.865 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.546 1.81 0 O4'-C1'-C2' 107.841 1.03 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C3'-C2'-C1' 100.672 -0.92 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 O4'-C1'-C2' 107.358 0.684 . 0.025 0k . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.725 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -136.16 -150.21 0.36 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.4 -0.92 . . . . 0.0 112.827 173.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -161.81 149.24 14.45 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 122.97 0.508 . . . . 5.88 111.526 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.4 mt -140.73 143.56 35.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 5.25 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -96.54 125.14 40.8 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 6.58 108.879 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.69 101.22 8.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.069 0.461 . . . . 5.06 110.242 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.76 -179.2 34.86 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.033 -0.53 . . . . 6.2 112.728 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.1 41.35 23.48 Favored 'General case' 0 CA--C 1.575 1.939 0 C-N-CA 125.175 1.39 . . . . 0.0 110.326 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.69 149.85 88.43 Favored Pre-proline 1 C--N 1.429 4.023 0 C-N-CA 123.726 0.81 . . . . 7.79 111.32 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.08 144.45 89.98 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.247 1.964 . . . . 8.57 110.968 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.92 139.78 52.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 11.37 111.938 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.48 61.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.282 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.05 136.5 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.316 0.558 . . . . 8.91 110.359 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.85 153.88 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.693 0.282 . . . . 9.64 110.653 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.22 -43.07 96.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.176 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -61.82 -45.99 91.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.971 -0.559 . . . . 9.89 110.547 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.412 3.312 0 O-C-N 119.076 -2.265 . . . . 0.0 111.701 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.19 67.91 Favored 'General case' 1 C--N 1.429 4.059 0 O-C-N 123.934 0.771 . . . . 6.64 111.731 171.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.32 7.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.353 0.661 . . . . 6.69 111.119 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.48 -33.75 60.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.388 -0.824 . . . . 8.8 111.428 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.72 -53.7 17.25 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.552 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.3 -48.21 82.4 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.77 -42.85 80.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.164 -0.614 . . . . 7.12 109.594 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.98 -23.46 65.04 Favored 'General case' 0 C--N 1.406 3.042 0 O-C-N 120.279 -1.513 . . . . 0.0 111.31 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -79.3 -37.76 36.97 Favored 'General case' 1 C--N 1.428 4.014 0 CA-C-N 118.499 0.59 . . . . 7.79 110.354 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.66 -36.82 83.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.589 -0.732 . . . . 7.73 111.085 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -76.0 -43.13 45.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.349 0.5 . . . . 9.61 112.349 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.5 mt -62.99 -37.74 88.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.272 0.558 . . . . 10.06 110.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.03 -16.45 74.7 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.224 -0.988 . . . . 9.23 112.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.14 72.02 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.801 -0.92 . . . . 9.25 110.801 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.96 5.33 51.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.865 0.691 . . . . 8.31 112.865 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 p -82.62 143.46 30.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 9.16 110.575 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.44 23.88 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.689 -0.232 . . . . 9.89 110.706 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.3 143.48 99.72 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.017 1.812 . . . . 11.04 110.834 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.33 161.55 20.56 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.534 -0.841 . . . . 9.31 112.431 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.2 m-20 -75.26 134.52 73.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.02 0.378 . . . . 7.97 112.02 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.28 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.553 2.169 . . . . 6.59 111.327 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.63 105.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.118 -0.492 . . . . 5.87 111.11 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 70.47 0.71 Allowed 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 124.752 1.221 . . . . 0.0 109.441 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.73 151.32 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 129.383 3.073 . . . . 0.0 112.78 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.52 130.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 129.47 3.108 . . . . 5.67 109.273 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.743 -0.465 . . . . 6.47 109.743 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 125.97 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 116.958 2.207 . . . . 7.1 116.958 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.03 91.38 5.28 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 103.165 -2.902 . . . . 8.1 103.165 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -57.39 8.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.606 1.706 . . . . 10.19 115.606 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.28 -48.67 76.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.845 0.683 . . . . 10.51 112.845 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.01 -9.12 50.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.726 0.298 . . . . 9.72 111.803 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.1 36.07 15.44 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.556 1.317 . . . . 8.04 114.556 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.42 168.7 19.2 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.134 -1.027 . . . . 6.83 111.703 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.69 161.09 41.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.235 -1.348 . . . . 5.19 110.482 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.36 129.37 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.641 -0.874 . . . . 5.71 108.641 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.92 137.58 33.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 4.27 110.312 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.72 114.77 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.721 -0.474 . . . . 6.21 109.721 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.665 0.603 . . . . 6.14 111.919 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.94 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 8.37 111.411 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.3 p -128.94 159.57 35.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 7.92 111.648 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.24 -41.78 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.751 . . . . 8.77 112.232 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.71 -41.78 95.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.354 0.502 . . . . 9.08 112.354 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.91 -43.86 97.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.248 -0.279 . . . . 7.46 110.248 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.0 m -54.18 -53.87 47.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.261 1.029 . . . . 6.18 108.261 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.1 m -55.06 -27.22 43.14 Favored 'General case' 0 C--N 1.424 3.845 0 C-N-CA 127.118 2.167 . . . . 0.0 109.888 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.35 -34.01 42.47 Favored 'General case' 0 C--N 1.421 3.682 0 N-CA-C 113.585 0.957 . . . . 8.7 113.585 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.58 -17.39 64.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.82 63.34 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.473 1.108 . . . . 6.89 111.633 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.51 -9.21 52.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.355 . . . . 7.4 111.611 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.83 16.16 14.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.564 -0.289 . . . . 6.97 111.627 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.87 120.92 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.826 0.346 . . . . 7.38 110.777 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.84 65.98 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.938 -0.648 . . . . 7.92 113.577 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.06 142.38 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.936 0.368 . . . . 7.5 111.084 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.97 121.54 37.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.34 0.591 . . . . 9.49 111.262 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.29 107.76 7.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 8.45 110.378 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.69 42.71 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 10.44 111.771 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.99 -5.35 54.21 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 115.195 0.838 . . . . 10.21 115.195 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.61 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.669 0.735 . . . . 9.94 112.469 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.44 10.83 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.56 -0.904 . . . . 8.4 108.56 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.31 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.758 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.55 110.24 21.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.555 -1.276 . . . . 8.29 107.555 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.93 126.89 58.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 6.17 112.32 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.434 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.62 170.54 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.03 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.14 154.76 49.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.537 -0.912 . . . . 7.86 108.537 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.412 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.7 Cg_exo -57.44 175.17 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.921 1.748 . . . . 7.79 112.026 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -103.39 -6.61 21.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 1.17 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 10.5 m-20 -85.29 15.89 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.274 172.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.44 150.11 44.43 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.29 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 10.5 pt20 -51.11 129.12 30.4 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.446 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 4.3 Cg_exo -80.68 -178.52 4.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.101 2.534 . . . . 0.0 111.016 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.78 125.72 90.37 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.13 138.97 88.35 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.707 2.271 . . . . 0.0 111.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.44 167.84 54.64 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.101 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 42.0 ttp 65.32 31.84 10.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.429 0.633 . . . . 0.0 110.225 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 41.1 m -102.56 96.14 6.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.518 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -121.83 -43.98 2.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.139 0.495 . . . . 0.0 110.168 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 90.5 m-20 -100.23 115.19 65.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 20.5 Cg_exo -66.44 111.03 1.96 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.64 2.226 . . . . 0.0 112.238 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.3 m -71.19 -32.07 68.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 109.869 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.09 137.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.068 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -87.89 89.67 8.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.072 0.463 . . . . 0.0 110.142 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.8 158.08 34.12 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.713 ' HD2' HG22 ' A' ' 254' ' ' VAL . 31.6 Cg_exo -60.45 -42.35 41.62 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.898 2.398 . . . . 0.0 112.952 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.825 ' HA3' ' HB ' ' A' ' 252' ' ' THR . . . -111.59 -139.01 7.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.116 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.54 -68.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.8 0.3 . . . . 0.0 110.225 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.47 -44.65 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.051 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.5 m -129.64 2.28 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.132 0.492 . . . . 0.0 110.237 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.825 ' HB ' ' HA3' ' A' ' 248' ' ' GLY . 0.2 OUTLIER -59.92 121.95 13.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.127 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 252' ' ' THR . 4.3 p 50.77 22.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 112.082 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.713 HG22 ' HD2' ' A' ' 247' ' ' PRO . 90.7 t -80.48 117.8 69.44 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.39 113.47 2.48 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.73 2.287 . . . . 0.0 112.723 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -125.0 152.15 44.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t -73.61 90.86 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -142.82 54.46 1.39 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -80.32 30.98 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 10.8 110.782 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 306' ' ' GLU . 7.0 tppt? -62.87 139.34 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 8.21 110.349 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 313' ' ' THR . 78.9 mt -109.75 143.99 38.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.006 -0.997 . . . . 6.33 112.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -104.48 132.24 50.95 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.141 -1.429 . . . . 6.75 107.141 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.99 121.15 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.603 -0.517 . . . . 5.68 109.603 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.14 179.25 16.47 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.72 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.53 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.555 -0.831 . . . . 7.67 111.596 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 99.1 mt -70.86 135.3 85.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.192 . . . . 8.16 111.496 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.3 Cg_exo -61.79 141.53 90.56 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.879 1.719 . . . . 8.96 108.843 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -65.42 -14.86 61.84 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -84.17 -23.14 30.71 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.781 1.401 . . . . 11.06 114.781 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.31 149.22 50.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.115 0.416 . . . . 9.36 111.332 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 275' ' ' VAL . 27.4 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.229 -0.286 . . . . 10.46 110.229 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 18.7 m-20 -53.55 -55.27 27.02 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 114.659 1.355 . . . . 9.92 114.659 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.67 -26.42 68.01 Favored 'General case' 0 C--N 1.405 3.009 0 C-N-CA 125.707 1.603 . . . . 0.0 112.461 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -80.02 -48.26 13.61 Favored 'General case' 1 C--N 1.431 4.119 0 CA-C-N 118.263 0.483 . . . . 10.06 111.455 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 271' ' ' ASN . 84.4 t -62.74 -49.21 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.8 -0.636 . . . . 7.76 110.273 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 45.1 mtmt -54.25 -36.4 63.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 9.67 111.336 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.06 -53.26 57.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.092 0.472 . . . . 10.2 110.772 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.401 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.72 -33.21 33.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.964 -0.562 . . . . 7.62 110.365 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.64 -41.66 19.17 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.549 0.574 . . . . 7.74 112.549 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 32.3 m -56.92 -29.82 63.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.586 0.958 . . . . 10.09 113.586 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.1 m -49.9 -10.33 0.05 OUTLIER 'General case' 0 C--N 1.394 2.507 0 C-N-CA 124.846 1.258 . . . . 0.0 112.776 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -111.59 -11.99 13.98 Favored 'General case' 1 C--N 1.443 4.669 0 CA-C-N 118.341 0.519 . . . . 10.23 111.467 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.3 10.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.9 -0.667 . . . . 10.4 111.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 147.12 93.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.716 2.277 . . . . 12.19 112.689 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 81.6 mt -102.49 146.29 28.32 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.932 -0.576 . . . . 10.66 111.217 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -101.07 -22.58 14.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.271 -0.64 . . . . 11.41 109.271 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.58 126.13 5.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.174 -2.204 . . . . 0.0 109.172 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.547 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 50.1 t80 -143.41 134.68 25.92 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.792 0.437 . . . . 8.77 112.028 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.12 13.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.797 0.332 . . . . 8.38 111.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 60.7 tp -101.08 118.24 36.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.568 -1.271 . . . . 8.94 107.568 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.6 t -74.14 122.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.44 0.904 . . . . 9.37 113.44 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -119.18 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.353 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.6 t70 -58.9 141.19 54.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 13.83 110.98 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.674 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 14.4 m -49.75 -61.56 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.736 0.643 . . . . 14.58 112.736 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.21 -64.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.465 0.543 . . . . 16.19 112.465 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 9.0 m -42.59 -59.22 1.98 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.306 -0.406 . . . . 14.94 111.176 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.15 62.58 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.599 -0.81 . . . . 13.57 114.499 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 70.3 mt -88.24 167.67 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.401 0.601 . . . . 13.28 110.911 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 33.5 t -59.22 142.1 52.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 10.43 111.656 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.821 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.97 -9.43 53.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 11.2 109.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.5 -3.29 39.73 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.669 -0.696 . . . . 8.63 113.935 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.461 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 38.2 p90 -143.01 146.4 33.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.038 0.919 . . . . 9.19 112.827 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.13 46.73 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.037 -0.983 . . . . 6.21 112.206 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.35 146.77 36.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.192 -0.913 . . . . 7.09 110.415 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.547 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.6 p -157.78 156.29 31.3 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.969 -0.692 . . . . 6.77 111.868 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.796 ' HB2' ' HD3' ' A' ' 260' ' ' LYS . 78.4 tt0 -145.35 127.05 15.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.737 -0.665 . . . . 9.59 109.682 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 51.8 m-85 -82.42 164.87 20.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.953 0.406 . . . . 9.91 112.007 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.53 -46.1 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.43 -0.952 . . . . 12.81 108.43 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.4 t70 -96.28 102.29 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.436 -1.32 . . . . 13.18 107.436 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 115.299 1.592 . . . . 12.23 115.299 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -56.92 -38.69 73.23 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.184 0.992 . . . . 13.04 108.966 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.64 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 112.358 -2.201 . . . . 11.08 109.613 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 91.6 m -54.71 -48.13 72.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.908 -0.775 . . . . 9.11 108.908 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -62.43 -42.89 99.78 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.285 -0.566 . . . . 10.31 110.473 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.7 -32.43 73.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 119.93 -0.708 . . . . 11.98 111.98 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.71 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.641 -1.618 . . . . 8.25 113.076 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 72.8 mt -68.61 -51.39 46.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.354 0.597 . . . . 7.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.88 67.31 Favored 'General case' 0 C--N 1.42 3.668 0 C-N-CA 126.225 1.81 . . . . 0.0 113.13 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.02 -24.07 36.11 Favored Glycine 1 C--N 1.399 4.077 0 N-CA-C 116.762 1.465 . . . . 8.35 116.762 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 330' ' ' LEU . 84.3 mt -96.86 -45.76 6.51 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 120.176 1.988 . . . . 7.2 113.938 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -50.44 129.94 22.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 7.86 111.526 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.69 56.7 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.108 -0.568 . . . . 8.64 113.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.3 ttt -50.65 147.18 4.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.84 0.32 . . . . 8.0 111.337 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.01 115.64 27.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.407 . . . . 10.39 111.723 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.24 106.63 12.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.116 -1.068 . . . . 8.95 108.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.2 -118.68 10.5 Favored Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -115.84 22.36 13.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 12.25 109.714 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -123.88 153.94 40.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.667 -0.697 . . . . 9.98 111.618 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -101.79 118.22 36.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.138 -1.06 . . . . 10.14 108.138 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.643 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.1 tp -63.0 143.15 58.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.545 0.688 . . . . 7.52 112.637 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.23 127.92 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.469 -1.242 . . . . 7.48 108.981 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.84 124.01 26.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 O-C-N 120.976 -1.078 . . . . 6.45 110.011 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -152.78 155.4 37.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.042 -1.661 . . . . 7.66 109.51 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.654 ' HD2' ' HA3' ' A' ' 338' ' ' GLY . 98.5 mtt180 -58.65 122.54 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 118.435 -1.306 . . . . 8.94 107.58 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.78 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.3 m -119.36 -78.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.575 -0.45 . . . . 9.07 111.212 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.71 146.42 24.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.819 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . 0.654 ' HA3' ' HD2' ' A' ' 334' ' ' ARG . . . 161.38 21.56 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.755 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.86 110.96 17.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.37 169.06 11.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.54 9.67 35.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.401 178.776 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.821 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.509 -1.876 0 O4'-C1'-N19 109.424 1.224 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 0.4 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.933 0 O4'-C1'-C2' 107.545 0.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.461 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.425 -0.933 0 C4'-C3'-C2' 103.496 0.796 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.758 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.498 5.385 0 C4'-C3'-C2' 98.948 -3.752 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.674 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.679 5.985 1 C4'-C3'-C2' 106.708 4.008 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 002 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.412 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 105.35 2.65 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 1.17 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.541 1.311 0 O4'-C1'-C2' 107.927 1.091 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.959 0 O4'-C1'-C2' 107.3 0.643 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.611 -0.988 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.758 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -144.11 -156.76 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.294 167.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -158.81 149.26 19.79 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 123.646 0.591 . . . . 5.88 111.577 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.81 143.64 34.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 5.25 111.231 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -96.57 125.17 40.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.905 -0.776 . . . . 6.58 108.905 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.82 101.23 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 5.06 110.21 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.85 -179.32 34.68 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.07 -0.586 . . . . 6.2 112.769 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.3 m120 49.95 41.6 23.21 Favored 'General case' 0 CA--C 1.574 1.899 0 C-N-CA 125.395 1.478 . . . . 0.0 110.292 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.43 149.87 89.01 Favored Pre-proline 1 C--N 1.43 4.07 0 C-N-CA 123.861 0.864 . . . . 7.79 111.355 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.15 144.44 90.35 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.317 2.011 . . . . 8.57 110.977 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.96 139.77 52.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.929 0.395 . . . . 11.37 111.992 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.59 61.25 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.876 -0.602 . . . . 9.94 114.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.2 136.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 117.338 0.569 . . . . 8.91 110.254 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.7 p -84.96 153.85 22.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 9.64 110.637 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.09 -43.18 95.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 7.44 110.185 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.74 -46.03 91.37 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.994 -0.548 . . . . 9.89 110.54 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.56 -26.4 68.56 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.271 -2.143 . . . . 0.0 111.698 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.478 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.38 -34.08 67.68 Favored 'General case' 1 C--N 1.43 4.071 0 O-C-N 123.952 0.783 . . . . 6.64 111.811 171.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.55 -54.29 7.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.442 0.697 . . . . 6.69 111.078 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.66 -33.64 61.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.419 -0.81 . . . . 8.8 111.373 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.76 -53.6 17.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 120.634 -0.426 . . . . 7.44 111.603 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.25 -48.37 81.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.181 0.438 . . . . 5.94 112.181 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.6 m-20 -56.74 -42.85 80.0 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.193 -0.603 . . . . 7.12 109.606 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.4 65.07 Favored 'General case' 0 C--N 1.406 3.06 0 O-C-N 120.27 -1.519 . . . . 0.0 111.251 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.5 -37.66 36.21 Favored 'General case' 1 C--N 1.429 4.03 0 CA-C-N 118.576 0.625 . . . . 7.79 110.332 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.82 83.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 7.73 111.022 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.01 -43.07 45.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.437 0.532 . . . . 9.61 112.437 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.02 -37.82 88.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 10.06 110.397 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.96 -16.52 74.67 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.309 -0.948 . . . . 9.23 112.881 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.11 71.55 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.816 -0.914 . . . . 9.25 110.816 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.01 5.28 52.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.816 0.672 . . . . 8.31 112.816 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.5 p -82.59 143.44 31.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.565 0.221 . . . . 9.16 110.598 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.157 0.429 . . . . 10.23 112.157 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.47 23.82 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.688 -0.233 . . . . 9.89 110.689 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.33 143.49 99.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.928 1.752 . . . . 11.04 110.797 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.57 20.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 9.31 112.385 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.23 134.52 73.84 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.046 0.387 . . . . 7.97 112.046 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.29 -50.91 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.564 2.176 . . . . 6.59 111.358 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.79 105.43 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.183 -0.462 . . . . 5.87 111.096 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -31.4 29.19 Favored 'General case' 0 N--CA 1.529 3.482 0 O-C-N 119.988 -1.695 . . . . 0.0 113.404 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.21 163.37 39.66 Favored 'General case' 0 C--N 1.391 2.372 0 C-N-CA 126.244 1.818 . . . . 0.0 110.798 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.27 130.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.376 1.752 0 C-N-CA 126.556 1.943 . . . . 5.67 109.313 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.17 126.6 55.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.715 -0.476 . . . . 6.47 109.715 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.96 126.0 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 116.985 2.217 . . . . 7.1 116.985 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.01 91.37 5.27 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 103.163 -2.902 . . . . 8.1 103.163 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -57.36 8.09 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.634 1.716 . . . . 10.19 115.634 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.23 -48.75 75.87 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.891 0.7 . . . . 10.51 112.891 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.14 50.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.895 0.331 . . . . 9.72 111.895 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.05 36.23 15.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.565 1.32 . . . . 8.04 114.565 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.61 168.59 19.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.063 -1.055 . . . . 6.83 111.633 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.52 161.17 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.413 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.46 129.4 51.2 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.556 -0.905 . . . . 5.71 108.556 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.87 137.53 33.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.353 -0.385 . . . . 4.27 110.33 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -114.74 114.7 25.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.678 -0.49 . . . . 6.21 109.678 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.939 -0.573 . . . . 6.14 111.93 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -25.99 22.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 8.37 111.47 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.2 p -128.89 159.54 35.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.104 0.478 . . . . 7.92 111.688 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.27 -41.78 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 8.77 112.231 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.74 -41.68 95.75 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.385 0.513 . . . . 9.08 112.385 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.83 -43.84 98.04 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.292 -0.262 . . . . 7.46 110.292 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.2 m -54.17 -54.03 45.25 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.108 -1.071 . . . . 6.18 108.108 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 m -54.99 -27.14 41.85 Favored 'General case' 1 C--N 1.429 4.039 0 C-N-CA 127.072 2.149 . . . . 0.0 109.905 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.3 -34.1 42.69 Favored 'General case' 0 C--N 1.422 3.734 0 N-CA-C 113.586 0.958 . . . . 8.7 113.586 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.657 0.614 . . . . 5.94 112.657 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.1 -19.83 63.39 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.451 1.095 . . . . 6.89 111.602 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.26 52.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 7.4 111.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.89 16.28 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.528 -0.305 . . . . 6.97 111.584 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.97 14.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.869 0.366 . . . . 7.38 110.715 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.9 65.98 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.89 -0.671 . . . . 7.92 113.587 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.809 0.305 . . . . 7.5 111.121 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.91 121.54 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.271 0.558 . . . . 9.49 111.343 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.23 107.75 7.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 8.45 110.354 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.7 13.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.064 -0.517 . . . . 10.44 111.751 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.53 53.6 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.234 0.854 . . . . 10.21 115.234 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.52 130.86 55.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.58 0.69 . . . . 9.94 112.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.68 101.51 10.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.52 -0.918 . . . . 8.4 108.52 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.31 137.88 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.027 1.121 . . . . 6.9 114.027 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.764 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.5 tttt -108.61 110.32 21.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.548 -1.279 . . . . 8.29 107.548 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.05 126.92 58.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.129 0.49 . . . . 6.17 112.288 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.63 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 7.99 110.026 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.05 154.7 49.69 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.56 -0.904 . . . . 7.86 108.56 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.45 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.3 Cg_exo -57.4 175.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 121.89 1.726 . . . . 7.79 112.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -111.19 13.28 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.739 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 13.0 m-20 -64.43 116.19 5.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.264 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -76.37 135.12 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 57.74 82.72 0.23 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.111 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.5 97.48 0.96 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 112.042 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 99.2 mt 63.12 101.63 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.649 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.13 128.07 21.41 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.267 2.645 . . . . 0.0 113.049 -176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 150.24 38.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.053 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 240' ' ' GLU . 44.3 tpp -61.92 139.5 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 94.7 p 62.09 -9.61 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.918 1.287 . . . . 0.0 112.714 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 238' ' ' MET . 37.1 mt-10 -91.04 -40.38 11.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.838 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 90.5 m-20 -102.91 -57.55 0.1 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.739 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.838 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 12.6 Cg_exo -71.09 126.85 12.84 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.101 1.867 . . . . 0.0 111.53 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.5 p -79.28 90.35 4.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 0.0 111.025 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.28 3.08 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.814 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.2 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.9 m -100.47 132.91 21.75 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.845 0.355 . . . . 0.0 110.415 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.66 -63.48 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.593 2.195 . . . . 0.0 111.912 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -156.73 42.21 0.54 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.54 152.11 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.603 -0.298 . . . . 0.0 110.2 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 252' ' ' THR . 23.5 m -116.77 -172.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 74.3 m -75.47 8.55 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.534 ' H ' HG23 ' A' ' 250' ' ' VAL . 29.0 m -73.04 -38.44 66.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 254' ' ' VAL . 61.3 t -95.72 121.71 46.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 253' ' ' VAL . 41.1 t 63.33 74.3 0.45 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.746 0.784 . . . . 0.0 109.545 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -90.51 -167.9 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.004 2.469 . . . . 0.0 112.198 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.75 102.24 14.64 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.9 t -75.72 103.68 5.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.191 0.519 . . . . 0.0 109.808 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -137.57 109.53 7.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.815 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -128.97 30.97 4.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.878 -0.601 . . . . 10.8 110.806 173.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 260' ' ' LYS . 16.3 ttmt -62.9 139.34 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.21 110.323 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 313' ' ' THR . 64.4 mt -109.8 143.94 38.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.02 -0.991 . . . . 6.33 112.806 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -104.47 132.12 51.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.19 -1.411 . . . . 6.75 107.19 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.661 -0.496 . . . . 5.68 109.661 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.25 16.48 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.537 -0.839 . . . . 6.53 112.659 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.2 86.51 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.643 -0.789 . . . . 7.67 111.554 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 95.2 mt -70.83 135.19 85.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.503 0.186 . . . . 8.16 111.503 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.8 Cg_exo -61.78 141.6 90.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.883 1.722 . . . . 8.96 108.843 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.37 -14.96 62.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.779 1.4 . . . . 11.61 114.779 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.08 -23.21 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.842 1.423 . . . . 11.06 114.842 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.29 149.19 50.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.159 0.436 . . . . 9.36 111.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.4 p-10 -114.5 -176.43 2.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 110.29 -0.263 . . . . 10.46 110.29 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.61 -55.2 27.85 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.618 1.34 . . . . 9.92 114.618 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.79 -26.34 68.04 Favored 'General case' 0 C--N 1.406 3.033 0 C-N-CA 125.669 1.588 . . . . 0.0 112.408 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -80.04 -48.3 13.52 Favored 'General case' 1 C--N 1.43 4.072 0 CA-C-N 118.301 0.5 . . . . 10.06 111.412 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 271' ' ' ASN . 67.6 t -62.63 -49.27 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 7.76 110.28 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -54.22 -36.46 63.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 9.67 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.0 -53.36 56.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.133 0.492 . . . . 10.2 110.709 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 278' ' ' LEU . 1.5 tm? -51.78 -33.14 33.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.081 -0.509 . . . . 7.62 110.364 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.1 mt -82.66 -41.67 19.11 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.602 0.593 . . . . 7.74 112.602 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.7 m -56.73 -29.9 62.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.567 0.951 . . . . 10.09 113.567 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 m -50.21 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.555 0 C-N-CA 124.796 1.238 . . . . 0.0 112.587 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -111.46 -12.06 14.03 Favored 'General case' 1 C--N 1.442 4.596 0 CA-C-N 118.379 0.536 . . . . 10.23 111.452 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.12 162.36 10.28 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.786 -0.643 . . . . 10.4 111.913 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.66 147.12 93.3 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.731 2.287 . . . . 12.19 112.712 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 84.1 mt -102.52 146.25 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.918 -0.583 . . . . 10.66 111.215 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.7 ptpt -100.99 -22.65 14.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.266 -0.642 . . . . 11.41 109.266 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.64 126.15 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 119.07 -2.269 . . . . 0.0 109.15 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 62.9 t80 -143.3 134.7 26.12 Favored 'General case' 0 C--N 1.362 1.142 0 C-N-CA 122.886 0.474 . . . . 8.77 112.009 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 4.2 p-10 -144.78 124.04 12.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.73 0.3 . . . . 8.38 111.557 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 54.2 tp -101.01 118.3 36.73 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.552 -1.277 . . . . 8.94 107.552 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.17 122.86 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.511 0.93 . . . . 9.37 113.511 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -119.09 148.13 43.39 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 115.332 -0.849 . . . . 11.34 109.336 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 37.2 t70 -58.94 141.1 54.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 13.83 110.95 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.67 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 5.6 m -49.71 -61.66 1.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.625 0.602 . . . . 14.58 112.625 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.18 -63.95 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.493 0.553 . . . . 16.19 112.493 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.4 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.414 . . . . 14.94 111.179 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.07 62.69 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.607 -0.806 . . . . 13.57 114.557 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.33 167.64 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.34 0.57 . . . . 13.28 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.1 t -59.17 141.96 52.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 10.43 111.617 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.596 ' HE2' ' O2 ' ' B' ' 601' ' ' ' U' . 4.4 mmmp? -87.95 -9.42 53.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 11.2 109.574 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.37 39.53 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.727 . . . . 8.63 113.875 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.55 ' CE1' ' OP1' ' B' ' 603' ' ' ' U' . 55.3 p90 -142.92 146.43 33.99 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.051 0.925 . . . . 9.19 112.846 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.13 46.72 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.004 -0.998 . . . . 6.21 112.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 97.5 m-85 -111.44 146.83 36.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.168 -0.924 . . . . 7.09 110.449 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.6 p -157.72 156.24 31.32 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.003 -0.679 . . . . 6.77 111.869 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.4 127.08 15.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.723 -0.671 . . . . 9.59 109.649 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.568 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 53.2 m-85 -82.37 164.92 20.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.095 0.406 . . . . 9.91 112.095 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.62 -46.08 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.343 -0.984 . . . . 12.81 108.343 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 312' ' ' VAL . 12.1 t70 -96.32 102.28 14.04 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.381 -1.34 . . . . 13.18 107.381 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.68 -35.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 115.337 1.606 . . . . 12.23 115.337 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -56.78 -38.73 72.89 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.259 1.028 . . . . 13.04 109.097 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.69 -22.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.306 -2.225 . . . . 11.08 109.529 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 94.5 m -54.64 -48.13 72.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.929 -0.767 . . . . 9.11 108.929 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.46 -42.89 99.8 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.308 -0.557 . . . . 10.31 110.467 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -63.8 -32.44 73.94 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 119.923 -0.711 . . . . 11.98 111.941 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.66 74.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.586 -1.643 . . . . 8.25 113.103 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.61 -51.31 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.362 0.601 . . . . 7.4 110.876 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.88 -38.66 67.82 Favored 'General case' 0 C--N 1.419 3.596 0 C-N-CA 126.281 1.832 . . . . 0.0 113.151 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.11 -24.08 35.81 Favored Glycine 1 C--N 1.399 4.033 0 N-CA-C 116.778 1.471 . . . . 8.35 116.778 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 99.1 mt -96.81 -45.81 6.5 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.107 1.954 . . . . 7.2 113.946 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -50.47 130.04 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 7.86 111.463 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.66 56.76 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.111 -0.566 . . . . 8.64 113.948 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.7 mtt -50.65 147.21 4.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.783 0.325 . . . . 8.0 111.264 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -95.14 115.69 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.076 0.465 . . . . 10.39 111.715 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.0 mm? -120.26 106.83 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.082 -1.081 . . . . 8.95 108.082 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.1 -118.74 10.65 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.397 -1.481 . . . . 10.63 109.397 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -115.78 22.36 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 12.25 109.781 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.8 153.91 40.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.616 -0.72 . . . . 9.98 111.624 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.73 118.25 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.117 -1.068 . . . . 10.14 108.117 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.09 143.09 58.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 7.52 112.586 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 1.004 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 20.8 mt -128.12 128.0 44.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.504 -1.225 . . . . 7.48 108.997 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.92 124.04 26.28 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 O-C-N 120.984 -1.073 . . . . 6.45 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -152.76 155.33 36.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 119.987 -1.696 . . . . 7.66 109.547 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.488 ' HA ' HD23 ' A' ' 261' ' ' LEU . 95.0 mtt180 -58.55 122.43 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.395 -1.322 . . . . 8.94 107.626 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.94 -11.77 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.786 1.402 . . . . 7.52 114.786 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.6 m -119.36 -77.84 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.55 -0.46 . . . . 9.07 111.422 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.42 93.91 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.477 0.656 . . . . 0.0 110.581 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 167.84 136.59 2.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.012 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -166.01 -173.54 2.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.99 105.46 17.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.414 0.626 . . . . 0.0 110.181 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -97.53 -35.47 10.62 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.079 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.677 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.596 ' O2 ' ' HE2' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.101 0 C3'-C2'-C1' 100.208 -1.435 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 1.004 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C1'-C2' 107.578 0.842 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.582 H5'' ' H6 ' ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.151 0 O4'-C1'-C2' 107.723 0.945 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.764 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.498 5.385 0 C4'-C3'-C2' 99.31 -3.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.67 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.677 5.823 0 C4'-C3'-C2' 106.672 3.972 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.45 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O5'--C5' 1.423 -1.08 0 C4'-C3'-C2' 105.18 2.48 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 0.739 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.54 1.186 0 O4'-C4'-C3' 103.912 -1.134 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . 0.409 H5'' " H2'" ' B' ' 607' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 O4'-C1'-C2' 107.604 0.86 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-C1' 100.785 -0.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.924 ' HB3' HG13 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.093 0.473 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 74.5 ttt180 -179.66 16.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.018 -173.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.34 148.4 21.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.762 -1.108 . . . . 5.88 111.36 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.74 143.47 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 5.25 111.205 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.55 125.14 40.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.901 -0.777 . . . . 6.58 108.901 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.77 101.29 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.098 0.475 . . . . 5.06 110.147 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.81 -179.32 34.73 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.964 -0.562 . . . . 6.2 112.795 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.4 m120 50.28 41.31 24.14 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 125.258 1.423 . . . . 0.0 110.194 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.46 149.83 88.94 Favored Pre-proline 1 C--N 1.429 4.048 0 C-N-CA 123.832 0.853 . . . . 7.79 111.316 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.07 144.41 90.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.308 2.005 . . . . 8.57 111.013 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.67 52.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.93 0.395 . . . . 11.37 111.964 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.33 6.42 61.52 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.838 -0.619 . . . . 9.94 114.319 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.11 136.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.31 0.555 . . . . 8.91 110.276 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.6 p -84.86 153.91 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 9.64 110.691 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.1 -43.19 95.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 7.44 110.204 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.78 -45.92 91.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.901 -0.59 . . . . 9.89 110.499 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.76 -26.38 68.68 Favored 'General case' 0 C--N 1.408 3.142 0 O-C-N 119.262 -2.149 . . . . 0.0 111.689 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.29 -34.1 67.92 Favored 'General case' 0 C--N 1.428 3.98 0 O-C-N 123.978 0.799 . . . . 6.64 111.79 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.54 -54.22 7.92 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.412 0.685 . . . . 6.69 111.132 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.73 -33.61 61.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 8.8 111.353 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.83 -53.55 17.64 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.531 -0.468 . . . . 7.44 111.61 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.31 -48.28 82.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.13 0.419 . . . . 5.94 112.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.76 -42.85 80.08 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.277 -0.569 . . . . 7.12 109.559 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.28 64.83 Favored 'General case' 0 C--N 1.405 3.001 0 O-C-N 120.199 -1.563 . . . . 0.0 111.234 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.37 -37.72 36.7 Favored 'General case' 0 C--N 1.427 3.956 0 CA-C-N 118.528 0.604 . . . . 7.79 110.354 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.75 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.577 -0.738 . . . . 7.73 111.059 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -76.1 -42.94 45.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.413 0.523 . . . . 9.61 112.413 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.259 0.552 . . . . 10.06 110.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.04 -16.52 74.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.322 -0.942 . . . . 9.23 112.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.19 37.14 71.88 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.843 -0.903 . . . . 9.25 110.843 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.35 51.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 8.31 112.918 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.8 p -82.58 143.49 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 9.16 110.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.61 -18.47 21.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.18 0.437 . . . . 10.23 112.18 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.49 23.74 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.709 -0.223 . . . . 9.89 110.693 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.4 143.61 99.66 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.926 1.751 . . . . 11.04 110.825 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.22 161.63 20.69 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.639 -0.791 . . . . 9.31 112.441 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.3 134.5 73.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.089 0.403 . . . . 7.97 112.089 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.26 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.492 2.128 . . . . 6.59 111.315 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.65 105.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.135 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -35.05 33.28 Favored 'General case' 0 N--CA 1.53 3.525 0 O-C-N 120.279 -1.513 . . . . 0.0 113.277 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.84 163.95 39.18 Favored 'General case' 0 C--N 1.386 2.167 0 C-N-CA 126.05 1.74 . . . . 0.0 110.591 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.19 130.45 11.04 Favored 'Isoleucine or valine' 0 C--N 1.372 1.549 0 C-N-CA 126.534 1.934 . . . . 5.67 109.297 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.06 126.7 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.798 -0.445 . . . . 6.47 109.798 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -115.06 125.98 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 116.904 2.187 . . . . 7.1 116.904 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -98.05 91.38 5.27 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 103.193 -2.891 . . . . 8.1 103.193 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -57.4 7.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.612 1.708 . . . . 10.19 115.612 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.76 75.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.839 0.681 . . . . 10.51 112.839 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.04 -9.11 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.834 0.309 . . . . 9.72 111.834 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.15 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.495 1.294 . . . . 8.04 114.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.64 168.56 19.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.184 -1.007 . . . . 6.83 111.663 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.51 161.17 41.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.446 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.27 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.726 -0.842 . . . . 5.71 108.726 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.0 mt -94.82 137.58 33.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.451 -0.34 . . . . 4.27 110.337 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.73 25.98 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.702 -0.481 . . . . 6.21 109.702 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.7 164.78 11.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.928 -0.578 . . . . 6.14 111.953 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.67 -25.87 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 8.37 111.484 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.5 p -129.0 159.6 35.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.17 0.509 . . . . 7.92 111.579 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.924 HG13 ' HB3' ' A' ' 148' ' ' ALA . 40.9 t -74.34 -41.73 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.523 -0.762 . . . . 8.77 112.201 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.78 -41.72 95.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.32 0.489 . . . . 9.08 112.32 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.91 -43.85 97.99 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.192 -0.299 . . . . 7.46 110.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.15 -53.28 55.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.332 1.063 . . . . 6.18 108.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.619 HG22 HH22 ' A' ' 228' ' ' ARG . 3.7 p -56.19 -26.15 49.64 Favored 'General case' 1 C--N 1.449 4.894 0 C-N-CA 126.15 1.78 . . . . 0.0 110.195 178.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.51 -34.05 41.57 Favored 'General case' 0 C--N 1.428 3.995 0 N-CA-C 113.602 0.964 . . . . 8.7 113.602 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.36 64.14 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.72 0.637 . . . . 5.94 112.72 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.02 -19.93 63.38 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.532 1.145 . . . . 6.89 111.597 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.42 -9.27 52.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 7.4 111.683 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.18 14.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 6.97 111.704 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.86 120.99 14.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.886 0.374 . . . . 7.38 110.803 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.86 -4.85 66.06 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.906 -0.664 . . . . 7.92 113.584 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.858 0.329 . . . . 7.5 111.086 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.95 121.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.271 0.558 . . . . 9.49 111.286 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.64 7.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.698 -0.683 . . . . 8.45 110.347 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.73 42.71 13.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 10.44 111.759 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.1 -5.5 54.08 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.186 0.834 . . . . 10.21 115.186 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.62 130.84 55.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.654 0.727 . . . . 9.94 112.405 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.72 101.49 10.91 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.535 -0.913 . . . . 8.4 108.535 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.28 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.088 1.144 . . . . 6.9 114.088 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.727 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.51 110.26 21.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.588 -1.264 . . . . 8.29 107.588 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.92 126.95 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 6.17 112.334 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.62 170.52 15.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.047 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 209' ' ' THR . 3.5 mtp180 -89.09 154.67 49.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.559 -0.904 . . . . 7.86 108.559 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.38 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.97 1.78 . . . . 7.79 111.987 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -83.87 -30.39 26.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.9 p-10 -96.97 21.99 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.973 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -70.02 -22.53 63.09 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -111.43 100.7 48.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.09 19.8 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.908 2.405 . . . . 0.0 111.323 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 34.0 tp 58.75 75.41 0.52 Allowed Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.678 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.69 46.6 2.2 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.417 2.745 . . . . 0.0 112.351 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.17 57.11 6.4 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.692 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 26.2 ttt -101.81 -26.64 13.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.4 p -104.23 139.62 38.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 241' ' ' ASN . 34.3 tt0 -137.45 179.74 6.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.831 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 18.5 m120 -63.13 -54.56 44.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 121.352 -0.139 . . . . 0.0 110.938 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.831 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 8.5 Cg_endo -91.41 -175.25 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.673 2.249 . . . . 0.0 111.613 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 246' ' ' VAL . 45.8 m 62.09 27.17 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.204 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.73 -14.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -125.34 -48.43 1.7 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.098 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 243' ' ' SER . 5.5 m -126.24 133.25 24.77 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.51 31.29 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.985 2.456 . . . . 0.0 113.158 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 141.59 -157.77 26.34 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.6 t -75.68 -41.99 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.66 178.89 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.817 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.8 m -145.65 90.42 2.0 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.2 m -77.98 -42.19 33.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.651 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.03 86.85 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.348 0.594 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.36 136.46 22.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.617 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.59 119.92 5.67 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.611 2.208 . . . . 0.0 113.076 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.97 150.75 20.84 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 p -63.72 145.04 56.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.98 169.91 12.36 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -92.79 31.12 1.43 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.042 -0.663 . . . . 10.8 110.74 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.01 139.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.185 0.517 . . . . 8.21 110.278 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 334' ' ' ARG . 47.9 mt -109.73 143.86 38.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.032 -0.986 . . . . 6.33 112.862 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -104.49 132.14 51.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.0 121.21 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.54 -0.541 . . . . 5.68 109.54 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.722 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.19 86.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.656 -0.783 . . . . 7.67 111.511 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.5 mt -70.86 135.25 85.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.154 . . . . 8.16 111.409 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 35.4 Cg_exo -61.82 141.55 90.52 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.952 1.768 . . . . 8.96 108.737 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.39 -14.94 62.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.703 1.371 . . . . 11.61 114.703 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -84.07 -23.27 30.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.811 1.412 . . . . 11.06 114.811 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.23 149.17 50.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.125 0.421 . . . . 9.36 111.366 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.5 p-10 -114.51 -176.46 2.91 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.293 -0.262 . . . . 10.46 110.293 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -53.55 -55.4 25.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 114.632 1.345 . . . . 9.92 114.632 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -26.46 67.89 Favored 'General case' 0 C--N 1.406 3.042 0 C-N-CA 125.639 1.576 . . . . 0.0 112.531 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -79.95 -48.34 13.55 Favored 'General case' 0 C--N 1.428 3.979 0 CA-C-N 118.307 0.503 . . . . 10.06 111.447 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 79.5 t -62.67 -49.14 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 7.76 110.286 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 33.0 mtmm -54.28 -36.48 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 9.67 111.332 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.99 -53.38 56.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 10.2 110.716 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.77 -33.09 33.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.08 -0.509 . . . . 7.62 110.393 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.469 HD13 ' SG ' ' A' ' 305' ' ' CYS . 78.5 mt -82.62 -41.72 19.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.588 0.588 . . . . 7.74 112.588 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 83.0 m -56.82 -29.9 63.22 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.523 0.935 . . . . 10.09 113.523 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 19.8 m -50.26 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.549 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 316' ' ' ALA . 33.8 m-85 -111.33 -11.95 14.1 Favored 'General case' 1 C--N 1.444 4.688 0 CA-C-N 118.372 0.533 . . . . 10.23 111.426 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.835 -0.621 . . . . 10.4 111.94 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.72 147.11 93.48 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.743 2.295 . . . . 12.19 112.627 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 82.5 mt -102.43 146.24 28.36 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.869 -0.605 . . . . 10.66 111.23 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.06 -22.48 14.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.308 -0.627 . . . . 11.41 109.308 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.33 127.66 5.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 119.294 -2.129 . . . . 0.0 109.099 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.0 t80 -144.56 134.65 24.07 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 122.852 0.461 . . . . 8.77 112.008 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -144.73 124.14 13.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.764 0.316 . . . . 8.38 111.513 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -101.02 118.2 36.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.524 -1.287 . . . . 8.94 107.524 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.22 122.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.465 0.913 . . . . 9.37 113.465 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -119.19 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.436 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.2 t70 -58.89 141.15 54.27 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.966 0.412 . . . . 13.83 111.039 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.614 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 15.5 m -49.68 -61.7 1.97 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.616 . . . . 14.58 112.633 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.06 -64.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.476 0.547 . . . . 16.19 112.476 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.49 -59.33 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 14.94 111.18 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.07 62.55 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.567 -0.825 . . . . 13.57 114.554 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.29 167.64 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.394 0.597 . . . . 13.28 110.886 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.5 t -59.24 142.03 52.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 10.43 111.635 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.857 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.8 mmmp? -87.91 -9.46 53.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 11.2 109.573 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.42 39.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.644 -0.707 . . . . 8.63 113.895 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -142.9 146.43 34.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.126 0.963 . . . . 9.19 112.903 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.1 46.73 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.106 -0.952 . . . . 6.21 112.23 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -111.39 146.93 36.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.221 -0.899 . . . . 7.09 110.348 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.568 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.6 p -157.91 156.21 30.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.924 -0.711 . . . . 6.77 111.919 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -145.31 127.1 15.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.68 -0.691 . . . . 9.59 109.61 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 63.9 m-85 -82.55 164.87 20.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.417 . . . . 9.91 112.041 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.5 -46.13 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.384 -0.969 . . . . 12.81 108.384 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.705 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.28 102.35 14.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.355 -1.35 . . . . 13.18 107.355 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.05 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 115.303 1.594 . . . . 12.23 115.303 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -56.84 -38.71 73.05 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.264 1.03 . . . . 13.04 109.009 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.78 -22.63 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 112.265 -2.243 . . . . 11.08 109.549 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.62 -48.22 72.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.931 -0.766 . . . . 9.11 108.931 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.45 -42.81 99.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.184 -0.607 . . . . 10.31 110.52 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.8 -32.47 73.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 119.943 -0.703 . . . . 11.98 111.909 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . . . -69.43 -34.79 74.96 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.626 -1.624 . . . . 8.25 113.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 74.7 mt -68.54 -51.3 47.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 121.403 0.621 . . . . 7.4 110.861 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.1 -38.63 68.38 Favored 'General case' 0 C--N 1.419 3.603 0 C-N-CA 126.141 1.776 . . . . 0.0 113.172 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -23.92 36.68 Favored Glycine 1 C--N 1.398 4.008 0 N-CA-C 116.845 1.498 . . . . 8.35 116.845 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 330' ' ' LEU . 80.2 mt -96.9 -45.71 6.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 120.122 1.961 . . . . 7.2 113.957 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -50.54 130.07 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 7.86 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.16 -16.65 56.76 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.091 -0.576 . . . . 8.64 113.955 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.2 ttt -50.67 147.19 4.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.755 0.312 . . . . 8.0 111.298 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -95.05 115.61 27.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 10.39 111.635 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.25 106.77 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.118 -1.068 . . . . 8.95 108.118 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.08 -118.67 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.382 -1.487 . . . . 10.63 109.382 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -115.84 22.49 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.129 0.49 . . . . 12.25 109.749 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -123.9 153.83 40.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.673 -0.694 . . . . 9.98 111.612 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -101.79 118.3 36.64 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.071 -1.085 . . . . 10.14 108.071 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.711 ' HB2' HD23 ' A' ' 325' ' ' LEU . 23.8 tp -63.03 143.13 58.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.502 0.668 . . . . 7.52 112.642 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 1.451 ' CD1' ' H3 ' ' B' ' 602' ' ' ' U' . 3.7 mp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.574 -1.193 . . . . 7.48 108.977 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.96 123.98 26.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 O-C-N 120.939 -1.101 . . . . 6.45 109.997 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 339' ' ' ALA . 16.0 pt20 -152.68 155.35 37.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 119.965 -1.709 . . . . 7.66 109.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.541 ' HA ' HD23 ' A' ' 261' ' ' LEU . 82.1 mtt180 -58.63 122.53 13.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.403 -1.319 . . . . 8.94 107.533 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.734 1.383 . . . . 7.52 114.734 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.0 m -119.4 -78.29 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.623 -0.431 . . . . 9.07 111.262 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 30.0 m -126.75 141.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.604 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 152.05 -71.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 333' ' ' GLN . . . -102.05 112.84 25.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.078 0.466 . . . . 0.0 110.19 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -167.52 -56.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.965 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -93.32 -41.55 9.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.901 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 339' ' ' ALA . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.857 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.176 0 O4'-C1'-N19 109.398 1.198 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 1.451 ' H3 ' ' CD1' ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 O4'-C1'-C2' 107.522 0.801 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.451 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.104 0 C4'-C3'-C2' 103.642 0.942 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.727 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 O3'--C3' 1.516 6.607 1 C4'-C3'-C2' 98.382 -4.318 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 004 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.614 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.696 7.456 0 C4'-C3'-C2' 106.662 3.962 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.975 0 C4'-C3'-C2' 105.54 2.84 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 0.61 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 O4'-C1'-C2' 107.589 0.849 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.964 0 C3'-C2'-C1' 100.84 -0.734 . 0.028 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-C1' 100.763 -0.819 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' HG13 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.634 0.254 . . . . 0.0 111.483 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -87.29 50.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 110.53 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -156.22 148.61 23.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 5.88 111.203 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.3 mt -140.8 143.56 34.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 5.25 111.185 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.59 125.16 40.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.851 -0.796 . . . . 6.58 108.851 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.79 101.21 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.088 0.47 . . . . 5.06 110.201 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -178.96 34.97 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.998 -0.547 . . . . 6.2 112.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 50.53 40.71 24.09 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.122 1.369 . . . . 0.0 110.224 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.62 149.88 88.59 Favored Pre-proline 1 C--N 1.428 4.01 0 C-N-CA 123.595 0.758 . . . . 7.79 111.302 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.07 144.47 89.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.297 1.998 . . . . 8.57 110.967 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.0 139.71 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.987 0.422 . . . . 11.37 111.94 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.19 6.56 61.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.792 -0.64 . . . . 9.94 114.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.17 136.47 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 117.331 0.566 . . . . 8.91 110.283 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.3 p -84.9 153.99 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.517 -0.31 . . . . 9.64 110.652 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.19 -43.21 96.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 7.44 110.146 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.72 -45.96 91.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.575 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.62 -26.35 68.57 Favored 'General case' 0 C--N 1.41 3.199 0 O-C-N 119.296 -2.127 . . . . 0.0 111.664 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.41 -34.17 67.66 Favored 'General case' 0 C--N 1.428 3.982 0 O-C-N 123.985 0.803 . . . . 6.64 111.708 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.6 -54.24 7.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 123.47 0.708 . . . . 6.69 111.102 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.54 -33.77 60.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.426 -0.806 . . . . 8.8 111.391 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.75 -53.6 17.65 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.604 -0.438 . . . . 7.44 111.572 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.39 -48.22 82.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.79 -42.93 80.35 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.342 -0.543 . . . . 7.12 109.591 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.2 -22.98 64.78 Favored 'General case' 0 C--N 1.406 3.038 0 O-C-N 120.181 -1.574 . . . . 0.0 111.302 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.63 -37.55 35.8 Favored 'General case' 0 C--N 1.427 3.961 0 CA-C-N 118.56 0.618 . . . . 7.79 110.309 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.81 -36.67 82.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.614 -0.721 . . . . 7.73 111.022 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -76.12 -43.03 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.375 0.509 . . . . 9.61 112.375 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.99 -37.69 88.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.186 0.517 . . . . 10.06 110.471 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.44 74.58 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.196 -1.002 . . . . 9.23 112.871 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.1 37.09 72.65 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.908 -0.877 . . . . 9.25 110.908 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.8 5.22 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.945 0.72 . . . . 8.31 112.945 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.3 p -82.65 143.46 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.591 0.234 . . . . 9.16 110.524 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.69 -18.41 21.33 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.047 0.388 . . . . 10.23 112.047 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.44 23.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.704 -0.225 . . . . 9.89 110.674 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.31 143.46 99.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.033 1.822 . . . . 11.04 110.748 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.4 161.67 20.53 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.611 -0.804 . . . . 9.31 112.355 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.36 134.42 73.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.003 0.372 . . . . 7.97 112.003 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.24 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 6.59 111.325 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.6 105.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.174 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -33.78 29.67 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 120.212 -1.555 . . . . 0.0 113.418 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.17 40.58 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 126.054 1.742 . . . . 0.0 110.647 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.73 130.43 12.12 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 126.309 1.844 . . . . 5.67 109.298 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.04 126.65 55.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.823 -0.436 . . . . 6.47 109.823 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 116.875 2.176 . . . . 7.1 116.875 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.11 91.32 5.22 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.186 -2.894 . . . . 8.1 103.186 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.22 -57.43 7.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.619 1.711 . . . . 10.19 115.619 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.18 -48.73 75.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.884 0.698 . . . . 10.51 112.884 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.01 -9.13 50.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.74 0.305 . . . . 9.72 111.764 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.14 15.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 114.516 1.302 . . . . 8.04 114.516 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.418 ' CD2' ' OP1' ' B' ' 606' ' ' ' U' . 13.2 p90 -143.58 168.64 19.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.11 -1.036 . . . . 6.83 111.632 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.604 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.05 41.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.149 -1.387 . . . . 5.19 110.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.35 51.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.691 -0.855 . . . . 5.71 108.691 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.87 137.6 33.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 4.27 110.297 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.8 114.74 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.698 -0.482 . . . . 6.21 109.698 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.69 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.965 -0.561 . . . . 6.14 111.935 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.68 -25.93 22.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.822 . . . . 8.37 111.462 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.4 p -128.85 159.6 35.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 7.92 111.687 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.458 HG13 ' HB1' ' A' ' 148' ' ' ALA . 40.6 t -74.29 -41.77 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 8.77 112.247 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.7 -41.77 95.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.343 0.497 . . . . 9.08 112.343 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.236 -0.283 . . . . 7.46 110.236 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.8 m -54.24 -53.9 47.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.317 1.056 . . . . 6.18 108.15 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 m -55.03 -27.22 42.85 Favored 'General case' 1 C--N 1.429 4.041 0 C-N-CA 127.082 2.153 . . . . 0.0 109.859 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.27 -34.21 42.78 Favored 'General case' 0 C--N 1.42 3.662 0 N-CA-C 113.578 0.955 . . . . 8.7 113.578 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.45 64.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.621 0.6 . . . . 5.94 112.621 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.82 63.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.449 1.093 . . . . 6.89 111.617 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.2 52.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 7.4 111.62 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.91 16.2 14.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.529 -0.305 . . . . 6.97 111.591 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.95 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 7.38 110.767 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.81 -4.76 66.14 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.907 -0.663 . . . . 7.92 113.619 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.37 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.877 0.338 . . . . 7.5 111.08 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.278 0.561 . . . . 9.49 111.31 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.31 107.81 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 8.45 110.3 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.62 42.74 13.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.034 -0.53 . . . . 10.44 111.823 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.0 -5.47 53.71 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.225 0.85 . . . . 10.21 115.225 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.58 130.96 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.686 0.743 . . . . 9.94 112.405 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.56 10.96 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.507 -0.923 . . . . 8.4 108.507 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.35 137.84 58.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.974 1.102 . . . . 6.9 113.974 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.605 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.54 110.31 21.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.513 -1.291 . . . . 8.29 107.513 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.99 126.88 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.35 0.5 . . . . 6.17 112.35 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.43 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.6 170.44 15.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.474 -0.785 . . . . 7.99 110.067 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.06 154.68 49.66 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.599 -0.889 . . . . 7.86 108.599 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.31 174.9 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.795 1.663 . . . . 7.79 112.057 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -104.29 -80.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 1.175 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 3.7 m-20 46.28 -98.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.903 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.13 -72.55 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -160.45 129.1 3.01 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.922 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.53 -45.31 41.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.841 2.361 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.0 tp -114.3 99.53 51.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.409 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.69 117.14 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.605 2.203 . . . . 0.0 112.441 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.56 -43.19 4.01 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -148.35 165.5 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 70.4 m -120.41 -58.5 1.84 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.5 0.19 . . . . 0.0 110.922 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -18.48 1.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.901 0.381 . . . . 0.0 110.994 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -105.04 147.69 34.91 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.49 -49.97 14.26 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.926 2.417 . . . . 0.0 112.505 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m 69.71 161.42 0.21 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.909 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.6 t 67.37 99.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.804 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -96.33 -47.74 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.117 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 18.4 m -91.34 140.2 25.54 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.243 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 36.5 Cg_exo -57.44 -50.57 10.51 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.057 2.504 . . . . 0.0 112.884 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 68.53 38.26 86.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.686 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.74 -14.99 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.476 0.655 . . . . 0.0 110.108 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.46 165.28 2.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.233 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 27.5 p 50.66 85.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.453 0.701 . . . . 0.0 111.487 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 48.1 m -64.8 100.53 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.211 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.02 -51.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.727 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.4 t 63.6 89.22 0.11 Allowed Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.311 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.08 -45.53 15.72 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.787 2.325 . . . . 0.0 112.022 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.52 88.49 7.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 110.102 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.2 t -141.97 150.01 40.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.419 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.641 ' O ' ' HB2' ' A' ' 259' ' ' HIS . . . -146.62 -69.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.275 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.641 ' HB2' ' O ' ' A' ' 258' ' ' ALA . 59.4 m80 89.65 30.43 0.02 OUTLIER 'General case' 0 C--N 1.344 0.326 0 O-C-N 124.456 1.097 . . . . 10.8 110.958 -172.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.92 139.27 58.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.204 0.526 . . . . 8.21 110.367 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 334' ' ' ARG . 59.4 mt -109.74 143.97 38.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.015 -0.993 . . . . 6.33 112.829 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.4 132.17 50.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.147 -1.427 . . . . 6.75 107.147 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.04 121.29 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.565 -0.532 . . . . 5.68 109.565 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.22 16.5 Favored Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.461 -0.876 . . . . 6.53 112.693 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.12 86.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.634 -0.794 . . . . 7.67 111.517 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 92.7 mt -70.79 135.27 85.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.48 0.178 . . . . 8.16 111.48 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.6 Cg_exo -61.85 141.51 90.18 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.923 1.748 . . . . 8.96 108.796 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -65.36 -14.86 61.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.763 1.394 . . . . 11.61 114.763 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -84.15 -23.17 30.75 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.77 1.396 . . . . 11.06 114.77 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 149.21 50.71 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.121 0.418 . . . . 9.36 111.31 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 10.0 p-10 -114.51 -176.39 2.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.578 -0.283 . . . . 10.46 110.296 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 10.8 m-20 -53.64 -55.21 27.9 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 114.622 1.341 . . . . 9.92 114.622 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.33 -26.77 68.03 Favored 'General case' 0 C--N 1.405 2.995 0 C-N-CA 125.697 1.599 . . . . 0.0 112.456 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.07 -48.22 13.61 Favored 'General case' 1 C--N 1.429 4.031 0 O-C-N 123.489 0.493 . . . . 10.06 111.398 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 71.9 t -62.69 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 7.76 110.237 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 26.7 mtmm -54.27 -36.45 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.662 -0.699 . . . . 9.67 111.297 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.06 -53.3 57.37 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 10.2 110.7 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -51.73 -33.15 33.45 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 116.195 -0.457 . . . . 7.62 110.322 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.499 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.9 mt -82.67 -41.67 19.08 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.568 0.581 . . . . 7.74 112.568 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 53.1 m -56.86 -29.41 62.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.546 0.943 . . . . 10.09 113.546 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -50.11 -10.82 0.06 Allowed 'General case' 0 C--N 1.395 2.572 0 C-N-CA 125.062 1.345 . . . . 0.0 112.563 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.51 -12.03 14.01 Favored 'General case' 1 C--N 1.445 4.733 0 CA-C-N 118.174 0.443 . . . . 10.23 111.499 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.31 10.25 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.795 -0.638 . . . . 10.4 111.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.64 147.09 93.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.677 2.252 . . . . 12.19 112.681 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.3 mt -102.47 146.31 28.29 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.889 -0.596 . . . . 10.66 111.304 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.6 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 12.8 ptpt -101.11 -22.56 14.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 11.41 109.227 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.07 127.23 5.73 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 119.152 -2.217 . . . . 0.0 108.975 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.618 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 60.2 t80 -144.43 134.75 24.41 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 122.769 0.428 . . . . 8.77 112.013 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -144.79 124.03 12.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.813 0.339 . . . . 8.38 111.634 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 52.0 tp -100.88 118.27 36.6 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.592 -1.262 . . . . 8.94 107.592 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.24 122.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.507 0.929 . . . . 9.37 113.507 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.09 148.1 43.42 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.315 -0.857 . . . . 11.34 109.373 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 36.9 t70 -58.92 141.05 54.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.92 0.39 . . . . 13.83 110.958 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.738 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 14.6 m -49.59 -61.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.795 -0.638 . . . . 14.58 112.65 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.2 -64.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.422 0.527 . . . . 16.19 112.422 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.621 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 18.4 m -42.4 -59.39 1.86 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 14.94 111.209 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.65 -6.05 62.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.643 -0.789 . . . . 13.57 114.493 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.29 167.69 13.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.425 0.612 . . . . 13.28 110.913 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -59.25 142.01 52.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 10.43 111.572 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.913 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.96 -9.4 53.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.795 -0.639 . . . . 11.2 109.619 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.61 -3.4 39.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.597 -0.729 . . . . 8.63 113.874 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.97 146.41 33.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.03 0.915 . . . . 9.19 112.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.2 46.74 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.101 -0.954 . . . . 6.21 112.242 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -111.42 146.84 36.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.186 -0.916 . . . . 7.09 110.422 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.618 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.2 p -157.87 156.19 30.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 119.9 -0.72 . . . . 6.77 111.875 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.404 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 37.5 tt0 -145.27 127.0 15.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.702 -0.681 . . . . 9.59 109.713 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.6 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 56.4 m-85 -82.39 164.85 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.941 0.4 . . . . 9.91 112.06 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.51 -46.11 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.428 -0.953 . . . . 12.81 108.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.1 t70 -96.32 102.39 14.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.391 -1.337 . . . . 13.18 107.391 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -52.76 -34.97 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 115.288 1.588 . . . . 12.23 115.288 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.84 -38.76 73.11 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 122.175 0.988 . . . . 13.04 108.979 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.7 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 112.366 -2.197 . . . . 11.08 109.552 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.67 -48.1 72.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.935 -0.765 . . . . 9.11 108.935 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -62.52 -42.77 99.74 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.205 -0.598 . . . . 10.31 110.486 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -63.88 -32.39 73.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.932 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.77 74.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.711 -1.586 . . . . 8.25 113.036 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 313' ' ' THR . 63.6 mt -68.63 -51.3 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 7.4 110.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.03 67.59 Favored 'General case' 0 C--N 1.42 3.642 0 C-N-CA 126.185 1.794 . . . . 0.0 113.152 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.93 -23.9 36.92 Favored Glycine 1 C--N 1.399 4.055 0 N-CA-C 116.781 1.472 . . . . 8.35 116.781 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 330' ' ' LEU . 96.9 mt -96.92 -45.7 6.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.214 2.007 . . . . 7.2 114.039 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -50.45 129.98 22.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.845 0.355 . . . . 7.86 111.426 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.65 56.79 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.145 -0.55 . . . . 8.64 113.956 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 16.4 mtt -50.64 147.19 4.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.822 0.311 . . . . 8.0 111.267 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -95.09 115.65 27.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.03 0.443 . . . . 10.39 111.71 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.7 mm? -120.2 106.77 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.113 -1.069 . . . . 8.95 108.113 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.14 -118.65 10.51 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.38 -1.488 . . . . 10.63 109.38 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -115.86 22.41 13.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.202 0.525 . . . . 12.25 109.818 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -123.82 153.91 40.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.599 -0.728 . . . . 9.98 111.629 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -101.7 118.41 36.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.115 -1.068 . . . . 10.14 108.115 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.601 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.6 tp -63.21 143.16 58.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.515 0.674 . . . . 7.52 112.653 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.539 -1.209 . . . . 7.48 108.942 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.96 124.02 26.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 O-C-N 120.935 -1.103 . . . . 6.45 110.01 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -152.7 155.31 37.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.973 -1.704 . . . . 7.66 109.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.673 ' HD2' ' HA2' ' A' ' 338' ' ' GLY . 84.6 mtt180 -58.66 122.44 13.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 118.463 -1.295 . . . . 8.94 107.612 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.77 0.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.766 1.395 . . . . 7.52 114.766 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.5 m -119.47 -79.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.539 -0.465 . . . . 9.07 111.297 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.02 158.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.619 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . 0.673 ' HA2' ' HD2' ' A' ' 334' ' ' ARG . . . -85.51 63.41 4.31 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.911 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -69.87 100.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.961 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -126.42 144.03 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.363 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.74 100.7 0.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.987 0.804 . . . . 0.0 110.91 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.724 179.181 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.913 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.505 -2.264 0 C3'-C2'-C1' 100.424 -1.196 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 0.412 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.907 0 O4'-C1'-C2' 107.514 0.796 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.446 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C4'-C3'-C2' 103.427 0.727 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.605 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.503 5.738 0 C4'-C3'-C2' 99.205 -3.495 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.738 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.683 6.373 0 C4'-C3'-C2' 106.186 3.486 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.418 ' OP1' ' CD2' ' A' ' 197' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.012 0 C4'-C3'-C2' 105.671 2.971 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 1.175 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.035 0 O4'-C1'-C2' 107.645 0.889 . 0.075 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 O4'-C1'-C2' 107.135 0.525 . 0.105 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 O4'-C1'-C2' 107.197 0.569 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 56.09 46.1 22.27 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.581 0.55 . . . . 0.0 111.438 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -158.7 148.52 19.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.064 0.946 . . . . 5.88 111.127 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 28.0 mt -140.67 143.55 35.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.541 . . . . 5.25 111.282 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.61 125.19 40.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.854 -0.795 . . . . 6.58 108.854 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.8 101.33 8.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 5.06 110.196 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.77 -178.63 35.0 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.914 -0.585 . . . . 6.2 112.792 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.25 40.83 23.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 124.969 1.308 . . . . 0.0 110.121 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.83 149.8 88.09 Favored Pre-proline 1 C--N 1.428 4.021 0 C-N-CA 123.477 0.711 . . . . 7.79 111.286 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.07 144.48 89.84 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.297 1.998 . . . . 8.57 110.989 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.96 139.72 52.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 11.37 111.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.1 6.6 61.0 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.833 -0.621 . . . . 9.94 114.303 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.12 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.399 0.6 . . . . 8.91 110.305 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.4 p -84.89 153.98 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.614 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -60.18 -43.31 95.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 7.44 110.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.51 -46.22 90.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.106 -0.497 . . . . 9.89 110.516 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.37 -26.39 68.43 Favored 'General case' 0 C--N 1.41 3.233 0 O-C-N 119.26 -2.15 . . . . 0.0 111.734 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.484 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.49 -34.08 67.41 Favored 'General case' 1 C--N 1.429 4.034 0 O-C-N 123.984 0.802 . . . . 6.64 111.742 171.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.63 -54.31 7.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.424 0.69 . . . . 6.69 111.057 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.61 -33.68 60.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.453 -0.794 . . . . 8.8 111.345 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.76 -53.53 17.93 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 120.41 -0.516 . . . . 7.44 111.611 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.31 -48.27 82.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.82 -42.81 80.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.294 -0.562 . . . . 7.12 109.64 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.57 65.16 Favored 'General case' 0 C--N 1.407 3.076 0 O-C-N 120.261 -1.524 . . . . 0.0 111.227 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.38 -37.66 36.77 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.528 0.604 . . . . 7.79 110.319 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.8 -36.61 82.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.58 -0.736 . . . . 7.73 111.079 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HD3' HH11 ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.17 -43.02 44.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.38 0.511 . . . . 9.61 112.38 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.2 mt -63.0 -37.73 88.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.203 0.525 . . . . 10.06 110.415 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -16.46 74.61 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.225 -0.988 . . . . 9.23 112.894 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.15 71.6 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.774 -0.93 . . . . 9.25 110.774 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.9 5.27 51.95 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.939 0.718 . . . . 8.31 112.939 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.0 p -82.6 143.42 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.183 -0.207 . . . . 9.16 110.609 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.149 0.426 . . . . 10.23 112.149 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.5 23.71 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.731 -0.213 . . . . 9.89 110.688 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.37 143.56 99.68 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.915 1.743 . . . . 11.04 110.821 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.29 161.61 20.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.656 -0.783 . . . . 9.31 112.467 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.25 134.48 73.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.025 0.38 . . . . 7.97 112.025 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.4 Cg_exo -73.25 -50.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.573 2.182 . . . . 6.59 111.368 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.151 -0.477 . . . . 5.87 111.107 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -33.17 33.27 Favored 'General case' 0 N--CA 1.524 3.272 0 C-N-CA 124.878 1.271 . . . . 0.0 113.394 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 163.78 39.17 Favored 'General case' 0 C--N 1.386 2.181 0 C-N-CA 125.757 1.623 . . . . 0.0 110.577 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.45 130.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 C-N-CA 126.091 1.756 . . . . 5.67 109.338 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.686 -0.487 . . . . 6.47 109.686 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.1 mt -114.93 125.99 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 116.903 2.186 . . . . 7.1 116.903 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.14 91.42 5.26 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 103.187 -2.894 . . . . 8.1 103.187 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -57.46 7.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.645 1.72 . . . . 10.19 115.645 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.14 -48.78 75.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.853 0.686 . . . . 10.51 112.853 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.566 ' HD3' " O2'" ' B' ' 605' ' ' ' U' . 9.5 mmtm -68.99 -9.07 50.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 9.72 111.849 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.15 15.5 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.579 1.326 . . . . 8.04 114.579 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.52 168.7 19.23 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.12 -1.032 . . . . 6.83 111.671 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.61 161.02 42.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.035 -1.438 . . . . 5.19 110.515 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.35 51.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.624 -0.88 . . . . 5.71 108.624 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.8 137.56 33.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.355 -0.384 . . . . 4.27 110.351 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.83 114.82 26.05 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 6.21 109.645 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -99.77 164.67 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 6.14 111.947 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -26.04 22.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.425 -0.807 . . . . 8.37 111.461 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.1 p -128.86 159.64 35.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.1 0.476 . . . . 7.92 111.646 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.569 -0.741 . . . . 8.77 112.303 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.64 -41.79 95.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.364 0.505 . . . . 9.08 112.364 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.77 98.17 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.25 -54.48 39.49 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.13 -1.063 . . . . 6.18 108.13 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.0 m -54.3 -27.56 36.26 Favored 'General case' 1 C--N 1.429 4.032 0 C-N-CA 127.029 2.132 . . . . 0.0 109.853 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.01 -34.0 44.42 Favored 'General case' 0 C--N 1.426 3.897 0 N-CA-C 113.648 0.981 . . . . 8.7 113.648 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.55 -17.35 64.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.626 0.602 . . . . 5.94 112.626 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.5 mtp -62.12 -19.86 63.46 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.29 0.994 . . . . 6.89 111.569 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.24 52.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.383 -0.371 . . . . 7.4 111.608 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.77 16.16 14.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.747 0.308 . . . . 6.97 111.725 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.85 120.9 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 7.38 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.84 65.95 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.859 -0.686 . . . . 7.92 113.553 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.17 142.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.836 0.318 . . . . 7.5 111.066 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.57 37.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.271 0.558 . . . . 9.49 111.327 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.29 107.71 7.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 8.45 110.354 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.72 42.62 13.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 10.44 111.771 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.34 54.53 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.229 0.851 . . . . 10.21 115.229 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.69 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.652 0.726 . . . . 9.94 112.475 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.71 101.58 10.96 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.486 -0.931 . . . . 8.4 108.486 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.42 137.82 58.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.032 1.123 . . . . 6.9 114.032 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.777 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.47 110.24 21.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.539 -1.282 . . . . 8.29 107.539 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.5 mt -104.12 126.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.217 0.532 . . . . 6.17 112.233 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.433 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.54 170.54 15.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.376 -0.829 . . . . 7.99 110.079 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.13 154.7 49.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.39 175.26 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.954 1.77 . . . . 7.79 112.038 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -98.09 -23.6 15.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.87 137.14 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 233' ' ' GLN . 37.7 t80 -96.17 -53.16 3.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.956 0.408 . . . . 0.0 110.511 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 236' ' ' PRO . 27.2 mm-40 -130.61 154.36 81.7 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.84 -66.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.755 2.303 . . . . 0.0 112.507 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 236' ' ' PRO . 81.6 mt -92.69 -55.31 0.24 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 235' ' ' LEU . 46.3 Cg_endo -69.29 148.2 67.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.908 1.739 . . . . 0.0 112.972 -176.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -156.42 53.1 0.42 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -139.58 153.33 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.624 0.25 . . . . 0.0 110.335 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 47.6 m -127.22 114.28 17.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 111.301 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.6 -48.54 69.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.352 0.596 . . . . 0.0 109.51 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -127.33 99.69 27.32 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.446 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.89 113.19 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.879 2.386 . . . . 0.0 112.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -106.5 115.49 30.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.79 -30.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.762 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -152.49 102.01 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.265 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.33 130.9 23.9 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.176 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.08 119.54 6.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.78 2.32 . . . . 0.0 112.124 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 137.88 -176.33 20.73 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 95.9 t 62.45 96.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 111.162 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.9 m -79.35 153.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.486 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.0 t -124.42 -77.62 0.59 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.9 m 67.83 -69.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.512 0.508 . . . . 0.0 111.306 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.3 p -152.94 105.41 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.44 0.638 . . . . 0.0 109.618 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.95 151.3 50.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.95 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.54 12.68 2.8 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.774 2.316 . . . . 0.0 112.355 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.13 156.13 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.586 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 13.1 m -74.91 76.15 2.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -149.03 72.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.484 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -140.05 30.95 1.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 10.8 110.793 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -62.98 139.4 58.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.276 0.56 . . . . 8.21 110.318 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.9 mt -109.8 144.05 38.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.989 -1.005 . . . . 6.33 112.789 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.44 132.03 51.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.02 121.23 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.618 -0.512 . . . . 5.68 109.618 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.13 179.26 16.46 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.483 -0.865 . . . . 6.53 112.719 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.08 86.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.625 -0.798 . . . . 7.67 111.561 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.1 mt -70.79 135.27 85.7 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 111.522 0.193 . . . . 8.16 111.522 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.1 Cg_exo -61.84 141.53 90.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.998 1.799 . . . . 8.96 108.744 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.44 -14.86 61.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.724 1.379 . . . . 11.61 114.724 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -84.21 -22.98 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.827 1.417 . . . . 11.06 114.827 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.31 149.12 50.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.144 0.429 . . . . 9.36 111.325 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.9 p-10 -114.59 -176.49 2.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.233 -0.284 . . . . 10.46 110.233 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.54 -55.35 26.29 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.604 1.335 . . . . 9.92 114.604 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -61.4 -26.53 67.91 Favored 'General case' 0 C--N 1.405 3.006 0 C-N-CA 125.72 1.608 . . . . 0.0 112.51 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.12 -48.28 13.46 Favored 'General case' 1 C--N 1.43 4.086 0 CA-C-N 118.283 0.492 . . . . 10.06 111.385 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.9 t -62.7 -49.16 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.6 . . . . 7.76 110.318 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -54.3 -36.36 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.678 -0.692 . . . . 9.67 111.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.01 -53.43 55.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.167 0.508 . . . . 10.2 110.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 320' ' ' LEU . 3.2 tm? -51.65 -33.28 32.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.115 -0.493 . . . . 7.62 110.365 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.496 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.52 -41.6 19.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.649 0.611 . . . . 7.74 112.649 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 43.5 m -56.94 -29.96 63.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.48 0.919 . . . . 10.09 113.48 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 17.1 m -50.25 -10.02 0.05 Allowed 'General case' 0 C--N 1.395 2.58 0 C-N-CA 124.753 1.221 . . . . 0.0 112.641 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.46 -12.02 14.04 Favored 'General case' 1 C--N 1.444 4.699 0 CA-C-N 118.379 0.536 . . . . 10.23 111.503 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.36 10.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.821 -0.627 . . . . 10.4 111.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.6 147.11 93.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.72 2.28 . . . . 12.19 112.65 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 89.7 mt -102.56 146.27 28.39 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.959 -0.564 . . . . 10.66 111.241 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.01 -22.53 14.73 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.273 -0.64 . . . . 11.41 109.273 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -157.32 129.25 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.483 -2.011 . . . . 0.0 108.836 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -146.21 134.72 22.04 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.654 0.382 . . . . 8.77 111.98 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -144.86 124.11 12.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.866 0.365 . . . . 8.38 111.566 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -100.99 118.17 36.47 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.584 -1.265 . . . . 8.94 107.584 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.18 122.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.515 0.931 . . . . 9.37 113.515 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -119.13 148.14 43.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.262 -0.881 . . . . 11.34 109.413 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.9 t70 -58.92 141.12 54.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.921 0.391 . . . . 13.83 110.914 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.503 ' HB3' ' N3 ' ' B' ' 605' ' ' ' U' . 50.0 m -49.71 -61.72 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.863 -0.608 . . . . 14.58 112.6 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.08 -64.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.471 0.545 . . . . 16.19 112.471 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.48 -59.32 1.91 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.306 -0.407 . . . . 14.94 111.214 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.04 62.54 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.613 -0.804 . . . . 13.57 114.528 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.35 167.6 13.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.334 0.567 . . . . 13.28 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.0 t -59.19 142.07 52.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 10.43 111.624 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.619 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.95 -9.43 53.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.793 -0.64 . . . . 11.2 109.569 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.31 39.53 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.67 -0.695 . . . . 8.63 113.942 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.469 ' CZ ' " H4'" ' B' ' 603' ' ' ' U' . 27.2 p90 -143.01 146.41 33.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.979 0.889 . . . . 9.19 112.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.61 155.16 46.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.078 -0.965 . . . . 6.21 112.169 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.25 146.81 36.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.077 -0.965 . . . . 7.09 110.394 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.597 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.4 p -157.89 156.21 30.95 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 119.983 -0.687 . . . . 6.77 111.871 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -145.3 127.09 15.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 9.59 109.608 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.531 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 52.9 m-85 -82.46 164.85 20.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.932 0.396 . . . . 9.91 112.045 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.55 -46.1 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 108.4 -0.963 . . . . 12.81 108.4 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.34 102.37 14.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.361 -1.348 . . . . 13.18 107.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.02 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 115.291 1.589 . . . . 12.23 115.291 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -56.78 -38.86 73.08 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.294 1.045 . . . . 13.04 109.014 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.52 -22.92 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 112.402 -2.181 . . . . 11.08 109.519 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.53 -48.24 72.2 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.896 -0.779 . . . . 9.11 108.896 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.5 -42.71 99.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.187 -0.605 . . . . 10.31 110.513 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.82 -32.43 73.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 119.939 -0.704 . . . . 11.98 111.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.78 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.67 -1.605 . . . . 8.25 113.027 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.6 -51.23 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.393 0.616 . . . . 7.4 110.833 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.69 -39.0 67.68 Favored 'General case' 0 C--N 1.42 3.649 0 C-N-CA 126.301 1.84 . . . . 0.0 113.171 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.9 -24.09 36.39 Favored Glycine 1 C--N 1.399 4.08 0 N-CA-C 116.817 1.487 . . . . 8.35 116.817 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 278' ' ' LEU . 78.9 mt -96.89 -45.86 6.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 120.189 1.994 . . . . 7.2 113.892 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -50.4 129.99 22.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.812 0.339 . . . . 7.86 111.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.19 -16.69 56.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.11 -0.567 . . . . 8.64 113.905 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.57 147.21 4.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.868 0.334 . . . . 8.0 111.337 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -95.2 115.67 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.053 0.454 . . . . 10.39 111.681 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.595 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -120.19 106.75 12.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.15 -118.75 10.62 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -115.8 22.4 13.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.243 0.544 . . . . 12.25 109.786 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.9 154.0 40.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.642 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.8 118.2 36.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.086 -1.079 . . . . 10.14 108.086 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.595 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.2 tp -63.0 143.06 58.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.485 0.659 . . . . 7.52 112.687 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 1.469 ' CD1' ' H3 ' ' B' ' 602' ' ' ' U' . 3.1 mp -128.13 127.94 43.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.555 -1.202 . . . . 7.48 108.971 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.4 t -137.91 123.98 26.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 O-C-N 121.044 -1.035 . . . . 6.45 109.966 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -152.69 155.29 36.96 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.117 -1.614 . . . . 7.66 109.587 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.51 ' HA ' HD23 ' A' ' 261' ' ' LEU . 92.2 mtt180 -58.56 122.45 13.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 118.544 -1.263 . . . . 8.94 107.603 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.97 -11.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.808 1.41 . . . . 7.52 114.808 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.5 m -119.37 -77.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.629 -0.428 . . . . 9.07 111.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 4.7 m -101.12 79.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.523 0.677 . . . . 0.0 110.744 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -75.77 148.43 36.67 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.813 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.95 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.177 0.513 . . . . 0.0 110.677 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -102.0 136.41 41.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.224 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.03 101.87 13.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.927 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.319 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.619 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.079 0 O4'-C1'-N19 109.358 1.158 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 1.469 ' H3 ' ' CD1' ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 O4'-C1'-C2' 107.604 0.86 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.469 " H4'" ' CZ ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.421 -1.191 0 C4'-C3'-C2' 103.984 1.284 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.777 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 C4'--C3' 1.581 5.153 1 C3'-C2'-C1' 105.204 4.116 . 0.077 4g . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.639 " O2'" ' P ' ' B' ' 606' ' ' ' U' . . . . . . . . 1 P--O3' 1.702 7.89 1 P-O3'-C3' 126.116 5.347 OUTLIER-EPSILON 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 5 4 . 1 . 006 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.639 ' P ' " O2'" ' B' ' 605' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.414 -1.625 0 P-O3'-C3' 122.833 2.611 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.541 1.265 0 O4'-C1'-C2' 107.899 1.07 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C3'-C2'-C1' 100.74 -0.844 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-C1' 100.656 -0.938 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 119.876 -0.107 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.734 ' HB3' HG21 ' A' ' 208' ' ' THR . 5.7 mmt-85 -127.73 -152.26 0.51 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.074 164.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -159.85 149.34 18.05 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 123.259 0.623 . . . . 5.88 111.628 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.71 143.65 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 5.25 111.281 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.62 125.15 40.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.853 -0.795 . . . . 6.58 108.853 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 5.06 110.33 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.66 -179.07 35.07 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.86 -0.609 . . . . 6.2 112.823 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 49.79 41.73 22.76 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 125.214 1.406 . . . . 0.0 110.268 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.85 149.75 88.01 Favored Pre-proline 0 C--N 1.426 3.935 0 C-N-CA 123.684 0.794 . . . . 7.79 111.312 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 144.41 89.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.283 1.989 . . . . 8.57 111.032 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.93 139.66 52.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 11.37 111.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.27 6.5 61.46 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.799 -0.637 . . . . 9.94 114.259 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.05 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.363 0.581 . . . . 8.91 110.271 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.99 153.89 22.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 9.64 110.6 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.1 -43.16 95.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 7.44 110.257 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.68 -46.03 91.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.963 -0.562 . . . . 9.89 110.616 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -26.71 68.58 Favored 'General case' 0 C--N 1.409 3.159 0 O-C-N 119.264 -2.148 . . . . 0.0 111.661 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.42 -34.06 67.58 Favored 'General case' 0 C--N 1.428 3.979 0 O-C-N 123.967 0.792 . . . . 6.64 111.737 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.34 7.73 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.481 0.713 . . . . 6.69 111.115 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.55 -33.72 60.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.367 -0.833 . . . . 8.8 111.387 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.78 -53.57 17.67 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 120.543 -0.463 . . . . 7.44 111.576 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.3 -48.34 81.84 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.145 0.424 . . . . 5.94 112.145 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.78 -42.6 79.72 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.258 -0.577 . . . . 7.12 109.608 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.29 64.72 Favored 'General case' 0 C--N 1.405 3.004 0 O-C-N 120.388 -1.445 . . . . 0.0 111.21 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -79.5 -37.67 36.17 Favored 'General case' 1 C--N 1.428 4.019 0 CA-C-N 118.455 0.57 . . . . 7.79 110.298 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.8 83.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 7.73 111.009 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.15 -42.95 45.03 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.387 0.514 . . . . 9.61 112.387 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.0 -37.75 88.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.259 0.552 . . . . 10.06 110.492 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.02 -16.56 74.46 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.273 -0.965 . . . . 9.23 112.886 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.26 37.01 71.22 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 110.873 -0.891 . . . . 9.25 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.97 5.35 51.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.92 0.711 . . . . 8.31 112.92 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.9 p -82.61 143.48 30.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.586 0.232 . . . . 9.16 110.593 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.61 -18.45 21.37 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.176 0.435 . . . . 10.23 112.176 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.8 163.46 23.78 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.632 -0.258 . . . . 9.89 110.694 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.35 143.54 99.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.965 1.777 . . . . 11.04 110.793 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.58 20.58 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.677 -0.773 . . . . 9.31 112.505 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.033 0.383 . . . . 7.97 112.033 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.558 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.25 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.454 2.103 . . . . 6.59 111.32 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.67 105.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.132 -0.485 . . . . 5.87 111.134 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -36.33 37.92 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 125.37 1.468 . . . . 0.0 112.954 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.13 164.36 38.62 Favored 'General case' 0 C--N 1.386 2.173 0 C-N-CA 125.826 1.651 . . . . 0.0 110.959 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.9 130.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 125.999 1.72 . . . . 5.67 109.337 175.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.93 126.64 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.765 -0.458 . . . . 6.47 109.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 126.0 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 116.941 2.2 . . . . 7.1 116.941 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.12 91.37 5.24 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.149 -2.908 . . . . 8.1 103.149 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.21 -57.43 7.8 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.662 1.727 . . . . 10.19 115.662 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.24 -48.69 75.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.877 0.695 . . . . 10.51 112.877 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.483 ' HD3' " O2'" ' B' ' 605' ' ' ' U' . 9.5 mmtm -68.97 -9.22 51.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.716 0.293 . . . . 9.72 111.77 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 36.11 15.0 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.53 1.307 . . . . 8.04 114.53 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.56 168.63 19.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.093 -1.043 . . . . 6.83 111.612 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.56 161.12 41.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.18 -1.373 . . . . 5.19 110.486 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.38 129.31 51.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.73 -0.841 . . . . 5.71 108.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.81 137.5 33.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.44 -0.345 . . . . 4.27 110.364 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.71 114.73 26.02 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.718 -0.475 . . . . 6.21 109.718 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.73 164.66 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 6.14 111.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.56 -25.98 22.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.515 -0.766 . . . . 8.37 111.392 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.0 p -128.95 159.57 35.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.094 0.473 . . . . 7.92 111.521 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.28 -41.74 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 8.77 112.266 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.63 -41.79 95.92 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.396 0.517 . . . . 9.08 112.396 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.28 -0.267 . . . . 7.46 110.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.9 m -54.17 -53.97 46.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 6.18 108.123 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.6 m -55.07 -27.3 43.78 Favored 'General case' 1 C--N 1.43 4.066 0 C-N-CA 126.953 2.101 . . . . 0.0 109.863 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.14 -34.0 43.69 Favored 'General case' 0 C--N 1.422 3.743 0 N-CA-C 113.657 0.984 . . . . 8.7 113.657 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.33 64.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.651 0.611 . . . . 5.94 112.651 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.09 -19.85 63.41 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.493 1.12 . . . . 6.89 111.614 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.35 53.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 7.4 111.613 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.22 14.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.585 -0.279 . . . . 6.97 111.658 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.89 121.02 14.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.827 0.346 . . . . 7.38 110.782 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.83 66.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.855 -0.688 . . . . 7.92 113.587 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.23 142.39 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.87 0.335 . . . . 7.5 111.153 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.245 0.545 . . . . 9.49 111.278 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.23 107.69 7.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 8.45 110.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.74 42.7 13.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 10.44 111.747 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.44 54.03 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 115.219 0.847 . . . . 10.21 115.219 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.69 130.89 55.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.574 0.687 . . . . 9.94 112.358 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.48 10.86 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.587 -0.894 . . . . 8.4 108.587 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.83 58.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.088 . . . . 6.9 113.939 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.635 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.51 110.24 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.602 -1.259 . . . . 8.29 107.602 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.02 126.96 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.265 0.555 . . . . 6.17 112.289 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.428 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.49 15.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.332 -0.849 . . . . 7.99 110.041 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.04 154.71 49.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.614 -0.884 . . . . 7.86 108.614 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.52 175.12 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.929 1.753 . . . . 7.79 112.007 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -93.74 -9.56 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.946 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.3 p-10 -93.41 9.22 37.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.917 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -55.44 -52.47 63.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.221 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.97 134.3 22.51 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.122 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.01 133.98 28.98 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.062 2.508 . . . . 0.0 112.026 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.82 142.02 90.51 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.606 -177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.14 125.1 15.65 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.672 2.248 . . . . 0.0 111.959 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -171.59 -67.33 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -131.72 164.05 26.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 14.2 m -130.47 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.79 -88.57 0.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.83 95.67 49.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.08 -66.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.46 2.107 . . . . 0.0 111.913 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.6 t 51.79 63.58 2.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.398 0.618 . . . . 0.0 110.082 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.8 96.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.848 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -145.52 104.29 3.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.244 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.5 m -96.87 154.84 38.16 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.221 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.38 -33.29 97.54 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.516 2.144 . . . . 0.0 111.81 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 72.55 31.86 62.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.647 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.85 101.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.4 t 65.26 -77.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.762 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 69.3 m -154.67 105.64 2.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.377 . . . . 0.0 110.181 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.8 m -71.61 -29.02 64.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.419 0.628 . . . . 0.0 109.853 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 138.03 26.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.053 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 88.6 t -120.5 117.04 31.73 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.366 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.77 140.09 65.88 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.497 2.131 . . . . 0.0 111.343 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.35 136.33 57.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.034 0.445 . . . . 0.0 111.155 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.5 p -135.2 111.69 9.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -95.49 159.12 15.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -93.83 31.02 1.68 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.8 110.727 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.0 139.4 58.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 8.21 110.33 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 334' ' ' ARG . 67.4 mt -109.8 143.96 38.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.944 -1.026 . . . . 6.33 112.788 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -104.38 132.06 51.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.219 -1.4 . . . . 6.75 107.219 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.99 121.26 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 109.59 -0.522 . . . . 5.68 109.59 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.27 16.47 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.436 -0.888 . . . . 6.53 112.648 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.607 -0.806 . . . . 7.67 111.573 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 90.8 mt -70.78 135.25 85.72 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.835 -0.182 . . . . 8.16 111.477 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.4 Cg_exo -61.84 141.47 90.13 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.955 1.77 . . . . 8.96 108.795 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.34 -14.86 61.77 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.803 1.408 . . . . 11.61 114.803 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -84.14 -23.19 30.77 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.816 1.413 . . . . 11.06 114.816 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.33 149.13 50.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.17 0.441 . . . . 9.36 111.368 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 18.9 p-10 -114.39 -176.41 2.89 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.284 -0.265 . . . . 10.46 110.284 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -53.59 -55.46 25.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.629 1.344 . . . . 9.92 114.629 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -25.94 67.79 Favored 'General case' 0 C--N 1.406 3.026 0 C-N-CA 125.596 1.558 . . . . 0.0 112.478 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.18 -48.3 13.36 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.363 0.529 . . . . 10.06 111.378 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 78.5 t -62.66 -49.19 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 7.76 110.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -54.25 -36.41 63.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.312 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.13 -53.27 57.83 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.096 0.474 . . . . 10.2 110.699 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.403 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.73 -33.23 33.77 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.146 -0.479 . . . . 7.62 110.318 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.479 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.7 mt -82.54 -41.8 19.16 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.572 0.582 . . . . 7.74 112.572 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.2 m -56.75 -29.67 62.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.65 0.981 . . . . 10.09 113.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.2 m -50.42 -10.15 0.06 Allowed 'General case' 0 C--N 1.397 2.652 0 C-N-CA 124.846 1.258 . . . . 0.0 112.558 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -111.52 -12.03 14.01 Favored 'General case' 1 C--N 1.444 4.678 0 CA-C-N 118.335 0.516 . . . . 10.23 111.495 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.32 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.826 -0.625 . . . . 10.4 111.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.63 147.07 93.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.276 . . . . 12.19 112.716 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 83.0 mt -102.42 146.32 28.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.899 -0.591 . . . . 10.66 111.244 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 18.9 ptpt -101.05 -22.57 14.7 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.274 -0.639 . . . . 11.41 109.274 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.38 126.43 5.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.142 -2.224 . . . . 0.0 109.088 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 52.5 t80 -143.76 134.79 25.51 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 122.774 0.43 . . . . 8.77 112.006 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.77 124.01 12.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.513 -0.312 . . . . 8.38 111.595 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 61.0 tp -101.01 118.3 36.74 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.512 -1.292 . . . . 8.94 107.512 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.23 122.8 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.509 0.929 . . . . 9.37 113.509 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -119.13 148.06 43.48 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.31 -0.859 . . . . 11.34 109.353 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 38.7 t70 -58.81 141.13 53.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.922 0.391 . . . . 13.83 110.979 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.633 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 52.8 m -49.72 -61.71 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.816 -0.629 . . . . 14.58 112.649 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.04 -64.01 1.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.512 0.56 . . . . 16.19 112.512 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 12.8 m -42.55 -59.23 1.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.293 -0.412 . . . . 14.94 111.241 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.14 62.59 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.53 -0.843 . . . . 13.57 114.492 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.3 167.6 13.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.435 0.618 . . . . 13.28 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.9 t -59.22 142.07 52.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.526 . . . . 10.43 111.606 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 24.1 mmtp -87.95 -9.38 53.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.783 -0.644 . . . . 11.2 109.581 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.49 -3.43 39.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.674 -0.694 . . . . 8.63 113.929 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.468 ' HE1' ' OP2' ' B' ' 604' ' ' ' U' . 46.0 p90 -142.98 146.46 33.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.133 0.966 . . . . 9.19 112.812 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.62 155.18 46.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.041 -0.982 . . . . 6.21 112.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -111.38 146.81 36.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.17 -0.923 . . . . 7.09 110.333 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.57 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.5 p -157.8 156.21 31.11 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.972 -0.691 . . . . 6.77 111.903 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -145.23 127.07 15.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.708 . . . . 9.59 109.656 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.489 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 55.4 m-85 -82.36 164.88 20.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.097 0.406 . . . . 9.91 112.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.54 -46.09 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.413 -0.958 . . . . 12.81 108.413 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.692 ' O ' HG22 ' A' ' 312' ' ' VAL . 13.8 t70 -96.35 102.36 14.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.388 -1.338 . . . . 13.18 107.388 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.526 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.74 -34.97 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.305 1.595 . . . . 12.23 115.305 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -56.87 -38.71 73.11 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.238 1.018 . . . . 13.04 109.016 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.75 -22.58 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 112.243 -2.253 . . . . 11.08 109.594 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 88.5 m -54.67 -48.2 72.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.932 -0.766 . . . . 9.11 108.932 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.43 -42.83 99.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.245 -0.582 . . . . 10.31 110.52 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -63.83 -32.41 73.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.9 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.78 74.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.781 -1.554 . . . . 8.25 113.052 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.63 -51.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.373 0.606 . . . . 7.4 110.857 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.8 -38.59 67.49 Favored 'General case' 0 C--N 1.421 3.678 0 C-N-CA 126.289 1.836 . . . . 0.0 113.166 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.03 -24.1 35.96 Favored Glycine 1 C--N 1.398 4.007 0 N-CA-C 116.847 1.499 . . . . 8.35 116.847 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 330' ' ' LEU . 88.1 mt -96.84 -45.77 6.51 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.117 1.958 . . . . 7.2 113.956 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -50.47 130.04 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.883 0.373 . . . . 7.86 111.511 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.24 -16.79 56.56 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.056 -0.592 . . . . 8.64 113.975 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.5 ttt -50.61 147.17 4.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.729 0.299 . . . . 8.0 111.324 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -95.08 115.55 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 10.39 111.751 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.3 mp -120.16 106.74 12.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.127 -1.064 . . . . 8.95 108.127 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.09 -118.64 10.53 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.408 -1.477 . . . . 10.63 109.408 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -115.9 22.51 12.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.169 0.509 . . . . 12.25 109.765 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -123.9 153.91 40.45 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.64 -0.709 . . . . 9.98 111.599 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.69 118.28 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.078 -1.082 . . . . 10.14 108.078 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.66 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.4 tp -63.07 143.17 58.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.519 0.676 . . . . 7.52 112.707 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.477 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 90.0 mt -128.14 127.97 43.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.593 -1.185 . . . . 7.48 108.962 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.92 124.04 26.29 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 O-C-N 120.96 -1.088 . . . . 6.45 109.999 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.71 155.34 37.04 Favored 'General case' 0 N--CA 1.432 -1.367 0 O-C-N 119.986 -1.696 . . . . 7.66 109.561 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.508 ' HA ' HD23 ' A' ' 261' ' ' LEU . 83.3 mtt180 -58.61 122.44 13.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 118.453 -1.299 . . . . 8.94 107.612 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.93 -11.76 0.1 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.794 1.405 . . . . 7.52 114.794 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.9 m -119.45 -77.68 0.58 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.532 -0.467 . . . . 9.07 111.156 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 8.2 m -89.85 108.02 18.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.33 0.586 . . . . 0.0 111.305 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -84.4 139.07 17.83 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.386 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -74.96 110.6 9.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.28 -42.95 61.85 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -113.27 107.29 15.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.79 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.845 -179.314 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.407 " O2'" ' OP2' ' B' ' 602' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.506 -2.207 0 O4'-C1'-N19 109.38 1.18 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 0.477 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.425 -0.916 0 O4'-C1'-C2' 107.487 0.777 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.525 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O3'--C3' 1.446 1.618 0 C1'-O4'-C4' 110.61 1.122 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.635 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.509 6.162 0 C4'-C3'-C2' 99.165 -3.535 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.633 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.689 6.868 0 C3'-C2'-C1' 104.602 3.446 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.586 ' P ' " O2'" ' B' ' 605' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.541 1.307 0 C4'-C3'-C2' 105.421 2.721 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 0.946 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 O4'-C1'-C2' 107.589 0.849 . 0.01 3a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.962 0 O4'-C1'-C2' 107.131 0.522 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-C1' 100.838 -0.736 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 149' ' ' ARG . 9.8 ptt180 -91.75 57.47 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.401 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.51 148.5 21.43 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.608 -0.724 . . . . 5.88 111.196 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.577 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.77 143.54 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 5.25 111.218 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.52 125.21 40.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.855 -0.795 . . . . 6.58 108.855 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.83 101.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.134 0.493 . . . . 5.06 110.253 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.72 -178.86 35.03 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.921 -0.581 . . . . 6.2 112.765 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.5 m120 51.17 39.97 24.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.993 1.317 . . . . 0.0 110.195 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.58 149.76 88.64 Favored Pre-proline 1 C--N 1.43 4.103 0 C-N-CA 123.525 0.73 . . . . 7.79 111.366 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.99 144.45 89.49 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.325 2.017 . . . . 8.57 110.924 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -69.99 139.72 52.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.991 0.424 . . . . 11.37 111.916 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.22 6.49 61.26 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.755 -0.657 . . . . 9.94 114.277 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 117.395 0.597 . . . . 8.91 110.281 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.82 153.88 22.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.636 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.27 95.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.203 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.55 -46.07 91.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.568 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.73 -26.22 68.58 Favored 'General case' 0 C--N 1.41 3.22 0 O-C-N 119.25 -2.156 . . . . 0.0 111.658 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.492 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.39 -34.16 67.7 Favored 'General case' 1 C--N 1.429 4.046 0 O-C-N 123.949 0.781 . . . . 6.64 111.758 171.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.47 -54.4 7.64 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.412 0.685 . . . . 6.69 111.079 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.46 -33.76 60.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.397 -0.819 . . . . 8.8 111.403 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.76 -53.66 17.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.543 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.492 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.22 -48.23 82.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 5.94 112.255 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.75 -42.85 80.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.351 -0.54 . . . . 7.12 109.579 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.1 -23.31 64.9 Favored 'General case' 0 C--N 1.407 3.09 0 O-C-N 120.279 -1.513 . . . . 0.0 111.276 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.4 -37.7 36.58 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.468 0.576 . . . . 7.79 110.325 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.76 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.512 -0.767 . . . . 7.73 111.062 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.6 mtt-85 -75.93 -43.36 45.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.377 0.51 . . . . 9.61 112.377 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.73 -37.86 88.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.177 0.513 . . . . 10.06 110.47 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.9 -16.56 74.71 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.307 -0.949 . . . . 9.23 112.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.29 36.95 70.83 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.809 -0.917 . . . . 9.25 110.809 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.84 5.25 51.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.888 0.699 . . . . 8.31 112.888 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.549 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.59 143.46 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.588 0.233 . . . . 9.16 110.573 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -94.6 -18.52 21.3 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.138 0.421 . . . . 10.23 112.138 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.56 23.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.722 -0.217 . . . . 9.89 110.735 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.41 143.54 99.68 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.947 1.765 . . . . 11.04 110.798 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.54 20.57 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 120.558 -0.83 . . . . 9.31 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.36 73.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 7.97 112.051 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.549 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.23 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.543 2.162 . . . . 6.59 111.308 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.68 105.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.117 -0.492 . . . . 5.87 111.161 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 71.39 0.74 Allowed 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 124.636 1.175 . . . . 0.0 109.31 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.13 151.1 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 129.44 3.096 . . . . 0.0 112.946 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.41 130.55 8.39 Favored 'Isoleucine or valine' 0 C--N 1.374 1.64 0 C-N-CA 129.288 3.035 . . . . 5.67 109.31 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.19 126.55 55.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.772 -0.455 . . . . 6.47 109.772 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.599 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.9 125.97 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 116.983 2.216 . . . . 7.1 116.983 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.42 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 103.157 -2.905 . . . . 8.1 103.157 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.28 -57.38 7.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.678 1.733 . . . . 10.19 115.678 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.82 75.48 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.852 0.686 . . . . 10.51 112.852 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.16 50.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 9.72 111.847 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.18 36.05 15.22 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.548 1.314 . . . . 8.04 114.548 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.44 168.67 19.27 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.081 -1.047 . . . . 6.83 111.629 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.599 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.6 161.06 41.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.022 -1.445 . . . . 5.19 110.483 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.37 129.41 51.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.662 -0.866 . . . . 5.71 108.662 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.361 -0.382 . . . . 4.27 110.288 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.68 25.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.482 . . . . 6.21 109.697 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -99.73 164.69 11.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.016 -0.538 . . . . 6.14 111.981 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.88 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.432 -0.804 . . . . 8.37 111.46 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.8 p -128.91 159.61 35.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.114 0.483 . . . . 7.92 111.612 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.74 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 8.77 112.257 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.71 -41.76 95.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.424 0.527 . . . . 9.08 112.424 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.86 98.0 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.268 -0.271 . . . . 7.46 110.268 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.577 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.6 m -54.15 -54.0 45.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.125 -1.065 . . . . 6.18 108.125 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.7 m -55.31 -26.93 43.58 Favored 'General case' 1 C--N 1.43 4.081 0 C-N-CA 126.977 2.111 . . . . 0.0 109.878 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.15 -34.14 43.49 Favored 'General case' 0 C--N 1.421 3.683 0 N-CA-C 113.642 0.979 . . . . 8.7 113.642 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.52 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.88 63.42 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.309 1.006 . . . . 6.89 111.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.31 53.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.416 -0.357 . . . . 7.4 111.647 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.19 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 6.97 111.666 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.89 121.04 14.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 7.38 110.751 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.71 -4.75 66.38 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 7.92 113.615 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.855 0.327 . . . . 7.5 111.094 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.96 121.61 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.311 0.577 . . . . 9.49 111.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.76 7.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.45 110.287 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.75 42.67 13.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.035 -0.53 . . . . 10.44 111.724 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.03 -5.47 53.88 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 115.247 0.859 . . . . 10.21 115.247 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.59 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.615 0.708 . . . . 9.94 112.417 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.88 101.49 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.542 -0.91 . . . . 8.4 108.542 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.3 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.036 1.124 . . . . 6.9 114.036 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 1.035 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.55 110.26 21.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.57 -1.27 . . . . 8.29 107.57 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.98 126.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.405 0.52 . . . . 6.17 112.405 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.52 170.5 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.48 -0.782 . . . . 7.99 110.093 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.65 49.52 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.515 -0.92 . . . . 7.86 108.515 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.461 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 46.3 Cg_exo -57.43 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.953 1.769 . . . . 7.79 112.012 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -115.06 27.49 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 1.083 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 5.9 m-20 -75.33 126.57 31.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.326 174.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 65.71 106.54 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.625 0.726 . . . . 0.0 111.08 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 15.9 pt20 -63.03 141.89 97.7 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.71 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 29.8 Cg_exo -62.36 -35.14 74.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.147 2.565 . . . . 0.0 112.401 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 236' ' ' PRO . 9.5 mp -88.15 135.64 32.97 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.243 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 13.9 Cg_exo -69.48 175.84 7.34 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.97 2.447 . . . . 0.0 112.221 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.69 -178.33 51.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.924 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 26.8 ptm -140.2 174.55 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.75 0.275 . . . . 0.0 110.484 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.2 t -113.63 163.6 14.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.69 94.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.1 139.53 35.92 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.245 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.97 106.34 1.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.562 2.175 . . . . 0.0 111.522 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.3 m -134.85 116.83 15.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.819 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.18 11.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 49.4 t80 62.59 83.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.035 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 57.8 t -82.25 -62.49 0.31 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.316 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 48.6 Cg_endo -69.46 110.41 2.49 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.763 1.642 . . . . 0.0 111.972 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.04 -6.88 88.5 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.372 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.9 m -113.27 129.38 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 0.0 110.97 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.34 143.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.556 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.7 m -115.75 101.62 8.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.276 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.7 t -162.53 162.43 27.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.408 HG22 HD11 ' A' ' 235' ' ' LEU . 41.5 t 65.05 95.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.307 0.643 . . . . 0.0 111.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.48 119.7 18.53 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.202 0.525 . . . . 0.0 110.891 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.34 -149.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.012 2.474 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.8 104.66 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.0 m -149.5 100.59 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.777 -173.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -124.77 -71.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.875 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -140.56 31.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.996 -0.547 . . . . 10.8 110.862 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.94 139.33 58.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 8.21 110.365 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 334' ' ' ARG . 62.5 mt -109.79 144.07 38.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.076 -0.966 . . . . 6.33 112.826 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -104.47 132.02 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.228 -1.397 . . . . 6.75 107.228 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.95 121.2 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.608 -0.516 . . . . 5.68 109.608 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.19 16.52 Favored Glycine 0 CA--C 1.508 -0.389 0 C-N-CA 120.446 -0.883 . . . . 6.53 112.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.89 9.17 86.73 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.566 -0.826 . . . . 7.67 111.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.85 135.3 85.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 111.427 0.158 . . . . 8.16 111.427 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.85 141.48 90.14 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.962 1.775 . . . . 8.96 108.833 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -65.39 -14.83 61.76 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.788 1.403 . . . . 11.61 114.788 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -84.18 -23.13 30.71 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.788 1.403 . . . . 11.06 114.788 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.33 149.18 50.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.112 0.415 . . . . 9.36 111.344 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 31.0 p-10 -114.43 -176.44 2.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.608 -0.269 . . . . 10.46 110.279 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.55 -55.11 28.36 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.624 1.342 . . . . 9.92 114.624 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.94 -27.74 68.45 Favored 'General case' 0 C--N 1.406 3.052 0 C-N-CA 125.873 1.669 . . . . 0.0 112.332 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -79.64 -48.28 14.0 Favored 'General case' 1 C--N 1.429 4.065 0 O-C-N 123.486 0.491 . . . . 10.06 111.388 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.1 t -62.72 -49.17 84.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 7.76 110.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -54.24 -36.49 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 9.67 111.27 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.92 -53.39 56.44 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.156 0.503 . . . . 10.2 110.728 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.8 OUTLIER -51.8 -33.14 34.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.064 -0.516 . . . . 7.62 110.374 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.5 mt -82.62 -41.67 19.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.566 0.58 . . . . 7.74 112.566 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.0 m -56.87 -29.65 63.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.6 0.963 . . . . 10.09 113.6 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.5 m -50.36 -10.33 0.06 Allowed 'General case' 0 C--N 1.395 2.552 0 C-N-CA 124.809 1.244 . . . . 0.0 112.544 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -111.42 -11.94 14.07 Favored 'General case' 1 C--N 1.442 4.618 0 CA-C-N 118.281 0.491 . . . . 10.23 111.521 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.08 162.24 10.2 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.78 -0.646 . . . . 10.4 111.932 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.56 147.05 93.38 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.694 2.263 . . . . 12.19 112.736 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.7 mt -102.44 146.3 28.29 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.862 -0.608 . . . . 10.66 111.25 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 15.4 ptpt -101.14 -21.51 14.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.2 -0.667 . . . . 11.41 109.2 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -159.94 128.56 4.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.213 -2.179 . . . . 0.0 108.798 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.583 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.2 t80 -145.07 134.69 23.34 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.084 0.553 . . . . 8.77 112.005 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -144.8 124.09 13.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.809 0.338 . . . . 8.38 111.536 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 59.5 tp -100.99 118.23 36.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.578 -1.267 . . . . 8.94 107.578 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.17 122.91 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 9.37 113.457 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -119.15 148.15 43.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.297 -0.865 . . . . 11.34 109.371 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 34.1 t70 -58.96 141.17 54.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.893 0.378 . . . . 13.83 110.943 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.1 m -49.73 -61.69 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.653 0.612 . . . . 14.58 112.653 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.11 -63.97 1.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.468 0.544 . . . . 16.19 112.468 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.1 m -42.51 -59.32 1.92 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.265 -0.425 . . . . 14.94 111.228 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.03 62.5 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 120.617 -0.801 . . . . 13.57 114.503 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 79.9 mt -88.38 167.63 13.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.339 0.57 . . . . 13.28 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -59.32 142.22 52.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.529 . . . . 10.43 111.684 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 300' ' ' LYS . 3.8 mmmp? -87.89 -9.51 53.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 11.2 109.561 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.62 -3.34 39.42 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.625 -0.716 . . . . 8.63 113.89 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -143.06 146.35 33.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.055 0.927 . . . . 9.19 112.814 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.21 46.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.085 -0.961 . . . . 6.21 112.206 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.39 146.84 36.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.996 -1.002 . . . . 7.09 110.395 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.583 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 20.4 p -157.84 156.22 31.06 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 119.929 -0.708 . . . . 6.77 111.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -145.37 127.05 15.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.613 -0.722 . . . . 9.59 109.628 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.56 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 51.2 m-85 -82.38 164.91 20.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.98 0.419 . . . . 9.91 112.071 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.6 -46.05 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.463 -0.94 . . . . 12.81 108.463 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.32 102.36 14.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.41 -1.33 . . . . 13.18 107.41 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.76 -34.96 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 N-CA-C 115.244 1.572 . . . . 12.23 115.244 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -56.77 -38.83 73.03 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 122.305 1.05 . . . . 13.04 109.048 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 309' ' ' ASP . 1.9 m -62.65 -22.81 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 112.283 -2.235 . . . . 11.08 109.518 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.5 m -54.52 -48.2 72.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.918 -0.771 . . . . 9.11 108.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.49 -42.8 99.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.239 -0.584 . . . . 10.31 110.521 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.89 -0.724 . . . . 11.98 111.974 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.73 74.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.647 -1.615 . . . . 8.25 113.076 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.61 -51.29 47.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 7.4 110.864 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.39 67.71 Favored 'General case' 0 C--N 1.421 3.679 0 C-N-CA 126.211 1.805 . . . . 0.0 113.296 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.18 -24.0 35.85 Favored Glycine 1 C--N 1.4 4.125 0 N-CA-C 116.779 1.472 . . . . 8.35 116.779 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 330' ' ' LEU . 98.1 mt -96.93 -45.69 6.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.193 1.997 . . . . 7.2 113.957 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -50.52 130.03 23.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.844 0.354 . . . . 7.86 111.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.22 -16.81 56.48 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.151 -0.547 . . . . 8.64 113.977 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 19.0 mtt -50.53 147.15 4.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.723 0.297 . . . . 8.0 111.363 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -95.0 115.6 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.018 0.437 . . . . 10.39 111.759 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.8 mp -120.25 106.72 12.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.094 -1.076 . . . . 8.95 108.094 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.11 -118.75 10.65 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.347 -1.501 . . . . 10.63 109.347 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -115.8 22.45 13.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 12.25 109.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.83 153.95 40.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.682 -0.69 . . . . 9.98 111.685 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.74 118.26 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.139 -1.06 . . . . 10.14 108.139 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.7 tp -63.11 143.08 58.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.547 0.689 . . . . 7.52 112.601 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LEU . . . . . 0.478 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 88.1 mt -128.08 128.0 44.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.563 -1.199 . . . . 7.48 109.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.98 124.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 O-C-N 120.99 -1.069 . . . . 6.45 109.945 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -152.79 155.33 36.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 120.126 -1.609 . . . . 7.66 109.514 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.516 ' HA ' HD23 ' A' ' 261' ' ' LEU . 69.7 mtt85 -58.68 122.57 13.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 118.418 -1.313 . . . . 8.94 107.617 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.98 -11.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.756 1.391 . . . . 7.52 114.756 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.4 m -119.46 -78.18 0.58 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.641 -0.424 . . . . 9.07 111.21 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.6 p -168.36 -42.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.467 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 176.15 -121.76 0.82 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.008 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -161.16 -164.94 1.24 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.32 118.95 9.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.049 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.946 -179.657 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.404 " O2'" ' OP2' ' B' ' 602' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.508 -2.049 0 O4'-C1'-N19 109.397 1.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 0.478 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.427 -0.791 0 O4'-C1'-C2' 107.546 0.819 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.434 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C4'-C3'-C2' 103.728 1.028 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 1.035 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 0 O3'--C3' 1.475 3.717 1 C3'-C2'-C1' 106.1 5.111 . 0.0 OUTLIER '7D dist 4g' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.686 6.568 0 P-O3'-C3' 122.926 2.689 . 0.046 9a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.461 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 C3'--C2' 1.54 1.332 0 C4'-C3'-C2' 105.502 2.802 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 1.083 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C1'-C2' 107.611 0.865 . 0.0 OUTLIER '7D dist 3a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . 0.452 H5'' " H2'" ' B' ' 607' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.965 0 C3'-C2'-C1' 100.848 -0.724 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 O4'-C1'-C2' 107.23 0.593 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.578 ' HB2' HD13 ' A' ' 235' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.168 0.508 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -120.33 45.2 2.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.575 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -155.83 148.44 23.96 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.072 0.949 . . . . 5.88 111.087 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.568 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.75 143.54 35.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 5.25 111.171 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.62 125.18 40.91 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.891 -0.781 . . . . 6.58 108.891 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.27 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.077 0.465 . . . . 5.06 110.166 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.74 -178.57 35.06 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.895 -0.593 . . . . 6.2 112.766 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.16 40.81 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.031 1.333 . . . . 0.0 110.151 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.79 149.85 88.2 Favored Pre-proline 1 C--N 1.429 4.062 0 C-N-CA 123.478 0.711 . . . . 7.79 111.33 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.01 144.43 89.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.251 1.967 . . . . 8.57 111.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -69.91 139.66 53.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.429 . . . . 11.37 111.954 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.05 6.76 61.16 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.298 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 117.314 0.557 . . . . 8.91 110.245 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.79 153.88 22.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 9.64 110.692 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.25 95.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 7.44 110.174 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.6 -46.12 91.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.064 -0.517 . . . . 9.89 110.548 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.59 68.52 Favored 'General case' 0 C--N 1.409 3.179 0 O-C-N 119.261 -2.149 . . . . 0.0 111.675 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.483 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.4 -34.11 67.65 Favored 'General case' 0 C--N 1.427 3.975 0 O-C-N 123.889 0.743 . . . . 6.64 111.727 172.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.61 -54.3 7.72 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.51 0.724 . . . . 6.69 111.052 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.52 -33.73 60.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.43 -0.804 . . . . 8.8 111.381 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.52 17.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 120.43 -0.508 . . . . 7.44 111.617 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.114 0.413 . . . . 5.94 112.114 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.0 m-20 -56.83 -43.0 80.63 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.547 -0.538 . . . . 7.12 109.547 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -23.53 65.18 Favored 'General case' 0 C--N 1.406 3.026 0 O-C-N 120.192 -1.567 . . . . 0.0 111.231 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -79.35 -37.67 36.91 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.546 0.612 . . . . 7.79 110.31 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.81 83.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.498 -0.774 . . . . 7.73 111.033 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.4 mtt-85 -76.1 -43.03 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.37 0.507 . . . . 9.61 112.37 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.99 -37.76 88.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.193 0.52 . . . . 10.06 110.388 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.11 -16.39 74.64 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.239 -0.981 . . . . 9.23 112.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.98 71.59 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.888 -0.885 . . . . 9.25 110.888 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.3 51.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.941 0.719 . . . . 8.31 112.941 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.64 143.44 30.98 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.129 -0.228 . . . . 9.16 110.665 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.57 -18.51 21.34 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.45 23.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.691 -0.231 . . . . 9.89 110.722 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.32 143.45 99.73 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.997 1.798 . . . . 11.04 110.771 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.37 161.62 20.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.642 -0.789 . . . . 9.31 112.465 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.8 m-20 -75.33 134.49 73.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 7.97 112.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.33 -50.97 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.519 2.146 . . . . 6.59 111.315 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.32 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.111 -0.495 . . . . 5.87 111.146 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -37.59 40.47 Favored 'General case' 0 N--CA 1.533 3.68 0 C-N-CA 125.508 1.523 . . . . 0.0 112.848 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.38 164.48 38.09 Favored 'General case' 0 C--N 1.387 2.224 0 C-N-CA 125.938 1.695 . . . . 0.0 110.891 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.08 130.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.372 1.573 0 C-N-CA 126.291 1.836 . . . . 5.67 109.329 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.12 126.65 55.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.475 . . . . 6.47 109.716 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.91 125.92 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 116.937 2.199 . . . . 7.1 116.937 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.34 5.24 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 103.182 -2.896 . . . . 8.1 103.182 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.26 -57.34 8.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.676 1.732 . . . . 10.19 115.676 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.15 -48.87 75.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.831 0.678 . . . . 10.51 112.831 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.96 -9.12 50.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.768 0.285 . . . . 9.72 111.768 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.07 36.17 15.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.547 1.314 . . . . 8.04 114.547 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -143.5 168.73 19.16 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.118 -1.033 . . . . 6.83 111.661 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.6 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.63 161.03 41.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.031 -1.44 . . . . 5.19 110.518 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.4 129.41 51.24 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.676 -0.861 . . . . 5.71 108.676 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.75 137.58 33.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.361 . . . . 4.27 110.359 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -114.86 114.68 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.703 -0.48 . . . . 6.21 109.703 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.68 164.65 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 6.14 111.951 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.93 22.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.439 -0.8 . . . . 8.37 111.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.2 p -128.92 159.59 35.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.155 0.503 . . . . 7.92 111.607 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.21 -41.82 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.59 -0.732 . . . . 8.77 112.247 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.7 -41.73 95.8 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.339 0.496 . . . . 9.08 112.339 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.88 -43.89 97.93 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.202 -0.295 . . . . 7.46 110.202 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.568 HG23 ' HG ' ' A' ' 151' ' ' LEU . 56.0 m -54.17 -53.88 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.159 -1.052 . . . . 6.18 108.159 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.1 m -55.1 -27.2 43.33 Favored 'General case' 1 C--N 1.429 4.051 0 C-N-CA 127.127 2.171 . . . . 0.0 109.739 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.46 -33.95 41.9 Favored 'General case' 0 C--N 1.423 3.779 0 N-CA-C 113.6 0.963 . . . . 8.7 113.6 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.62 -17.3 64.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 5.94 112.638 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.12 -19.84 63.43 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.377 1.048 . . . . 6.89 111.556 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.3 53.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.456 -0.338 . . . . 7.4 111.656 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.85 16.18 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.466 -0.333 . . . . 6.97 111.651 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.82 120.96 13.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 7.38 110.75 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.83 -4.79 66.09 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.884 -0.674 . . . . 7.92 113.579 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.833 0.316 . . . . 7.5 111.098 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -85.0 121.63 37.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.35 0.595 . . . . 9.49 111.286 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.36 107.67 7.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 8.45 110.357 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.69 42.64 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 10.44 111.767 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.08 -5.45 54.18 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.248 0.859 . . . . 10.21 115.248 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.58 130.94 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.627 0.713 . . . . 9.94 112.375 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.53 10.95 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.506 -0.924 . . . . 8.4 108.506 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.89 58.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.979 1.103 . . . . 6.9 113.979 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.918 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.8 tttt -108.59 110.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.477 -1.305 . . . . 8.29 107.477 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.98 126.89 58.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.36 0.504 . . . . 6.17 112.36 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.61 170.46 15.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.388 -0.824 . . . . 7.99 110.019 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.02 154.67 49.74 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.635 -0.876 . . . . 7.86 108.635 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.485 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.7 Cg_exo -57.21 174.82 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.985 1.79 . . . . 7.79 111.982 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -113.08 23.72 13.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.566 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.726 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 7.3 m-20 -64.07 149.7 47.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.01 0.433 . . . . 0.0 111.647 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.07 113.81 2.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.88 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 62.01 93.75 0.06 OUTLIER Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.04 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.54 -179.43 3.68 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.674 2.25 . . . . 0.0 111.489 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' ' 148' ' ' ALA . 10.8 mp -72.5 142.31 83.89 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.964 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.01 119.34 5.93 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.98 2.453 . . . . 0.0 112.765 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.91 143.49 11.72 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 95.6 mmm -122.02 9.99 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.861 0.331 . . . . 0.0 111.046 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.0 m 58.88 23.58 11.52 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 110.782 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -98.44 16.5 21.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.908 -175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.715 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 25.3 t-20 -50.59 -54.2 38.1 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.652 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 67.0 Cg_endo -91.09 16.81 1.51 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.151 1.901 . . . . 0.0 112.13 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t 68.35 146.62 0.05 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.748 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 31.2 m -114.49 166.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.931 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.848 ' HA ' HG22 ' A' ' 249' ' ' VAL . 37.7 t80 71.29 12.64 6.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.443 0.639 . . . . 0.0 110.055 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.658 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 58.8 t -67.13 -59.04 8.03 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.72 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 81.0 Cg_endo -77.97 9.16 3.13 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.107 1.872 . . . . 0.0 113.138 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.75 79.49 1.01 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.094 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' VAL . . . . . 0.848 HG22 ' HA ' ' A' ' 245' ' ' TYR . 32.0 m -110.31 -172.72 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.29 115.88 50.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 50.6 m 71.54 170.55 0.32 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.233 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.8 t -74.88 -13.86 60.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.174 0.511 . . . . 0.0 110.763 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.7 117.7 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.351 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 256' ' ' ASP . 5.7 p -125.75 126.38 24.92 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 339' ' ' ALA . 12.4 Cg_exo -71.5 15.52 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.368 2.712 . . . . 0.0 113.715 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -96.64 -8.63 31.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.3 m -61.75 138.46 58.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.998 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 70.32 105.69 0.06 Allowed 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.991 0.807 . . . . 0.0 110.35 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -98.21 31.02 2.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.213 -0.903 . . . . 10.8 110.791 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.91 139.37 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 8.21 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 334' ' ' ARG . 52.2 mt -109.77 143.95 38.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.019 -0.991 . . . . 6.33 112.849 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -104.39 132.05 51.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.138 -1.43 . . . . 6.75 107.138 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.03 121.25 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.601 -0.518 . . . . 5.68 109.601 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.2 16.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.444 -0.884 . . . . 6.53 112.71 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.19 86.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.668 -0.777 . . . . 7.67 111.532 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.3 mt -70.89 135.32 85.47 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 111.465 0.172 . . . . 8.16 111.465 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.0 Cg_exo -61.79 141.54 90.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.95 1.767 . . . . 8.96 108.792 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.39 -14.87 61.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.759 1.392 . . . . 11.61 114.759 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -84.15 -23.18 30.74 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.758 1.392 . . . . 11.06 114.758 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.26 149.18 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.165 0.439 . . . . 9.36 111.388 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 37.7 p-10 -114.59 -176.4 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.207 -0.294 . . . . 10.46 110.207 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.56 -55.3 26.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.617 1.34 . . . . 9.92 114.617 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -27.05 68.21 Favored 'General case' 0 C--N 1.407 3.084 0 C-N-CA 125.565 1.546 . . . . 0.0 112.392 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.59 -48.3 14.02 Favored 'General case' 1 C--N 1.429 4.024 0 CA-C-N 118.263 0.483 . . . . 10.06 111.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 66.2 t -62.65 -49.26 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 7.76 110.285 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.25 -36.41 63.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.279 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.12 -53.35 56.63 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.052 0.453 . . . . 10.2 110.642 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.8 -33.17 34.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.889 0.476 . . . . 7.62 110.283 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.517 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.2 mt -82.6 -41.7 19.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.552 0.575 . . . . 7.74 112.552 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.6 m -56.82 -30.69 63.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.589 0.959 . . . . 10.09 113.589 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.6 m -52.4 -7.73 0.07 Allowed 'General case' 0 C--N 1.397 2.65 0 O-C-N 120.602 -1.311 . . . . 0.0 112.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -110.31 -12.05 14.48 Favored 'General case' 1 C--N 1.443 4.67 0 CA-C-N 118.413 0.552 . . . . 10.23 111.492 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.09 162.28 10.22 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.775 -0.648 . . . . 10.4 111.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.54 146.98 93.6 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.776 2.317 . . . . 12.19 112.746 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 73.0 mt -102.43 146.27 28.32 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.935 -0.575 . . . . 10.66 111.348 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.98 -22.73 14.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.256 -0.646 . . . . 11.41 109.256 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.15 5.08 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.155 -2.216 . . . . 0.0 109.159 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.631 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -143.39 134.68 25.94 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.785 0.434 . . . . 8.77 111.98 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.75 124.05 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.547 -0.297 . . . . 8.38 111.58 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 53.0 tp -101.06 118.21 36.55 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.413 HG12 ' HG3' ' A' ' 300' ' ' LYS . 41.2 t -74.11 122.87 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.469 0.915 . . . . 9.37 113.469 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.07 148.1 43.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.359 -0.837 . . . . 11.34 109.345 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.3 t70 -58.89 141.19 54.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.894 0.378 . . . . 13.83 110.984 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.5 m -49.82 -61.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.842 -0.617 . . . . 14.58 112.571 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.09 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.527 0.566 . . . . 16.19 112.527 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.4 m -42.5 -59.25 1.94 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 14.94 111.184 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.61 -6.08 62.66 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.62 -0.8 . . . . 13.57 114.493 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.35 167.64 13.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.415 0.608 . . . . 13.28 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.9 t -59.21 142.07 52.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 10.43 111.58 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.413 ' HG3' HG12 ' A' ' 291' ' ' VAL . 4.1 mmmp? -87.91 -9.43 53.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.762 -0.653 . . . . 11.2 109.627 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.32 39.63 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.68 -0.691 . . . . 8.63 113.892 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.702 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 26.4 p90 -142.96 146.33 33.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.054 0.927 . . . . 9.19 112.92 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.19 46.71 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.158 -0.928 . . . . 6.21 112.213 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.37 146.77 36.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 7.09 110.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.631 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 23.1 p -157.73 156.18 31.2 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.906 -0.717 . . . . 6.77 111.928 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -145.2 127.07 15.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.722 -0.672 . . . . 9.59 109.716 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 54.8 m-85 -82.47 164.88 20.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.932 0.396 . . . . 9.91 112.025 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.58 -46.12 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.369 -0.975 . . . . 12.81 108.369 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.3 102.37 14.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.385 -1.339 . . . . 13.18 107.385 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.04 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 115.293 1.59 . . . . 12.23 115.293 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -56.85 -38.68 73.02 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 122.263 1.03 . . . . 13.04 109.005 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.75 -22.65 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.322 -2.217 . . . . 11.08 109.578 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.9 m -54.72 -48.07 72.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.966 -0.753 . . . . 9.11 108.966 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.52 -42.67 99.67 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.138 -0.625 . . . . 10.31 110.554 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -63.94 -32.33 73.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.867 -0.733 . . . . 11.98 111.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.78 74.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.791 -1.55 . . . . 8.25 113.021 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.58 -51.36 47.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.384 0.611 . . . . 7.4 110.872 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.7 67.78 Favored 'General case' 0 C--N 1.421 3.712 0 C-N-CA 126.273 1.829 . . . . 0.0 113.086 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.06 -23.97 36.33 Favored Glycine 1 C--N 1.401 4.188 0 N-CA-C 116.807 1.483 . . . . 8.35 116.807 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 330' ' ' LEU . 99.0 mt -96.89 -45.75 6.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.19 1.995 . . . . 7.2 113.984 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -50.47 130.14 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.851 0.358 . . . . 7.86 111.468 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.04 -16.64 56.61 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.134 -0.555 . . . . 8.64 113.983 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 17.2 mtt -50.61 147.19 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.836 0.318 . . . . 8.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -95.09 115.57 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 10.39 111.662 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.6 mm? -120.16 106.72 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.111 -1.07 . . . . 8.95 108.111 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.13 -118.65 10.52 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.406 -1.477 . . . . 10.63 109.406 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -115.94 22.48 12.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.145 0.498 . . . . 12.25 109.741 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 328' ' ' LYS . 34.1 mtpt -123.89 153.91 40.46 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.583 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.76 118.28 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.116 -1.068 . . . . 10.14 108.116 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.629 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.3 tp -63.11 143.22 57.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.537 0.684 . . . . 7.52 112.612 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.5 tp -128.21 128.01 43.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.486 -1.234 . . . . 7.48 108.961 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.02 124.0 25.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 O-C-N 121.038 -1.039 . . . . 6.45 109.955 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.73 155.34 37.02 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.938 -1.726 . . . . 7.66 109.488 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.539 ' HA ' HD23 ' A' ' 261' ' ' LEU . 99.2 mtt180 -58.62 122.51 13.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.422 -1.311 . . . . 8.94 107.59 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.88 -11.82 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 337' ' ' VAL . 17.3 m -119.4 -75.9 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.613 -0.435 . . . . 9.07 111.303 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 336' ' ' SER . 70.0 t 79.04 120.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -167.52 -53.48 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.894 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 255' ' ' PRO . . . -101.35 96.13 6.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.899 0.381 . . . . 0.0 111.028 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -128.46 -49.5 1.28 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.638 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -127.03 -3.63 6.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.047 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.545 178.38 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.507 -2.07 0 O4'-C1'-N19 109.397 1.197 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.949 0 O4'-C1'-C2' 107.714 0.939 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.702 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.423 -1.039 0 C1'-O4'-C4' 110.243 0.714 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.918 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 C4'--C3' 1.569 4.07 1 C3'-C2'-C1' 105.705 4.672 . 0.0 OUTLIER '7D dist 4g' 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.688 6.782 0 P-O3'-C3' 124.066 3.638 . 0.01 9a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . 0.485 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O4'--C1' 1.402 -1.024 0 C4'-C3'-C2' 105.74 3.04 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 0.726 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 O4'-C1'-C2' 107.444 0.746 . 0.02 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C1'-C2' 107.281 0.63 . 0.01 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.986 0 C3'-C2'-C1' 100.714 -0.873 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.599 0.238 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -126.49 53.92 1.62 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.371 -0.206 . . . . 0.0 111.039 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.01 148.53 22.31 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.832 0.708 . . . . 5.88 111.351 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.65 143.54 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 5.25 111.21 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -96.6 125.21 40.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 6.58 108.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.84 101.3 8.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.512 . . . . 5.06 110.199 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.76 34.62 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.983 -0.553 . . . . 6.2 112.734 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 m120 49.21 42.54 21.75 Favored 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.649 1.58 . . . . 0.0 110.391 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.28 149.84 89.35 Favored Pre-proline 0 C--N 1.426 3.929 0 CA-C-N 114.95 -1.023 . . . . 7.79 111.333 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.06 144.5 89.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.341 2.027 . . . . 8.57 110.972 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.95 139.71 52.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 11.37 111.947 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.53 61.03 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.837 -0.619 . . . . 9.94 114.32 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.1 136.47 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.332 0.566 . . . . 8.91 110.303 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.88 153.8 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.694 0.283 . . . . 9.64 110.626 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.09 -43.1 95.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 7.44 110.23 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.75 -45.88 92.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.012 -0.54 . . . . 9.89 110.535 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.83 68.69 Favored 'General case' 0 C--N 1.41 3.217 0 O-C-N 119.408 -2.057 . . . . 0.0 111.606 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.479 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.27 -34.12 67.99 Favored 'General case' 1 C--N 1.429 4.043 0 O-C-N 123.978 0.799 . . . . 6.64 111.875 172.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ttt -74.53 -54.28 7.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.368 0.667 . . . . 6.69 111.055 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.65 -33.69 61.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.434 -0.803 . . . . 8.8 111.378 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.59 17.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.555 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.479 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.3 -48.26 82.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.175 0.435 . . . . 5.94 112.175 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.7 79.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.196 -0.602 . . . . 7.12 109.54 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.96 64.38 Favored 'General case' 0 C--N 1.404 2.965 0 O-C-N 120.213 -1.554 . . . . 0.0 111.246 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -79.37 -37.69 36.78 Favored 'General case' 0 C--N 1.427 3.977 0 CA-C-N 118.502 0.592 . . . . 7.79 110.291 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.541 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.75 -36.66 82.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.707 . . . . 7.73 111.054 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.15 -42.88 45.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.386 0.514 . . . . 9.61 112.386 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.22 -37.66 88.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.274 0.559 . . . . 10.06 110.399 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.12 -16.44 74.49 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.338 -0.934 . . . . 9.23 112.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.15 37.04 72.19 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.871 -0.892 . . . . 9.25 110.871 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.99 5.42 51.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.828 0.677 . . . . 8.31 112.828 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.66 143.53 30.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.599 0.237 . . . . 9.16 110.534 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -94.74 -18.4 21.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.105 0.409 . . . . 10.23 112.105 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.79 163.4 24.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.682 -0.235 . . . . 9.89 110.75 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.28 143.45 99.74 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.935 1.757 . . . . 11.04 110.853 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.56 20.53 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.606 -0.807 . . . . 9.31 112.436 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.3 134.46 73.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 7.97 111.982 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.31 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.493 2.129 . . . . 6.59 111.298 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.67 106.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 5.87 111.16 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -32.44 25.58 Favored 'General case' 0 N--CA 1.525 3.283 0 O-C-N 119.686 -1.884 . . . . 0.0 113.856 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.33 163.26 40.23 Favored 'General case' 0 C--N 1.384 2.07 0 C-N-CA 125.754 1.621 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.88 130.56 11.94 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 C-N-CA 126.529 1.931 . . . . 5.67 109.31 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.11 126.57 55.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.776 -0.453 . . . . 6.47 109.776 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 116.893 2.183 . . . . 7.1 116.893 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -97.9 91.35 5.29 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 103.234 -2.876 . . . . 8.1 103.234 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.33 -57.47 7.83 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.566 1.691 . . . . 10.19 115.566 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.11 -48.77 75.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.9 0.704 . . . . 10.51 112.9 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -68.94 -9.18 50.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.855 0.317 . . . . 9.72 111.855 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 35.87 15.13 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.55 1.315 . . . . 8.04 114.55 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -143.38 168.79 18.99 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.116 -1.033 . . . . 6.83 111.612 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.605 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.7 161.14 41.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.23 -1.35 . . . . 5.19 110.355 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.43 51.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.716 -0.846 . . . . 5.71 108.716 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.6 mt -94.97 137.56 33.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.518 -0.31 . . . . 4.27 110.349 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -114.83 114.72 25.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.674 -0.491 . . . . 6.21 109.674 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.68 164.68 11.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.876 -0.602 . . . . 6.14 111.971 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.421 -0.809 . . . . 8.37 111.427 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.3 p -128.96 159.6 35.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.115 0.483 . . . . 7.92 111.666 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.25 -41.8 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.571 -0.74 . . . . 8.77 112.272 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -64.66 -41.71 95.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.388 0.514 . . . . 9.08 112.388 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.95 97.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.243 -0.281 . . . . 7.46 110.243 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.56 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.4 m -54.13 -53.97 46.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.192 -1.04 . . . . 6.18 108.192 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m -55.22 -27.11 43.83 Favored 'General case' 0 C--N 1.428 4.0 0 C-N-CA 127.001 2.12 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -79.16 -34.11 43.47 Favored 'General case' 0 C--N 1.42 3.641 0 N-CA-C 113.613 0.968 . . . . 8.7 113.613 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.57 -17.32 64.11 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.654 0.613 . . . . 5.94 112.654 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.05 -19.84 63.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.505 1.128 . . . . 6.89 111.652 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.21 52.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 7.4 111.654 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -93.8 16.25 14.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 6.97 111.625 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.88 120.96 13.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 7.38 110.765 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.87 -4.81 66.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.928 -0.653 . . . . 7.92 113.599 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.845 0.323 . . . . 7.5 111.124 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.265 0.555 . . . . 9.49 111.333 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -135.34 107.74 7.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 8.45 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.74 42.67 13.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 10.44 111.771 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.96 -5.33 54.2 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 115.201 0.84 . . . . 10.21 115.201 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -110.67 130.9 55.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.651 0.726 . . . . 9.94 112.356 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.67 101.46 10.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.556 -0.905 . . . . 8.4 108.556 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.85 58.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.84 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.58 110.28 21.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.523 -1.288 . . . . 8.29 107.523 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.4 mt -103.95 126.94 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 6.17 112.338 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.427 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.56 15.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.384 -0.826 . . . . 7.99 110.038 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.67 49.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.16 174.78 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.988 1.792 . . . . 7.79 112.033 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.13 -46.88 13.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 1.207 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.7 p-10 -79.85 174.48 11.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.335 166.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.16 -36.18 1.76 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.04 0.448 . . . . 0.0 109.912 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -140.21 153.36 68.92 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.569 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.18 -23.11 73.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.611 2.207 . . . . 0.0 112.085 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.24 142.88 30.24 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.57 111.81 1.27 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.879 2.386 . . . . 0.0 112.764 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -138.35 66.41 0.53 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.919 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.5 ttt -109.62 -60.48 1.77 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 t -110.76 -38.09 5.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.811 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -83.8 101.34 11.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.101 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.562 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 27.5 t-20 -143.83 132.28 11.11 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.124 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 73.0 Cg_exo -49.91 104.52 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.198 2.599 . . . . 0.0 113.566 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.3 m 60.41 29.67 19.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.052 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 241' ' ' ASN . 7.3 p -64.35 110.98 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.553 0.692 . . . . 0.0 112.023 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -169.8 129.81 0.99 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.104 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 30.2 m -111.71 144.95 31.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.608 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 7.9 Cg_exo -72.84 109.76 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.804 2.336 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.75 94.49 1.44 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.552 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.8 m -76.3 -17.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 111.279 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.04 -46.95 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.36 0.6 . . . . 0.0 109.418 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 t -114.6 92.26 3.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.555 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.0 m -87.31 -13.36 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.052 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t 62.64 72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.894 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.546 ' HB ' ' HD2' ' A' ' 255' ' ' PRO . 30.0 m -115.99 164.26 18.4 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.337 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 254' ' ' VAL . 18.9 Cg_endo -61.52 -22.32 74.19 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.149 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -74.11 101.91 4.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 p -134.35 98.59 4.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.362 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -86.4 154.48 21.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.853 0.835 . . . . 0.0 112.477 -171.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -135.16 31.07 3.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.334 -1.303 . . . . 10.8 110.745 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -63.01 139.36 58.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.211 0.529 . . . . 8.21 110.306 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 334' ' ' ARG . 69.6 mt -109.74 144.0 38.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.957 -1.019 . . . . 6.33 112.783 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.414 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 51.4 t80 -104.5 132.15 51.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.245 -1.391 . . . . 6.75 107.245 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.22 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.531 -0.544 . . . . 5.68 109.531 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.21 16.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.516 -0.849 . . . . 6.53 112.674 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.8 9.18 86.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.589 -0.815 . . . . 7.67 111.552 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.85 135.27 85.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 111.446 0.165 . . . . 8.16 111.446 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.77 141.54 90.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.832 1.688 . . . . 8.96 108.832 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -65.39 -14.92 61.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -84.1 -23.13 30.89 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.836 1.421 . . . . 11.06 114.836 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.34 149.2 50.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.105 0.411 . . . . 9.36 111.333 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 25.1 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.244 -0.28 . . . . 10.46 110.244 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 4.5 m-20 -53.59 -55.54 24.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.611 1.338 . . . . 9.92 114.611 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.14 -26.83 67.96 Favored 'General case' 0 C--N 1.405 3.008 0 C-N-CA 125.724 1.61 . . . . 0.0 112.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -79.78 -48.35 13.74 Favored 'General case' 1 C--N 1.432 4.185 0 CA-C-N 118.3 0.5 . . . . 10.06 111.387 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 88.9 t -62.69 -49.15 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 7.76 110.315 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 31.8 mtmm -54.35 -36.3 63.67 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.616 -0.72 . . . . 9.67 111.362 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.06 -53.45 55.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.096 0.474 . . . . 10.2 110.644 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.73 -33.02 32.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.092 -0.503 . . . . 7.62 110.447 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.461 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.76 -41.72 18.86 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.497 0.554 . . . . 7.74 112.497 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 55.7 m -56.76 -30.08 63.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.583 0.957 . . . . 10.09 113.583 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.6 m -50.36 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.395 2.563 0 C-N-CA 124.78 1.232 . . . . 0.0 112.671 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -111.67 -12.05 13.93 Favored 'General case' 1 C--N 1.444 4.705 0 CA-C-N 118.388 0.54 . . . . 10.23 111.435 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.17 162.23 10.21 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.874 -0.603 . . . . 10.4 111.951 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 147.01 93.51 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.7 2.267 . . . . 12.19 112.78 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 76.1 mt -102.41 146.23 28.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.95 -0.568 . . . . 10.66 111.254 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.5 ptpt -101.0 -22.72 14.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 11.41 109.302 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.57 125.36 4.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.051 -2.281 . . . . 0.0 109.245 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.53 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 47.1 t80 -142.82 134.76 27.01 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 122.777 0.431 . . . . 8.77 112.014 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -144.8 124.11 13.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.714 0.292 . . . . 8.38 111.481 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.9 tp -101.04 118.24 36.6 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.55 -1.278 . . . . 8.94 107.55 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 49.0 t -74.23 122.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.473 0.916 . . . . 9.37 113.473 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -119.15 148.08 43.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.232 -0.894 . . . . 11.34 109.329 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 25.5 t70 -58.95 141.2 54.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.412 . . . . 13.83 110.894 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.592 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 18.7 m -49.78 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.802 -0.635 . . . . 14.58 112.606 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.07 -64.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.536 0.569 . . . . 16.19 112.536 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 3.9 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.254 -0.43 . . . . 14.94 111.21 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.72 -6.16 62.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.592 -0.814 . . . . 13.57 114.545 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.29 167.55 13.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.355 0.578 . . . . 13.28 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.0 t -59.15 142.08 52.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 10.43 111.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.939 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.4 mmmp? -87.94 -9.46 53.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.802 -0.636 . . . . 11.2 109.625 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.39 39.54 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.56 -0.746 . . . . 8.63 113.857 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.629 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 42.7 p90 -142.96 146.46 33.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.146 0.973 . . . . 9.19 112.75 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.59 155.13 46.66 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.094 -0.957 . . . . 6.21 112.187 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' PHE . . . . . 0.414 ' CE1' ' HD1' ' A' ' 262' ' ' PHE . 88.9 m-85 -111.42 146.85 36.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.273 -0.876 . . . . 7.09 110.422 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' CYS . . . . . 0.53 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.1 p -157.75 156.26 31.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.994 -0.683 . . . . 6.77 111.903 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -145.41 127.08 15.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.738 -0.664 . . . . 9.59 109.656 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.602 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 54.8 m-85 -82.46 164.9 20.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.081 0.467 . . . . 9.91 112.027 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.55 -46.01 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.436 -0.95 . . . . 12.81 108.436 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 312' ' ' VAL . 19.7 t70 -96.36 102.32 14.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.357 -1.349 . . . . 13.18 107.357 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ILE . . . . . 0.533 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.69 -34.98 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 115.326 1.602 . . . . 12.23 115.326 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -56.82 -38.82 73.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.236 1.017 . . . . 13.04 109.022 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.69 -22.57 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 112.268 -2.242 . . . . 11.08 109.61 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 97.8 m -54.66 -48.24 72.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.869 -0.789 . . . . 9.11 108.869 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.45 -42.82 99.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.3 -0.56 . . . . 10.31 110.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 119.871 -0.732 . . . . 11.98 111.993 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.76 74.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.597 -1.638 . . . . 8.25 113.023 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.65 -51.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.316 0.579 . . . . 7.4 110.859 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.25 67.27 Favored 'General case' 0 C--N 1.419 3.589 0 C-N-CA 126.337 1.855 . . . . 0.0 113.2 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.25 -24.05 35.52 Favored Glycine 1 C--N 1.4 4.132 0 N-CA-C 116.815 1.486 . . . . 8.35 116.815 177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.87 -45.68 6.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 120.097 1.949 . . . . 7.2 113.956 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -50.53 129.97 23.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.808 0.337 . . . . 7.86 111.46 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.56 56.96 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.156 -0.545 . . . . 8.64 113.978 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.3 mtt -50.71 147.18 4.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.846 0.323 . . . . 8.0 111.259 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.06 115.57 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.055 0.455 . . . . 10.39 111.712 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -120.18 106.85 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 66.99 -118.64 10.63 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.373 -1.491 . . . . 10.63 109.373 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -115.84 22.4 13.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 12.25 109.752 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -123.83 153.98 40.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.609 -0.723 . . . . 9.98 111.617 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -101.79 118.27 36.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.083 -1.08 . . . . 10.14 108.083 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.0 143.04 58.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.516 0.674 . . . . 7.52 112.649 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 61.5 tp -128.14 127.94 43.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.597 -1.183 . . . . 7.48 109.014 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.85 124.02 26.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 120.909 -1.119 . . . . 6.45 109.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.8 155.31 36.89 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.961 -1.712 . . . . 7.66 109.557 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.49 ' HA ' HD23 ' A' ' 261' ' ' LEU . 66.4 mtt180 -58.54 122.44 13.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 118.424 -1.31 . . . . 8.94 107.577 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.92 -11.8 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.814 1.413 . . . . 7.52 114.814 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.4 m -119.44 -77.59 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.522 -0.471 . . . . 9.07 111.239 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 7.3 p -166.53 134.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.873 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -83.35 60.45 4.88 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -65.18 105.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 111.937 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.47 90.71 3.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.504 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -107.21 113.4 26.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.177 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.601 179.4 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 601' ' ' ' U' . . . . . 0.939 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.102 0 O4'-C1'-N19 109.29 1.09 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 602' ' ' ' U' . . . . . 0.417 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 O4'-C1'-C2' 107.57 0.836 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 603' ' ' ' U' . . . . . 0.629 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C4'-C3'-C2' 103.511 0.811 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 604' ' ' ' U' . . . . . 0.84 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.501 5.57 0 C4'-C3'-C2' 99.077 -3.623 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 605' ' ' ' U' . . . . . 0.592 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.68 6.051 1 C4'-C3'-C2' 106.717 4.017 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 010 nuclear build full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.401 -1.093 0 C4'-C3'-C2' 105.707 3.007 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 607' ' ' ' U' . . . . . 1.207 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.053 0 O4'-C1'-C2' 107.617 0.869 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C3'-C2'-C1' 100.613 -0.986 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.518 -0.961 0 C3'-C2'-C1' 100.75 -0.833 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.554 0.216 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -157.11 148.58 22.18 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 122.962 0.505 . . . . 5.88 111.293 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.8 143.55 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 5.25 111.188 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.57 125.15 40.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.859 -0.793 . . . . 6.58 108.859 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.22 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.097 0.475 . . . . 5.06 110.24 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.78 -178.22 35.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.002 -0.618 . . . . 6.2 112.763 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.87 40.76 21.43 Favored 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 125.065 1.346 . . . . 0.0 110.201 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.77 149.78 88.21 Favored Pre-proline 1 C--N 1.428 4.015 0 C-N-CA 123.448 0.699 . . . . 7.79 111.327 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.98 144.43 89.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.288 1.992 . . . . 8.57 110.978 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.65 52.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.022 0.439 . . . . 11.37 111.934 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.56 61.18 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.818 -0.628 . . . . 9.94 114.313 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.07 136.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.307 0.553 . . . . 8.91 110.306 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.84 153.92 22.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.697 0.284 . . . . 9.64 110.645 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.13 -43.24 95.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 7.44 110.192 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.7 -45.93 91.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.001 -0.545 . . . . 9.89 110.562 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.3 -2.125 . . . . 0.0 111.724 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.48 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.11 67.84 Favored 'General case' 1 C--N 1.428 4.006 0 O-C-N 123.877 0.736 . . . . 6.64 111.733 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.56 -54.35 7.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.449 0.699 . . . . 6.69 111.074 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -54.48 -33.7 60.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.366 -0.834 . . . . 8.8 111.41 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.79 -53.62 17.42 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.58 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.1 m-85 -61.27 -48.29 82.09 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.97 80.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.265 -0.574 . . . . 7.12 109.586 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.7 -23.58 65.3 Favored 'General case' 0 C--N 1.407 3.097 0 O-C-N 120.254 -1.529 . . . . 0.0 111.298 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.48 -37.62 36.4 Favored 'General case' 0 C--N 1.427 3.972 0 O-C-N 123.611 0.569 . . . . 7.79 110.328 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.79 -36.79 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.595 -0.73 . . . . 7.73 111.014 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -75.93 -43.12 46.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.429 0.529 . . . . 9.61 112.429 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.03 -37.71 88.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.189 0.519 . . . . 10.06 110.447 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.15 -16.42 74.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.297 -0.954 . . . . 9.23 112.814 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.02 72.03 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 110.878 -0.889 . . . . 9.25 110.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.89 5.31 51.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.975 0.732 . . . . 8.31 112.975 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.63 143.45 30.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.616 0.246 . . . . 9.16 110.577 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.586 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.148 0.425 . . . . 10.23 112.148 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.4 24.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.646 -0.252 . . . . 9.89 110.714 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.29 143.51 99.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.946 1.764 . . . . 11.04 110.822 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.35 161.6 20.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.663 -0.779 . . . . 9.31 112.43 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 112.117 0.414 . . . . 7.97 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.21 -51.04 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.544 2.163 . . . . 6.59 111.283 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.64 106.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.126 -0.488 . . . . 5.87 111.075 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 -37.15 30.41 Favored 'General case' 0 N--CA 1.536 3.837 0 O-C-N 119.885 -1.76 . . . . 0.0 112.963 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.36 164.38 36.83 Favored 'General case' 0 C--N 1.382 1.983 0 C-N-CA 125.78 1.632 . . . . 0.0 110.736 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 130.45 10.53 Favored 'Isoleucine or valine' 0 C--N 1.37 1.499 0 C-N-CA 126.584 1.954 . . . . 5.67 109.331 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -114.06 126.61 55.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.789 -0.449 . . . . 6.47 109.789 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.92 125.95 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 116.912 2.189 . . . . 7.1 116.912 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.06 91.42 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 103.153 -2.906 . . . . 8.1 103.153 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -57.37 7.99 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 115.73 1.752 . . . . 10.19 115.73 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.21 -48.78 75.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.812 0.671 . . . . 10.51 112.812 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.0 -9.06 50.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.832 0.308 . . . . 9.72 111.832 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.21 15.49 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.528 1.307 . . . . 8.04 114.528 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.59 168.68 19.29 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 119.074 -1.05 . . . . 6.83 111.601 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.04 41.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.143 -1.389 . . . . 5.19 110.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.3 129.5 51.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.657 -0.868 . . . . 5.71 108.657 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.94 137.56 33.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 4.27 110.272 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.77 114.65 25.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.744 -0.465 . . . . 6.21 109.744 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -99.6 164.7 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.597 0.561 . . . . 6.14 112.073 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.59 -25.98 22.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.473 -0.785 . . . . 8.37 111.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.9 p -128.89 159.59 35.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.173 0.511 . . . . 7.92 111.568 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.33 -41.71 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 8.77 112.232 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.586 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.72 -41.79 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.325 0.491 . . . . 9.08 112.325 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.82 98.09 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.2 m -54.19 -53.97 46.24 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.149 -1.056 . . . . 6.18 108.149 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.5 m -55.18 -27.11 43.43 Favored 'General case' 0 C--N 1.428 3.98 0 C-N-CA 126.956 2.102 . . . . 0.0 109.86 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -34.03 43.12 Favored 'General case' 0 C--N 1.422 3.73 0 N-CA-C 113.606 0.965 . . . . 8.7 113.606 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.659 0.614 . . . . 5.94 112.659 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.86 63.38 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.394 1.059 . . . . 6.89 111.587 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.38 -9.37 53.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 7.4 111.651 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.2 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.516 -0.311 . . . . 6.97 111.619 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.84 120.92 13.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 7.38 110.78 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.91 65.94 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.918 -0.658 . . . . 7.92 113.559 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.07 142.36 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.854 0.327 . . . . 7.5 111.101 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.333 0.587 . . . . 9.49 111.266 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.28 107.73 7.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 8.45 110.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.67 13.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 10.44 111.73 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.06 -5.47 54.01 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.169 0.828 . . . . 10.21 115.169 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.62 130.94 55.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.665 0.733 . . . . 9.94 112.381 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.79 101.55 11.0 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.449 -0.945 . . . . 8.4 108.449 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.981 1.104 . . . . 6.9 113.981 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.9 tttt -108.53 110.21 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.567 -1.272 . . . . 8.29 107.567 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.91 126.91 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.349 0.5 . . . . 6.17 112.349 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.57 170.53 15.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.413 -0.812 . . . . 7.99 110.051 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.12 154.7 49.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.38 175.04 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.942 1.761 . . . . 7.79 112.079 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.797 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.004 0.43 . . . . 10.8 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.92 139.41 58.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 8.21 110.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.5 mt -109.88 143.94 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.114 -0.948 . . . . 6.33 112.769 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -104.38 132.08 51.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.176 -1.416 . . . . 6.75 107.176 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.573 -0.529 . . . . 5.68 109.573 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.456 -0.878 . . . . 6.53 112.679 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.2 86.6 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 7.67 111.506 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.6 mt -70.89 135.21 85.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.492 0.182 . . . . 8.16 111.492 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 26.2 Cg_exo -61.82 141.56 90.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.93 1.753 . . . . 8.96 108.76 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -65.36 -14.88 61.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.797 1.406 . . . . 11.61 114.797 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.16 -23.1 30.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.807 1.41 . . . . 11.06 114.807 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.35 149.12 50.86 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.169 0.44 . . . . 9.36 111.306 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 17.6 p-10 -114.53 -176.48 2.91 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.269 -0.271 . . . . 10.46 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 9.9 m-20 -53.46 -55.41 25.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 114.699 1.37 . . . . 9.92 114.699 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.66 -26.05 67.77 Favored 'General case' 0 C--N 1.406 3.023 0 C-N-CA 125.633 1.573 . . . . 0.0 112.559 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -80.28 -48.3 13.25 Favored 'General case' 1 C--N 1.429 4.064 0 CA-C-N 118.27 0.487 . . . . 10.06 111.414 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 75.1 t -62.63 -49.16 84.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.784 -0.644 . . . . 7.76 110.329 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.6 mtmm -54.37 -36.44 63.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.647 -0.706 . . . . 9.67 111.312 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.97 -53.37 56.63 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.137 0.494 . . . . 10.2 110.701 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 320' ' ' LEU . 3.1 tm? -51.74 -33.19 33.72 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.124 -0.489 . . . . 7.62 110.328 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -82.64 -41.55 19.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.651 0.611 . . . . 7.74 112.651 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.8 m -56.85 -29.57 63.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.566 0.95 . . . . 10.09 113.566 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 m -50.61 -9.99 0.06 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 124.873 1.269 . . . . 0.0 112.511 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.76 -11.96 13.9 Favored 'General case' 1 C--N 1.443 4.637 0 CA-C-N 118.398 0.544 . . . . 10.23 111.483 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 10.4 111.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.66 147.03 93.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.681 2.254 . . . . 12.19 112.744 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.4 mt -102.4 146.29 28.29 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.913 -0.585 . . . . 10.66 111.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.488 ' HD2' ' OE2' ' A' ' 306' ' ' GLU . 18.7 ptpt -101.02 -22.67 14.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.222 -0.658 . . . . 11.41 109.222 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.59 4.67 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.061 -2.274 . . . . 0.0 109.229 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.594 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.4 t80 -142.79 134.78 27.08 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 122.81 0.444 . . . . 8.77 111.968 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.82 124.09 12.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.794 0.33 . . . . 8.38 111.467 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.8 tp -101.03 118.13 36.4 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.2 122.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.445 0.906 . . . . 9.37 113.445 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.09 148.1 43.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.263 -0.88 . . . . 11.34 109.359 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.7 t70 -58.89 141.14 54.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.919 0.39 . . . . 13.83 111.039 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 38.0 m -49.59 -61.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.649 0.611 . . . . 14.58 112.649 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.16 -63.96 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.497 0.555 . . . . 16.19 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 14.9 m -42.46 -59.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.302 -0.408 . . . . 14.94 111.221 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.58 -6.04 62.7 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.65 -0.786 . . . . 13.57 114.531 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.32 167.56 13.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.411 0.606 . . . . 13.28 110.926 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.5 t -59.13 142.08 52.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 10.43 111.588 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.457 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 5.4 mmmp? -87.99 -9.47 53.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.771 -0.65 . . . . 11.2 109.566 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.55 -3.29 39.6 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.624 -0.716 . . . . 8.63 113.908 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -143.02 146.4 33.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.04 0.92 . . . . 9.19 112.837 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.63 155.14 46.62 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.131 -0.941 . . . . 6.21 112.258 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.34 146.86 36.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.172 -0.922 . . . . 7.09 110.405 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.594 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.3 p -157.91 156.18 30.87 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 119.903 -0.719 . . . . 6.77 111.84 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 31.3 tt0 -145.26 127.16 15.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.585 -0.734 . . . . 9.59 109.629 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 57.8 m-85 -82.5 164.89 20.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.042 0.386 . . . . 9.91 112.042 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . 0.475 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 64.0 t -71.59 -46.08 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.357 -0.979 . . . . 12.81 108.357 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.3 t70 -96.35 102.35 14.13 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.442 -1.318 . . . . 13.18 107.442 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 115.27 1.582 . . . . 12.23 115.27 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -56.87 -38.69 73.08 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 122.246 1.022 . . . . 13.04 109.026 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.84 -22.57 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.296 -2.229 . . . . 11.08 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.61 -48.26 72.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.933 -0.766 . . . . 9.11 108.933 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.36 -42.82 99.71 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.252 -0.579 . . . . 10.31 110.554 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.82 -32.41 73.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.857 -0.737 . . . . 11.98 111.949 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.54 -34.78 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.671 -1.604 . . . . 8.25 113.025 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 73.0 mt -68.57 -51.25 48.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 7.4 110.883 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.78 67.86 Favored 'General case' 0 C--N 1.419 3.611 0 C-N-CA 126.266 1.826 . . . . 0.0 113.178 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -24.02 36.35 Favored Glycine 1 C--N 1.398 4.01 0 N-CA-C 116.846 1.499 . . . . 8.35 116.846 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 278' ' ' LEU . 87.9 mt -96.9 -45.77 6.49 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 120.093 1.947 . . . . 7.2 113.971 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -50.53 130.06 23.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 7.86 111.492 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.66 56.72 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.103 -0.57 . . . . 8.64 113.987 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.3 ttt -50.58 147.15 4.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.797 0.298 . . . . 8.0 111.336 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -95.05 115.73 27.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 10.39 111.703 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.4 mm? -120.24 106.71 12.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.108 -1.071 . . . . 8.95 108.108 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.06 -118.64 10.56 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.388 -1.485 . . . . 10.63 109.388 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.87 22.35 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 12.25 109.781 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -123.82 153.9 40.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.59 -0.732 . . . . 9.98 111.683 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.73 118.29 36.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.133 -1.062 . . . . 10.14 108.133 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.67 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.9 tp -62.99 143.1 58.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.413 0.625 . . . . 7.52 112.663 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 94.8 mt -128.12 128.06 44.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.535 -1.211 . . . . 7.48 108.917 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.5 t -137.98 123.93 25.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.927 -1.108 . . . . 6.45 109.997 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -152.65 155.41 37.26 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.947 -1.72 . . . . 7.66 109.5 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.515 ' HA ' HD23 ' A' ' 261' ' ' LEU . 98.8 mtt180 -58.69 122.49 13.63 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.459 -1.297 . . . . 8.94 107.586 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.91 -11.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.757 1.391 . . . . 7.52 114.757 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.3 m -119.41 -77.84 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.547 -0.461 . . . . 9.07 111.362 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.725 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -161.81 149.24 14.45 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 122.97 0.508 . . . . 5.88 111.526 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.4 mt -140.73 143.56 35.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 5.25 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -96.54 125.14 40.8 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 6.58 108.879 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.69 101.22 8.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.069 0.461 . . . . 5.06 110.242 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.76 -179.2 34.86 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.033 -0.53 . . . . 6.2 112.728 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.1 41.35 23.48 Favored 'General case' 0 CA--C 1.575 1.939 0 C-N-CA 125.175 1.39 . . . . 0.0 110.326 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.69 149.85 88.43 Favored Pre-proline 1 C--N 1.429 4.023 0 C-N-CA 123.726 0.81 . . . . 7.79 111.32 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.08 144.45 89.98 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.247 1.964 . . . . 8.57 110.968 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.92 139.78 52.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 11.37 111.938 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.48 61.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.282 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.05 136.5 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.316 0.558 . . . . 8.91 110.359 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.85 153.88 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.693 0.282 . . . . 9.64 110.653 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.22 -43.07 96.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.176 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -61.82 -45.99 91.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.971 -0.559 . . . . 9.89 110.547 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.412 3.312 0 O-C-N 119.076 -2.265 . . . . 0.0 111.701 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.19 67.91 Favored 'General case' 1 C--N 1.429 4.059 0 O-C-N 123.934 0.771 . . . . 6.64 111.731 171.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.32 7.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.353 0.661 . . . . 6.69 111.119 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.48 -33.75 60.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.388 -0.824 . . . . 8.8 111.428 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.72 -53.7 17.25 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.552 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.3 -48.21 82.4 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.77 -42.85 80.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.164 -0.614 . . . . 7.12 109.594 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.98 -23.46 65.04 Favored 'General case' 0 C--N 1.406 3.042 0 O-C-N 120.279 -1.513 . . . . 0.0 111.31 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.3 -37.76 36.97 Favored 'General case' 1 C--N 1.428 4.014 0 CA-C-N 118.499 0.59 . . . . 7.79 110.354 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.66 -36.82 83.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.589 -0.732 . . . . 7.73 111.085 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -76.0 -43.13 45.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.349 0.5 . . . . 9.61 112.349 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.5 mt -62.99 -37.74 88.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.272 0.558 . . . . 10.06 110.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.03 -16.45 74.7 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.224 -0.988 . . . . 9.23 112.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.14 72.02 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.801 -0.92 . . . . 9.25 110.801 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.96 5.33 51.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.865 0.691 . . . . 8.31 112.865 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 p -82.62 143.46 30.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 9.16 110.575 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.44 23.88 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.689 -0.232 . . . . 9.89 110.706 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.3 143.48 99.72 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.017 1.812 . . . . 11.04 110.834 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.33 161.55 20.56 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.534 -0.841 . . . . 9.31 112.431 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.2 m-20 -75.26 134.52 73.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.02 0.378 . . . . 7.97 112.02 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.28 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.553 2.169 . . . . 6.59 111.327 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.63 105.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.118 -0.492 . . . . 5.87 111.11 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 70.47 0.71 Allowed 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 124.752 1.221 . . . . 0.0 109.441 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.73 151.32 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 129.383 3.073 . . . . 0.0 112.78 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.52 130.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 129.47 3.108 . . . . 5.67 109.273 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.743 -0.465 . . . . 6.47 109.743 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 125.97 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 116.958 2.207 . . . . 7.1 116.958 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.03 91.38 5.28 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 103.165 -2.902 . . . . 8.1 103.165 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -57.39 8.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.606 1.706 . . . . 10.19 115.606 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.28 -48.67 76.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.845 0.683 . . . . 10.51 112.845 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.01 -9.12 50.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.726 0.298 . . . . 9.72 111.803 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.1 36.07 15.44 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.556 1.317 . . . . 8.04 114.556 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.42 168.7 19.2 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.134 -1.027 . . . . 6.83 111.703 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.69 161.09 41.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.235 -1.348 . . . . 5.19 110.482 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.36 129.37 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.641 -0.874 . . . . 5.71 108.641 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.92 137.58 33.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 4.27 110.312 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.72 114.77 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.721 -0.474 . . . . 6.21 109.721 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.665 0.603 . . . . 6.14 111.919 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.94 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 8.37 111.411 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.3 p -128.94 159.57 35.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 7.92 111.648 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.24 -41.78 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.751 . . . . 8.77 112.232 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.584 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.71 -41.78 95.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.354 0.502 . . . . 9.08 112.354 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.91 -43.86 97.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.248 -0.279 . . . . 7.46 110.248 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.0 m -54.18 -53.87 47.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.261 1.029 . . . . 6.18 108.261 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.1 m -55.06 -27.22 43.14 Favored 'General case' 0 C--N 1.424 3.845 0 C-N-CA 127.118 2.167 . . . . 0.0 109.888 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.35 -34.01 42.47 Favored 'General case' 0 C--N 1.421 3.682 0 N-CA-C 113.585 0.957 . . . . 8.7 113.585 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.58 -17.39 64.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.82 63.34 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.473 1.108 . . . . 6.89 111.633 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.51 -9.21 52.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.355 . . . . 7.4 111.611 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.83 16.16 14.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.564 -0.289 . . . . 6.97 111.627 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.87 120.92 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.826 0.346 . . . . 7.38 110.777 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.84 65.98 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.938 -0.648 . . . . 7.92 113.577 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.06 142.38 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.936 0.368 . . . . 7.5 111.084 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.97 121.54 37.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.34 0.591 . . . . 9.49 111.262 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.29 107.76 7.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 8.45 110.378 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.69 42.71 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 10.44 111.771 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.99 -5.35 54.21 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 115.195 0.838 . . . . 10.21 115.195 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.61 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.669 0.735 . . . . 9.94 112.469 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.44 10.83 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.56 -0.904 . . . . 8.4 108.56 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.31 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.434 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.55 110.24 21.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.555 -1.276 . . . . 8.29 107.555 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.93 126.89 58.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 6.17 112.32 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.434 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.62 170.54 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.03 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.14 154.76 49.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.537 -0.912 . . . . 7.86 108.537 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.44 175.17 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.921 1.748 . . . . 7.79 112.026 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 60.7 t60 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 66.9 m80 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.911 0.386 . . . . 10.8 110.782 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 306' ' ' GLU . 7.0 tppt? -62.87 139.34 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 8.21 110.349 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 313' ' ' THR . 78.9 mt -109.75 143.99 38.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.006 -0.997 . . . . 6.33 112.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -104.48 132.24 50.95 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.141 -1.429 . . . . 6.75 107.141 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.99 121.15 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.603 -0.517 . . . . 5.68 109.603 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.14 179.25 16.47 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.72 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.53 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.555 -0.831 . . . . 7.67 111.596 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 99.1 mt -70.86 135.3 85.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.192 . . . . 8.16 111.496 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.3 Cg_exo -61.79 141.53 90.56 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.879 1.719 . . . . 8.96 108.843 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -65.42 -14.86 61.84 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -84.17 -23.14 30.71 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.781 1.401 . . . . 11.06 114.781 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.31 149.22 50.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.115 0.416 . . . . 9.36 111.332 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 275' ' ' VAL . 27.4 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.229 -0.286 . . . . 10.46 110.229 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 18.7 m-20 -53.55 -55.27 27.02 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 114.659 1.355 . . . . 9.92 114.659 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.67 -26.42 68.01 Favored 'General case' 0 C--N 1.405 3.009 0 C-N-CA 125.707 1.603 . . . . 0.0 112.461 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -80.02 -48.26 13.61 Favored 'General case' 1 C--N 1.431 4.119 0 CA-C-N 118.263 0.483 . . . . 10.06 111.455 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 271' ' ' ASN . 84.4 t -62.74 -49.21 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.8 -0.636 . . . . 7.76 110.273 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 45.1 mtmt -54.25 -36.4 63.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 9.67 111.336 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.06 -53.26 57.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.092 0.472 . . . . 10.2 110.772 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.401 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.72 -33.21 33.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.964 -0.562 . . . . 7.62 110.365 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.64 -41.66 19.17 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.549 0.574 . . . . 7.74 112.549 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 32.3 m -56.92 -29.82 63.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.586 0.958 . . . . 10.09 113.586 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.1 m -49.9 -10.33 0.05 OUTLIER 'General case' 0 C--N 1.394 2.507 0 C-N-CA 124.846 1.258 . . . . 0.0 112.776 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -111.59 -11.99 13.98 Favored 'General case' 1 C--N 1.443 4.669 0 CA-C-N 118.341 0.519 . . . . 10.23 111.467 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.3 10.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.9 -0.667 . . . . 10.4 111.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 147.12 93.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.716 2.277 . . . . 12.19 112.689 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 81.6 mt -102.49 146.29 28.32 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.932 -0.576 . . . . 10.66 111.217 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -101.07 -22.58 14.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.271 -0.64 . . . . 11.41 109.271 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.58 126.13 5.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.174 -2.204 . . . . 0.0 109.172 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.547 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 50.1 t80 -143.41 134.68 25.92 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.792 0.437 . . . . 8.77 112.028 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.12 13.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.797 0.332 . . . . 8.38 111.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 60.7 tp -101.08 118.24 36.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.568 -1.271 . . . . 8.94 107.568 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.6 t -74.14 122.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.44 0.904 . . . . 9.37 113.44 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -119.18 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.353 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.6 t70 -58.9 141.19 54.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 13.83 110.98 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.4 m -49.75 -61.56 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.736 0.643 . . . . 14.58 112.736 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.21 -64.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.465 0.543 . . . . 16.19 112.465 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 9.0 m -42.59 -59.22 1.98 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.306 -0.406 . . . . 14.94 111.176 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.15 62.58 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.599 -0.81 . . . . 13.57 114.499 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 70.3 mt -88.24 167.67 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.401 0.601 . . . . 13.28 110.911 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 33.5 t -59.22 142.1 52.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 10.43 111.656 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.97 -9.43 53.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 11.2 109.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.5 -3.29 39.73 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.669 -0.696 . . . . 8.63 113.935 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -143.01 146.4 33.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.038 0.919 . . . . 9.19 112.827 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.13 46.73 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.037 -0.983 . . . . 6.21 112.206 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.35 146.77 36.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.192 -0.913 . . . . 7.09 110.415 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.547 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.6 p -157.78 156.29 31.3 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.969 -0.692 . . . . 6.77 111.868 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.796 ' HB2' ' HD3' ' A' ' 260' ' ' LYS . 78.4 tt0 -145.35 127.05 15.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.737 -0.665 . . . . 9.59 109.682 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 51.8 m-85 -82.42 164.87 20.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.953 0.406 . . . . 9.91 112.007 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.53 -46.1 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.43 -0.952 . . . . 12.81 108.43 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.4 t70 -96.28 102.29 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.436 -1.32 . . . . 13.18 107.436 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 115.299 1.592 . . . . 12.23 115.299 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -56.92 -38.69 73.23 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.184 0.992 . . . . 13.04 108.966 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.64 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 112.358 -2.201 . . . . 11.08 109.613 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 91.6 m -54.71 -48.13 72.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.908 -0.775 . . . . 9.11 108.908 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -62.43 -42.89 99.78 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.285 -0.566 . . . . 10.31 110.473 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.7 -32.43 73.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 119.93 -0.708 . . . . 11.98 111.98 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.71 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.641 -1.618 . . . . 8.25 113.076 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 72.8 mt -68.61 -51.39 46.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.354 0.597 . . . . 7.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.88 67.31 Favored 'General case' 0 C--N 1.42 3.668 0 C-N-CA 126.225 1.81 . . . . 0.0 113.13 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.02 -24.07 36.11 Favored Glycine 1 C--N 1.399 4.077 0 N-CA-C 116.762 1.465 . . . . 8.35 116.762 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 330' ' ' LEU . 84.3 mt -96.86 -45.76 6.51 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 120.176 1.988 . . . . 7.2 113.938 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -50.44 129.94 22.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 7.86 111.526 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.69 56.7 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.108 -0.568 . . . . 8.64 113.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.3 ttt -50.65 147.18 4.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.84 0.32 . . . . 8.0 111.337 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.01 115.64 27.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.407 . . . . 10.39 111.723 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.24 106.63 12.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.116 -1.068 . . . . 8.95 108.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.2 -118.68 10.5 Favored Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -115.84 22.36 13.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 12.25 109.714 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -123.88 153.94 40.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.667 -0.697 . . . . 9.98 111.618 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -101.79 118.22 36.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.138 -1.06 . . . . 10.14 108.138 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.643 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.1 tp -63.0 143.15 58.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.545 0.688 . . . . 7.52 112.637 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.23 127.92 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.469 -1.242 . . . . 7.48 108.981 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.84 124.01 26.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 O-C-N 120.976 -1.078 . . . . 6.45 110.011 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -152.78 155.4 37.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.042 -1.661 . . . . 7.66 109.51 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.463 ' HA ' HD23 ' A' ' 261' ' ' LEU . 98.5 mtt180 -58.65 122.54 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 118.435 -1.306 . . . . 8.94 107.58 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.78 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.3 m -119.36 -78.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.575 -0.45 . . . . 9.07 111.212 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.819 -177.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.758 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -158.81 149.26 19.79 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 123.646 0.591 . . . . 5.88 111.577 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.81 143.64 34.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 5.25 111.231 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -96.57 125.17 40.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.905 -0.776 . . . . 6.58 108.905 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.82 101.23 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 5.06 110.21 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.85 -179.32 34.68 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.07 -0.586 . . . . 6.2 112.769 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.3 m120 49.95 41.6 23.21 Favored 'General case' 0 CA--C 1.574 1.899 0 C-N-CA 125.395 1.478 . . . . 0.0 110.292 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.43 149.87 89.01 Favored Pre-proline 1 C--N 1.43 4.07 0 C-N-CA 123.861 0.864 . . . . 7.79 111.355 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.15 144.44 90.35 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.317 2.011 . . . . 8.57 110.977 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.96 139.77 52.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.929 0.395 . . . . 11.37 111.992 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.59 61.25 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.876 -0.602 . . . . 9.94 114.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.2 136.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 117.338 0.569 . . . . 8.91 110.254 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.7 p -84.96 153.85 22.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 9.64 110.637 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.09 -43.18 95.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 7.44 110.185 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.74 -46.03 91.37 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.994 -0.548 . . . . 9.89 110.54 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.56 -26.4 68.56 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.271 -2.143 . . . . 0.0 111.698 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.478 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.38 -34.08 67.68 Favored 'General case' 1 C--N 1.43 4.071 0 O-C-N 123.952 0.783 . . . . 6.64 111.811 171.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.55 -54.29 7.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.442 0.697 . . . . 6.69 111.078 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.66 -33.64 61.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.419 -0.81 . . . . 8.8 111.373 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.76 -53.6 17.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 120.634 -0.426 . . . . 7.44 111.603 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.25 -48.37 81.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.181 0.438 . . . . 5.94 112.181 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.6 m-20 -56.74 -42.85 80.0 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.193 -0.603 . . . . 7.12 109.606 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.4 65.07 Favored 'General case' 0 C--N 1.406 3.06 0 O-C-N 120.27 -1.519 . . . . 0.0 111.251 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.5 -37.66 36.21 Favored 'General case' 1 C--N 1.429 4.03 0 CA-C-N 118.576 0.625 . . . . 7.79 110.332 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.82 83.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 7.73 111.022 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.01 -43.07 45.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.437 0.532 . . . . 9.61 112.437 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.02 -37.82 88.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 10.06 110.397 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.96 -16.52 74.67 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.309 -0.948 . . . . 9.23 112.881 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.11 71.55 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.816 -0.914 . . . . 9.25 110.816 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.01 5.28 52.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.816 0.672 . . . . 8.31 112.816 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.5 p -82.59 143.44 31.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.565 0.221 . . . . 9.16 110.598 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.157 0.429 . . . . 10.23 112.157 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.47 23.82 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.688 -0.233 . . . . 9.89 110.689 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.33 143.49 99.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.928 1.752 . . . . 11.04 110.797 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.57 20.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 9.31 112.385 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.23 134.52 73.84 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.046 0.387 . . . . 7.97 112.046 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.29 -50.91 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.564 2.176 . . . . 6.59 111.358 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.79 105.43 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.183 -0.462 . . . . 5.87 111.096 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -31.4 29.19 Favored 'General case' 0 N--CA 1.529 3.482 0 O-C-N 119.988 -1.695 . . . . 0.0 113.404 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.21 163.37 39.66 Favored 'General case' 0 C--N 1.391 2.372 0 C-N-CA 126.244 1.818 . . . . 0.0 110.798 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.27 130.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.376 1.752 0 C-N-CA 126.556 1.943 . . . . 5.67 109.313 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.17 126.6 55.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.715 -0.476 . . . . 6.47 109.715 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.96 126.0 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 116.985 2.217 . . . . 7.1 116.985 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.01 91.37 5.27 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 103.163 -2.902 . . . . 8.1 103.163 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -57.36 8.09 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.634 1.716 . . . . 10.19 115.634 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.23 -48.75 75.87 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.891 0.7 . . . . 10.51 112.891 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.14 50.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.895 0.331 . . . . 9.72 111.895 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.05 36.23 15.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.565 1.32 . . . . 8.04 114.565 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.61 168.59 19.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.063 -1.055 . . . . 6.83 111.633 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.52 161.17 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.413 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.46 129.4 51.2 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.556 -0.905 . . . . 5.71 108.556 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.87 137.53 33.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.353 -0.385 . . . . 4.27 110.33 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -114.74 114.7 25.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.678 -0.49 . . . . 6.21 109.678 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.939 -0.573 . . . . 6.14 111.93 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -25.99 22.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 8.37 111.47 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.2 p -128.89 159.54 35.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.104 0.478 . . . . 7.92 111.688 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.27 -41.78 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 8.77 112.231 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.584 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.74 -41.68 95.75 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.385 0.513 . . . . 9.08 112.385 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.83 -43.84 98.04 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.292 -0.262 . . . . 7.46 110.292 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.2 m -54.17 -54.03 45.25 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.108 -1.071 . . . . 6.18 108.108 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 m -54.99 -27.14 41.85 Favored 'General case' 1 C--N 1.429 4.039 0 C-N-CA 127.072 2.149 . . . . 0.0 109.905 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -34.1 42.69 Favored 'General case' 0 C--N 1.422 3.734 0 N-CA-C 113.586 0.958 . . . . 8.7 113.586 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.657 0.614 . . . . 5.94 112.657 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.1 -19.83 63.39 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.451 1.095 . . . . 6.89 111.602 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.26 52.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 7.4 111.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.89 16.28 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.528 -0.305 . . . . 6.97 111.584 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.97 14.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.869 0.366 . . . . 7.38 110.715 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.9 65.98 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.89 -0.671 . . . . 7.92 113.587 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.809 0.305 . . . . 7.5 111.121 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.91 121.54 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.271 0.558 . . . . 9.49 111.343 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.23 107.75 7.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 8.45 110.354 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.7 13.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.064 -0.517 . . . . 10.44 111.751 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.53 53.6 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.234 0.854 . . . . 10.21 115.234 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.52 130.86 55.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.58 0.69 . . . . 9.94 112.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.68 101.51 10.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.52 -0.918 . . . . 8.4 108.52 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.31 137.88 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.027 1.121 . . . . 6.9 114.027 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.5 tttt -108.61 110.32 21.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.548 -1.279 . . . . 8.29 107.548 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.05 126.92 58.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.129 0.49 . . . . 6.17 112.288 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.63 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 7.99 110.026 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.05 154.7 49.69 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.56 -0.904 . . . . 7.86 108.56 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.4 175.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 121.89 1.726 . . . . 7.79 112.057 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m170 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.003 0.43 . . . . 10.8 110.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 260' ' ' LYS . 16.3 ttmt -62.9 139.34 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.21 110.323 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 313' ' ' THR . 64.4 mt -109.8 143.94 38.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.02 -0.991 . . . . 6.33 112.806 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -104.47 132.12 51.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.19 -1.411 . . . . 6.75 107.19 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.661 -0.496 . . . . 5.68 109.661 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.25 16.48 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.537 -0.839 . . . . 6.53 112.659 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.2 86.51 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.643 -0.789 . . . . 7.67 111.554 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 95.2 mt -70.83 135.19 85.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.503 0.186 . . . . 8.16 111.503 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.8 Cg_exo -61.78 141.6 90.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.883 1.722 . . . . 8.96 108.843 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.37 -14.96 62.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.779 1.4 . . . . 11.61 114.779 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.08 -23.21 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.842 1.423 . . . . 11.06 114.842 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.29 149.19 50.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.159 0.436 . . . . 9.36 111.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.4 p-10 -114.5 -176.43 2.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 110.29 -0.263 . . . . 10.46 110.29 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.61 -55.2 27.85 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.618 1.34 . . . . 9.92 114.618 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.79 -26.34 68.04 Favored 'General case' 0 C--N 1.406 3.033 0 C-N-CA 125.669 1.588 . . . . 0.0 112.408 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -80.04 -48.3 13.52 Favored 'General case' 1 C--N 1.43 4.072 0 CA-C-N 118.301 0.5 . . . . 10.06 111.412 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 271' ' ' ASN . 67.6 t -62.63 -49.27 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 7.76 110.28 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -54.22 -36.46 63.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 9.67 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.0 -53.36 56.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.133 0.492 . . . . 10.2 110.709 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 278' ' ' LEU . 1.5 tm? -51.78 -33.14 33.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.081 -0.509 . . . . 7.62 110.364 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.1 mt -82.66 -41.67 19.11 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.602 0.593 . . . . 7.74 112.602 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.7 m -56.73 -29.9 62.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.567 0.951 . . . . 10.09 113.567 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 m -50.21 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.555 0 C-N-CA 124.796 1.238 . . . . 0.0 112.587 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -111.46 -12.06 14.03 Favored 'General case' 1 C--N 1.442 4.596 0 CA-C-N 118.379 0.536 . . . . 10.23 111.452 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.12 162.36 10.28 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.786 -0.643 . . . . 10.4 111.913 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.66 147.12 93.3 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.731 2.287 . . . . 12.19 112.712 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 84.1 mt -102.52 146.25 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.918 -0.583 . . . . 10.66 111.215 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.7 ptpt -100.99 -22.65 14.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.266 -0.642 . . . . 11.41 109.266 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.64 126.15 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 119.07 -2.269 . . . . 0.0 109.15 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 62.9 t80 -143.3 134.7 26.12 Favored 'General case' 0 C--N 1.362 1.142 0 C-N-CA 122.886 0.474 . . . . 8.77 112.009 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 4.2 p-10 -144.78 124.04 12.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.73 0.3 . . . . 8.38 111.557 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 54.2 tp -101.01 118.3 36.73 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.552 -1.277 . . . . 8.94 107.552 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.17 122.86 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.511 0.93 . . . . 9.37 113.511 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -119.09 148.13 43.39 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 115.332 -0.849 . . . . 11.34 109.336 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 37.2 t70 -58.94 141.1 54.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 13.83 110.95 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.6 m -49.71 -61.66 1.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.625 0.602 . . . . 14.58 112.625 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.18 -63.95 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.493 0.553 . . . . 16.19 112.493 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.4 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.414 . . . . 14.94 111.179 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.07 62.69 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.607 -0.806 . . . . 13.57 114.557 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.33 167.64 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.34 0.57 . . . . 13.28 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.1 t -59.17 141.96 52.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 10.43 111.617 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.419 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.4 mmmp? -87.95 -9.42 53.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 11.2 109.574 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.37 39.53 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.727 . . . . 8.63 113.875 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -142.92 146.43 33.99 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.051 0.925 . . . . 9.19 112.846 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.13 46.72 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.004 -0.998 . . . . 6.21 112.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 97.5 m-85 -111.44 146.83 36.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.168 -0.924 . . . . 7.09 110.449 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.6 p -157.72 156.24 31.32 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.003 -0.679 . . . . 6.77 111.869 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.4 127.08 15.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.723 -0.671 . . . . 9.59 109.649 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.568 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 53.2 m-85 -82.37 164.92 20.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.095 0.406 . . . . 9.91 112.095 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.62 -46.08 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.343 -0.984 . . . . 12.81 108.343 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 312' ' ' VAL . 12.1 t70 -96.32 102.28 14.04 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.381 -1.34 . . . . 13.18 107.381 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.68 -35.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 115.337 1.606 . . . . 12.23 115.337 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -56.78 -38.73 72.89 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.259 1.028 . . . . 13.04 109.097 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.69 -22.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.306 -2.225 . . . . 11.08 109.529 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 94.5 m -54.64 -48.13 72.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.929 -0.767 . . . . 9.11 108.929 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.46 -42.89 99.8 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.308 -0.557 . . . . 10.31 110.467 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -63.8 -32.44 73.94 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 119.923 -0.711 . . . . 11.98 111.941 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.66 74.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.586 -1.643 . . . . 8.25 113.103 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.61 -51.31 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.362 0.601 . . . . 7.4 110.876 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.88 -38.66 67.82 Favored 'General case' 0 C--N 1.419 3.596 0 C-N-CA 126.281 1.832 . . . . 0.0 113.151 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.11 -24.08 35.81 Favored Glycine 1 C--N 1.399 4.033 0 N-CA-C 116.778 1.471 . . . . 8.35 116.778 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 99.1 mt -96.81 -45.81 6.5 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.107 1.954 . . . . 7.2 113.946 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -50.47 130.04 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 7.86 111.463 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.66 56.76 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.111 -0.566 . . . . 8.64 113.948 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.7 mtt -50.65 147.21 4.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.783 0.325 . . . . 8.0 111.264 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -95.14 115.69 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.076 0.465 . . . . 10.39 111.715 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.0 mm? -120.26 106.83 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.082 -1.081 . . . . 8.95 108.082 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.1 -118.74 10.65 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.397 -1.481 . . . . 10.63 109.397 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -115.78 22.36 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 12.25 109.781 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.8 153.91 40.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.616 -0.72 . . . . 9.98 111.624 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.73 118.25 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.117 -1.068 . . . . 10.14 108.117 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.09 143.09 58.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 7.52 112.586 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 20.8 mt -128.12 128.0 44.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.504 -1.225 . . . . 7.48 108.997 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.92 124.04 26.28 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 O-C-N 120.984 -1.073 . . . . 6.45 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -152.76 155.33 36.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 119.987 -1.696 . . . . 7.66 109.547 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.488 ' HA ' HD23 ' A' ' 261' ' ' LEU . 95.0 mtt180 -58.55 122.43 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.395 -1.322 . . . . 8.94 107.626 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.94 -11.77 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.786 1.402 . . . . 7.52 114.786 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.6 m -119.36 -77.84 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.55 -0.46 . . . . 9.07 111.422 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.477 0.656 . . . . 0.0 110.581 178.139 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 74.5 ttt180 . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.34 148.4 21.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.762 -1.108 . . . . 5.88 111.36 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.74 143.47 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 5.25 111.205 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.55 125.14 40.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.901 -0.777 . . . . 6.58 108.901 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.77 101.29 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.098 0.475 . . . . 5.06 110.147 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.81 -179.32 34.73 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.964 -0.562 . . . . 6.2 112.795 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.4 m120 50.28 41.31 24.14 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 125.258 1.423 . . . . 0.0 110.194 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.46 149.83 88.94 Favored Pre-proline 1 C--N 1.429 4.048 0 C-N-CA 123.832 0.853 . . . . 7.79 111.316 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.07 144.41 90.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.308 2.005 . . . . 8.57 111.013 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.67 52.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.93 0.395 . . . . 11.37 111.964 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.33 6.42 61.52 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.838 -0.619 . . . . 9.94 114.319 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.11 136.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.31 0.555 . . . . 8.91 110.276 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.6 p -84.86 153.91 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 9.64 110.691 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.1 -43.19 95.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 7.44 110.204 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.78 -45.92 91.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.901 -0.59 . . . . 9.89 110.499 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.76 -26.38 68.68 Favored 'General case' 0 C--N 1.408 3.142 0 O-C-N 119.262 -2.149 . . . . 0.0 111.689 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.29 -34.1 67.92 Favored 'General case' 0 C--N 1.428 3.98 0 O-C-N 123.978 0.799 . . . . 6.64 111.79 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.54 -54.22 7.92 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.412 0.685 . . . . 6.69 111.132 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.73 -33.61 61.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 8.8 111.353 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.83 -53.55 17.64 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.531 -0.468 . . . . 7.44 111.61 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.31 -48.28 82.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.13 0.419 . . . . 5.94 112.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.76 -42.85 80.08 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.277 -0.569 . . . . 7.12 109.559 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.28 64.83 Favored 'General case' 0 C--N 1.405 3.001 0 O-C-N 120.199 -1.563 . . . . 0.0 111.234 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.72 36.7 Favored 'General case' 0 C--N 1.427 3.956 0 CA-C-N 118.528 0.604 . . . . 7.79 110.354 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.75 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.577 -0.738 . . . . 7.73 111.059 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -76.1 -42.94 45.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.413 0.523 . . . . 9.61 112.413 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.259 0.552 . . . . 10.06 110.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.04 -16.52 74.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.322 -0.942 . . . . 9.23 112.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.19 37.14 71.88 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.843 -0.903 . . . . 9.25 110.843 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.35 51.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 8.31 112.918 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.8 p -82.58 143.49 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 9.16 110.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.582 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.47 21.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.18 0.437 . . . . 10.23 112.18 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.49 23.74 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.709 -0.223 . . . . 9.89 110.693 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.4 143.61 99.66 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.926 1.751 . . . . 11.04 110.825 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.22 161.63 20.69 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.639 -0.791 . . . . 9.31 112.441 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.3 134.5 73.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.089 0.403 . . . . 7.97 112.089 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.26 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.492 2.128 . . . . 6.59 111.315 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.65 105.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.135 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -35.05 33.28 Favored 'General case' 0 N--CA 1.53 3.525 0 O-C-N 120.279 -1.513 . . . . 0.0 113.277 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.84 163.95 39.18 Favored 'General case' 0 C--N 1.386 2.167 0 C-N-CA 126.05 1.74 . . . . 0.0 110.591 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.19 130.45 11.04 Favored 'Isoleucine or valine' 0 C--N 1.372 1.549 0 C-N-CA 126.534 1.934 . . . . 5.67 109.297 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.06 126.7 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.798 -0.445 . . . . 6.47 109.798 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -115.06 125.98 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 116.904 2.187 . . . . 7.1 116.904 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -98.05 91.38 5.27 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 103.193 -2.891 . . . . 8.1 103.193 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -57.4 7.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.612 1.708 . . . . 10.19 115.612 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.76 75.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.839 0.681 . . . . 10.51 112.839 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.04 -9.11 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.834 0.309 . . . . 9.72 111.834 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.15 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.495 1.294 . . . . 8.04 114.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.64 168.56 19.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.184 -1.007 . . . . 6.83 111.663 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.51 161.17 41.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.446 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.27 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.726 -0.842 . . . . 5.71 108.726 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.0 mt -94.82 137.58 33.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.451 -0.34 . . . . 4.27 110.337 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.73 25.98 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.702 -0.481 . . . . 6.21 109.702 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.7 164.78 11.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.928 -0.578 . . . . 6.14 111.953 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.67 -25.87 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 8.37 111.484 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.5 p -129.0 159.6 35.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.17 0.509 . . . . 7.92 111.579 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 209' ' ' THR . 40.9 t -74.34 -41.73 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.523 -0.762 . . . . 8.77 112.201 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.582 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.78 -41.72 95.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.32 0.489 . . . . 9.08 112.32 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.91 -43.85 97.99 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.192 -0.299 . . . . 7.46 110.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.15 -53.28 55.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.332 1.063 . . . . 6.18 108.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.619 HG22 HH22 ' A' ' 228' ' ' ARG . 3.7 p -56.19 -26.15 49.64 Favored 'General case' 1 C--N 1.449 4.894 0 C-N-CA 126.15 1.78 . . . . 0.0 110.195 178.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -34.05 41.57 Favored 'General case' 0 C--N 1.428 3.995 0 N-CA-C 113.602 0.964 . . . . 8.7 113.602 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.36 64.14 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.72 0.637 . . . . 5.94 112.72 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.02 -19.93 63.38 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.532 1.145 . . . . 6.89 111.597 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.42 -9.27 52.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 7.4 111.683 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.18 14.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 6.97 111.704 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.86 120.99 14.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.886 0.374 . . . . 7.38 110.803 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.86 -4.85 66.06 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.906 -0.664 . . . . 7.92 113.584 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.858 0.329 . . . . 7.5 111.086 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.95 121.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.271 0.558 . . . . 9.49 111.286 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.64 7.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.698 -0.683 . . . . 8.45 110.347 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.73 42.71 13.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 10.44 111.759 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.1 -5.5 54.08 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.186 0.834 . . . . 10.21 115.186 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.62 130.84 55.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.654 0.727 . . . . 9.94 112.405 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.72 101.49 10.91 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.535 -0.913 . . . . 8.4 108.535 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.28 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.088 1.144 . . . . 6.9 114.088 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.51 110.26 21.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.588 -1.264 . . . . 8.29 107.588 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.92 126.95 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 6.17 112.334 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.62 170.52 15.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.047 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 209' ' ' THR . 3.5 mtp180 -89.09 154.67 49.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.559 -0.904 . . . . 7.86 108.559 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.38 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.97 1.78 . . . . 7.79 111.987 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.9 t60 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 78.9 m80 . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.961 0.41 . . . . 10.8 110.74 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.01 139.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.185 0.517 . . . . 8.21 110.278 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 334' ' ' ARG . 47.9 mt -109.73 143.86 38.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.032 -0.986 . . . . 6.33 112.862 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -104.49 132.14 51.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.0 121.21 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.54 -0.541 . . . . 5.68 109.54 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.722 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.19 86.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.656 -0.783 . . . . 7.67 111.511 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.5 mt -70.86 135.25 85.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.154 . . . . 8.16 111.409 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 35.4 Cg_exo -61.82 141.55 90.52 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.952 1.768 . . . . 8.96 108.737 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.39 -14.94 62.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.703 1.371 . . . . 11.61 114.703 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -84.07 -23.27 30.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.811 1.412 . . . . 11.06 114.811 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.23 149.17 50.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.125 0.421 . . . . 9.36 111.366 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.5 p-10 -114.51 -176.46 2.91 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.293 -0.262 . . . . 10.46 110.293 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -53.55 -55.4 25.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 114.632 1.345 . . . . 9.92 114.632 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -26.46 67.89 Favored 'General case' 0 C--N 1.406 3.042 0 C-N-CA 125.639 1.576 . . . . 0.0 112.531 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -79.95 -48.34 13.55 Favored 'General case' 0 C--N 1.428 3.979 0 CA-C-N 118.307 0.503 . . . . 10.06 111.447 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 79.5 t -62.67 -49.14 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 7.76 110.286 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 33.0 mtmm -54.28 -36.48 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 9.67 111.332 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.99 -53.38 56.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 10.2 110.716 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.77 -33.09 33.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.08 -0.509 . . . . 7.62 110.393 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.469 HD13 ' SG ' ' A' ' 305' ' ' CYS . 78.5 mt -82.62 -41.72 19.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.588 0.588 . . . . 7.74 112.588 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 83.0 m -56.82 -29.9 63.22 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.523 0.935 . . . . 10.09 113.523 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 19.8 m -50.26 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.549 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 316' ' ' ALA . 33.8 m-85 -111.33 -11.95 14.1 Favored 'General case' 1 C--N 1.444 4.688 0 CA-C-N 118.372 0.533 . . . . 10.23 111.426 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.835 -0.621 . . . . 10.4 111.94 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.72 147.11 93.48 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.743 2.295 . . . . 12.19 112.627 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 82.5 mt -102.43 146.24 28.36 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.869 -0.605 . . . . 10.66 111.23 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.06 -22.48 14.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.308 -0.627 . . . . 11.41 109.308 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.33 127.66 5.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 119.294 -2.129 . . . . 0.0 109.099 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.0 t80 -144.56 134.65 24.07 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 122.852 0.461 . . . . 8.77 112.008 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -144.73 124.14 13.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.764 0.316 . . . . 8.38 111.513 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -101.02 118.2 36.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.524 -1.287 . . . . 8.94 107.524 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.22 122.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.465 0.913 . . . . 9.37 113.465 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -119.19 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.436 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.2 t70 -58.89 141.15 54.27 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.966 0.412 . . . . 13.83 111.039 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 15.5 m -49.68 -61.7 1.97 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.616 . . . . 14.58 112.633 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.06 -64.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.476 0.547 . . . . 16.19 112.476 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.49 -59.33 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 14.94 111.18 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.07 62.55 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.567 -0.825 . . . . 13.57 114.554 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.29 167.64 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.394 0.597 . . . . 13.28 110.886 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.5 t -59.24 142.03 52.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 10.43 111.635 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 4.8 mmmp? -87.91 -9.46 53.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 11.2 109.573 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.42 39.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.644 -0.707 . . . . 8.63 113.895 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -142.9 146.43 34.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.126 0.963 . . . . 9.19 112.903 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.1 46.73 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.106 -0.952 . . . . 6.21 112.23 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -111.39 146.93 36.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.221 -0.899 . . . . 7.09 110.348 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.568 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.6 p -157.91 156.21 30.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.924 -0.711 . . . . 6.77 111.919 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -145.31 127.1 15.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.68 -0.691 . . . . 9.59 109.61 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 63.9 m-85 -82.55 164.87 20.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.417 . . . . 9.91 112.041 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.5 -46.13 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.384 -0.969 . . . . 12.81 108.384 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.705 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.28 102.35 14.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.355 -1.35 . . . . 13.18 107.355 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.05 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 115.303 1.594 . . . . 12.23 115.303 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -56.84 -38.71 73.05 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.264 1.03 . . . . 13.04 109.009 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.78 -22.63 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 112.265 -2.243 . . . . 11.08 109.549 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.62 -48.22 72.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.931 -0.766 . . . . 9.11 108.931 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.45 -42.81 99.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.184 -0.607 . . . . 10.31 110.52 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.8 -32.47 73.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 119.943 -0.703 . . . . 11.98 111.909 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . . . -69.43 -34.79 74.96 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.626 -1.624 . . . . 8.25 113.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 74.7 mt -68.54 -51.3 47.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 121.403 0.621 . . . . 7.4 110.861 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.1 -38.63 68.38 Favored 'General case' 0 C--N 1.419 3.603 0 C-N-CA 126.141 1.776 . . . . 0.0 113.172 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -23.92 36.68 Favored Glycine 1 C--N 1.398 4.008 0 N-CA-C 116.845 1.498 . . . . 8.35 116.845 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 330' ' ' LEU . 80.2 mt -96.9 -45.71 6.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 120.122 1.961 . . . . 7.2 113.957 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -50.54 130.07 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 7.86 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.16 -16.65 56.76 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.091 -0.576 . . . . 8.64 113.955 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.2 ttt -50.67 147.19 4.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.755 0.312 . . . . 8.0 111.298 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -95.05 115.61 27.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 10.39 111.635 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.25 106.77 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.118 -1.068 . . . . 8.95 108.118 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.08 -118.67 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.382 -1.487 . . . . 10.63 109.382 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -115.84 22.49 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.129 0.49 . . . . 12.25 109.749 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -123.9 153.83 40.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.673 -0.694 . . . . 9.98 111.612 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -101.79 118.3 36.64 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.071 -1.085 . . . . 10.14 108.071 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.711 ' HB2' HD23 ' A' ' 325' ' ' LEU . 23.8 tp -63.03 143.13 58.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.502 0.668 . . . . 7.52 112.642 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.574 -1.193 . . . . 7.48 108.977 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.96 123.98 26.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 O-C-N 120.939 -1.101 . . . . 6.45 109.997 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.68 155.35 37.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 119.965 -1.709 . . . . 7.66 109.502 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.541 ' HA ' HD23 ' A' ' 261' ' ' LEU . 82.1 mtt180 -58.63 122.53 13.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.403 -1.319 . . . . 8.94 107.533 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.734 1.383 . . . . 7.52 114.734 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.0 m -119.4 -78.29 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.623 -0.431 . . . . 9.07 111.262 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.604 -178.398 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.665 0.269 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -156.22 148.61 23.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 5.88 111.203 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.3 mt -140.8 143.56 34.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 5.25 111.185 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.59 125.16 40.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.851 -0.796 . . . . 6.58 108.851 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.79 101.21 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.088 0.47 . . . . 5.06 110.201 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -178.96 34.97 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.998 -0.547 . . . . 6.2 112.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 50.53 40.71 24.09 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.122 1.369 . . . . 0.0 110.224 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.62 149.88 88.59 Favored Pre-proline 1 C--N 1.428 4.01 0 C-N-CA 123.595 0.758 . . . . 7.79 111.302 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.07 144.47 89.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.297 1.998 . . . . 8.57 110.967 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.0 139.71 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.987 0.422 . . . . 11.37 111.94 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.19 6.56 61.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.792 -0.64 . . . . 9.94 114.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.17 136.47 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 117.331 0.566 . . . . 8.91 110.283 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.3 p -84.9 153.99 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.517 -0.31 . . . . 9.64 110.652 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.19 -43.21 96.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 7.44 110.146 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.72 -45.96 91.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.575 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.62 -26.35 68.57 Favored 'General case' 0 C--N 1.41 3.199 0 O-C-N 119.296 -2.127 . . . . 0.0 111.664 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.41 -34.17 67.66 Favored 'General case' 0 C--N 1.428 3.982 0 O-C-N 123.985 0.803 . . . . 6.64 111.708 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.6 -54.24 7.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 123.47 0.708 . . . . 6.69 111.102 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.54 -33.77 60.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.426 -0.806 . . . . 8.8 111.391 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.75 -53.6 17.65 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.604 -0.438 . . . . 7.44 111.572 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.39 -48.22 82.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.79 -42.93 80.35 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.342 -0.543 . . . . 7.12 109.591 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.2 -22.98 64.78 Favored 'General case' 0 C--N 1.406 3.038 0 O-C-N 120.181 -1.574 . . . . 0.0 111.302 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.63 -37.55 35.8 Favored 'General case' 0 C--N 1.427 3.961 0 CA-C-N 118.56 0.618 . . . . 7.79 110.309 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.81 -36.67 82.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.614 -0.721 . . . . 7.73 111.022 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -76.12 -43.03 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.375 0.509 . . . . 9.61 112.375 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.99 -37.69 88.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.186 0.517 . . . . 10.06 110.471 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.44 74.58 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.196 -1.002 . . . . 9.23 112.871 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.1 37.09 72.65 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.908 -0.877 . . . . 9.25 110.908 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.8 5.22 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.945 0.72 . . . . 8.31 112.945 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.3 p -82.65 143.46 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.591 0.234 . . . . 9.16 110.524 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.581 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.69 -18.41 21.33 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.047 0.388 . . . . 10.23 112.047 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.44 23.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.704 -0.225 . . . . 9.89 110.674 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.31 143.46 99.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.033 1.822 . . . . 11.04 110.748 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.4 161.67 20.53 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.611 -0.804 . . . . 9.31 112.355 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.36 134.42 73.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.003 0.372 . . . . 7.97 112.003 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.24 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 6.59 111.325 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.6 105.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.174 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -33.78 29.67 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 120.212 -1.555 . . . . 0.0 113.418 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.17 40.58 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 126.054 1.742 . . . . 0.0 110.647 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.73 130.43 12.12 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 126.309 1.844 . . . . 5.67 109.298 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.04 126.65 55.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.823 -0.436 . . . . 6.47 109.823 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 116.875 2.176 . . . . 7.1 116.875 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.11 91.32 5.22 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.186 -2.894 . . . . 8.1 103.186 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.22 -57.43 7.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.619 1.711 . . . . 10.19 115.619 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.18 -48.73 75.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.884 0.698 . . . . 10.51 112.884 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.01 -9.13 50.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.74 0.305 . . . . 9.72 111.764 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.14 15.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 114.516 1.302 . . . . 8.04 114.516 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.58 168.64 19.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.11 -1.036 . . . . 6.83 111.632 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.604 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.05 41.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.149 -1.387 . . . . 5.19 110.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.35 51.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.691 -0.855 . . . . 5.71 108.691 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.87 137.6 33.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 4.27 110.297 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.8 114.74 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.698 -0.482 . . . . 6.21 109.698 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.69 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.965 -0.561 . . . . 6.14 111.935 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.68 -25.93 22.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.822 . . . . 8.37 111.462 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.4 p -128.85 159.6 35.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 7.92 111.687 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.29 -41.77 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 8.77 112.247 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.581 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.7 -41.77 95.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.343 0.497 . . . . 9.08 112.343 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.236 -0.283 . . . . 7.46 110.236 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.8 m -54.24 -53.9 47.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.317 1.056 . . . . 6.18 108.15 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 m -55.03 -27.22 42.85 Favored 'General case' 1 C--N 1.429 4.041 0 C-N-CA 127.082 2.153 . . . . 0.0 109.859 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -34.21 42.78 Favored 'General case' 0 C--N 1.42 3.662 0 N-CA-C 113.578 0.955 . . . . 8.7 113.578 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.45 64.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.621 0.6 . . . . 5.94 112.621 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.82 63.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.449 1.093 . . . . 6.89 111.617 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.2 52.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 7.4 111.62 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.91 16.2 14.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.529 -0.305 . . . . 6.97 111.591 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.95 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 7.38 110.767 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.81 -4.76 66.14 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.907 -0.663 . . . . 7.92 113.619 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.37 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.877 0.338 . . . . 7.5 111.08 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.278 0.561 . . . . 9.49 111.31 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.31 107.81 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 8.45 110.3 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.62 42.74 13.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.034 -0.53 . . . . 10.44 111.823 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.0 -5.47 53.71 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.225 0.85 . . . . 10.21 115.225 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.58 130.96 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.686 0.743 . . . . 9.94 112.405 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.56 10.96 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.507 -0.923 . . . . 8.4 108.507 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.35 137.84 58.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.974 1.102 . . . . 6.9 113.974 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.43 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.54 110.31 21.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.513 -1.291 . . . . 8.29 107.513 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.99 126.88 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.35 0.5 . . . . 6.17 112.35 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.43 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.6 170.44 15.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.474 -0.785 . . . . 7.99 110.067 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.06 154.68 49.66 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.599 -0.889 . . . . 7.86 108.599 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.31 174.9 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.795 1.663 . . . . 7.79 112.057 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.189 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 59.4 m80 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 120.968 0.414 . . . . 10.8 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.92 139.27 58.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.204 0.526 . . . . 8.21 110.367 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 334' ' ' ARG . 59.4 mt -109.74 143.97 38.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.015 -0.993 . . . . 6.33 112.829 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.4 132.17 50.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.147 -1.427 . . . . 6.75 107.147 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.04 121.29 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.565 -0.532 . . . . 5.68 109.565 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.22 16.5 Favored Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.461 -0.876 . . . . 6.53 112.693 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.12 86.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.634 -0.794 . . . . 7.67 111.517 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 92.7 mt -70.79 135.27 85.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.48 0.178 . . . . 8.16 111.48 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.6 Cg_exo -61.85 141.51 90.18 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.923 1.748 . . . . 8.96 108.796 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -65.36 -14.86 61.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.763 1.394 . . . . 11.61 114.763 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -84.15 -23.17 30.75 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.77 1.396 . . . . 11.06 114.77 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 149.21 50.71 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.121 0.418 . . . . 9.36 111.31 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 10.0 p-10 -114.51 -176.39 2.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.578 -0.283 . . . . 10.46 110.296 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 10.8 m-20 -53.64 -55.21 27.9 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 114.622 1.341 . . . . 9.92 114.622 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.33 -26.77 68.03 Favored 'General case' 0 C--N 1.405 2.995 0 C-N-CA 125.697 1.599 . . . . 0.0 112.456 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.07 -48.22 13.61 Favored 'General case' 1 C--N 1.429 4.031 0 O-C-N 123.489 0.493 . . . . 10.06 111.398 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 71.9 t -62.69 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 7.76 110.237 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 26.7 mtmm -54.27 -36.45 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.662 -0.699 . . . . 9.67 111.297 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.06 -53.3 57.37 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 10.2 110.7 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -51.73 -33.15 33.45 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 116.195 -0.457 . . . . 7.62 110.322 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.499 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.9 mt -82.67 -41.67 19.08 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.568 0.581 . . . . 7.74 112.568 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 53.1 m -56.86 -29.41 62.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.546 0.943 . . . . 10.09 113.546 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -50.11 -10.82 0.06 Allowed 'General case' 0 C--N 1.395 2.572 0 C-N-CA 125.062 1.345 . . . . 0.0 112.563 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.51 -12.03 14.01 Favored 'General case' 1 C--N 1.445 4.733 0 CA-C-N 118.174 0.443 . . . . 10.23 111.499 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.31 10.25 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.795 -0.638 . . . . 10.4 111.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.64 147.09 93.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.677 2.252 . . . . 12.19 112.681 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.3 mt -102.47 146.31 28.29 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.889 -0.596 . . . . 10.66 111.304 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.6 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 12.8 ptpt -101.11 -22.56 14.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 11.41 109.227 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.07 127.23 5.73 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 119.152 -2.217 . . . . 0.0 108.975 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.618 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 60.2 t80 -144.43 134.75 24.41 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 122.769 0.428 . . . . 8.77 112.013 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -144.79 124.03 12.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.813 0.339 . . . . 8.38 111.634 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 52.0 tp -100.88 118.27 36.6 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.592 -1.262 . . . . 8.94 107.592 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.24 122.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.507 0.929 . . . . 9.37 113.507 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.09 148.1 43.42 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.315 -0.857 . . . . 11.34 109.373 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 36.9 t70 -58.92 141.05 54.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.92 0.39 . . . . 13.83 110.958 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 14.6 m -49.59 -61.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.795 -0.638 . . . . 14.58 112.65 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.2 -64.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.422 0.527 . . . . 16.19 112.422 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.621 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 18.4 m -42.4 -59.39 1.86 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 14.94 111.209 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.65 -6.05 62.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.643 -0.789 . . . . 13.57 114.493 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.29 167.69 13.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.425 0.612 . . . . 13.28 110.913 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -59.25 142.01 52.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 10.43 111.572 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 4.7 mmmp? -87.96 -9.4 53.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.795 -0.639 . . . . 11.2 109.619 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.61 -3.4 39.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.597 -0.729 . . . . 8.63 113.874 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.97 146.41 33.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.03 0.915 . . . . 9.19 112.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.2 46.74 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.101 -0.954 . . . . 6.21 112.242 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -111.42 146.84 36.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.186 -0.916 . . . . 7.09 110.422 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.618 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.2 p -157.87 156.19 30.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 119.9 -0.72 . . . . 6.77 111.875 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.404 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 37.5 tt0 -145.27 127.0 15.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.702 -0.681 . . . . 9.59 109.713 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.6 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 56.4 m-85 -82.39 164.85 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.941 0.4 . . . . 9.91 112.06 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.51 -46.11 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.428 -0.953 . . . . 12.81 108.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.1 t70 -96.32 102.39 14.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.391 -1.337 . . . . 13.18 107.391 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -52.76 -34.97 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 115.288 1.588 . . . . 12.23 115.288 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.84 -38.76 73.11 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 122.175 0.988 . . . . 13.04 108.979 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.7 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 112.366 -2.197 . . . . 11.08 109.552 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.67 -48.1 72.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.935 -0.765 . . . . 9.11 108.935 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -62.52 -42.77 99.74 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.205 -0.598 . . . . 10.31 110.486 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -63.88 -32.39 73.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.932 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.77 74.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.711 -1.586 . . . . 8.25 113.036 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 313' ' ' THR . 63.6 mt -68.63 -51.3 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 7.4 110.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.03 67.59 Favored 'General case' 0 C--N 1.42 3.642 0 C-N-CA 126.185 1.794 . . . . 0.0 113.152 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.93 -23.9 36.92 Favored Glycine 1 C--N 1.399 4.055 0 N-CA-C 116.781 1.472 . . . . 8.35 116.781 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 330' ' ' LEU . 96.9 mt -96.92 -45.7 6.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.214 2.007 . . . . 7.2 114.039 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -50.45 129.98 22.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.845 0.355 . . . . 7.86 111.426 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.65 56.79 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.145 -0.55 . . . . 8.64 113.956 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 16.4 mtt -50.64 147.19 4.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.822 0.311 . . . . 8.0 111.267 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -95.09 115.65 27.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.03 0.443 . . . . 10.39 111.71 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.7 mm? -120.2 106.77 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.113 -1.069 . . . . 8.95 108.113 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.14 -118.65 10.51 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.38 -1.488 . . . . 10.63 109.38 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -115.86 22.41 13.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.202 0.525 . . . . 12.25 109.818 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -123.82 153.91 40.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.599 -0.728 . . . . 9.98 111.629 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -101.7 118.41 36.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.115 -1.068 . . . . 10.14 108.115 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.601 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.6 tp -63.21 143.16 58.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.515 0.674 . . . . 7.52 112.653 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.539 -1.209 . . . . 7.48 108.942 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.96 124.02 26.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 O-C-N 120.935 -1.103 . . . . 6.45 110.01 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -152.7 155.31 37.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.973 -1.704 . . . . 7.66 109.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.507 ' HA ' HD23 ' A' ' 261' ' ' LEU . 84.6 mtt180 -58.66 122.44 13.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 118.463 -1.295 . . . . 8.94 107.612 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.77 0.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.766 1.395 . . . . 7.52 114.766 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.5 m -119.47 -79.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.539 -0.465 . . . . 9.07 111.297 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.619 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.983 0.421 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -158.7 148.52 19.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.064 0.946 . . . . 5.88 111.127 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 28.0 mt -140.67 143.55 35.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.541 . . . . 5.25 111.282 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.61 125.19 40.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.854 -0.795 . . . . 6.58 108.854 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.8 101.33 8.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 5.06 110.196 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.77 -178.63 35.0 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.914 -0.585 . . . . 6.2 112.792 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.25 40.83 23.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 124.969 1.308 . . . . 0.0 110.121 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.83 149.8 88.09 Favored Pre-proline 1 C--N 1.428 4.021 0 C-N-CA 123.477 0.711 . . . . 7.79 111.286 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.07 144.48 89.84 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.297 1.998 . . . . 8.57 110.989 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.96 139.72 52.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 11.37 111.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.1 6.6 61.0 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.833 -0.621 . . . . 9.94 114.303 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.12 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.399 0.6 . . . . 8.91 110.305 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.4 p -84.89 153.98 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.614 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -60.18 -43.31 95.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 7.44 110.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.51 -46.22 90.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.106 -0.497 . . . . 9.89 110.516 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.37 -26.39 68.43 Favored 'General case' 0 C--N 1.41 3.233 0 O-C-N 119.26 -2.15 . . . . 0.0 111.734 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.484 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.49 -34.08 67.41 Favored 'General case' 1 C--N 1.429 4.034 0 O-C-N 123.984 0.802 . . . . 6.64 111.742 171.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.63 -54.31 7.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.424 0.69 . . . . 6.69 111.057 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.61 -33.68 60.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.453 -0.794 . . . . 8.8 111.345 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.76 -53.53 17.93 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 120.41 -0.516 . . . . 7.44 111.611 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.31 -48.27 82.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.82 -42.81 80.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.294 -0.562 . . . . 7.12 109.64 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.57 65.16 Favored 'General case' 0 C--N 1.407 3.076 0 O-C-N 120.261 -1.524 . . . . 0.0 111.227 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.38 -37.66 36.77 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.528 0.604 . . . . 7.79 110.319 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.8 -36.61 82.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.58 -0.736 . . . . 7.73 111.079 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HD3' HH11 ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.17 -43.02 44.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.38 0.511 . . . . 9.61 112.38 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.2 mt -63.0 -37.73 88.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.203 0.525 . . . . 10.06 110.415 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -16.46 74.61 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.225 -0.988 . . . . 9.23 112.894 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.15 71.6 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.774 -0.93 . . . . 9.25 110.774 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.9 5.27 51.95 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.939 0.718 . . . . 8.31 112.939 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.0 p -82.6 143.42 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.183 -0.207 . . . . 9.16 110.609 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.149 0.426 . . . . 10.23 112.149 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.5 23.71 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.731 -0.213 . . . . 9.89 110.688 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.37 143.56 99.68 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.915 1.743 . . . . 11.04 110.821 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.29 161.61 20.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.656 -0.783 . . . . 9.31 112.467 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.25 134.48 73.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.025 0.38 . . . . 7.97 112.025 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.4 Cg_exo -73.25 -50.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.573 2.182 . . . . 6.59 111.368 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.151 -0.477 . . . . 5.87 111.107 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -33.17 33.27 Favored 'General case' 0 N--CA 1.524 3.272 0 C-N-CA 124.878 1.271 . . . . 0.0 113.394 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 163.78 39.17 Favored 'General case' 0 C--N 1.386 2.181 0 C-N-CA 125.757 1.623 . . . . 0.0 110.577 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.45 130.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 C-N-CA 126.091 1.756 . . . . 5.67 109.338 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.686 -0.487 . . . . 6.47 109.686 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.1 mt -114.93 125.99 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 116.903 2.186 . . . . 7.1 116.903 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.14 91.42 5.26 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 103.187 -2.894 . . . . 8.1 103.187 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -57.46 7.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.645 1.72 . . . . 10.19 115.645 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.14 -48.78 75.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.853 0.686 . . . . 10.51 112.853 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.99 -9.07 50.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 9.72 111.849 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.15 15.5 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.579 1.326 . . . . 8.04 114.579 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.52 168.7 19.23 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.12 -1.032 . . . . 6.83 111.671 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.61 161.02 42.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.035 -1.438 . . . . 5.19 110.515 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.35 51.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.624 -0.88 . . . . 5.71 108.624 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.8 137.56 33.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.355 -0.384 . . . . 4.27 110.351 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.83 114.82 26.05 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 6.21 109.645 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -99.77 164.67 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 6.14 111.947 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -26.04 22.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.425 -0.807 . . . . 8.37 111.461 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.1 p -128.86 159.64 35.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.1 0.476 . . . . 7.92 111.646 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.569 -0.741 . . . . 8.77 112.303 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.584 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.64 -41.79 95.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.364 0.505 . . . . 9.08 112.364 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.77 98.17 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.25 -54.48 39.49 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.13 -1.063 . . . . 6.18 108.13 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.0 m -54.3 -27.56 36.26 Favored 'General case' 1 C--N 1.429 4.032 0 C-N-CA 127.029 2.132 . . . . 0.0 109.853 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -34.0 44.42 Favored 'General case' 0 C--N 1.426 3.897 0 N-CA-C 113.648 0.981 . . . . 8.7 113.648 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.55 -17.35 64.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.626 0.602 . . . . 5.94 112.626 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.5 mtp -62.12 -19.86 63.46 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.29 0.994 . . . . 6.89 111.569 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.24 52.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.383 -0.371 . . . . 7.4 111.608 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.77 16.16 14.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.747 0.308 . . . . 6.97 111.725 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.85 120.9 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 7.38 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.84 65.95 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.859 -0.686 . . . . 7.92 113.553 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.17 142.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.836 0.318 . . . . 7.5 111.066 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.57 37.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.271 0.558 . . . . 9.49 111.327 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.29 107.71 7.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 8.45 110.354 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.72 42.62 13.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 10.44 111.771 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.34 54.53 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.229 0.851 . . . . 10.21 115.229 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.69 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.652 0.726 . . . . 9.94 112.475 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.71 101.58 10.96 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.486 -0.931 . . . . 8.4 108.486 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.42 137.82 58.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.032 1.123 . . . . 6.9 114.032 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.433 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.47 110.24 21.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.539 -1.282 . . . . 8.29 107.539 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.5 mt -104.12 126.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.217 0.532 . . . . 6.17 112.233 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.433 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.54 170.54 15.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.376 -0.829 . . . . 7.99 110.079 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.13 154.7 49.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.39 175.26 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.954 1.77 . . . . 7.79 112.038 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 t60 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 77.6 m80 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.968 0.413 . . . . 10.8 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -62.98 139.4 58.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.276 0.56 . . . . 8.21 110.318 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.9 mt -109.8 144.05 38.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.989 -1.005 . . . . 6.33 112.789 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.44 132.03 51.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.02 121.23 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.618 -0.512 . . . . 5.68 109.618 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.13 179.26 16.46 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.483 -0.865 . . . . 6.53 112.719 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.08 86.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.625 -0.798 . . . . 7.67 111.561 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.1 mt -70.79 135.27 85.7 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 111.522 0.193 . . . . 8.16 111.522 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.1 Cg_exo -61.84 141.53 90.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.998 1.799 . . . . 8.96 108.744 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.44 -14.86 61.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.724 1.379 . . . . 11.61 114.724 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -84.21 -22.98 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.827 1.417 . . . . 11.06 114.827 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.31 149.12 50.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.144 0.429 . . . . 9.36 111.325 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.9 p-10 -114.59 -176.49 2.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.233 -0.284 . . . . 10.46 110.233 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.54 -55.35 26.29 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.604 1.335 . . . . 9.92 114.604 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -61.4 -26.53 67.91 Favored 'General case' 0 C--N 1.405 3.006 0 C-N-CA 125.72 1.608 . . . . 0.0 112.51 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.12 -48.28 13.46 Favored 'General case' 1 C--N 1.43 4.086 0 CA-C-N 118.283 0.492 . . . . 10.06 111.385 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.9 t -62.7 -49.16 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.6 . . . . 7.76 110.318 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -54.3 -36.36 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.678 -0.692 . . . . 9.67 111.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.01 -53.43 55.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.167 0.508 . . . . 10.2 110.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 320' ' ' LEU . 3.2 tm? -51.65 -33.28 32.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.115 -0.493 . . . . 7.62 110.365 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.496 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.52 -41.6 19.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.649 0.611 . . . . 7.74 112.649 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 43.5 m -56.94 -29.96 63.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.48 0.919 . . . . 10.09 113.48 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 17.1 m -50.25 -10.02 0.05 Allowed 'General case' 0 C--N 1.395 2.58 0 C-N-CA 124.753 1.221 . . . . 0.0 112.641 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.46 -12.02 14.04 Favored 'General case' 1 C--N 1.444 4.699 0 CA-C-N 118.379 0.536 . . . . 10.23 111.503 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.36 10.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.821 -0.627 . . . . 10.4 111.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.6 147.11 93.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.72 2.28 . . . . 12.19 112.65 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 89.7 mt -102.56 146.27 28.39 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.959 -0.564 . . . . 10.66 111.241 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.01 -22.53 14.73 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.273 -0.64 . . . . 11.41 109.273 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -157.32 129.25 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.483 -2.011 . . . . 0.0 108.836 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -146.21 134.72 22.04 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.654 0.382 . . . . 8.77 111.98 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -144.86 124.11 12.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.866 0.365 . . . . 8.38 111.566 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -100.99 118.17 36.47 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.584 -1.265 . . . . 8.94 107.584 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.18 122.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.515 0.931 . . . . 9.37 113.515 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -119.13 148.14 43.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.262 -0.881 . . . . 11.34 109.413 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.9 t70 -58.92 141.12 54.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.921 0.391 . . . . 13.83 110.914 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 50.0 m -49.71 -61.72 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.863 -0.608 . . . . 14.58 112.6 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.08 -64.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.471 0.545 . . . . 16.19 112.471 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.48 -59.32 1.91 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.306 -0.407 . . . . 14.94 111.214 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.04 62.54 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.613 -0.804 . . . . 13.57 114.528 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.35 167.6 13.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.334 0.567 . . . . 13.28 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.0 t -59.19 142.07 52.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 10.43 111.624 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 300' ' ' LYS . 4.7 mmmp? -87.95 -9.43 53.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.793 -0.64 . . . . 11.2 109.569 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.31 39.53 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.67 -0.695 . . . . 8.63 113.942 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -143.01 146.41 33.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.979 0.889 . . . . 9.19 112.845 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.61 155.16 46.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.078 -0.965 . . . . 6.21 112.169 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.25 146.81 36.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.077 -0.965 . . . . 7.09 110.394 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.597 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.4 p -157.89 156.21 30.95 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 119.983 -0.687 . . . . 6.77 111.871 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -145.3 127.09 15.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 9.59 109.608 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.531 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 52.9 m-85 -82.46 164.85 20.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.932 0.396 . . . . 9.91 112.045 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.55 -46.1 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 108.4 -0.963 . . . . 12.81 108.4 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.34 102.37 14.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.361 -1.348 . . . . 13.18 107.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.02 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 115.291 1.589 . . . . 12.23 115.291 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -56.78 -38.86 73.08 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.294 1.045 . . . . 13.04 109.014 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.52 -22.92 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 112.402 -2.181 . . . . 11.08 109.519 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.53 -48.24 72.2 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.896 -0.779 . . . . 9.11 108.896 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.5 -42.71 99.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.187 -0.605 . . . . 10.31 110.513 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.82 -32.43 73.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 119.939 -0.704 . . . . 11.98 111.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.78 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.67 -1.605 . . . . 8.25 113.027 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.6 -51.23 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.393 0.616 . . . . 7.4 110.833 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.69 -39.0 67.68 Favored 'General case' 0 C--N 1.42 3.649 0 C-N-CA 126.301 1.84 . . . . 0.0 113.171 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.9 -24.09 36.39 Favored Glycine 1 C--N 1.399 4.08 0 N-CA-C 116.817 1.487 . . . . 8.35 116.817 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 278' ' ' LEU . 78.9 mt -96.89 -45.86 6.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 120.189 1.994 . . . . 7.2 113.892 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -50.4 129.99 22.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.812 0.339 . . . . 7.86 111.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.19 -16.69 56.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.11 -0.567 . . . . 8.64 113.905 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.57 147.21 4.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.868 0.334 . . . . 8.0 111.337 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -95.2 115.67 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.053 0.454 . . . . 10.39 111.681 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.595 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -120.19 106.75 12.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.15 -118.75 10.62 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -115.8 22.4 13.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.243 0.544 . . . . 12.25 109.786 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.9 154.0 40.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.642 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.8 118.2 36.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.086 -1.079 . . . . 10.14 108.086 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.595 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.2 tp -63.0 143.06 58.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.485 0.659 . . . . 7.52 112.687 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 3.1 mp -128.13 127.94 43.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.555 -1.202 . . . . 7.48 108.971 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.4 t -137.91 123.98 26.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 O-C-N 121.044 -1.035 . . . . 6.45 109.966 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -152.69 155.29 36.96 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.117 -1.614 . . . . 7.66 109.587 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.51 ' HA ' HD23 ' A' ' 261' ' ' LEU . 92.2 mtt180 -58.56 122.45 13.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 118.544 -1.263 . . . . 8.94 107.603 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.97 -11.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.808 1.41 . . . . 7.52 114.808 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.5 m -119.37 -77.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.629 -0.428 . . . . 9.07 111.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.523 0.677 . . . . 0.0 110.744 179.023 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.734 ' HB3' HG21 ' A' ' 208' ' ' THR . 5.7 mmt-85 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -159.85 149.34 18.05 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 123.259 0.623 . . . . 5.88 111.628 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.71 143.65 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 5.25 111.281 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.62 125.15 40.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.853 -0.795 . . . . 6.58 108.853 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 5.06 110.33 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.66 -179.07 35.07 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.86 -0.609 . . . . 6.2 112.823 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 49.79 41.73 22.76 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 125.214 1.406 . . . . 0.0 110.268 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.85 149.75 88.01 Favored Pre-proline 0 C--N 1.426 3.935 0 C-N-CA 123.684 0.794 . . . . 7.79 111.312 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 144.41 89.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.283 1.989 . . . . 8.57 111.032 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.93 139.66 52.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 11.37 111.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.27 6.5 61.46 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.799 -0.637 . . . . 9.94 114.259 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.05 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.363 0.581 . . . . 8.91 110.271 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.99 153.89 22.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 9.64 110.6 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.1 -43.16 95.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 7.44 110.257 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.68 -46.03 91.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.963 -0.562 . . . . 9.89 110.616 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -26.71 68.58 Favored 'General case' 0 C--N 1.409 3.159 0 O-C-N 119.264 -2.148 . . . . 0.0 111.661 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.42 -34.06 67.58 Favored 'General case' 0 C--N 1.428 3.979 0 O-C-N 123.967 0.792 . . . . 6.64 111.737 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.34 7.73 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.481 0.713 . . . . 6.69 111.115 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.55 -33.72 60.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.367 -0.833 . . . . 8.8 111.387 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.78 -53.57 17.67 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 120.543 -0.463 . . . . 7.44 111.576 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.3 -48.34 81.84 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.145 0.424 . . . . 5.94 112.145 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.78 -42.6 79.72 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.258 -0.577 . . . . 7.12 109.608 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.29 64.72 Favored 'General case' 0 C--N 1.405 3.004 0 O-C-N 120.388 -1.445 . . . . 0.0 111.21 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.5 -37.67 36.17 Favored 'General case' 1 C--N 1.428 4.019 0 CA-C-N 118.455 0.57 . . . . 7.79 110.298 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.8 83.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 7.73 111.009 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.15 -42.95 45.03 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.387 0.514 . . . . 9.61 112.387 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.0 -37.75 88.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.259 0.552 . . . . 10.06 110.492 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.02 -16.56 74.46 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.273 -0.965 . . . . 9.23 112.886 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.26 37.01 71.22 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 110.873 -0.891 . . . . 9.25 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.97 5.35 51.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.92 0.711 . . . . 8.31 112.92 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.9 p -82.61 143.48 30.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.586 0.232 . . . . 9.16 110.593 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.583 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.45 21.37 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.176 0.435 . . . . 10.23 112.176 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.8 163.46 23.78 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.632 -0.258 . . . . 9.89 110.694 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.35 143.54 99.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.965 1.777 . . . . 11.04 110.793 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.58 20.58 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.677 -0.773 . . . . 9.31 112.505 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.033 0.383 . . . . 7.97 112.033 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.558 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.25 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.454 2.103 . . . . 6.59 111.32 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.67 105.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.132 -0.485 . . . . 5.87 111.134 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -36.33 37.92 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 125.37 1.468 . . . . 0.0 112.954 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.13 164.36 38.62 Favored 'General case' 0 C--N 1.386 2.173 0 C-N-CA 125.826 1.651 . . . . 0.0 110.959 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.9 130.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 125.999 1.72 . . . . 5.67 109.337 175.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.93 126.64 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.765 -0.458 . . . . 6.47 109.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 126.0 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 116.941 2.2 . . . . 7.1 116.941 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.12 91.37 5.24 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.149 -2.908 . . . . 8.1 103.149 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.21 -57.43 7.8 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.662 1.727 . . . . 10.19 115.662 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.24 -48.69 75.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.877 0.695 . . . . 10.51 112.877 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.97 -9.22 51.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.716 0.293 . . . . 9.72 111.77 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 36.11 15.0 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.53 1.307 . . . . 8.04 114.53 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.56 168.63 19.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.093 -1.043 . . . . 6.83 111.612 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.56 161.12 41.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.18 -1.373 . . . . 5.19 110.486 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.38 129.31 51.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.73 -0.841 . . . . 5.71 108.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.81 137.5 33.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.44 -0.345 . . . . 4.27 110.364 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.71 114.73 26.02 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.718 -0.475 . . . . 6.21 109.718 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.73 164.66 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 6.14 111.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.56 -25.98 22.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.515 -0.766 . . . . 8.37 111.392 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.0 p -128.95 159.57 35.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.094 0.473 . . . . 7.92 111.521 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.28 -41.74 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 8.77 112.266 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.583 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.7 t70 -64.63 -41.79 95.92 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.396 0.517 . . . . 9.08 112.396 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.28 -0.267 . . . . 7.46 110.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.9 m -54.17 -53.97 46.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 6.18 108.123 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.6 m -55.07 -27.3 43.78 Favored 'General case' 1 C--N 1.43 4.066 0 C-N-CA 126.953 2.101 . . . . 0.0 109.863 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -34.0 43.69 Favored 'General case' 0 C--N 1.422 3.743 0 N-CA-C 113.657 0.984 . . . . 8.7 113.657 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.33 64.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.651 0.611 . . . . 5.94 112.651 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.09 -19.85 63.41 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.493 1.12 . . . . 6.89 111.614 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.35 53.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 7.4 111.613 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.22 14.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.585 -0.279 . . . . 6.97 111.658 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.89 121.02 14.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.827 0.346 . . . . 7.38 110.782 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.83 66.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.855 -0.688 . . . . 7.92 113.587 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.23 142.39 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.87 0.335 . . . . 7.5 111.153 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.245 0.545 . . . . 9.49 111.278 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.23 107.69 7.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 8.45 110.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.74 42.7 13.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 10.44 111.747 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.44 54.03 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 115.219 0.847 . . . . 10.21 115.219 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -110.69 130.89 55.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.574 0.687 . . . . 9.94 112.358 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.48 10.86 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.587 -0.894 . . . . 8.4 108.587 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.83 58.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.088 . . . . 6.9 113.939 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.428 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.51 110.24 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.602 -1.259 . . . . 8.29 107.602 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.02 126.96 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.265 0.555 . . . . 6.17 112.289 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.428 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.49 15.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.332 -0.849 . . . . 7.99 110.041 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.04 154.71 49.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.614 -0.884 . . . . 7.86 108.614 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.52 175.12 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.929 1.753 . . . . 7.79 112.007 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 79.9 m80 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.953 0.406 . . . . 10.8 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.0 139.4 58.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 8.21 110.33 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 334' ' ' ARG . 67.4 mt -109.8 143.96 38.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.944 -1.026 . . . . 6.33 112.788 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -104.38 132.06 51.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.219 -1.4 . . . . 6.75 107.219 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.99 121.26 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 109.59 -0.522 . . . . 5.68 109.59 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.27 16.47 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.436 -0.888 . . . . 6.53 112.648 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.607 -0.806 . . . . 7.67 111.573 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 90.8 mt -70.78 135.25 85.72 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.835 -0.182 . . . . 8.16 111.477 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.4 Cg_exo -61.84 141.47 90.13 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.955 1.77 . . . . 8.96 108.795 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.34 -14.86 61.77 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.803 1.408 . . . . 11.61 114.803 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -84.14 -23.19 30.77 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.816 1.413 . . . . 11.06 114.816 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.33 149.13 50.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.17 0.441 . . . . 9.36 111.368 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 18.9 p-10 -114.39 -176.41 2.89 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.284 -0.265 . . . . 10.46 110.284 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -53.59 -55.46 25.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.629 1.344 . . . . 9.92 114.629 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -25.94 67.79 Favored 'General case' 0 C--N 1.406 3.026 0 C-N-CA 125.596 1.558 . . . . 0.0 112.478 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.18 -48.3 13.36 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.363 0.529 . . . . 10.06 111.378 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 78.5 t -62.66 -49.19 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 7.76 110.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -54.25 -36.41 63.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.312 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.13 -53.27 57.83 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.096 0.474 . . . . 10.2 110.699 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.403 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.73 -33.23 33.77 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.146 -0.479 . . . . 7.62 110.318 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.479 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.7 mt -82.54 -41.8 19.16 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.572 0.582 . . . . 7.74 112.572 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.2 m -56.75 -29.67 62.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.65 0.981 . . . . 10.09 113.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.2 m -50.42 -10.15 0.06 Allowed 'General case' 0 C--N 1.397 2.652 0 C-N-CA 124.846 1.258 . . . . 0.0 112.558 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -111.52 -12.03 14.01 Favored 'General case' 1 C--N 1.444 4.678 0 CA-C-N 118.335 0.516 . . . . 10.23 111.495 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.32 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.826 -0.625 . . . . 10.4 111.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.63 147.07 93.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.276 . . . . 12.19 112.716 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 83.0 mt -102.42 146.32 28.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.899 -0.591 . . . . 10.66 111.244 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 18.9 ptpt -101.05 -22.57 14.7 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.274 -0.639 . . . . 11.41 109.274 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.38 126.43 5.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.142 -2.224 . . . . 0.0 109.088 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 52.5 t80 -143.76 134.79 25.51 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 122.774 0.43 . . . . 8.77 112.006 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.77 124.01 12.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.513 -0.312 . . . . 8.38 111.595 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 61.0 tp -101.01 118.3 36.74 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.512 -1.292 . . . . 8.94 107.512 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.23 122.8 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.509 0.929 . . . . 9.37 113.509 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -119.13 148.06 43.48 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.31 -0.859 . . . . 11.34 109.353 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 38.7 t70 -58.81 141.13 53.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.922 0.391 . . . . 13.83 110.979 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 52.8 m -49.72 -61.71 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.816 -0.629 . . . . 14.58 112.649 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.04 -64.01 1.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.512 0.56 . . . . 16.19 112.512 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 12.8 m -42.55 -59.23 1.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.293 -0.412 . . . . 14.94 111.241 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.14 62.59 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.53 -0.843 . . . . 13.57 114.492 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.3 167.6 13.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.435 0.618 . . . . 13.28 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.9 t -59.22 142.07 52.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.526 . . . . 10.43 111.606 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 24.1 mmtp -87.95 -9.38 53.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.783 -0.644 . . . . 11.2 109.581 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.49 -3.43 39.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.674 -0.694 . . . . 8.63 113.929 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -142.98 146.46 33.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.133 0.966 . . . . 9.19 112.812 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.62 155.18 46.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.041 -0.982 . . . . 6.21 112.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -111.38 146.81 36.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.17 -0.923 . . . . 7.09 110.333 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.57 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.5 p -157.8 156.21 31.11 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.972 -0.691 . . . . 6.77 111.903 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -145.23 127.07 15.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.708 . . . . 9.59 109.656 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.489 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 55.4 m-85 -82.36 164.88 20.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.097 0.406 . . . . 9.91 112.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.54 -46.09 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.413 -0.958 . . . . 12.81 108.413 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.692 ' O ' HG22 ' A' ' 312' ' ' VAL . 13.8 t70 -96.35 102.36 14.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.388 -1.338 . . . . 13.18 107.388 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.526 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.74 -34.97 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.305 1.595 . . . . 12.23 115.305 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -56.87 -38.71 73.11 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.238 1.018 . . . . 13.04 109.016 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.75 -22.58 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 112.243 -2.253 . . . . 11.08 109.594 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 88.5 m -54.67 -48.2 72.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.932 -0.766 . . . . 9.11 108.932 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.43 -42.83 99.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.245 -0.582 . . . . 10.31 110.52 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -63.83 -32.41 73.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.9 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.78 74.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.781 -1.554 . . . . 8.25 113.052 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.63 -51.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.373 0.606 . . . . 7.4 110.857 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.8 -38.59 67.49 Favored 'General case' 0 C--N 1.421 3.678 0 C-N-CA 126.289 1.836 . . . . 0.0 113.166 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.03 -24.1 35.96 Favored Glycine 1 C--N 1.398 4.007 0 N-CA-C 116.847 1.499 . . . . 8.35 116.847 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 330' ' ' LEU . 88.1 mt -96.84 -45.77 6.51 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.117 1.958 . . . . 7.2 113.956 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -50.47 130.04 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.883 0.373 . . . . 7.86 111.511 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.24 -16.79 56.56 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.056 -0.592 . . . . 8.64 113.975 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.5 ttt -50.61 147.17 4.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.729 0.299 . . . . 8.0 111.324 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -95.08 115.55 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 10.39 111.751 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.3 mp -120.16 106.74 12.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.127 -1.064 . . . . 8.95 108.127 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.09 -118.64 10.53 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.408 -1.477 . . . . 10.63 109.408 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -115.9 22.51 12.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.169 0.509 . . . . 12.25 109.765 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -123.9 153.91 40.45 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.64 -0.709 . . . . 9.98 111.599 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.69 118.28 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.078 -1.082 . . . . 10.14 108.078 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.66 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.4 tp -63.07 143.17 58.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.519 0.676 . . . . 7.52 112.707 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 90.0 mt -128.14 127.97 43.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.593 -1.185 . . . . 7.48 108.962 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.92 124.04 26.29 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 O-C-N 120.96 -1.088 . . . . 6.45 109.999 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.71 155.34 37.04 Favored 'General case' 0 N--CA 1.432 -1.367 0 O-C-N 119.986 -1.696 . . . . 7.66 109.561 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.508 ' HA ' HD23 ' A' ' 261' ' ' LEU . 83.3 mtt180 -58.61 122.44 13.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 118.453 -1.299 . . . . 8.94 107.612 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.93 -11.76 0.1 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.794 1.405 . . . . 7.52 114.794 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.9 m -119.45 -77.68 0.58 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.532 -0.467 . . . . 9.07 111.156 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 8.2 m . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.33 0.586 . . . . 0.0 111.305 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.958 0.408 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.51 148.5 21.43 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.608 -0.724 . . . . 5.88 111.196 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.577 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.77 143.54 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 5.25 111.218 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.52 125.21 40.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.855 -0.795 . . . . 6.58 108.855 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.83 101.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.134 0.493 . . . . 5.06 110.253 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.72 -178.86 35.03 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.921 -0.581 . . . . 6.2 112.765 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.5 m120 51.17 39.97 24.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.993 1.317 . . . . 0.0 110.195 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.58 149.76 88.64 Favored Pre-proline 1 C--N 1.43 4.103 0 C-N-CA 123.525 0.73 . . . . 7.79 111.366 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.99 144.45 89.49 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.325 2.017 . . . . 8.57 110.924 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -69.99 139.72 52.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.991 0.424 . . . . 11.37 111.916 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.22 6.49 61.26 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.755 -0.657 . . . . 9.94 114.277 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 117.395 0.597 . . . . 8.91 110.281 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.82 153.88 22.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.636 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.27 95.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.203 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.55 -46.07 91.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.568 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.73 -26.22 68.58 Favored 'General case' 0 C--N 1.41 3.22 0 O-C-N 119.25 -2.156 . . . . 0.0 111.658 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.492 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.39 -34.16 67.7 Favored 'General case' 1 C--N 1.429 4.046 0 O-C-N 123.949 0.781 . . . . 6.64 111.758 171.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.47 -54.4 7.64 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.412 0.685 . . . . 6.69 111.079 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.46 -33.76 60.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.397 -0.819 . . . . 8.8 111.403 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.76 -53.66 17.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.543 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.492 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.22 -48.23 82.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 5.94 112.255 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.75 -42.85 80.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.351 -0.54 . . . . 7.12 109.579 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.1 -23.31 64.9 Favored 'General case' 0 C--N 1.407 3.09 0 O-C-N 120.279 -1.513 . . . . 0.0 111.276 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.4 -37.7 36.58 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.468 0.576 . . . . 7.79 110.325 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.76 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.512 -0.767 . . . . 7.73 111.062 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.6 mtt-85 -75.93 -43.36 45.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.377 0.51 . . . . 9.61 112.377 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.73 -37.86 88.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.177 0.513 . . . . 10.06 110.47 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.9 -16.56 74.71 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.307 -0.949 . . . . 9.23 112.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.29 36.95 70.83 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.809 -0.917 . . . . 9.25 110.809 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.84 5.25 51.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.888 0.699 . . . . 8.31 112.888 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.549 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.59 143.46 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.588 0.233 . . . . 9.16 110.573 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.586 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.52 21.3 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.138 0.421 . . . . 10.23 112.138 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.56 23.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.722 -0.217 . . . . 9.89 110.735 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.41 143.54 99.68 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.947 1.765 . . . . 11.04 110.798 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.54 20.57 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 120.558 -0.83 . . . . 9.31 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.36 73.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 7.97 112.051 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.549 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.23 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.543 2.162 . . . . 6.59 111.308 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.68 105.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.117 -0.492 . . . . 5.87 111.161 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 71.39 0.74 Allowed 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 124.636 1.175 . . . . 0.0 109.31 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.13 151.1 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 129.44 3.096 . . . . 0.0 112.946 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.41 130.55 8.39 Favored 'Isoleucine or valine' 0 C--N 1.374 1.64 0 C-N-CA 129.288 3.035 . . . . 5.67 109.31 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.19 126.55 55.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.772 -0.455 . . . . 6.47 109.772 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.599 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.9 125.97 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 116.983 2.216 . . . . 7.1 116.983 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.42 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 103.157 -2.905 . . . . 8.1 103.157 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.28 -57.38 7.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.678 1.733 . . . . 10.19 115.678 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.82 75.48 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.852 0.686 . . . . 10.51 112.852 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.16 50.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 9.72 111.847 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.18 36.05 15.22 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.548 1.314 . . . . 8.04 114.548 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.44 168.67 19.27 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.081 -1.047 . . . . 6.83 111.629 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.599 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.6 161.06 41.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.022 -1.445 . . . . 5.19 110.483 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.37 129.41 51.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.662 -0.866 . . . . 5.71 108.662 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.361 -0.382 . . . . 4.27 110.288 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.68 25.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.482 . . . . 6.21 109.697 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -99.73 164.69 11.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.016 -0.538 . . . . 6.14 111.981 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.88 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.432 -0.804 . . . . 8.37 111.46 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.8 p -128.91 159.61 35.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.114 0.483 . . . . 7.92 111.612 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.74 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 8.77 112.257 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.586 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.71 -41.76 95.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.424 0.527 . . . . 9.08 112.424 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.86 98.0 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.268 -0.271 . . . . 7.46 110.268 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.577 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.6 m -54.15 -54.0 45.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.125 -1.065 . . . . 6.18 108.125 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.7 m -55.31 -26.93 43.58 Favored 'General case' 1 C--N 1.43 4.081 0 C-N-CA 126.977 2.111 . . . . 0.0 109.878 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.15 -34.14 43.49 Favored 'General case' 0 C--N 1.421 3.683 0 N-CA-C 113.642 0.979 . . . . 8.7 113.642 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.52 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.88 63.42 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.309 1.006 . . . . 6.89 111.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.31 53.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.416 -0.357 . . . . 7.4 111.647 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.19 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 6.97 111.666 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.89 121.04 14.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 7.38 110.751 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.71 -4.75 66.38 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 7.92 113.615 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.855 0.327 . . . . 7.5 111.094 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.96 121.61 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.311 0.577 . . . . 9.49 111.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.76 7.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.45 110.287 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.75 42.67 13.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.035 -0.53 . . . . 10.44 111.724 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.03 -5.47 53.88 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 115.247 0.859 . . . . 10.21 115.247 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.59 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.615 0.708 . . . . 9.94 112.417 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.88 101.49 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.542 -0.91 . . . . 8.4 108.542 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.3 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.036 1.124 . . . . 6.9 114.036 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.436 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.7 tttt -108.55 110.26 21.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.57 -1.27 . . . . 8.29 107.57 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.98 126.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.405 0.52 . . . . 6.17 112.405 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.436 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.52 170.5 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.48 -0.782 . . . . 7.99 110.093 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.65 49.52 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.515 -0.92 . . . . 7.86 108.515 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.43 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.953 1.769 . . . . 7.79 112.012 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 CA--C 1.52 -0.177 0 CA-C-O 120.931 0.396 . . . . 10.8 110.862 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.94 139.33 58.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 8.21 110.365 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 334' ' ' ARG . 62.5 mt -109.79 144.07 38.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.076 -0.966 . . . . 6.33 112.826 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -104.47 132.02 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.228 -1.397 . . . . 6.75 107.228 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.95 121.2 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.608 -0.516 . . . . 5.68 109.608 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.19 16.52 Favored Glycine 0 CA--C 1.508 -0.389 0 C-N-CA 120.446 -0.883 . . . . 6.53 112.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.89 9.17 86.73 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.566 -0.826 . . . . 7.67 111.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.85 135.3 85.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 111.427 0.158 . . . . 8.16 111.427 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.85 141.48 90.14 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.962 1.775 . . . . 8.96 108.833 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -65.39 -14.83 61.76 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.788 1.403 . . . . 11.61 114.788 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -84.18 -23.13 30.71 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.788 1.403 . . . . 11.06 114.788 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.33 149.18 50.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.112 0.415 . . . . 9.36 111.344 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 31.0 p-10 -114.43 -176.44 2.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.608 -0.269 . . . . 10.46 110.279 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.55 -55.11 28.36 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.624 1.342 . . . . 9.92 114.624 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.94 -27.74 68.45 Favored 'General case' 0 C--N 1.406 3.052 0 C-N-CA 125.873 1.669 . . . . 0.0 112.332 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -79.64 -48.28 14.0 Favored 'General case' 1 C--N 1.429 4.065 0 O-C-N 123.486 0.491 . . . . 10.06 111.388 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.1 t -62.72 -49.17 84.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 7.76 110.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -54.24 -36.49 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 9.67 111.27 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.92 -53.39 56.44 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.156 0.503 . . . . 10.2 110.728 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.8 OUTLIER -51.8 -33.14 34.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.064 -0.516 . . . . 7.62 110.374 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.5 mt -82.62 -41.67 19.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.566 0.58 . . . . 7.74 112.566 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.0 m -56.87 -29.65 63.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.6 0.963 . . . . 10.09 113.6 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.5 m -50.36 -10.33 0.06 Allowed 'General case' 0 C--N 1.395 2.552 0 C-N-CA 124.809 1.244 . . . . 0.0 112.544 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -111.42 -11.94 14.07 Favored 'General case' 1 C--N 1.442 4.618 0 CA-C-N 118.281 0.491 . . . . 10.23 111.521 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.08 162.24 10.2 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.78 -0.646 . . . . 10.4 111.932 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.56 147.05 93.38 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.694 2.263 . . . . 12.19 112.736 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.7 mt -102.44 146.3 28.29 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.862 -0.608 . . . . 10.66 111.25 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 15.4 ptpt -101.14 -21.51 14.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.2 -0.667 . . . . 11.41 109.2 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -159.94 128.56 4.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.213 -2.179 . . . . 0.0 108.798 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.583 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.2 t80 -145.07 134.69 23.34 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.084 0.553 . . . . 8.77 112.005 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -144.8 124.09 13.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.809 0.338 . . . . 8.38 111.536 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 59.5 tp -100.99 118.23 36.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.578 -1.267 . . . . 8.94 107.578 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.17 122.91 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 9.37 113.457 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -119.15 148.15 43.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.297 -0.865 . . . . 11.34 109.371 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 34.1 t70 -58.96 141.17 54.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.893 0.378 . . . . 13.83 110.943 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.1 m -49.73 -61.69 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.653 0.612 . . . . 14.58 112.653 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.11 -63.97 1.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.468 0.544 . . . . 16.19 112.468 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.1 m -42.51 -59.32 1.92 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.265 -0.425 . . . . 14.94 111.228 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.03 62.5 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 120.617 -0.801 . . . . 13.57 114.503 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 79.9 mt -88.38 167.63 13.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.339 0.57 . . . . 13.28 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -59.32 142.22 52.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.529 . . . . 10.43 111.684 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 300' ' ' LYS . 3.8 mmmp? -87.89 -9.51 53.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 11.2 109.561 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.62 -3.34 39.42 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.625 -0.716 . . . . 8.63 113.89 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -143.06 146.35 33.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.055 0.927 . . . . 9.19 112.814 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.21 46.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.085 -0.961 . . . . 6.21 112.206 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.39 146.84 36.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.996 -1.002 . . . . 7.09 110.395 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.583 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 20.4 p -157.84 156.22 31.06 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 119.929 -0.708 . . . . 6.77 111.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -145.37 127.05 15.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.613 -0.722 . . . . 9.59 109.628 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.56 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 51.2 m-85 -82.38 164.91 20.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.98 0.419 . . . . 9.91 112.071 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.6 -46.05 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.463 -0.94 . . . . 12.81 108.463 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.32 102.36 14.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.41 -1.33 . . . . 13.18 107.41 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.76 -34.96 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 N-CA-C 115.244 1.572 . . . . 12.23 115.244 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -56.77 -38.83 73.03 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 122.305 1.05 . . . . 13.04 109.048 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 309' ' ' ASP . 1.9 m -62.65 -22.81 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 112.283 -2.235 . . . . 11.08 109.518 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.5 m -54.52 -48.2 72.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.918 -0.771 . . . . 9.11 108.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.49 -42.8 99.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.239 -0.584 . . . . 10.31 110.521 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.89 -0.724 . . . . 11.98 111.974 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.73 74.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.647 -1.615 . . . . 8.25 113.076 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.61 -51.29 47.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 7.4 110.864 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.39 67.71 Favored 'General case' 0 C--N 1.421 3.679 0 C-N-CA 126.211 1.805 . . . . 0.0 113.296 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.18 -24.0 35.85 Favored Glycine 1 C--N 1.4 4.125 0 N-CA-C 116.779 1.472 . . . . 8.35 116.779 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 330' ' ' LEU . 98.1 mt -96.93 -45.69 6.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.193 1.997 . . . . 7.2 113.957 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -50.52 130.03 23.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.844 0.354 . . . . 7.86 111.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.22 -16.81 56.48 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.151 -0.547 . . . . 8.64 113.977 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 19.0 mtt -50.53 147.15 4.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.723 0.297 . . . . 8.0 111.363 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -95.0 115.6 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.018 0.437 . . . . 10.39 111.759 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.8 mp -120.25 106.72 12.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.094 -1.076 . . . . 8.95 108.094 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.11 -118.75 10.65 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.347 -1.501 . . . . 10.63 109.347 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -115.8 22.45 13.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 12.25 109.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.83 153.95 40.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.682 -0.69 . . . . 9.98 111.685 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.74 118.26 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.139 -1.06 . . . . 10.14 108.139 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.7 tp -63.11 143.08 58.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.547 0.689 . . . . 7.52 112.601 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.08 128.0 44.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.563 -1.199 . . . . 7.48 109.032 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.98 124.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 O-C-N 120.99 -1.069 . . . . 6.45 109.945 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -152.79 155.33 36.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 120.126 -1.609 . . . . 7.66 109.514 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.516 ' HA ' HD23 ' A' ' 261' ' ' LEU . 69.7 mtt85 -58.68 122.57 13.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 118.418 -1.313 . . . . 8.94 107.617 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.98 -11.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.756 1.391 . . . . 7.52 114.756 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.4 m -119.46 -78.18 0.58 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.641 -0.424 . . . . 9.07 111.21 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.467 -179.681 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 120.843 0.354 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -155.83 148.44 23.96 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.072 0.949 . . . . 5.88 111.087 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.568 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.75 143.54 35.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 5.25 111.171 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.62 125.18 40.91 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.891 -0.781 . . . . 6.58 108.891 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.27 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.077 0.465 . . . . 5.06 110.166 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.74 -178.57 35.06 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.895 -0.593 . . . . 6.2 112.766 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.16 40.81 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.031 1.333 . . . . 0.0 110.151 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.79 149.85 88.2 Favored Pre-proline 1 C--N 1.429 4.062 0 C-N-CA 123.478 0.711 . . . . 7.79 111.33 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.01 144.43 89.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.251 1.967 . . . . 8.57 111.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -69.91 139.66 53.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.429 . . . . 11.37 111.954 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.05 6.76 61.16 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.298 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 117.314 0.557 . . . . 8.91 110.245 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.79 153.88 22.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 9.64 110.692 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.25 95.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 7.44 110.174 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.6 -46.12 91.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.064 -0.517 . . . . 9.89 110.548 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.59 68.52 Favored 'General case' 0 C--N 1.409 3.179 0 O-C-N 119.261 -2.149 . . . . 0.0 111.675 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.483 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.4 -34.11 67.65 Favored 'General case' 0 C--N 1.427 3.975 0 O-C-N 123.889 0.743 . . . . 6.64 111.727 172.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.61 -54.3 7.72 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.51 0.724 . . . . 6.69 111.052 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.52 -33.73 60.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.43 -0.804 . . . . 8.8 111.381 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.52 17.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 120.43 -0.508 . . . . 7.44 111.617 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.114 0.413 . . . . 5.94 112.114 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.0 m-20 -56.83 -43.0 80.63 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.547 -0.538 . . . . 7.12 109.547 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -23.53 65.18 Favored 'General case' 0 C--N 1.406 3.026 0 O-C-N 120.192 -1.567 . . . . 0.0 111.231 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.35 -37.67 36.91 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.546 0.612 . . . . 7.79 110.31 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.81 83.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.498 -0.774 . . . . 7.73 111.033 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.4 mtt-85 -76.1 -43.03 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.37 0.507 . . . . 9.61 112.37 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.99 -37.76 88.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.193 0.52 . . . . 10.06 110.388 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.11 -16.39 74.64 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.239 -0.981 . . . . 9.23 112.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.98 71.59 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.888 -0.885 . . . . 9.25 110.888 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.3 51.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.941 0.719 . . . . 8.31 112.941 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.64 143.44 30.98 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.129 -0.228 . . . . 9.16 110.665 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.585 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.51 21.34 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.45 23.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.691 -0.231 . . . . 9.89 110.722 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.32 143.45 99.73 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.997 1.798 . . . . 11.04 110.771 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.37 161.62 20.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.642 -0.789 . . . . 9.31 112.465 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.8 m-20 -75.33 134.49 73.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 7.97 112.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.33 -50.97 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.519 2.146 . . . . 6.59 111.315 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.32 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.111 -0.495 . . . . 5.87 111.146 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -37.59 40.47 Favored 'General case' 0 N--CA 1.533 3.68 0 C-N-CA 125.508 1.523 . . . . 0.0 112.848 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.38 164.48 38.09 Favored 'General case' 0 C--N 1.387 2.224 0 C-N-CA 125.938 1.695 . . . . 0.0 110.891 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.08 130.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.372 1.573 0 C-N-CA 126.291 1.836 . . . . 5.67 109.329 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.12 126.65 55.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.475 . . . . 6.47 109.716 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.91 125.92 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 116.937 2.199 . . . . 7.1 116.937 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.34 5.24 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 103.182 -2.896 . . . . 8.1 103.182 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.26 -57.34 8.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.676 1.732 . . . . 10.19 115.676 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.15 -48.87 75.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.831 0.678 . . . . 10.51 112.831 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.96 -9.12 50.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.768 0.285 . . . . 9.72 111.768 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.07 36.17 15.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.547 1.314 . . . . 8.04 114.547 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -143.5 168.73 19.16 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.118 -1.033 . . . . 6.83 111.661 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.6 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.63 161.03 41.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.031 -1.44 . . . . 5.19 110.518 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.4 129.41 51.24 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.676 -0.861 . . . . 5.71 108.676 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.75 137.58 33.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.361 . . . . 4.27 110.359 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -114.86 114.68 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.703 -0.48 . . . . 6.21 109.703 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.68 164.65 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 6.14 111.951 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.93 22.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.439 -0.8 . . . . 8.37 111.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.2 p -128.92 159.59 35.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.155 0.503 . . . . 7.92 111.607 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.21 -41.82 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.59 -0.732 . . . . 8.77 112.247 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.585 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.7 -41.73 95.8 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.339 0.496 . . . . 9.08 112.339 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.88 -43.89 97.93 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.202 -0.295 . . . . 7.46 110.202 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.568 HG23 ' HG ' ' A' ' 151' ' ' LEU . 56.0 m -54.17 -53.88 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.159 -1.052 . . . . 6.18 108.159 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.1 m -55.1 -27.2 43.33 Favored 'General case' 1 C--N 1.429 4.051 0 C-N-CA 127.127 2.171 . . . . 0.0 109.739 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.46 -33.95 41.9 Favored 'General case' 0 C--N 1.423 3.779 0 N-CA-C 113.6 0.963 . . . . 8.7 113.6 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.62 -17.3 64.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 5.94 112.638 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.12 -19.84 63.43 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.377 1.048 . . . . 6.89 111.556 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.3 53.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.456 -0.338 . . . . 7.4 111.656 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.85 16.18 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.466 -0.333 . . . . 6.97 111.651 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.82 120.96 13.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 7.38 110.75 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.83 -4.79 66.09 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.884 -0.674 . . . . 7.92 113.579 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.833 0.316 . . . . 7.5 111.098 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -85.0 121.63 37.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.35 0.595 . . . . 9.49 111.286 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.36 107.67 7.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 8.45 110.357 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.69 42.64 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 10.44 111.767 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.08 -5.45 54.18 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.248 0.859 . . . . 10.21 115.248 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.58 130.94 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.627 0.713 . . . . 9.94 112.375 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.53 10.95 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.506 -0.924 . . . . 8.4 108.506 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.89 58.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.979 1.103 . . . . 6.9 113.979 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.8 tttt -108.59 110.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.477 -1.305 . . . . 8.29 107.477 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.98 126.89 58.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.36 0.504 . . . . 6.17 112.36 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.61 170.46 15.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.388 -0.824 . . . . 7.99 110.019 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.02 154.67 49.74 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.635 -0.876 . . . . 7.86 108.635 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.21 174.82 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.985 1.79 . . . . 7.79 111.982 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.4 t60 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.566 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.908 0.385 . . . . 10.8 110.791 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.91 139.37 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 8.21 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 334' ' ' ARG . 52.2 mt -109.77 143.95 38.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.019 -0.991 . . . . 6.33 112.849 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -104.39 132.05 51.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.138 -1.43 . . . . 6.75 107.138 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.03 121.25 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.601 -0.518 . . . . 5.68 109.601 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.2 16.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.444 -0.884 . . . . 6.53 112.71 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.19 86.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.668 -0.777 . . . . 7.67 111.532 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.3 mt -70.89 135.32 85.47 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 111.465 0.172 . . . . 8.16 111.465 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.0 Cg_exo -61.79 141.54 90.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.95 1.767 . . . . 8.96 108.792 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.39 -14.87 61.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.759 1.392 . . . . 11.61 114.759 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -84.15 -23.18 30.74 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.758 1.392 . . . . 11.06 114.758 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.26 149.18 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.165 0.439 . . . . 9.36 111.388 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 37.7 p-10 -114.59 -176.4 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.207 -0.294 . . . . 10.46 110.207 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.56 -55.3 26.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.617 1.34 . . . . 9.92 114.617 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -27.05 68.21 Favored 'General case' 0 C--N 1.407 3.084 0 C-N-CA 125.565 1.546 . . . . 0.0 112.392 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.59 -48.3 14.02 Favored 'General case' 1 C--N 1.429 4.024 0 CA-C-N 118.263 0.483 . . . . 10.06 111.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 66.2 t -62.65 -49.26 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 7.76 110.285 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.25 -36.41 63.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.279 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.12 -53.35 56.63 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.052 0.453 . . . . 10.2 110.642 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.8 -33.17 34.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.889 0.476 . . . . 7.62 110.283 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.517 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.2 mt -82.6 -41.7 19.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.552 0.575 . . . . 7.74 112.552 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.6 m -56.82 -30.69 63.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.589 0.959 . . . . 10.09 113.589 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.6 m -52.4 -7.73 0.07 Allowed 'General case' 0 C--N 1.397 2.65 0 O-C-N 120.602 -1.311 . . . . 0.0 112.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -110.31 -12.05 14.48 Favored 'General case' 1 C--N 1.443 4.67 0 CA-C-N 118.413 0.552 . . . . 10.23 111.492 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.09 162.28 10.22 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.775 -0.648 . . . . 10.4 111.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.54 146.98 93.6 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.776 2.317 . . . . 12.19 112.746 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 73.0 mt -102.43 146.27 28.32 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.935 -0.575 . . . . 10.66 111.348 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.98 -22.73 14.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.256 -0.646 . . . . 11.41 109.256 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.15 5.08 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.155 -2.216 . . . . 0.0 109.159 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.631 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -143.39 134.68 25.94 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.785 0.434 . . . . 8.77 111.98 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.75 124.05 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.547 -0.297 . . . . 8.38 111.58 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 53.0 tp -101.06 118.21 36.55 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.413 HG12 ' HG3' ' A' ' 300' ' ' LYS . 41.2 t -74.11 122.87 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.469 0.915 . . . . 9.37 113.469 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.07 148.1 43.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.359 -0.837 . . . . 11.34 109.345 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.3 t70 -58.89 141.19 54.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.894 0.378 . . . . 13.83 110.984 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.5 m -49.82 -61.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.842 -0.617 . . . . 14.58 112.571 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.09 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.527 0.566 . . . . 16.19 112.527 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.4 m -42.5 -59.25 1.94 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 14.94 111.184 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.61 -6.08 62.66 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.62 -0.8 . . . . 13.57 114.493 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.35 167.64 13.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.415 0.608 . . . . 13.28 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.9 t -59.21 142.07 52.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 10.43 111.58 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.413 ' HG3' HG12 ' A' ' 291' ' ' VAL . 4.1 mmmp? -87.91 -9.43 53.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.762 -0.653 . . . . 11.2 109.627 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.32 39.63 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.68 -0.691 . . . . 8.63 113.892 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -142.96 146.33 33.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.054 0.927 . . . . 9.19 112.92 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.19 46.71 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.158 -0.928 . . . . 6.21 112.213 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.37 146.77 36.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 7.09 110.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.631 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 23.1 p -157.73 156.18 31.2 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.906 -0.717 . . . . 6.77 111.928 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -145.2 127.07 15.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.722 -0.672 . . . . 9.59 109.716 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 54.8 m-85 -82.47 164.88 20.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.932 0.396 . . . . 9.91 112.025 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.58 -46.12 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.369 -0.975 . . . . 12.81 108.369 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.3 102.37 14.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.385 -1.339 . . . . 13.18 107.385 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.04 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 115.293 1.59 . . . . 12.23 115.293 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -56.85 -38.68 73.02 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 122.263 1.03 . . . . 13.04 109.005 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.75 -22.65 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.322 -2.217 . . . . 11.08 109.578 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.9 m -54.72 -48.07 72.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.966 -0.753 . . . . 9.11 108.966 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.52 -42.67 99.67 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.138 -0.625 . . . . 10.31 110.554 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -63.94 -32.33 73.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.867 -0.733 . . . . 11.98 111.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.78 74.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.791 -1.55 . . . . 8.25 113.021 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.58 -51.36 47.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.384 0.611 . . . . 7.4 110.872 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.7 67.78 Favored 'General case' 0 C--N 1.421 3.712 0 C-N-CA 126.273 1.829 . . . . 0.0 113.086 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.06 -23.97 36.33 Favored Glycine 1 C--N 1.401 4.188 0 N-CA-C 116.807 1.483 . . . . 8.35 116.807 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 330' ' ' LEU . 99.0 mt -96.89 -45.75 6.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.19 1.995 . . . . 7.2 113.984 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -50.47 130.14 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.851 0.358 . . . . 7.86 111.468 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.04 -16.64 56.61 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.134 -0.555 . . . . 8.64 113.983 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 17.2 mtt -50.61 147.19 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.836 0.318 . . . . 8.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -95.09 115.57 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 10.39 111.662 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.6 mm? -120.16 106.72 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.111 -1.07 . . . . 8.95 108.111 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.13 -118.65 10.52 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.406 -1.477 . . . . 10.63 109.406 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -115.94 22.48 12.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.145 0.498 . . . . 12.25 109.741 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 328' ' ' LYS . 34.1 mtpt -123.89 153.91 40.46 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.583 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.76 118.28 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.116 -1.068 . . . . 10.14 108.116 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.629 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.3 tp -63.11 143.22 57.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.537 0.684 . . . . 7.52 112.612 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.5 tp -128.21 128.01 43.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.486 -1.234 . . . . 7.48 108.961 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.02 124.0 25.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 O-C-N 121.038 -1.039 . . . . 6.45 109.955 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.73 155.34 37.02 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.938 -1.726 . . . . 7.66 109.488 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.539 ' HA ' HD23 ' A' ' 261' ' ' LEU . 99.2 mtt180 -58.62 122.51 13.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.422 -1.311 . . . . 8.94 107.59 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.88 -11.82 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 337' ' ' VAL . 17.3 m -119.4 -75.9 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.613 -0.435 . . . . 9.07 111.303 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 336' ' ' SER . 70.0 t . . . . . 0 N--CA 1.467 0.411 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.415 0.15 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.01 148.53 22.31 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.832 0.708 . . . . 5.88 111.351 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.65 143.54 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 5.25 111.21 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -96.6 125.21 40.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 6.58 108.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.84 101.3 8.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.512 . . . . 5.06 110.199 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.76 34.62 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.983 -0.553 . . . . 6.2 112.734 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 m120 49.21 42.54 21.75 Favored 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.649 1.58 . . . . 0.0 110.391 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.28 149.84 89.35 Favored Pre-proline 0 C--N 1.426 3.929 0 CA-C-N 114.95 -1.023 . . . . 7.79 111.333 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.06 144.5 89.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.341 2.027 . . . . 8.57 110.972 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.95 139.71 52.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 11.37 111.947 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.53 61.03 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.837 -0.619 . . . . 9.94 114.32 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.1 136.47 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.332 0.566 . . . . 8.91 110.303 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.88 153.8 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.694 0.283 . . . . 9.64 110.626 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.09 -43.1 95.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 7.44 110.23 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.75 -45.88 92.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.012 -0.54 . . . . 9.89 110.535 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.83 68.69 Favored 'General case' 0 C--N 1.41 3.217 0 O-C-N 119.408 -2.057 . . . . 0.0 111.606 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.479 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.27 -34.12 67.99 Favored 'General case' 1 C--N 1.429 4.043 0 O-C-N 123.978 0.799 . . . . 6.64 111.875 172.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ttt -74.53 -54.28 7.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.368 0.667 . . . . 6.69 111.055 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.65 -33.69 61.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.434 -0.803 . . . . 8.8 111.378 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.59 17.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.555 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.479 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.3 -48.26 82.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.175 0.435 . . . . 5.94 112.175 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.7 79.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.196 -0.602 . . . . 7.12 109.54 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.96 64.38 Favored 'General case' 0 C--N 1.404 2.965 0 O-C-N 120.213 -1.554 . . . . 0.0 111.246 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.69 36.78 Favored 'General case' 0 C--N 1.427 3.977 0 CA-C-N 118.502 0.592 . . . . 7.79 110.291 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.541 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.75 -36.66 82.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.707 . . . . 7.73 111.054 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.15 -42.88 45.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.386 0.514 . . . . 9.61 112.386 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.22 -37.66 88.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.274 0.559 . . . . 10.06 110.399 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.12 -16.44 74.49 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.338 -0.934 . . . . 9.23 112.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.15 37.04 72.19 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.871 -0.892 . . . . 9.25 110.871 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.99 5.42 51.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.828 0.677 . . . . 8.31 112.828 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.66 143.53 30.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.599 0.237 . . . . 9.16 110.534 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.585 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.74 -18.4 21.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.105 0.409 . . . . 10.23 112.105 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.79 163.4 24.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.682 -0.235 . . . . 9.89 110.75 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.28 143.45 99.74 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.935 1.757 . . . . 11.04 110.853 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.56 20.53 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.606 -0.807 . . . . 9.31 112.436 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.3 134.46 73.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 7.97 111.982 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.31 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.493 2.129 . . . . 6.59 111.298 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.67 106.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 5.87 111.16 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -32.44 25.58 Favored 'General case' 0 N--CA 1.525 3.283 0 O-C-N 119.686 -1.884 . . . . 0.0 113.856 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.33 163.26 40.23 Favored 'General case' 0 C--N 1.384 2.07 0 C-N-CA 125.754 1.621 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.88 130.56 11.94 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 C-N-CA 126.529 1.931 . . . . 5.67 109.31 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.11 126.57 55.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.776 -0.453 . . . . 6.47 109.776 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 116.893 2.183 . . . . 7.1 116.893 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -97.9 91.35 5.29 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 103.234 -2.876 . . . . 8.1 103.234 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.33 -57.47 7.83 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.566 1.691 . . . . 10.19 115.566 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.11 -48.77 75.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.9 0.704 . . . . 10.51 112.9 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -68.94 -9.18 50.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.855 0.317 . . . . 9.72 111.855 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 35.87 15.13 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.55 1.315 . . . . 8.04 114.55 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -143.38 168.79 18.99 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.116 -1.033 . . . . 6.83 111.612 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.605 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.7 161.14 41.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.23 -1.35 . . . . 5.19 110.355 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.43 51.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.716 -0.846 . . . . 5.71 108.716 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.6 mt -94.97 137.56 33.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.518 -0.31 . . . . 4.27 110.349 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -114.83 114.72 25.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.674 -0.491 . . . . 6.21 109.674 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.68 164.68 11.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.876 -0.602 . . . . 6.14 111.971 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.421 -0.809 . . . . 8.37 111.427 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.3 p -128.96 159.6 35.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.115 0.483 . . . . 7.92 111.666 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.25 -41.8 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.571 -0.74 . . . . 8.77 112.272 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.585 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.66 -41.71 95.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.388 0.514 . . . . 9.08 112.388 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.95 97.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.243 -0.281 . . . . 7.46 110.243 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.56 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.4 m -54.13 -53.97 46.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.192 -1.04 . . . . 6.18 108.192 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m -55.22 -27.11 43.83 Favored 'General case' 0 C--N 1.428 4.0 0 C-N-CA 127.001 2.12 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -34.11 43.47 Favored 'General case' 0 C--N 1.42 3.641 0 N-CA-C 113.613 0.968 . . . . 8.7 113.613 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.57 -17.32 64.11 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.654 0.613 . . . . 5.94 112.654 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.05 -19.84 63.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.505 1.128 . . . . 6.89 111.652 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.21 52.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 7.4 111.654 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -93.8 16.25 14.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 6.97 111.625 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.88 120.96 13.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 7.38 110.765 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.87 -4.81 66.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.928 -0.653 . . . . 7.92 113.599 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.845 0.323 . . . . 7.5 111.124 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.265 0.555 . . . . 9.49 111.333 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -135.34 107.74 7.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 8.45 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.74 42.67 13.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 10.44 111.771 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.96 -5.33 54.2 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 115.201 0.84 . . . . 10.21 115.201 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.67 130.9 55.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.651 0.726 . . . . 9.94 112.356 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.67 101.46 10.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.556 -0.905 . . . . 8.4 108.556 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.85 58.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.427 ' HE3' ' NH1' ' A' ' 227' ' ' ARG . 75.6 tttt -108.58 110.28 21.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.523 -1.288 . . . . 8.29 107.523 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.4 mt -103.95 126.94 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 6.17 112.338 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.427 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.56 15.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.384 -0.826 . . . . 7.99 110.038 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.67 49.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.16 174.78 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.988 1.792 . . . . 7.79 112.033 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 . . . . . 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 68.6 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.995 0.426 . . . . 10.8 110.745 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -63.01 139.36 58.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.211 0.529 . . . . 8.21 110.306 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 334' ' ' ARG . 69.6 mt -109.74 144.0 38.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.957 -1.019 . . . . 6.33 112.783 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.414 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 51.4 t80 -104.5 132.15 51.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.245 -1.391 . . . . 6.75 107.245 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.22 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.531 -0.544 . . . . 5.68 109.531 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.21 16.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.516 -0.849 . . . . 6.53 112.674 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.8 9.18 86.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.589 -0.815 . . . . 7.67 111.552 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.85 135.27 85.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 111.446 0.165 . . . . 8.16 111.446 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.77 141.54 90.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.832 1.688 . . . . 8.96 108.832 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -65.39 -14.92 61.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -84.1 -23.13 30.89 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.836 1.421 . . . . 11.06 114.836 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.34 149.2 50.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.105 0.411 . . . . 9.36 111.333 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 25.1 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.244 -0.28 . . . . 10.46 110.244 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 4.5 m-20 -53.59 -55.54 24.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.611 1.338 . . . . 9.92 114.611 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.14 -26.83 67.96 Favored 'General case' 0 C--N 1.405 3.008 0 C-N-CA 125.724 1.61 . . . . 0.0 112.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -79.78 -48.35 13.74 Favored 'General case' 1 C--N 1.432 4.185 0 CA-C-N 118.3 0.5 . . . . 10.06 111.387 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 88.9 t -62.69 -49.15 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 7.76 110.315 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 31.8 mtmm -54.35 -36.3 63.67 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.616 -0.72 . . . . 9.67 111.362 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.06 -53.45 55.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.096 0.474 . . . . 10.2 110.644 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.73 -33.02 32.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.092 -0.503 . . . . 7.62 110.447 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.461 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.76 -41.72 18.86 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.497 0.554 . . . . 7.74 112.497 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 55.7 m -56.76 -30.08 63.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.583 0.957 . . . . 10.09 113.583 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.6 m -50.36 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.395 2.563 0 C-N-CA 124.78 1.232 . . . . 0.0 112.671 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -111.67 -12.05 13.93 Favored 'General case' 1 C--N 1.444 4.705 0 CA-C-N 118.388 0.54 . . . . 10.23 111.435 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.17 162.23 10.21 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.874 -0.603 . . . . 10.4 111.951 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 147.01 93.51 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.7 2.267 . . . . 12.19 112.78 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 76.1 mt -102.41 146.23 28.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.95 -0.568 . . . . 10.66 111.254 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.5 ptpt -101.0 -22.72 14.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 11.41 109.302 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.57 125.36 4.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.051 -2.281 . . . . 0.0 109.245 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.53 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 47.1 t80 -142.82 134.76 27.01 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 122.777 0.431 . . . . 8.77 112.014 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -144.8 124.11 13.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.714 0.292 . . . . 8.38 111.481 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.9 tp -101.04 118.24 36.6 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.55 -1.278 . . . . 8.94 107.55 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 49.0 t -74.23 122.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.473 0.916 . . . . 9.37 113.473 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -119.15 148.08 43.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.232 -0.894 . . . . 11.34 109.329 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 25.5 t70 -58.95 141.2 54.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.412 . . . . 13.83 110.894 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 18.7 m -49.78 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.802 -0.635 . . . . 14.58 112.606 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.07 -64.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.536 0.569 . . . . 16.19 112.536 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 3.9 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.254 -0.43 . . . . 14.94 111.21 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.72 -6.16 62.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.592 -0.814 . . . . 13.57 114.545 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.29 167.55 13.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.355 0.578 . . . . 13.28 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.0 t -59.15 142.08 52.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 10.43 111.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.436 ' HD3' ' HB2' ' A' ' 293' ' ' ASP . 4.4 mmmp? -87.94 -9.46 53.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.802 -0.636 . . . . 11.2 109.625 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.39 39.54 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.56 -0.746 . . . . 8.63 113.857 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -142.96 146.46 33.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.146 0.973 . . . . 9.19 112.75 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.59 155.13 46.66 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.094 -0.957 . . . . 6.21 112.187 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' PHE . . . . . 0.414 ' CE1' ' HD1' ' A' ' 262' ' ' PHE . 88.9 m-85 -111.42 146.85 36.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.273 -0.876 . . . . 7.09 110.422 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' CYS . . . . . 0.53 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.1 p -157.75 156.26 31.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.994 -0.683 . . . . 6.77 111.903 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -145.41 127.08 15.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.738 -0.664 . . . . 9.59 109.656 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.602 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 54.8 m-85 -82.46 164.9 20.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.081 0.467 . . . . 9.91 112.027 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.55 -46.01 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.436 -0.95 . . . . 12.81 108.436 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 312' ' ' VAL . 19.7 t70 -96.36 102.32 14.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.357 -1.349 . . . . 13.18 107.357 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ILE . . . . . 0.533 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.69 -34.98 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 115.326 1.602 . . . . 12.23 115.326 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -56.82 -38.82 73.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.236 1.017 . . . . 13.04 109.022 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.69 -22.57 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 112.268 -2.242 . . . . 11.08 109.61 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 97.8 m -54.66 -48.24 72.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.869 -0.789 . . . . 9.11 108.869 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.45 -42.82 99.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.3 -0.56 . . . . 10.31 110.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 119.871 -0.732 . . . . 11.98 111.993 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.76 74.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.597 -1.638 . . . . 8.25 113.023 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.65 -51.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.316 0.579 . . . . 7.4 110.859 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.25 67.27 Favored 'General case' 0 C--N 1.419 3.589 0 C-N-CA 126.337 1.855 . . . . 0.0 113.2 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.25 -24.05 35.52 Favored Glycine 1 C--N 1.4 4.132 0 N-CA-C 116.815 1.486 . . . . 8.35 116.815 177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.87 -45.68 6.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 120.097 1.949 . . . . 7.2 113.956 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -50.53 129.97 23.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.808 0.337 . . . . 7.86 111.46 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.56 56.96 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.156 -0.545 . . . . 8.64 113.978 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.3 mtt -50.71 147.18 4.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.846 0.323 . . . . 8.0 111.259 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.06 115.57 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.055 0.455 . . . . 10.39 111.712 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -120.18 106.85 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 66.99 -118.64 10.63 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.373 -1.491 . . . . 10.63 109.373 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -115.84 22.4 13.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 12.25 109.752 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -123.83 153.98 40.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.609 -0.723 . . . . 9.98 111.617 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -101.79 118.27 36.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.083 -1.08 . . . . 10.14 108.083 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.0 143.04 58.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.516 0.674 . . . . 7.52 112.649 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 61.5 tp -128.14 127.94 43.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.597 -1.183 . . . . 7.48 109.014 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.85 124.02 26.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 120.909 -1.119 . . . . 6.45 109.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.8 155.31 36.89 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.961 -1.712 . . . . 7.66 109.557 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.49 ' HA ' HD23 ' A' ' 261' ' ' LEU . 66.4 mtt180 -58.54 122.44 13.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 118.424 -1.31 . . . . 8.94 107.577 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.92 -11.8 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.814 1.413 . . . . 7.52 114.814 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.4 m -119.44 -77.59 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.522 -0.471 . . . . 9.07 111.239 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.873 179.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.614 0.245 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.11 46.75 1.12 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.916 173.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -157.11 148.58 22.18 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 122.962 0.505 . . . . 5.88 111.293 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.8 143.55 34.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 5.25 111.188 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.57 125.15 40.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.859 -0.793 . . . . 6.58 108.859 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.41 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.22 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.097 0.475 . . . . 5.06 110.24 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.78 -178.22 35.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.002 -0.618 . . . . 6.2 112.763 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 49.87 40.76 21.43 Favored 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 125.065 1.346 . . . . 0.0 110.201 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.77 149.78 88.21 Favored Pre-proline 1 C--N 1.428 4.015 0 C-N-CA 123.448 0.699 . . . . 7.79 111.327 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.98 144.43 89.41 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.288 1.992 . . . . 8.57 110.978 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.65 52.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.022 0.439 . . . . 11.37 111.934 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.56 61.18 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.818 -0.628 . . . . 9.94 114.313 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.07 136.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 117.307 0.553 . . . . 8.91 110.306 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.84 153.92 22.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.697 0.284 . . . . 9.64 110.645 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.13 -43.24 95.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.411 . . . . 7.44 110.192 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.7 -45.93 91.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.001 -0.545 . . . . 9.89 110.562 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.46 -26.59 68.6 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.3 -2.125 . . . . 0.0 111.724 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.48 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.11 67.84 Favored 'General case' 1 C--N 1.428 4.006 0 O-C-N 123.877 0.736 . . . . 6.64 111.733 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.56 -54.35 7.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.449 0.699 . . . . 6.69 111.074 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -54.48 -33.7 60.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.366 -0.834 . . . . 8.8 111.41 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.79 -53.62 17.42 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.58 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.1 m-85 -61.27 -48.29 82.09 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.97 80.25 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.265 -0.574 . . . . 7.12 109.586 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.7 -23.58 65.3 Favored 'General case' 0 C--N 1.407 3.097 0 O-C-N 120.254 -1.529 . . . . 0.0 111.298 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.48 -37.62 36.4 Favored 'General case' 0 C--N 1.427 3.972 0 O-C-N 123.611 0.569 . . . . 7.79 110.328 176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.79 -36.79 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.595 -0.73 . . . . 7.73 111.014 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -75.93 -43.12 46.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.429 0.529 . . . . 9.61 112.429 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.03 -37.71 88.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.189 0.519 . . . . 10.06 110.447 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.15 -16.42 74.49 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.297 -0.954 . . . . 9.23 112.814 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.02 72.03 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 110.878 -0.889 . . . . 9.25 110.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.89 5.31 51.8 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.975 0.732 . . . . 8.31 112.975 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.63 143.45 30.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.616 0.246 . . . . 9.16 110.577 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.586 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 112.148 0.425 . . . . 10.23 112.148 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.4 24.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.646 -0.252 . . . . 9.89 110.714 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -59.29 143.51 99.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.946 1.764 . . . . 11.04 110.822 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.35 161.6 20.55 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.663 -0.779 . . . . 9.31 112.43 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 112.117 0.414 . . . . 7.97 112.117 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.21 -51.04 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.544 2.163 . . . . 6.59 111.283 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.64 106.26 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 116.126 -0.488 . . . . 5.87 111.075 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.86 -37.15 30.41 Favored 'General case' 0 N--CA 1.536 3.837 0 O-C-N 119.885 -1.76 . . . . 0.0 112.963 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.36 164.38 36.83 Favored 'General case' 0 C--N 1.382 1.983 0 C-N-CA 125.78 1.632 . . . . 0.0 110.736 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.4 130.45 10.53 Favored 'Isoleucine or valine' 0 C--N 1.37 1.499 0 C-N-CA 126.584 1.954 . . . . 5.67 109.331 175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -114.06 126.61 55.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.789 -0.449 . . . . 6.47 109.789 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.594 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.92 125.95 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 116.912 2.189 . . . . 7.1 116.912 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.06 91.42 5.28 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 103.153 -2.906 . . . . 8.1 103.153 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.27 -57.37 7.99 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 115.73 1.752 . . . . 10.19 115.73 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.21 -48.78 75.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.812 0.671 . . . . 10.51 112.812 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.0 -9.06 50.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.832 0.308 . . . . 9.72 111.832 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.21 15.49 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.528 1.307 . . . . 8.04 114.528 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.59 168.68 19.29 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 119.074 -1.05 . . . . 6.83 111.601 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.594 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.04 41.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.143 -1.389 . . . . 5.19 110.515 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.3 129.5 51.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.657 -0.868 . . . . 5.71 108.657 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.94 137.56 33.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.33 -0.395 . . . . 4.27 110.272 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.77 114.65 25.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.744 -0.465 . . . . 6.21 109.744 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -99.6 164.7 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.597 0.561 . . . . 6.14 112.073 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.59 -25.98 22.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.473 -0.785 . . . . 8.37 111.429 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.9 p -128.89 159.59 35.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.173 0.511 . . . . 7.92 111.568 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.33 -41.71 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.593 -0.73 . . . . 8.77 112.232 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.586 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.72 -41.79 95.71 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.325 0.491 . . . . 9.08 112.325 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.82 98.09 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.2 m -54.19 -53.97 46.24 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.149 -1.056 . . . . 6.18 108.149 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.5 m -55.18 -27.11 43.43 Favored 'General case' 0 C--N 1.428 3.98 0 C-N-CA 126.956 2.102 . . . . 0.0 109.86 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -34.03 43.12 Favored 'General case' 0 C--N 1.422 3.73 0 N-CA-C 113.606 0.965 . . . . 8.7 113.606 176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.659 0.614 . . . . 5.94 112.659 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.86 63.38 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 124.394 1.059 . . . . 6.89 111.587 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.38 -9.37 53.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.416 -0.356 . . . . 7.4 111.651 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.2 14.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.516 -0.311 . . . . 6.97 111.619 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.84 120.92 13.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 7.38 110.78 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.93 -4.91 65.94 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.918 -0.658 . . . . 7.92 113.559 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.07 142.36 9.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.854 0.327 . . . . 7.5 111.101 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.53 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.333 0.587 . . . . 9.49 111.266 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.28 107.73 7.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.676 -0.693 . . . . 8.45 110.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.67 13.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 10.44 111.73 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.06 -5.47 54.01 Favored Glycine 0 C--N 1.333 0.395 0 N-CA-C 115.169 0.828 . . . . 10.21 115.169 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.62 130.94 55.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.665 0.733 . . . . 9.94 112.381 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.79 101.55 11.0 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.449 -0.945 . . . . 8.4 108.449 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.981 1.104 . . . . 6.9 113.981 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 1.011 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.9 tttt -108.53 110.21 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.567 -1.272 . . . . 8.29 107.567 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -103.91 126.91 58.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.349 0.5 . . . . 6.17 112.349 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.57 170.53 15.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.413 -0.812 . . . . 7.99 110.051 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.12 154.7 49.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.448 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.8 Cg_exo -57.38 175.04 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 121.942 1.761 . . . . 7.79 112.079 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -116.83 25.84 10.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.797 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.865 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 7.8 m-20 -68.76 -13.18 62.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.642 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -77.49 98.5 5.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.026 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -100.85 162.07 21.83 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.41 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.8 -29.35 80.68 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.547 2.165 . . . . 0.0 111.877 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 44.0 tp 62.01 82.81 0.21 Allowed Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.595 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.48 63.6 8.45 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.427 2.751 . . . . 0.0 112.123 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -90.43 -4.58 70.59 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.972 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.8 mmt 67.16 -174.77 0.19 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.818 0.447 . . . . 0.0 110.844 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 9.7 m 53.57 60.81 3.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.994 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -56.18 105.61 0.21 Allowed 'General case' 0 C--N 1.334 -0.073 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.667 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 27.1 t-20 -141.67 -56.32 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.21 175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 89.6 Cg_endo -82.36 9.89 3.8 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 121.927 1.751 . . . . 0.0 111.776 176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.2 p -131.84 -88.33 0.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.362 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 247' ' ' PRO . 39.8 t 61.73 -81.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 123.219 0.608 . . . . 0.0 110.921 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -178.1 -61.52 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.183 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.668 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 50.6 t -77.29 -54.3 1.51 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.649 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.668 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 73.3 Cg_exo -50.54 117.43 3.23 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.406 2.07 . . . . 0.0 112.723 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 113.31 -30.74 7.11 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.95 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 249' ' ' VAL . 7.5 p -146.03 78.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.197 0.998 . . . . 0.0 110.3 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.658 HG22 HG12 ' A' ' 246' ' ' VAL . 48.4 t -94.34 -24.63 4.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.521 178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 34.7 t 70.44 104.02 0.06 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.593 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 27.0 m -56.07 -48.26 76.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.143 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.0 p -178.81 113.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.841 175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 15.6 m -68.46 127.12 93.27 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 110.696 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 254' ' ' VAL . 12.8 Cg_exo -70.84 163.08 40.39 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.814 2.343 . . . . 0.0 111.193 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.92 99.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.791 0.805 . . . . 0.0 109.895 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.3 m -150.65 179.32 8.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.412 -177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 62.01 85.48 0.12 Allowed 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.768 0.667 . . . . 0.0 111.836 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -128.81 30.98 5.01 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.803 -0.635 . . . . 10.8 110.803 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.92 139.41 58.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.055 -0.521 . . . . 8.21 110.296 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.5 mt -109.88 143.94 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.114 -0.948 . . . . 6.33 112.769 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -104.38 132.08 51.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.176 -1.416 . . . . 6.75 107.176 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.573 -0.529 . . . . 5.68 109.573 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.531 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.456 -0.878 . . . . 6.53 112.679 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.2 86.6 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 7.67 111.506 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.6 mt -70.89 135.21 85.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 111.492 0.182 . . . . 8.16 111.492 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 26.2 Cg_exo -61.82 141.56 90.54 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.93 1.753 . . . . 8.96 108.76 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -65.36 -14.88 61.84 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.797 1.406 . . . . 11.61 114.797 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.16 -23.1 30.76 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.807 1.41 . . . . 11.06 114.807 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.35 149.12 50.86 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.169 0.44 . . . . 9.36 111.306 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 17.6 p-10 -114.53 -176.48 2.91 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 110.269 -0.271 . . . . 10.46 110.269 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 9.9 m-20 -53.46 -55.41 25.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 114.699 1.37 . . . . 9.92 114.699 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.66 -26.05 67.77 Favored 'General case' 0 C--N 1.406 3.023 0 C-N-CA 125.633 1.573 . . . . 0.0 112.559 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -80.28 -48.3 13.25 Favored 'General case' 1 C--N 1.429 4.064 0 CA-C-N 118.27 0.487 . . . . 10.06 111.414 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 75.1 t -62.63 -49.16 84.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.784 -0.644 . . . . 7.76 110.329 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 32.6 mtmm -54.37 -36.44 63.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.647 -0.706 . . . . 9.67 111.312 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -61.97 -53.37 56.63 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.137 0.494 . . . . 10.2 110.701 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.424 HD11 HD22 ' A' ' 320' ' ' LEU . 3.1 tm? -51.74 -33.19 33.72 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.124 -0.489 . . . . 7.62 110.328 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.1 mt -82.64 -41.55 19.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.651 0.611 . . . . 7.74 112.651 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.8 m -56.85 -29.57 63.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.566 0.95 . . . . 10.09 113.566 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.8 m -50.61 -9.99 0.06 Allowed 'General case' 0 C--N 1.393 2.486 0 C-N-CA 124.873 1.269 . . . . 0.0 112.511 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -111.76 -11.96 13.9 Favored 'General case' 1 C--N 1.443 4.637 0 CA-C-N 118.398 0.544 . . . . 10.23 111.483 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 10.4 111.9 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.66 147.03 93.72 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.681 2.254 . . . . 12.19 112.744 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 91.4 mt -102.4 146.29 28.29 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.913 -0.585 . . . . 10.66 111.268 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.488 ' HD2' ' OE2' ' A' ' 306' ' ' GLU . 18.7 ptpt -101.02 -22.67 14.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.222 -0.658 . . . . 11.41 109.222 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.92 125.59 4.67 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 119.061 -2.274 . . . . 0.0 109.229 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.594 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.4 t80 -142.79 134.78 27.08 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 122.81 0.444 . . . . 8.77 111.968 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.82 124.09 12.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.794 0.33 . . . . 8.38 111.467 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.8 tp -101.03 118.13 36.4 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.2 122.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.445 0.906 . . . . 9.37 113.445 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -119.09 148.1 43.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.263 -0.88 . . . . 11.34 109.359 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.7 t70 -58.89 141.14 54.32 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.919 0.39 . . . . 13.83 111.039 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 38.0 m -49.59 -61.76 1.93 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.649 0.611 . . . . 14.58 112.649 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.16 -63.96 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.497 0.555 . . . . 16.19 112.497 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 14.9 m -42.46 -59.3 1.91 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.302 -0.408 . . . . 14.94 111.221 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.58 -6.04 62.7 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.65 -0.786 . . . . 13.57 114.531 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 82.0 mt -88.32 167.56 13.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.411 0.606 . . . . 13.28 110.926 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 48.5 t -59.13 142.08 52.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.954 -0.567 . . . . 10.43 111.588 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.986 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 5.4 mmmp? -87.99 -9.47 53.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.771 -0.65 . . . . 11.2 109.566 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.55 -3.29 39.6 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.624 -0.716 . . . . 8.63 113.908 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.413 ' HH ' " H4'" ' B' ' 603' ' ' ' U' . 37.8 p90 -143.02 146.4 33.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.04 0.92 . . . . 9.19 112.837 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.63 155.14 46.62 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.131 -0.941 . . . . 6.21 112.258 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.34 146.86 36.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.172 -0.922 . . . . 7.09 110.405 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.594 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.3 p -157.91 156.18 30.87 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 119.903 -0.719 . . . . 6.77 111.84 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.488 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 31.3 tt0 -145.26 127.16 15.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.585 -0.734 . . . . 9.59 109.629 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 57.8 m-85 -82.5 164.89 20.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.042 0.386 . . . . 9.91 112.042 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.475 ' HA ' ' HE3' ' A' ' 286' ' ' LYS . 64.0 t -71.59 -46.08 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.357 -0.979 . . . . 12.81 108.357 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.3 t70 -96.35 102.35 14.13 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.442 -1.318 . . . . 13.18 107.442 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.512 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 115.27 1.582 . . . . 12.23 115.27 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -56.87 -38.69 73.08 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 122.246 1.022 . . . . 13.04 109.026 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.84 -22.57 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 112.296 -2.229 . . . . 11.08 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.61 -48.26 72.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.933 -0.766 . . . . 9.11 108.933 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.36 -42.82 99.71 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.252 -0.579 . . . . 10.31 110.554 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -63.82 -32.41 73.91 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 119.857 -0.737 . . . . 11.98 111.949 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.54 -34.78 74.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.671 -1.604 . . . . 8.25 113.025 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 73.0 mt -68.57 -51.25 48.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.392 0.615 . . . . 7.4 110.883 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.84 -38.78 67.86 Favored 'General case' 0 C--N 1.419 3.611 0 C-N-CA 126.266 1.826 . . . . 0.0 113.178 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -24.02 36.35 Favored Glycine 1 C--N 1.398 4.01 0 N-CA-C 116.846 1.499 . . . . 8.35 116.846 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 278' ' ' LEU . 87.9 mt -96.9 -45.77 6.49 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 120.093 1.947 . . . . 7.2 113.971 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -50.53 130.06 23.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 7.86 111.492 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.66 56.72 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 121.103 -0.57 . . . . 8.64 113.987 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.3 ttt -50.58 147.15 4.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.797 0.298 . . . . 8.0 111.336 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -95.05 115.73 27.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.432 . . . . 10.39 111.703 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.4 mm? -120.24 106.71 12.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.108 -1.071 . . . . 8.95 108.108 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.06 -118.64 10.56 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.388 -1.485 . . . . 10.63 109.388 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -115.87 22.35 13.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.139 0.495 . . . . 12.25 109.781 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -123.82 153.9 40.37 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.59 -0.732 . . . . 9.98 111.683 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.73 118.29 36.63 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.133 -1.062 . . . . 10.14 108.133 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.67 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.9 tp -62.99 143.1 58.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.413 0.625 . . . . 7.52 112.663 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.471 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 94.8 mt -128.12 128.06 44.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.535 -1.211 . . . . 7.48 108.917 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.5 t -137.98 123.93 25.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.039 0 O-C-N 120.927 -1.108 . . . . 6.45 109.997 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -152.65 155.41 37.26 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.947 -1.72 . . . . 7.66 109.5 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.843 ' HD2' ' HA3' ' A' ' 338' ' ' GLY . 98.8 mtt180 -58.69 122.49 13.63 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 118.459 -1.297 . . . . 8.94 107.586 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.91 -11.83 0.1 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 114.757 1.391 . . . . 7.52 114.757 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 15.3 m -119.41 -77.84 0.58 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.547 -0.461 . . . . 9.07 111.362 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.58 136.53 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . 0.843 ' HA3' ' HD2' ' A' ' 334' ' ' ARG . . . 125.89 53.41 0.16 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.504 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -97.81 -0.04 45.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -126.15 167.17 15.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.901 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -137.63 118.7 14.41 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.955 0.407 . . . . 0.0 110.688 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.835 177.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.986 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.158 0 C3'-C2'-C1' 100.456 -1.16 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 0.471 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.425 -0.927 0 O4'-C1'-C2' 107.562 0.83 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.446 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.105 0 C4'-C3'-C2' 103.821 1.121 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 1.011 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 0 O3'--C3' 1.472 3.493 0 C3'-C2'-C1' 103.318 2.02 . 0.213 4g . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.684 6.402 1 P-O3'-C3' 124.824 4.27 . 0.0 OUTLIER '7D dist 9a' 0.0 . . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.461 ' H6 ' ' OP2' ' B' ' 606' ' ' ' U' . . . . . . . . 0 C3'--C2' 1.538 1.216 0 C4'-C3'-C2' 105.583 2.883 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 0.865 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.546 1.81 0 O4'-C1'-C2' 107.841 1.03 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.883 0 C3'-C2'-C1' 100.672 -0.92 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 O4'-C1'-C2' 107.358 0.684 . 0.025 0k . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.675 -0.12 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.725 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -136.16 -150.21 0.36 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 119.4 -0.92 . . . . 0.0 112.827 173.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -161.81 149.24 14.45 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 122.97 0.508 . . . . 5.88 111.526 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.554 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.4 mt -140.73 143.56 35.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.56 . . . . 5.25 111.253 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -96.54 125.14 40.8 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 6.58 108.879 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.69 101.22 8.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.069 0.461 . . . . 5.06 110.242 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.76 -179.2 34.86 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.033 -0.53 . . . . 6.2 112.728 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 50.1 41.35 23.48 Favored 'General case' 0 CA--C 1.575 1.939 0 C-N-CA 125.175 1.39 . . . . 0.0 110.326 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.69 149.85 88.43 Favored Pre-proline 1 C--N 1.429 4.023 0 C-N-CA 123.726 0.81 . . . . 7.79 111.32 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.08 144.45 89.98 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.247 1.964 . . . . 8.57 110.968 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.92 139.78 52.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 11.37 111.938 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.48 61.02 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.282 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.05 136.5 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 117.316 0.558 . . . . 8.91 110.359 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.85 153.88 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.693 0.282 . . . . 9.64 110.653 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.22 -43.07 96.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.176 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -61.82 -45.99 91.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.971 -0.559 . . . . 9.89 110.547 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.412 3.312 0 O-C-N 119.076 -2.265 . . . . 0.0 111.701 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.32 -34.19 67.91 Favored 'General case' 1 C--N 1.429 4.059 0 O-C-N 123.934 0.771 . . . . 6.64 111.731 171.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.32 7.77 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.353 0.661 . . . . 6.69 111.119 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.48 -33.75 60.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.388 -0.824 . . . . 8.8 111.428 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.72 -53.7 17.25 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.552 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.3 -48.21 82.4 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.77 -42.85 80.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.164 -0.614 . . . . 7.12 109.594 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.98 -23.46 65.04 Favored 'General case' 0 C--N 1.406 3.042 0 O-C-N 120.279 -1.513 . . . . 0.0 111.31 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.3 -37.76 36.97 Favored 'General case' 1 C--N 1.428 4.014 0 CA-C-N 118.499 0.59 . . . . 7.79 110.354 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.557 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.66 -36.82 83.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.589 -0.732 . . . . 7.73 111.085 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.5 mtt-85 -76.0 -43.13 45.76 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.349 0.5 . . . . 9.61 112.349 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.5 mt -62.99 -37.74 88.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.272 0.558 . . . . 10.06 110.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.03 -16.45 74.7 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.224 -0.988 . . . . 9.23 112.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.17 37.14 72.02 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.801 -0.92 . . . . 9.25 110.801 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.96 5.33 51.8 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.865 0.691 . . . . 8.31 112.865 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 p -82.62 143.46 30.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.596 0.236 . . . . 9.16 110.575 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.44 23.88 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.689 -0.232 . . . . 9.89 110.706 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.3 143.48 99.72 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.017 1.812 . . . . 11.04 110.834 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.33 161.55 20.56 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.534 -0.841 . . . . 9.31 112.431 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.2 m-20 -75.26 134.52 73.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.02 0.378 . . . . 7.97 112.02 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.569 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.28 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.553 2.169 . . . . 6.59 111.327 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.63 105.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.118 -0.492 . . . . 5.87 111.11 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.96 70.47 0.71 Allowed 'General case' 0 N--CA 1.512 2.637 0 C-N-CA 124.752 1.221 . . . . 0.0 109.441 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.73 151.32 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 129.383 3.073 . . . . 0.0 112.78 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.52 130.51 8.13 Favored 'Isoleucine or valine' 0 C--N 1.375 1.68 0 C-N-CA 129.47 3.108 . . . . 5.67 109.273 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.743 -0.465 . . . . 6.47 109.743 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 125.97 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 116.958 2.207 . . . . 7.1 116.958 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.03 91.38 5.28 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 103.165 -2.902 . . . . 8.1 103.165 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.32 -57.39 8.0 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.606 1.706 . . . . 10.19 115.606 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.28 -48.67 76.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.845 0.683 . . . . 10.51 112.845 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.01 -9.12 50.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.726 0.298 . . . . 9.72 111.803 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.1 36.07 15.44 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.556 1.317 . . . . 8.04 114.556 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -143.42 168.7 19.2 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.134 -1.027 . . . . 6.83 111.703 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.593 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.69 161.09 41.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.235 -1.348 . . . . 5.19 110.482 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.36 129.37 51.2 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.641 -0.874 . . . . 5.71 108.641 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.92 137.58 33.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 4.27 110.312 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.72 114.77 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.721 -0.474 . . . . 6.21 109.721 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.665 0.603 . . . . 6.14 111.919 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.94 22.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.374 -0.83 . . . . 8.37 111.411 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.3 p -128.94 159.57 35.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.121 0.486 . . . . 7.92 111.648 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.24 -41.78 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.751 . . . . 8.77 112.232 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.584 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.71 -41.78 95.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.354 0.502 . . . . 9.08 112.354 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.91 -43.86 97.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.248 -0.279 . . . . 7.46 110.248 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.0 m -54.18 -53.87 47.58 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.261 1.029 . . . . 6.18 108.261 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 20.1 m -55.06 -27.22 43.14 Favored 'General case' 0 C--N 1.424 3.845 0 C-N-CA 127.118 2.167 . . . . 0.0 109.888 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.35 -34.01 42.47 Favored 'General case' 0 C--N 1.421 3.682 0 N-CA-C 113.585 0.957 . . . . 8.7 113.585 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.58 -17.39 64.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.07 -19.82 63.34 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.473 1.108 . . . . 6.89 111.633 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.51 -9.21 52.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.42 -0.355 . . . . 7.4 111.611 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.83 16.16 14.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.564 -0.289 . . . . 6.97 111.627 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.87 120.92 13.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.826 0.346 . . . . 7.38 110.777 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.89 -4.84 65.98 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.938 -0.648 . . . . 7.92 113.577 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.06 142.38 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.936 0.368 . . . . 7.5 111.084 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.97 121.54 37.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.34 0.591 . . . . 9.49 111.262 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.29 107.76 7.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 8.45 110.378 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.69 42.71 13.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 10.44 111.771 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.99 -5.35 54.21 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 115.195 0.838 . . . . 10.21 115.195 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.61 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.669 0.735 . . . . 9.94 112.469 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.44 10.83 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.56 -0.904 . . . . 8.4 108.56 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -61.31 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.758 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.55 110.24 21.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.555 -1.276 . . . . 8.29 107.555 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.93 126.89 58.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 6.17 112.32 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.434 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.62 170.54 15.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.03 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.14 154.76 49.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.537 -0.912 . . . . 7.86 108.537 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.412 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.7 Cg_exo -57.44 175.17 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.921 1.748 . . . . 7.79 112.026 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -103.39 -6.61 21.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 1.17 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 10.5 m-20 -85.29 15.89 4.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.274 172.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -63.44 150.11 44.43 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.29 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.477 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 10.5 pt20 -51.11 129.12 30.4 Favored Pre-proline 0 C--O 1.236 0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.446 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 4.3 Cg_exo -80.68 -178.52 4.48 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.101 2.534 . . . . 0.0 111.016 176.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.78 125.72 90.37 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.13 138.97 88.35 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.707 2.271 . . . . 0.0 111.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -76.44 167.84 54.64 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.101 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 42.0 ttp 65.32 31.84 10.25 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.429 0.633 . . . . 0.0 110.225 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 41.1 m -102.56 96.14 6.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.518 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -121.83 -43.98 2.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.139 0.495 . . . . 0.0 110.168 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 16.7 m120 -100.23 115.19 65.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 20.5 Cg_exo -66.44 111.03 1.96 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.64 2.226 . . . . 0.0 112.238 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 47.3 m -71.19 -32.07 68.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 109.869 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.09 137.39 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.068 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -87.89 89.67 8.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.072 0.463 . . . . 0.0 110.142 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.8 158.08 34.12 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.713 ' HD2' HG22 ' A' ' 254' ' ' VAL . 31.6 Cg_exo -60.45 -42.35 41.62 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.898 2.398 . . . . 0.0 112.952 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.825 ' HA3' ' HB ' ' A' ' 252' ' ' THR . . . -111.59 -139.01 7.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.116 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.54 -68.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.8 0.3 . . . . 0.0 110.225 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.9 m -128.47 -44.65 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.051 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.5 m -129.64 2.28 4.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.132 0.492 . . . . 0.0 110.237 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.825 ' HB ' ' HA3' ' A' ' 248' ' ' GLY . 0.2 OUTLIER -59.92 121.95 13.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.127 -179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 252' ' ' THR . 4.3 p 50.77 22.66 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 112.082 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.713 HG22 ' HD2' ' A' ' 247' ' ' PRO . 90.7 t -80.48 117.8 69.44 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.39 113.47 2.48 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.73 2.287 . . . . 0.0 112.723 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -125.0 152.15 44.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.9 t -73.61 90.86 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -142.82 54.46 1.39 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -80.32 30.98 0.28 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 10.8 110.782 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.796 ' HD3' ' HB2' ' A' ' 306' ' ' GLU . 7.0 tppt? -62.87 139.34 58.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 8.21 110.349 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 313' ' ' THR . 78.9 mt -109.75 143.99 38.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.006 -0.997 . . . . 6.33 112.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -104.48 132.24 50.95 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.141 -1.429 . . . . 6.75 107.141 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -126.99 121.15 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 109.603 -0.517 . . . . 5.68 109.603 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.538 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.14 179.25 16.47 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.72 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.53 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.555 -0.831 . . . . 7.67 111.596 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 99.1 mt -70.86 135.3 85.53 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.817 -0.192 . . . . 8.16 111.496 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.3 Cg_exo -61.79 141.53 90.56 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 121.879 1.719 . . . . 8.96 108.843 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -65.42 -14.86 61.84 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -84.17 -23.14 30.71 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.781 1.401 . . . . 11.06 114.781 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.31 149.22 50.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.115 0.416 . . . . 9.36 111.332 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 275' ' ' VAL . 27.4 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.229 -0.286 . . . . 10.46 110.229 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 18.7 m-20 -53.55 -55.27 27.02 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 114.659 1.355 . . . . 9.92 114.659 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.67 -26.42 68.01 Favored 'General case' 0 C--N 1.405 3.009 0 C-N-CA 125.707 1.603 . . . . 0.0 112.461 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -80.02 -48.26 13.61 Favored 'General case' 1 C--N 1.431 4.119 0 CA-C-N 118.263 0.483 . . . . 10.06 111.455 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 271' ' ' ASN . 84.4 t -62.74 -49.21 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.8 -0.636 . . . . 7.76 110.273 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 45.1 mtmt -54.25 -36.4 63.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.7 -0.682 . . . . 9.67 111.336 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.06 -53.26 57.96 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.092 0.472 . . . . 10.2 110.772 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.401 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.72 -33.21 33.52 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.964 -0.562 . . . . 7.62 110.365 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.47 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.64 -41.66 19.17 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.549 0.574 . . . . 7.74 112.549 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 32.3 m -56.92 -29.82 63.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.586 0.958 . . . . 10.09 113.586 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.1 m -49.9 -10.33 0.05 OUTLIER 'General case' 0 C--N 1.394 2.507 0 C-N-CA 124.846 1.258 . . . . 0.0 112.776 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -111.59 -11.99 13.98 Favored 'General case' 1 C--N 1.443 4.669 0 CA-C-N 118.341 0.519 . . . . 10.23 111.467 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.3 10.24 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.9 -0.667 . . . . 10.4 111.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.65 147.12 93.27 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.716 2.277 . . . . 12.19 112.689 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 81.6 mt -102.49 146.29 28.32 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.932 -0.576 . . . . 10.66 111.217 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -101.07 -22.58 14.68 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.271 -0.64 . . . . 11.41 109.271 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.58 126.13 5.03 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.174 -2.204 . . . . 0.0 109.172 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.547 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 50.1 t80 -143.41 134.68 25.92 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.792 0.437 . . . . 8.77 112.028 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -144.78 124.12 13.04 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.797 0.332 . . . . 8.38 111.562 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 60.7 tp -101.08 118.24 36.59 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.568 -1.271 . . . . 8.94 107.568 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 41.6 t -74.14 122.93 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 113.44 0.904 . . . . 9.37 113.44 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -119.18 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.353 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.6 t70 -58.9 141.19 54.21 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.923 0.392 . . . . 13.83 110.98 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.674 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 14.4 m -49.75 -61.56 2.06 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.736 0.643 . . . . 14.58 112.736 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.21 -64.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.465 0.543 . . . . 16.19 112.465 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 9.0 m -42.59 -59.22 1.98 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.306 -0.406 . . . . 14.94 111.176 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.15 62.58 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.599 -0.81 . . . . 13.57 114.499 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 70.3 mt -88.24 167.67 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.401 0.601 . . . . 13.28 110.911 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 33.5 t -59.22 142.1 52.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 10.43 111.656 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.821 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.97 -9.43 53.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.877 -0.601 . . . . 11.2 109.563 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.5 -3.29 39.73 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.669 -0.696 . . . . 8.63 113.935 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.461 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 38.2 p90 -143.01 146.4 33.83 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.038 0.919 . . . . 9.19 112.827 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.13 46.73 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.037 -0.983 . . . . 6.21 112.206 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -111.35 146.77 36.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.192 -0.913 . . . . 7.09 110.415 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.547 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.6 p -157.78 156.29 31.3 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 119.969 -0.692 . . . . 6.77 111.868 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.796 ' HB2' ' HD3' ' A' ' 260' ' ' LYS . 78.4 tt0 -145.35 127.05 15.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.737 -0.665 . . . . 9.59 109.682 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 51.8 m-85 -82.42 164.87 20.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.953 0.406 . . . . 9.91 112.007 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.53 -46.1 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.43 -0.952 . . . . 12.81 108.43 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.76 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.4 t70 -96.28 102.29 14.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.436 -1.32 . . . . 13.18 107.436 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.0 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 115.299 1.592 . . . . 12.23 115.299 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -56.92 -38.69 73.23 Favored 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.184 0.992 . . . . 13.04 108.966 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.64 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 112.358 -2.201 . . . . 11.08 109.613 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 91.6 m -54.71 -48.13 72.86 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.908 -0.775 . . . . 9.11 108.908 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -62.43 -42.89 99.78 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.285 -0.566 . . . . 10.31 110.473 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -63.7 -32.43 73.91 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 119.93 -0.708 . . . . 11.98 111.98 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.56 -34.71 74.57 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.641 -1.618 . . . . 8.25 113.076 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 72.8 mt -68.61 -51.39 46.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.354 0.597 . . . . 7.4 110.819 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.61 -38.88 67.31 Favored 'General case' 0 C--N 1.42 3.668 0 C-N-CA 126.225 1.81 . . . . 0.0 113.13 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.02 -24.07 36.11 Favored Glycine 1 C--N 1.399 4.077 0 N-CA-C 116.762 1.465 . . . . 8.35 116.762 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.412 ' O ' HD23 ' A' ' 330' ' ' LEU . 84.3 mt -96.86 -45.76 6.51 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 120.176 1.988 . . . . 7.2 113.938 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -50.44 129.94 22.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.767 0.318 . . . . 7.86 111.526 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.69 56.7 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.108 -0.568 . . . . 8.64 113.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 26.3 ttt -50.65 147.18 4.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.84 0.32 . . . . 8.0 111.337 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.01 115.64 27.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.407 . . . . 10.39 111.723 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.24 106.63 12.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.116 -1.068 . . . . 8.95 108.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.2 -118.68 10.5 Favored Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -115.84 22.36 13.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 12.25 109.714 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -123.88 153.94 40.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.667 -0.697 . . . . 9.98 111.618 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -101.79 118.22 36.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.138 -1.06 . . . . 10.14 108.138 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.643 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.1 tp -63.0 143.15 58.03 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.545 0.688 . . . . 7.52 112.637 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.23 127.92 43.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.469 -1.242 . . . . 7.48 108.981 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.84 124.01 26.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 O-C-N 120.976 -1.078 . . . . 6.45 110.011 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -152.78 155.4 37.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.042 -1.661 . . . . 7.66 109.51 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.654 ' HD2' ' HA3' ' A' ' 338' ' ' GLY . 98.5 mtt180 -58.65 122.54 13.72 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 118.435 -1.306 . . . . 8.94 107.58 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.78 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.3 m -119.36 -78.77 0.59 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.575 -0.45 . . . . 9.07 111.212 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 17.9 m -140.71 146.42 24.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.819 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . 0.654 ' HA3' ' HD2' ' A' ' 334' ' ' ARG . . . 161.38 21.56 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.755 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -81.86 110.96 17.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -89.37 169.06 11.73 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.477 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.54 9.67 35.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.401 178.776 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.821 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.509 -1.876 0 O4'-C1'-N19 109.424 1.224 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 0.4 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.933 0 O4'-C1'-C2' 107.545 0.818 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.461 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.425 -0.933 0 C4'-C3'-C2' 103.496 0.796 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.758 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.498 5.385 0 C4'-C3'-C2' 98.948 -3.752 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.674 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.679 5.985 1 C4'-C3'-C2' 106.708 4.008 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.412 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 105.35 2.65 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 1.17 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.541 1.311 0 O4'-C1'-C2' 107.927 1.091 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.959 0 O4'-C1'-C2' 107.3 0.643 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.611 -0.988 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.758 ' HB3' HG21 ' A' ' 208' ' ' THR . 0.0 OUTLIER -144.11 -156.76 0.72 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 120.434 -0.506 . . . . 0.0 112.294 167.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -158.81 149.26 19.79 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 123.646 0.591 . . . . 5.88 111.577 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.81 143.64 34.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 5.25 111.231 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -96.57 125.17 40.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.905 -0.776 . . . . 6.58 108.905 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.82 101.23 8.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 5.06 110.21 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.85 -179.32 34.68 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.07 -0.586 . . . . 6.2 112.769 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.3 m120 49.95 41.6 23.21 Favored 'General case' 0 CA--C 1.574 1.899 0 C-N-CA 125.395 1.478 . . . . 0.0 110.292 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.43 149.87 89.01 Favored Pre-proline 1 C--N 1.43 4.07 0 C-N-CA 123.861 0.864 . . . . 7.79 111.355 176.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.15 144.44 90.35 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.317 2.011 . . . . 8.57 110.977 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.96 139.77 52.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.929 0.395 . . . . 11.37 111.992 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.17 6.59 61.25 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.876 -0.602 . . . . 9.94 114.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.449 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.2 136.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 117.338 0.569 . . . . 8.91 110.254 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.7 p -84.96 153.85 22.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 9.64 110.637 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.09 -43.18 95.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 7.44 110.185 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.74 -46.03 91.37 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.994 -0.548 . . . . 9.89 110.54 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.56 -26.4 68.56 Favored 'General case' 0 C--N 1.409 3.162 0 O-C-N 119.271 -2.143 . . . . 0.0 111.698 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.478 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.38 -34.08 67.68 Favored 'General case' 1 C--N 1.43 4.071 0 O-C-N 123.952 0.783 . . . . 6.64 111.811 171.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.55 -54.29 7.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.442 0.697 . . . . 6.69 111.078 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.66 -33.64 61.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.419 -0.81 . . . . 8.8 111.373 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.76 -53.6 17.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 120.634 -0.426 . . . . 7.44 111.603 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.25 -48.37 81.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.181 0.438 . . . . 5.94 112.181 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.6 m-20 -56.74 -42.85 80.0 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.193 -0.603 . . . . 7.12 109.606 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.4 65.07 Favored 'General case' 0 C--N 1.406 3.06 0 O-C-N 120.27 -1.519 . . . . 0.0 111.251 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.5 -37.66 36.21 Favored 'General case' 1 C--N 1.429 4.03 0 CA-C-N 118.576 0.625 . . . . 7.79 110.332 176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.553 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.82 83.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.61 -0.723 . . . . 7.73 111.022 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.01 -43.07 45.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.437 0.532 . . . . 9.61 112.437 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.02 -37.82 88.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.219 0.533 . . . . 10.06 110.397 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.96 -16.52 74.67 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.309 -0.948 . . . . 9.23 112.881 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.11 71.55 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.816 -0.914 . . . . 9.25 110.816 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -93.01 5.28 52.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.816 0.672 . . . . 8.31 112.816 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.5 p -82.59 143.44 31.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.565 0.221 . . . . 9.16 110.598 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.54 21.31 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 112.157 0.429 . . . . 10.23 112.157 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.47 23.82 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.688 -0.233 . . . . 9.89 110.689 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.33 143.49 99.71 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.928 1.752 . . . . 11.04 110.797 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.57 20.54 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 9.31 112.385 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.23 134.52 73.84 Favored Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 112.046 0.387 . . . . 7.97 112.046 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.29 -50.91 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.564 2.176 . . . . 6.59 111.358 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.79 105.43 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 116.183 -0.462 . . . . 5.87 111.096 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -31.4 29.19 Favored 'General case' 0 N--CA 1.529 3.482 0 O-C-N 119.988 -1.695 . . . . 0.0 113.404 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.21 163.37 39.66 Favored 'General case' 0 C--N 1.391 2.372 0 C-N-CA 126.244 1.818 . . . . 0.0 110.798 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.27 130.53 10.94 Favored 'Isoleucine or valine' 0 C--N 1.376 1.752 0 C-N-CA 126.556 1.943 . . . . 5.67 109.313 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.17 126.6 55.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.715 -0.476 . . . . 6.47 109.715 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.96 126.0 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 116.985 2.217 . . . . 7.1 116.985 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.01 91.37 5.27 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 103.163 -2.902 . . . . 8.1 103.163 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.34 -57.36 8.09 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.634 1.716 . . . . 10.19 115.634 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.23 -48.75 75.87 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.891 0.7 . . . . 10.51 112.891 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.14 50.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.895 0.331 . . . . 9.72 111.895 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.05 36.23 15.5 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.565 1.32 . . . . 8.04 114.565 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.61 168.59 19.52 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.063 -1.055 . . . . 6.83 111.633 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.598 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.52 161.17 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.413 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.46 129.4 51.2 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.556 -0.905 . . . . 5.71 108.556 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.9 mt -94.87 137.53 33.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.353 -0.385 . . . . 4.27 110.33 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -114.74 114.7 25.95 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.678 -0.49 . . . . 6.21 109.678 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -99.74 164.68 11.94 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.939 -0.573 . . . . 6.14 111.93 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -25.99 22.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 8.37 111.47 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.2 p -128.89 159.54 35.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.104 0.478 . . . . 7.92 111.688 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.27 -41.78 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 8.77 112.231 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.584 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.74 -41.68 95.75 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.385 0.513 . . . . 9.08 112.385 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -61.83 -43.84 98.04 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.292 -0.262 . . . . 7.46 110.292 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.2 m -54.17 -54.03 45.25 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.108 -1.071 . . . . 6.18 108.108 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 m -54.99 -27.14 41.85 Favored 'General case' 1 C--N 1.429 4.039 0 C-N-CA 127.072 2.149 . . . . 0.0 109.905 177.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.3 -34.1 42.69 Favored 'General case' 0 C--N 1.422 3.734 0 N-CA-C 113.586 0.958 . . . . 8.7 113.586 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.657 0.614 . . . . 5.94 112.657 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.1 -19.83 63.39 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.451 1.095 . . . . 6.89 111.602 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.26 52.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.406 -0.361 . . . . 7.4 111.617 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.89 16.28 14.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.528 -0.305 . . . . 6.97 111.584 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.97 14.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.869 0.366 . . . . 7.38 110.715 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.9 65.98 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.89 -0.671 . . . . 7.92 113.587 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.809 0.305 . . . . 7.5 111.121 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.91 121.54 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.271 0.558 . . . . 9.49 111.343 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -135.23 107.75 7.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.701 -0.682 . . . . 8.45 110.354 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.73 42.7 13.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.064 -0.517 . . . . 10.44 111.751 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.53 53.6 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 115.234 0.854 . . . . 10.21 115.234 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.52 130.86 55.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.58 0.69 . . . . 9.94 112.439 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.68 101.51 10.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.52 -0.918 . . . . 8.4 108.52 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.31 137.88 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.027 1.121 . . . . 6.9 114.027 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.764 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.5 tttt -108.61 110.32 21.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.548 -1.279 . . . . 8.29 107.548 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.05 126.92 58.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.129 0.49 . . . . 6.17 112.288 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.63 170.45 15.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.33 -0.85 . . . . 7.99 110.026 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.05 154.7 49.69 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.56 -0.904 . . . . 7.86 108.56 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.45 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.3 Cg_exo -57.4 175.19 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 121.89 1.726 . . . . 7.79 112.057 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -111.19 13.28 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.26 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.739 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 13.0 m-20 -64.43 116.19 5.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.264 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -76.37 135.12 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.711 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 57.74 82.72 0.23 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.111 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.5 97.48 0.96 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 112.042 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 99.2 mt 63.12 101.63 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.649 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.13 128.07 21.41 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.267 2.645 . . . . 0.0 113.049 -176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 150.24 38.02 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.053 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . 0.478 ' C ' ' H ' ' A' ' 240' ' ' GLU . 44.3 tpp -61.92 139.5 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 94.7 p 62.09 -9.61 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.918 1.287 . . . . 0.0 112.714 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 238' ' ' MET . 37.1 mt-10 -91.04 -40.38 11.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.838 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 90.5 m-20 -102.91 -57.55 0.1 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.739 175.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.838 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 12.6 Cg_exo -71.09 126.85 12.84 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.101 1.867 . . . . 0.0 111.53 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.5 p -79.28 90.35 4.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 0.0 111.025 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.28 3.08 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.814 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.2 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.9 m -100.47 132.91 21.75 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.845 0.355 . . . . 0.0 110.415 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.66 -63.48 0.09 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.593 2.195 . . . . 0.0 111.912 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -156.73 42.21 0.54 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 14.2 p -137.54 152.11 26.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.603 -0.298 . . . . 0.0 110.2 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 252' ' ' THR . 23.5 m -116.77 -172.55 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 175.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 74.3 m -75.47 8.55 2.75 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.534 ' H ' HG23 ' A' ' 250' ' ' VAL . 29.0 m -73.04 -38.44 66.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.459 HG12 HG23 ' A' ' 254' ' ' VAL . 61.3 t -95.72 121.71 46.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 253' ' ' VAL . 41.1 t 63.33 74.3 0.45 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.746 0.784 . . . . 0.0 109.545 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -90.51 -167.9 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.004 2.469 . . . . 0.0 112.198 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.75 102.24 14.64 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.9 t -75.72 103.68 5.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.191 0.519 . . . . 0.0 109.808 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -137.57 109.53 7.19 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.815 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -128.97 30.97 4.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.878 -0.601 . . . . 10.8 110.806 173.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 260' ' ' LYS . 16.3 ttmt -62.9 139.34 58.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 8.21 110.323 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 313' ' ' THR . 64.4 mt -109.8 143.94 38.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.02 -0.991 . . . . 6.33 112.806 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -104.47 132.12 51.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.19 -1.411 . . . . 6.75 107.19 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.04 121.16 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.661 -0.496 . . . . 5.68 109.661 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.25 16.48 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.537 -0.839 . . . . 6.53 112.659 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.2 86.51 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.643 -0.789 . . . . 7.67 111.554 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 95.2 mt -70.83 135.19 85.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 111.503 0.186 . . . . 8.16 111.503 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.8 Cg_exo -61.78 141.6 90.88 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.883 1.722 . . . . 8.96 108.843 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.37 -14.96 62.02 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.779 1.4 . . . . 11.61 114.779 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -84.08 -23.21 30.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.842 1.423 . . . . 11.06 114.842 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.29 149.19 50.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.159 0.436 . . . . 9.36 111.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 275' ' ' VAL . 30.4 p-10 -114.5 -176.43 2.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 110.29 -0.263 . . . . 10.46 110.29 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.61 -55.2 27.85 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.618 1.34 . . . . 9.92 114.618 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.79 -26.34 68.04 Favored 'General case' 0 C--N 1.406 3.033 0 C-N-CA 125.669 1.588 . . . . 0.0 112.408 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -80.04 -48.3 13.52 Favored 'General case' 1 C--N 1.43 4.072 0 CA-C-N 118.301 0.5 . . . . 10.06 111.412 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 271' ' ' ASN . 67.6 t -62.63 -49.27 84.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.782 -0.644 . . . . 7.76 110.28 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -54.22 -36.46 63.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.683 -0.69 . . . . 9.67 111.348 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.0 -53.36 56.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.133 0.492 . . . . 10.2 110.709 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 278' ' ' LEU . 1.5 tm? -51.78 -33.14 33.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.081 -0.509 . . . . 7.62 110.364 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.1 mt -82.66 -41.67 19.11 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.602 0.593 . . . . 7.74 112.602 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.7 m -56.73 -29.9 62.97 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.567 0.951 . . . . 10.09 113.567 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 15.9 m -50.21 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.555 0 C-N-CA 124.796 1.238 . . . . 0.0 112.587 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -111.46 -12.06 14.03 Favored 'General case' 1 C--N 1.442 4.596 0 CA-C-N 118.379 0.536 . . . . 10.23 111.452 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.12 162.36 10.28 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.786 -0.643 . . . . 10.4 111.913 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.66 147.12 93.3 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.731 2.287 . . . . 12.19 112.712 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 84.1 mt -102.52 146.25 28.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.918 -0.583 . . . . 10.66 111.215 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.568 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.7 ptpt -100.99 -22.65 14.71 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.266 -0.642 . . . . 11.41 109.266 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.64 126.15 5.01 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 119.07 -2.269 . . . . 0.0 109.15 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 62.9 t80 -143.3 134.7 26.12 Favored 'General case' 0 C--N 1.362 1.142 0 C-N-CA 122.886 0.474 . . . . 8.77 112.009 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 304' ' ' PHE . 4.2 p-10 -144.78 124.04 12.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.73 0.3 . . . . 8.38 111.557 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 54.2 tp -101.01 118.3 36.73 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.552 -1.277 . . . . 8.94 107.552 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 30.5 t -74.17 122.86 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 113.511 0.93 . . . . 9.37 113.511 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -119.09 148.13 43.39 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 115.332 -0.849 . . . . 11.34 109.336 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.607 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 37.2 t70 -58.94 141.1 54.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.925 0.393 . . . . 13.83 110.95 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.67 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 5.6 m -49.71 -61.66 1.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.625 0.602 . . . . 14.58 112.625 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.18 -63.95 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.493 0.553 . . . . 16.19 112.493 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.4 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.414 . . . . 14.94 111.179 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.59 -6.07 62.69 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.607 -0.806 . . . . 13.57 114.557 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 67.3 mt -88.33 167.64 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.34 0.57 . . . . 13.28 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.1 t -59.17 141.96 52.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 10.43 111.617 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.596 ' HE2' ' O2 ' ' B' ' 601' ' ' ' U' . 4.4 mmmp? -87.95 -9.42 53.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.858 -0.61 . . . . 11.2 109.574 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.37 39.53 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.727 . . . . 8.63 113.875 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.55 ' CE1' ' OP1' ' B' ' 603' ' ' ' U' . 55.3 p90 -142.92 146.43 33.99 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.051 0.925 . . . . 9.19 112.846 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.13 46.72 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.004 -0.998 . . . . 6.21 112.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 289' ' ' ASN . 97.5 m-85 -111.44 146.83 36.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.168 -0.924 . . . . 7.09 110.449 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.6 p -157.72 156.24 31.32 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.003 -0.679 . . . . 6.77 111.869 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -145.4 127.08 15.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.723 -0.671 . . . . 9.59 109.649 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.568 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 53.2 m-85 -82.37 164.92 20.73 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.095 0.406 . . . . 9.91 112.095 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.62 -46.08 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.343 -0.984 . . . . 12.81 108.343 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 312' ' ' VAL . 12.1 t70 -96.32 102.28 14.04 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 107.381 -1.34 . . . . 13.18 107.381 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.519 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.68 -35.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 115.337 1.606 . . . . 12.23 115.337 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -56.78 -38.73 72.89 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.259 1.028 . . . . 13.04 109.097 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.69 -22.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.306 -2.225 . . . . 11.08 109.529 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 94.5 m -54.64 -48.13 72.65 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 108.929 -0.767 . . . . 9.11 108.929 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -62.46 -42.89 99.8 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.308 -0.557 . . . . 10.31 110.467 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -63.8 -32.44 73.94 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 119.923 -0.711 . . . . 11.98 111.941 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.66 74.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.586 -1.643 . . . . 8.25 113.103 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.61 -51.31 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.362 0.601 . . . . 7.4 110.876 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.88 -38.66 67.82 Favored 'General case' 0 C--N 1.419 3.596 0 C-N-CA 126.281 1.832 . . . . 0.0 113.151 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.11 -24.08 35.81 Favored Glycine 1 C--N 1.399 4.033 0 N-CA-C 116.778 1.471 . . . . 8.35 116.778 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 99.1 mt -96.81 -45.81 6.5 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 120.107 1.954 . . . . 7.2 113.946 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -50.47 130.04 23.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 7.86 111.463 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.66 56.76 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.111 -0.566 . . . . 8.64 113.948 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.7 mtt -50.65 147.21 4.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.783 0.325 . . . . 8.0 111.264 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -95.14 115.69 27.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.076 0.465 . . . . 10.39 111.715 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.602 HD23 ' HB2' ' A' ' 330' ' ' LEU . 4.0 mm? -120.26 106.83 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.082 -1.081 . . . . 8.95 108.082 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.1 -118.74 10.65 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.397 -1.481 . . . . 10.63 109.397 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -115.78 22.36 13.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 12.25 109.781 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.8 153.91 40.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.616 -0.72 . . . . 9.98 111.624 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.73 118.25 36.54 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.117 -1.068 . . . . 10.14 108.117 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.602 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.09 143.09 58.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.57 0.7 . . . . 7.52 112.586 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 1.004 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 20.8 mt -128.12 128.0 44.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.504 -1.225 . . . . 7.48 108.997 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.92 124.04 26.28 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 O-C-N 120.984 -1.073 . . . . 6.45 109.983 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -152.76 155.33 36.98 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 119.987 -1.696 . . . . 7.66 109.547 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.488 ' HA ' HD23 ' A' ' 261' ' ' LEU . 95.0 mtt180 -58.55 122.43 13.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 118.395 -1.322 . . . . 8.94 107.626 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.94 -11.77 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.786 1.402 . . . . 7.52 114.786 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.6 m -119.36 -77.84 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.55 -0.46 . . . . 9.07 111.422 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.42 93.91 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.477 0.656 . . . . 0.0 110.581 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 167.84 136.59 2.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.012 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -166.01 -173.54 2.67 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.99 105.46 17.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.414 0.626 . . . . 0.0 110.181 174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -97.53 -35.47 10.62 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.079 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.677 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.596 ' O2 ' ' HE2' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.101 0 C3'-C2'-C1' 100.208 -1.435 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 1.004 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C1'-C2' 107.578 0.842 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.582 H5'' ' H6 ' ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.151 0 O4'-C1'-C2' 107.723 0.945 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.764 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.498 5.385 0 C4'-C3'-C2' 99.31 -3.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.67 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.677 5.823 0 C4'-C3'-C2' 106.672 3.972 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.45 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O5'--C5' 1.423 -1.08 0 C4'-C3'-C2' 105.18 2.48 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 0.739 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 C2'--C1' 1.54 1.186 0 O4'-C4'-C3' 103.912 -1.134 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . 0.409 H5'' " H2'" ' B' ' 607' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 O4'-C1'-C2' 107.604 0.86 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-C1' 100.785 -0.794 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.924 ' HB3' HG13 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.093 0.473 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 149' ' ' ARG . 74.5 ttt180 -179.66 16.54 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.018 -173.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.34 148.4 21.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.762 -1.108 . . . . 5.88 111.36 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.6 mt -140.74 143.47 34.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 5.25 111.205 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.55 125.14 40.82 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.901 -0.777 . . . . 6.58 108.901 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.77 101.29 8.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.098 0.475 . . . . 5.06 110.147 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.81 -179.32 34.73 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.964 -0.562 . . . . 6.2 112.795 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 30.4 m120 50.28 41.31 24.14 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 125.258 1.423 . . . . 0.0 110.194 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.46 149.83 88.94 Favored Pre-proline 1 C--N 1.429 4.048 0 C-N-CA 123.832 0.853 . . . . 7.79 111.316 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.07 144.41 90.05 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.308 2.005 . . . . 8.57 111.013 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.94 139.67 52.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.93 0.395 . . . . 11.37 111.964 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.33 6.42 61.52 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.838 -0.619 . . . . 9.94 114.319 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.446 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.11 136.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.31 0.555 . . . . 8.91 110.276 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.6 p -84.86 153.91 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.72 0.295 . . . . 9.64 110.691 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.1 -43.19 95.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.399 . . . . 7.44 110.204 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.78 -45.92 91.79 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.901 -0.59 . . . . 9.89 110.499 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.76 -26.38 68.68 Favored 'General case' 0 C--N 1.408 3.142 0 O-C-N 119.262 -2.149 . . . . 0.0 111.689 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.29 -34.1 67.92 Favored 'General case' 0 C--N 1.428 3.98 0 O-C-N 123.978 0.799 . . . . 6.64 111.79 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.1 ttt -74.54 -54.22 7.92 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.412 0.685 . . . . 6.69 111.132 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.73 -33.61 61.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 8.8 111.353 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.83 -53.55 17.64 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 120.531 -0.468 . . . . 7.44 111.61 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.31 -48.28 82.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.13 0.419 . . . . 5.94 112.13 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.76 -42.85 80.08 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 120.277 -0.569 . . . . 7.12 109.559 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.28 64.83 Favored 'General case' 0 C--N 1.405 3.001 0 O-C-N 120.199 -1.563 . . . . 0.0 111.234 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.72 36.7 Favored 'General case' 0 C--N 1.427 3.956 0 CA-C-N 118.528 0.604 . . . . 7.79 110.354 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.75 83.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.577 -0.738 . . . . 7.73 111.059 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -76.1 -42.94 45.57 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.413 0.523 . . . . 9.61 112.413 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.09 -37.76 88.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.259 0.552 . . . . 10.06 110.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.04 -16.52 74.48 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.322 -0.942 . . . . 9.23 112.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.19 37.14 71.88 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.843 -0.903 . . . . 9.25 110.843 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.35 51.7 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.918 0.71 . . . . 8.31 112.918 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.8 p -82.58 143.49 30.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.546 0.213 . . . . 9.16 110.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.582 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.47 21.34 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.18 0.437 . . . . 10.23 112.18 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.49 23.74 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.709 -0.223 . . . . 9.89 110.693 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.4 143.61 99.66 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.926 1.751 . . . . 11.04 110.825 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.22 161.63 20.69 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.639 -0.791 . . . . 9.31 112.441 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.3 134.5 73.62 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 112.089 0.403 . . . . 7.97 112.089 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.26 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.492 2.128 . . . . 6.59 111.315 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.65 105.59 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.135 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -35.05 33.28 Favored 'General case' 0 N--CA 1.53 3.525 0 O-C-N 120.279 -1.513 . . . . 0.0 113.277 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.84 163.95 39.18 Favored 'General case' 0 C--N 1.386 2.167 0 C-N-CA 126.05 1.74 . . . . 0.0 110.591 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.19 130.45 11.04 Favored 'Isoleucine or valine' 0 C--N 1.372 1.549 0 C-N-CA 126.534 1.934 . . . . 5.67 109.297 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.06 126.7 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.798 -0.445 . . . . 6.47 109.798 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.597 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -115.06 125.98 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 116.904 2.187 . . . . 7.1 116.904 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -98.05 91.38 5.27 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 103.193 -2.891 . . . . 8.1 103.193 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.31 -57.4 7.97 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.612 1.708 . . . . 10.19 115.612 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.76 75.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.839 0.681 . . . . 10.51 112.839 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.04 -9.11 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.834 0.309 . . . . 9.72 111.834 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.15 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.495 1.294 . . . . 8.04 114.495 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.64 168.56 19.61 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.184 -1.007 . . . . 6.83 111.663 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.597 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.51 161.17 41.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.27 -1.332 . . . . 5.19 110.446 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.27 51.05 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.726 -0.842 . . . . 5.71 108.726 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.0 mt -94.82 137.58 33.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.451 -0.34 . . . . 4.27 110.337 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.73 25.98 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.702 -0.481 . . . . 6.21 109.702 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.7 164.78 11.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.928 -0.578 . . . . 6.14 111.953 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.67 -25.87 22.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.475 -0.784 . . . . 8.37 111.484 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.5 p -129.0 159.6 35.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.17 0.509 . . . . 7.92 111.579 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.924 HG13 ' HB3' ' A' ' 148' ' ' ALA . 40.9 t -74.34 -41.73 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.523 -0.762 . . . . 8.77 112.201 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.582 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.4 t70 -64.78 -41.72 95.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.32 0.489 . . . . 9.08 112.32 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -61.91 -43.85 97.99 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 110.192 -0.299 . . . . 7.46 110.192 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.15 -53.28 55.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.332 1.063 . . . . 6.18 108.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.619 HG22 HH22 ' A' ' 228' ' ' ARG . 3.7 p -56.19 -26.15 49.64 Favored 'General case' 1 C--N 1.449 4.894 0 C-N-CA 126.15 1.78 . . . . 0.0 110.195 178.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.51 -34.05 41.57 Favored 'General case' 0 C--N 1.428 3.995 0 N-CA-C 113.602 0.964 . . . . 8.7 113.602 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.53 -17.36 64.14 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.72 0.637 . . . . 5.94 112.72 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.02 -19.93 63.38 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.532 1.145 . . . . 6.89 111.597 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.42 -9.27 52.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 7.4 111.683 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.18 14.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.713 0.292 . . . . 6.97 111.704 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.86 120.99 14.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.886 0.374 . . . . 7.38 110.803 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.86 -4.85 66.06 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.906 -0.664 . . . . 7.92 113.584 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.858 0.329 . . . . 7.5 111.086 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.95 121.55 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.271 0.558 . . . . 9.49 111.286 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.64 7.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.698 -0.683 . . . . 8.45 110.347 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.73 42.71 13.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.043 -0.526 . . . . 10.44 111.759 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.1 -5.5 54.08 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.186 0.834 . . . . 10.21 115.186 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.62 130.84 55.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.654 0.727 . . . . 9.94 112.405 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.72 101.49 10.91 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 108.535 -0.913 . . . . 8.4 108.535 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.28 137.78 58.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.088 1.144 . . . . 6.9 114.088 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.727 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.51 110.26 21.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.588 -1.264 . . . . 8.29 107.588 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.92 126.95 58.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.154 0.502 . . . . 6.17 112.334 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.62 170.52 15.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.401 -0.818 . . . . 7.99 110.047 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 209' ' ' THR . 3.5 mtp180 -89.09 154.67 49.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.559 -0.904 . . . . 7.86 108.559 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.38 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.97 1.78 . . . . 7.79 111.987 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -83.87 -30.39 26.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.286 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.9 p-10 -96.97 21.99 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.973 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -70.02 -22.53 63.09 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -111.43 100.7 48.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.917 0.389 . . . . 0.0 110.584 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.09 19.8 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.908 2.405 . . . . 0.0 111.323 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 34.0 tp 58.75 75.41 0.52 Allowed Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.678 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.69 46.6 2.2 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.417 2.745 . . . . 0.0 112.351 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 71.17 57.11 6.4 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.692 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 26.2 ttt -101.81 -26.64 13.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 25.4 p -104.23 139.62 38.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.548 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 241' ' ' ASN . 34.3 tt0 -137.45 179.74 6.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.831 ' HB2' ' HD3' ' A' ' 242' ' ' PRO . 18.5 m120 -63.13 -54.56 44.69 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 121.352 -0.139 . . . . 0.0 110.938 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.831 ' HD3' ' HB2' ' A' ' 241' ' ' ASN . 8.5 Cg_endo -91.41 -175.25 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.673 2.249 . . . . 0.0 111.613 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 246' ' ' VAL . 45.8 m 62.09 27.17 16.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.204 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 23.1 m -76.73 -14.55 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.404 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -125.34 -48.43 1.7 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.098 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 243' ' ' SER . 5.5 m -126.24 133.25 24.77 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.51 31.29 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.985 2.456 . . . . 0.0 113.158 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 141.59 -157.77 26.34 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 58.6 t -75.68 -41.99 40.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.66 178.89 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.817 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.8 m -145.65 90.42 2.0 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.072 0.463 . . . . 0.0 110.351 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 19.2 m -77.98 -42.19 33.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.651 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.03 86.85 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.348 0.594 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.36 136.46 22.38 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.617 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -75.59 119.92 5.67 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.611 2.208 . . . . 0.0 113.076 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.97 150.75 20.84 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 p -63.72 145.04 56.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -69.98 169.91 12.36 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -92.79 31.12 1.43 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.042 -0.663 . . . . 10.8 110.74 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -63.01 139.41 58.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.185 0.517 . . . . 8.21 110.278 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 334' ' ' ARG . 47.9 mt -109.73 143.86 38.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.032 -0.986 . . . . 6.33 112.862 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -104.49 132.14 51.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.9 mp -127.0 121.21 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 109.54 -0.541 . . . . 5.68 109.54 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.19 179.21 16.5 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.515 -0.85 . . . . 6.53 112.722 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.19 86.6 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.656 -0.783 . . . . 7.67 111.511 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.5 mt -70.86 135.25 85.54 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.892 -0.154 . . . . 8.16 111.409 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 35.4 Cg_exo -61.82 141.55 90.52 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.952 1.768 . . . . 8.96 108.737 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -65.39 -14.94 62.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.703 1.371 . . . . 11.61 114.703 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -84.07 -23.27 30.9 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.811 1.412 . . . . 11.06 114.811 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.0 mp -66.23 149.17 50.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.125 0.421 . . . . 9.36 111.366 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.5 p-10 -114.51 -176.46 2.91 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.293 -0.262 . . . . 10.46 110.293 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.519 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 1.5 m-20 -53.55 -55.4 25.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 114.632 1.345 . . . . 9.92 114.632 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -26.46 67.89 Favored 'General case' 0 C--N 1.406 3.042 0 C-N-CA 125.639 1.576 . . . . 0.0 112.531 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -79.95 -48.34 13.55 Favored 'General case' 0 C--N 1.428 3.979 0 CA-C-N 118.307 0.503 . . . . 10.06 111.447 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 79.5 t -62.67 -49.14 84.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 7.76 110.286 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 33.0 mtmm -54.28 -36.48 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.697 -0.683 . . . . 9.67 111.332 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.99 -53.38 56.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 10.2 110.716 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.77 -33.09 33.65 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.08 -0.509 . . . . 7.62 110.393 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.469 HD13 ' SG ' ' A' ' 305' ' ' CYS . 78.5 mt -82.62 -41.72 19.12 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.588 0.588 . . . . 7.74 112.588 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 83.0 m -56.82 -29.9 63.22 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.523 0.935 . . . . 10.09 113.523 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 19.8 m -50.26 -10.23 0.05 Allowed 'General case' 0 C--N 1.395 2.549 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 316' ' ' ALA . 33.8 m-85 -111.33 -11.95 14.1 Favored 'General case' 1 C--N 1.444 4.688 0 CA-C-N 118.372 0.533 . . . . 10.23 111.426 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.29 10.24 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.835 -0.621 . . . . 10.4 111.94 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.72 147.11 93.48 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.743 2.295 . . . . 12.19 112.627 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 82.5 mt -102.43 146.24 28.36 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.869 -0.605 . . . . 10.66 111.23 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.06 -22.48 14.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.308 -0.627 . . . . 11.41 109.308 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.33 127.66 5.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 119.294 -2.129 . . . . 0.0 109.099 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.568 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 56.0 t80 -144.56 134.65 24.07 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 122.852 0.461 . . . . 8.77 112.008 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -144.73 124.14 13.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.764 0.316 . . . . 8.38 111.513 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -101.02 118.2 36.53 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.524 -1.287 . . . . 8.94 107.524 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 42.7 t -74.22 122.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 113.465 0.913 . . . . 9.37 113.465 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -119.19 148.06 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.293 -0.867 . . . . 11.34 109.436 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.2 t70 -58.89 141.15 54.27 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.966 0.412 . . . . 13.83 111.039 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.614 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 15.5 m -49.68 -61.7 1.97 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.844 -0.616 . . . . 14.58 112.633 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.06 -64.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.476 0.547 . . . . 16.19 112.476 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.49 -59.33 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 14.94 111.18 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.07 62.55 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.567 -0.825 . . . . 13.57 114.554 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.29 167.64 13.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.394 0.597 . . . . 13.28 110.886 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.5 t -59.24 142.03 52.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 10.43 111.635 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.857 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.8 mmmp? -87.91 -9.46 53.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.865 -0.607 . . . . 11.2 109.573 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.42 39.69 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.644 -0.707 . . . . 8.63 113.895 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -142.9 146.43 34.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.126 0.963 . . . . 9.19 112.903 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.53 155.1 46.73 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.106 -0.952 . . . . 6.21 112.23 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -111.39 146.93 36.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.221 -0.899 . . . . 7.09 110.348 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.568 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.6 p -157.91 156.21 30.93 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.924 -0.711 . . . . 6.77 111.919 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -145.31 127.1 15.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.68 -0.691 . . . . 9.59 109.61 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.51 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 63.9 m-85 -82.55 164.87 20.57 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.977 0.417 . . . . 9.91 112.041 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.5 -46.13 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.384 -0.969 . . . . 12.81 108.384 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.705 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.28 102.35 14.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.355 -1.35 . . . . 13.18 107.355 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.67 -35.05 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 N-CA-C 115.303 1.594 . . . . 12.23 115.303 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -56.84 -38.71 73.05 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.264 1.03 . . . . 13.04 109.009 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.78 -22.63 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 112.265 -2.243 . . . . 11.08 109.549 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 98.5 m -54.62 -48.22 72.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.931 -0.766 . . . . 9.11 108.931 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.45 -42.81 99.73 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.184 -0.607 . . . . 10.31 110.52 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.8 -32.47 73.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 119.943 -0.703 . . . . 11.98 111.909 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . . . -69.43 -34.79 74.96 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.626 -1.624 . . . . 8.25 113.124 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 74.7 mt -68.54 -51.3 47.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-O 121.403 0.621 . . . . 7.4 110.861 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.1 -38.63 68.38 Favored 'General case' 0 C--N 1.419 3.603 0 C-N-CA 126.141 1.776 . . . . 0.0 113.172 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.99 -23.92 36.68 Favored Glycine 1 C--N 1.398 4.008 0 N-CA-C 116.845 1.498 . . . . 8.35 116.845 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 330' ' ' LEU . 80.2 mt -96.9 -45.71 6.51 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 120.122 1.961 . . . . 7.2 113.957 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -50.54 130.07 23.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.352 . . . . 7.86 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.16 -16.65 56.76 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.091 -0.576 . . . . 8.64 113.955 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 28.2 ttt -50.67 147.19 4.92 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.755 0.312 . . . . 8.0 111.298 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -95.05 115.61 27.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.981 0.419 . . . . 10.39 111.635 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.5 mm? -120.25 106.77 12.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.118 -1.068 . . . . 8.95 108.118 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.08 -118.67 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.382 -1.487 . . . . 10.63 109.382 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -115.84 22.49 13.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.129 0.49 . . . . 12.25 109.749 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -123.9 153.83 40.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.673 -0.694 . . . . 9.98 111.612 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -101.79 118.3 36.64 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.071 -1.085 . . . . 10.14 108.071 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.711 ' HB2' HD23 ' A' ' 325' ' ' LEU . 23.8 tp -63.03 143.13 58.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.502 0.668 . . . . 7.52 112.642 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 1.451 ' CD1' ' H3 ' ' B' ' 602' ' ' ' U' . 3.7 mp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.574 -1.193 . . . . 7.48 108.977 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.8 t -137.96 123.98 26.0 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 O-C-N 120.939 -1.101 . . . . 6.45 109.997 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 339' ' ' ALA . 16.0 pt20 -152.68 155.35 37.1 Favored 'General case' 0 N--CA 1.433 -1.278 0 O-C-N 119.965 -1.709 . . . . 7.66 109.502 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.541 ' HA ' HD23 ' A' ' 261' ' ' LEU . 82.1 mtt180 -58.63 122.53 13.69 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 118.403 -1.319 . . . . 8.94 107.533 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -51.01 -11.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.734 1.383 . . . . 7.52 114.734 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 5.0 m -119.4 -78.29 0.59 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.623 -0.431 . . . . 9.07 111.262 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 30.0 m -126.75 141.83 45.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.604 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 152.05 -71.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 333' ' ' GLN . . . -102.05 112.84 25.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.078 0.466 . . . . 0.0 110.19 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -167.52 -56.18 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.965 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -93.32 -41.55 9.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.901 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 339' ' ' ALA . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.341 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.857 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.506 -2.176 0 O4'-C1'-N19 109.398 1.198 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 1.451 ' H3 ' ' CD1' ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 O4'-C1'-C2' 107.522 0.801 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.451 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.104 0 C4'-C3'-C2' 103.642 0.942 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.727 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 O3'--C3' 1.516 6.607 1 C4'-C3'-C2' 98.382 -4.318 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.614 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.696 7.456 0 C4'-C3'-C2' 106.662 3.962 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.975 0 C4'-C3'-C2' 105.54 2.84 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 0.61 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 O4'-C1'-C2' 107.589 0.849 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.964 0 C3'-C2'-C1' 100.84 -0.734 . 0.028 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-C1' 100.763 -0.819 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' HG13 ' A' ' 205' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.634 0.254 . . . . 0.0 111.483 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -87.29 50.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.665 0.269 . . . . 0.0 110.53 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -156.22 148.61 23.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 5.88 111.203 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.3 mt -140.8 143.56 34.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 5.25 111.185 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.59 125.16 40.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.851 -0.796 . . . . 6.58 108.851 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.79 101.21 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.088 0.47 . . . . 5.06 110.201 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -178.96 34.97 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.998 -0.547 . . . . 6.2 112.76 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 50.53 40.71 24.09 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.122 1.369 . . . . 0.0 110.224 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.62 149.88 88.59 Favored Pre-proline 1 C--N 1.428 4.01 0 C-N-CA 123.595 0.758 . . . . 7.79 111.302 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.07 144.47 89.87 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.297 1.998 . . . . 8.57 110.967 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -70.0 139.71 52.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.987 0.422 . . . . 11.37 111.94 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.19 6.56 61.27 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.792 -0.64 . . . . 9.94 114.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 11.0 tp -66.17 136.47 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 117.331 0.566 . . . . 8.91 110.283 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.3 p -84.9 153.99 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.517 -0.31 . . . . 9.64 110.652 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -60.19 -43.21 96.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.341 -0.39 . . . . 7.44 110.146 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.72 -45.96 91.73 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.575 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.62 -26.35 68.57 Favored 'General case' 0 C--N 1.41 3.199 0 O-C-N 119.296 -2.127 . . . . 0.0 111.664 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.473 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.41 -34.17 67.66 Favored 'General case' 0 C--N 1.428 3.982 0 O-C-N 123.985 0.803 . . . . 6.64 111.708 171.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.6 -54.24 7.84 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 123.47 0.708 . . . . 6.69 111.102 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -54.54 -33.77 60.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.426 -0.806 . . . . 8.8 111.391 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.75 -53.6 17.65 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 120.604 -0.438 . . . . 7.44 111.572 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.473 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.39 -48.22 82.23 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 5.94 112.139 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.79 -42.93 80.35 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.342 -0.543 . . . . 7.12 109.591 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.2 -22.98 64.78 Favored 'General case' 0 C--N 1.406 3.038 0 O-C-N 120.181 -1.574 . . . . 0.0 111.302 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -79.63 -37.55 35.8 Favored 'General case' 0 C--N 1.427 3.961 0 CA-C-N 118.56 0.618 . . . . 7.79 110.309 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.548 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.81 -36.67 82.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.614 -0.721 . . . . 7.73 111.022 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -76.12 -43.03 45.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.375 0.509 . . . . 9.61 112.375 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.99 -37.69 88.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.186 0.517 . . . . 10.06 110.471 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.09 -16.44 74.58 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.196 -1.002 . . . . 9.23 112.871 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.1 37.09 72.65 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.908 -0.877 . . . . 9.25 110.908 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.8 5.22 51.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.945 0.72 . . . . 8.31 112.945 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.3 p -82.65 143.46 30.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.591 0.234 . . . . 9.16 110.524 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.581 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.69 -18.41 21.33 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.047 0.388 . . . . 10.23 112.047 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.44 23.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.704 -0.225 . . . . 9.89 110.674 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.31 143.46 99.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.033 1.822 . . . . 11.04 110.748 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.4 161.67 20.53 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.611 -0.804 . . . . 9.31 112.355 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.36 134.42 73.51 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 112.003 0.372 . . . . 7.97 112.003 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.24 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.499 2.133 . . . . 6.59 111.325 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.6 105.94 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.119 -0.491 . . . . 5.87 111.174 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -33.78 29.67 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 120.212 -1.555 . . . . 0.0 113.418 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.17 40.58 Favored 'General case' 0 C--N 1.386 2.169 0 C-N-CA 126.054 1.742 . . . . 0.0 110.647 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.73 130.43 12.12 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 126.309 1.844 . . . . 5.67 109.298 175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.04 126.65 55.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.823 -0.436 . . . . 6.47 109.823 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.604 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.93 125.98 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 116.875 2.176 . . . . 7.1 116.875 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.11 91.32 5.22 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 103.186 -2.894 . . . . 8.1 103.186 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.22 -57.43 7.82 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.619 1.711 . . . . 10.19 115.619 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.18 -48.73 75.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.884 0.698 . . . . 10.51 112.884 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -69.01 -9.13 50.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.74 0.305 . . . . 9.72 111.764 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.21 36.14 15.07 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 114.516 1.302 . . . . 8.04 114.516 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.418 ' CD2' ' OP1' ' B' ' 606' ' ' ' U' . 13.2 p90 -143.58 168.64 19.41 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.11 -1.036 . . . . 6.83 111.632 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.604 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.58 161.05 41.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.149 -1.387 . . . . 5.19 110.459 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.35 51.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.691 -0.855 . . . . 5.71 108.691 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.87 137.6 33.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.425 -0.352 . . . . 4.27 110.297 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.8 114.74 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.698 -0.482 . . . . 6.21 109.698 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.69 164.78 11.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.965 -0.561 . . . . 6.14 111.935 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.68 -25.93 22.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.822 . . . . 8.37 111.462 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 89.4 p -128.85 159.6 35.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 7.92 111.687 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.458 HG13 ' HB1' ' A' ' 148' ' ' ALA . 40.6 t -74.29 -41.77 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 8.77 112.247 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.581 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.7 -41.77 95.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.343 0.497 . . . . 9.08 112.343 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.236 -0.283 . . . . 7.46 110.236 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.553 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.8 m -54.24 -53.9 47.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.317 1.056 . . . . 6.18 108.15 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.4 m -55.03 -27.22 42.85 Favored 'General case' 1 C--N 1.429 4.041 0 C-N-CA 127.082 2.153 . . . . 0.0 109.859 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.27 -34.21 42.78 Favored 'General case' 0 C--N 1.42 3.662 0 N-CA-C 113.578 0.955 . . . . 8.7 113.578 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.44 -17.45 64.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.621 0.6 . . . . 5.94 112.621 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.82 63.35 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.449 1.093 . . . . 6.89 111.617 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.2 52.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 7.4 111.62 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.91 16.2 14.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.529 -0.305 . . . . 6.97 111.591 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.93 120.95 14.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.869 0.366 . . . . 7.38 110.767 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.81 -4.76 66.14 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.907 -0.663 . . . . 7.92 113.619 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.14 142.37 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.877 0.338 . . . . 7.5 111.08 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.278 0.561 . . . . 9.49 111.31 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.31 107.81 7.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 8.45 110.3 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.62 42.74 13.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.034 -0.53 . . . . 10.44 111.823 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.0 -5.47 53.71 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.225 0.85 . . . . 10.21 115.225 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.58 130.96 55.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.686 0.743 . . . . 9.94 112.405 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.56 10.96 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.507 -0.923 . . . . 8.4 108.507 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.35 137.84 58.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.974 1.102 . . . . 6.9 113.974 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.605 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.54 110.31 21.76 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.513 -1.291 . . . . 8.29 107.513 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.99 126.88 58.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.35 0.5 . . . . 6.17 112.35 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.43 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.6 170.44 15.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.474 -0.785 . . . . 7.99 110.067 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.06 154.68 49.66 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 108.599 -0.889 . . . . 7.86 108.599 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.31 174.9 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 121.795 1.663 . . . . 7.79 112.057 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -104.29 -80.37 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 1.175 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 3.7 m-20 46.28 -98.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.903 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.13 -72.55 0.42 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -160.45 129.1 3.01 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.922 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.53 -45.31 41.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.841 2.361 . . . . 0.0 112.099 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 67.0 tp -114.3 99.53 51.17 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.409 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.69 117.14 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.605 2.203 . . . . 0.0 112.441 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -93.56 -43.19 4.01 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -148.35 165.5 30.88 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 70.4 m -120.41 -58.5 1.84 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.5 0.19 . . . . 0.0 110.922 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -18.48 1.67 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.901 0.381 . . . . 0.0 110.994 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -105.04 147.69 34.91 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.49 -49.97 14.26 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.926 2.417 . . . . 0.0 112.505 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.6 m 69.71 161.42 0.21 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.909 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.6 t 67.37 99.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.804 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -96.33 -47.74 5.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.117 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 18.4 m -91.34 140.2 25.54 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.243 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 36.5 Cg_exo -57.44 -50.57 10.51 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.057 2.504 . . . . 0.0 112.884 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 68.53 38.26 86.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.686 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 8.1 p -96.74 -14.99 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.476 0.655 . . . . 0.0 110.108 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.46 165.28 2.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.233 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 27.5 p 50.66 85.1 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.453 0.701 . . . . 0.0 111.487 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 48.1 m -64.8 100.53 0.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.211 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.02 -51.76 5.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.727 176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 47.4 t 63.6 89.22 0.11 Allowed Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.311 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.08 -45.53 15.72 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.787 2.325 . . . . 0.0 112.022 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.52 88.49 7.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.137 0.494 . . . . 0.0 110.102 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.2 t -141.97 150.01 40.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.419 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.641 ' O ' ' HB2' ' A' ' 259' ' ' HIS . . . -146.62 -69.93 0.25 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.275 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.641 ' HB2' ' O ' ' A' ' 258' ' ' ALA . 59.4 m80 89.65 30.43 0.02 OUTLIER 'General case' 0 C--N 1.344 0.326 0 O-C-N 124.456 1.097 . . . . 10.8 110.958 -172.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.92 139.27 58.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.204 0.526 . . . . 8.21 110.367 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 334' ' ' ARG . 59.4 mt -109.74 143.97 38.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.015 -0.993 . . . . 6.33 112.829 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -104.4 132.17 50.95 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.147 -1.427 . . . . 6.75 107.147 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -127.04 121.29 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.565 -0.532 . . . . 5.68 109.565 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.22 16.5 Favored Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.461 -0.876 . . . . 6.53 112.693 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.82 9.12 86.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.634 -0.794 . . . . 7.67 111.517 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 92.7 mt -70.79 135.27 85.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.48 0.178 . . . . 8.16 111.48 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.6 Cg_exo -61.85 141.51 90.18 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.923 1.748 . . . . 8.96 108.796 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -65.36 -14.86 61.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.763 1.394 . . . . 11.61 114.763 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -84.15 -23.17 30.75 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.77 1.396 . . . . 11.06 114.77 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 149.21 50.71 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.121 0.418 . . . . 9.36 111.31 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 275' ' ' VAL . 10.0 p-10 -114.51 -176.39 2.89 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.578 -0.283 . . . . 10.46 110.296 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 10.8 m-20 -53.64 -55.21 27.9 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 114.622 1.341 . . . . 9.92 114.622 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -61.33 -26.77 68.03 Favored 'General case' 0 C--N 1.405 2.995 0 C-N-CA 125.697 1.599 . . . . 0.0 112.456 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.07 -48.22 13.61 Favored 'General case' 1 C--N 1.429 4.031 0 O-C-N 123.489 0.493 . . . . 10.06 111.398 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 271' ' ' ASN . 71.9 t -62.69 -49.25 84.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 7.76 110.237 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 26.7 mtmm -54.27 -36.45 63.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.662 -0.699 . . . . 9.67 111.297 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.06 -53.3 57.37 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.055 0.455 . . . . 10.2 110.7 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -51.73 -33.15 33.45 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 116.195 -0.457 . . . . 7.62 110.322 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.499 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.9 mt -82.67 -41.67 19.08 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.568 0.581 . . . . 7.74 112.568 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 53.1 m -56.86 -29.41 62.86 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.546 0.943 . . . . 10.09 113.546 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -50.11 -10.82 0.06 Allowed 'General case' 0 C--N 1.395 2.572 0 C-N-CA 125.062 1.345 . . . . 0.0 112.563 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -111.51 -12.03 14.01 Favored 'General case' 1 C--N 1.445 4.733 0 CA-C-N 118.174 0.443 . . . . 10.23 111.499 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.13 162.31 10.25 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.795 -0.638 . . . . 10.4 111.947 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.64 147.09 93.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.677 2.252 . . . . 12.19 112.681 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.3 mt -102.47 146.31 28.29 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.889 -0.596 . . . . 10.66 111.304 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.6 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 12.8 ptpt -101.11 -22.56 14.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.227 -0.657 . . . . 11.41 109.227 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.07 127.23 5.73 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 119.152 -2.217 . . . . 0.0 108.975 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.618 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 60.2 t80 -144.43 134.75 24.41 Favored 'General case' 0 C--N 1.363 1.153 0 C-N-CA 122.769 0.428 . . . . 8.77 112.013 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -144.79 124.03 12.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.813 0.339 . . . . 8.38 111.634 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.479 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 52.0 tp -100.88 118.27 36.6 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.592 -1.262 . . . . 8.94 107.592 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.24 122.79 28.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.507 0.929 . . . . 9.37 113.507 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.09 148.1 43.42 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.315 -0.857 . . . . 11.34 109.373 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.621 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 36.9 t70 -58.92 141.05 54.65 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.92 0.39 . . . . 13.83 110.958 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.738 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 14.6 m -49.59 -61.67 1.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.795 -0.638 . . . . 14.58 112.65 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.2 -64.05 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.422 0.527 . . . . 16.19 112.422 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.621 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 18.4 m -42.4 -59.39 1.86 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.34 -0.391 . . . . 14.94 111.209 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.65 -6.05 62.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.643 -0.789 . . . . 13.57 114.493 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.5 mt -88.29 167.69 13.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.425 0.612 . . . . 13.28 110.913 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.4 t -59.25 142.01 52.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.021 -0.536 . . . . 10.43 111.572 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.913 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.96 -9.4 53.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.795 -0.639 . . . . 11.2 109.619 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.61 -3.4 39.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.597 -0.729 . . . . 8.63 113.874 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -142.97 146.41 33.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.03 0.915 . . . . 9.19 112.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.2 46.74 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.101 -0.954 . . . . 6.21 112.242 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -111.42 146.84 36.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.186 -0.916 . . . . 7.09 110.422 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.618 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 21.2 p -157.87 156.19 30.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 119.9 -0.72 . . . . 6.77 111.875 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.404 ' OE2' ' HD2' ' A' ' 286' ' ' LYS . 37.5 tt0 -145.27 127.0 15.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.702 -0.681 . . . . 9.59 109.713 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.6 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 56.4 m-85 -82.39 164.85 20.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.941 0.4 . . . . 9.91 112.06 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.51 -46.11 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 108.428 -0.953 . . . . 12.81 108.428 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.735 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.1 t70 -96.32 102.39 14.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.391 -1.337 . . . . 13.18 107.391 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 310' ' ' ILE . 0.2 OUTLIER -52.76 -34.97 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 N-CA-C 115.288 1.588 . . . . 12.23 115.288 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -56.84 -38.76 73.11 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 122.175 0.988 . . . . 13.04 108.979 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.7 -22.7 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 112.366 -2.197 . . . . 11.08 109.552 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.67 -48.1 72.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.935 -0.765 . . . . 9.11 108.935 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -62.52 -42.77 99.74 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.205 -0.598 . . . . 10.31 110.486 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -63.88 -32.39 73.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.932 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.53 -34.77 74.72 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.711 -1.586 . . . . 8.25 113.036 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 313' ' ' THR . 63.6 mt -68.63 -51.3 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 7.4 110.848 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.03 67.59 Favored 'General case' 0 C--N 1.42 3.642 0 C-N-CA 126.185 1.794 . . . . 0.0 113.152 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.93 -23.9 36.92 Favored Glycine 1 C--N 1.399 4.055 0 N-CA-C 116.781 1.472 . . . . 8.35 116.781 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.404 ' O ' HD23 ' A' ' 330' ' ' LEU . 96.9 mt -96.92 -45.7 6.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 120.214 2.007 . . . . 7.2 114.039 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -50.45 129.98 22.9 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.845 0.355 . . . . 7.86 111.426 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.18 -16.65 56.79 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.145 -0.55 . . . . 8.64 113.956 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 16.4 mtt -50.64 147.19 4.89 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.822 0.311 . . . . 8.0 111.267 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -95.09 115.65 27.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.03 0.443 . . . . 10.39 111.71 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.7 mm? -120.2 106.77 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.113 -1.069 . . . . 8.95 108.113 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.14 -118.65 10.51 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 109.38 -1.488 . . . . 10.63 109.38 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -115.86 22.41 13.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.202 0.525 . . . . 12.25 109.818 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -123.82 153.91 40.35 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.599 -0.728 . . . . 9.98 111.629 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -101.7 118.41 36.88 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.115 -1.068 . . . . 10.14 108.115 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.601 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.6 tp -63.21 143.16 58.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.515 0.674 . . . . 7.52 112.653 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 62.2 tp -128.17 128.01 44.0 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.539 -1.209 . . . . 7.48 108.942 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.96 124.02 26.07 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 O-C-N 120.935 -1.103 . . . . 6.45 110.01 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -152.7 155.31 37.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.973 -1.704 . . . . 7.66 109.53 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.673 ' HD2' ' HA2' ' A' ' 338' ' ' GLY . 84.6 mtt180 -58.66 122.44 13.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 118.463 -1.295 . . . . 8.94 107.612 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.89 -11.77 0.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.766 1.395 . . . . 7.52 114.766 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.5 m -119.47 -79.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.539 -0.465 . . . . 9.07 111.297 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 15.9 m -149.02 158.46 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.619 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . 0.673 ' HA2' ' HD2' ' A' ' 334' ' ' ARG . . . -85.51 63.41 4.31 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.911 177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -69.87 100.61 1.58 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.961 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -126.42 144.03 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.363 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 8.9 t30 70.74 100.7 0.06 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.987 0.804 . . . . 0.0 110.91 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.724 179.181 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.913 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.505 -2.264 0 C3'-C2'-C1' 100.424 -1.196 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 0.412 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.907 0 O4'-C1'-C2' 107.514 0.796 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.446 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C4'-C3'-C2' 103.427 0.727 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.605 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.503 5.738 0 C4'-C3'-C2' 99.205 -3.495 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.738 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.683 6.373 0 C4'-C3'-C2' 106.186 3.486 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.418 ' OP1' ' CD2' ' A' ' 197' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -1.012 0 C4'-C3'-C2' 105.671 2.971 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 1.175 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.035 0 O4'-C1'-C2' 107.645 0.889 . 0.075 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 O4'-C1'-C2' 107.135 0.525 . 0.105 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 O4'-C1'-C2' 107.197 0.569 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 56.09 46.1 22.27 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.581 0.55 . . . . 0.0 111.438 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.6 mtt180 -158.7 148.52 19.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.064 0.946 . . . . 5.88 111.127 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.569 ' HG ' HG23 ' A' ' 208' ' ' THR . 28.0 mt -140.67 143.55 35.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.541 . . . . 5.25 111.282 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.61 125.19 40.9 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.854 -0.795 . . . . 6.58 108.854 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.8 101.33 8.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 5.06 110.196 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.77 -178.63 35.0 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.914 -0.585 . . . . 6.2 112.792 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.25 40.83 23.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 124.969 1.308 . . . . 0.0 110.121 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.83 149.8 88.09 Favored Pre-proline 1 C--N 1.428 4.021 0 C-N-CA 123.477 0.711 . . . . 7.79 111.286 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.07 144.48 89.84 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.297 1.998 . . . . 8.57 110.989 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.96 139.72 52.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.911 0.386 . . . . 11.37 111.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.1 6.6 61.0 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.833 -0.621 . . . . 9.94 114.303 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.12 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 117.399 0.6 . . . . 8.91 110.305 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.4 p -84.89 153.98 22.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.614 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -60.18 -43.31 95.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 7.44 110.149 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.51 -46.22 90.9 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.106 -0.497 . . . . 9.89 110.516 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.37 -26.39 68.43 Favored 'General case' 0 C--N 1.41 3.233 0 O-C-N 119.26 -2.15 . . . . 0.0 111.734 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.484 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.49 -34.08 67.41 Favored 'General case' 1 C--N 1.429 4.034 0 O-C-N 123.984 0.802 . . . . 6.64 111.742 171.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.63 -54.31 7.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.424 0.69 . . . . 6.69 111.057 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.61 -33.68 60.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.453 -0.794 . . . . 8.8 111.345 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.76 -53.53 17.93 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 120.41 -0.516 . . . . 7.44 111.611 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.31 -48.27 82.13 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.18 0.437 . . . . 5.94 112.18 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.82 -42.81 80.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.294 -0.562 . . . . 7.12 109.64 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.57 65.16 Favored 'General case' 0 C--N 1.407 3.076 0 O-C-N 120.261 -1.524 . . . . 0.0 111.227 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.38 -37.66 36.77 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.528 0.604 . . . . 7.79 110.319 176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.8 -36.61 82.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.58 -0.736 . . . . 7.73 111.079 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.433 ' HD3' HH11 ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.17 -43.02 44.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.38 0.511 . . . . 9.61 112.38 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.2 mt -63.0 -37.73 88.35 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.203 0.525 . . . . 10.06 110.415 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.06 -16.46 74.61 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.225 -0.988 . . . . 9.23 112.894 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.22 37.15 71.6 Favored Glycine 0 CA--C 1.518 0.249 0 N-CA-C 110.774 -0.93 . . . . 9.25 110.774 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.9 5.27 51.95 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.939 0.718 . . . . 8.31 112.939 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.0 p -82.6 143.42 31.03 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.183 -0.207 . . . . 9.16 110.609 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.47 21.35 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.149 0.426 . . . . 10.23 112.149 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.73 163.5 23.71 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.731 -0.213 . . . . 9.89 110.688 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.37 143.56 99.68 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.915 1.743 . . . . 11.04 110.821 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.29 161.61 20.62 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.656 -0.783 . . . . 9.31 112.467 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.9 m-20 -75.25 134.48 73.83 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 112.025 0.38 . . . . 7.97 112.025 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.4 Cg_exo -73.25 -50.94 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.573 2.182 . . . . 6.59 111.368 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.151 -0.477 . . . . 5.87 111.107 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -33.17 33.27 Favored 'General case' 0 N--CA 1.524 3.272 0 C-N-CA 124.878 1.271 . . . . 0.0 113.394 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -156.18 163.78 39.17 Favored 'General case' 0 C--N 1.386 2.181 0 C-N-CA 125.757 1.623 . . . . 0.0 110.577 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.45 130.51 10.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.698 0 C-N-CA 126.091 1.756 . . . . 5.67 109.338 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.15 126.62 55.28 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.686 -0.487 . . . . 6.47 109.686 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.1 mt -114.93 125.99 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 116.903 2.186 . . . . 7.1 116.903 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.14 91.42 5.26 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 103.187 -2.894 . . . . 8.1 103.187 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -57.46 7.79 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.645 1.72 . . . . 10.19 115.645 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.14 -48.78 75.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.853 0.686 . . . . 10.51 112.853 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.566 ' HD3' " O2'" ' B' ' 605' ' ' ' U' . 9.5 mmtm -68.99 -9.07 50.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 9.72 111.849 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.06 36.15 15.5 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.579 1.326 . . . . 8.04 114.579 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.52 168.7 19.23 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.12 -1.032 . . . . 6.83 111.671 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.61 161.02 42.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.035 -1.438 . . . . 5.19 110.515 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.39 129.35 51.17 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.624 -0.88 . . . . 5.71 108.624 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.8 137.56 33.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.355 -0.384 . . . . 4.27 110.351 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -114.83 114.82 26.05 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 6.21 109.645 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -99.77 164.67 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 6.14 111.947 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.54 -26.04 22.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.425 -0.807 . . . . 8.37 111.461 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.1 p -128.86 159.64 35.15 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.1 0.476 . . . . 7.92 111.646 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.79 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.569 -0.741 . . . . 8.77 112.303 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.584 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.64 -41.79 95.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.364 0.505 . . . . 9.08 112.364 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.77 98.17 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 110.298 -0.26 . . . . 7.46 110.298 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.569 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.5 m -54.25 -54.48 39.49 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.13 -1.063 . . . . 6.18 108.13 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 19.0 m -54.3 -27.56 36.26 Favored 'General case' 1 C--N 1.429 4.032 0 C-N-CA 127.029 2.132 . . . . 0.0 109.853 177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -34.0 44.42 Favored 'General case' 0 C--N 1.426 3.897 0 N-CA-C 113.648 0.981 . . . . 8.7 113.648 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.55 -17.35 64.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.626 0.602 . . . . 5.94 112.626 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.5 mtp -62.12 -19.86 63.46 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.29 0.994 . . . . 6.89 111.569 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.5 -9.24 52.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.383 -0.371 . . . . 7.4 111.608 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -93.77 16.16 14.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.747 0.308 . . . . 6.97 111.725 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.85 120.9 13.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 7.38 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.91 -4.84 65.95 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.859 -0.686 . . . . 7.92 113.553 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.17 142.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.836 0.318 . . . . 7.5 111.066 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.57 37.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.271 0.558 . . . . 9.49 111.327 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -135.29 107.71 7.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 8.45 110.354 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.72 42.62 13.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 10.44 111.771 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.34 54.53 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 115.229 0.851 . . . . 10.21 115.229 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.69 130.88 55.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.652 0.726 . . . . 9.94 112.475 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.71 101.58 10.96 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.486 -0.931 . . . . 8.4 108.486 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.42 137.82 58.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.032 1.123 . . . . 6.9 114.032 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.777 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.47 110.24 21.71 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.539 -1.282 . . . . 8.29 107.539 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.5 mt -104.12 126.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.217 0.532 . . . . 6.17 112.233 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.433 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.54 170.54 15.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.376 -0.829 . . . . 7.99 110.079 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.13 154.7 49.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.39 175.26 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.954 1.77 . . . . 7.79 112.038 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -98.09 -23.6 15.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.87 137.14 55.05 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 233' ' ' GLN . 37.7 t80 -96.17 -53.16 3.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.956 0.408 . . . . 0.0 110.511 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.485 ' HB3' ' HG2' ' A' ' 236' ' ' PRO . 27.2 mm-40 -130.61 154.36 81.7 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -61.84 -66.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.755 2.303 . . . . 0.0 112.507 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.493 ' HB2' ' HD3' ' A' ' 236' ' ' PRO . 81.6 mt -92.69 -55.31 0.24 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 235' ' ' LEU . 46.3 Cg_endo -69.29 148.2 67.58 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.908 1.739 . . . . 0.0 112.972 -176.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -156.42 53.1 0.42 Allowed Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.299 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -139.58 153.33 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.624 0.25 . . . . 0.0 110.335 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 47.6 m -127.22 114.28 17.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 111.301 -177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.6 -48.54 69.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.352 0.596 . . . . 0.0 109.51 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -127.33 99.69 27.32 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.446 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.89 113.19 1.21 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.879 2.386 . . . . 0.0 112.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 20.7 m -106.5 115.49 30.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.667 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.9 p -159.79 -30.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.762 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -152.49 102.01 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.1 0.476 . . . . 0.0 110.265 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.33 130.9 23.9 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.176 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.08 119.54 6.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.78 2.32 . . . . 0.0 112.124 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 137.88 -176.33 20.73 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 95.9 t 62.45 96.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 111.162 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 20.9 m -79.35 153.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.486 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.0 t -124.42 -77.62 0.59 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 24.9 m 67.83 -69.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 123.512 0.508 . . . . 0.0 111.306 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 3.3 p -152.94 105.41 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.44 0.638 . . . . 0.0 109.618 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 23.9 m -118.95 151.3 50.16 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.95 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.54 12.68 2.8 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.774 2.316 . . . . 0.0 112.355 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -76.13 156.13 34.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.586 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 13.1 m -74.91 76.15 2.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.097 0.475 . . . . 0.0 111.242 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -149.03 72.92 1.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.484 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -140.05 30.95 1.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.579 . . . . 10.8 110.793 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -62.98 139.4 58.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.276 0.56 . . . . 8.21 110.318 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 334' ' ' ARG . 65.9 mt -109.8 144.05 38.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.989 -1.005 . . . . 6.33 112.789 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -104.44 132.03 51.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.214 -1.402 . . . . 6.75 107.214 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.02 121.23 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 109.618 -0.512 . . . . 5.68 109.618 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.13 179.26 16.46 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.483 -0.865 . . . . 6.53 112.719 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.08 86.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.625 -0.798 . . . . 7.67 111.561 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 97.1 mt -70.79 135.27 85.7 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 111.522 0.193 . . . . 8.16 111.522 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 38.1 Cg_exo -61.84 141.53 90.32 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 121.998 1.799 . . . . 8.96 108.744 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -65.44 -14.86 61.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.724 1.379 . . . . 11.61 114.724 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -84.21 -22.98 30.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.827 1.417 . . . . 11.06 114.827 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.31 149.12 50.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.144 0.429 . . . . 9.36 111.325 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.402 ' O ' HG23 ' A' ' 275' ' ' VAL . 20.9 p-10 -114.59 -176.49 2.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 110.233 -0.284 . . . . 10.46 110.233 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.54 -55.35 26.29 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 114.604 1.335 . . . . 9.92 114.604 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -61.4 -26.53 67.91 Favored 'General case' 0 C--N 1.405 3.006 0 C-N-CA 125.72 1.608 . . . . 0.0 112.51 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -80.12 -48.28 13.46 Favored 'General case' 1 C--N 1.43 4.086 0 CA-C-N 118.283 0.492 . . . . 10.06 111.385 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.9 t -62.7 -49.16 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.6 . . . . 7.76 110.318 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -54.3 -36.36 63.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.678 -0.692 . . . . 9.67 111.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.01 -53.43 55.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.167 0.508 . . . . 10.2 110.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 320' ' ' LEU . 3.2 tm? -51.65 -33.28 32.88 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.115 -0.493 . . . . 7.62 110.365 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.496 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.52 -41.6 19.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.649 0.611 . . . . 7.74 112.649 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 43.5 m -56.94 -29.96 63.61 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.48 0.919 . . . . 10.09 113.48 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 17.1 m -50.25 -10.02 0.05 Allowed 'General case' 0 C--N 1.395 2.58 0 C-N-CA 124.753 1.221 . . . . 0.0 112.641 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -111.46 -12.02 14.04 Favored 'General case' 1 C--N 1.444 4.699 0 CA-C-N 118.379 0.536 . . . . 10.23 111.503 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.36 10.29 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.821 -0.627 . . . . 10.4 111.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.6 147.11 93.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.72 2.28 . . . . 12.19 112.65 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 89.7 mt -102.56 146.27 28.39 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.959 -0.564 . . . . 10.66 111.241 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 16.0 ptpt -101.01 -22.53 14.73 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.273 -0.64 . . . . 11.41 109.273 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -157.32 129.25 7.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 119.483 -2.011 . . . . 0.0 108.836 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -146.21 134.72 22.04 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.654 0.382 . . . . 8.77 111.98 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -144.86 124.11 12.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.866 0.365 . . . . 8.38 111.566 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 57.3 tp -100.99 118.17 36.47 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.584 -1.265 . . . . 8.94 107.584 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.18 122.92 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 113.515 0.931 . . . . 9.37 113.515 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -119.13 148.14 43.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.262 -0.881 . . . . 11.34 109.413 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.597 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 33.9 t70 -58.92 141.12 54.47 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.921 0.391 . . . . 13.83 110.914 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.503 ' HB3' ' N3 ' ' B' ' 605' ' ' ' U' . 50.0 m -49.71 -61.72 1.96 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.863 -0.608 . . . . 14.58 112.6 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.08 -64.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.471 0.545 . . . . 16.19 112.471 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 5.5 m -42.48 -59.32 1.91 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.306 -0.407 . . . . 14.94 111.214 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.04 62.54 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.613 -0.804 . . . . 13.57 114.528 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.35 167.6 13.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.334 0.567 . . . . 13.28 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 43.0 t -59.19 142.07 52.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 10.43 111.624 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.619 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.7 mmmp? -87.95 -9.43 53.58 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.793 -0.64 . . . . 11.2 109.569 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.57 -3.31 39.53 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.67 -0.695 . . . . 8.63 113.942 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.469 ' CZ ' " H4'" ' B' ' 603' ' ' ' U' . 27.2 p90 -143.01 146.41 33.83 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.979 0.889 . . . . 9.19 112.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.61 155.16 46.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.078 -0.965 . . . . 6.21 112.169 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -111.25 146.81 36.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.077 -0.965 . . . . 7.09 110.394 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.597 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.4 p -157.89 156.21 30.95 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 119.983 -0.687 . . . . 6.77 111.871 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -145.3 127.09 15.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 9.59 109.608 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.531 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 52.9 m-85 -82.46 164.85 20.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.932 0.396 . . . . 9.91 112.045 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.55 -46.1 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 108.4 -0.963 . . . . 12.81 108.4 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.738 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.34 102.37 14.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.361 -1.348 . . . . 13.18 107.361 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.02 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 115.291 1.589 . . . . 12.23 115.291 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -56.78 -38.86 73.08 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.294 1.045 . . . . 13.04 109.014 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.52 -22.92 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 112.402 -2.181 . . . . 11.08 109.519 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 99.4 m -54.53 -48.24 72.2 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.896 -0.779 . . . . 9.11 108.896 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -62.5 -42.71 99.69 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.187 -0.605 . . . . 10.31 110.513 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -63.82 -32.43 73.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 119.939 -0.704 . . . . 11.98 111.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.78 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.67 -1.605 . . . . 8.25 113.027 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.6 -51.23 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.393 0.616 . . . . 7.4 110.833 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.69 -39.0 67.68 Favored 'General case' 0 C--N 1.42 3.649 0 C-N-CA 126.301 1.84 . . . . 0.0 113.171 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.9 -24.09 36.39 Favored Glycine 1 C--N 1.399 4.08 0 N-CA-C 116.817 1.487 . . . . 8.35 116.817 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 278' ' ' LEU . 78.9 mt -96.89 -45.86 6.46 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 120.189 1.994 . . . . 7.2 113.892 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -50.4 129.99 22.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.812 0.339 . . . . 7.86 111.564 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.19 -16.69 56.73 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 121.11 -0.567 . . . . 8.64 113.905 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.57 147.21 4.78 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.868 0.334 . . . . 8.0 111.337 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -95.2 115.67 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.053 0.454 . . . . 10.39 111.681 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.595 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.9 mm? -120.19 106.75 12.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.15 -118.75 10.62 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 109.343 -1.503 . . . . 10.63 109.343 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -115.8 22.4 13.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.243 0.544 . . . . 12.25 109.786 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.9 154.0 40.34 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.642 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -101.8 118.2 36.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.086 -1.079 . . . . 10.14 108.086 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.595 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.2 tp -63.0 143.06 58.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.485 0.659 . . . . 7.52 112.687 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 1.469 ' CD1' ' H3 ' ' B' ' 602' ' ' ' U' . 3.1 mp -128.13 127.94 43.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.555 -1.202 . . . . 7.48 108.971 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 59.4 t -137.91 123.98 26.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 O-C-N 121.044 -1.035 . . . . 6.45 109.966 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -152.69 155.29 36.96 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 120.117 -1.614 . . . . 7.66 109.587 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.51 ' HA ' HD23 ' A' ' 261' ' ' LEU . 92.2 mtt180 -58.56 122.45 13.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 118.544 -1.263 . . . . 8.94 107.603 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.97 -11.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.808 1.41 . . . . 7.52 114.808 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 19.5 m -119.37 -77.88 0.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.629 -0.428 . . . . 9.07 111.283 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 4.7 m -101.12 79.13 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.523 0.677 . . . . 0.0 110.744 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -75.77 148.43 36.67 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.813 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.95 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.177 0.513 . . . . 0.0 110.677 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -102.0 136.41 41.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.224 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -96.03 101.87 13.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.927 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.319 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.619 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.079 0 O4'-C1'-N19 109.358 1.158 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 1.469 ' H3 ' ' CD1' ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 O4'-C1'-C2' 107.604 0.86 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.469 " H4'" ' CZ ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.421 -1.191 0 C4'-C3'-C2' 103.984 1.284 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.777 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 C4'--C3' 1.581 5.153 1 C3'-C2'-C1' 105.204 4.116 . 0.077 4g . 0.0 . . . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.639 " O2'" ' P ' ' B' ' 606' ' ' ' U' . . . . . . . . 1 P--O3' 1.702 7.89 1 P-O3'-C3' 126.116 5.347 OUTLIER-EPSILON 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 5 4 . 1 . 006 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.639 ' P ' " O2'" ' B' ' 605' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.414 -1.625 0 P-O3'-C3' 122.833 2.611 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.541 1.265 0 O4'-C1'-C2' 107.899 1.07 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C3'-C2'-C1' 100.74 -0.844 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-C1' 100.656 -0.938 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 119.876 -0.107 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.734 ' HB3' HG21 ' A' ' 208' ' ' THR . 5.7 mmt-85 -127.73 -152.26 0.51 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.257 -0.977 . . . . 0.0 113.074 164.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -159.85 149.34 18.05 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 123.259 0.623 . . . . 5.88 111.628 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.71 143.65 35.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 5.25 111.281 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.62 125.15 40.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.853 -0.795 . . . . 6.58 108.853 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.77 101.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.167 0.508 . . . . 5.06 110.33 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.66 -179.07 35.07 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.86 -0.609 . . . . 6.2 112.823 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 49.79 41.73 22.76 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 125.214 1.406 . . . . 0.0 110.268 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.85 149.75 88.01 Favored Pre-proline 0 C--N 1.426 3.935 0 C-N-CA 123.684 0.794 . . . . 7.79 111.312 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.96 144.41 89.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.283 1.989 . . . . 8.57 111.032 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -69.93 139.66 52.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.966 0.412 . . . . 11.37 111.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.27 6.5 61.46 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.799 -0.637 . . . . 9.94 114.259 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.05 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.363 0.581 . . . . 8.91 110.271 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.99 153.89 22.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.743 0.306 . . . . 9.64 110.6 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.1 -43.16 95.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.322 -0.399 . . . . 7.44 110.257 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.68 -46.03 91.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.963 -0.562 . . . . 9.89 110.616 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.33 -26.71 68.58 Favored 'General case' 0 C--N 1.409 3.159 0 O-C-N 119.264 -2.148 . . . . 0.0 111.661 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.477 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.42 -34.06 67.58 Favored 'General case' 0 C--N 1.428 3.979 0 O-C-N 123.967 0.792 . . . . 6.64 111.737 172.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.5 -54.34 7.73 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 123.481 0.713 . . . . 6.69 111.115 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.55 -33.72 60.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.367 -0.833 . . . . 8.8 111.387 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.78 -53.57 17.67 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 120.543 -0.463 . . . . 7.44 111.576 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.3 -48.34 81.84 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.145 0.424 . . . . 5.94 112.145 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.2 m-20 -56.78 -42.6 79.72 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.258 -0.577 . . . . 7.12 109.608 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.29 64.72 Favored 'General case' 0 C--N 1.405 3.004 0 O-C-N 120.388 -1.445 . . . . 0.0 111.21 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.5 -37.67 36.17 Favored 'General case' 1 C--N 1.428 4.019 0 CA-C-N 118.455 0.57 . . . . 7.79 110.298 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.538 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.68 -36.8 83.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.618 -0.719 . . . . 7.73 111.009 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.5 mtt-85 -76.15 -42.95 45.03 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.387 0.514 . . . . 9.61 112.387 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.8 mt -63.0 -37.75 88.42 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.259 0.552 . . . . 10.06 110.492 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.02 -16.56 74.46 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.273 -0.965 . . . . 9.23 112.886 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.26 37.01 71.22 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 110.873 -0.891 . . . . 9.25 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.97 5.35 51.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.92 0.711 . . . . 8.31 112.92 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.9 p -82.61 143.48 30.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.586 0.232 . . . . 9.16 110.593 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.583 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.61 -18.45 21.37 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.176 0.435 . . . . 10.23 112.176 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.8 163.46 23.78 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.632 -0.258 . . . . 9.89 110.694 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -59.35 143.54 99.69 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 121.965 1.777 . . . . 11.04 110.793 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.58 20.58 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.677 -0.773 . . . . 9.31 112.505 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.28 134.44 73.75 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.033 0.383 . . . . 7.97 112.033 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.558 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.5 Cg_exo -73.25 -50.99 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.454 2.103 . . . . 6.59 111.32 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.67 105.26 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.132 -0.485 . . . . 5.87 111.134 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 -36.33 37.92 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 125.37 1.468 . . . . 0.0 112.954 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.13 164.36 38.62 Favored 'General case' 0 C--N 1.386 2.173 0 C-N-CA 125.826 1.651 . . . . 0.0 110.959 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.9 130.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 125.999 1.72 . . . . 5.67 109.337 175.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.93 126.64 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.765 -0.458 . . . . 6.47 109.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.608 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.93 126.0 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 116.941 2.2 . . . . 7.1 116.941 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -98.12 91.37 5.24 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.149 -2.908 . . . . 8.1 103.149 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.21 -57.43 7.8 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.662 1.727 . . . . 10.19 115.662 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.24 -48.69 75.99 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.877 0.695 . . . . 10.51 112.877 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.483 ' HD3' " O2'" ' B' ' 605' ' ' ' U' . 9.5 mmtm -68.97 -9.22 51.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.716 0.293 . . . . 9.72 111.77 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 36.11 15.0 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 114.53 1.307 . . . . 8.04 114.53 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.56 168.63 19.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.093 -1.043 . . . . 6.83 111.612 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.56 161.12 41.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.18 -1.373 . . . . 5.19 110.486 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.38 129.31 51.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.73 -0.841 . . . . 5.71 108.73 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.81 137.5 33.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.44 -0.345 . . . . 4.27 110.364 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.71 114.73 26.02 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.718 -0.475 . . . . 6.21 109.718 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.73 164.66 11.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 6.14 111.943 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.56 -25.98 22.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.515 -0.766 . . . . 8.37 111.392 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.0 p -128.95 159.57 35.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.094 0.473 . . . . 7.92 111.521 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.28 -41.74 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.499 -0.773 . . . . 8.77 112.266 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.583 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.7 t70 -64.63 -41.79 95.92 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.396 0.517 . . . . 9.08 112.396 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.85 98.02 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.28 -0.267 . . . . 7.46 110.28 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 149' ' ' ARG . 55.9 m -54.17 -53.97 46.15 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.123 -1.066 . . . . 6.18 108.123 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.6 m -55.07 -27.3 43.78 Favored 'General case' 1 C--N 1.43 4.066 0 C-N-CA 126.953 2.101 . . . . 0.0 109.863 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -34.0 43.69 Favored 'General case' 0 C--N 1.422 3.743 0 N-CA-C 113.657 0.984 . . . . 8.7 113.657 176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.56 -17.33 64.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.651 0.611 . . . . 5.94 112.651 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.09 -19.85 63.41 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.493 1.12 . . . . 6.89 111.614 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.4 -9.35 53.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.379 -0.373 . . . . 7.4 111.613 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.82 16.22 14.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.585 -0.279 . . . . 6.97 111.658 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.89 121.02 14.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.827 0.346 . . . . 7.38 110.782 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.83 66.02 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.855 -0.688 . . . . 7.92 113.587 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.23 142.39 9.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.87 0.335 . . . . 7.5 111.153 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.93 121.57 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.245 0.545 . . . . 9.49 111.278 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.23 107.69 7.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.721 -0.672 . . . . 8.45 110.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 60.74 42.7 13.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 10.44 111.747 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.04 -5.44 54.03 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 115.219 0.847 . . . . 10.21 115.219 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -110.69 130.89 55.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.574 0.687 . . . . 9.94 112.358 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.66 101.48 10.86 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.587 -0.894 . . . . 8.4 108.587 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.1 mt -61.36 137.83 58.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.939 1.088 . . . . 6.9 113.939 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.635 ' NZ ' " O2'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.51 110.24 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.602 -1.259 . . . . 8.29 107.602 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -104.02 126.96 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.265 0.555 . . . . 6.17 112.289 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.428 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.49 15.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.332 -0.849 . . . . 7.99 110.041 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.04 154.71 49.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.614 -0.884 . . . . 7.86 108.614 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.52 175.12 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.929 1.753 . . . . 7.79 112.007 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -93.74 -9.56 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.946 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.3 p-10 -93.41 9.22 37.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.917 172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -55.44 -52.47 63.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.221 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.97 134.3 22.51 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.122 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.01 133.98 28.98 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.062 2.508 . . . . 0.0 112.026 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.82 142.02 90.51 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.606 -177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.14 125.1 15.65 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.672 2.248 . . . . 0.0 111.959 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -171.59 -67.33 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -131.72 164.05 26.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 14.2 m -130.47 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.79 -88.57 0.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.83 95.67 49.38 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.08 -66.5 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.46 2.107 . . . . 0.0 111.913 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 13.6 t 51.79 63.58 2.19 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.398 0.618 . . . . 0.0 110.082 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.8 96.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.848 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -145.52 104.29 3.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.244 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.5 m -96.87 154.84 38.16 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.221 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.38 -33.29 97.54 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.516 2.144 . . . . 0.0 111.81 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 72.55 31.86 62.54 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.647 176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.85 101.57 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.4 t 65.26 -77.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.762 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 69.3 m -154.67 105.64 2.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.377 . . . . 0.0 110.181 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 20.8 m -71.61 -29.02 64.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.419 0.628 . . . . 0.0 109.853 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 138.03 26.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.053 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 88.6 t -120.5 117.04 31.73 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.366 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.77 140.09 65.88 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.497 2.131 . . . . 0.0 111.343 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.35 136.33 57.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.034 0.445 . . . . 0.0 111.155 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.5 p -135.2 111.69 9.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -95.49 159.12 15.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.577 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -93.83 31.02 1.68 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.953 0.406 . . . . 10.8 110.727 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -63.0 139.4 58.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 8.21 110.33 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 334' ' ' ARG . 67.4 mt -109.8 143.96 38.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.944 -1.026 . . . . 6.33 112.788 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -104.38 132.06 51.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.219 -1.4 . . . . 6.75 107.219 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.99 121.26 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 109.59 -0.522 . . . . 5.68 109.59 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.27 16.47 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.436 -0.888 . . . . 6.53 112.648 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.76 9.13 86.54 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.607 -0.806 . . . . 7.67 111.573 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 90.8 mt -70.78 135.25 85.72 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.835 -0.182 . . . . 8.16 111.477 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.4 Cg_exo -61.84 141.47 90.13 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.955 1.77 . . . . 8.96 108.795 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.34 -14.86 61.77 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 114.803 1.408 . . . . 11.61 114.803 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -84.14 -23.19 30.77 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.816 1.413 . . . . 11.06 114.816 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.33 149.13 50.83 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.17 0.441 . . . . 9.36 111.368 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 18.9 p-10 -114.39 -176.41 2.89 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.284 -0.265 . . . . 10.46 110.284 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -53.59 -55.46 25.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.629 1.344 . . . . 9.92 114.629 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -25.94 67.79 Favored 'General case' 0 C--N 1.406 3.026 0 C-N-CA 125.596 1.558 . . . . 0.0 112.478 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -80.18 -48.3 13.36 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.363 0.529 . . . . 10.06 111.378 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 78.5 t -62.66 -49.19 84.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.803 -0.635 . . . . 7.76 110.321 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -54.25 -36.41 63.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.312 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -62.13 -53.27 57.83 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.096 0.474 . . . . 10.2 110.699 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.403 HD11 HD22 ' A' ' 320' ' ' LEU . 3.0 tm? -51.73 -33.23 33.77 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.146 -0.479 . . . . 7.62 110.318 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.479 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.7 mt -82.54 -41.8 19.16 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.572 0.582 . . . . 7.74 112.572 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 46.2 m -56.75 -29.67 62.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.65 0.981 . . . . 10.09 113.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 24.2 m -50.42 -10.15 0.06 Allowed 'General case' 0 C--N 1.397 2.652 0 C-N-CA 124.846 1.258 . . . . 0.0 112.558 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -111.52 -12.03 14.01 Favored 'General case' 1 C--N 1.444 4.678 0 CA-C-N 118.335 0.516 . . . . 10.23 111.495 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.15 162.32 10.26 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.826 -0.625 . . . . 10.4 111.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.63 147.07 93.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.276 . . . . 12.19 112.716 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 83.0 mt -102.42 146.32 28.25 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.899 -0.591 . . . . 10.66 111.244 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 18.9 ptpt -101.05 -22.57 14.7 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.274 -0.639 . . . . 11.41 109.274 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.38 126.43 5.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 119.142 -2.224 . . . . 0.0 109.088 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.57 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 52.5 t80 -143.76 134.79 25.51 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 122.774 0.43 . . . . 8.77 112.006 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -144.77 124.01 12.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.513 -0.312 . . . . 8.38 111.595 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 61.0 tp -101.01 118.3 36.74 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.512 -1.292 . . . . 8.94 107.512 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.23 122.8 28.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.509 0.929 . . . . 9.37 113.509 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -119.13 148.06 43.48 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.31 -0.859 . . . . 11.34 109.353 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 38.7 t70 -58.81 141.13 53.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.922 0.391 . . . . 13.83 110.979 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.633 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 52.8 m -49.72 -61.71 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.816 -0.629 . . . . 14.58 112.649 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.04 -64.01 1.28 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.512 0.56 . . . . 16.19 112.512 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 12.8 m -42.55 -59.23 1.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.293 -0.412 . . . . 14.94 111.241 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.66 -6.14 62.59 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.53 -0.843 . . . . 13.57 114.492 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.3 167.6 13.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.435 0.618 . . . . 13.28 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.9 t -59.22 142.07 52.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.044 -0.526 . . . . 10.43 111.606 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 293' ' ' ASP . 24.1 mmtp -87.95 -9.38 53.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.783 -0.644 . . . . 11.2 109.581 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.49 -3.43 39.82 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.674 -0.694 . . . . 8.63 113.929 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.468 ' HE1' ' OP2' ' B' ' 604' ' ' ' U' . 46.0 p90 -142.98 146.46 33.94 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.133 0.966 . . . . 9.19 112.812 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.62 155.18 46.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.041 -0.982 . . . . 6.21 112.238 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -111.38 146.81 36.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.17 -0.923 . . . . 7.09 110.333 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.57 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 24.5 p -157.8 156.21 31.11 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.972 -0.691 . . . . 6.77 111.903 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -145.23 127.07 15.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.641 -0.708 . . . . 9.59 109.656 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.489 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 55.4 m-85 -82.36 164.88 20.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.097 0.406 . . . . 9.91 112.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.54 -46.09 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.413 -0.958 . . . . 12.81 108.413 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.692 ' O ' HG22 ' A' ' 312' ' ' VAL . 13.8 t70 -96.35 102.36 14.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.388 -1.338 . . . . 13.18 107.388 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.526 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.74 -34.97 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 N-CA-C 115.305 1.595 . . . . 12.23 115.305 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -56.87 -38.71 73.11 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.238 1.018 . . . . 13.04 109.016 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.2 m -62.75 -22.58 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 112.243 -2.253 . . . . 11.08 109.594 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 88.5 m -54.67 -48.2 72.66 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.932 -0.766 . . . . 9.11 108.932 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -62.43 -42.83 99.74 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.245 -0.582 . . . . 10.31 110.52 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -63.83 -32.41 73.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 119.931 -0.708 . . . . 11.98 111.9 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.52 -34.78 74.77 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.781 -1.554 . . . . 8.25 113.052 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 67.8 mt -68.63 -51.39 46.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.373 0.606 . . . . 7.4 110.857 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.8 -38.59 67.49 Favored 'General case' 0 C--N 1.421 3.678 0 C-N-CA 126.289 1.836 . . . . 0.0 113.166 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.03 -24.1 35.96 Favored Glycine 1 C--N 1.398 4.007 0 N-CA-C 116.847 1.499 . . . . 8.35 116.847 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 330' ' ' LEU . 88.1 mt -96.84 -45.77 6.51 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 120.117 1.958 . . . . 7.2 113.956 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -50.47 130.04 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.883 0.373 . . . . 7.86 111.511 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.24 -16.79 56.56 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.056 -0.592 . . . . 8.64 113.975 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 25.5 ttt -50.61 147.17 4.86 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.729 0.299 . . . . 8.0 111.324 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -95.08 115.55 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 10.39 111.751 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.3 mp -120.16 106.74 12.23 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.127 -1.064 . . . . 8.95 108.127 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.09 -118.64 10.53 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.408 -1.477 . . . . 10.63 109.408 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -115.9 22.51 12.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.169 0.509 . . . . 12.25 109.765 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -123.9 153.91 40.45 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.64 -0.709 . . . . 9.98 111.599 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.69 118.28 36.61 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.078 -1.082 . . . . 10.14 108.078 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.66 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.4 tp -63.07 143.17 58.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.519 0.676 . . . . 7.52 112.707 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.477 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 90.0 mt -128.14 127.97 43.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.593 -1.185 . . . . 7.48 108.962 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 62.5 t -137.92 124.04 26.29 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 O-C-N 120.96 -1.088 . . . . 6.45 109.999 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.71 155.34 37.04 Favored 'General case' 0 N--CA 1.432 -1.367 0 O-C-N 119.986 -1.696 . . . . 7.66 109.561 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.508 ' HA ' HD23 ' A' ' 261' ' ' LEU . 83.3 mtt180 -58.61 122.44 13.45 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 118.453 -1.299 . . . . 8.94 107.612 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.93 -11.76 0.1 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.794 1.405 . . . . 7.52 114.794 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 14.9 m -119.45 -77.68 0.58 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.532 -0.467 . . . . 9.07 111.156 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 8.2 m -89.85 108.02 18.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.33 0.586 . . . . 0.0 111.305 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -84.4 139.07 17.83 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.386 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -74.96 110.6 9.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.826 0.346 . . . . 0.0 111.088 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.28 -42.95 61.85 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -113.27 107.29 15.68 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.79 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.845 -179.314 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.407 " O2'" ' OP2' ' B' ' 602' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.506 -2.207 0 O4'-C1'-N19 109.38 1.18 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 0.477 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.425 -0.916 0 O4'-C1'-C2' 107.487 0.777 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.525 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O3'--C3' 1.446 1.618 0 C1'-O4'-C4' 110.61 1.122 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.635 " O2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.509 6.162 0 C4'-C3'-C2' 99.165 -3.535 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.633 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 2 P--O3' 1.689 6.868 0 C3'-C2'-C1' 104.602 3.446 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.586 ' P ' " O2'" ' B' ' 605' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.541 1.307 0 C4'-C3'-C2' 105.421 2.721 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 0.946 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 O4'-C1'-C2' 107.589 0.849 . 0.01 3a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.962 0 O4'-C1'-C2' 107.131 0.522 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-C1' 100.838 -0.736 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.42 ' H ' ' HG2' ' A' ' 149' ' ' ARG . 9.8 ptt180 -91.75 57.47 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.401 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.51 148.5 21.43 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 115.608 -0.724 . . . . 5.88 111.196 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.577 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.77 143.54 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.075 -0.511 . . . . 5.25 111.218 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -96.52 125.21 40.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.855 -0.795 . . . . 6.58 108.855 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.83 101.21 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.134 0.493 . . . . 5.06 110.253 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.72 -178.86 35.03 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.921 -0.581 . . . . 6.2 112.765 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.5 m120 51.17 39.97 24.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.993 1.317 . . . . 0.0 110.195 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.1 pt -73.58 149.76 88.64 Favored Pre-proline 1 C--N 1.43 4.103 0 C-N-CA 123.525 0.73 . . . . 7.79 111.366 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.99 144.45 89.49 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.325 2.017 . . . . 8.57 110.924 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -69.99 139.72 52.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.991 0.424 . . . . 11.37 111.916 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.22 6.49 61.26 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.755 -0.657 . . . . 9.94 114.277 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 117.395 0.597 . . . . 8.91 110.281 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.1 p -84.82 153.88 22.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 9.64 110.636 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.27 95.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 7.44 110.203 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -61.55 -46.07 91.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.979 -0.555 . . . . 9.89 110.568 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.73 -26.22 68.58 Favored 'General case' 0 C--N 1.41 3.22 0 O-C-N 119.25 -2.156 . . . . 0.0 111.658 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.492 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.39 -34.16 67.7 Favored 'General case' 1 C--N 1.429 4.046 0 O-C-N 123.949 0.781 . . . . 6.64 111.758 171.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.47 -54.4 7.64 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.412 0.685 . . . . 6.69 111.079 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -54.46 -33.76 60.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.397 -0.819 . . . . 8.8 111.403 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -69.76 -53.66 17.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 120.472 -0.491 . . . . 7.44 111.543 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.492 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.3 m-85 -61.22 -48.23 82.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.255 0.465 . . . . 5.94 112.255 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.5 m-20 -56.75 -42.85 80.06 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.351 -0.54 . . . . 7.12 109.579 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.1 -23.31 64.9 Favored 'General case' 0 C--N 1.407 3.09 0 O-C-N 120.279 -1.513 . . . . 0.0 111.276 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.4 -37.7 36.58 Favored 'General case' 1 C--N 1.429 4.05 0 CA-C-N 118.468 0.576 . . . . 7.79 110.325 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.531 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.76 83.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.512 -0.767 . . . . 7.73 111.062 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.6 mtt-85 -75.93 -43.36 45.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.377 0.51 . . . . 9.61 112.377 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.73 -37.86 88.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.177 0.513 . . . . 10.06 110.47 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.9 -16.56 74.71 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.307 -0.949 . . . . 9.23 112.889 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.29 36.95 70.83 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 110.809 -0.917 . . . . 9.25 110.809 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.84 5.25 51.95 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.888 0.699 . . . . 8.31 112.888 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.549 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.59 143.46 31.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.588 0.233 . . . . 9.16 110.573 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.586 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.6 -18.52 21.3 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.138 0.421 . . . . 10.23 112.138 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.71 163.56 23.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.722 -0.217 . . . . 9.89 110.735 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.41 143.54 99.68 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.947 1.765 . . . . 11.04 110.798 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.32 161.54 20.57 Favored Glycine 0 C--N 1.329 0.144 0 C-N-CA 120.558 -0.83 . . . . 9.31 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.0 m-20 -75.28 134.36 73.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 7.97 112.051 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.549 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.23 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.543 2.162 . . . . 6.59 111.308 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.68 105.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.117 -0.492 . . . . 5.87 111.161 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.42 71.39 0.74 Allowed 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 124.636 1.175 . . . . 0.0 109.31 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . 107.13 151.1 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 129.44 3.096 . . . . 0.0 112.946 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.41 130.55 8.39 Favored 'Isoleucine or valine' 0 C--N 1.374 1.64 0 C-N-CA 129.288 3.035 . . . . 5.67 109.31 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.19 126.55 55.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.772 -0.455 . . . . 6.47 109.772 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.599 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.9 125.97 72.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 116.983 2.216 . . . . 7.1 116.983 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.42 5.28 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 103.157 -2.905 . . . . 8.1 103.157 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.28 -57.38 7.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.678 1.733 . . . . 10.19 115.678 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -56.13 -48.82 75.48 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.852 0.686 . . . . 10.51 112.852 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.93 -9.16 50.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 9.72 111.847 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.18 36.05 15.22 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.548 1.314 . . . . 8.04 114.548 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -143.44 168.67 19.27 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.081 -1.047 . . . . 6.83 111.629 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.599 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.6 161.06 41.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.022 -1.445 . . . . 5.19 110.483 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.37 129.41 51.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.662 -0.866 . . . . 5.71 108.662 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.2 mt -94.86 137.52 33.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.361 -0.382 . . . . 4.27 110.288 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -114.76 114.68 25.91 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.697 -0.482 . . . . 6.21 109.697 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -99.73 164.69 11.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.016 -0.538 . . . . 6.14 111.981 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.88 22.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.432 -0.804 . . . . 8.37 111.46 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 87.8 p -128.91 159.61 35.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.114 0.483 . . . . 7.92 111.612 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.7 t -74.27 -41.74 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 8.77 112.257 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.586 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.71 -41.76 95.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.424 0.527 . . . . 9.08 112.424 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.85 -43.86 98.0 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 110.268 -0.271 . . . . 7.46 110.268 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.577 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.6 m -54.15 -54.0 45.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.125 -1.065 . . . . 6.18 108.125 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.7 m -55.31 -26.93 43.58 Favored 'General case' 1 C--N 1.43 4.081 0 C-N-CA 126.977 2.111 . . . . 0.0 109.878 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.15 -34.14 43.49 Favored 'General case' 0 C--N 1.421 3.683 0 N-CA-C 113.642 0.979 . . . . 8.7 113.642 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.52 -17.32 64.13 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.653 0.612 . . . . 5.94 112.653 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.8 mtp -62.08 -19.88 63.42 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 124.309 1.006 . . . . 6.89 111.631 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.31 53.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.416 -0.357 . . . . 7.4 111.647 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.77 16.19 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.487 -0.324 . . . . 6.97 111.666 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.89 121.04 14.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 7.38 110.751 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.71 -4.75 66.38 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 7.92 113.615 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.1 142.38 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.855 0.327 . . . . 7.5 111.094 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.96 121.61 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.311 0.577 . . . . 9.49 111.332 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -135.32 107.76 7.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.72 -0.673 . . . . 8.45 110.287 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.75 42.67 13.2 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.035 -0.53 . . . . 10.44 111.724 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.03 -5.47 53.88 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 115.247 0.859 . . . . 10.21 115.247 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -110.59 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.615 0.708 . . . . 9.94 112.417 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.4 t -82.88 101.49 11.04 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.542 -0.91 . . . . 8.4 108.542 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 69.9 mt -61.3 137.85 58.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.036 1.124 . . . . 6.9 114.036 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 1.035 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.7 tttt -108.55 110.26 21.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.57 -1.27 . . . . 8.29 107.57 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.98 126.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.405 0.52 . . . . 6.17 112.405 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.436 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.52 170.5 15.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.48 -0.782 . . . . 7.99 110.093 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.65 49.52 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.515 -0.92 . . . . 7.86 108.515 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.461 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 46.3 Cg_exo -57.43 175.18 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.953 1.769 . . . . 7.79 112.012 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -115.06 27.49 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 1.083 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 5.9 m-20 -75.33 126.57 31.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.326 174.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 65.71 106.54 0.04 OUTLIER 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.625 0.726 . . . . 0.0 111.08 -177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 234' ' ' PRO . 15.9 pt20 -63.03 141.89 97.7 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.71 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 233' ' ' GLN . 29.8 Cg_exo -62.36 -35.14 74.6 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.147 2.565 . . . . 0.0 112.401 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 236' ' ' PRO . 9.5 mp -88.15 135.64 32.97 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.243 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 235' ' ' LEU . 13.9 Cg_exo -69.48 175.84 7.34 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.97 2.447 . . . . 0.0 112.221 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -79.69 -178.33 51.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.924 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 26.8 ptm -140.2 174.55 10.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.75 0.275 . . . . 0.0 110.484 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 23.2 t -113.63 163.6 14.76 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.69 94.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -130.1 139.53 35.92 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.245 -174.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.97 106.34 1.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.562 2.175 . . . . 0.0 111.522 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.3 m -134.85 116.83 15.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.819 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.18 11.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 49.4 t80 62.59 83.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.035 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.626 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 57.8 t -82.25 -62.49 0.31 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.316 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 48.6 Cg_endo -69.46 110.41 2.49 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.763 1.642 . . . . 0.0 111.972 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -82.04 -6.88 88.5 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.372 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 17.9 m -113.27 129.38 69.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.085 0.469 . . . . 0.0 110.97 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 7.4 p -154.34 143.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.556 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 16.7 m -115.75 101.62 8.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.276 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 13.7 t -162.53 162.43 27.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.408 HG22 HD11 ' A' ' 235' ' ' LEU . 41.5 t 65.05 95.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 123.307 0.643 . . . . 0.0 111.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.48 119.7 18.53 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.202 0.525 . . . . 0.0 110.891 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.34 -149.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.012 2.474 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.8 104.66 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 68.0 m -149.5 100.59 3.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.777 -173.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -124.77 -71.16 0.72 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.875 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -140.56 31.07 1.88 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.996 -0.547 . . . . 10.8 110.862 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -62.94 139.33 58.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.035 -0.53 . . . . 8.21 110.365 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 334' ' ' ARG . 62.5 mt -109.79 144.07 38.74 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.076 -0.966 . . . . 6.33 112.826 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -104.47 132.02 51.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.228 -1.397 . . . . 6.75 107.228 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.95 121.2 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 109.608 -0.516 . . . . 5.68 109.608 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.21 179.19 16.52 Favored Glycine 0 CA--C 1.508 -0.389 0 C-N-CA 120.446 -0.883 . . . . 6.53 112.642 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.89 9.17 86.73 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.566 -0.826 . . . . 7.67 111.453 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.85 135.3 85.56 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 111.427 0.158 . . . . 8.16 111.427 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.85 141.48 90.14 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.962 1.775 . . . . 8.96 108.833 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -65.39 -14.83 61.76 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 114.788 1.403 . . . . 11.61 114.788 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -84.18 -23.13 30.71 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.788 1.403 . . . . 11.06 114.788 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.33 149.18 50.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.112 0.415 . . . . 9.36 111.344 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 31.0 p-10 -114.43 -176.44 2.9 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.608 -0.269 . . . . 10.46 110.279 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.55 -55.11 28.36 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.624 1.342 . . . . 9.92 114.624 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.94 -27.74 68.45 Favored 'General case' 0 C--N 1.406 3.052 0 C-N-CA 125.873 1.669 . . . . 0.0 112.332 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -79.64 -48.28 14.0 Favored 'General case' 1 C--N 1.429 4.065 0 O-C-N 123.486 0.491 . . . . 10.06 111.388 177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 72.1 t -62.72 -49.17 84.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.894 -0.594 . . . . 7.76 110.312 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -54.24 -36.49 63.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.679 -0.691 . . . . 9.67 111.27 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -61.92 -53.39 56.44 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.156 0.503 . . . . 10.2 110.728 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 278' ' ' LEU . 0.8 OUTLIER -51.8 -33.14 34.24 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.064 -0.516 . . . . 7.62 110.374 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.478 HD13 ' SG ' ' A' ' 305' ' ' CYS . 84.5 mt -82.62 -41.67 19.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.566 0.58 . . . . 7.74 112.566 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 61.0 m -56.87 -29.65 63.13 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.6 0.963 . . . . 10.09 113.6 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 18.5 m -50.36 -10.33 0.06 Allowed 'General case' 0 C--N 1.395 2.552 0 C-N-CA 124.809 1.244 . . . . 0.0 112.544 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -111.42 -11.94 14.07 Favored 'General case' 1 C--N 1.442 4.618 0 CA-C-N 118.281 0.491 . . . . 10.23 111.521 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.08 162.24 10.2 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.78 -0.646 . . . . 10.4 111.932 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.56 147.05 93.38 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.694 2.263 . . . . 12.19 112.736 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 85.7 mt -102.44 146.3 28.29 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.862 -0.608 . . . . 10.66 111.25 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 15.4 ptpt -101.14 -21.51 14.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.2 -0.667 . . . . 11.41 109.2 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -159.94 128.56 4.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 119.213 -2.179 . . . . 0.0 108.798 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.583 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.2 t80 -145.07 134.69 23.34 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.084 0.553 . . . . 8.77 112.005 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -144.8 124.09 13.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.809 0.338 . . . . 8.38 111.536 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 59.5 tp -100.99 118.23 36.59 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.578 -1.267 . . . . 8.94 107.578 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 25.3 t -74.17 122.91 28.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 113.457 0.91 . . . . 9.37 113.457 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -119.15 148.15 43.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.297 -0.865 . . . . 11.34 109.371 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 34.1 t70 -58.96 141.17 54.48 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.893 0.378 . . . . 13.83 110.943 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.1 m -49.73 -61.69 1.98 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.653 0.612 . . . . 14.58 112.653 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.11 -63.97 1.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.468 0.544 . . . . 16.19 112.468 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 7.1 m -42.51 -59.32 1.92 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.265 -0.425 . . . . 14.94 111.228 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.67 -6.03 62.5 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 120.617 -0.801 . . . . 13.57 114.503 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 79.9 mt -88.38 167.63 13.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.339 0.57 . . . . 13.28 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.6 t -59.32 142.22 52.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.529 . . . . 10.43 111.684 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 300' ' ' LYS . 3.8 mmmp? -87.89 -9.51 53.48 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 11.2 109.561 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.62 -3.34 39.42 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.625 -0.716 . . . . 8.63 113.89 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -143.06 146.35 33.72 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.055 0.927 . . . . 9.19 112.814 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.49 155.21 46.73 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.085 -0.961 . . . . 6.21 112.206 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -111.39 146.84 36.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.996 -1.002 . . . . 7.09 110.395 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.583 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 20.4 p -157.84 156.22 31.06 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 119.929 -0.708 . . . . 6.77 111.847 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -145.37 127.05 15.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.613 -0.722 . . . . 9.59 109.628 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.56 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 51.2 m-85 -82.38 164.91 20.73 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.98 0.419 . . . . 9.91 112.071 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.6 -46.05 64.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 108.463 -0.94 . . . . 12.81 108.463 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.701 ' O ' HG22 ' A' ' 312' ' ' VAL . 15.1 t70 -96.32 102.36 14.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.41 -1.33 . . . . 13.18 107.41 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.76 -34.96 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 N-CA-C 115.244 1.572 . . . . 12.23 115.244 -179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -56.77 -38.83 73.03 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 122.305 1.05 . . . . 13.04 109.048 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 309' ' ' ASP . 1.9 m -62.65 -22.81 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 112.283 -2.235 . . . . 11.08 109.518 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.5 m -54.52 -48.2 72.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.918 -0.771 . . . . 9.11 108.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.49 -42.8 99.74 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.239 -0.584 . . . . 10.31 110.521 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.89 -0.724 . . . . 11.98 111.974 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.73 74.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.647 -1.615 . . . . 8.25 113.076 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.61 -51.29 47.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.28 0.562 . . . . 7.4 110.864 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.96 -38.39 67.71 Favored 'General case' 0 C--N 1.421 3.679 0 C-N-CA 126.211 1.805 . . . . 0.0 113.296 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.18 -24.0 35.85 Favored Glycine 1 C--N 1.4 4.125 0 N-CA-C 116.779 1.472 . . . . 8.35 116.779 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.41 ' O ' HD23 ' A' ' 330' ' ' LEU . 98.1 mt -96.93 -45.69 6.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 120.193 1.997 . . . . 7.2 113.957 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -50.52 130.03 23.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.844 0.354 . . . . 7.86 111.514 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.22 -16.81 56.48 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.151 -0.547 . . . . 8.64 113.977 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 19.0 mtt -50.53 147.15 4.78 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.723 0.297 . . . . 8.0 111.363 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -95.0 115.6 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.018 0.437 . . . . 10.39 111.759 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 330' ' ' LEU . 8.8 mp -120.25 106.72 12.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.094 -1.076 . . . . 8.95 108.094 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.11 -118.75 10.65 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 109.347 -1.501 . . . . 10.63 109.347 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -115.8 22.45 13.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.141 0.496 . . . . 12.25 109.788 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.83 153.95 40.31 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.682 -0.69 . . . . 9.98 111.685 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.74 118.26 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.139 -1.06 . . . . 10.14 108.139 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 325' ' ' LEU . 22.7 tp -63.11 143.08 58.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.547 0.689 . . . . 7.52 112.601 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . 0.478 HD12 ' C2 ' ' B' ' 602' ' ' ' U' . 88.1 mt -128.08 128.0 44.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.563 -1.199 . . . . 7.48 109.032 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 60.7 t -137.98 124.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.957 0 O-C-N 120.99 -1.069 . . . . 6.45 109.945 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -152.79 155.33 36.94 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 120.126 -1.609 . . . . 7.66 109.514 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.516 ' HA ' HD23 ' A' ' 261' ' ' LEU . 69.7 mtt85 -58.68 122.57 13.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 118.418 -1.313 . . . . 8.94 107.617 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.98 -11.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.756 1.391 . . . . 7.52 114.756 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 23.4 m -119.46 -78.18 0.58 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.641 -0.424 . . . . 9.07 111.21 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 6.6 p -168.36 -42.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 0.0 110.467 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 176.15 -121.76 0.82 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.008 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -161.16 -164.94 1.24 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -69.97 -45.34 67.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.32 118.95 9.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.049 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.946 -179.657 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.404 " O2'" ' OP2' ' B' ' 602' ' ' ' U' . . . . . . . . 0 C2'--C1' 1.508 -2.049 0 O4'-C1'-N19 109.397 1.197 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 0.478 ' C2 ' HD12 ' A' ' 331' ' ' LEU . . . . . . . . 0 O5'--C5' 1.427 -0.791 0 O4'-C1'-C2' 107.546 0.819 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.434 ' H6 ' " O5'" ' B' ' 603' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 C4'-C3'-C2' 103.728 1.028 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 1.035 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 0 O3'--C3' 1.475 3.717 1 C3'-C2'-C1' 106.1 5.111 . 0.0 OUTLIER '7D dist 4g' 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.686 6.568 0 P-O3'-C3' 122.926 2.689 . 0.046 9a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.461 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 C3'--C2' 1.54 1.332 0 C4'-C3'-C2' 105.502 2.802 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 1.083 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C1'-C2' 107.611 0.865 . 0.0 OUTLIER '7D dist 3a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . 0.452 H5'' " H2'" ' B' ' 607' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.965 0 C3'-C2'-C1' 100.848 -0.724 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 O4'-C1'-C2' 107.23 0.593 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.578 ' HB2' HD13 ' A' ' 235' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.168 0.508 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -120.33 45.2 2.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.575 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -155.83 148.44 23.96 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 124.072 0.949 . . . . 5.88 111.087 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.568 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.7 mt -140.75 143.54 35.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 5.25 111.171 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -96.62 125.18 40.91 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.891 -0.781 . . . . 6.58 108.891 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.78 101.27 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.077 0.465 . . . . 5.06 110.166 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.74 -178.57 35.06 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.895 -0.593 . . . . 6.2 112.766 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.16 40.81 22.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.031 1.333 . . . . 0.0 110.151 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.79 149.85 88.2 Favored Pre-proline 1 C--N 1.429 4.062 0 C-N-CA 123.478 0.711 . . . . 7.79 111.33 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.01 144.43 89.71 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.251 1.967 . . . . 8.57 111.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -69.91 139.66 53.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.429 . . . . 11.37 111.954 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.05 6.76 61.16 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.745 -0.661 . . . . 9.94 114.298 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.15 136.49 26.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 117.314 0.557 . . . . 8.91 110.245 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -84.79 153.88 22.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.503 -0.317 . . . . 9.64 110.692 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -60.13 -43.25 95.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.347 -0.388 . . . . 7.44 110.174 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.6 -46.12 91.18 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.064 -0.517 . . . . 9.89 110.548 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.34 -26.59 68.52 Favored 'General case' 0 C--N 1.409 3.179 0 O-C-N 119.261 -2.149 . . . . 0.0 111.675 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.483 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.4 -34.11 67.65 Favored 'General case' 0 C--N 1.427 3.975 0 O-C-N 123.889 0.743 . . . . 6.64 111.727 172.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.2 ttt -74.61 -54.3 7.72 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.51 0.724 . . . . 6.69 111.052 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.52 -33.73 60.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.43 -0.804 . . . . 8.8 111.381 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.52 17.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 120.43 -0.508 . . . . 7.44 111.617 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.0 m-85 -61.4 -48.18 82.41 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.114 0.413 . . . . 5.94 112.114 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.0 m-20 -56.83 -43.0 80.63 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.547 -0.538 . . . . 7.12 109.547 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -23.53 65.18 Favored 'General case' 0 C--N 1.406 3.026 0 O-C-N 120.192 -1.567 . . . . 0.0 111.231 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.35 -37.67 36.91 Favored 'General case' 1 C--N 1.429 4.061 0 CA-C-N 118.546 0.612 . . . . 7.79 110.31 176.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.549 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.69 -36.81 83.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.498 -0.774 . . . . 7.73 111.033 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.4 mtt-85 -76.1 -43.03 45.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.37 0.507 . . . . 9.61 112.37 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.3 mt -62.99 -37.76 88.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.193 0.52 . . . . 10.06 110.388 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.11 -16.39 74.64 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.239 -0.981 . . . . 9.23 112.796 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.98 71.59 Favored Glycine 0 C--N 1.332 0.355 0 N-CA-C 110.888 -0.885 . . . . 9.25 110.888 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 5.3 51.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.941 0.719 . . . . 8.31 112.941 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 185' ' ' PRO . 70.7 p -82.64 143.44 30.98 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.129 -0.228 . . . . 9.16 110.665 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.585 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.57 -18.51 21.34 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 112.156 0.428 . . . . 10.23 112.156 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.45 23.82 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.691 -0.231 . . . . 9.89 110.722 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.32 143.45 99.73 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.997 1.798 . . . . 11.04 110.771 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.37 161.62 20.54 Favored Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.642 -0.789 . . . . 9.31 112.465 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 88.8 m-20 -75.33 134.49 73.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 7.97 112.029 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.33 -50.97 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.519 2.146 . . . . 6.59 111.315 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.71 105.32 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.111 -0.495 . . . . 5.87 111.146 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -37.59 40.47 Favored 'General case' 0 N--CA 1.533 3.68 0 C-N-CA 125.508 1.523 . . . . 0.0 112.848 -178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.38 164.48 38.09 Favored 'General case' 0 C--N 1.387 2.224 0 C-N-CA 125.938 1.695 . . . . 0.0 110.891 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.08 130.49 11.34 Favored 'Isoleucine or valine' 0 C--N 1.372 1.573 0 C-N-CA 126.291 1.836 . . . . 5.67 109.329 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -114.12 126.65 55.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.716 -0.475 . . . . 6.47 109.716 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.3 mt -114.91 125.92 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 116.937 2.199 . . . . 7.1 116.937 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -98.09 91.34 5.24 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 103.182 -2.896 . . . . 8.1 103.182 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.26 -57.34 8.05 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.676 1.732 . . . . 10.19 115.676 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.15 -48.87 75.44 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.831 0.678 . . . . 10.51 112.831 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -68.96 -9.12 50.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.768 0.285 . . . . 9.72 111.768 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.07 36.17 15.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.547 1.314 . . . . 8.04 114.547 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -143.5 168.73 19.16 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 119.118 -1.033 . . . . 6.83 111.661 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.6 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.63 161.03 41.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.031 -1.44 . . . . 5.19 110.518 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -123.4 129.41 51.24 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.676 -0.861 . . . . 5.71 108.676 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 97.3 mt -94.75 137.58 33.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.407 -0.361 . . . . 4.27 110.359 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -114.86 114.68 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.703 -0.48 . . . . 6.21 109.703 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -99.68 164.65 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.989 -0.55 . . . . 6.14 111.951 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.62 -25.93 22.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.439 -0.8 . . . . 8.37 111.427 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.2 p -128.92 159.59 35.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.155 0.503 . . . . 7.92 111.607 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.21 -41.82 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.59 -0.732 . . . . 8.77 112.247 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.585 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.5 t70 -64.7 -41.73 95.8 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.339 0.496 . . . . 9.08 112.339 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.88 -43.89 97.93 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.202 -0.295 . . . . 7.46 110.202 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.568 HG23 ' HG ' ' A' ' 151' ' ' LEU . 56.0 m -54.17 -53.88 47.37 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.159 -1.052 . . . . 6.18 108.159 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 16.1 m -55.1 -27.2 43.33 Favored 'General case' 1 C--N 1.429 4.051 0 C-N-CA 127.127 2.171 . . . . 0.0 109.739 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.46 -33.95 41.9 Favored 'General case' 0 C--N 1.423 3.779 0 N-CA-C 113.6 0.963 . . . . 8.7 113.6 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.62 -17.3 64.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 5.94 112.638 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.9 mtp -62.12 -19.84 63.43 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.377 1.048 . . . . 6.89 111.556 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.43 -9.3 53.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.456 -0.338 . . . . 7.4 111.656 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -93.85 16.18 14.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.466 -0.333 . . . . 6.97 111.651 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -65.82 120.96 13.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 7.38 110.75 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.83 -4.79 66.09 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.884 -0.674 . . . . 7.92 113.579 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.833 0.316 . . . . 7.5 111.098 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -85.0 121.63 37.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.35 0.595 . . . . 9.49 111.286 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -135.36 107.67 7.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 8.45 110.357 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.69 42.64 13.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.975 -0.557 . . . . 10.44 111.767 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 78.08 -5.45 54.18 Favored Glycine 0 C--N 1.33 0.242 0 N-CA-C 115.248 0.859 . . . . 10.21 115.248 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -110.58 130.94 55.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.627 0.713 . . . . 9.94 112.375 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.3 t -82.73 101.53 10.95 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.506 -0.924 . . . . 8.4 108.506 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.89 58.25 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.979 1.103 . . . . 6.9 113.979 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.918 ' NZ ' " H2'" ' B' ' 604' ' ' ' U' . 75.8 tttt -108.59 110.29 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.477 -1.305 . . . . 8.29 107.477 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.2 mt -103.98 126.89 58.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.36 0.504 . . . . 6.17 112.36 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.432 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.5 mmt85 -141.61 170.46 15.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.388 -0.824 . . . . 7.99 110.019 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -89.02 154.67 49.74 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 108.635 -0.876 . . . . 7.86 108.635 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.485 ' HA ' ' O2 ' ' B' ' 606' ' ' ' U' . 45.7 Cg_exo -57.21 174.82 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.985 1.79 . . . . 7.79 111.982 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -113.08 23.72 13.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.566 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.726 ' OD2' ' O4 ' ' B' ' 607' ' ' ' U' . 7.3 m-20 -64.07 149.7 47.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.01 0.433 . . . . 0.0 111.647 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -61.07 113.81 2.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.88 -175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 62.01 93.75 0.06 OUTLIER Pre-proline 0 N--CA 1.461 0.108 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.04 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.54 -179.43 3.68 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.674 2.25 . . . . 0.0 111.489 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.578 HD13 ' HB2' ' A' ' 148' ' ' ALA . 10.8 mp -72.5 142.31 83.89 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.964 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.01 119.34 5.93 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.98 2.453 . . . . 0.0 112.765 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -145.91 143.49 11.72 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 95.6 mmm -122.02 9.99 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.861 0.331 . . . . 0.0 111.046 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.0 m 58.88 23.58 11.52 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.436 0.636 . . . . 0.0 110.782 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -98.44 16.5 21.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.908 -175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.715 ' HB3' ' HD3' ' A' ' 242' ' ' PRO . 25.3 t-20 -50.59 -54.2 38.1 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.652 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.715 ' HD3' ' HB3' ' A' ' 241' ' ' ASN . 67.0 Cg_endo -91.09 16.81 1.51 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.151 1.901 . . . . 0.0 112.13 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.0 t 68.35 146.62 0.05 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.748 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 31.2 m -114.49 166.08 8.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.931 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.848 ' HA ' HG22 ' A' ' 249' ' ' VAL . 37.7 t80 71.29 12.64 6.72 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.443 0.639 . . . . 0.0 110.055 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.658 ' HB ' ' HD3' ' A' ' 247' ' ' PRO . 58.8 t -67.13 -59.04 8.03 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.72 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.658 ' HD3' ' HB ' ' A' ' 246' ' ' VAL . 81.0 Cg_endo -77.97 9.16 3.13 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.107 1.872 . . . . 0.0 113.138 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 82.75 79.49 1.01 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.094 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . 0.848 HG22 ' HA ' ' A' ' 245' ' ' TYR . 32.0 m -110.31 -172.72 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.29 115.88 50.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 50.6 m 71.54 170.55 0.32 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.233 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 9.8 t -74.88 -13.86 60.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.174 0.511 . . . . 0.0 110.763 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 6.7 p -132.7 117.7 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.351 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 256' ' ' ASP . 5.7 p -125.75 126.38 24.92 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.826 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 339' ' ' ALA . 12.4 Cg_exo -71.5 15.52 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.368 2.712 . . . . 0.0 113.715 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -96.64 -8.63 31.15 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.3 m -61.75 138.46 58.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.998 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . 70.32 105.69 0.06 Allowed 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.991 0.807 . . . . 0.0 110.35 -174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -98.21 31.02 2.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.213 -0.903 . . . . 10.8 110.791 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.91 139.37 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.501 . . . . 8.21 110.337 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' A' ' 334' ' ' ARG . 52.2 mt -109.77 143.95 38.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.019 -0.991 . . . . 6.33 112.849 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -104.39 132.05 51.07 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.138 -1.43 . . . . 6.75 107.138 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.03 121.25 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 109.601 -0.518 . . . . 5.68 109.601 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.17 179.2 16.5 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.444 -0.884 . . . . 6.53 112.71 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.79 9.19 86.56 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.668 -0.777 . . . . 7.67 111.532 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 267' ' ' PRO . 98.3 mt -70.89 135.32 85.47 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 111.465 0.172 . . . . 8.16 111.465 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 266' ' ' LEU . 37.0 Cg_exo -61.79 141.54 90.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.95 1.767 . . . . 8.96 108.792 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -65.39 -14.87 61.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.759 1.392 . . . . 11.61 114.759 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -84.15 -23.18 30.74 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.758 1.392 . . . . 11.06 114.758 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.26 149.18 50.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.165 0.439 . . . . 9.36 111.388 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 275' ' ' VAL . 37.7 p-10 -114.59 -176.4 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 110.207 -0.294 . . . . 10.46 110.207 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -53.56 -55.3 26.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.617 1.34 . . . . 9.92 114.617 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -61.32 -27.05 68.21 Favored 'General case' 0 C--N 1.407 3.084 0 C-N-CA 125.565 1.546 . . . . 0.0 112.392 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -79.59 -48.3 14.02 Favored 'General case' 1 C--N 1.429 4.024 0 CA-C-N 118.263 0.483 . . . . 10.06 111.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 271' ' ' ASN . 66.2 t -62.65 -49.26 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.834 -0.621 . . . . 7.76 110.285 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.25 -36.41 63.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.635 -0.711 . . . . 9.67 111.279 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -62.12 -53.35 56.63 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.052 0.453 . . . . 10.2 110.642 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.8 -33.17 34.38 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.889 0.476 . . . . 7.62 110.283 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.517 HD13 ' SG ' ' A' ' 305' ' ' CYS . 85.2 mt -82.6 -41.7 19.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.552 0.575 . . . . 7.74 112.552 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 50.6 m -56.82 -30.69 63.99 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.589 0.959 . . . . 10.09 113.589 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.6 m -52.4 -7.73 0.07 Allowed 'General case' 0 C--N 1.397 2.65 0 O-C-N 120.602 -1.311 . . . . 0.0 112.766 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -110.31 -12.05 14.48 Favored 'General case' 1 C--N 1.443 4.67 0 CA-C-N 118.413 0.552 . . . . 10.23 111.492 178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.09 162.28 10.22 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.775 -0.648 . . . . 10.4 111.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.54 146.98 93.6 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.776 2.317 . . . . 12.19 112.746 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 73.0 mt -102.43 146.27 28.32 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.935 -0.575 . . . . 10.66 111.348 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.98 -22.73 14.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.256 -0.646 . . . . 11.41 109.256 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.15 5.08 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 119.155 -2.216 . . . . 0.0 109.159 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.631 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 59.3 t80 -143.39 134.68 25.94 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 122.785 0.434 . . . . 8.77 111.98 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -144.75 124.05 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.547 -0.297 . . . . 8.38 111.58 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 53.0 tp -101.06 118.21 36.55 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 107.634 -1.247 . . . . 8.94 107.634 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.413 HG12 ' HG3' ' A' ' 300' ' ' LYS . 41.2 t -74.11 122.87 28.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.469 0.915 . . . . 9.37 113.469 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.07 148.1 43.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.359 -0.837 . . . . 11.34 109.345 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 35.3 t70 -58.89 141.19 54.14 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.894 0.378 . . . . 13.83 110.984 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 26.5 m -49.82 -61.67 2.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.842 -0.617 . . . . 14.58 112.571 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.09 -63.99 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.527 0.566 . . . . 16.19 112.527 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 6.4 m -42.5 -59.25 1.94 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.324 -0.398 . . . . 14.94 111.184 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.61 -6.08 62.66 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.62 -0.8 . . . . 13.57 114.493 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 90.0 mt -88.35 167.64 13.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.415 0.608 . . . . 13.28 110.878 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 46.9 t -59.21 142.07 52.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 10.43 111.58 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.413 ' HG3' HG12 ' A' ' 291' ' ' VAL . 4.1 mmmp? -87.91 -9.43 53.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.762 -0.653 . . . . 11.2 109.627 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.32 39.63 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.68 -0.691 . . . . 8.63 113.892 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.702 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 26.4 p90 -142.96 146.33 33.84 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.054 0.927 . . . . 9.19 112.92 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.52 155.19 46.71 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.158 -0.928 . . . . 6.21 112.213 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -111.37 146.77 36.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.055 -0.975 . . . . 7.09 110.407 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.631 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 23.1 p -157.73 156.18 31.2 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.906 -0.717 . . . . 6.77 111.928 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -145.2 127.07 15.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.722 -0.672 . . . . 9.59 109.716 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 285' ' ' LEU . 54.8 m-85 -82.47 164.88 20.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.932 0.396 . . . . 9.91 112.025 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.58 -46.12 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.369 -0.975 . . . . 12.81 108.369 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.739 ' O ' HG22 ' A' ' 312' ' ' VAL . 16.9 t70 -96.3 102.37 14.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.385 -1.339 . . . . 13.18 107.385 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.71 -35.04 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 115.293 1.59 . . . . 12.23 115.293 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -56.85 -38.68 73.02 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-O 122.263 1.03 . . . . 13.04 109.005 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.5 m -62.75 -22.65 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.322 -2.217 . . . . 11.08 109.578 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 93.9 m -54.72 -48.07 72.96 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.966 -0.753 . . . . 9.11 108.966 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.52 -42.67 99.67 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 120.138 -0.625 . . . . 10.31 110.554 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -63.94 -32.33 73.82 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.867 -0.733 . . . . 11.98 111.918 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.78 74.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.791 -1.55 . . . . 8.25 113.021 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.58 -51.36 47.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.384 0.611 . . . . 7.4 110.872 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.85 -38.7 67.78 Favored 'General case' 0 C--N 1.421 3.712 0 C-N-CA 126.273 1.829 . . . . 0.0 113.086 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.06 -23.97 36.33 Favored Glycine 1 C--N 1.401 4.188 0 N-CA-C 116.807 1.483 . . . . 8.35 116.807 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' 330' ' ' LEU . 99.0 mt -96.89 -45.75 6.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 120.19 1.995 . . . . 7.2 113.984 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -50.47 130.14 23.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.851 0.358 . . . . 7.86 111.468 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.04 -16.64 56.61 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.134 -0.555 . . . . 8.64 113.983 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 17.2 mtt -50.61 147.19 4.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.836 0.318 . . . . 8.0 111.302 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -95.09 115.57 27.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.968 0.413 . . . . 10.39 111.662 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.629 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.6 mm? -120.16 106.72 12.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.111 -1.07 . . . . 8.95 108.111 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 67.13 -118.65 10.52 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.406 -1.477 . . . . 10.63 109.406 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -115.94 22.48 12.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.145 0.498 . . . . 12.25 109.741 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 328' ' ' LYS . 34.1 mtpt -123.89 153.91 40.46 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.597 -0.729 . . . . 9.98 111.583 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.76 118.28 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.116 -1.068 . . . . 10.14 108.116 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.629 ' HB2' HD23 ' A' ' 325' ' ' LEU . 22.3 tp -63.11 143.22 57.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.537 0.684 . . . . 7.52 112.612 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 59.5 tp -128.21 128.01 43.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.486 -1.234 . . . . 7.48 108.961 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.02 124.0 25.76 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 O-C-N 121.038 -1.039 . . . . 6.45 109.955 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.73 155.34 37.02 Favored 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 119.938 -1.726 . . . . 7.66 109.488 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.539 ' HA ' HD23 ' A' ' 261' ' ' LEU . 99.2 mtt180 -58.62 122.51 13.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.422 -1.311 . . . . 8.94 107.59 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.88 -11.82 0.1 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.795 1.406 . . . . 7.52 114.795 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . 0.511 ' O ' ' HB ' ' A' ' 337' ' ' VAL . 17.3 m -119.4 -75.9 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.613 -0.435 . . . . 9.07 111.303 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 336' ' ' SER . 70.0 t 79.04 120.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.374 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -167.52 -53.48 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.894 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 255' ' ' PRO . . . -101.35 96.13 6.97 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.899 0.381 . . . . 0.0 111.028 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -128.46 -49.5 1.28 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.638 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -127.03 -3.63 6.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.047 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.474 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.545 178.38 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.507 -2.07 0 O4'-C1'-N19 109.397 1.197 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.949 0 O4'-C1'-C2' 107.714 0.939 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.702 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.423 -1.039 0 C1'-O4'-C4' 110.243 0.714 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.918 " H2'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 2 C4'--C3' 1.569 4.07 1 C3'-C2'-C1' 105.705 4.672 . 0.0 OUTLIER '7D dist 4g' 0.0 . . . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.688 6.782 0 P-O3'-C3' 124.066 3.638 . 0.01 9a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . 0.485 ' O2 ' ' HA ' ' A' ' 229' ' ' PRO . . . . . . . . 0 O4'--C1' 1.402 -1.024 0 C4'-C3'-C2' 105.74 3.04 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 0.726 ' O4 ' ' OD2' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 O4'-C1'-C2' 107.444 0.746 . 0.02 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C1'-C2' 107.281 0.63 . 0.01 1f . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.986 0 C3'-C2'-C1' 100.714 -0.873 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.599 0.238 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -126.49 53.92 1.62 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.371 -0.206 . . . . 0.0 111.039 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 5.5 mtt180 -157.01 148.53 22.31 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.832 0.708 . . . . 5.88 111.351 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' HG ' HG23 ' A' ' 208' ' ' THR . 27.5 mt -140.65 143.54 35.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 5.25 111.21 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -96.6 125.21 40.91 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.822 -0.807 . . . . 6.58 108.822 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 198' ' ' ALA . 2.3 p -124.84 101.3 8.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.174 0.512 . . . . 5.06 110.199 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.75 -179.76 34.62 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.983 -0.553 . . . . 6.2 112.734 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 m120 49.21 42.54 21.75 Favored 'General case' 0 CA--C 1.573 1.829 0 C-N-CA 125.649 1.58 . . . . 0.0 110.391 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.0 pt -73.28 149.84 89.35 Favored Pre-proline 0 C--N 1.426 3.929 0 CA-C-N 114.95 -1.023 . . . . 7.79 111.333 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.06 144.5 89.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.341 2.027 . . . . 8.57 110.972 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -69.95 139.71 52.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 11.37 111.947 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 71.14 6.53 61.03 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.837 -0.619 . . . . 9.94 114.32 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 191' ' ' ILE . 10.9 tp -66.1 136.47 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.332 0.566 . . . . 8.91 110.303 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.6 p -84.88 153.8 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.694 0.283 . . . . 9.64 110.626 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -60.09 -43.1 95.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 7.44 110.23 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -61.75 -45.88 92.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.012 -0.54 . . . . 9.89 110.535 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.4 -26.83 68.69 Favored 'General case' 0 C--N 1.41 3.217 0 O-C-N 119.408 -2.057 . . . . 0.0 111.606 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.479 ' HE2' ' HE2' ' A' ' 169' ' ' PHE . 4.6 tpt -72.27 -34.12 67.99 Favored 'General case' 1 C--N 1.429 4.043 0 O-C-N 123.978 0.799 . . . . 6.64 111.875 172.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 22.3 ttt -74.53 -54.28 7.81 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.368 0.667 . . . . 6.69 111.055 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -54.65 -33.69 61.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.434 -0.803 . . . . 8.8 111.378 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -69.78 -53.59 17.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 120.612 -0.435 . . . . 7.44 111.555 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.479 ' HE2' ' HE2' ' A' ' 165' ' ' MET . 29.2 m-85 -61.3 -48.26 82.17 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.175 0.435 . . . . 5.94 112.175 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 185' ' ' PRO . 58.3 m-20 -56.75 -42.7 79.78 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.196 -0.602 . . . . 7.12 109.54 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.64 -22.96 64.38 Favored 'General case' 0 C--N 1.404 2.965 0 O-C-N 120.213 -1.554 . . . . 0.0 111.246 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -79.37 -37.69 36.78 Favored 'General case' 0 C--N 1.427 3.977 0 CA-C-N 118.502 0.592 . . . . 7.79 110.291 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.541 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 4.0 mmt -66.75 -36.66 82.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.707 . . . . 7.73 111.054 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 174' ' ' ARG . 57.3 mtt-85 -76.15 -42.88 45.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.386 0.514 . . . . 9.61 112.386 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 46.4 mt -63.22 -37.66 88.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.274 0.559 . . . . 10.06 110.399 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.12 -16.44 74.49 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.338 -0.934 . . . . 9.23 112.835 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.15 37.04 72.19 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.871 -0.892 . . . . 9.25 110.871 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.99 5.42 51.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.828 0.677 . . . . 8.31 112.828 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 185' ' ' PRO . 71.3 p -82.66 143.53 30.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.599 0.237 . . . . 9.16 110.534 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.585 HE22 ' HB3' ' A' ' 206' ' ' ASP . 3.8 pt20 -94.74 -18.4 21.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 112.105 0.409 . . . . 10.23 112.105 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -150.79 163.4 24.01 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.682 -0.235 . . . . 9.89 110.75 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -59.28 143.45 99.74 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 121.935 1.757 . . . . 11.04 110.853 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 108.36 161.56 20.53 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.606 -0.807 . . . . 9.31 112.436 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 89.1 m-20 -75.3 134.46 73.66 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 7.97 111.982 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 179' ' ' THR . 12.6 Cg_exo -73.31 -51.0 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.493 2.129 . . . . 6.59 111.298 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.67 106.18 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.147 -0.479 . . . . 5.87 111.16 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -32.44 25.58 Favored 'General case' 0 N--CA 1.525 3.283 0 O-C-N 119.686 -1.884 . . . . 0.0 113.856 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -153.33 163.26 40.23 Favored 'General case' 0 C--N 1.384 2.07 0 C-N-CA 125.754 1.621 . . . . 0.0 110.409 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.88 130.56 11.94 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 C-N-CA 126.529 1.931 . . . . 5.67 109.31 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -114.11 126.57 55.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.776 -0.453 . . . . 6.47 109.776 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 198' ' ' ALA . 97.2 mt -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 116.893 2.183 . . . . 7.1 116.893 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -97.9 91.35 5.29 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 103.234 -2.876 . . . . 8.1 103.234 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.33 -57.47 7.83 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.566 1.691 . . . . 10.19 115.566 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.11 -48.77 75.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.9 0.704 . . . . 10.51 112.9 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -68.94 -9.18 50.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.855 0.317 . . . . 9.72 111.855 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 62.24 35.87 15.13 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.55 1.315 . . . . 8.04 114.55 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -143.38 168.79 18.99 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.116 -1.033 . . . . 6.83 111.612 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.605 ' HB2' HG12 ' A' ' 191' ' ' ILE . . . -147.7 161.14 41.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.23 -1.35 . . . . 5.19 110.355 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -123.35 129.43 51.3 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.716 -0.846 . . . . 5.71 108.716 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 150' ' ' ARG . 96.6 mt -94.97 137.56 33.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.518 -0.31 . . . . 4.27 110.349 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -114.83 114.72 25.91 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.674 -0.491 . . . . 6.21 109.674 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.68 164.68 11.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.876 -0.602 . . . . 6.14 111.971 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -88.65 -25.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.421 -0.809 . . . . 8.37 111.427 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 88.3 p -128.96 159.6 35.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.115 0.483 . . . . 7.92 111.666 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -74.25 -41.8 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.571 -0.74 . . . . 8.77 112.272 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.585 ' HB3' HE22 ' A' ' 180' ' ' GLN . 27.6 t70 -64.66 -41.71 95.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.388 0.514 . . . . 9.08 112.388 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -61.84 -43.95 97.81 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.243 -0.281 . . . . 7.46 110.243 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.56 HG23 ' HG ' ' A' ' 151' ' ' LEU . 55.4 m -54.13 -53.97 46.03 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.192 -1.04 . . . . 6.18 108.192 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.8 m -55.22 -27.11 43.83 Favored 'General case' 0 C--N 1.428 4.0 0 C-N-CA 127.001 2.12 . . . . 0.0 109.796 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -34.11 43.47 Favored 'General case' 0 C--N 1.42 3.641 0 N-CA-C 113.613 0.968 . . . . 8.7 113.613 176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -68.57 -17.32 64.11 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.654 0.613 . . . . 5.94 112.654 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 57.7 mtp -62.05 -19.84 63.33 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 124.505 1.128 . . . . 6.89 111.652 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.53 -9.21 52.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 7.4 111.654 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -93.8 16.25 14.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 6.97 111.625 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -65.88 120.96 13.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 7.38 110.765 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 95.87 -4.81 66.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.928 -0.653 . . . . 7.92 113.599 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 20.9 tt -55.16 142.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.845 0.323 . . . . 7.5 111.124 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 218' ' ' ILE . 10.0 tp -84.94 121.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.265 0.555 . . . . 9.49 111.333 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -135.34 107.74 7.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 8.45 110.292 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 60.74 42.67 13.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 10.44 111.771 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 77.96 -5.33 54.2 Favored Glycine 0 C--N 1.331 0.287 0 N-CA-C 115.201 0.84 . . . . 10.21 115.201 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -110.67 130.9 55.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.651 0.726 . . . . 9.94 112.356 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 33.2 t -82.67 101.46 10.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.556 -0.905 . . . . 8.4 108.556 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.3 mt -61.37 137.85 58.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.994 1.109 . . . . 6.9 113.994 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.84 ' NZ ' " H1'" ' B' ' 604' ' ' ' U' . 75.6 tttt -108.58 110.28 21.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.523 -1.288 . . . . 8.29 107.523 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 65.4 mt -103.95 126.94 58.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 6.17 112.338 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.427 ' NH1' ' HE3' ' A' ' 225' ' ' LYS . 5.6 mmt85 -141.61 170.56 15.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.384 -0.826 . . . . 7.99 110.038 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 228' ' ' ARG . 3.5 mtp180 -89.11 154.67 49.55 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 108.535 -0.913 . . . . 7.86 108.535 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.16 174.78 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 121.988 1.792 . . . . 7.79 112.033 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.13 -46.88 13.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 1.207 ' OD1' ' O4 ' ' B' ' 607' ' ' ' U' . 6.7 p-10 -79.85 174.48 11.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.335 166.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -129.16 -36.18 1.76 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.04 0.448 . . . . 0.0 109.912 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -140.21 153.36 68.92 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.569 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.18 -23.11 73.01 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.611 2.207 . . . . 0.0 112.085 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 95.2 mt -89.24 142.88 30.24 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.585 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.57 111.81 1.27 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.879 2.386 . . . . 0.0 112.764 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . -138.35 66.41 0.53 Allowed Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.919 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' MET . . . . . . . . . . . . . 24.5 ttt -109.62 -60.48 1.77 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.5 t -110.76 -38.09 5.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.811 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -83.8 101.34 11.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.304 0.573 . . . . 0.0 110.101 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.562 ' HB3' ' HB ' ' A' ' 244' ' ' VAL . 27.5 t-20 -143.83 132.28 11.11 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.124 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 241' ' ' ASN . 73.0 Cg_exo -49.91 104.52 0.08 OUTLIER 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.198 2.599 . . . . 0.0 113.566 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.3 m 60.41 29.67 19.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.052 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 241' ' ' ASN . 7.3 p -64.35 110.98 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.553 0.692 . . . . 0.0 112.023 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -169.8 129.81 0.99 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.104 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 247' ' ' PRO . 30.2 m -111.71 144.95 31.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.608 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 246' ' ' VAL . 7.9 Cg_exo -72.84 109.76 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.804 2.336 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.75 94.49 1.44 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.552 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' VAL . . . . . . . . . . . . . 26.8 m -76.3 -17.27 15.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 111.279 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.04 -46.95 8.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.36 0.6 . . . . 0.0 109.418 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 t -114.6 92.26 3.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.555 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.0 m -87.31 -13.36 43.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.052 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.5 t 62.64 72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.894 -176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.546 ' HB ' ' HD2' ' A' ' 255' ' ' PRO . 30.0 m -115.99 164.26 18.4 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.337 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.546 ' HD2' ' HB ' ' A' ' 254' ' ' VAL . 18.9 Cg_endo -61.52 -22.32 74.19 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.149 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -74.11 101.91 4.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 p -134.35 98.59 4.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.362 175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -86.4 154.48 21.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.853 0.835 . . . . 0.0 112.477 -171.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -135.16 31.07 3.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.334 -1.303 . . . . 10.8 110.745 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -63.01 139.36 58.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.211 0.529 . . . . 8.21 110.306 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 334' ' ' ARG . 69.6 mt -109.74 144.0 38.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.957 -1.019 . . . . 6.33 112.783 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.414 ' HD1' ' CE1' ' A' ' 304' ' ' PHE . 51.4 t80 -104.5 132.15 51.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.245 -1.391 . . . . 6.75 107.245 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.0 121.22 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.531 -0.544 . . . . 5.68 109.531 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 330' ' ' LEU . . . -127.2 179.21 16.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.516 -0.849 . . . . 6.53 112.674 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.8 9.18 86.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.589 -0.815 . . . . 7.67 111.552 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.85 135.27 85.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 111.446 0.165 . . . . 8.16 111.446 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.77 141.54 90.76 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 121.832 1.688 . . . . 8.96 108.832 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -65.39 -14.92 61.96 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.752 1.39 . . . . 11.61 114.752 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -84.1 -23.13 30.89 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.836 1.421 . . . . 11.06 114.836 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.34 149.2 50.73 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.105 0.411 . . . . 9.36 111.333 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 275' ' ' VAL . 25.1 p-10 -114.49 -176.45 2.9 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 110.244 -0.28 . . . . 10.46 110.244 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 276' ' ' LYS . 4.5 m-20 -53.59 -55.54 24.89 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.611 1.338 . . . . 9.92 114.611 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.14 -26.83 67.96 Favored 'General case' 0 C--N 1.405 3.008 0 C-N-CA 125.724 1.61 . . . . 0.0 112.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -79.78 -48.35 13.74 Favored 'General case' 1 C--N 1.432 4.185 0 CA-C-N 118.3 0.5 . . . . 10.06 111.387 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 271' ' ' ASN . 88.9 t -62.69 -49.15 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 7.76 110.315 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 272' ' ' ASP . 31.8 mtmm -54.35 -36.3 63.67 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.616 -0.72 . . . . 9.67 111.362 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.06 -53.45 55.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.096 0.474 . . . . 10.2 110.644 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -51.73 -33.02 32.72 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.092 -0.503 . . . . 7.62 110.447 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.461 HD13 ' SG ' ' A' ' 305' ' ' CYS . 77.3 mt -82.76 -41.72 18.86 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.497 0.554 . . . . 7.74 112.497 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' THR . . . . . . . . . . . . . 55.7 m -56.76 -30.08 63.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.583 0.957 . . . . 10.09 113.583 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 29.6 m -50.36 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.395 2.563 0 C-N-CA 124.78 1.232 . . . . 0.0 112.671 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -111.67 -12.05 13.93 Favored 'General case' 1 C--N 1.444 4.705 0 CA-C-N 118.388 0.54 . . . . 10.23 111.435 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 149.17 162.23 10.21 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.874 -0.603 . . . . 10.4 111.951 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 147.01 93.51 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.7 2.267 . . . . 12.19 112.78 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 307' ' ' TYR . 76.1 mt -102.41 146.23 28.38 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.95 -0.568 . . . . 10.66 111.254 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 307' ' ' TYR . 14.5 ptpt -101.0 -22.72 14.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 11.41 109.302 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -158.57 125.36 4.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 119.051 -2.281 . . . . 0.0 109.245 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.53 ' HD1' ' HB3' ' A' ' 305' ' ' CYS . 47.1 t80 -142.82 134.76 27.01 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 122.777 0.431 . . . . 8.77 112.014 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -144.8 124.11 13.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.714 0.292 . . . . 8.38 111.481 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 303' ' ' ALA . 56.9 tp -101.04 118.24 36.6 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.55 -1.278 . . . . 8.94 107.55 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 49.0 t -74.23 122.87 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 113.473 0.916 . . . . 9.37 113.473 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -119.15 148.08 43.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.232 -0.894 . . . . 11.34 109.329 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' A' ' 296' ' ' THR . 25.5 t70 -58.95 141.2 54.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.966 0.412 . . . . 13.83 110.894 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.592 ' HB3' ' C2 ' ' B' ' 605' ' ' ' U' . 18.7 m -49.78 -61.68 1.99 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.802 -0.635 . . . . 14.58 112.606 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.07 -64.02 1.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.536 0.569 . . . . 16.19 112.536 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 293' ' ' ASP . 3.9 m -42.51 -59.3 1.93 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.254 -0.43 . . . . 14.94 111.21 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 97.72 -6.16 62.47 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.592 -0.814 . . . . 13.57 114.545 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.29 167.55 13.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.355 0.578 . . . . 13.28 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 47.0 t -59.15 142.08 52.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 10.43 111.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.939 ' NZ ' " O2'" ' B' ' 601' ' ' ' U' . 4.4 mmmp? -87.94 -9.46 53.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.802 -0.636 . . . . 11.2 109.625 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . 105.59 -3.39 39.54 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.56 -0.746 . . . . 8.63 113.857 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.629 ' OH ' " H4'" ' B' ' 603' ' ' ' U' . 42.7 p90 -142.96 146.46 33.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.146 0.973 . . . . 9.19 112.75 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 290' ' ' LEU . . . -140.59 155.13 46.66 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.094 -0.957 . . . . 6.21 112.187 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' PHE . . . . . 0.414 ' CE1' ' HD1' ' A' ' 262' ' ' PHE . 88.9 m-85 -111.42 146.85 36.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.273 -0.876 . . . . 7.09 110.422 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' CYS . . . . . 0.53 ' HB3' ' HD1' ' A' ' 288' ' ' PHE . 22.1 p -157.75 156.26 31.3 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.994 -0.683 . . . . 6.77 111.903 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -145.41 127.08 15.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.738 -0.664 . . . . 9.59 109.656 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.602 ' O ' ' HE3' ' A' ' 286' ' ' LYS . 54.8 m-85 -82.46 164.9 20.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.081 0.467 . . . . 9.91 112.027 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 53.8 t -71.55 -46.01 65.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.436 -0.95 . . . . 12.81 108.436 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASP . . . . . 0.719 ' O ' HG22 ' A' ' 312' ' ' VAL . 19.7 t70 -96.36 102.32 14.1 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.357 -1.349 . . . . 13.18 107.357 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ILE . . . . . 0.533 ' O ' ' HB ' ' A' ' 313' ' ' THR . 0.2 OUTLIER -52.69 -34.98 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 115.326 1.602 . . . . 12.23 115.326 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -56.82 -38.82 73.13 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.236 1.017 . . . . 13.04 109.022 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 309' ' ' ASP . 2.4 m -62.69 -22.57 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 112.268 -2.242 . . . . 11.08 109.61 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 310' ' ' ILE . 97.8 m -54.66 -48.24 72.59 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.869 -0.789 . . . . 9.11 108.869 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -62.45 -42.82 99.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.3 -0.56 . . . . 10.31 110.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -63.76 -32.46 73.96 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 119.871 -0.732 . . . . 11.98 111.993 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.76 74.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.597 -1.638 . . . . 8.25 113.023 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.65 -51.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.316 0.579 . . . . 7.4 110.859 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.25 67.27 Favored 'General case' 0 C--N 1.419 3.589 0 C-N-CA 126.337 1.855 . . . . 0.0 113.2 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -88.25 -24.05 35.52 Favored Glycine 1 C--N 1.4 4.132 0 N-CA-C 116.815 1.486 . . . . 8.35 116.815 177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 97.0 mt -96.87 -45.68 6.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 120.097 1.949 . . . . 7.2 113.956 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -50.53 129.97 23.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.808 0.337 . . . . 7.86 111.46 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.56 56.96 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.156 -0.545 . . . . 8.64 113.978 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' MET . . . . . . . . . . . . . 18.3 mtt -50.71 147.18 4.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.846 0.323 . . . . 8.0 111.259 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.06 115.57 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.055 0.455 . . . . 10.39 111.712 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 330' ' ' LEU . 3.8 mm? -120.18 106.85 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.146 -1.057 . . . . 8.95 108.146 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . 66.99 -118.64 10.63 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.373 -1.491 . . . . 10.63 109.373 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -115.84 22.4 13.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 12.25 109.752 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -123.83 153.98 40.25 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.609 -0.723 . . . . 9.98 111.617 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -101.79 118.27 36.58 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.083 -1.08 . . . . 10.14 108.083 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 325' ' ' LEU . 21.2 tp -63.0 143.04 58.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.516 0.674 . . . . 7.52 112.649 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LEU . . . . . . . . . . . . . 61.5 tp -128.14 127.94 43.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.597 -1.183 . . . . 7.48 109.014 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.85 124.02 26.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 O-C-N 120.909 -1.119 . . . . 6.45 109.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -152.8 155.31 36.89 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.961 -1.712 . . . . 7.66 109.557 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.49 ' HA ' HD23 ' A' ' 261' ' ' LEU . 66.4 mtt180 -58.54 122.44 13.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 118.424 -1.31 . . . . 8.94 107.577 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -50.92 -11.8 0.1 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.814 1.413 . . . . 7.52 114.814 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' SER . . . . . . . . . . . . . 3.4 m -119.44 -77.59 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.522 -0.471 . . . . 9.07 111.239 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 7.3 p -166.53 134.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.93 0.395 . . . . 0.0 110.873 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -83.35 60.45 4.88 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ALA . . . . . . . . . . . . . . . -65.18 105.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.2 0.524 . . . . 0.0 111.937 -172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.47 90.71 3.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.504 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -107.21 113.4 26.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.177 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.601 179.4 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 601' ' ' ' U' . . . . . 0.939 " O2'" ' NZ ' ' A' ' 300' ' ' LYS . . . . . . . . 0 C2'--C1' 1.507 -2.102 0 O4'-C1'-N19 109.29 1.09 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 602' ' ' ' U' . . . . . 0.417 ' OP2' " O2'" ' B' ' 601' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 O4'-C1'-C2' 107.57 0.836 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 603' ' ' ' U' . . . . . 0.629 " H4'" ' OH ' ' A' ' 302' ' ' TYR . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C4'-C3'-C2' 103.511 0.811 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 604' ' ' ' U' . . . . . 0.84 " H1'" ' NZ ' ' A' ' 225' ' ' LYS . . . . . . . . 1 O3'--C3' 1.501 5.57 0 C4'-C3'-C2' 99.077 -3.623 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 605' ' ' ' U' . . . . . 0.592 ' C2 ' ' HB3' ' A' ' 294' ' ' SER . . . . . . . . 1 P--O3' 1.68 6.051 1 C4'-C3'-C2' 106.717 4.017 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' B' B ' 606' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C1' 1.401 -1.093 0 C4'-C3'-C2' 105.707 3.007 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 607' ' ' ' U' . . . . . 1.207 ' O4 ' ' OD1' ' A' ' 231' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.053 0 O4'-C1'-C2' 107.617 0.869 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 608' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.985 0 C3'-C2'-C1' 100.613 -0.986 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 609' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.518 -0.961 0 C3'-C2'-C1' 100.75 -0.833 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_